data_1xob_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1xob _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.5 mt . . . . . 0 N--CA 1.463 0.178 0 CA-C-O 120.863 0.363 . . . . 0.0 110.45 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.5 mm -88.0 112.67 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 123.324 0.65 . . . . 0.0 109.488 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -83.52 106.43 15.25 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.75 -0.594 . . . . 0.0 109.662 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 43.0 mt -89.15 164.04 15.18 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.799 1.24 . . . . 0.0 111.14 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 35.0 p -136.78 167.16 21.97 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 175.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -58.33 -46.51 86.08 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 177.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -57.26 -46.79 82.71 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.976 0.911 . . . . 0.0 111.322 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.1 p -78.64 -25.63 45.03 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.932 -176.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -43.41 -46.81 6.81 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.59 1.556 . . . . 0.0 113.123 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -49.07 -65.69 0.53 Allowed 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 121.791 0.805 . . . . 0.0 110.48 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -71.37 -44.62 64.65 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.058 -174.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -73.14 -37.36 66.64 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -173.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.8 t -108.99 -60.42 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.058 0 C-N-CA 123.151 0.58 . . . . 0.0 110.706 -176.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 84.0 mt -63.73 -36.38 83.66 Favored 'General case' 0 C--N 1.334 -0.088 0 C-N-CA 120.029 -0.668 . . . . 0.0 112.597 -174.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -99.95 28.03 5.1 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.673 0.669 . . . . 0.0 110.148 176.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -74.84 172.53 12.04 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.959 0.885 . . . . 0.0 112.263 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -141.96 129.63 21.55 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 171.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.4 -172.0 27.21 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -175.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -98.15 120.43 38.54 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.064 1.346 . . . . 0.0 111.206 -177.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.7 mt -118.13 120.22 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 124.863 1.265 . . . . 0.0 109.01 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -93.42 107.77 19.55 Favored 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 176.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.1 t -98.38 109.4 23.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 123.503 0.721 . . . . 0.0 109.415 -178.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -93.59 108.8 20.46 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 123.669 0.788 . . . . 0.0 108.881 176.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -78.78 128.52 33.51 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 25.7 p-90 -145.43 173.7 11.77 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.623 0.769 . . . . 0.0 112.819 -176.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.51 144.37 22.74 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 125.593 1.557 . . . . 0.0 107.81 176.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -47.63 -51.09 22.59 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.533 1.133 . . . . 0.0 112.307 -177.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 62.2 p-90 -65.31 -23.76 67.1 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.819 0.847 . . . . 0.0 112.621 -178.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 35.3 t -79.91 72.83 6.68 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 121.482 -0.761 . . . . 0.0 111.481 -176.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -21.2 -64.17 0.02 OUTLIER Glycine 0 CA--C 1.537 1.462 0 C-N-CA 127.57 2.509 . . . . 0.0 116.043 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -48.55 -29.09 13.24 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 123.419 2.746 . . . . 0.0 114.443 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.8 m -59.26 -44.71 92.39 Favored 'General case' 0 N--CA 1.462 0.154 0 O-C-N 121.508 -0.745 . . . . 0.0 109.558 176.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -66.65 -36.24 82.08 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.562 0.745 . . . . 0.0 109.017 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 26.0 ttt -62.97 -46.34 88.16 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 119.614 -0.232 . . . . 0.0 110.48 177.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 38.3 pt -75.34 -28.02 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-O 118.417 -0.802 . . . . 0.0 112.363 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -37.11 -58.68 1.09 Allowed Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -58.05 -41.42 68.17 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.025 1.817 . . . . 0.0 111.4 177.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.0 mt -57.8 -51.16 73.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.6 mt -55.71 -41.36 73.7 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.108 0.563 . . . . 0.0 110.359 177.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -63.37 -45.95 88.77 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.226 0.921 . . . . 0.0 111.07 176.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -57.18 -50.56 72.46 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 25.8 mm -54.32 -50.18 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 C-N-CA 123.533 0.733 . . . . 0.0 109.303 176.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.16 -48.71 64.79 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 122.096 -0.377 . . . . 0.0 110.268 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -60.37 -55.23 36.13 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 122.448 0.299 . . . . 0.0 110.677 178.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -54.0 -44.96 71.34 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.093 0.957 . . . . 0.0 112.221 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -98.59 29.83 3.52 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.395 1.078 . . . . 0.0 111.943 -177.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -54.24 127.27 26.31 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.363 -0.836 . . . . 0.0 109.901 177.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.52 -13.62 16.02 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 119.234 -0.759 . . . . 0.0 113.188 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -99.61 -39.37 8.33 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 118.567 1.184 . . . . 0.0 109.994 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.9 tp -137.67 129.7 28.92 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 123.134 0.574 . . . . 0.0 110.272 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.8 m -89.83 101.57 14.27 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 175.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 91.8 t -79.83 130.19 36.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.81 154.43 51.2 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 123.673 0.789 . . . . 0.0 111.134 -177.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -127.49 143.78 51.15 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.306 1.442 . . . . 0.0 107.418 177.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.5 tt -132.32 115.01 15.08 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -80.23 104.35 10.73 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 122.38 0.272 . . . . 0.0 110.656 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.0 pt -70.23 -28.72 36.67 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.28 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -57.21 -45.95 83.33 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 119.103 0.865 . . . . 0.0 108.844 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.49 -38.41 59.53 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.221 0.608 . . . . 0.0 109.943 177.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -117.15 67.36 4.48 Favored Pre-proline 0 CA--C 1.534 0.335 0 C-N-CA 124.252 1.021 . . . . 0.0 112.173 -175.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -58.47 -47.8 17.88 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.476 2.117 . . . . 0.0 112.465 -176.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -40.49 -34.95 0.74 Allowed Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.863 1.696 . . . . 0.0 115.237 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 75.2 p -61.4 -38.72 88.09 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 117.795 0.798 . . . . 0.0 111.643 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . 0.284 . . -56.95 -62.76 4.52 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-O 118.071 -0.966 . . . . 0.0 111.571 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -49.07 -50.75 12.03 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.822 2.348 . . . . 0.0 111.525 173.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -51.88 -41.26 61.75 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -104.15 20.69 17.84 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 118.286 0.494 . . . . 0.0 111.75 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 44.79 42.03 7.51 Favored Glycine 0 C--N 1.341 0.844 0 C-N-CA 124.245 0.926 . . . . 0.0 111.624 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.7 mm -57.97 122.66 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-O 121.156 0.503 . . . . 0.0 110.091 -177.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 50.8 mmt-85 -79.7 -40.02 29.93 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.663 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -179.76 146.32 6.95 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 108.335 -1.906 . . . . 0.0 108.335 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.2 pt -93.67 153.43 41.16 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 123.876 0.87 . . . . 0.0 110.769 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.25 139.64 51.1 Favored 'Cis proline' 0 N--CA 1.458 -0.61 0 CA-C-N 119.614 0.898 . . . . 0.0 110.96 -1.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.8 112.98 16.01 Favored 'General case' 0 CA--C 1.523 -0.077 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.2 mt -94.81 122.05 37.03 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -114.61 117.97 32.37 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 177.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.5 tp -94.93 97.85 10.29 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -89.98 110.56 21.53 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.187 1.395 . . . . 0.0 111.288 -177.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -96.68 114.23 25.85 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 171.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.9 m120 47.24 48.66 15.97 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.011 0.524 . . . . 0.0 111.518 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 76.72 -6.8 37.42 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 118.737 -1.035 . . . . 0.0 115.083 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -102.03 126.32 48.94 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 119.575 1.687 . . . . 0.0 109.541 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 92.4 t -66.18 108.55 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.35 -41.07 28.69 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.947 0.899 . . . . 0.0 109.372 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -157.65 171.86 19.57 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.2 t -152.76 164.0 38.63 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -145.04 126.89 15.37 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.467 1.507 . . . . 0.0 107.398 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.2 t -101.58 122.89 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 174.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.49 175.54 32.67 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 -178.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.5 174.25 9.23 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.619 0.767 . . . . 0.0 111.733 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.1 mt -147.04 156.01 42.68 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.708 1.603 . . . . 0.0 107.962 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.9 p -87.09 154.8 20.46 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.357 -1.719 . . . . 0.0 106.357 171.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -49.58 -51.83 34.39 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 122.089 -0.382 . . . . 0.0 111.654 -177.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.05 -58.12 13.96 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -56.1 -41.29 75.0 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 122.411 -0.464 . . . . 0.0 110.927 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 37.2 tp -62.42 -49.37 75.76 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -55.24 -47.1 75.88 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.474 0.579 . . . . 0.0 110.356 177.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -57.11 -53.93 52.56 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.124 0.57 . . . . 0.0 110.397 178.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -52.65 -52.34 56.08 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.899 1.28 . . . . 0.0 110.857 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 76.0 mt -62.51 -50.87 69.66 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 122.176 -0.327 . . . . 0.0 110.305 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -53.57 -48.98 68.67 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.358 0.663 . . . . 0.0 110.771 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.56 -34.51 67.19 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.792 0.837 . . . . 0.0 111.607 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -78.94 -48.06 15.25 Favored 'General case' 0 C--O 1.228 -0.07 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 45.0 mt -58.39 -45.34 88.52 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.415 0.686 . . . . 0.0 110.827 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.172 0 C-N-CA 124.847 1.259 . . . . 0.0 111.711 179.135 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 15.7 mt . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.1 mm -87.4 104.76 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 177.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -79.44 80.6 5.8 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 177.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 77.6 mt -63.88 163.41 11.98 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.049 0.94 . . . . 0.0 113.208 -175.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 47.4 p -138.31 165.8 25.83 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 126.08 1.752 . . . . 0.0 106.506 174.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -55.23 -47.34 75.51 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.476 0.71 . . . . 0.0 110.932 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -63.72 -38.73 92.21 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.0 p -77.98 -32.5 51.35 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.03 0.377 . . . . 0.0 110.482 -177.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -36.61 -48.78 0.72 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.273 1.829 . . . . 0.0 113.364 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -49.36 -65.37 0.58 Allowed 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 121.961 0.886 . . . . 0.0 111.163 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.3 m -72.29 -45.21 61.0 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.569 -174.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -76.2 -21.83 55.99 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -174.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 45.9 t -120.77 -62.86 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.094 0 CA-C-N 119.548 1.067 . . . . 0.0 109.947 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 72.1 mt -58.81 -37.32 76.11 Favored 'General case' 0 CA--C 1.528 0.098 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -174.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -95.72 14.42 23.21 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 118.587 0.63 . . . . 0.0 111.924 177.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.38 103.36 16.01 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 119.073 0.852 . . . . 0.0 112.367 -178.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -76.31 72.67 3.08 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 174.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -174.63 179.39 45.97 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.95 118.76 32.34 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.489 1.516 . . . . 0.0 109.987 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.6 mt -127.57 115.97 41.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 124.796 1.239 . . . . 0.0 110.73 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 35.0 tp -83.53 96.41 8.6 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 174.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.4 t -86.51 105.85 15.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 122.999 0.519 . . . . 0.0 109.872 -179.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -91.35 112.42 24.33 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 176.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -85.05 120.82 26.99 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 173.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 21.9 p-90 -138.88 177.66 7.73 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.983 0.913 . . . . 0.0 112.351 -174.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -150.94 150.16 30.5 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.472 1.509 . . . . 0.0 107.716 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -62.84 -50.3 71.51 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.852 0.358 . . . . 0.0 111.308 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 63.9 p-90 -62.25 -26.25 68.28 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.489 0.716 . . . . 0.0 112.743 -178.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.6 t -79.16 77.68 5.65 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 121.554 -0.716 . . . . 0.0 109.829 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -22.15 -63.12 0.03 OUTLIER Glycine 0 CA--C 1.534 1.276 0 C-N-CA 127.661 2.553 . . . . 0.0 115.198 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -42.58 -36.0 4.4 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 124.503 3.469 . . . . 0.0 114.525 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 80.5 m -53.92 -46.06 71.36 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 121.508 0.67 . . . . 0.0 109.956 176.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.91 -24.47 63.38 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.348 0.659 . . . . 0.0 110.967 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 23.1 mmt -74.2 -43.92 55.33 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 30.4 pt -75.2 -27.23 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 118.905 -0.569 . . . . 0.0 111.694 177.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -36.6 -60.06 0.8 Allowed Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -56.89 -40.6 83.0 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.224 1.949 . . . . 0.0 111.918 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.0 mt -58.79 -50.72 78.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.7 mt -56.12 -43.77 78.5 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.592 0.357 . . . . 0.0 110.201 177.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -58.5 -49.59 76.82 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.255 0.55 . . . . 0.0 109.794 178.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -56.13 -52.07 65.68 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 31.7 mm -54.04 -50.01 56.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 123.066 0.547 . . . . 0.0 109.869 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.24 -46.47 65.73 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.219 0.608 . . . . 0.0 110.603 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -66.13 -56.91 9.1 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 178.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -47.25 -49.89 22.47 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.711 1.204 . . . . 0.0 112.329 -178.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -99.69 26.19 6.45 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.149 0.58 . . . . 0.0 111.705 -178.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.54 111.85 0.99 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.253 0.933 . . . . 0.0 111.022 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.35 -15.84 61.61 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.01 0.814 . . . . 0.0 112.243 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -99.52 -39.17 8.46 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.943 1.297 . . . . 0.0 109.158 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 46.9 tp -140.2 130.64 25.39 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 178.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 91.0 m -91.09 145.92 24.28 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 105.836 -1.912 . . . . 0.0 105.836 174.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 94.9 t -120.54 141.28 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 177.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.86 148.82 50.22 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.127 0.571 . . . . 0.0 109.889 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -127.33 96.57 4.61 Favored 'General case' 0 C--O 1.23 0.066 0 C-N-CA 124.906 1.283 . . . . 0.0 108.91 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 tt -96.7 109.4 22.05 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -176.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -80.45 108.61 14.22 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.934 -178.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.7 pt -64.46 -25.31 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-O 119.1 -0.476 . . . . 0.0 111.644 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -53.65 -25.72 19.19 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.825 0.739 . . . . 0.0 111.966 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -119.01 3.03 11.52 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.015 0.926 . . . . 0.0 110.89 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -147.23 62.75 7.5 Favored Pre-proline 0 CA--C 1.529 0.137 0 C-N-CA 124.614 1.166 . . . . 0.0 109.523 -177.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -61.82 -52.07 3.31 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 121.776 1.651 . . . . 0.0 111.285 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -40.83 -43.11 3.05 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.529 1.538 . . . . 0.0 114.918 -177.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.31 -31.12 67.22 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 117.808 0.804 . . . . 0.0 111.788 -178.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.36 -67.24 0.92 Allowed Pre-proline 0 CA--C 1.539 0.529 0 CA-C-O 118.276 -0.869 . . . . 0.0 112.619 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -60.0 -38.47 78.05 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 121.72 1.613 . . . . 0.0 110.882 178.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -52.25 -38.56 58.5 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 118.874 0.761 . . . . 0.0 111.484 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -106.67 19.77 20.0 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.657 0.383 . . . . 0.0 111.999 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.23 38.05 55.97 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.111 0.862 . . . . 0.0 113.528 176.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.38 129.23 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -89.79 -48.84 6.99 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.45 1.1 . . . . 0.0 110.095 -178.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -162.14 146.5 12.09 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 107.285 -2.326 . . . . 0.0 107.285 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.3 pt -98.55 149.14 35.44 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 123.461 0.704 . . . . 0.0 110.048 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.17 139.47 53.05 Favored 'Cis proline' 0 N--CA 1.455 -0.772 0 CA-C-N 119.873 0.99 . . . . 0.0 111.094 -0.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.77 139.49 52.23 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 176.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.6 mt -118.46 106.07 12.32 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.0 mp -100.16 113.23 25.73 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 176.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.9 tp -90.23 101.8 14.52 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -86.53 143.2 27.83 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.556 1.143 . . . . 0.0 109.166 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -140.96 110.42 6.33 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 175.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.1 t30 55.73 67.93 0.94 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 121.438 0.637 . . . . 0.0 110.337 -177.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.31 -31.76 0.26 Allowed Glycine 0 CA--C 1.533 1.187 0 N-CA-C 117.04 1.576 . . . . 0.0 117.04 176.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -97.71 155.03 17.2 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 119.5 1.65 . . . . 0.0 111.224 -177.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 93.3 t -76.19 118.31 22.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.93 -47.13 15.53 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 123.662 0.785 . . . . 0.0 109.177 177.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -156.77 171.9 19.57 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 123.944 0.898 . . . . 0.0 108.689 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 90.8 m -149.96 148.86 29.59 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 122.01 -0.431 . . . . 0.0 110.111 -178.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -130.59 151.14 51.38 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 126.314 1.846 . . . . 0.0 107.62 177.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.2 t -129.96 131.64 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -178.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.95 -178.58 45.2 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 111.439 -0.665 . . . . 0.0 111.439 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.75 165.72 24.28 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.836 0.454 . . . . 0.0 110.894 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.5 mt -145.05 151.41 38.5 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.662 1.185 . . . . 0.0 108.533 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.4 p -84.52 149.42 25.93 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 172.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -51.71 -45.04 63.42 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-O 119.481 -0.295 . . . . 0.0 111.648 -177.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.92 -55.34 29.58 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 118.343 0.52 . . . . 0.0 111.844 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -56.81 -47.67 79.73 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 122.048 -0.678 . . . . 0.0 110.077 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 48.4 tp -56.77 -51.59 68.3 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 119.539 -0.267 . . . . 0.0 110.489 178.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.1 mmmp? -51.93 -49.45 63.08 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.279 0.631 . . . . 0.0 110.336 177.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -58.87 -50.37 74.27 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 110.558 -0.164 . . . . 0.0 110.558 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -53.9 -53.01 58.58 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.546 0.739 . . . . 0.0 110.865 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.8 mt -59.97 -49.95 75.68 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 122.726 0.41 . . . . 0.0 110.377 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -54.74 -50.73 67.66 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 117.844 0.293 . . . . 0.0 110.353 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.75 -36.92 70.32 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.577 0.751 . . . . 0.0 111.696 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -77.7 -42.98 32.55 Favored 'General case' 0 C--O 1.227 -0.082 0 O-C-N 122.205 -0.309 . . . . 0.0 110.367 -178.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 47.3 mt -61.75 -47.37 85.52 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.29 0 C-N-CA 123.208 0.603 . . . . 0.0 109.644 177.518 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.2 mt . . . . . 0 N--CA 1.45 -0.475 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.5 mm -90.97 111.41 23.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 124.419 1.088 . . . . 0.0 109.387 178.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -82.37 101.44 10.6 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 67.1 mt -85.09 162.9 19.11 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.697 0.799 . . . . 0.0 111.849 -177.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 48.0 p -137.64 165.67 25.79 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 126.042 1.737 . . . . 0.0 106.406 175.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -56.58 -44.02 80.63 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.853 -0.529 . . . . 0.0 110.216 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -59.28 -44.16 92.49 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.025 0.93 . . . . 0.0 112.192 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.1 p -78.79 -30.94 45.79 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 122.107 -0.371 . . . . 0.0 111.003 -177.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -36.36 -56.48 0.78 Allowed 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 126.37 1.868 . . . . 0.0 114.092 -178.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -54.29 -57.59 10.64 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 121.822 -0.549 . . . . 0.0 110.953 -177.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.3 m -62.02 -47.62 83.97 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.708 0.803 . . . . 0.0 112.446 -177.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.16 -50.68 13.92 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -175.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.4 t -90.97 -57.05 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 124.048 0.939 . . . . 0.0 112.533 -173.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 72.2 mt -66.76 -41.06 88.38 Favored 'General case' 0 CA--C 1.523 -0.074 0 C-N-CA 119.564 -0.854 . . . . 0.0 110.918 -174.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -93.0 30.67 1.56 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 122.64 0.376 . . . . 0.0 110.041 176.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.0 156.66 36.82 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.766 -0.584 . . . . 0.0 110.826 177.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -131.69 55.18 1.88 Allowed 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 124.699 1.2 . . . . 0.0 108.109 176.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 164.5 -173.01 40.41 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.506 -1.037 . . . . 0.0 110.506 -178.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.95 113.65 23.81 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.543 1.537 . . . . 0.0 109.947 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.5 mt -113.52 117.46 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 124.258 1.023 . . . . 0.0 109.479 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.7 tp -89.72 96.32 10.64 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 177.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.7 t -89.32 109.35 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 123.427 0.691 . . . . 0.0 109.629 -179.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -93.58 105.36 17.41 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -79.18 123.95 27.88 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 175.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 24.5 p-90 -138.93 172.69 12.49 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 124.292 1.037 . . . . 0.0 111.943 -175.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.99 147.79 32.05 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.297 1.039 . . . . 0.0 108.651 175.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -54.61 -52.23 62.84 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.904 0.882 . . . . 0.0 111.78 -178.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 61.4 p-90 -67.25 -21.58 65.71 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.958 0.903 . . . . 0.0 112.747 -178.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 46.0 t -79.58 70.0 5.98 Favored 'General case' 0 N--CA 1.456 -0.144 0 O-C-N 121.38 -0.825 . . . . 0.0 110.935 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -16.14 -65.59 0.01 OUTLIER Glycine 0 CA--C 1.534 1.266 0 C-N-CA 128.253 2.835 . . . . 0.0 115.903 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -42.95 -32.38 2.65 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 124.532 3.488 . . . . 0.0 115.036 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 99.6 m -53.9 -44.73 70.76 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.221 0.608 . . . . 0.0 110.121 176.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -67.33 -26.6 66.58 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.323 0.649 . . . . 0.0 111.13 178.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 23.3 mmt -74.54 -43.68 54.64 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 19.6 pt -74.95 -28.95 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 119.006 -0.521 . . . . 0.0 111.922 178.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -38.67 -59.45 1.34 Allowed Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -56.6 -40.08 86.91 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.158 1.905 . . . . 0.0 111.441 177.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 16.3 mt -58.85 -48.82 85.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 74.7 mt -57.25 -43.67 83.16 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 119.415 -0.326 . . . . 0.0 110.352 177.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -60.02 -48.09 83.13 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.839 0.745 . . . . 0.0 110.446 177.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -57.01 -52.16 66.38 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.2 mm -55.44 -45.06 78.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 124.102 0.961 . . . . 0.0 110.017 178.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.51 -41.71 73.47 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 123.048 0.539 . . . . 0.0 110.05 178.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -67.67 -55.13 14.44 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 176.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -48.06 -48.99 33.02 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.903 0.881 . . . . 0.0 112.068 -178.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -103.2 28.87 5.95 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.654 0.782 . . . . 0.0 111.594 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -55.37 126.53 25.43 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.152 0.887 . . . . 0.0 111.212 -178.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.36 -13.13 29.16 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 119.237 -0.757 . . . . 0.0 113.21 -178.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -99.8 -43.93 6.26 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.455 1.127 . . . . 0.0 109.357 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.9 tp -125.4 125.5 43.5 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.755 1.222 . . . . 0.0 108.025 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 60.4 m -87.59 101.84 14.02 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 176.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.6 t -79.39 131.74 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.66 151.65 48.49 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 122.635 0.374 . . . . 0.0 110.096 -178.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -128.69 135.43 49.24 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 tt -124.54 113.62 18.33 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.645 0.778 . . . . 0.0 109.223 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -79.39 108.89 13.25 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.1 pt -70.74 -22.59 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -58.16 -48.47 80.17 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.221 0.919 . . . . 0.0 109.092 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -79.88 -31.76 40.34 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.914 0.885 . . . . 0.0 110.367 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -119.26 67.11 8.97 Favored Pre-proline 0 N--CA 1.463 0.219 0 C-N-CA 123.482 0.713 . . . . 0.0 112.082 -176.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.1 -47.04 8.94 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 121.877 1.718 . . . . 0.0 110.966 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -41.2 -41.0 2.7 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.756 1.646 . . . . 0.0 115.038 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.77 -27.08 68.65 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.158 0.979 . . . . 0.0 112.639 -178.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.8 -63.0 4.63 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 118.347 -0.835 . . . . 0.0 113.053 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -60.56 -37.03 83.27 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.151 1.901 . . . . 0.0 111.464 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -51.99 -31.43 29.35 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.813 0.733 . . . . 0.0 112.003 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -118.56 19.34 13.31 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.25 0.62 . . . . 0.0 111.658 177.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 47.35 43.59 19.9 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.46 1.029 . . . . 0.0 113.308 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.6 mp -53.49 117.66 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 117.908 0.854 . . . . 0.0 109.181 177.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 29.3 mmm180 -79.8 -45.48 18.7 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.238 1.015 . . . . 0.0 110.807 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -164.17 147.25 12.5 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 107.819 -2.112 . . . . 0.0 107.819 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.6 pt -100.27 152.82 37.94 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 123.913 0.885 . . . . 0.0 110.101 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -68.66 142.18 66.06 Favored 'Cis proline' 0 N--CA 1.456 -0.697 0 CA-C-N 119.519 0.864 . . . . 0.0 110.454 -1.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.37 109.82 15.35 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.3 mt -89.53 93.08 9.36 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.925 0.89 . . . . 0.0 109.781 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.2 mp -91.28 115.84 28.35 Favored 'General case' 0 CA--C 1.522 -0.105 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.3 tp -92.6 96.0 9.94 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -87.51 104.5 16.53 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.026 1.33 . . . . 0.0 110.226 -178.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -93.42 108.48 20.14 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 174.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 49.95 50.48 18.4 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.707 0.803 . . . . 0.0 110.626 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 79.75 -14.19 20.12 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 118.879 -0.956 . . . . 0.0 114.565 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -94.82 121.34 36.31 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 119.591 1.695 . . . . 0.0 110.141 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 98.3 t -64.15 104.86 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 175.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.31 -38.03 36.26 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.862 0.865 . . . . 0.0 109.813 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -155.44 166.17 34.37 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.71 0.804 . . . . 0.0 108.899 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 69.7 m -147.79 117.96 7.31 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.629 0.772 . . . . 0.0 108.986 -178.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -104.74 112.5 25.63 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.2 t -90.32 124.15 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 177.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.65 168.44 36.79 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 123.804 0.716 . . . . 0.0 112.249 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.62 166.23 19.49 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.082 0.553 . . . . 0.0 110.244 179.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -155.63 170.69 21.43 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.695 0.798 . . . . 0.0 109.863 -177.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 80.9 p -86.18 162.81 18.16 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 177.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.01 -39.01 80.57 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 175.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -57.06 -56.36 25.44 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 177.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -54.22 -46.56 72.54 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.942 0.371 . . . . 0.0 110.225 178.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 22.8 tp -59.06 -50.25 74.79 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 121.283 -0.167 . . . . 0.0 110.765 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.9 mmmm -54.53 -48.84 71.5 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.723 -0.611 . . . . 0.0 111.338 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -65.95 -43.5 87.78 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 119.584 -0.846 . . . . 0.0 111.022 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -53.24 -52.24 59.59 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.158 0.583 . . . . 0.0 109.497 177.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.8 mt -58.73 -55.19 38.27 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 122.743 0.417 . . . . 0.0 110.3 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -51.24 -50.53 59.02 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.04 0.382 . . . . 0.0 111.13 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.14 -38.45 70.84 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.397 0.679 . . . . 0.0 111.807 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -78.5 -43.48 26.83 Favored 'General case' 0 C--O 1.228 -0.048 0 O-C-N 122.199 -0.313 . . . . 0.0 111.049 -178.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 69.5 mt -63.58 -45.63 89.53 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.2 0 C-N-CA 122.909 0.483 . . . . 0.0 109.832 177.745 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 16.6 mt . . . . . 0 N--CA 1.455 -0.2 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.2 mm -90.31 114.43 27.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.433 1.093 . . . . 0.0 109.297 177.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -84.54 104.82 14.86 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.3 mt -87.84 163.79 16.23 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.598 1.159 . . . . 0.0 111.679 -178.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 61.3 p -138.48 165.19 27.46 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 126.257 1.823 . . . . 0.0 106.385 174.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -55.13 -44.69 75.28 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.128 0.571 . . . . 0.0 110.104 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -59.82 -43.83 94.32 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.867 0.867 . . . . 0.0 112.383 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.8 p -78.75 -30.47 45.75 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 122.152 -0.342 . . . . 0.0 111.22 -177.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -36.76 -54.77 0.9 Allowed 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 126.407 1.883 . . . . 0.0 114.017 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -54.07 -57.66 10.23 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.265 0.555 . . . . 0.0 111.132 -178.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.4 m -63.79 -48.07 78.37 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.385 0.674 . . . . 0.0 112.059 -177.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.59 -52.26 12.27 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -175.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.7 t -89.63 -56.22 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 123.891 0.876 . . . . 0.0 112.203 -174.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 66.6 mt -66.15 -42.7 88.7 Favored 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 119.489 -0.884 . . . . 0.0 111.168 -175.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -91.98 31.72 1.22 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 118.045 0.384 . . . . 0.0 110.18 175.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.68 143.67 57.14 Favored 'General case' 0 C--N 1.341 0.208 0 O-C-N 121.538 -0.726 . . . . 0.0 112.172 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -108.7 54.33 0.66 Allowed 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.495 1.118 . . . . 0.0 108.769 176.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 150.46 -160.47 28.58 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 123.759 0.695 . . . . 0.0 111.566 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.51 122.45 34.1 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 126.103 1.761 . . . . 0.0 110.356 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.5 mt -122.62 122.39 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 124.732 1.213 . . . . 0.0 109.18 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -93.47 106.87 18.8 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 42.6 t -97.46 110.33 25.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -92.15 103.58 16.05 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 176.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -78.92 118.05 20.57 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 104.046 -2.576 . . . . 0.0 104.046 175.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 34.5 p-90 -130.66 168.71 16.69 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 124.545 1.138 . . . . 0.0 111.933 -175.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -141.49 143.05 33.61 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.087 1.355 . . . . 0.0 108.304 176.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -58.3 -49.13 78.24 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.261 1.024 . . . . 0.0 112.171 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 50.9 p-90 -63.96 -28.11 69.6 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.519 0.728 . . . . 0.0 112.358 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.6 t -79.59 79.18 6.09 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 121.556 -0.715 . . . . 0.0 110.643 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -24.17 -62.88 0.05 OUTLIER Glycine 0 CA--C 1.535 1.324 0 C-N-CA 127.074 2.273 . . . . 0.0 114.44 178.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -40.46 -33.71 1.0 Allowed 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 125.035 3.823 . . . . 0.0 115.503 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 99.8 m -53.67 -43.04 68.54 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.589 0.709 . . . . 0.0 109.995 177.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -69.05 -26.89 65.19 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.411 1.084 . . . . 0.0 110.973 178.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -75.58 -43.15 49.78 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 33.7 pt -72.79 -29.85 31.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.607 177.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -37.81 -60.46 0.94 Allowed Pre-proline 0 CA--C 1.545 0.769 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -56.32 -39.35 91.88 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.363 2.042 . . . . 0.0 111.938 177.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 21.0 mt -59.61 -52.69 57.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 177.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 60.8 mt -55.12 -40.58 70.66 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.961 0.504 . . . . 0.0 110.363 177.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -61.26 -47.8 84.38 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.243 0.928 . . . . 0.0 110.023 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -56.8 -52.35 65.4 Favored 'General case' 0 C--N 1.34 0.18 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.0 mm -53.28 -49.08 54.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 123.37 0.668 . . . . 0.0 109.538 177.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.47 -43.4 68.13 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.506 0.722 . . . . 0.0 110.76 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -69.31 -55.66 9.79 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.71 0.29 . . . . 0.0 110.638 177.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -50.53 -47.66 57.43 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.57 1.148 . . . . 0.0 112.322 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -99.81 24.36 8.5 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.264 1.026 . . . . 0.0 110.795 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -55.39 124.18 16.3 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.516 -0.74 . . . . 0.0 110.122 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.34 -14.24 46.57 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 119.454 -0.637 . . . . 0.0 112.907 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -99.74 -42.27 6.92 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.371 1.069 . . . . 0.0 109.3 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.1 tp -133.01 125.35 29.5 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.726 1.211 . . . . 0.0 108.168 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 56.2 m -85.41 101.84 12.94 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 176.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 85.1 t -79.31 133.62 29.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -138.16 154.04 49.18 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.126 0.57 . . . . 0.0 110.417 -177.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -126.44 137.38 53.4 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.6 tt -127.28 115.15 18.59 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -78.66 104.54 9.34 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 pp -68.54 -29.11 42.82 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.19 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -56.86 -45.18 82.62 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 118.437 0.562 . . . . 0.0 109.752 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -81.48 -31.43 32.94 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.929 0.892 . . . . 0.0 110.395 177.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -119.83 68.91 12.51 Favored Pre-proline 0 C--O 1.235 0.326 0 C-N-CA 123.663 0.785 . . . . 0.0 111.557 -177.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -61.39 -52.64 3.03 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.463 2.109 . . . . 0.0 112.586 -177.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -38.28 -45.43 1.79 Allowed Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.538 1.542 . . . . 0.0 114.556 -177.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.45 -33.91 46.45 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.89 0.876 . . . . 0.0 112.964 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.55 -67.67 0.89 Allowed Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 118.136 -0.935 . . . . 0.0 112.184 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -59.42 -37.18 91.38 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.77 1.646 . . . . 0.0 111.218 177.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -51.35 -38.38 52.89 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.291 0.951 . . . . 0.0 111.778 178.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -110.83 22.53 15.25 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.895 0.478 . . . . 0.0 111.574 178.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 42.9 43.06 5.23 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 126.085 1.802 . . . . 0.0 112.976 178.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.3 mp -43.95 131.98 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 123.69 0.796 . . . . 0.0 112.137 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.15 -51.7 9.84 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.472 1.109 . . . . 0.0 109.218 -177.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -179.53 135.16 2.44 Favored Glycine 0 C--N 1.333 0.409 0 N-CA-C 107.228 -2.349 . . . . 0.0 107.228 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.0 pp -79.98 145.37 61.18 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 117.251 0.525 . . . . 0.0 111.511 -176.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.81 135.1 32.25 Favored 'Cis proline' 0 N--CA 1.456 -0.69 0 CA-C-N 119.744 0.944 . . . . 0.0 111.512 -0.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.5 m -123.23 117.51 25.48 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.6 mt -95.64 122.25 38.21 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -114.17 119.58 37.57 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 177.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.15 98.24 10.49 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -90.26 107.67 19.29 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.374 1.47 . . . . 0.0 110.786 -178.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -96.66 108.63 21.28 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 173.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 35.8 m120 48.43 51.59 14.99 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.75 0.82 . . . . 0.0 111.339 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.51 -13.97 14.51 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 118.851 -0.972 . . . . 0.0 114.64 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -94.71 122.59 37.48 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 119.563 1.682 . . . . 0.0 109.557 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 98.9 t -65.53 108.95 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 175.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.93 -39.52 34.5 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -163.16 173.9 12.85 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.5 t -149.73 159.39 44.39 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.7 mmtp -138.79 151.9 47.45 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.534 1.934 . . . . 0.0 107.271 177.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.9 t -129.08 135.22 62.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 124.722 1.209 . . . . 0.0 107.906 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.47 -171.12 51.23 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 112.077 -0.409 . . . . 0.0 112.077 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.63 163.31 27.86 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.051 0.541 . . . . 0.0 111.357 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.7 mt -146.25 154.62 41.92 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.303 1.441 . . . . 0.0 107.823 178.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.1 p -84.98 150.83 24.64 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 172.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -48.95 -49.32 40.93 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.063 0.545 . . . . 0.0 110.768 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.35 -59.13 10.55 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 112.108 -0.397 . . . . 0.0 112.108 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -55.32 -45.15 76.34 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 117.527 0.664 . . . . 0.0 111.077 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.2 tp -59.51 -50.21 74.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 177.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -55.33 -46.35 76.36 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.613 0.642 . . . . 0.0 111.222 177.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -57.11 -52.55 64.83 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.111 0.565 . . . . 0.0 109.769 178.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -53.81 -53.79 47.45 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.053 0.941 . . . . 0.0 110.781 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 88.3 mt -59.2 -49.76 76.63 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.256 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -54.71 -50.52 68.11 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 122.807 0.443 . . . . 0.0 110.489 178.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.3 -36.18 68.37 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.518 0.727 . . . . 0.0 111.651 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -78.04 -44.15 27.27 Favored 'General case' 0 N--CA 1.46 0.068 0 O-C-N 122.157 -0.339 . . . . 0.0 110.162 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 40.4 mt -59.51 -45.73 90.89 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.2 0 C-N-CA 123.183 0.593 . . . . 0.0 109.812 177.727 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 13.4 mt . . . . . 0 N--CA 1.452 -0.331 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 25.7 mm -91.36 116.72 33.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 177.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -82.92 113.29 20.42 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.3 mt -96.18 164.0 12.86 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.896 0.878 . . . . 0.0 112.148 -177.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 32.4 p -135.81 166.34 23.52 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 171.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -59.13 -47.8 83.96 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.446 0.566 . . . . 0.0 109.556 178.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -60.9 -44.56 96.97 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.663 0.785 . . . . 0.0 111.535 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 82.5 p -79.21 -24.41 43.15 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -176.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -34.21 -59.68 0.43 Allowed 'General case' 0 C--N 1.339 0.124 0 C-N-CA 126.598 1.959 . . . . 0.0 113.836 -178.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -51.69 -59.23 4.52 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.288 0.635 . . . . 0.0 110.82 -177.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 m -60.09 -43.69 95.36 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 123.248 0.619 . . . . 0.0 111.732 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -72.69 -36.7 67.92 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -174.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.4 t -112.88 -60.3 2.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 123.807 0.843 . . . . 0.0 111.205 -173.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.5 mt -61.37 -35.9 78.74 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-O 119.257 -0.402 . . . . 0.0 111.736 -175.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -92.22 10.47 29.4 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.368 0.531 . . . . 0.0 112.071 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.67 103.39 15.07 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 119.081 0.855 . . . . 0.0 109.965 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -74.31 65.38 1.2 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.524 0.73 . . . . 0.0 110.592 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -166.01 177.84 40.92 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.03 107.19 18.32 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.994 1.318 . . . . 0.0 111.059 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 mt -113.42 114.14 46.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 124.523 1.129 . . . . 0.0 110.78 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.4 tp -84.05 98.94 10.13 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 107.005 -1.479 . . . . 0.0 107.005 174.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.0 t -87.58 118.74 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 123.125 0.57 . . . . 0.0 109.54 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -102.63 108.19 19.37 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.52 1.128 . . . . 0.0 108.951 177.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -81.29 119.18 23.32 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 175.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 37.4 p-90 -135.28 171.97 13.68 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 124.154 0.981 . . . . 0.0 113.196 -174.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.11 132.05 17.15 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 125.736 1.614 . . . . 0.0 108.036 175.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.3 pm0 -49.42 -39.29 32.22 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -178.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 61.4 p-90 -77.26 -19.95 55.83 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 43.8 t -79.53 76.21 6.15 Favored 'General case' 0 N--CA 1.456 -0.162 0 O-C-N 121.409 -0.807 . . . . 0.0 110.411 -176.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -12.58 -69.75 0.01 OUTLIER Glycine 0 CA--C 1.536 1.39 0 C-N-CA 127.752 2.596 . . . . 0.0 115.565 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -41.63 -38.78 4.43 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 124.683 3.588 . . . . 0.0 114.766 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 87.7 m -50.86 -47.37 60.36 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.331 1.052 . . . . 0.0 110.584 177.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt -70.57 -28.67 65.06 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.582 0.753 . . . . 0.0 110.621 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 84.7 mmm -71.45 -43.29 66.96 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 177.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.3 pt -76.82 -27.91 16.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 CA-C-O 118.536 -0.745 . . . . 0.0 112.102 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -38.07 -59.21 1.25 Allowed Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -56.92 -41.15 78.4 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.208 1.939 . . . . 0.0 111.911 177.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 27.6 mt -58.27 -52.04 63.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 68.6 mt -56.68 -44.04 81.07 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.432 0.693 . . . . 0.0 110.494 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -58.43 -48.46 80.63 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.737 0.415 . . . . 0.0 110.281 178.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -60.7 -52.25 65.9 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.9 mm -50.79 -47.14 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.267 1.027 . . . . 0.0 110.402 177.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.48 -37.35 65.15 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.323 0.649 . . . . 0.0 110.848 178.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -75.04 -55.44 5.74 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 176.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -45.56 -51.4 11.99 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 125.37 1.468 . . . . 0.0 112.28 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -101.26 23.11 11.4 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.96 0.504 . . . . 0.0 111.637 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -55.35 130.26 41.76 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 119.455 1.025 . . . . 0.0 110.643 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.75 -19.68 23.56 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 119.466 -0.63 . . . . 0.0 112.625 -178.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -99.4 -41.24 7.5 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.261 1.024 . . . . 0.0 108.829 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.0 tp -133.29 143.88 49.34 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.243 1.817 . . . . 0.0 107.217 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 94.5 m -107.16 140.27 40.28 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 105.314 -2.106 . . . . 0.0 105.314 173.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.1 t -112.82 140.51 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 178.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.38 149.41 46.95 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -178.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -126.26 131.43 51.91 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.261 1.024 . . . . 0.0 108.255 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 tt -122.79 116.24 23.37 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.739 0.816 . . . . 0.0 109.653 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -80.06 107.62 12.99 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 pp -66.83 -30.89 51.13 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -177.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -60.08 -49.46 77.56 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 119.03 0.832 . . . . 0.0 109.295 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -69.89 -36.09 75.16 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.006 177.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -121.25 70.78 22.44 Favored Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 123.907 0.883 . . . . 0.0 112.049 -175.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.94 -52.36 2.25 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.543 2.162 . . . . 0.0 112.616 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -39.03 -44.31 1.98 Allowed Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.438 1.494 . . . . 0.0 114.276 -177.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -53.13 -32.92 50.01 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.813 0.845 . . . . 0.0 112.874 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.78 -68.27 0.76 Allowed Pre-proline 0 CA--C 1.538 0.513 0 CA-C-O 118.072 -0.966 . . . . 0.0 111.662 178.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -59.38 -36.86 93.11 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 121.55 1.5 . . . . 0.0 111.45 177.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -51.58 -40.56 60.01 Favored 'General case' 0 C--N 1.345 0.398 0 CA-C-N 119.558 1.072 . . . . 0.0 111.601 178.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -107.7 21.7 17.06 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 122.704 0.402 . . . . 0.0 111.275 178.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 43.88 43.5 6.82 Favored Glycine 0 C--N 1.338 0.684 0 C-N-CA 125.798 1.666 . . . . 0.0 113.034 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.3 mp -49.02 129.5 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 117.975 0.887 . . . . 0.0 110.839 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.73 -53.86 6.7 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.045 0.938 . . . . 0.0 108.924 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -168.87 150.12 15.15 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 107.062 -2.415 . . . . 0.0 107.062 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 23.8 pt -91.47 149.18 39.02 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-N 117.701 0.75 . . . . 0.0 110.373 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -70.88 137.69 47.89 Favored 'Cis proline' 0 N--CA 1.456 -0.684 0 CA-C-N 119.644 0.908 . . . . 0.0 110.416 -1.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.95 116.69 27.43 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 20.8 mt -98.29 120.83 39.37 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.5 mp -121.08 118.91 30.95 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 177.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.3 tp -93.35 96.11 9.74 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -84.97 101.86 12.71 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.665 1.186 . . . . 0.0 110.002 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -93.45 114.53 26.95 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 173.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 55.89 39.31 30.64 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.8 0.84 . . . . 0.0 110.979 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.51 -0.6 75.26 Favored Glycine 0 CA--C 1.532 1.121 0 CA-C-O 118.758 -1.024 . . . . 0.0 113.738 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -108.24 126.68 53.08 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.346 1.573 . . . . 0.0 109.354 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.7 t -63.57 106.36 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.08 -40.82 30.21 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.026 0.931 . . . . 0.0 109.535 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -156.78 169.46 24.69 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.9 t -151.84 159.63 43.81 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -146.75 131.41 17.87 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.6 t -102.36 125.58 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.26 170.92 38.04 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.21 166.1 16.98 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.685 0.794 . . . . 0.0 112.875 -177.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.0 mt -138.93 153.52 48.24 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 126.228 1.811 . . . . 0.0 107.513 177.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.1 p -84.09 155.54 22.61 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.514 -1.662 . . . . 0.0 106.514 171.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -50.31 -51.36 45.93 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 122.126 -0.359 . . . . 0.0 111.084 -178.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -53.64 -58.45 12.28 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 111.913 -0.475 . . . . 0.0 111.913 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -56.2 -42.34 77.01 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 122.232 -0.569 . . . . 0.0 110.856 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 30.9 tp -62.55 -48.49 79.28 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -54.78 -47.84 73.43 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.558 0.617 . . . . 0.0 110.125 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -57.51 -53.84 53.56 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.541 0.737 . . . . 0.0 110.397 178.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -52.19 -50.16 62.43 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.63 1.172 . . . . 0.0 110.174 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 87.2 mt -60.52 -52.29 65.81 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 119.184 -0.436 . . . . 0.0 110.329 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -52.8 -49.4 65.71 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 118.197 0.453 . . . . 0.0 110.459 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.66 -37.5 70.88 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.546 0.738 . . . . 0.0 111.658 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -78.07 -44.24 26.86 Favored 'General case' 0 N--CA 1.462 0.135 0 O-C-N 122.083 -0.385 . . . . 0.0 110.439 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 53.8 mt -59.05 -48.18 82.53 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.276 0 C-N-CA 123.259 0.623 . . . . 0.0 109.607 177.465 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.4 mt . . . . . 0 N--CA 1.449 -0.511 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.8 mm -87.1 106.9 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -82.2 105.67 13.48 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.9 mt -88.24 166.35 14.4 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.854 1.662 . . . . 0.0 112.161 -177.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 44.0 p -137.33 165.72 25.51 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 172.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -59.05 -46.57 87.89 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 118.271 0.487 . . . . 0.0 110.102 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -60.23 -45.36 93.49 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.498 0.719 . . . . 0.0 111.127 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 81.9 p -79.18 -24.24 43.35 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -176.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -37.71 -53.91 1.23 Allowed 'General case' 0 CA--C 1.527 0.073 0 C-N-CA 126.758 2.023 . . . . 0.0 114.359 -178.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -53.19 -60.35 3.4 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.307 0.575 . . . . 0.0 110.637 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.1 m -60.46 -45.54 93.33 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 123.062 0.545 . . . . 0.0 111.601 -178.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -71.63 -36.18 70.65 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -173.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 41.4 t -112.87 -60.92 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 123.619 0.768 . . . . 0.0 110.762 -174.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.4 mt -62.91 -35.51 80.29 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 119.183 -0.437 . . . . 0.0 111.991 -174.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -96.67 15.78 20.83 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.336 0.516 . . . . 0.0 111.765 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -102.87 104.13 14.35 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 118.877 0.762 . . . . 0.0 110.192 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -74.09 65.17 1.1 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.582 0.753 . . . . 0.0 110.995 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -165.84 177.27 41.05 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.56 103.8 14.73 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 125.204 1.402 . . . . 0.0 110.798 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mt -109.98 118.63 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 C-N-CA 123.937 0.895 . . . . 0.0 110.236 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 19.3 tp -89.38 98.06 11.55 Favored 'General case' 0 C--N 1.338 0.068 0 N-CA-C 106.444 -1.688 . . . . 0.0 106.444 175.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.4 t -85.94 110.31 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 123.387 0.675 . . . . 0.0 109.341 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -97.49 108.92 21.74 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.172 0.589 . . . . 0.0 109.679 177.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -81.63 123.25 28.54 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 175.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 37.9 p-90 -136.62 167.43 21.42 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 124.601 1.161 . . . . 0.0 112.122 -177.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -141.39 137.76 32.51 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.976 1.31 . . . . 0.0 107.834 177.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -52.33 -48.23 65.57 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.871 0.868 . . . . 0.0 112.495 -177.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 57.7 p-90 -68.74 -22.42 64.32 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.063 0.545 . . . . 0.0 112.407 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 42.1 t -79.75 77.37 6.39 Favored 'General case' 0 N--CA 1.456 -0.142 0 O-C-N 121.402 -0.811 . . . . 0.0 111.073 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -23.03 -62.69 0.03 OUTLIER Glycine 0 CA--C 1.536 1.401 0 C-N-CA 127.34 2.4 . . . . 0.0 115.499 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -44.16 -31.52 4.19 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 124.511 3.474 . . . . 0.0 114.955 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 88.1 m -55.97 -43.29 77.43 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.613 -0.68 . . . . 0.0 109.724 176.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -66.18 -33.09 74.97 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.703 0.801 . . . . 0.0 110.147 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 46.7 ttm -67.22 -44.36 79.74 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 19.6 pt -77.5 -27.31 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 118.954 -0.546 . . . . 0.0 112.451 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -39.7 -57.45 2.53 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -58.9 -39.44 81.2 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.074 1.849 . . . . 0.0 111.474 177.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 27.9 mt -58.15 -50.78 77.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 177.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 53.2 mt -57.13 -42.85 81.67 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.032 0.533 . . . . 0.0 110.411 177.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -59.0 -48.24 82.29 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.716 0.689 . . . . 0.0 110.492 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -59.63 -49.3 78.3 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.0 mm -55.66 -44.34 76.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 123.597 0.759 . . . . 0.0 109.657 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.18 -41.78 72.35 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.465 0.575 . . . . 0.0 110.355 178.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -66.6 -59.05 3.96 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.122 0.486 . . . . 0.0 110.075 177.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -51.29 -45.45 62.14 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.176 0.99 . . . . 0.0 112.375 -177.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -97.83 22.9 8.56 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.822 0.849 . . . . 0.0 111.78 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.4 130.14 26.64 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.293 0.951 . . . . 0.0 110.525 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.84 -16.54 4.2 Favored Glycine 0 CA--C 1.534 1.23 0 CA-C-O 119.22 -0.767 . . . . 0.0 113.948 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -99.66 -35.32 9.86 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.703 1.251 . . . . 0.0 110.129 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.8 tp -136.42 136.04 39.21 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.269 1.027 . . . . 0.0 108.783 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 85.6 m -97.03 104.73 16.77 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 175.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 63.2 t -79.86 128.15 38.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -129.88 151.85 50.0 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.59 0.756 . . . . 0.0 109.79 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.4 mttm -128.16 142.32 51.22 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.637 1.175 . . . . 0.0 108.135 177.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.4 tt -132.88 115.42 15.23 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -80.72 108.84 14.71 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.9 pt -72.04 -19.08 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -60.88 -47.83 84.61 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 119.342 0.974 . . . . 0.0 108.663 178.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -80.06 -32.85 39.35 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.169 0.988 . . . . 0.0 109.997 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -121.5 64.48 15.49 Favored Pre-proline 0 CA--C 1.533 0.319 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -175.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -65.69 -42.35 12.37 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 121.687 1.591 . . . . 0.0 110.674 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -45.23 -30.15 2.67 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 125.791 1.662 . . . . 0.0 114.922 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.22 -26.75 62.15 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.415 1.108 . . . . 0.0 112.297 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.03 -58.59 15.58 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 119.307 0.958 . . . . 0.0 111.137 178.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -45.68 -45.04 17.05 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 124.031 3.154 . . . . 0.0 113.201 175.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -50.78 -31.15 16.04 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -120.15 19.71 12.18 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.146 0.578 . . . . 0.0 110.781 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 45.92 37.66 7.55 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.527 1.537 . . . . 0.0 112.54 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.4 mt -60.76 140.22 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 117.351 0.575 . . . . 0.0 110.959 -177.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -79.38 -38.39 35.06 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.113 0.965 . . . . 0.0 112.169 -174.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -179.94 -152.27 10.69 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 107.074 -2.41 . . . . 0.0 107.074 -177.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -146.13 157.44 49.82 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-O 117.764 -1.112 . . . . 0.0 108.872 178.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -66.84 135.92 29.14 Favored 'Cis proline' 0 N--CA 1.457 -0.662 0 CA-C-N 120.494 1.212 . . . . 0.0 110.151 -1.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.9 m -132.58 146.76 52.15 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 106.09 -1.818 . . . . 0.0 106.09 175.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.8 mt -127.49 124.86 39.33 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.567 1.547 . . . . 0.0 107.363 -175.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.3 mp -121.3 119.46 32.28 Favored 'General case' 0 CA--C 1.522 -0.106 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 176.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.45 95.62 9.75 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -85.44 101.86 12.97 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.657 1.183 . . . . 0.0 109.207 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -93.78 114.04 26.22 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 174.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 56.16 40.06 30.19 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.676 0.79 . . . . 0.0 111.177 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.68 -1.61 66.56 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 118.734 -1.037 . . . . 0.0 113.521 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -107.01 128.69 54.59 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 119.419 1.609 . . . . 0.0 109.368 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.9 t -66.28 107.87 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.15 -40.94 29.67 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.596 0.758 . . . . 0.0 109.416 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.11 170.75 20.58 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 177.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.9 t -151.32 160.76 43.62 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.7 tptt -148.13 131.1 16.22 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.557 1.543 . . . . 0.0 107.221 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 94.7 t -108.32 133.21 54.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 106.538 -1.652 . . . . 0.0 106.538 177.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.72 173.28 41.17 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.934 -0.867 . . . . 0.0 110.934 -178.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.12 170.37 16.17 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.976 0.511 . . . . 0.0 110.858 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -161.68 164.52 29.12 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.723 1.609 . . . . 0.0 107.614 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 83.8 p -81.26 165.02 21.82 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.067 0.46 . . . . 0.0 110.077 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -57.21 -41.73 79.95 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 174.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.81 -55.24 30.94 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -57.03 -43.73 82.17 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 117.687 0.743 . . . . 0.0 109.94 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 27.6 tp -59.9 -49.69 76.7 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 177.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -53.53 -48.38 69.11 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.011 0.823 . . . . 0.0 111.463 177.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -59.27 -50.57 73.51 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -53.15 -51.82 60.74 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.892 0.877 . . . . 0.0 110.05 178.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.5 mt -57.95 -53.04 62.76 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 122.952 0.501 . . . . 0.0 110.538 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -53.74 -50.45 65.95 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 117.866 0.303 . . . . 0.0 110.637 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.7 -37.56 68.53 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.362 0.665 . . . . 0.0 111.631 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -78.22 -46.16 21.11 Favored 'General case' 0 C--O 1.227 -0.121 0 O-C-N 122.182 -0.324 . . . . 0.0 110.862 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 54.8 mt -60.85 -46.7 89.52 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.265 0.626 . . . . 0.0 109.397 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.282 0 C-N-CA 123.025 0.53 . . . . 0.0 109.75 177.568 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.2 mt . . . . . 0 N--CA 1.446 -0.652 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.9 mm -89.82 116.2 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 123.763 0.825 . . . . 0.0 109.356 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 -82.27 105.49 13.39 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.1 mt -90.76 155.14 19.02 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.369 0.668 . . . . 0.0 112.143 -177.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.0 p -126.06 158.5 35.25 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 172.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -55.13 -45.14 75.56 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.749 0.82 . . . . 0.0 109.815 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -57.7 -44.55 85.97 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.266 1.026 . . . . 0.0 111.309 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.9 p -78.22 -31.96 49.58 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -176.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -36.79 -48.43 0.73 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.605 1.962 . . . . 0.0 114.321 -176.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -55.3 -39.09 69.5 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -178.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.5 m -90.68 -50.66 5.79 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.348 0.659 . . . . 0.0 110.036 -178.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.87 -29.41 67.71 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -174.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.5 t -114.41 -60.69 2.77 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.076 0 CA-C-N 118.856 0.753 . . . . 0.0 110.723 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 72.1 mt -61.52 -30.94 70.96 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -174.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 42.6 mttp -97.95 16.61 20.43 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.045 0.838 . . . . 0.0 110.596 175.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.64 94.49 4.4 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 121.245 -0.909 . . . . 0.0 111.485 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -75.8 68.98 2.42 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 177.43 -170.56 43.11 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 108.386 -1.885 . . . . 0.0 108.386 -177.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -105.27 118.15 35.82 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.707 1.603 . . . . 0.0 110.783 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.1 mt -122.32 116.75 50.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 125.248 1.419 . . . . 0.0 110.036 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 24.5 tp -84.16 97.07 9.16 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 173.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 51.4 t -86.4 115.57 27.72 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.097 0 C-N-CA 123.361 0.664 . . . . 0.0 109.519 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -100.03 104.45 16.04 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.203 1.001 . . . . 0.0 109.212 177.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -79.57 120.79 24.41 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 105.026 -2.213 . . . . 0.0 105.026 174.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 13.7 p-90 -141.18 164.51 30.07 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -173.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -128.76 139.81 52.03 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.209 1.003 . . . . 0.0 109.215 175.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -54.2 -48.63 70.79 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.977 1.311 . . . . 0.0 111.419 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 54.9 p-90 -69.81 -21.59 63.38 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.794 0.838 . . . . 0.0 112.374 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 42.7 t -79.87 76.93 6.55 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 121.323 -0.861 . . . . 0.0 110.351 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -22.97 -60.99 0.03 OUTLIER Glycine 0 CA--C 1.535 1.315 0 C-N-CA 127.691 2.567 . . . . 0.0 115.632 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -44.21 -35.46 7.99 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 123.921 3.081 . . . . 0.0 114.129 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.8 m -59.12 -48.74 80.5 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 121.721 0.772 . . . . 0.0 109.844 177.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -65.5 -36.91 85.25 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 25.0 ttt -60.77 -45.33 94.78 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 119.622 -0.227 . . . . 0.0 110.715 177.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 34.8 pt -76.35 -25.72 16.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-O 118.635 -0.697 . . . . 0.0 112.49 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -37.26 -58.63 1.15 Allowed Pre-proline 0 CA--C 1.545 0.75 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -56.71 -40.32 85.16 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.241 1.96 . . . . 0.0 112.172 177.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 26.4 mt -59.24 -51.08 76.85 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 177.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 76.8 mt -56.59 -43.44 80.08 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.997 0.519 . . . . 0.0 110.804 178.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -60.22 -48.8 80.19 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.657 0.662 . . . . 0.0 110.215 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -59.25 -50.83 72.49 Favored 'General case' 0 C--O 1.226 -0.183 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.3 mm -54.3 -48.78 67.17 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.38 -49.34 64.61 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 122.975 0.51 . . . . 0.0 109.918 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -61.03 -57.85 10.86 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.785 0.326 . . . . 0.0 110.805 178.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -50.38 -45.96 55.68 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.44 1.096 . . . . 0.0 112.438 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -94.69 22.61 6.14 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -177.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -50.52 127.8 18.61 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.641 1.11 . . . . 0.0 110.384 177.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.48 -20.67 13.12 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-O 119.281 -0.733 . . . . 0.0 113.264 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -99.6 -40.49 7.78 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.566 1.183 . . . . 0.0 110.258 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.3 tp -143.18 136.9 28.61 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.853 0.861 . . . . 0.0 108.703 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 92.8 m -98.13 143.94 28.13 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 173.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 68.7 t -118.43 138.53 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 178.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.34 152.93 50.25 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -177.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.1 mttm -125.83 132.3 52.26 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.875 1.27 . . . . 0.0 107.623 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.8 tt -123.1 106.59 10.92 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -78.14 102.43 7.52 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.202 -177.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 pp -55.59 -30.99 27.6 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.231 0 C-N-CA 124.214 1.006 . . . . 0.0 112.072 -179.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -57.0 -45.36 83.05 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.26 0.482 . . . . 0.0 109.825 178.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -81.94 -35.92 28.57 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.077 0.951 . . . . 0.0 110.581 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -123.49 69.9 43.99 Favored Pre-proline 0 CA--C 1.529 0.15 0 C-N-CA 123.861 0.864 . . . . 0.0 111.182 -176.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -64.97 -41.98 15.72 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.033 1.822 . . . . 0.0 110.898 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -41.78 -41.02 3.27 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.456 1.503 . . . . 0.0 114.765 -178.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.92 -23.81 65.13 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.23 1.015 . . . . 0.0 112.975 -177.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.23 -62.14 6.15 Favored Pre-proline 0 CA--C 1.539 0.557 0 O-C-N 121.388 -0.82 . . . . 0.0 113.035 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -60.74 -37.48 78.4 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.087 1.858 . . . . 0.0 111.651 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -50.96 -36.54 39.38 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 118.836 0.744 . . . . 0.0 112.095 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -112.58 16.41 19.75 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.918 0.487 . . . . 0.0 111.44 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 49.01 43.6 31.73 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 125.043 1.306 . . . . 0.0 112.743 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mp -44.38 118.41 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 117.903 0.852 . . . . 0.0 110.585 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -79.56 -48.28 14.09 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.297 1.039 . . . . 0.0 111.153 -174.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -166.69 141.95 7.28 Favored Glycine 0 C--N 1.334 0.468 0 N-CA-C 107.609 -2.196 . . . . 0.0 107.609 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 22.9 pt -92.96 146.19 31.56 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 123.489 0.716 . . . . 0.0 110.665 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.41 133.19 24.14 Favored 'Cis proline' 0 N--CA 1.459 -0.511 0 CA-C-N 119.963 1.023 . . . . 0.0 110.424 -1.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.94 111.91 23.61 Favored 'General case' 0 C--N 1.338 0.078 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 24.3 mt -93.88 117.72 30.48 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.7 mp -118.17 115.67 25.27 Favored 'General case' 0 C--N 1.334 -0.106 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 177.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 tp -89.99 95.55 10.27 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -84.78 108.61 17.55 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.53 1.132 . . . . 0.0 110.231 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -107.36 122.91 47.53 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 174.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 52.39 47.59 24.41 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.379 0.609 . . . . 0.0 109.99 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.37 -3.0 6.4 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-O 118.181 -1.344 . . . . 0.0 115.687 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -111.99 143.43 43.0 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 120.051 1.925 . . . . 0.0 110.66 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.6 t -70.94 110.49 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.94 -41.41 29.44 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -158.53 169.98 23.22 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 177.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.5 t -150.47 161.25 42.88 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -147.66 131.11 16.68 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.0 t -102.2 121.61 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.38 171.7 38.08 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 121.444 0.469 . . . . 0.0 112.094 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.67 164.22 14.85 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.004 0.922 . . . . 0.0 112.761 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.9 mt -135.52 152.35 51.23 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.972 1.709 . . . . 0.0 108.194 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.9 p -81.77 150.04 28.11 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 170.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -49.84 -48.53 50.95 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -176.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.03 -57.63 17.44 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -55.6 -41.71 73.82 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 122.896 0.478 . . . . 0.0 110.686 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.3 tp -61.12 -51.53 68.71 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -55.41 -45.69 76.67 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.627 0.649 . . . . 0.0 110.906 177.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -57.84 -53.47 57.79 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.18 0.592 . . . . 0.0 110.274 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -52.71 -50.82 62.6 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.92 1.288 . . . . 0.0 110.149 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 98.2 mt -60.32 -51.28 70.18 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 122.592 0.357 . . . . 0.0 110.424 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -53.55 -49.36 67.82 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 117.964 0.347 . . . . 0.0 110.398 178.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.5 -35.67 70.51 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.759 0.823 . . . . 0.0 111.74 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -78.45 -43.65 26.69 Favored 'General case' 0 C--O 1.227 -0.12 0 CA-C-N 118.057 0.39 . . . . 0.0 110.582 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 53.7 mt -62.79 -46.6 87.26 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.241 0.616 . . . . 0.0 109.905 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.164 0 C-N-CA 124.743 1.217 . . . . 0.0 111.739 179.133 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 32.1 mt . . . . . 0 N--CA 1.45 -0.459 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.5 mm -87.81 104.61 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 177.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 29.6 m-70 -80.55 95.26 6.45 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 42.9 mt -79.01 162.51 25.89 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.835 1.254 . . . . 0.0 111.922 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 30.0 p -134.16 162.4 32.23 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.38 1.872 . . . . 0.0 106.574 172.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -54.2 -47.63 71.9 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.723 0.809 . . . . 0.0 110.337 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -56.25 -44.83 80.03 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.933 0.893 . . . . 0.0 111.759 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.5 p -78.31 -28.46 47.45 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -176.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -38.99 -49.82 1.73 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.738 1.615 . . . . 0.0 113.879 -176.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -50.81 -63.92 0.98 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.659 0.742 . . . . 0.0 111.0 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.3 m -68.31 -46.89 69.05 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.834 -175.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -75.53 -23.17 56.61 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 -174.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.0 t -118.34 -63.31 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-N 119.432 1.014 . . . . 0.0 110.057 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 72.4 mt -60.21 -37.53 80.58 Favored 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -174.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -93.45 12.28 25.54 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.598 0.636 . . . . 0.0 111.834 177.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.39 102.56 14.66 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 119.098 0.863 . . . . 0.0 110.885 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -76.09 65.7 2.14 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.377 0.671 . . . . 0.0 109.9 177.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -173.84 -175.03 41.2 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.87 124.42 35.97 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.269 1.427 . . . . 0.0 111.052 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.3 mt -133.32 124.07 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 124.811 1.244 . . . . 0.0 109.917 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -93.73 108.57 20.3 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 105.534 -2.025 . . . . 0.0 105.534 174.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.6 t -99.6 107.34 20.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -178.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -91.62 102.86 15.5 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -78.49 121.37 24.48 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 103.758 -2.682 . . . . 0.0 103.758 174.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 25.8 p-90 -137.0 168.54 19.4 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 123.61 0.764 . . . . 0.0 112.631 -174.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -141.48 140.45 33.54 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.813 1.245 . . . . 0.0 108.099 176.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -55.81 -50.76 69.63 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.483 0.713 . . . . 0.0 112.688 -176.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 43.3 p-90 -59.92 -29.68 68.54 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.77 0.828 . . . . 0.0 112.828 -178.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 48.8 t -79.6 80.45 5.98 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 121.432 -0.793 . . . . 0.0 110.507 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -23.06 -61.2 0.03 OUTLIER Glycine 0 CA--C 1.537 1.459 0 C-N-CA 127.422 2.439 . . . . 0.0 115.243 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -41.98 -37.77 4.57 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 124.309 3.34 . . . . 0.0 114.335 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 86.4 m -54.9 -44.23 73.97 Favored 'General case' 0 CA--C 1.527 0.058 0 C-N-CA 123.661 0.785 . . . . 0.0 110.597 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -69.92 -45.21 68.03 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 87.5 mmm -53.69 -42.76 68.31 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 30.7 pt -76.65 -12.06 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.22 -58.35 10.86 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 120.162 1.346 . . . . 0.0 112.79 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -55.43 -41.37 78.72 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.141 1.894 . . . . 0.0 111.377 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 19.2 mt -57.56 -53.65 41.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.3 mt -56.29 -39.19 72.29 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.312 0.645 . . . . 0.0 110.682 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -62.0 -48.84 78.5 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.013 0.824 . . . . 0.0 110.396 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -57.17 -51.73 68.13 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.2 mm -53.05 -48.06 53.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.675 1.19 . . . . 0.0 109.399 177.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.34 -45.76 76.42 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 122.927 0.491 . . . . 0.0 110.645 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -63.2 -53.17 57.4 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 177.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -50.29 -50.15 51.29 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.977 0.911 . . . . 0.0 111.687 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -98.86 30.5 3.33 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.464 0.706 . . . . 0.0 111.347 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -60.35 120.77 10.5 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.491 -0.755 . . . . 0.0 110.005 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.69 3.54 89.06 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 119.615 -0.547 . . . . 0.0 112.487 -177.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.1 mttm -114.03 -41.84 3.47 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.134 1.373 . . . . 0.0 109.281 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.0 tp -133.4 131.54 40.11 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.245 1.018 . . . . 0.0 108.498 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.5 m -86.87 100.35 12.49 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.1 t -79.3 125.07 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -131.74 151.72 51.45 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.58 0.752 . . . . 0.0 110.663 -176.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.7 mttm -127.22 143.76 51.18 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 176.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 tt -133.44 111.34 10.66 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -79.28 110.12 14.26 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.2 pt -71.28 -22.81 22.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 118.94 -0.552 . . . . 0.0 112.276 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -58.79 -46.58 87.22 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 119.352 0.978 . . . . 0.0 108.824 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -80.39 -25.18 39.23 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.282 1.033 . . . . 0.0 110.949 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -127.37 66.95 70.51 Favored Pre-proline 0 CA--C 1.534 0.341 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.48 -55.85 2.99 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.531 2.154 . . . . 0.0 113.265 -178.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -37.8 -46.61 1.69 Allowed Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.872 1.701 . . . . 0.0 114.544 -176.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -53.12 -34.56 57.26 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.489 0.715 . . . . 0.0 112.288 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.72 -68.6 0.57 Allowed Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 118.255 -0.878 . . . . 0.0 112.374 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -58.96 -38.24 89.14 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 CA-C-N 121.085 1.423 . . . . 0.0 110.94 177.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -52.26 -39.92 61.03 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 118.926 0.784 . . . . 0.0 111.732 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -104.59 19.46 20.33 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.106 0.412 . . . . 0.0 111.907 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.7 39.04 54.05 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 124.021 0.82 . . . . 0.0 113.216 177.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.5 mp -56.94 122.33 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -79.81 -47.24 15.51 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.721 0.808 . . . . 0.0 109.364 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -168.92 146.09 10.01 Favored Glycine 0 CA--C 1.521 0.424 0 N-CA-C 106.896 -2.481 . . . . 0.0 106.896 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.6 pp -92.02 150.32 40.32 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 117.382 0.591 . . . . 0.0 110.378 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -70.93 136.5 41.61 Favored 'Cis proline' 0 N--CA 1.457 -0.649 0 CA-C-N 120.107 1.074 . . . . 0.0 111.31 0.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -120.68 113.47 20.26 Favored 'General case' 0 C--O 1.23 0.042 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 178.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.4 mt -95.9 101.17 12.82 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 -178.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -92.79 111.98 23.78 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 176.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 tp -92.77 105.59 17.7 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -93.81 143.66 26.13 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.24 1.416 . . . . 0.0 109.835 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -138.01 121.96 17.78 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 172.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 46.1 m-20 50.18 48.55 21.95 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.858 0.863 . . . . 0.0 110.803 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.57 -5.51 10.83 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 118.527 -1.152 . . . . 0.0 115.389 178.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -106.26 138.47 42.38 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 119.932 1.866 . . . . 0.0 110.163 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 94.2 t -66.55 109.17 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 176.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.75 -43.63 22.22 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 124.526 1.131 . . . . 0.0 109.604 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -150.55 169.32 21.81 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 97.2 m -150.98 139.34 20.36 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -177.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -131.47 137.02 48.4 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.0 t -110.94 122.2 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 177.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.01 171.76 37.09 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 123.38 0.514 . . . . 0.0 112.068 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.83 170.71 10.53 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.105 0.962 . . . . 0.0 112.441 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.1 mt -140.57 162.39 35.48 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 126.227 1.811 . . . . 0.0 108.321 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 99.9 p -83.67 162.11 20.86 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 169.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -57.06 -44.11 82.72 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 177.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -58.05 -57.59 19.01 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 123.37 0.51 . . . . 0.0 111.964 178.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -60.3 -38.64 84.26 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 121.842 -0.799 . . . . 0.0 110.739 -178.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.0 tp -64.17 -49.39 72.26 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 119.153 -0.451 . . . . 0.0 110.013 178.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 10.2 mmmm -52.65 -49.84 64.4 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.667 0.667 . . . . 0.0 109.47 176.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -56.13 -54.82 40.49 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.249 0.62 . . . . 0.0 110.73 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -52.59 -53.37 47.59 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.957 1.303 . . . . 0.0 111.05 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.3 mt -61.96 -52.14 65.25 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -51.92 -50.88 60.23 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.336 0.654 . . . . 0.0 110.842 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.43 -36.75 66.84 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.522 0.729 . . . . 0.0 111.664 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -78.52 -45.21 22.47 Favored 'General case' 0 N--CA 1.458 -0.057 0 O-C-N 122.263 -0.273 . . . . 0.0 110.516 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 53.2 mt -58.3 -47.45 83.63 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.306 0 C-N-CA 123.232 0.613 . . . . 0.0 109.665 177.423 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 16.0 mt . . . . . 0 C--O 1.232 0.135 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.5 mm -87.89 108.1 18.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -79.78 114.77 18.95 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 64.9 mt -96.35 167.03 11.42 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 124.38 1.072 . . . . 0.0 112.397 -176.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 33.9 p -136.86 164.58 27.97 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 171.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -59.27 -45.97 89.78 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.463 0.574 . . . . 0.0 109.923 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -59.85 -45.64 91.79 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.708 0.803 . . . . 0.0 111.263 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.8 p -78.86 -24.44 44.31 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -176.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -38.25 -49.93 1.41 Allowed 'General case' 0 CA--C 1.527 0.075 0 C-N-CA 126.576 1.95 . . . . 0.0 113.613 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -54.41 -61.18 2.47 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 121.483 0.659 . . . . 0.0 110.888 -178.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.7 m -63.27 -42.06 99.1 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.444 -177.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -71.16 -43.58 67.22 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -174.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.4 t -107.54 -59.12 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 123.861 0.864 . . . . 0.0 110.893 -174.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 64.4 mt -62.41 -35.62 79.78 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -173.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -90.43 7.05 40.71 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.555 0.616 . . . . 0.0 112.253 178.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.86 102.1 14.21 Favored 'General case' 0 C--N 1.341 0.239 0 CA-C-N 119.185 0.902 . . . . 0.0 111.946 -178.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -75.58 73.48 2.59 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 175.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -172.72 178.57 44.71 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.76 115.19 26.11 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.0 1.32 . . . . 0.0 109.943 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.4 mt -122.6 120.18 60.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 124.528 1.131 . . . . 0.0 109.833 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.4 tp -91.08 100.27 13.15 Favored 'General case' 0 CA--C 1.521 -0.159 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 175.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 63.4 t -90.88 114.25 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -101.14 110.19 22.18 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.953 0.901 . . . . 0.0 109.186 177.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -79.79 124.8 28.94 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 175.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 28.6 p-90 -140.17 172.48 12.69 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.731 0.812 . . . . 0.0 112.864 -175.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.4 132.28 17.08 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.549 1.539 . . . . 0.0 108.024 175.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -49.23 -39.52 30.39 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 61.3 p-90 -76.86 -19.98 56.85 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 40.4 t -79.58 77.0 6.2 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 121.372 -0.83 . . . . 0.0 111.511 -175.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -9.72 -71.87 0.01 OUTLIER Glycine 0 CA--C 1.538 1.509 0 C-N-CA 127.729 2.585 . . . . 0.0 116.349 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -47.29 -33.59 16.68 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 124.089 3.193 . . . . 0.0 114.61 -178.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 88.2 m -52.94 -47.98 67.65 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.635 0.774 . . . . 0.0 109.955 176.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -68.89 -29.19 67.42 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.385 0.674 . . . . 0.0 110.611 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 24.2 mmt -70.28 -44.91 67.42 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 34.3 pt -74.17 -30.53 27.26 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 CA-C-O 118.371 -0.823 . . . . 0.0 112.231 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -36.84 -60.1 0.82 Allowed Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -57.79 -40.39 79.37 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.0 1.8 . . . . 0.0 111.414 178.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 15.7 mt -58.68 -49.67 81.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 177.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 76.9 mt -55.63 -44.17 76.85 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.213 0.605 . . . . 0.0 110.071 177.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -60.7 -46.89 88.67 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.76 -0.587 . . . . 0.0 110.746 177.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -57.25 -51.51 69.08 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 23.4 mm -53.03 -49.28 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 124.057 0.943 . . . . 0.0 109.478 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.56 -47.6 73.05 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 117.967 0.349 . . . . 0.0 110.547 178.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -61.17 -44.47 97.26 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 122.284 0.234 . . . . 0.0 111.283 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -65.54 -46.27 80.21 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.364 1.065 . . . . 0.0 112.723 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -100.22 38.68 1.45 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.516 1.127 . . . . 0.0 110.807 -178.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.1 122.13 8.82 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.644 -0.66 . . . . 0.0 111.905 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.62 -5.95 6.76 Favored Glycine 0 CA--C 1.535 1.29 0 CA-C-O 119.487 -0.618 . . . . 0.0 113.7 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 51.7 mttt -99.68 -36.27 9.54 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.964 1.306 . . . . 0.0 108.491 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.3 tp -136.28 122.48 20.4 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 35.3 m -86.58 103.52 15.15 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 177.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 91.8 t -79.67 128.02 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 107.057 -1.461 . . . . 0.0 107.057 178.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -132.53 149.53 52.31 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.373 0.669 . . . . 0.0 110.05 -177.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -129.36 132.49 47.08 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 123.794 0.838 . . . . 0.0 108.89 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.5 tt -120.63 116.13 24.73 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.766 0.826 . . . . 0.0 110.059 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -78.22 108.03 11.24 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 pp -67.33 -29.8 46.99 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 C-N-CA 123.335 0.654 . . . . 0.0 112.701 -177.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -60.49 -47.71 84.93 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 118.934 0.788 . . . . 0.0 109.491 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -74.88 -32.92 61.99 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.147 176.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -121.23 69.95 21.03 Favored Pre-proline 0 CA--C 1.531 0.228 0 C-N-CA 123.651 0.78 . . . . 0.0 112.01 -176.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -64.8 -47.45 5.13 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.977 1.785 . . . . 0.0 111.431 -178.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -42.02 -40.72 3.39 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.358 1.456 . . . . 0.0 114.659 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.43 -29.31 69.86 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.62 -0.929 . . . . 0.0 112.479 -178.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.84 -65.23 1.79 Allowed Pre-proline 0 CA--C 1.537 0.456 0 CA-C-O 118.395 -0.812 . . . . 0.0 112.912 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -59.78 -38.44 80.29 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 121.718 1.612 . . . . 0.0 111.036 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -51.79 -36.38 47.41 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-N 118.683 0.674 . . . . 0.0 112.029 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -111.65 20.59 16.97 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.683 0.393 . . . . 0.0 111.883 178.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 51.09 40.33 43.6 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.043 0.83 . . . . 0.0 113.481 177.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mp -53.94 127.87 12.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 117.883 0.841 . . . . 0.0 109.069 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -92.91 -50.64 5.45 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.75 1.22 . . . . 0.0 110.133 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.02 146.56 13.2 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 107.406 -2.278 . . . . 0.0 107.406 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.7 pt -95.61 148.64 34.92 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 123.715 0.806 . . . . 0.0 110.131 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.96 140.89 60.75 Favored 'Cis proline' 0 N--CA 1.456 -0.71 0 CA-C-N 119.788 0.96 . . . . 0.0 110.72 -1.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.61 118.69 30.8 Favored 'General case' 0 CA--C 1.523 -0.083 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.8 mt -96.82 126.6 42.09 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -120.89 111.57 17.7 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 104.066 -2.568 . . . . 0.0 104.066 175.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.5 tp -93.29 99.54 12.06 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -84.7 142.02 30.16 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.569 1.148 . . . . 0.0 109.676 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -138.13 97.86 3.49 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 175.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.2 t30 55.42 71.52 0.54 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.3 0.64 . . . . 0.0 110.3 -176.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 70.62 -37.68 0.47 Allowed Glycine 0 CA--C 1.531 1.093 0 N-CA-C 116.146 1.218 . . . . 0.0 116.146 176.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -86.6 146.03 26.5 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 119.147 1.474 . . . . 0.0 110.529 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 96.6 t -79.04 115.19 20.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 175.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.3 -42.11 26.5 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.346 0.659 . . . . 0.0 109.448 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -155.34 169.86 23.24 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 177.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.8 t -147.88 168.35 22.46 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.68 146.22 23.15 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.827 1.251 . . . . 0.0 108.327 -177.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.9 t -124.01 124.8 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.26 177.11 37.54 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 123.324 0.487 . . . . 0.0 112.052 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.71 173.58 8.85 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.416 0.686 . . . . 0.0 111.885 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 mt -147.65 160.71 42.37 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 125.679 1.592 . . . . 0.0 108.708 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 44.6 p -90.4 154.15 19.89 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 170.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -51.76 -45.52 63.74 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 122.213 -0.305 . . . . 0.0 110.921 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -57.6 -57.24 20.86 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 111.74 -0.544 . . . . 0.0 111.74 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -58.01 -41.09 82.35 Favored 'General case' 0 N--CA 1.456 -0.168 0 O-C-N 121.996 -0.708 . . . . 0.0 110.739 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 29.3 tp -62.19 -49.21 76.71 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -52.93 -48.66 67.12 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.898 0.479 . . . . 0.0 109.895 176.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -56.98 -53.98 51.84 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.946 0.498 . . . . 0.0 110.617 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -52.25 -51.25 59.49 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.002 0.921 . . . . 0.0 110.437 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 89.7 mt -61.28 -51.49 68.69 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.631 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -52.78 -48.98 66.47 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.941 0.496 . . . . 0.0 110.406 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.05 -36.12 70.13 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.292 0.637 . . . . 0.0 111.832 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -78.89 -44.64 22.34 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 117.783 0.265 . . . . 0.0 111.013 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 56.9 mt -64.7 -43.08 94.66 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.434 0.694 . . . . 0.0 110.211 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.213 0 C-N-CA 124.84 1.256 . . . . 0.0 111.807 179.066 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.8 mt . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 120.678 0.275 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.9 mm -87.54 106.7 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 175.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 37.9 m-70 -81.26 95.54 6.99 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 177.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 44.8 mt -79.9 163.44 24.33 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.598 1.159 . . . . 0.0 113.067 -175.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.6 p -139.06 164.73 29.01 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 126.261 1.824 . . . . 0.0 106.459 174.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -57.46 -46.25 83.85 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.673 -0.642 . . . . 0.0 110.14 -178.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -61.87 -38.9 90.02 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.8 p -78.13 -35.52 48.99 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 121.992 -0.443 . . . . 0.0 110.223 -177.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -33.74 -51.17 0.38 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 126.912 2.085 . . . . 0.0 114.019 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -54.92 -48.09 73.54 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.07 0.462 . . . . 0.0 111.636 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.1 m -76.33 -52.09 10.64 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 121.996 -0.44 . . . . 0.0 110.769 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.52 -47.31 64.18 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -173.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.3 t -94.53 -50.09 12.12 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.11 0 C-N-CA 123.33 0.652 . . . . 0.0 111.915 -175.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 70.4 mt -73.67 -48.69 30.38 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.988 -177.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -91.36 42.33 1.1 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.134 0.879 . . . . 0.0 109.252 175.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.03 177.08 2.33 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 125.395 1.478 . . . . 0.0 113.686 -178.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -134.88 101.93 5.07 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.993 2.117 . . . . 0.0 106.594 175.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.09 -162.03 45.98 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-O 121.588 0.549 . . . . 0.0 113.87 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.48 117.9 20.11 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.47 1.508 . . . . 0.0 112.536 -177.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.1 mt -116.53 120.77 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 124.552 1.141 . . . . 0.0 109.049 176.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -91.97 108.08 19.67 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 176.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.9 t -98.53 106.59 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 123.86 0.864 . . . . 0.0 109.954 -177.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -91.35 105.11 17.54 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 176.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -79.59 125.24 29.35 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 174.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 44.7 p-90 -142.39 169.52 17.42 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.828 0.851 . . . . 0.0 112.729 -176.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -146.93 137.97 23.96 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.954 1.302 . . . . 0.0 107.586 174.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -50.55 -48.54 57.33 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.586 0.754 . . . . 0.0 112.759 -176.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 58.5 p-90 -62.7 -26.05 68.47 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 50.8 t -79.8 79.44 6.31 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 121.316 -0.865 . . . . 0.0 109.233 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -25.96 -60.39 0.07 OUTLIER Glycine 0 CA--C 1.536 1.359 0 C-N-CA 127.139 2.304 . . . . 0.0 114.801 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -43.08 -35.06 4.46 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 124.315 3.343 . . . . 0.0 114.586 178.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 78.3 m -57.09 -47.24 81.52 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 121.588 -0.695 . . . . 0.0 109.846 176.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -65.87 -31.18 71.98 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.696 0.799 . . . . 0.0 109.776 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 85.1 mtp -68.5 -45.04 73.36 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 177.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.0 pt -75.39 -27.52 19.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 118.521 0.6 . . . . 0.0 112.33 178.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -37.94 -58.66 1.34 Allowed Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -58.27 -39.01 88.34 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.41 2.073 . . . . 0.0 111.514 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.5 mt -59.51 -51.08 76.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 177.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 44.3 mt -56.44 -42.55 78.3 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.621 0.368 . . . . 0.0 110.505 177.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -59.51 -48.7 80.64 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.674 0.67 . . . . 0.0 110.259 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -58.42 -52.62 64.86 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.677 -0.639 . . . . 0.0 109.606 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 11.2 mm -54.39 -46.29 69.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 124.735 1.214 . . . . 0.0 110.179 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.23 -44.73 68.31 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.361 0.664 . . . . 0.0 110.179 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -66.34 -56.78 9.48 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 176.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -45.71 -50.76 13.39 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.937 0.895 . . . . 0.0 112.423 -178.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -95.44 26.2 4.01 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.663 0.785 . . . . 0.0 112.463 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.58 130.15 23.62 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.264 0.938 . . . . 0.0 109.933 176.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.6 -16.48 5.04 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-O 119.147 -0.807 . . . . 0.0 114.181 -178.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -99.6 -39.08 8.48 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 118.87 1.335 . . . . 0.0 110.214 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 26.0 tp -137.78 126.55 23.87 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.8 m -86.94 102.39 14.32 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 176.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 96.3 t -79.02 137.51 21.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.42 147.41 45.39 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.023 0.929 . . . . 0.0 109.445 -177.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -125.26 135.3 52.39 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.6 tt -127.78 112.57 14.92 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.606 0.763 . . . . 0.0 109.692 -178.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -78.98 104.52 9.67 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 122.902 0.481 . . . . 0.0 109.824 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.2 pt -69.03 -24.25 28.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 118.866 -0.588 . . . . 0.0 112.559 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -53.31 -53.82 45.4 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.061 0.846 . . . . 0.0 109.502 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -78.2 -28.71 48.12 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.961 0.904 . . . . 0.0 110.763 179.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -118.11 67.0 6.26 Favored Pre-proline 0 C--O 1.235 0.315 0 C-N-CA 124.1 0.96 . . . . 0.0 111.495 -176.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -61.14 -53.65 2.36 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.465 2.11 . . . . 0.0 112.383 -176.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -37.97 -47.12 1.85 Allowed Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.631 1.586 . . . . 0.0 114.267 -177.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -51.71 -33.79 35.9 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.23 1.012 . . . . 0.0 112.962 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.27 -68.25 0.79 Allowed Pre-proline 0 CA--C 1.537 0.478 0 CA-C-O 117.987 -1.006 . . . . 0.0 112.017 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -59.32 -35.95 95.65 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.005 1.803 . . . . 0.0 111.358 177.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -51.44 -37.64 49.65 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.526 1.057 . . . . 0.0 111.661 177.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -111.9 22.31 15.04 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.098 0.559 . . . . 0.0 111.187 177.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 42.69 43.24 5.06 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 125.465 1.507 . . . . 0.0 113.04 178.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.5 mp -51.07 118.17 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 118.094 0.947 . . . . 0.0 109.315 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -79.14 -44.38 22.12 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.371 0.669 . . . . 0.0 110.415 -177.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -164.91 141.91 7.39 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 108.451 -1.86 . . . . 0.0 108.451 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.7 pt -95.79 148.88 35.26 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 124.017 0.927 . . . . 0.0 109.997 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.35 141.05 62.81 Favored 'Cis proline' 0 N--CA 1.456 -0.697 0 CA-C-N 119.846 0.981 . . . . 0.0 111.177 -0.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.02 114.81 21.46 Favored 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.7 mt -98.0 102.08 13.73 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.7 mp -96.58 118.59 33.39 Favored 'General case' 0 CA--C 1.523 -0.072 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 177.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 tp -92.19 98.67 11.67 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -89.27 103.33 15.96 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 125.225 1.41 . . . . 0.0 110.413 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -83.61 102.19 12.02 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 172.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 45.76 41.43 7.49 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.069 1.748 . . . . 0.0 113.934 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 106.2 -21.28 33.7 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-O 118.784 -1.009 . . . . 0.0 113.358 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -100.32 128.55 46.36 Favored 'General case' 0 C--O 1.227 -0.085 0 CA-C-N 119.254 1.527 . . . . 0.0 110.948 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 89.7 t -68.04 107.29 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.57 -41.61 26.81 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.884 0.874 . . . . 0.0 109.987 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -155.13 167.49 30.2 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 93.7 m -149.72 140.7 22.89 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -116.5 138.37 51.44 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 177.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 26.3 t -120.96 123.32 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 178.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.92 175.09 45.47 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 111.579 -0.609 . . . . 0.0 111.579 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.38 172.77 8.83 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.22 0.608 . . . . 0.0 110.954 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -162.8 167.99 22.07 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.625 1.17 . . . . 0.0 108.75 -177.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 88.2 p -81.67 160.1 23.8 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -57.48 -40.35 78.41 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 175.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.95 -53.06 42.38 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 176.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -60.46 -39.65 88.34 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 117.616 0.708 . . . . 0.0 111.148 178.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 23.3 tp -62.19 -50.93 69.85 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.586 0.63 . . . . 0.0 109.874 178.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -53.41 -49.52 67.12 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.32 0.648 . . . . 0.0 109.567 176.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -55.56 -55.86 27.03 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.063 0.945 . . . . 0.0 110.424 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -52.93 -54.38 35.64 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.489 1.516 . . . . 0.0 110.828 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.7 mt -61.32 -51.93 66.8 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.44 0.296 . . . . 0.0 110.658 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -53.95 -50.38 66.63 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.028 0.531 . . . . 0.0 110.631 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.02 -36.53 65.58 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.429 0.692 . . . . 0.0 111.623 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -78.64 -48.32 15.31 Favored 'General case' 0 C--O 1.227 -0.115 0 O-C-N 122.238 -0.289 . . . . 0.0 110.406 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 58.0 mt -59.18 -42.78 91.66 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.936 0.494 . . . . 0.0 110.294 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.282 0 C-N-CA 123.097 0.559 . . . . 0.0 109.777 177.889 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 36.9 mt . . . . . 0 N--CA 1.446 -0.648 0 CA-C-O 120.969 0.414 . . . . 0.0 110.674 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.2 mm -89.26 120.28 37.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 123.978 0.911 . . . . 0.0 109.492 178.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -85.71 111.39 20.07 Favored 'General case' 0 CA--C 1.528 0.099 0 O-C-N 121.515 -0.741 . . . . 0.0 109.349 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 65.8 mt -95.5 160.87 14.31 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 124.458 1.103 . . . . 0.0 111.203 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 48.9 p -134.68 163.48 29.67 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 174.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -58.48 -47.18 84.91 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.809 0.732 . . . . 0.0 109.601 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -63.69 -41.2 98.17 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.664 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.1 p -78.42 -24.82 45.98 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.38 0.536 . . . . 0.0 111.368 -177.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -41.6 -43.69 2.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 126.602 1.961 . . . . 0.0 113.068 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -52.39 -65.14 0.61 Allowed 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 121.697 0.761 . . . . 0.0 110.251 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.9 m -67.17 -42.53 84.13 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.583 -176.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -70.81 -39.3 73.14 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -174.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.0 t -112.84 -58.48 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 123.446 0.698 . . . . 0.0 110.345 -175.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 67.0 mt -61.43 -35.59 78.0 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -174.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -97.4 16.18 20.88 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.451 0.569 . . . . 0.0 111.73 178.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -102.15 102.43 12.88 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 119.042 0.837 . . . . 0.0 111.724 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -77.25 59.21 1.75 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.949 1.3 . . . . 0.0 110.305 176.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -159.05 168.08 35.01 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.5 114.09 20.68 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.257 0.623 . . . . 0.0 110.817 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.5 mt -120.25 122.44 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 124.537 1.135 . . . . 0.0 109.986 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -91.99 107.55 19.29 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 175.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 67.2 t -96.19 108.09 20.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 123.992 0.917 . . . . 0.0 109.241 -178.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -97.18 105.32 17.44 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.592 1.157 . . . . 0.0 109.514 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -79.16 126.39 30.68 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 177.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 26.4 p-90 -141.47 173.86 11.1 Favored 'General case' 0 C--N 1.343 0.289 0 C-N-CA 124.304 1.042 . . . . 0.0 112.83 -176.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -149.97 156.89 42.52 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.985 1.714 . . . . 0.0 108.221 175.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.1 mp0 -63.3 -48.79 76.59 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.226 0.536 . . . . 0.0 110.688 -178.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 54.2 p-90 -65.73 -20.8 66.41 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.064 0.946 . . . . 0.0 112.562 -178.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 47.6 t -79.36 75.68 5.95 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 121.481 -0.762 . . . . 0.0 110.08 -178.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -25.74 -63.12 0.06 OUTLIER Glycine 0 CA--C 1.536 1.357 0 C-N-CA 126.509 2.004 . . . . 0.0 114.692 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -43.44 -35.83 6.17 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 124.559 3.506 . . . . 0.0 114.881 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 87.5 m -52.59 -40.71 62.94 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.172 0.589 . . . . 0.0 110.188 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -67.28 -30.83 70.8 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.633 0.773 . . . . 0.0 111.311 179.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -74.36 -46.12 42.6 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 28.0 pt -73.7 -29.26 26.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 118.66 -0.686 . . . . 0.0 112.255 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -39.16 -60.88 1.08 Allowed Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -56.59 -40.84 81.69 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.372 2.048 . . . . 0.0 111.673 178.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.8 mt -57.44 -52.35 58.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 177.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 47.6 mt -57.44 -40.52 78.59 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.281 0.632 . . . . 0.0 110.973 178.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -61.86 -47.86 83.12 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.1 0.864 . . . . 0.0 110.262 177.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -57.87 -52.59 64.87 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.6 mm -53.15 -47.5 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 124.035 0.934 . . . . 0.0 109.591 177.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.94 -49.95 62.14 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 122.842 0.457 . . . . 0.0 110.103 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -62.23 -54.29 42.91 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.723 0.296 . . . . 0.0 110.932 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -53.24 -46.74 69.29 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.767 0.827 . . . . 0.0 112.308 -178.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -94.48 26.99 3.15 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.967 0.907 . . . . 0.0 112.37 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -54.45 128.65 32.76 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.169 0.895 . . . . 0.0 109.724 176.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.1 -14.75 25.8 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-O 119.25 -0.75 . . . . 0.0 112.993 -178.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -99.82 -44.06 6.21 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 118.507 1.153 . . . . 0.0 109.881 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 24.6 tp -139.42 132.38 29.41 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.415 0.686 . . . . 0.0 110.431 -176.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 62.5 m -91.69 103.28 15.87 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 175.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 63.1 t -79.86 130.81 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.66 151.81 50.58 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.28 0.632 . . . . 0.0 110.844 -176.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -126.8 139.94 52.74 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.908 1.283 . . . . 0.0 108.948 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.5 tt -127.8 115.86 19.3 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.608 0.763 . . . . 0.0 109.734 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -79.25 107.15 11.8 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.9 pt -69.0 -26.96 33.59 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.29 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -177.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -59.75 -47.04 87.28 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 119.067 0.849 . . . . 0.0 109.744 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -77.18 -30.58 54.94 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.148 0.579 . . . . 0.0 110.241 176.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -121.79 67.42 22.21 Favored Pre-proline 0 C--O 1.234 0.25 0 C-N-CA 123.933 0.893 . . . . 0.0 111.735 -176.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -62.22 -53.43 1.97 Allowed 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 122.534 2.156 . . . . 0.0 112.777 -176.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -38.86 -47.2 2.38 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.189 1.376 . . . . 0.0 113.989 -177.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -50.52 -34.46 25.38 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.427 1.091 . . . . 0.0 112.897 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.71 -68.99 0.57 Allowed Pre-proline 0 CA--C 1.538 0.518 0 CA-C-O 118.241 -0.885 . . . . 0.0 112.168 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -59.19 -37.2 93.14 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.64 1.56 . . . . 0.0 111.149 177.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -50.83 -40.61 56.18 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-N 119.281 0.946 . . . . 0.0 111.67 178.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -106.76 19.83 19.9 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.586 0.354 . . . . 0.0 111.893 178.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 51.0 40.31 42.9 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.097 0.856 . . . . 0.0 113.043 177.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mp -53.24 120.7 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 177.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 55.5 mmt-85 -79.14 -46.89 17.07 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.769 0.828 . . . . 0.0 109.417 -178.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -170.72 145.53 9.07 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 106.601 -2.6 . . . . 0.0 106.601 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.5 pt -90.83 150.95 43.03 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-O 118.907 -0.568 . . . . 0.0 109.842 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -70.08 138.11 48.21 Favored 'Cis proline' 0 N--CA 1.458 -0.609 0 CA-C-N 119.485 0.852 . . . . 0.0 111.285 -0.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -123.62 120.27 32.29 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 178.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.3 mt -103.25 117.39 34.4 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -110.2 116.83 32.22 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 177.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 tp -92.28 101.22 13.71 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -90.83 145.42 24.78 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.096 1.358 . . . . 0.0 111.595 -178.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -141.59 116.86 10.09 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.317 1.847 . . . . 0.0 106.102 174.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 49.66 48.64 21.25 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.678 0.752 . . . . 0.0 110.61 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.51 -9.74 4.33 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-O 118.283 -1.287 . . . . 0.0 115.86 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -98.52 142.38 30.19 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 119.983 1.892 . . . . 0.0 109.851 178.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 89.5 t -76.72 116.84 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 177.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.19 -44.21 22.35 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 177.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -161.88 175.34 11.99 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.3 t -150.82 163.48 38.53 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 54.2 mmtt -141.74 148.5 39.09 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 126.96 2.104 . . . . 0.0 106.672 177.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.9 t -130.52 132.33 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.81 -177.33 46.49 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.82 165.3 24.38 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.978 0.511 . . . . 0.0 111.316 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.3 mt -144.35 157.17 44.4 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.44 1.496 . . . . 0.0 108.28 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 88.2 p -81.52 157.16 24.92 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 170.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -55.68 -44.03 76.94 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -56.29 -56.35 24.79 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 123.671 0.653 . . . . 0.0 111.852 177.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -60.89 -41.25 95.65 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 118.211 1.005 . . . . 0.0 111.298 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 37.6 tp -60.95 -50.99 71.15 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.877 -0.514 . . . . 0.0 109.625 178.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -54.24 -47.75 71.87 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.739 0.7 . . . . 0.0 110.407 176.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -55.05 -53.25 58.29 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.082 0.953 . . . . 0.0 109.919 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -55.21 -54.71 39.91 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.598 1.159 . . . . 0.0 110.894 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 89.8 mt -58.62 -50.17 74.82 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.311 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -55.77 -50.37 70.62 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.17 0.588 . . . . 0.0 110.467 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.8 -35.05 65.89 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.48 0.712 . . . . 0.0 111.479 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -78.03 -50.11 12.72 Favored 'General case' 0 CA--C 1.524 -0.057 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 53.0 mt -56.07 -45.23 79.39 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.049 0.539 . . . . 0.0 110.09 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.251 0 C-N-CA 123.085 0.554 . . . . 0.0 109.693 177.599 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 13.6 mt . . . . . 0 CA--C 1.527 0.076 0 CA-C-O 120.776 0.322 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.0 mm -88.02 107.12 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 123.476 0.71 . . . . 0.0 109.344 177.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -79.58 99.52 7.36 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 76.0 mt -81.85 160.76 23.4 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 122.071 0.939 . . . . 0.0 113.348 -175.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 35.4 p -134.66 163.32 30.02 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 126.951 2.1 . . . . 0.0 106.961 173.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -57.03 -44.09 82.57 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.467 0.707 . . . . 0.0 110.059 179.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -55.84 -46.01 78.27 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.939 0.896 . . . . 0.0 111.458 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.5 p -78.02 -27.26 48.85 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 122.242 -0.286 . . . . 0.0 111.207 -177.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -42.15 -46.79 4.47 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.252 1.421 . . . . 0.0 113.499 -177.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -51.88 -64.83 0.69 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.902 0.858 . . . . 0.0 111.261 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.9 m -68.67 -40.6 80.08 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.106 -174.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -76.53 -55.38 5.58 Favored 'General case' 0 N--CA 1.451 -0.375 0 O-C-N 122.251 -0.281 . . . . 0.0 111.659 -177.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.4 t -91.72 -53.31 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -172.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 68.8 mt -66.26 -37.03 84.51 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 118.924 -1.11 . . . . 0.0 111.163 -176.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -93.68 33.54 1.28 Allowed 'General case' 0 CA--C 1.543 0.711 0 O-C-N 122.064 -0.398 . . . . 0.0 110.048 173.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.94 81.47 0.3 Allowed 'General case' 0 C--N 1.342 0.258 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -77.41 62.87 2.48 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 174.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 163.3 176.47 35.33 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 126.464 1.983 . . . . 0.0 108.432 -177.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.12 123.57 32.92 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 117.605 0.703 . . . . 0.0 109.93 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.2 mt -126.07 120.63 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 124.429 1.092 . . . . 0.0 109.88 -179.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.6 tp -92.18 97.0 10.64 Favored 'General case' 0 N--CA 1.458 -0.064 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 176.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.6 t -86.6 103.88 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 123.757 0.823 . . . . 0.0 108.946 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -95.2 108.18 20.3 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.214 1.005 . . . . 0.0 108.495 177.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -79.72 129.07 34.16 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 176.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 25.8 p-90 -143.53 174.29 10.89 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.293 1.037 . . . . 0.0 112.8 -176.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.49 144.44 20.68 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 125.736 1.615 . . . . 0.0 108.359 176.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -50.09 -49.19 52.38 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.804 0.842 . . . . 0.0 111.981 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 59.8 p-90 -66.55 -22.65 66.15 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -177.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 49.3 t -79.79 69.87 6.21 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 121.439 -0.788 . . . . 0.0 111.233 -176.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -16.64 -65.74 0.01 OUTLIER Glycine 0 CA--C 1.535 1.307 0 C-N-CA 128.128 2.775 . . . . 0.0 115.889 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -44.08 -31.29 3.88 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 124.533 3.489 . . . . 0.0 115.253 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 96.1 m -53.44 -41.62 66.27 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.804 -0.56 . . . . 0.0 109.831 176.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -67.4 -28.24 67.75 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.651 0.781 . . . . 0.0 111.161 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 84.1 mtp -74.76 -45.23 45.19 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 29.9 pt -74.56 -28.02 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.88 177.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -38.09 -59.55 1.18 Allowed Pre-proline 0 CA--C 1.544 0.749 0 CA-C-N 119.899 1.227 . . . . 0.0 114.286 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -56.15 -40.21 86.29 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.179 1.919 . . . . 0.0 111.498 177.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 19.7 mt -59.4 -51.01 77.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 55.5 mt -55.63 -41.62 73.78 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.691 0.396 . . . . 0.0 110.054 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -61.44 -48.55 80.64 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.569 0.622 . . . . 0.0 110.61 177.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -55.94 -51.6 67.09 Favored 'General case' 0 N--CA 1.457 -0.083 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 33.4 mm -55.8 -46.87 80.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 123.377 0.671 . . . . 0.0 110.031 177.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.18 -40.48 67.57 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.212 0.605 . . . . 0.0 110.575 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -71.95 -58.58 3.32 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 176.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -47.54 -48.13 27.72 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.004 1.322 . . . . 0.0 112.921 -178.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -102.39 22.36 13.54 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.726 0.81 . . . . 0.0 111.45 -178.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -54.31 131.66 42.28 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.988 0.813 . . . . 0.0 110.731 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.36 -19.87 9.9 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-O 119.25 -0.75 . . . . 0.0 112.953 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -99.56 -41.17 7.47 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.594 1.197 . . . . 0.0 109.478 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.4 tp -128.38 126.45 40.69 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.78 1.232 . . . . 0.0 108.74 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 45.8 m -88.7 103.55 16.05 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 175.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.2 t -79.53 130.18 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -132.34 145.03 50.96 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 122.802 0.441 . . . . 0.0 110.3 -178.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.7 mtmt -124.05 104.87 9.13 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 124.231 1.012 . . . . 0.0 109.127 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.3 tt -97.54 115.47 27.9 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 121.695 -0.628 . . . . 0.0 110.556 -175.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -79.23 107.96 12.37 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.933 -178.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.2 pt -71.41 -32.14 45.57 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-O 118.997 -0.525 . . . . 0.0 111.969 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -54.97 -27.62 45.23 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.147 0.885 . . . . 0.0 111.749 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -109.84 -0.64 18.26 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.131 0.972 . . . . 0.0 111.406 177.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -146.93 62.5 7.5 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 124.068 0.947 . . . . 0.0 110.853 178.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -56.46 -48.23 20.07 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 121.75 1.633 . . . . 0.0 111.863 -178.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -40.68 -39.99 2.0 Allowed Glycine 0 CA--C 1.529 0.943 0 C-N-CA 126.106 1.812 . . . . 0.0 115.077 -177.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.59 -23.97 67.44 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 118.519 1.16 . . . . 0.0 112.808 -178.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.19 -62.69 5.13 Favored Pre-proline 0 CA--C 1.54 0.569 0 O-C-N 121.112 -0.992 . . . . 0.0 113.348 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -58.05 -34.13 98.09 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 C-N-CA 122.31 2.007 . . . . 0.0 111.906 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -52.58 -29.24 24.71 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.0 0.818 . . . . 0.0 112.024 177.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -119.29 17.72 13.05 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.223 0.609 . . . . 0.0 111.174 177.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 49.17 39.52 27.44 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 124.706 1.146 . . . . 0.0 112.006 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 58.6 mt -64.02 130.72 29.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 121.28 0.562 . . . . 0.0 110.335 -178.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -79.26 -34.72 42.37 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 125.332 1.453 . . . . 0.0 112.602 -175.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -175.92 -157.07 16.27 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 107.41 -2.276 . . . . 0.0 107.41 -178.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.9 pt -147.37 158.44 43.88 Favored Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -70.15 140.29 60.85 Favored 'Cis proline' 0 N--CA 1.458 -0.587 0 N-CA-C 109.289 -1.081 . . . . 0.0 109.289 -1.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 26.6 m -136.85 123.96 21.66 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -179.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.6 mt -100.84 119.24 38.38 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.143 1.777 . . . . 0.0 109.718 -176.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.8 mp -114.55 117.4 30.81 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 173.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 tp -93.38 100.8 13.06 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -90.38 136.67 32.91 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.476 1.11 . . . . 0.0 110.023 -178.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -139.44 119.35 13.38 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.746 1.619 . . . . 0.0 106.663 177.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 54.26 41.55 31.94 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.786 0.721 . . . . 0.0 110.211 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 73.56 -11.84 5.18 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 119.051 -0.861 . . . . 0.0 114.41 -178.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -93.73 136.39 34.07 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 119.139 1.47 . . . . 0.0 109.567 -178.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 95.8 t -73.12 112.85 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 175.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.87 -40.85 31.37 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -158.73 158.71 34.18 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 176.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 89.1 m -134.27 145.21 48.89 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.752 1.221 . . . . 0.0 108.285 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -137.38 122.59 19.26 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 63.5 t -104.11 126.61 58.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.53 166.43 28.55 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.09 0.852 . . . . 0.0 112.219 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.45 170.87 12.35 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.755 0.822 . . . . 0.0 111.542 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -162.96 172.7 14.67 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 124.885 1.274 . . . . 0.0 109.964 -178.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 90.9 p -88.02 162.7 16.68 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.513 0.725 . . . . 0.0 110.101 178.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -54.95 -45.04 74.85 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 175.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.52 -60.61 8.55 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 177.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -54.04 -42.08 68.78 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 117.858 0.829 . . . . 0.0 111.641 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 15.9 tp -59.37 -50.97 71.91 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 176.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -57.87 -42.13 83.89 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.397 -0.814 . . . . 0.0 111.988 178.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -57.92 -52.67 64.52 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.138 0.881 . . . . 0.0 109.493 175.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -52.82 -52.3 57.56 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.887 0.875 . . . . 0.0 110.332 179.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.9 mt -56.99 -53.97 52.03 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.853 0.461 . . . . 0.0 110.399 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -52.57 -51.11 61.32 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 122.754 0.422 . . . . 0.0 110.65 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.15 -39.12 69.11 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.1 0.56 . . . . 0.0 111.733 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -78.71 -42.11 29.21 Favored 'General case' 0 N--CA 1.462 0.128 0 O-C-N 122.223 -0.298 . . . . 0.0 111.567 -178.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 59.4 mt -64.64 -45.09 88.27 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.225 0 C-N-CA 123.016 0.526 . . . . 0.0 109.816 177.921 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.9 mt . . . . . 0 N--CA 1.453 -0.321 0 CA-C-O 120.84 0.352 . . . . 0.0 110.514 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.1 mm -87.81 114.39 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-O 121.237 0.542 . . . . 0.0 109.802 177.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 63.0 m80 -83.98 96.97 9.01 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 62.4 mt -86.95 163.57 17.04 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.247 1.019 . . . . 0.0 112.342 -175.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 31.4 p -138.71 165.15 27.7 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.15 1.78 . . . . 0.0 106.517 174.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -55.25 -46.68 76.08 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.034 0.534 . . . . 0.0 109.876 178.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -59.72 -43.54 94.12 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.099 0.959 . . . . 0.0 112.158 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.3 p -78.47 -29.8 47.01 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 122.084 -0.385 . . . . 0.0 111.419 -176.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -37.19 -49.12 0.89 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.244 1.818 . . . . 0.0 113.515 -179.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -50.36 -64.6 0.76 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 121.74 0.781 . . . . 0.0 110.955 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 m -69.83 -46.36 65.8 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.855 -175.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -77.21 -21.55 53.71 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 114.935 1.458 . . . . 0.0 114.935 -173.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.3 t -120.48 -61.37 2.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 119.475 1.034 . . . . 0.0 109.753 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 67.0 mt -60.33 -39.92 88.83 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -174.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -94.89 12.52 27.91 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.281 0.491 . . . . 0.0 111.511 178.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.91 98.61 11.17 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.01 0.823 . . . . 0.0 111.654 -178.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -76.44 67.1 2.58 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.492 0.663 . . . . 0.0 109.742 177.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -164.88 162.84 35.96 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.71 112.1 18.57 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.067 0.547 . . . . 0.0 110.47 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.7 mt -118.65 114.21 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 125.288 1.435 . . . . 0.0 110.666 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.9 tp -83.39 96.63 8.6 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 174.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.2 t -86.33 114.93 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 C-N-CA 123.243 0.617 . . . . 0.0 109.611 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -98.31 105.45 17.59 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.495 1.118 . . . . 0.0 108.501 177.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -79.79 121.64 25.62 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 104.672 -2.344 . . . . 0.0 104.672 174.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 38.5 p-90 -135.11 170.35 16.04 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 124.141 0.976 . . . . 0.0 113.347 -175.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.59 125.55 13.6 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.744 1.618 . . . . 0.0 107.558 177.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -46.65 -45.44 19.22 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.416 1.086 . . . . 0.0 113.915 -177.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 55.5 p-90 -68.93 -23.64 64.19 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.956 0.502 . . . . 0.0 112.316 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 42.4 t -79.86 74.24 6.59 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 121.284 -0.885 . . . . 0.0 111.083 -177.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -13.07 -66.15 0.01 OUTLIER Glycine 0 CA--C 1.535 1.319 0 C-N-CA 128.48 2.943 . . . . 0.0 115.891 178.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -41.27 -36.78 2.72 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 124.264 3.309 . . . . 0.0 114.881 178.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 98.8 m -56.11 -48.01 76.98 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.386 0.674 . . . . 0.0 110.003 177.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -64.77 -38.04 89.65 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.549 0.74 . . . . 0.0 109.345 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 52.6 mtm -64.28 -43.96 93.16 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 119.505 -0.283 . . . . 0.0 111.032 178.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 29.8 pt -76.33 -26.69 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 118.74 0.7 . . . . 0.0 112.494 179.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -38.17 -58.85 1.36 Allowed Pre-proline 0 CA--C 1.545 0.756 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -57.27 -39.71 87.85 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 121.959 1.773 . . . . 0.0 111.654 178.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 19.1 mt -59.35 -50.75 78.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 177.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.6 mt -56.05 -43.38 77.84 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.744 0.418 . . . . 0.0 110.434 178.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -59.58 -49.32 78.23 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.603 0.638 . . . . 0.0 109.683 177.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -56.34 -49.78 73.39 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 28.8 mm -56.02 -49.97 72.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 123.206 0.602 . . . . 0.0 109.709 177.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.77 -45.96 63.94 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.288 0.635 . . . . 0.0 110.296 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -66.3 -58.04 6.2 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.938 -0.119 . . . . 0.0 110.738 177.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -48.19 -49.25 33.49 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.52 1.128 . . . . 0.0 112.748 -177.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -98.05 21.79 10.27 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.231 0.612 . . . . 0.0 111.851 -177.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -52.81 128.35 26.47 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.597 1.089 . . . . 0.0 110.824 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.12 -17.35 23.42 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-O 119.33 -0.705 . . . . 0.0 113.419 -178.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -99.29 -42.95 6.78 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 118.477 1.138 . . . . 0.0 109.065 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.3 tp -136.29 137.7 40.99 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.444 1.497 . . . . 0.0 107.274 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.5 m -98.37 140.77 32.14 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 173.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 96.3 t -113.01 141.31 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 177.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -138.03 152.33 48.74 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -128.37 133.4 48.63 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.5 tt -127.8 115.75 19.13 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.72 0.808 . . . . 0.0 109.104 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -80.25 110.01 15.26 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 pp -67.76 -32.54 57.09 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.149 0 C-N-CA 123.412 0.685 . . . . 0.0 112.808 -177.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -60.36 -47.74 84.74 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 118.963 0.801 . . . . 0.0 109.155 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -69.42 -37.26 77.36 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.92 0.888 . . . . 0.0 110.131 177.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -119.87 72.31 16.55 Favored Pre-proline 0 C--O 1.233 0.231 0 C-N-CA 124.007 0.923 . . . . 0.0 111.779 -175.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -61.49 -53.6 2.22 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 122.361 2.04 . . . . 0.0 112.418 -177.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -38.32 -47.93 2.13 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 125.351 1.453 . . . . 0.0 114.377 -177.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.56 -33.34 45.26 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.299 1.039 . . . . 0.0 113.092 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.88 -68.43 0.72 Allowed Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 118.149 -0.929 . . . . 0.0 112.511 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -59.41 -38.23 85.2 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 121.68 1.587 . . . . 0.0 111.048 178.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -50.92 -39.44 54.61 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-N 118.903 0.774 . . . . 0.0 111.53 178.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -108.8 20.93 17.9 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 122.884 0.474 . . . . 0.0 112.132 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 51.49 38.82 43.5 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 124.128 0.87 . . . . 0.0 113.465 176.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mp -57.43 125.66 13.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 118.092 0.946 . . . . 0.0 108.47 177.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -88.92 -47.59 8.05 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.465 1.106 . . . . 0.0 109.118 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -166.64 145.41 9.92 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 107.363 -2.295 . . . . 0.0 107.363 178.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -91.19 154.71 44.87 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-O 118.834 -0.603 . . . . 0.0 110.306 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.31 129.26 12.46 Favored 'Cis proline' 0 N--CA 1.457 -0.624 0 CA-C-N 119.973 1.026 . . . . 0.0 110.628 -1.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -113.72 109.28 18.31 Favored 'General case' 0 N--CA 1.461 0.076 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 178.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.1 mt -89.75 122.55 32.95 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.0 mp -122.96 114.68 20.75 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 177.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 tp -90.11 95.93 10.44 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -87.02 142.29 28.04 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.688 1.195 . . . . 0.0 111.571 -177.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -137.81 109.61 7.12 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 174.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 52.31 48.67 22.16 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 118.983 0.81 . . . . 0.0 110.073 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.71 -13.21 2.42 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 118.731 -1.038 . . . . 0.0 114.957 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -88.59 125.25 34.71 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 119.637 1.719 . . . . 0.0 108.873 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 73.2 t -71.82 114.07 9.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 175.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.94 -41.25 29.82 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.304 0.641 . . . . 0.0 109.398 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -159.18 170.06 22.78 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 177.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.1 t -149.3 162.77 39.39 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -146.88 119.78 8.71 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.171 1.388 . . . . 0.0 108.08 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.2 t -94.24 120.71 44.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.39 174.92 29.97 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 121.537 0.52 . . . . 0.0 112.211 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.21 172.25 9.59 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.777 0.831 . . . . 0.0 112.156 -178.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.9 mt -144.4 158.47 43.73 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 125.81 1.644 . . . . 0.0 108.506 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.3 p -87.03 152.02 22.74 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 169.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -50.53 -47.93 57.33 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 122.065 -0.397 . . . . 0.0 111.006 -178.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.64 -53.53 38.44 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -62.38 -39.7 94.06 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.98 -0.718 . . . . 0.0 111.291 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 30.6 tp -62.53 -49.43 75.37 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -56.22 -44.92 80.03 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.429 0.559 . . . . 0.0 110.492 176.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -56.27 -54.68 42.46 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.569 0.748 . . . . 0.0 109.887 177.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -53.4 -51.66 61.83 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.669 1.188 . . . . 0.0 110.357 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.9 mt -58.83 -50.77 72.74 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.519 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -55.33 -49.86 71.12 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.8 -36.89 67.92 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.468 0.707 . . . . 0.0 111.601 178.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -78.06 -47.43 18.36 Favored 'General case' 0 C--N 1.337 0.042 0 O-C-N 122.113 -0.367 . . . . 0.0 110.475 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 54.2 mt -59.37 -44.67 92.7 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.227 0.611 . . . . 0.0 109.531 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.244 0 C-N-CA 122.933 0.493 . . . . 0.0 109.707 177.743 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.7 mt . . . . . 0 N--CA 1.447 -0.614 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.2 mm -87.71 108.78 18.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 176.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 27.1 m-70 -79.77 94.69 5.81 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 177.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 66.9 mt -82.09 159.18 23.47 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.832 0.853 . . . . 0.0 112.433 -177.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 26.6 p -134.25 163.15 30.27 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.991 1.716 . . . . 0.0 106.947 173.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -55.62 -46.58 77.37 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.492 0.717 . . . . 0.0 110.656 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -55.98 -45.13 79.07 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.997 0.919 . . . . 0.0 111.468 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.9 p -78.34 -29.78 47.76 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 111.6 0.222 . . . . 0.0 111.6 -177.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -37.62 -53.59 1.2 Allowed 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 125.782 1.633 . . . . 0.0 114.473 -176.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -50.87 -62.2 1.75 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.611 0.719 . . . . 0.0 111.045 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -66.39 -49.53 66.51 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.944 -176.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -74.39 -21.0 59.86 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -173.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.5 t -119.51 -64.99 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.23 0.066 0 CA-C-N 119.326 0.966 . . . . 0.0 110.161 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 67.9 mt -59.66 -37.46 78.79 Favored 'General case' 0 C--N 1.334 -0.082 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 -174.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -98.61 15.75 24.1 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.428 0.558 . . . . 0.0 111.949 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.58 108.39 20.98 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 118.979 0.809 . . . . 0.0 111.047 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -75.38 63.97 1.49 Allowed 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.933 1.293 . . . . 0.0 111.336 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -163.81 178.38 39.29 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.61 105.66 17.9 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.134 1.374 . . . . 0.0 109.44 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.7 mt -112.38 117.35 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 124.144 0.978 . . . . 0.0 110.352 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.5 tp -90.5 97.89 11.45 Favored 'General case' 0 CA--C 1.523 -0.062 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 175.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.8 t -88.78 111.79 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -95.54 106.8 18.93 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.709 1.204 . . . . 0.0 108.601 176.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -80.5 125.17 29.63 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 175.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 31.1 p-90 -143.84 176.2 9.43 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.858 0.863 . . . . 0.0 112.574 -174.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.17 144.71 16.15 Favored 'General case' 0 C--N 1.338 0.092 0 C-N-CA 125.065 1.346 . . . . 0.0 108.476 175.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 -48.93 -50.69 34.15 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.789 1.236 . . . . 0.0 112.099 -178.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 63.9 p-90 -60.41 -29.84 69.22 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -177.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 49.5 t -79.82 77.88 6.45 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 121.514 -0.741 . . . . 0.0 110.52 -178.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -24.66 -62.1 0.05 OUTLIER Glycine 0 CA--C 1.536 1.399 0 C-N-CA 127.094 2.283 . . . . 0.0 115.084 179.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -43.88 -31.16 3.49 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 124.683 3.589 . . . . 0.0 115.192 179.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 98.8 m -55.09 -42.73 73.21 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.688 -0.633 . . . . 0.0 109.705 176.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -67.77 -27.2 66.56 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.712 0.805 . . . . 0.0 111.007 178.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 12.7 tmm? -72.3 -48.99 38.03 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 43.5 pt -70.39 -31.49 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 118.696 -0.668 . . . . 0.0 112.209 178.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -37.53 -60.94 0.8 Allowed Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -57.48 -39.35 89.6 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.374 2.049 . . . . 0.0 111.734 178.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 16.1 mt -59.22 -52.27 62.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.5 mt -55.84 -43.64 77.22 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.652 0.781 . . . . 0.0 110.575 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -58.09 -50.52 73.19 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.121 0.486 . . . . 0.0 109.804 178.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -59.88 -49.98 75.57 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.6 mm -53.37 -46.59 58.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 123.688 0.795 . . . . 0.0 109.585 177.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.56 -45.96 70.08 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.753 0.421 . . . . 0.0 110.608 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -66.43 -55.65 14.73 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 177.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -50.36 -47.82 55.9 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.931 0.892 . . . . 0.0 112.291 -177.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -98.31 23.74 8.04 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.813 0.845 . . . . 0.0 111.614 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -53.82 130.86 38.49 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 119.396 0.998 . . . . 0.0 110.526 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.24 -18.64 12.92 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 119.151 -0.805 . . . . 0.0 113.087 -178.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -99.3 -42.38 7.03 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.788 1.294 . . . . 0.0 109.288 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.0 tp -132.42 131.87 42.22 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.511 1.125 . . . . 0.0 108.667 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 90.4 m -96.27 104.37 16.32 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 176.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 90.7 t -79.74 134.66 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.08 150.02 51.16 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.296 0.639 . . . . 0.0 109.284 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -126.39 136.27 52.48 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 178.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.5 tt -129.45 115.13 17.04 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.412 0.685 . . . . 0.0 109.16 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -80.63 111.11 16.75 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.1 pt -73.19 -25.1 21.19 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.139 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -177.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -61.54 -46.96 87.71 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 177.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -70.6 -40.13 73.41 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.222 1.009 . . . . 0.0 109.894 177.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -120.53 69.77 16.36 Favored Pre-proline 0 CA--C 1.532 0.269 0 C-N-CA 124.06 0.944 . . . . 0.0 112.691 -175.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -65.54 -41.42 15.23 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 121.802 1.668 . . . . 0.0 110.653 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -43.99 -35.99 3.65 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 125.569 1.557 . . . . 0.0 114.913 -178.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.98 -20.41 61.73 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.604 1.202 . . . . 0.0 112.92 -177.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.25 -59.22 13.6 Favored Pre-proline 0 CA--C 1.539 0.538 0 O-C-N 121.111 -0.993 . . . . 0.0 113.226 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -58.17 -33.25 97.29 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.281 1.987 . . . . 0.0 111.805 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -52.98 -29.0 26.48 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.87 0.759 . . . . 0.0 111.929 177.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -122.94 20.47 10.0 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.464 0.705 . . . . 0.0 110.57 177.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 40.3 43.39 2.74 Favored Glycine 0 C--N 1.342 0.875 0 C-N-CA 126.03 1.776 . . . . 0.0 111.535 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.5 mt -54.06 138.39 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -174.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.51 -41.4 32.47 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.55 1.14 . . . . 0.0 111.219 -174.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -178.25 -150.94 9.01 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 106.674 -2.57 . . . . 0.0 106.674 -177.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.3 pt -148.36 154.31 41.75 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 118.856 1.328 . . . . 0.0 108.979 178.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -70.72 141.41 68.38 Favored 'Cis proline' 0 N--CA 1.455 -0.767 0 CA-C-N 119.786 0.959 . . . . 0.0 110.333 -1.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 43.5 m -133.79 125.92 29.5 Favored 'General case' 0 C--O 1.231 0.111 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 178.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.2 mt -103.58 124.96 49.77 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.89 1.276 . . . . 0.0 109.15 -177.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -114.52 117.35 30.69 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 105.064 -2.199 . . . . 0.0 105.064 174.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.5 tp -94.98 95.41 8.6 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -86.88 102.9 14.77 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.162 1.385 . . . . 0.0 110.052 -178.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -97.93 114.68 26.85 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 174.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 54.23 46.99 24.11 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.536 0.734 . . . . 0.0 109.981 -178.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 69.55 -1.8 13.15 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-O 118.62 -1.1 . . . . 0.0 114.414 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -103.46 128.97 50.51 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 119.657 1.728 . . . . 0.0 109.253 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 98.8 t -66.35 102.7 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.17 -38.54 35.64 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.696 0.799 . . . . 0.0 109.652 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -150.76 167.29 27.88 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 97.4 m -147.49 149.92 33.57 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.13 141.31 31.16 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -177.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 36.7 t -125.36 128.44 72.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.38 175.87 37.37 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 123.829 0.728 . . . . 0.0 111.649 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.73 173.16 9.47 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.455 0.702 . . . . 0.0 111.44 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.0 mt -146.4 161.69 39.83 Favored 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 125.28 1.432 . . . . 0.0 109.333 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.6 p -92.47 152.42 19.69 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 169.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -51.1 -47.46 61.93 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 122.138 -0.351 . . . . 0.0 111.522 -177.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.8 -60.31 8.9 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -54.46 -41.36 69.38 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.989 -0.712 . . . . 0.0 111.422 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 30.3 tp -60.79 -48.67 80.74 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -55.65 -48.0 75.73 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 118.903 -0.57 . . . . 0.0 110.298 176.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -56.0 -52.13 65.31 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.975 0.807 . . . . 0.0 110.515 178.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -52.05 -51.34 58.14 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.789 0.835 . . . . 0.0 110.429 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 90.1 mt -61.97 -52.33 64.45 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.503 0.321 . . . . 0.0 110.723 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -50.55 -49.79 55.1 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.67 1.188 . . . . 0.0 110.126 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.47 -36.17 68.78 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.402 0.681 . . . . 0.0 111.906 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -78.88 -45.81 19.86 Favored 'General case' 0 N--CA 1.46 0.043 0 O-C-N 122.23 -0.294 . . . . 0.0 110.538 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 56.2 mt -60.26 -43.66 95.98 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.445 0.698 . . . . 0.0 109.655 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.278 0 C-N-CA 122.948 0.499 . . . . 0.0 109.795 177.827 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.3 mt . . . . . 0 N--CA 1.449 -0.505 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.9 mm -87.79 111.29 21.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 123.599 0.76 . . . . 0.0 109.073 178.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -83.04 101.21 10.97 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 70.7 mt -83.23 163.49 20.71 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.543 1.137 . . . . 0.0 112.139 -177.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 62.2 p -131.51 162.42 30.29 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 173.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -59.25 -46.09 89.43 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.866 0.757 . . . . 0.0 109.543 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -62.72 -41.62 99.25 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.896 0.478 . . . . 0.0 111.713 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 54.4 p -78.33 -26.16 46.75 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.409 0.55 . . . . 0.0 111.175 -177.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -41.85 -44.9 3.5 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 126.419 1.888 . . . . 0.0 112.415 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -53.25 -63.17 1.23 Allowed 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.535 0.684 . . . . 0.0 110.637 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.0 m -66.79 -42.63 85.65 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.742 -177.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -70.52 -50.14 40.89 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -175.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.0 t -100.07 -57.87 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 123.882 0.873 . . . . 0.0 111.141 -174.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 67.0 mt -63.21 -37.01 85.56 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 120.22 -0.592 . . . . 0.0 112.311 -174.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -94.5 21.94 6.68 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.344 0.52 . . . . 0.0 111.08 175.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.78 159.45 34.52 Favored 'General case' 0 C--N 1.34 0.16 0 O-C-N 121.471 -0.768 . . . . 0.0 110.568 177.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -138.6 58.41 1.66 Allowed 'General case' 0 C--O 1.226 -0.155 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 175.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 175.25 -174.2 46.66 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -178.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -86.55 128.28 34.96 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.595 1.158 . . . . 0.0 110.281 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.7 mt -132.99 121.08 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 124.417 1.087 . . . . 0.0 109.603 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -95.35 109.51 21.66 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 175.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.1 t -100.46 108.59 23.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 123.16 0.584 . . . . 0.0 110.043 -178.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -93.7 105.19 17.24 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.125 0.97 . . . . 0.0 109.745 178.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -79.57 114.25 18.35 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 105.048 -2.204 . . . . 0.0 105.048 174.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 39.4 p-90 -128.25 170.55 12.9 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.836 1.255 . . . . 0.0 112.185 -176.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -146.24 131.56 18.54 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.283 1.433 . . . . 0.0 107.763 176.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 -51.14 -37.05 43.98 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.923 0.889 . . . . 0.0 113.24 -178.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 57.7 p-90 -77.9 -20.49 52.83 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 52.8 t -79.83 74.16 6.56 Favored 'General case' 0 N--CA 1.456 -0.138 0 O-C-N 121.228 -0.92 . . . . 0.0 110.745 -177.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -9.68 -71.39 0.01 OUTLIER Glycine 0 CA--C 1.535 1.329 0 C-N-CA 128.294 2.854 . . . . 0.0 115.699 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -40.91 -32.81 0.97 Allowed 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 125.207 3.938 . . . . 0.0 115.61 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 89.3 m -52.66 -41.82 64.16 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.368 0.667 . . . . 0.0 110.207 177.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -66.23 -30.23 70.63 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.717 0.807 . . . . 0.0 111.234 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -75.61 -45.02 39.83 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.9 pt -73.28 -31.15 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-O 118.712 -0.661 . . . . 0.0 112.333 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -39.32 -60.95 1.09 Allowed Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -58.11 -36.86 97.57 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.376 2.051 . . . . 0.0 111.893 178.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 19.7 mt -60.92 -51.79 69.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 177.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.6 mt -56.31 -41.34 75.84 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.189 0.596 . . . . 0.0 110.117 177.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -60.76 -47.87 84.35 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.841 0.746 . . . . 0.0 110.093 176.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -56.91 -51.88 67.38 Favored 'General case' 0 C--N 1.339 0.117 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 31.4 mm -53.72 -46.12 61.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 123.302 0.641 . . . . 0.0 109.498 177.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.65 -36.75 67.39 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.939 0.496 . . . . 0.0 111.223 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -74.5 -58.14 3.48 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.938 0.399 . . . . 0.0 109.986 176.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -50.36 -41.91 52.36 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.734 1.214 . . . . 0.0 112.532 -177.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -107.07 25.45 11.36 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.642 1.177 . . . . 0.0 111.021 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -56.94 121.84 10.87 Favored 'General case' 0 CA--C 1.529 0.173 0 O-C-N 121.545 -0.722 . . . . 0.0 110.39 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.06 -9.83 55.54 Favored Glycine 0 CA--C 1.531 1.094 0 CA-C-O 119.556 -0.58 . . . . 0.0 112.85 -178.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 47.4 mttt -99.71 -41.3 7.35 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.691 1.196 . . . . 0.0 108.664 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 47.7 tp -131.82 133.6 44.86 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.572 1.149 . . . . 0.0 108.708 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.2 m -88.08 98.49 11.56 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 176.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 80.5 t -79.09 128.95 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 178.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.65 150.64 50.68 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.276 0.56 . . . . 0.0 110.662 -177.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -127.54 143.45 51.18 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.972 1.309 . . . . 0.0 107.597 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 tt -134.2 115.19 13.89 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -80.83 105.05 11.76 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pp -58.97 -33.87 51.25 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.242 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -177.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -63.05 -44.31 96.23 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.704 0.684 . . . . 0.0 110.226 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -72.06 -31.49 66.18 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 177.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -128.53 69.79 79.41 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -176.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.02 -50.89 10.89 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.488 2.792 . . . . 0.0 113.408 -178.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -41.37 -40.1 2.56 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 125.431 1.491 . . . . 0.0 114.34 -176.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.88 -30.64 69.13 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.767 -0.843 . . . . 0.0 113.113 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.11 -64.57 2.19 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-O 118.259 -0.877 . . . . 0.0 112.292 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -60.02 -37.21 86.3 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 121.833 1.689 . . . . 0.0 111.511 177.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -52.34 -37.18 55.35 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 119.386 0.994 . . . . 0.0 111.791 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -111.49 20.9 16.76 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.922 0.489 . . . . 0.0 110.92 177.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 41.9 45.08 4.73 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 125.537 1.541 . . . . 0.0 112.901 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mp -47.89 116.45 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 117.702 0.751 . . . . 0.0 110.411 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.41 -49.62 12.07 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.179 0.992 . . . . 0.0 110.295 -177.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -161.9 144.1 9.43 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 107.419 -2.272 . . . . 0.0 107.419 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.7 pt -96.85 150.8 37.31 Favored Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 123.837 0.855 . . . . 0.0 110.246 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -70.23 137.28 44.1 Favored 'Cis proline' 0 N--CA 1.457 -0.672 0 CA-C-N 119.591 0.89 . . . . 0.0 110.597 -1.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -115.43 118.91 34.51 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.3 mt -102.37 105.51 16.12 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -179.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -94.21 114.36 26.45 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 104.781 -2.304 . . . . 0.0 104.781 175.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.6 tp -97.24 105.53 17.7 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -179.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -94.18 150.01 20.71 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.584 1.554 . . . . 0.0 110.712 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -139.63 107.04 5.54 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 173.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 51.01 70.81 0.49 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.548 0.689 . . . . 0.0 111.457 -179.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 73.4 -37.09 0.82 Allowed Glycine 0 CA--C 1.531 1.04 0 N-CA-C 115.923 1.129 . . . . 0.0 115.923 176.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -90.14 147.88 23.32 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.146 1.473 . . . . 0.0 111.373 -177.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 75.3 t -74.38 114.66 14.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 175.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.04 -46.66 13.63 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.62 1.168 . . . . 0.0 109.852 178.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -148.64 170.85 17.22 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 58.9 m -152.57 144.92 24.0 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -177.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -135.29 143.88 46.46 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.4 t -121.94 120.77 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 178.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.03 169.7 35.05 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -177.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.27 170.53 8.57 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.983 0.913 . . . . 0.0 112.882 -178.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.1 mt -142.63 155.76 44.98 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 125.977 1.711 . . . . 0.0 108.572 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.6 p -87.78 152.51 22.06 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 171.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -48.21 -52.35 21.33 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -176.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -53.71 -57.26 16.63 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 26.8 mm100 -57.74 -40.93 80.79 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 122.194 -0.592 . . . . 0.0 111.122 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 42.2 tp -62.13 -49.4 76.01 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 177.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -54.1 -45.99 71.97 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.387 0.54 . . . . 0.0 110.403 176.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -57.96 -54.87 42.04 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 122.92 0.488 . . . . 0.0 110.453 178.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -51.44 -52.21 48.24 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.757 1.223 . . . . 0.0 110.584 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 85.4 mt -61.24 -53.39 57.45 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.805 0.442 . . . . 0.0 110.418 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -51.54 -50.29 60.3 Favored 'General case' 0 C--N 1.334 -0.083 0 C-N-CA 123.765 0.826 . . . . 0.0 111.067 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.82 -37.65 66.38 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.354 0.662 . . . . 0.0 111.654 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -78.78 -43.52 25.31 Favored 'General case' 0 N--CA 1.46 0.073 0 C-N-CA 122.456 0.302 . . . . 0.0 110.587 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 40.4 mt -58.82 -47.06 86.13 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.289 0 C-N-CA 123.364 0.666 . . . . 0.0 109.69 177.656 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 22.0 mt . . . . . 0 N--CA 1.447 -0.583 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.5 mm -88.03 112.09 23.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 -80.28 102.4 9.49 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 72.7 mt -90.93 161.96 14.97 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 121.814 0.816 . . . . 0.0 112.258 -177.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 82.6 p -139.96 167.15 22.78 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.733 2.013 . . . . 0.0 106.444 175.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -55.22 -47.77 74.87 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.459 0.704 . . . . 0.0 110.656 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -61.8 -40.15 94.22 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.2 p -78.74 -29.99 45.53 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 122.109 -0.369 . . . . 0.0 110.727 -178.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -39.27 -52.83 1.97 Allowed 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 125.841 1.656 . . . . 0.0 113.436 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -55.6 -59.18 5.2 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 121.868 -0.52 . . . . 0.0 110.908 -179.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.1 m -59.11 -48.85 80.08 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.222 1.009 . . . . 0.0 112.569 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.96 -47.1 16.97 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -174.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.8 t -94.56 -52.39 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 C-N-CA 123.347 0.659 . . . . 0.0 112.504 -174.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 73.6 mt -71.4 -42.72 68.0 Favored 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 119.545 -0.862 . . . . 0.0 111.218 -175.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -91.64 35.32 0.96 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 176.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -78.1 162.1 26.92 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.415 0.686 . . . . 0.0 111.987 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -141.8 94.28 2.66 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 172.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 135.52 -175.51 20.7 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -176.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.05 111.59 23.32 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.374 1.47 . . . . 0.0 109.687 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.0 mt -109.07 115.98 50.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 124.153 0.981 . . . . 0.0 109.686 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.6 tp -90.14 96.97 10.92 Favored 'General case' 0 C--N 1.338 0.076 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 176.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 45.4 t -88.51 114.58 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 123.328 0.651 . . . . 0.0 109.899 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -98.87 106.09 18.31 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 176.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -79.73 120.05 23.49 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 175.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 37.6 p-90 -133.84 170.52 15.47 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.332 1.053 . . . . 0.0 113.152 -175.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -142.76 138.68 30.64 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.192 1.397 . . . . 0.0 107.444 174.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -53.89 -47.64 70.92 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.015 0.526 . . . . 0.0 112.236 -177.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 62.6 p-90 -65.68 -23.75 66.85 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.108 0.563 . . . . 0.0 112.413 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 52.1 t -79.68 80.38 6.07 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 121.34 -0.85 . . . . 0.0 109.75 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -27.06 -59.89 0.09 OUTLIER Glycine 0 CA--C 1.535 1.304 0 C-N-CA 127.078 2.275 . . . . 0.0 114.391 178.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -41.75 -37.16 3.77 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 124.248 3.299 . . . . 0.0 114.699 177.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 75.1 m -58.24 -47.67 82.82 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.689 0.757 . . . . 0.0 109.837 177.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -65.37 -37.28 86.54 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.71 0.804 . . . . 0.0 109.094 178.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 54.3 mtm -63.44 -43.14 98.27 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 119.243 -0.408 . . . . 0.0 111.061 177.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 31.5 pt -75.46 -26.52 18.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 119.139 0.881 . . . . 0.0 112.164 178.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -38.26 -57.8 1.69 Allowed Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -57.42 -40.13 83.71 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.072 1.848 . . . . 0.0 111.499 177.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 16.4 mt -59.32 -49.19 84.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.9 mt -57.22 -43.53 82.89 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.75 0.42 . . . . 0.0 110.763 177.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.46 -50.76 72.58 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.725 0.693 . . . . 0.0 110.16 176.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -56.24 -52.1 65.68 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.4 mm -54.55 -46.88 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 124.891 1.276 . . . . 0.0 110.221 178.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.05 -44.69 79.07 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.723 0.409 . . . . 0.0 110.041 178.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -64.26 -53.34 50.48 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 177.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -49.46 -48.91 47.28 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.177 0.991 . . . . 0.0 111.684 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -100.82 29.63 4.45 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.347 0.659 . . . . 0.0 111.344 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -55.54 123.45 14.04 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.43 -0.794 . . . . 0.0 110.5 -179.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.71 -15.13 43.72 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 119.466 -0.63 . . . . 0.0 112.913 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -99.62 -40.23 7.9 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.371 1.086 . . . . 0.0 109.458 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.7 tp -126.41 132.88 51.41 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.656 1.183 . . . . 0.0 108.83 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.0 m -97.44 101.8 13.42 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 176.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 66.6 t -79.62 135.0 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 178.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.92 150.19 49.22 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.413 0.685 . . . . 0.0 109.732 -178.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 45.2 mttm -127.96 126.62 41.76 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.0 tt -116.66 115.82 26.39 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.442 0.697 . . . . 0.0 109.608 179.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -79.15 108.97 13.04 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 pp -68.37 -32.42 55.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 119.228 -0.415 . . . . 0.0 111.395 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -51.13 -33.19 25.51 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.654 0.661 . . . . 0.0 112.17 -179.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -110.43 1.32 18.26 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.41 1.084 . . . . 0.0 111.563 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -144.19 64.1 12.09 Favored Pre-proline 0 C--O 1.234 0.26 0 C-N-CA 124.42 1.088 . . . . 0.0 109.163 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -60.01 -53.33 3.22 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.646 2.231 . . . . 0.0 112.394 -177.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -38.42 -47.47 2.15 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.392 1.472 . . . . 0.0 114.478 -177.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.86 -33.29 49.14 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.367 1.067 . . . . 0.0 112.753 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.93 -68.32 0.75 Allowed Pre-proline 0 CA--C 1.54 0.564 0 CA-C-O 118.295 -0.859 . . . . 0.0 112.98 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.84 -39.36 82.31 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 121.484 1.456 . . . . 0.0 110.806 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -51.29 -38.48 53.03 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 118.415 0.552 . . . . 0.0 111.826 178.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -107.32 18.87 21.07 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 55.46 40.62 78.14 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 123.106 0.384 . . . . 0.0 113.043 176.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mp -63.52 104.31 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 176.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 47.6 mtt85 -79.62 -43.4 22.96 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.902 1.281 . . . . 0.0 110.186 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -157.49 141.91 8.18 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 107.874 -2.09 . . . . 0.0 107.874 179.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.1 pt -99.45 147.48 33.4 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 124.354 1.062 . . . . 0.0 109.762 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.57 142.41 66.88 Favored 'Cis proline' 0 N--CA 1.457 -0.649 0 CA-C-N 120.112 1.076 . . . . 0.0 111.156 0.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -121.38 110.69 16.4 Favored 'General case' 0 C--N 1.335 -0.062 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.2 mt -88.73 123.05 32.78 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.7 mp -122.32 118.97 29.74 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 176.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.8 tp -95.31 95.08 8.24 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -177.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -86.55 105.23 16.69 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.682 1.193 . . . . 0.0 110.768 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -93.62 111.07 22.67 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 173.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.5 m120 47.87 50.88 15.07 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.718 0.807 . . . . 0.0 111.169 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.38 -11.53 24.06 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 118.851 -0.972 . . . . 0.0 114.676 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -97.36 121.16 38.94 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 119.632 1.716 . . . . 0.0 109.745 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 89.4 t -64.07 106.08 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 175.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.98 -37.51 39.22 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.587 0.755 . . . . 0.0 109.553 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.81 170.04 21.51 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.3 t -149.59 156.89 42.67 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 178.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.2 tmtm? -138.55 116.38 11.54 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.853 1.661 . . . . 0.0 106.764 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 36.5 t -96.35 126.93 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -178.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.01 178.67 47.44 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.27 168.2 12.87 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.104 0.478 . . . . 0.0 110.342 178.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -158.09 165.33 35.28 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.842 0.857 . . . . 0.0 109.154 -178.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 83.1 p -80.2 160.29 25.67 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 177.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -58.62 -38.43 78.01 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 175.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -56.01 -54.73 33.31 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 110.656 -0.977 . . . . 0.0 110.656 176.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -52.91 -50.03 64.75 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 117.241 0.52 . . . . 0.0 110.424 177.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 14.6 tp -59.79 -50.11 75.1 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 121.141 -0.224 . . . . 0.0 110.704 -178.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -55.05 -49.14 72.34 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.185 0.594 . . . . 0.0 111.581 178.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -67.68 -43.81 79.29 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.509 -177.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -52.15 -53.0 48.32 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.655 0.782 . . . . 0.0 109.208 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 84.8 mt -59.42 -54.42 46.87 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 119.116 -0.469 . . . . 0.0 110.78 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -51.43 -50.01 60.55 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.106 0.412 . . . . 0.0 111.022 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.95 -38.8 73.44 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.492 0.717 . . . . 0.0 111.847 179.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -78.3 -40.93 35.31 Favored 'General case' 0 N--CA 1.461 0.117 0 O-C-N 122.092 -0.38 . . . . 0.0 110.995 -178.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 63.0 mt -64.14 -46.59 83.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.266 0 C-N-CA 122.922 0.489 . . . . 0.0 109.82 177.7 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.4 mt . . . . . 0 C--O 1.23 0.059 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.4 mm -87.03 108.2 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -81.68 110.55 17.12 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 177.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.0 mt -88.94 171.9 9.54 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.628 1.171 . . . . 0.0 110.502 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 51.0 p -136.21 164.26 28.48 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 171.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -57.1 -47.77 80.25 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 177.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -59.52 -45.35 91.99 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.674 1.19 . . . . 0.0 111.889 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 86.1 p -79.64 -24.43 41.89 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -176.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -31.7 -60.33 0.25 Allowed 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 127.121 2.169 . . . . 0.0 114.337 -178.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -52.36 -59.19 4.71 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.46 0.648 . . . . 0.0 111.048 -177.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.9 m -60.01 -41.66 92.65 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 123.6 0.76 . . . . 0.0 111.733 -178.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -74.79 -43.14 56.31 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -175.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 45.8 t -105.85 -57.31 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 C-N-CA 124.568 1.147 . . . . 0.0 112.08 -172.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 75.5 mt -61.38 -33.54 73.83 Favored 'General case' 0 N--CA 1.458 -0.037 0 O-C-N 121.702 -0.624 . . . . 0.0 111.876 -174.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -88.91 8.66 28.19 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 118.286 0.493 . . . . 0.0 111.809 177.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.79 100.58 11.02 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 121.253 -0.905 . . . . 0.0 112.489 -178.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -77.06 68.77 3.26 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 174.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -179.84 -172.11 43.5 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -178.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -99.6 115.76 30.14 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.562 1.545 . . . . 0.0 110.857 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 mt -121.53 123.44 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 125.43 1.492 . . . . 0.0 109.116 178.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -92.86 108.32 19.9 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 175.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 32.2 t -97.3 109.91 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -93.57 106.36 18.34 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 177.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -79.66 125.52 29.74 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 175.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 38.0 p-90 -143.79 166.12 25.78 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -174.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -144.59 137.24 26.6 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.168 1.387 . . . . 0.0 108.909 174.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -51.75 -47.82 63.94 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.865 0.866 . . . . 0.0 112.372 -177.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 50.4 p-90 -60.75 -27.04 67.66 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 46.8 t -79.86 81.48 6.12 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 121.42 -0.8 . . . . 0.0 109.098 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -28.14 -59.17 0.13 Allowed Glycine 0 CA--C 1.538 1.525 0 C-N-CA 125.962 1.744 . . . . 0.0 114.27 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -41.89 -39.27 5.27 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 124.311 3.341 . . . . 0.0 114.464 177.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 94.1 m -56.02 -50.52 70.66 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 121.668 0.747 . . . . 0.0 109.985 176.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -64.18 -38.07 89.74 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.319 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 83.9 mtp -61.7 -44.16 97.47 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 119.472 -0.299 . . . . 0.0 110.827 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.5 pt -76.17 -26.96 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 118.741 0.7 . . . . 0.0 112.635 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -37.8 -57.93 1.48 Allowed Pre-proline 0 CA--C 1.546 0.79 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -58.14 -39.7 83.1 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.07 1.847 . . . . 0.0 111.672 178.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 14.0 mt -59.52 -49.65 82.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 177.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 44.2 mt -56.1 -42.33 76.62 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 122.564 0.346 . . . . 0.0 110.161 177.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -61.71 -46.86 87.83 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.994 0.815 . . . . 0.0 111.147 176.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -56.14 -51.12 69.1 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 24.0 mm -55.92 -44.78 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 123.428 0.691 . . . . 0.0 109.831 177.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.86 70.68 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 118.321 0.509 . . . . 0.0 110.787 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -72.55 -57.61 4.01 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 177.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -51.18 -46.09 62.0 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.231 1.012 . . . . 0.0 112.605 -178.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -98.26 19.82 13.6 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.438 1.095 . . . . 0.0 111.426 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -54.93 131.85 45.44 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.25 -0.906 . . . . 0.0 110.085 -178.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.25 -18.76 7.64 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 119.334 -0.703 . . . . 0.0 113.235 -178.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -99.61 -37.42 9.15 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.486 1.143 . . . . 0.0 109.923 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 26.6 tp -136.68 128.01 28.26 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.496 1.118 . . . . 0.0 108.181 178.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 57.6 m -88.55 105.08 17.4 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 91.2 t -79.53 130.36 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.96 153.19 51.94 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.938 0.895 . . . . 0.0 110.45 -177.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -128.74 144.02 51.06 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.658 1.183 . . . . 0.0 108.221 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.0 tt -134.04 117.4 16.61 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -87.19 99.76 12.18 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 122.125 -0.359 . . . . 0.0 110.984 -175.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.9 pt -55.26 -28.11 21.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -56.99 -43.55 81.84 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.828 0.74 . . . . 0.0 110.294 177.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -95.28 -17.5 21.61 Favored 'General case' 0 CA--C 1.53 0.212 0 C-N-CA 124.818 1.247 . . . . 0.0 111.577 -178.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -129.82 59.35 44.3 Favored Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 124.532 1.133 . . . . 0.0 108.822 -175.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -62.42 -52.18 2.77 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.609 2.206 . . . . 0.0 113.768 -174.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -44.75 -42.99 7.93 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.016 0.817 . . . . 0.0 113.466 -175.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.43 -33.35 43.62 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.055 0.942 . . . . 0.0 112.663 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.54 -68.51 0.63 Allowed Pre-proline 0 CA--C 1.538 0.503 0 CA-C-O 118.139 -0.934 . . . . 0.0 112.294 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -59.86 -38.24 80.84 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 121.595 1.53 . . . . 0.0 111.016 177.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -51.44 -41.31 60.74 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.266 0.939 . . . . 0.0 111.458 178.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -104.59 19.43 20.4 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.505 0.322 . . . . 0.0 111.753 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.16 39.07 49.62 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.224 0.916 . . . . 0.0 113.401 176.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.5 mp -57.01 127.6 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 118.102 0.951 . . . . 0.0 108.903 177.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -92.24 -47.02 7.43 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.658 1.183 . . . . 0.0 110.238 -178.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -160.55 144.94 10.45 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 107.999 -2.04 . . . . 0.0 107.999 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 9.1 pt -99.08 149.34 35.68 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 124.111 0.964 . . . . 0.0 110.275 -179.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.15 140.02 52.91 Favored 'Cis proline' 0 N--CA 1.457 -0.65 0 CA-C-N 119.961 1.022 . . . . 0.0 111.268 -0.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.85 109.56 15.72 Favored 'General case' 0 CA--C 1.527 0.096 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 178.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.5 mt -91.31 93.17 8.94 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.913 0.885 . . . . 0.0 108.758 -178.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.7 mp -90.56 114.47 26.7 Favored 'General case' 0 CA--C 1.522 -0.117 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 177.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -91.6 103.43 16.02 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -91.49 115.24 27.88 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.144 1.378 . . . . 0.0 110.15 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -111.64 125.27 53.77 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 173.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 53.08 46.11 27.36 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.57 0.7 . . . . 0.0 109.621 -178.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.2 7.16 23.5 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 118.167 -1.352 . . . . 0.0 115.449 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -118.03 142.0 47.86 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 120.002 1.901 . . . . 0.0 110.175 178.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 87.4 t -65.92 110.3 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.39 -42.62 25.1 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.895 0.878 . . . . 0.0 108.647 176.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -158.88 170.95 20.96 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.076 0.95 . . . . 0.0 108.662 177.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 91.2 m -147.33 129.86 15.89 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -179.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -112.2 112.95 24.92 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.0 t -92.02 123.46 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.69 167.43 35.02 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 123.885 0.755 . . . . 0.0 112.232 178.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.3 170.56 12.86 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.108 0.563 . . . . 0.0 110.589 179.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -161.16 172.93 15.88 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.689 0.795 . . . . 0.0 109.913 -176.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 82.8 p -84.15 163.88 19.51 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -57.83 -40.78 80.87 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 175.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -59.51 -57.62 18.63 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 177.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -56.44 -40.45 74.8 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 117.589 0.695 . . . . 0.0 110.71 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 28.7 tp -61.05 -54.94 38.61 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 177.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -53.67 -46.36 70.61 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.314 0.506 . . . . 0.0 111.108 178.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -57.49 -53.71 55.04 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.581 0.753 . . . . 0.0 110.044 178.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -52.97 -54.02 41.33 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.327 1.051 . . . . 0.0 110.448 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.3 mt -59.27 -51.81 68.36 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.654 -179.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -54.77 -51.09 66.81 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.057 0.543 . . . . 0.0 110.661 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.2 -37.37 67.01 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.586 0.755 . . . . 0.0 111.46 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -78.13 -45.97 21.91 Favored 'General case' 0 C--O 1.227 -0.081 0 O-C-N 122.336 -0.227 . . . . 0.0 110.587 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 51.9 mt -58.23 -47.3 83.94 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.31 0 C-N-CA 123.286 0.634 . . . . 0.0 109.566 177.355 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.1 mt . . . . . 0 N--CA 1.45 -0.466 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.7 mm -87.31 107.78 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 -79.74 92.03 5.37 Favored 'General case' 0 N--CA 1.461 0.082 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 177.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.2 mt -75.79 162.53 28.1 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.794 0.838 . . . . 0.0 111.685 -178.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.3 p -137.28 162.1 34.44 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 171.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -53.25 -44.93 68.55 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.368 0.667 . . . . 0.0 109.965 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -56.01 -39.86 72.53 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.853 1.261 . . . . 0.0 111.564 178.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.35 -43.48 27.63 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 122.089 -0.382 . . . . 0.0 109.98 -177.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -31.05 -55.71 0.23 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 127.702 2.401 . . . . 0.0 114.773 -177.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -55.35 -36.37 66.22 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -177.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.0 m -90.26 -53.4 4.47 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.527 0.679 . . . . 0.0 109.305 179.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.21 -50.55 72.65 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 113.08 0.771 . . . . 0.0 113.08 -174.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.0 t -94.14 -60.29 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 123.467 0.707 . . . . 0.0 111.077 -174.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 65.3 mt -62.72 -24.17 67.54 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -174.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -114.82 32.39 6.03 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 174.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.88 143.72 41.57 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -99.52 36.25 1.81 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.776 1.23 . . . . 0.0 110.369 177.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 159.52 -157.17 28.34 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.42 118.46 26.89 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.706 1.602 . . . . 0.0 110.369 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.2 mt -119.72 120.79 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 C-N-CA 124.782 1.233 . . . . 0.0 109.017 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -91.78 106.41 18.45 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 105.788 -1.931 . . . . 0.0 105.788 175.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 53.9 t -98.02 108.74 22.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 123.36 0.664 . . . . 0.0 109.407 -178.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -93.9 110.09 21.77 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 177.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -81.52 119.44 23.76 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 175.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 27.7 p-90 -136.1 173.32 11.84 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.665 1.186 . . . . 0.0 112.049 -175.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.29 150.84 37.38 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.546 1.138 . . . . 0.0 108.721 175.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -56.92 -51.25 69.85 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.682 1.193 . . . . 0.0 111.834 -178.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 63.9 p-90 -68.68 -24.31 64.49 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.006 0.922 . . . . 0.0 112.835 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 51.4 t -79.35 79.26 5.8 Favored 'General case' 0 N--CA 1.456 -0.167 0 O-C-N 121.506 -0.746 . . . . 0.0 110.807 -177.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -26.78 -61.52 0.08 OUTLIER Glycine 0 CA--C 1.536 1.383 0 C-N-CA 127.018 2.246 . . . . 0.0 114.852 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -45.05 -29.54 3.98 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 124.493 3.462 . . . . 0.0 115.227 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 78.4 m -56.35 -40.98 75.37 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 121.219 -0.926 . . . . 0.0 109.615 176.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -71.21 -20.38 62.27 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.972 0.909 . . . . 0.0 111.23 178.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -74.98 -46.63 33.95 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 175.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 35.7 pt -72.49 -31.36 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.785 178.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -37.73 -60.28 0.96 Allowed Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -57.15 -40.27 84.37 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.297 1.998 . . . . 0.0 111.547 178.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.5 mt -58.7 -51.59 70.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.7 mt -56.54 -41.01 76.08 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.059 0.544 . . . . 0.0 110.347 177.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -60.28 -48.98 79.41 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.554 0.616 . . . . 0.0 110.013 177.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -57.06 -51.03 70.89 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 29.8 mm -54.9 -46.31 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 123.089 0.555 . . . . 0.0 109.738 177.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.93 -41.04 70.55 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.327 0.512 . . . . 0.0 110.754 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -69.8 -56.32 7.45 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 176.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -50.31 -49.94 52.19 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.955 0.902 . . . . 0.0 112.544 -178.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -97.08 27.15 4.23 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.444 1.098 . . . . 0.0 111.564 -177.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -55.94 124.38 17.48 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 119.202 0.91 . . . . 0.0 110.626 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.57 -10.47 37.39 Favored Glycine 0 CA--C 1.534 1.241 0 CA-C-O 119.423 -0.654 . . . . 0.0 113.238 -178.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.5 mttm -99.67 -42.15 7.0 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.56 1.144 . . . . 0.0 109.241 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.1 tp -134.72 128.61 33.27 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.282 1.033 . . . . 0.0 108.315 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 55.6 m -87.18 103.76 15.73 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 176.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.7 t -79.48 131.28 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 178.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.99 151.39 49.86 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.604 0.762 . . . . 0.0 110.076 -177.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.8 mttm -128.86 141.83 51.16 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 177.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 tt -132.13 114.84 15.0 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.002 0.921 . . . . 0.0 108.784 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 -80.65 108.32 14.19 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.1 pt -71.63 -23.17 22.29 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -179.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -61.58 -47.75 84.05 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 63.6 mm-40 -75.65 -33.81 60.47 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.347 178.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -119.76 70.79 13.99 Favored Pre-proline 0 N--CA 1.465 0.306 0 C-N-CA 123.954 0.902 . . . . 0.0 112.003 -177.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -61.45 -48.74 8.82 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 121.761 1.641 . . . . 0.0 111.231 -179.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -41.36 -42.68 3.43 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.416 1.484 . . . . 0.0 115.16 -178.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.55 -25.32 67.93 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.193 0.997 . . . . 0.0 112.609 -177.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.66 -64.26 3.09 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-O 118.306 -0.854 . . . . 0.0 112.61 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -59.72 -37.16 89.05 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.075 1.85 . . . . 0.0 111.184 178.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -51.98 -31.12 27.97 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 118.633 0.651 . . . . 0.0 111.865 178.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -119.29 22.2 11.89 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.115 0.566 . . . . 0.0 111.646 176.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 46.0 42.73 12.17 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.46 1.028 . . . . 0.0 113.126 177.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mp -50.17 117.31 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 117.865 0.833 . . . . 0.0 109.447 176.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.3 -36.87 39.0 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.208 1.003 . . . . 0.0 111.279 -175.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -170.74 -174.18 38.48 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 105.339 -3.104 . . . . 0.0 105.339 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.2 pt -140.13 151.61 65.26 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-N 119.503 1.651 . . . . 0.0 109.855 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -67.77 149.65 83.41 Favored 'Cis proline' 0 N--CA 1.457 -0.665 0 CA-C-N 119.593 0.89 . . . . 0.0 111.357 -0.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.5 m -134.07 145.38 49.33 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 175.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.2 mt -121.73 131.79 54.27 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -118.41 117.53 29.29 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 104.47 -2.419 . . . . 0.0 104.47 174.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -93.77 97.32 10.35 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -89.74 107.17 18.94 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.223 1.409 . . . . 0.0 110.935 -177.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -96.12 109.08 21.57 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 173.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 34.6 m120 48.08 47.89 18.73 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.314 1.046 . . . . 0.0 112.079 -179.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 86.0 -17.35 37.41 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 118.636 -1.091 . . . . 0.0 114.275 178.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -95.04 129.72 42.01 Favored 'General case' 0 N--CA 1.457 -0.093 0 CA-C-N 119.576 1.688 . . . . 0.0 110.146 178.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 90.4 t -69.03 109.5 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 176.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.05 -39.14 34.7 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.86 170.87 19.8 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.7 t -145.98 159.04 43.8 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -138.52 146.61 42.15 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 126.374 1.87 . . . . 0.0 106.946 -177.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.0 t -129.23 134.43 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 107.375 -1.342 . . . . 0.0 107.375 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.94 174.64 50.49 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 123.54 0.591 . . . . 0.0 111.687 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.3 167.95 19.35 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 122.783 0.433 . . . . 0.0 109.949 178.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -159.61 165.79 32.04 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.2 1.0 . . . . 0.0 108.487 -179.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 84.6 p -81.14 163.91 22.76 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -58.58 -41.32 85.47 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 174.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -56.88 -55.72 28.68 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 177.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -57.19 -44.73 83.87 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 122.059 -0.671 . . . . 0.0 110.28 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 48.0 tp -60.1 -51.13 70.95 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 117.792 0.269 . . . . 0.0 110.49 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -52.11 -50.26 62.0 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.661 0.784 . . . . 0.0 110.09 178.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -59.99 -51.36 69.98 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.096 0.158 . . . . 0.0 110.637 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -52.15 -53.63 40.57 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.026 0.93 . . . . 0.0 110.564 179.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.2 -53.21 60.37 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 122.872 0.469 . . . . 0.0 110.479 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -52.55 -51.28 60.43 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.05 0.54 . . . . 0.0 111.145 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.28 -37.7 67.65 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.57 0.748 . . . . 0.0 111.733 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -78.43 -43.88 26.2 Favored 'General case' 0 CA--C 1.524 -0.054 0 O-C-N 122.315 -0.24 . . . . 0.0 110.782 -178.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 46.3 mt -59.79 -47.31 86.2 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.261 0 C-N-CA 123.214 0.606 . . . . 0.0 109.642 177.351 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.8 mt . . . . . 0 N--CA 1.452 -0.338 0 CA-C-O 120.714 0.292 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.8 mm -91.21 104.29 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 175.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -79.52 81.85 5.73 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 77.3 mt -65.46 163.89 14.96 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -173.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 50.6 p -140.26 161.28 38.05 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 126.453 1.901 . . . . 0.0 106.733 175.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -52.62 -48.16 66.52 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.557 1.143 . . . . 0.0 111.29 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -62.35 -38.07 88.07 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.741 0.416 . . . . 0.0 112.029 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.3 m -78.07 -29.54 49.22 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 122.213 -0.304 . . . . 0.0 110.696 -178.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -42.16 -48.68 4.85 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.069 1.747 . . . . 0.0 113.517 -178.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -51.64 -63.8 1.02 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 121.617 0.722 . . . . 0.0 110.916 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.2 m -68.44 -43.84 76.24 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.171 -175.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -74.76 -48.14 27.19 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -174.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.8 t -95.64 -58.96 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.116 0 C-N-CA 123.269 0.628 . . . . 0.0 111.879 -175.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 80.3 mt -64.07 -39.49 94.18 Favored 'General case' 0 C--N 1.334 -0.085 0 C-N-CA 119.681 -0.808 . . . . 0.0 111.435 -174.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -96.83 30.13 2.78 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 176.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.84 156.11 34.31 Favored 'General case' 0 C--N 1.342 0.255 0 O-C-N 121.887 -0.508 . . . . 0.0 111.082 178.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -131.09 56.37 1.8 Allowed 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 124.808 1.243 . . . . 0.0 108.161 176.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 163.91 -173.66 39.98 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -178.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.64 115.17 25.98 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.47 1.508 . . . . 0.0 110.077 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 mt -114.85 116.67 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 124.561 1.144 . . . . 0.0 109.755 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 19.9 tp -88.26 93.67 9.59 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 176.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.8 t -86.21 103.81 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 123.024 0.53 . . . . 0.0 109.705 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -88.32 107.68 18.95 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 175.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -79.68 126.17 30.58 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 174.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 35.7 p-90 -139.45 169.84 17.01 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.347 1.059 . . . . 0.0 113.286 -174.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.41 136.52 21.07 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.27 1.428 . . . . 0.0 108.517 178.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 50.6 mp0 -49.68 -50.92 41.7 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.874 0.869 . . . . 0.0 112.126 -178.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 62.6 p-90 -64.41 -25.61 68.1 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.294 0.638 . . . . 0.0 112.38 -177.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 51.3 t -79.88 78.84 6.46 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 121.575 -0.703 . . . . 0.0 110.243 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -25.02 -61.07 0.06 OUTLIER Glycine 0 CA--C 1.536 1.389 0 C-N-CA 127.2 2.333 . . . . 0.0 114.936 178.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_exo -42.17 -34.92 3.06 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 124.315 3.343 . . . . 0.0 114.581 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 82.9 m -57.34 -48.67 78.4 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 121.44 0.638 . . . . 0.0 109.919 177.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -65.33 -33.93 77.13 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.32 0.648 . . . . 0.0 109.651 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 24.0 mmt -64.74 -44.52 89.87 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 110.083 -0.339 . . . . 0.0 110.083 177.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 30.7 pt -76.47 -26.13 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-O 118.367 -0.825 . . . . 0.0 112.642 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -38.05 -58.08 1.53 Allowed Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 120.092 1.315 . . . . 0.0 114.328 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -57.7 -37.18 97.6 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.207 1.938 . . . . 0.0 111.771 177.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.9 mt -62.6 -49.42 83.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.8 mt -56.61 -41.11 76.49 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 177.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -61.13 -47.85 84.35 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.586 0.63 . . . . 0.0 109.986 176.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -56.18 -51.87 66.47 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.9 mm -54.66 -49.31 68.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 122.946 0.498 . . . . 0.0 110.071 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.09 -42.48 69.41 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.295 0.638 . . . . 0.0 110.431 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -67.9 -58.81 3.95 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.819 0.342 . . . . 0.0 110.2 177.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -50.75 -46.96 59.56 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.006 1.323 . . . . 0.0 112.602 -178.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -100.29 25.54 7.47 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.541 1.137 . . . . 0.0 111.215 -178.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -54.49 126.97 25.65 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.171 0.896 . . . . 0.0 110.749 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.28 -12.79 24.24 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-O 119.189 -0.784 . . . . 0.0 113.333 -178.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -99.59 -41.83 7.16 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 118.657 1.228 . . . . 0.0 109.363 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.3 tp -130.8 130.56 43.84 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.419 1.087 . . . . 0.0 108.134 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 65.0 m -91.23 102.76 15.48 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 176.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 99.2 t -79.24 140.57 16.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -139.17 147.04 41.32 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 121.859 -0.526 . . . . 0.0 109.834 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.4 mtmt -128.68 99.47 5.36 Favored 'General case' 0 N--CA 1.46 0.065 0 C-N-CA 124.512 1.125 . . . . 0.0 109.087 -178.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.4 tt -97.54 115.08 27.15 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 121.795 -0.565 . . . . 0.0 110.771 -175.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -79.9 109.55 14.44 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.257 -178.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.8 pt -72.4 -25.77 23.52 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -61.43 -47.66 84.75 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 119.448 1.022 . . . . 0.0 108.447 178.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -70.96 -38.71 72.8 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 124.787 1.235 . . . . 0.0 110.003 177.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -118.39 71.83 9.57 Favored Pre-proline 0 N--CA 1.464 0.269 0 C-N-CA 124.16 0.984 . . . . 0.0 111.478 -176.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -60.6 -53.8 2.52 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.167 1.912 . . . . 0.0 112.419 -177.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -36.86 -49.03 1.4 Allowed Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.385 1.469 . . . . 0.0 114.45 -177.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -51.73 -34.61 39.81 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.281 1.032 . . . . 0.0 113.095 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.52 -68.34 0.72 Allowed Pre-proline 0 CA--C 1.538 0.497 0 CA-C-O 118.174 -0.917 . . . . 0.0 112.654 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -60.34 -37.66 80.49 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 121.757 1.638 . . . . 0.0 110.988 177.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -51.44 -38.27 52.84 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 119.065 0.848 . . . . 0.0 111.51 178.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -108.97 19.91 19.03 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 122.857 0.463 . . . . 0.0 112.004 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 51.0 39.7 41.46 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.108 0.861 . . . . 0.0 113.323 177.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.44 129.9 19.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 118.02 0.91 . . . . 0.0 108.563 177.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -87.33 -47.7 8.59 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.342 1.057 . . . . 0.0 108.985 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -169.09 142.26 7.24 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 107.73 -2.148 . . . . 0.0 107.73 178.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -88.25 151.96 49.56 Favored Pre-proline 0 N--CA 1.454 -0.265 0 CA-C-O 118.514 -0.755 . . . . 0.0 109.907 179.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.23 134.85 27.89 Favored 'Cis proline' 0 N--CA 1.456 -0.727 0 CA-C-N 120.102 1.072 . . . . 0.0 111.452 -0.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.48 109.92 14.44 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.1 mt -89.56 94.06 9.72 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.212 1.005 . . . . 0.0 109.858 -178.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.1 mp -92.02 112.88 24.98 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 176.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.4 tp -90.02 94.75 9.92 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -86.33 105.96 17.04 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 125.077 1.351 . . . . 0.0 110.617 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -94.74 108.4 20.4 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 173.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 49.98 52.24 15.05 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.87 0.868 . . . . 0.0 110.756 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 79.44 -16.4 10.32 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 118.918 -0.935 . . . . 0.0 114.33 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -94.21 118.89 32.22 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 119.579 1.69 . . . . 0.0 110.31 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 86.5 t -62.99 106.87 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 175.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.4 -42.44 25.51 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.921 0.888 . . . . 0.0 110.222 -179.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -153.4 154.76 35.1 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 58.1 p -132.83 111.46 11.11 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.139 0.976 . . . . 0.0 108.832 -177.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -103.58 113.19 26.5 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-N 118.718 0.69 . . . . 0.0 109.936 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.0 t -88.58 124.51 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 176.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.91 171.66 32.79 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 121.637 0.576 . . . . 0.0 113.017 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.61 173.16 8.43 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.152 0.981 . . . . 0.0 112.291 -178.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 mt -151.28 160.28 43.89 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 125.856 1.662 . . . . 0.0 108.729 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.1 p -91.43 152.9 20.19 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 171.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -52.58 -47.44 66.87 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.892 -0.505 . . . . 0.0 112.341 -176.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.53 -53.37 41.77 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-N 118.42 0.554 . . . . 0.0 112.16 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -60.15 -43.4 95.78 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 122.285 -0.538 . . . . 0.0 110.34 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 33.0 tp -59.99 -50.44 73.73 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -54.56 -46.1 73.6 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 118.609 0.64 . . . . 0.0 110.747 177.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -57.77 -52.85 63.76 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 178.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -52.24 -50.65 61.6 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.147 0.979 . . . . 0.0 110.324 178.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 87.4 mt -59.33 -50.98 71.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 122.927 0.491 . . . . 0.0 110.383 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -54.94 -50.6 68.46 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 118.054 0.388 . . . . 0.0 110.258 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.68 -38.31 69.49 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.452 0.701 . . . . 0.0 111.603 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -77.99 -44.09 27.69 Favored 'General case' 0 C--O 1.227 -0.099 0 O-C-N 122.243 -0.286 . . . . 0.0 110.72 -178.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 46.3 mt -59.73 -48.14 82.85 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.27 0 C-N-CA 123.116 0.566 . . . . 0.0 109.685 177.323 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.1 mt . . . . . 0 N--CA 1.454 -0.27 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.9 mm -89.27 111.56 23.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 123.616 0.766 . . . . 0.0 109.5 178.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -81.05 110.96 17.08 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 50.1 mt -92.05 170.02 10.18 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.53 1.132 . . . . 0.0 110.78 -178.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 67.7 p -136.67 159.54 41.53 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 171.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -56.75 -42.3 79.09 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.044 0.449 . . . . 0.0 109.793 177.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -60.34 -46.97 88.04 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.825 1.25 . . . . 0.0 111.338 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 90.0 p -79.27 -26.18 42.41 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -176.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -36.84 -47.37 0.68 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 127.329 2.252 . . . . 0.0 114.233 -179.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -55.89 -47.42 77.44 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.662 0.744 . . . . 0.0 111.321 -178.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.0 m -77.42 -45.56 25.46 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 123.57 0.748 . . . . 0.0 109.925 -177.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -69.05 -53.97 17.58 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -175.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 41.2 t -94.84 -56.68 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 124.147 0.979 . . . . 0.0 111.857 -173.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 77.3 mt -63.78 -39.42 94.22 Favored 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 119.216 -0.994 . . . . 0.0 111.398 -175.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -96.22 32.06 2.05 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.305 0.502 . . . . 0.0 110.137 174.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.43 146.02 49.76 Favored 'General case' 0 C--N 1.343 0.289 0 O-C-N 121.627 -0.671 . . . . 0.0 112.262 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -99.7 23.39 9.65 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.796 1.638 . . . . 0.0 111.961 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 171.27 -157.61 28.38 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.758 -0.537 . . . . 0.0 111.758 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.58 112.12 20.67 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 126.033 1.733 . . . . 0.0 110.601 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 mt -112.36 117.94 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 124.41 1.084 . . . . 0.0 110.048 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.8 tp -90.01 97.37 11.15 Favored 'General case' 0 C--N 1.338 0.089 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 175.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 56.6 t -87.41 107.43 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 123.416 0.687 . . . . 0.0 110.303 -178.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -92.41 108.18 19.77 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.009 0.924 . . . . 0.0 109.269 176.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -80.34 125.72 30.25 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 105.831 -1.915 . . . . 0.0 105.831 174.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 31.0 p-90 -145.43 175.16 10.53 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.073 0.949 . . . . 0.0 112.253 -176.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.95 147.61 16.72 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 125.487 1.515 . . . . 0.0 108.728 175.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -49.84 -51.65 38.44 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.681 1.193 . . . . 0.0 112.3 -178.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -60.39 -29.95 69.27 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -177.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 46.9 t -79.84 77.59 6.48 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 121.659 -0.651 . . . . 0.0 110.589 -178.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -24.45 -62.04 0.05 OUTLIER Glycine 0 CA--C 1.536 1.368 0 C-N-CA 127.089 2.281 . . . . 0.0 115.141 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -42.81 -33.21 2.92 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 124.725 3.617 . . . . 0.0 114.933 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 99.4 m -53.74 -43.32 69.0 Favored 'General case' 0 CA--C 1.529 0.172 0 O-C-N 121.808 -0.557 . . . . 0.0 110.061 176.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -66.96 -26.84 67.02 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.632 0.773 . . . . 0.0 111.173 178.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 22.7 mmt -76.1 -43.93 41.03 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 28.8 pt -74.74 -29.73 23.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.854 177.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -38.48 -59.6 1.26 Allowed Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 113.877 1.065 . . . . 0.0 113.877 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -57.38 -39.89 85.86 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.364 2.042 . . . . 0.0 111.733 178.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 20.1 mt -58.77 -52.35 61.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 177.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 72.3 mt -56.27 -42.75 77.94 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.085 0.554 . . . . 0.0 110.684 178.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -60.36 -48.34 82.19 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.402 0.546 . . . . 0.0 110.203 178.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -57.9 -51.35 69.96 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 23.1 mm -54.73 -45.8 73.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.749 0.82 . . . . 0.0 109.666 178.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.75 -44.74 70.23 Favored 'General case' 0 C--O 1.227 -0.089 0 C-N-CA 123.008 0.523 . . . . 0.0 110.391 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -68.84 -55.78 10.05 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 121.162 -0.215 . . . . 0.0 110.767 177.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -49.09 -48.85 44.01 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.784 0.834 . . . . 0.0 111.968 -178.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -98.26 24.68 6.93 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.067 0.947 . . . . 0.0 111.519 -178.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -55.07 125.86 22.26 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.571 1.078 . . . . 0.0 110.758 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.56 -11.36 32.82 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 119.522 -0.599 . . . . 0.0 113.353 -178.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.6 mttp -99.73 -42.86 6.67 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.933 1.293 . . . . 0.0 108.734 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.3 tp -133.97 131.55 39.11 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.164 1.386 . . . . 0.0 107.687 178.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 89.9 m -91.92 101.99 14.56 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 176.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 72.5 t -79.22 132.83 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 177.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.19 152.42 51.81 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 123.073 0.549 . . . . 0.0 110.17 -177.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.9 mttm -126.52 139.43 53.23 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 tt -130.94 119.96 22.87 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -87.79 99.07 11.83 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.048 0.539 . . . . 0.0 110.504 -175.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 20.7 pt -58.52 -29.3 38.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 O-C-N 121.266 -0.896 . . . . 0.0 113.224 -177.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -61.19 -25.94 67.37 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.048 0.84 . . . . 0.0 111.697 177.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -114.02 -10.95 12.81 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.312 1.045 . . . . 0.0 111.038 178.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -133.94 57.57 25.76 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 124.892 1.277 . . . . 0.0 108.524 -177.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.71 -49.22 4.44 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.166 1.91 . . . . 0.0 112.976 -174.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -40.26 -40.55 1.9 Allowed Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.421 1.486 . . . . 0.0 114.564 -177.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.64 -30.37 67.24 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.971 -0.723 . . . . 0.0 112.636 -178.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.28 -65.1 2.32 Favored Pre-proline 0 CA--C 1.539 0.542 0 O-C-N 121.257 -0.902 . . . . 0.0 112.501 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -59.27 -35.09 97.89 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.09 1.86 . . . . 0.0 111.276 178.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -51.75 -32.41 30.66 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.203 0.91 . . . . 0.0 112.131 177.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -115.08 17.84 16.58 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.097 0.559 . . . . 0.0 111.387 176.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 48.29 41.09 23.31 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.658 1.123 . . . . 0.0 111.887 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 53.2 mt -66.05 138.42 23.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-O 121.344 0.592 . . . . 0.0 110.623 -177.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -79.18 -42.37 26.24 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.211 1.404 . . . . 0.0 111.322 -176.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -171.36 -154.83 10.12 Favored Glycine 0 C--N 1.334 0.417 0 N-CA-C 108.17 -1.972 . . . . 0.0 108.17 -178.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.6 pt -146.13 156.6 50.61 Favored Pre-proline 0 CA--C 1.536 0.422 0 CA-C-N 118.19 0.995 . . . . 0.0 108.495 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -70.45 141.85 69.36 Favored 'Cis proline' 0 N--CA 1.456 -0.681 0 CA-C-N 120.156 1.091 . . . . 0.0 109.95 -1.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.4 m -139.06 122.33 17.04 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 mt -103.83 120.15 40.39 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.932 1.293 . . . . 0.0 109.318 -176.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.9 mp -110.5 121.89 46.39 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 175.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 tp -94.64 95.52 8.82 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -88.68 103.99 16.46 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.429 1.492 . . . . 0.0 110.713 -178.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -91.74 106.55 18.56 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 173.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 35.0 m120 49.29 51.19 16.77 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.664 0.786 . . . . 0.0 111.029 -178.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 79.81 -15.45 14.9 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-O 118.839 -0.978 . . . . 0.0 114.369 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -92.62 120.17 32.79 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.503 1.651 . . . . 0.0 109.668 179.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 88.5 t -64.45 106.75 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 175.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.97 -39.28 34.8 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.479 0.712 . . . . 0.0 109.356 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -159.83 171.37 19.59 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.6 m -150.32 149.41 30.07 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -178.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.5 mmtm -135.09 131.25 36.71 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 126.047 1.739 . . . . 0.0 107.648 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.2 t -113.33 125.12 70.54 Favored 'Isoleucine or valine' 0 C--O 1.231 0.1 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 178.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.13 179.06 33.0 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -177.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.6 170.99 15.09 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.065 0.546 . . . . 0.0 111.202 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.2 mt -143.55 154.61 43.78 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 125.138 1.375 . . . . 0.0 108.698 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.9 p -84.47 148.86 26.32 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 170.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -49.47 -47.84 48.15 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 122.143 -0.348 . . . . 0.0 111.728 -177.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.21 -53.09 42.87 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 111.889 -0.484 . . . . 0.0 111.889 179.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -61.37 -42.16 98.26 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.132 -0.628 . . . . 0.0 110.844 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 33.8 tp -60.15 -51.64 68.73 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 177.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -56.49 -44.34 80.55 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.638 -0.664 . . . . 0.0 111.169 177.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -55.87 -54.29 46.37 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.604 0.762 . . . . 0.0 109.685 177.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -53.28 -52.05 60.3 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.947 1.299 . . . . 0.0 110.444 178.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.0 mt -58.7 -50.61 73.26 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 122.647 0.379 . . . . 0.0 110.574 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -55.09 -50.53 68.94 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 178.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.84 -37.95 69.4 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.322 0.649 . . . . 0.0 111.784 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -77.97 -43.22 30.34 Favored 'General case' 0 C--N 1.339 0.125 0 O-C-N 122.129 -0.357 . . . . 0.0 110.708 -178.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 49.1 mt -61.42 -47.21 86.81 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.293 0 C-N-CA 123.094 0.557 . . . . 0.0 109.686 177.441 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.4 m . . . . . 0 CA--C 1.532 0.254 0 N-CA-C 113.024 0.749 . . . . 0.0 113.024 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -34.91 -47.31 0.35 Allowed 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 127.003 2.121 . . . . 0.0 112.798 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -129.37 44.51 2.96 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.336 0.654 . . . . 0.0 110.51 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.5 mt -121.15 139.13 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 O-C-N 121.947 -0.471 . . . . 0.0 110.45 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.5 mm -88.0 112.67 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 123.324 0.65 . . . . 0.0 109.488 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -83.52 106.43 15.25 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.75 -0.594 . . . . 0.0 109.662 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 43.0 mt -89.15 164.04 15.18 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.799 1.24 . . . . 0.0 111.14 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 35.0 p -136.78 167.16 21.97 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 175.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -58.33 -46.51 86.08 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 177.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -57.26 -46.79 82.71 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.976 0.911 . . . . 0.0 111.322 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.1 p -78.64 -25.63 45.03 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.932 -176.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -43.41 -46.81 6.81 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.59 1.556 . . . . 0.0 113.123 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -49.07 -65.69 0.53 Allowed 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 121.791 0.805 . . . . 0.0 110.48 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -71.37 -44.62 64.65 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.058 -174.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -73.14 -37.36 66.64 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -173.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.8 t -108.99 -60.42 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.058 0 C-N-CA 123.151 0.58 . . . . 0.0 110.706 -176.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 84.0 mt -63.73 -36.38 83.66 Favored 'General case' 0 C--N 1.334 -0.088 0 C-N-CA 120.029 -0.668 . . . . 0.0 112.597 -174.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -99.95 28.03 5.1 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.673 0.669 . . . . 0.0 110.148 176.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -74.84 172.53 12.04 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.959 0.885 . . . . 0.0 112.263 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -141.96 129.63 21.55 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 171.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.4 -172.0 27.21 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -175.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -98.15 120.43 38.54 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.064 1.346 . . . . 0.0 111.206 -177.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.7 mt -118.13 120.22 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 124.863 1.265 . . . . 0.0 109.01 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -93.42 107.77 19.55 Favored 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 176.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.1 t -98.38 109.4 23.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 123.503 0.721 . . . . 0.0 109.415 -178.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -93.59 108.8 20.46 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 123.669 0.788 . . . . 0.0 108.881 176.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -78.78 128.52 33.51 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 25.7 p-90 -145.43 173.7 11.77 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.623 0.769 . . . . 0.0 112.819 -176.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.51 144.37 22.74 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 125.593 1.557 . . . . 0.0 107.81 176.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -47.63 -51.09 22.59 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.533 1.133 . . . . 0.0 112.307 -177.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 62.2 p-90 -65.31 -23.76 67.1 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.819 0.847 . . . . 0.0 112.621 -178.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 35.3 t -79.91 72.83 6.68 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 121.482 -0.761 . . . . 0.0 111.481 -176.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -21.2 -64.17 0.02 OUTLIER Glycine 0 CA--C 1.537 1.462 0 C-N-CA 127.57 2.509 . . . . 0.0 116.043 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -48.55 -29.09 13.24 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 123.419 2.746 . . . . 0.0 114.443 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.8 m -59.26 -44.71 92.39 Favored 'General case' 0 N--CA 1.462 0.154 0 O-C-N 121.508 -0.745 . . . . 0.0 109.558 176.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -66.65 -36.24 82.08 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.562 0.745 . . . . 0.0 109.017 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 26.0 ttt -62.97 -46.34 88.16 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 119.614 -0.232 . . . . 0.0 110.48 177.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 38.3 pt -75.34 -28.02 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-O 118.417 -0.802 . . . . 0.0 112.363 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -37.11 -58.68 1.09 Allowed Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -58.05 -41.42 68.17 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.025 1.817 . . . . 0.0 111.4 177.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.0 mt -57.8 -51.16 73.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.6 mt -55.71 -41.36 73.7 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.108 0.563 . . . . 0.0 110.359 177.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -63.37 -45.95 88.77 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.226 0.921 . . . . 0.0 111.07 176.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -57.18 -50.56 72.46 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 25.8 mm -54.32 -50.18 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 C-N-CA 123.533 0.733 . . . . 0.0 109.303 176.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.16 -48.71 64.79 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 122.096 -0.377 . . . . 0.0 110.268 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -60.37 -55.23 36.13 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 122.448 0.299 . . . . 0.0 110.677 178.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -54.0 -44.96 71.34 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.093 0.957 . . . . 0.0 112.221 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -98.59 29.83 3.52 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.395 1.078 . . . . 0.0 111.943 -177.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -54.24 127.27 26.31 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.363 -0.836 . . . . 0.0 109.901 177.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.52 -13.62 16.02 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 119.234 -0.759 . . . . 0.0 113.188 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -99.61 -39.37 8.33 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 118.567 1.184 . . . . 0.0 109.994 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.9 tp -137.67 129.7 28.92 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 123.134 0.574 . . . . 0.0 110.272 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.8 m -89.83 101.57 14.27 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 175.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 91.8 t -79.83 130.19 36.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.81 154.43 51.2 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 123.673 0.789 . . . . 0.0 111.134 -177.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -127.49 143.78 51.15 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.306 1.442 . . . . 0.0 107.418 177.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.5 tt -132.32 115.01 15.08 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -80.23 104.35 10.73 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 122.38 0.272 . . . . 0.0 110.656 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.0 pt -70.23 -28.72 36.67 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.28 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -57.21 -45.95 83.33 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 119.103 0.865 . . . . 0.0 108.844 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.49 -38.41 59.53 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.221 0.608 . . . . 0.0 109.943 177.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -117.15 67.36 4.48 Favored Pre-proline 0 CA--C 1.534 0.335 0 C-N-CA 124.252 1.021 . . . . 0.0 112.173 -175.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -58.47 -47.8 17.88 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.476 2.117 . . . . 0.0 112.465 -176.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -40.49 -34.95 0.74 Allowed Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.863 1.696 . . . . 0.0 115.237 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 75.2 p -61.4 -38.72 88.09 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 117.795 0.798 . . . . 0.0 111.643 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . 0.284 . . -56.95 -62.76 4.52 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-O 118.071 -0.966 . . . . 0.0 111.571 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -49.07 -50.75 12.03 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.822 2.348 . . . . 0.0 111.525 173.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -51.88 -41.26 61.75 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -104.15 20.69 17.84 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 118.286 0.494 . . . . 0.0 111.75 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 44.79 42.03 7.51 Favored Glycine 0 C--N 1.341 0.844 0 C-N-CA 124.245 0.926 . . . . 0.0 111.624 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.7 mm -57.97 122.66 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-O 121.156 0.503 . . . . 0.0 110.091 -177.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 50.8 mmt-85 -79.7 -40.02 29.93 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.663 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -179.76 146.32 6.95 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 108.335 -1.906 . . . . 0.0 108.335 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.2 pt -93.67 153.43 41.16 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 123.876 0.87 . . . . 0.0 110.769 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.25 139.64 51.1 Favored 'Cis proline' 0 N--CA 1.458 -0.61 0 CA-C-N 119.614 0.898 . . . . 0.0 110.96 -1.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.8 112.98 16.01 Favored 'General case' 0 CA--C 1.523 -0.077 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.2 mt -94.81 122.05 37.03 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -114.61 117.97 32.37 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 177.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.5 tp -94.93 97.85 10.29 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -89.98 110.56 21.53 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.187 1.395 . . . . 0.0 111.288 -177.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -96.68 114.23 25.85 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 171.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.9 m120 47.24 48.66 15.97 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.011 0.524 . . . . 0.0 111.518 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 76.72 -6.8 37.42 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 118.737 -1.035 . . . . 0.0 115.083 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -102.03 126.32 48.94 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 119.575 1.687 . . . . 0.0 109.541 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 92.4 t -66.18 108.55 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.35 -41.07 28.69 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.947 0.899 . . . . 0.0 109.372 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -157.65 171.86 19.57 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.2 t -152.76 164.0 38.63 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -145.04 126.89 15.37 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.467 1.507 . . . . 0.0 107.398 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.2 t -101.58 122.89 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 174.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.49 175.54 32.67 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 -178.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.5 174.25 9.23 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.619 0.767 . . . . 0.0 111.733 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.1 mt -147.04 156.01 42.68 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.708 1.603 . . . . 0.0 107.962 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.9 p -87.09 154.8 20.46 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.357 -1.719 . . . . 0.0 106.357 171.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -49.58 -51.83 34.39 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 122.089 -0.382 . . . . 0.0 111.654 -177.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.05 -58.12 13.96 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -56.1 -41.29 75.0 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 122.411 -0.464 . . . . 0.0 110.927 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 37.2 tp -62.42 -49.37 75.76 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -55.24 -47.1 75.88 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.474 0.579 . . . . 0.0 110.356 177.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -57.11 -53.93 52.56 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.124 0.57 . . . . 0.0 110.397 178.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -52.65 -52.34 56.08 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.899 1.28 . . . . 0.0 110.857 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 76.0 mt -62.51 -50.87 69.66 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 122.176 -0.327 . . . . 0.0 110.305 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -53.57 -48.98 68.67 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.358 0.663 . . . . 0.0 110.771 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.56 -34.51 67.19 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.792 0.837 . . . . 0.0 111.607 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -78.94 -48.06 15.25 Favored 'General case' 0 C--O 1.228 -0.07 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 45.0 mt -58.39 -45.34 88.52 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.415 0.686 . . . . 0.0 110.827 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.172 0 C-N-CA 124.847 1.259 . . . . 0.0 111.711 179.135 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 37.3 p . . . . . 0 N--CA 1.454 -0.231 0 CA-C-O 120.765 0.317 . . . . 0.0 110.822 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -166.87 -136.88 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.76 1.624 . . . . 0.0 107.392 -177.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -81.67 54.47 2.4 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 119.3 0.955 . . . . 0.0 108.665 178.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 15.7 mt -125.02 140.62 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 C-N-CA 124.138 0.975 . . . . 0.0 108.701 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.1 mm -87.4 104.76 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 177.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -79.44 80.6 5.8 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 177.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 77.6 mt -63.88 163.41 11.98 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.049 0.94 . . . . 0.0 113.208 -175.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 47.4 p -138.31 165.8 25.83 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 126.08 1.752 . . . . 0.0 106.506 174.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -55.23 -47.34 75.51 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.476 0.71 . . . . 0.0 110.932 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -63.72 -38.73 92.21 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.0 p -77.98 -32.5 51.35 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.03 0.377 . . . . 0.0 110.482 -177.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -36.61 -48.78 0.72 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.273 1.829 . . . . 0.0 113.364 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -49.36 -65.37 0.58 Allowed 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 121.961 0.886 . . . . 0.0 111.163 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.3 m -72.29 -45.21 61.0 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.569 -174.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -76.2 -21.83 55.99 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -174.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 45.9 t -120.77 -62.86 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.094 0 CA-C-N 119.548 1.067 . . . . 0.0 109.947 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 72.1 mt -58.81 -37.32 76.11 Favored 'General case' 0 CA--C 1.528 0.098 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -174.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -95.72 14.42 23.21 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 118.587 0.63 . . . . 0.0 111.924 177.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.38 103.36 16.01 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 119.073 0.852 . . . . 0.0 112.367 -178.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -76.31 72.67 3.08 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 174.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -174.63 179.39 45.97 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.95 118.76 32.34 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.489 1.516 . . . . 0.0 109.987 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.6 mt -127.57 115.97 41.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 124.796 1.239 . . . . 0.0 110.73 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 35.0 tp -83.53 96.41 8.6 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 174.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.4 t -86.51 105.85 15.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 122.999 0.519 . . . . 0.0 109.872 -179.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -91.35 112.42 24.33 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 176.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -85.05 120.82 26.99 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 173.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 21.9 p-90 -138.88 177.66 7.73 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.983 0.913 . . . . 0.0 112.351 -174.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -150.94 150.16 30.5 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.472 1.509 . . . . 0.0 107.716 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -62.84 -50.3 71.51 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.852 0.358 . . . . 0.0 111.308 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 63.9 p-90 -62.25 -26.25 68.28 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.489 0.716 . . . . 0.0 112.743 -178.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.6 t -79.16 77.68 5.65 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 121.554 -0.716 . . . . 0.0 109.829 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -22.15 -63.12 0.03 OUTLIER Glycine 0 CA--C 1.534 1.276 0 C-N-CA 127.661 2.553 . . . . 0.0 115.198 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -42.58 -36.0 4.4 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 124.503 3.469 . . . . 0.0 114.525 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 80.5 m -53.92 -46.06 71.36 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 121.508 0.67 . . . . 0.0 109.956 176.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.91 -24.47 63.38 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.348 0.659 . . . . 0.0 110.967 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 23.1 mmt -74.2 -43.92 55.33 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 30.4 pt -75.2 -27.23 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 118.905 -0.569 . . . . 0.0 111.694 177.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -36.6 -60.06 0.8 Allowed Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -56.89 -40.6 83.0 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.224 1.949 . . . . 0.0 111.918 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.0 mt -58.79 -50.72 78.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.7 mt -56.12 -43.77 78.5 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.592 0.357 . . . . 0.0 110.201 177.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -58.5 -49.59 76.82 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.255 0.55 . . . . 0.0 109.794 178.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -56.13 -52.07 65.68 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 31.7 mm -54.04 -50.01 56.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 123.066 0.547 . . . . 0.0 109.869 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.24 -46.47 65.73 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.219 0.608 . . . . 0.0 110.603 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -66.13 -56.91 9.1 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 178.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -47.25 -49.89 22.47 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.711 1.204 . . . . 0.0 112.329 -178.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -99.69 26.19 6.45 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.149 0.58 . . . . 0.0 111.705 -178.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.54 111.85 0.99 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.253 0.933 . . . . 0.0 111.022 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.35 -15.84 61.61 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.01 0.814 . . . . 0.0 112.243 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -99.52 -39.17 8.46 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.943 1.297 . . . . 0.0 109.158 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 46.9 tp -140.2 130.64 25.39 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 178.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 91.0 m -91.09 145.92 24.28 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 105.836 -1.912 . . . . 0.0 105.836 174.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 94.9 t -120.54 141.28 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 177.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.86 148.82 50.22 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.127 0.571 . . . . 0.0 109.889 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -127.33 96.57 4.61 Favored 'General case' 0 C--O 1.23 0.066 0 C-N-CA 124.906 1.283 . . . . 0.0 108.91 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 tt -96.7 109.4 22.05 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -176.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -80.45 108.61 14.22 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.934 -178.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.7 pt -64.46 -25.31 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-O 119.1 -0.476 . . . . 0.0 111.644 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -53.65 -25.72 19.19 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.825 0.739 . . . . 0.0 111.966 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -119.01 3.03 11.52 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.015 0.926 . . . . 0.0 110.89 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -147.23 62.75 7.5 Favored Pre-proline 0 CA--C 1.529 0.137 0 C-N-CA 124.614 1.166 . . . . 0.0 109.523 -177.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -61.82 -52.07 3.31 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 121.776 1.651 . . . . 0.0 111.285 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -40.83 -43.11 3.05 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.529 1.538 . . . . 0.0 114.918 -177.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.31 -31.12 67.22 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 117.808 0.804 . . . . 0.0 111.788 -178.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.36 -67.24 0.92 Allowed Pre-proline 0 CA--C 1.539 0.529 0 CA-C-O 118.276 -0.869 . . . . 0.0 112.619 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -60.0 -38.47 78.05 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 121.72 1.613 . . . . 0.0 110.882 178.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -52.25 -38.56 58.5 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 118.874 0.761 . . . . 0.0 111.484 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -106.67 19.77 20.0 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.657 0.383 . . . . 0.0 111.999 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.23 38.05 55.97 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.111 0.862 . . . . 0.0 113.528 176.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.38 129.23 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -89.79 -48.84 6.99 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.45 1.1 . . . . 0.0 110.095 -178.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -162.14 146.5 12.09 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 107.285 -2.326 . . . . 0.0 107.285 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.3 pt -98.55 149.14 35.44 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 123.461 0.704 . . . . 0.0 110.048 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.17 139.47 53.05 Favored 'Cis proline' 0 N--CA 1.455 -0.772 0 CA-C-N 119.873 0.99 . . . . 0.0 111.094 -0.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.77 139.49 52.23 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 176.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.6 mt -118.46 106.07 12.32 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.0 mp -100.16 113.23 25.73 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 176.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.9 tp -90.23 101.8 14.52 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -86.53 143.2 27.83 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.556 1.143 . . . . 0.0 109.166 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -140.96 110.42 6.33 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 175.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.1 t30 55.73 67.93 0.94 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 121.438 0.637 . . . . 0.0 110.337 -177.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.31 -31.76 0.26 Allowed Glycine 0 CA--C 1.533 1.187 0 N-CA-C 117.04 1.576 . . . . 0.0 117.04 176.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -97.71 155.03 17.2 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 119.5 1.65 . . . . 0.0 111.224 -177.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 93.3 t -76.19 118.31 22.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.93 -47.13 15.53 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 123.662 0.785 . . . . 0.0 109.177 177.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -156.77 171.9 19.57 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 123.944 0.898 . . . . 0.0 108.689 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 90.8 m -149.96 148.86 29.59 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 122.01 -0.431 . . . . 0.0 110.111 -178.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -130.59 151.14 51.38 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 126.314 1.846 . . . . 0.0 107.62 177.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.2 t -129.96 131.64 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -178.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.95 -178.58 45.2 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 111.439 -0.665 . . . . 0.0 111.439 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.75 165.72 24.28 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.836 0.454 . . . . 0.0 110.894 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.5 mt -145.05 151.41 38.5 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.662 1.185 . . . . 0.0 108.533 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.4 p -84.52 149.42 25.93 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 172.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -51.71 -45.04 63.42 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-O 119.481 -0.295 . . . . 0.0 111.648 -177.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.92 -55.34 29.58 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 118.343 0.52 . . . . 0.0 111.844 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -56.81 -47.67 79.73 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 122.048 -0.678 . . . . 0.0 110.077 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 48.4 tp -56.77 -51.59 68.3 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 119.539 -0.267 . . . . 0.0 110.489 178.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.1 mmmp? -51.93 -49.45 63.08 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.279 0.631 . . . . 0.0 110.336 177.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -58.87 -50.37 74.27 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 110.558 -0.164 . . . . 0.0 110.558 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -53.9 -53.01 58.58 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.546 0.739 . . . . 0.0 110.865 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.8 mt -59.97 -49.95 75.68 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 122.726 0.41 . . . . 0.0 110.377 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -54.74 -50.73 67.66 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 117.844 0.293 . . . . 0.0 110.353 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.75 -36.92 70.32 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.577 0.751 . . . . 0.0 111.696 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -77.7 -42.98 32.55 Favored 'General case' 0 C--O 1.227 -0.082 0 O-C-N 122.205 -0.309 . . . . 0.0 110.367 -178.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 47.3 mt -61.75 -47.37 85.52 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.29 0 C-N-CA 123.208 0.603 . . . . 0.0 109.644 177.518 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.454 -0.263 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 21.6 t0 60.79 -73.53 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 126.38 1.872 . . . . 0.0 112.002 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -102.42 -19.99 14.73 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.677 1.191 . . . . 0.0 110.955 177.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.2 mt -79.45 133.7 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-N 118.118 0.417 . . . . 0.0 110.129 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.5 mm -90.97 111.41 23.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 124.419 1.088 . . . . 0.0 109.387 178.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -82.37 101.44 10.6 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 67.1 mt -85.09 162.9 19.11 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.697 0.799 . . . . 0.0 111.849 -177.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 48.0 p -137.64 165.67 25.79 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 126.042 1.737 . . . . 0.0 106.406 175.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -56.58 -44.02 80.63 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.853 -0.529 . . . . 0.0 110.216 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -59.28 -44.16 92.49 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.025 0.93 . . . . 0.0 112.192 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.1 p -78.79 -30.94 45.79 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 122.107 -0.371 . . . . 0.0 111.003 -177.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -36.36 -56.48 0.78 Allowed 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 126.37 1.868 . . . . 0.0 114.092 -178.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -54.29 -57.59 10.64 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 121.822 -0.549 . . . . 0.0 110.953 -177.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.3 m -62.02 -47.62 83.97 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.708 0.803 . . . . 0.0 112.446 -177.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.16 -50.68 13.92 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -175.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.4 t -90.97 -57.05 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 124.048 0.939 . . . . 0.0 112.533 -173.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 72.2 mt -66.76 -41.06 88.38 Favored 'General case' 0 CA--C 1.523 -0.074 0 C-N-CA 119.564 -0.854 . . . . 0.0 110.918 -174.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -93.0 30.67 1.56 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 122.64 0.376 . . . . 0.0 110.041 176.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.0 156.66 36.82 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.766 -0.584 . . . . 0.0 110.826 177.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -131.69 55.18 1.88 Allowed 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 124.699 1.2 . . . . 0.0 108.109 176.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 164.5 -173.01 40.41 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.506 -1.037 . . . . 0.0 110.506 -178.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.95 113.65 23.81 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.543 1.537 . . . . 0.0 109.947 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.5 mt -113.52 117.46 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 124.258 1.023 . . . . 0.0 109.479 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.7 tp -89.72 96.32 10.64 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 177.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.7 t -89.32 109.35 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 123.427 0.691 . . . . 0.0 109.629 -179.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -93.58 105.36 17.41 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -79.18 123.95 27.88 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 175.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 24.5 p-90 -138.93 172.69 12.49 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 124.292 1.037 . . . . 0.0 111.943 -175.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.99 147.79 32.05 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.297 1.039 . . . . 0.0 108.651 175.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -54.61 -52.23 62.84 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.904 0.882 . . . . 0.0 111.78 -178.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 61.4 p-90 -67.25 -21.58 65.71 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.958 0.903 . . . . 0.0 112.747 -178.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 46.0 t -79.58 70.0 5.98 Favored 'General case' 0 N--CA 1.456 -0.144 0 O-C-N 121.38 -0.825 . . . . 0.0 110.935 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -16.14 -65.59 0.01 OUTLIER Glycine 0 CA--C 1.534 1.266 0 C-N-CA 128.253 2.835 . . . . 0.0 115.903 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -42.95 -32.38 2.65 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 124.532 3.488 . . . . 0.0 115.036 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 99.6 m -53.9 -44.73 70.76 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.221 0.608 . . . . 0.0 110.121 176.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -67.33 -26.6 66.58 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.323 0.649 . . . . 0.0 111.13 178.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 23.3 mmt -74.54 -43.68 54.64 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 19.6 pt -74.95 -28.95 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 119.006 -0.521 . . . . 0.0 111.922 178.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -38.67 -59.45 1.34 Allowed Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -56.6 -40.08 86.91 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.158 1.905 . . . . 0.0 111.441 177.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 16.3 mt -58.85 -48.82 85.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 74.7 mt -57.25 -43.67 83.16 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 119.415 -0.326 . . . . 0.0 110.352 177.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -60.02 -48.09 83.13 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.839 0.745 . . . . 0.0 110.446 177.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -57.01 -52.16 66.38 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.2 mm -55.44 -45.06 78.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 124.102 0.961 . . . . 0.0 110.017 178.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.51 -41.71 73.47 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 123.048 0.539 . . . . 0.0 110.05 178.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -67.67 -55.13 14.44 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 176.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -48.06 -48.99 33.02 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.903 0.881 . . . . 0.0 112.068 -178.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -103.2 28.87 5.95 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.654 0.782 . . . . 0.0 111.594 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -55.37 126.53 25.43 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.152 0.887 . . . . 0.0 111.212 -178.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.36 -13.13 29.16 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 119.237 -0.757 . . . . 0.0 113.21 -178.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -99.8 -43.93 6.26 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.455 1.127 . . . . 0.0 109.357 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.9 tp -125.4 125.5 43.5 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.755 1.222 . . . . 0.0 108.025 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 60.4 m -87.59 101.84 14.02 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 176.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.6 t -79.39 131.74 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.66 151.65 48.49 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 122.635 0.374 . . . . 0.0 110.096 -178.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -128.69 135.43 49.24 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 tt -124.54 113.62 18.33 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.645 0.778 . . . . 0.0 109.223 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -79.39 108.89 13.25 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.1 pt -70.74 -22.59 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -58.16 -48.47 80.17 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.221 0.919 . . . . 0.0 109.092 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -79.88 -31.76 40.34 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.914 0.885 . . . . 0.0 110.367 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -119.26 67.11 8.97 Favored Pre-proline 0 N--CA 1.463 0.219 0 C-N-CA 123.482 0.713 . . . . 0.0 112.082 -176.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.1 -47.04 8.94 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 121.877 1.718 . . . . 0.0 110.966 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -41.2 -41.0 2.7 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.756 1.646 . . . . 0.0 115.038 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.77 -27.08 68.65 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.158 0.979 . . . . 0.0 112.639 -178.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.8 -63.0 4.63 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 118.347 -0.835 . . . . 0.0 113.053 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -60.56 -37.03 83.27 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.151 1.901 . . . . 0.0 111.464 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -51.99 -31.43 29.35 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.813 0.733 . . . . 0.0 112.003 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -118.56 19.34 13.31 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.25 0.62 . . . . 0.0 111.658 177.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 47.35 43.59 19.9 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.46 1.029 . . . . 0.0 113.308 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.6 mp -53.49 117.66 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 117.908 0.854 . . . . 0.0 109.181 177.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 29.3 mmm180 -79.8 -45.48 18.7 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.238 1.015 . . . . 0.0 110.807 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -164.17 147.25 12.5 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 107.819 -2.112 . . . . 0.0 107.819 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.6 pt -100.27 152.82 37.94 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 123.913 0.885 . . . . 0.0 110.101 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -68.66 142.18 66.06 Favored 'Cis proline' 0 N--CA 1.456 -0.697 0 CA-C-N 119.519 0.864 . . . . 0.0 110.454 -1.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.37 109.82 15.35 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.3 mt -89.53 93.08 9.36 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.925 0.89 . . . . 0.0 109.781 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.2 mp -91.28 115.84 28.35 Favored 'General case' 0 CA--C 1.522 -0.105 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.3 tp -92.6 96.0 9.94 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -87.51 104.5 16.53 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.026 1.33 . . . . 0.0 110.226 -178.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -93.42 108.48 20.14 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 174.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 49.95 50.48 18.4 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.707 0.803 . . . . 0.0 110.626 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 79.75 -14.19 20.12 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 118.879 -0.956 . . . . 0.0 114.565 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -94.82 121.34 36.31 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 119.591 1.695 . . . . 0.0 110.141 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 98.3 t -64.15 104.86 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 175.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.31 -38.03 36.26 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.862 0.865 . . . . 0.0 109.813 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -155.44 166.17 34.37 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.71 0.804 . . . . 0.0 108.899 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 69.7 m -147.79 117.96 7.31 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.629 0.772 . . . . 0.0 108.986 -178.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -104.74 112.5 25.63 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.2 t -90.32 124.15 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 177.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.65 168.44 36.79 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 123.804 0.716 . . . . 0.0 112.249 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.62 166.23 19.49 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.082 0.553 . . . . 0.0 110.244 179.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -155.63 170.69 21.43 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.695 0.798 . . . . 0.0 109.863 -177.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 80.9 p -86.18 162.81 18.16 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 177.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.01 -39.01 80.57 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 175.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -57.06 -56.36 25.44 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 177.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -54.22 -46.56 72.54 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.942 0.371 . . . . 0.0 110.225 178.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 22.8 tp -59.06 -50.25 74.79 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 121.283 -0.167 . . . . 0.0 110.765 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.9 mmmm -54.53 -48.84 71.5 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.723 -0.611 . . . . 0.0 111.338 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -65.95 -43.5 87.78 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 119.584 -0.846 . . . . 0.0 111.022 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -53.24 -52.24 59.59 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.158 0.583 . . . . 0.0 109.497 177.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.8 mt -58.73 -55.19 38.27 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 122.743 0.417 . . . . 0.0 110.3 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -51.24 -50.53 59.02 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.04 0.382 . . . . 0.0 111.13 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.14 -38.45 70.84 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.397 0.679 . . . . 0.0 111.807 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -78.5 -43.48 26.83 Favored 'General case' 0 C--O 1.228 -0.048 0 O-C-N 122.199 -0.313 . . . . 0.0 111.049 -178.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 69.5 mt -63.58 -45.63 89.53 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.2 0 C-N-CA 122.909 0.483 . . . . 0.0 109.832 177.745 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 13.2 m . . . . . 0 N--CA 1.452 -0.356 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 36.0 t70 58.6 -71.79 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 127.244 2.218 . . . . 0.0 112.267 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -84.91 -33.04 22.81 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.991 0.917 . . . . 0.0 109.791 176.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 16.6 mt -79.82 135.8 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.2 mm -90.31 114.43 27.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.433 1.093 . . . . 0.0 109.297 177.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -84.54 104.82 14.86 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.3 mt -87.84 163.79 16.23 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.598 1.159 . . . . 0.0 111.679 -178.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 61.3 p -138.48 165.19 27.46 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 126.257 1.823 . . . . 0.0 106.385 174.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -55.13 -44.69 75.28 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.128 0.571 . . . . 0.0 110.104 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -59.82 -43.83 94.32 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.867 0.867 . . . . 0.0 112.383 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.8 p -78.75 -30.47 45.75 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 122.152 -0.342 . . . . 0.0 111.22 -177.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -36.76 -54.77 0.9 Allowed 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 126.407 1.883 . . . . 0.0 114.017 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -54.07 -57.66 10.23 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.265 0.555 . . . . 0.0 111.132 -178.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.4 m -63.79 -48.07 78.37 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.385 0.674 . . . . 0.0 112.059 -177.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.59 -52.26 12.27 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -175.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.7 t -89.63 -56.22 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 123.891 0.876 . . . . 0.0 112.203 -174.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 66.6 mt -66.15 -42.7 88.7 Favored 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 119.489 -0.884 . . . . 0.0 111.168 -175.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -91.98 31.72 1.22 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 118.045 0.384 . . . . 0.0 110.18 175.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.68 143.67 57.14 Favored 'General case' 0 C--N 1.341 0.208 0 O-C-N 121.538 -0.726 . . . . 0.0 112.172 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -108.7 54.33 0.66 Allowed 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.495 1.118 . . . . 0.0 108.769 176.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 150.46 -160.47 28.58 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 123.759 0.695 . . . . 0.0 111.566 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.51 122.45 34.1 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 126.103 1.761 . . . . 0.0 110.356 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.5 mt -122.62 122.39 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 124.732 1.213 . . . . 0.0 109.18 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -93.47 106.87 18.8 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 42.6 t -97.46 110.33 25.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -92.15 103.58 16.05 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 176.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -78.92 118.05 20.57 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 104.046 -2.576 . . . . 0.0 104.046 175.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 34.5 p-90 -130.66 168.71 16.69 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 124.545 1.138 . . . . 0.0 111.933 -175.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -141.49 143.05 33.61 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.087 1.355 . . . . 0.0 108.304 176.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -58.3 -49.13 78.24 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.261 1.024 . . . . 0.0 112.171 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 50.9 p-90 -63.96 -28.11 69.6 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.519 0.728 . . . . 0.0 112.358 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.6 t -79.59 79.18 6.09 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 121.556 -0.715 . . . . 0.0 110.643 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -24.17 -62.88 0.05 OUTLIER Glycine 0 CA--C 1.535 1.324 0 C-N-CA 127.074 2.273 . . . . 0.0 114.44 178.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -40.46 -33.71 1.0 Allowed 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 125.035 3.823 . . . . 0.0 115.503 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 99.8 m -53.67 -43.04 68.54 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.589 0.709 . . . . 0.0 109.995 177.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -69.05 -26.89 65.19 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.411 1.084 . . . . 0.0 110.973 178.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -75.58 -43.15 49.78 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 33.7 pt -72.79 -29.85 31.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.607 177.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -37.81 -60.46 0.94 Allowed Pre-proline 0 CA--C 1.545 0.769 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -56.32 -39.35 91.88 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.363 2.042 . . . . 0.0 111.938 177.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 21.0 mt -59.61 -52.69 57.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 177.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 60.8 mt -55.12 -40.58 70.66 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.961 0.504 . . . . 0.0 110.363 177.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -61.26 -47.8 84.38 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.243 0.928 . . . . 0.0 110.023 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -56.8 -52.35 65.4 Favored 'General case' 0 C--N 1.34 0.18 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.0 mm -53.28 -49.08 54.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 123.37 0.668 . . . . 0.0 109.538 177.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.47 -43.4 68.13 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.506 0.722 . . . . 0.0 110.76 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -69.31 -55.66 9.79 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.71 0.29 . . . . 0.0 110.638 177.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -50.53 -47.66 57.43 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.57 1.148 . . . . 0.0 112.322 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -99.81 24.36 8.5 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.264 1.026 . . . . 0.0 110.795 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -55.39 124.18 16.3 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.516 -0.74 . . . . 0.0 110.122 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.34 -14.24 46.57 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 119.454 -0.637 . . . . 0.0 112.907 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -99.74 -42.27 6.92 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.371 1.069 . . . . 0.0 109.3 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.1 tp -133.01 125.35 29.5 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.726 1.211 . . . . 0.0 108.168 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 56.2 m -85.41 101.84 12.94 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 176.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 85.1 t -79.31 133.62 29.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -138.16 154.04 49.18 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.126 0.57 . . . . 0.0 110.417 -177.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -126.44 137.38 53.4 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.6 tt -127.28 115.15 18.59 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -78.66 104.54 9.34 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 pp -68.54 -29.11 42.82 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.19 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -56.86 -45.18 82.62 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 118.437 0.562 . . . . 0.0 109.752 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -81.48 -31.43 32.94 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.929 0.892 . . . . 0.0 110.395 177.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -119.83 68.91 12.51 Favored Pre-proline 0 C--O 1.235 0.326 0 C-N-CA 123.663 0.785 . . . . 0.0 111.557 -177.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -61.39 -52.64 3.03 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.463 2.109 . . . . 0.0 112.586 -177.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -38.28 -45.43 1.79 Allowed Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.538 1.542 . . . . 0.0 114.556 -177.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.45 -33.91 46.45 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.89 0.876 . . . . 0.0 112.964 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.55 -67.67 0.89 Allowed Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 118.136 -0.935 . . . . 0.0 112.184 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -59.42 -37.18 91.38 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.77 1.646 . . . . 0.0 111.218 177.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -51.35 -38.38 52.89 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.291 0.951 . . . . 0.0 111.778 178.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -110.83 22.53 15.25 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.895 0.478 . . . . 0.0 111.574 178.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 42.9 43.06 5.23 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 126.085 1.802 . . . . 0.0 112.976 178.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.3 mp -43.95 131.98 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 123.69 0.796 . . . . 0.0 112.137 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.15 -51.7 9.84 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.472 1.109 . . . . 0.0 109.218 -177.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -179.53 135.16 2.44 Favored Glycine 0 C--N 1.333 0.409 0 N-CA-C 107.228 -2.349 . . . . 0.0 107.228 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.0 pp -79.98 145.37 61.18 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 117.251 0.525 . . . . 0.0 111.511 -176.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.81 135.1 32.25 Favored 'Cis proline' 0 N--CA 1.456 -0.69 0 CA-C-N 119.744 0.944 . . . . 0.0 111.512 -0.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.5 m -123.23 117.51 25.48 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.6 mt -95.64 122.25 38.21 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -114.17 119.58 37.57 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 177.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.15 98.24 10.49 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -90.26 107.67 19.29 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.374 1.47 . . . . 0.0 110.786 -178.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -96.66 108.63 21.28 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 173.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 35.8 m120 48.43 51.59 14.99 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.75 0.82 . . . . 0.0 111.339 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.51 -13.97 14.51 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 118.851 -0.972 . . . . 0.0 114.64 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -94.71 122.59 37.48 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 119.563 1.682 . . . . 0.0 109.557 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 98.9 t -65.53 108.95 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 175.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.93 -39.52 34.5 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -163.16 173.9 12.85 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.5 t -149.73 159.39 44.39 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.7 mmtp -138.79 151.9 47.45 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.534 1.934 . . . . 0.0 107.271 177.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.9 t -129.08 135.22 62.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 124.722 1.209 . . . . 0.0 107.906 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.47 -171.12 51.23 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 112.077 -0.409 . . . . 0.0 112.077 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.63 163.31 27.86 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.051 0.541 . . . . 0.0 111.357 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.7 mt -146.25 154.62 41.92 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.303 1.441 . . . . 0.0 107.823 178.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.1 p -84.98 150.83 24.64 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 172.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -48.95 -49.32 40.93 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.063 0.545 . . . . 0.0 110.768 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.35 -59.13 10.55 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 112.108 -0.397 . . . . 0.0 112.108 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -55.32 -45.15 76.34 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 117.527 0.664 . . . . 0.0 111.077 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.2 tp -59.51 -50.21 74.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 177.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -55.33 -46.35 76.36 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.613 0.642 . . . . 0.0 111.222 177.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -57.11 -52.55 64.83 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.111 0.565 . . . . 0.0 109.769 178.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -53.81 -53.79 47.45 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.053 0.941 . . . . 0.0 110.781 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 88.3 mt -59.2 -49.76 76.63 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.256 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -54.71 -50.52 68.11 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 122.807 0.443 . . . . 0.0 110.489 178.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.3 -36.18 68.37 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.518 0.727 . . . . 0.0 111.651 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -78.04 -44.15 27.27 Favored 'General case' 0 N--CA 1.46 0.068 0 O-C-N 122.157 -0.339 . . . . 0.0 110.162 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 40.4 mt -59.51 -45.73 90.89 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.2 0 C-N-CA 123.183 0.593 . . . . 0.0 109.812 177.727 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.449 -0.507 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 43.56 42.31 3.95 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.145 1.778 . . . . 0.0 112.962 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -80.77 57.79 3.11 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.386 1.075 . . . . 0.0 108.872 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 13.4 mt -103.99 139.7 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 124.794 1.238 . . . . 0.0 110.355 -177.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 25.7 mm -91.36 116.72 33.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 177.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -82.92 113.29 20.42 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.3 mt -96.18 164.0 12.86 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.896 0.878 . . . . 0.0 112.148 -177.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 32.4 p -135.81 166.34 23.52 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 171.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -59.13 -47.8 83.96 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.446 0.566 . . . . 0.0 109.556 178.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -60.9 -44.56 96.97 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.663 0.785 . . . . 0.0 111.535 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 82.5 p -79.21 -24.41 43.15 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -176.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -34.21 -59.68 0.43 Allowed 'General case' 0 C--N 1.339 0.124 0 C-N-CA 126.598 1.959 . . . . 0.0 113.836 -178.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -51.69 -59.23 4.52 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.288 0.635 . . . . 0.0 110.82 -177.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 m -60.09 -43.69 95.36 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 123.248 0.619 . . . . 0.0 111.732 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -72.69 -36.7 67.92 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -174.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.4 t -112.88 -60.3 2.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 123.807 0.843 . . . . 0.0 111.205 -173.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.5 mt -61.37 -35.9 78.74 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-O 119.257 -0.402 . . . . 0.0 111.736 -175.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -92.22 10.47 29.4 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.368 0.531 . . . . 0.0 112.071 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.67 103.39 15.07 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 119.081 0.855 . . . . 0.0 109.965 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -74.31 65.38 1.2 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.524 0.73 . . . . 0.0 110.592 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -166.01 177.84 40.92 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.03 107.19 18.32 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.994 1.318 . . . . 0.0 111.059 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 mt -113.42 114.14 46.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 124.523 1.129 . . . . 0.0 110.78 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.4 tp -84.05 98.94 10.13 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 107.005 -1.479 . . . . 0.0 107.005 174.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.0 t -87.58 118.74 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 123.125 0.57 . . . . 0.0 109.54 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -102.63 108.19 19.37 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.52 1.128 . . . . 0.0 108.951 177.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -81.29 119.18 23.32 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 175.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 37.4 p-90 -135.28 171.97 13.68 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 124.154 0.981 . . . . 0.0 113.196 -174.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.11 132.05 17.15 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 125.736 1.614 . . . . 0.0 108.036 175.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.3 pm0 -49.42 -39.29 32.22 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -178.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 61.4 p-90 -77.26 -19.95 55.83 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 43.8 t -79.53 76.21 6.15 Favored 'General case' 0 N--CA 1.456 -0.162 0 O-C-N 121.409 -0.807 . . . . 0.0 110.411 -176.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -12.58 -69.75 0.01 OUTLIER Glycine 0 CA--C 1.536 1.39 0 C-N-CA 127.752 2.596 . . . . 0.0 115.565 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -41.63 -38.78 4.43 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 124.683 3.588 . . . . 0.0 114.766 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 87.7 m -50.86 -47.37 60.36 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.331 1.052 . . . . 0.0 110.584 177.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt -70.57 -28.67 65.06 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.582 0.753 . . . . 0.0 110.621 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 84.7 mmm -71.45 -43.29 66.96 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 177.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.3 pt -76.82 -27.91 16.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 CA-C-O 118.536 -0.745 . . . . 0.0 112.102 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -38.07 -59.21 1.25 Allowed Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -56.92 -41.15 78.4 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.208 1.939 . . . . 0.0 111.911 177.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 27.6 mt -58.27 -52.04 63.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 68.6 mt -56.68 -44.04 81.07 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.432 0.693 . . . . 0.0 110.494 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -58.43 -48.46 80.63 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.737 0.415 . . . . 0.0 110.281 178.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -60.7 -52.25 65.9 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.9 mm -50.79 -47.14 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.267 1.027 . . . . 0.0 110.402 177.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.48 -37.35 65.15 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.323 0.649 . . . . 0.0 110.848 178.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -75.04 -55.44 5.74 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 176.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -45.56 -51.4 11.99 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 125.37 1.468 . . . . 0.0 112.28 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -101.26 23.11 11.4 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.96 0.504 . . . . 0.0 111.637 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -55.35 130.26 41.76 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 119.455 1.025 . . . . 0.0 110.643 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.75 -19.68 23.56 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 119.466 -0.63 . . . . 0.0 112.625 -178.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -99.4 -41.24 7.5 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.261 1.024 . . . . 0.0 108.829 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.0 tp -133.29 143.88 49.34 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.243 1.817 . . . . 0.0 107.217 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 94.5 m -107.16 140.27 40.28 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 105.314 -2.106 . . . . 0.0 105.314 173.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.1 t -112.82 140.51 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 178.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.38 149.41 46.95 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -178.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -126.26 131.43 51.91 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.261 1.024 . . . . 0.0 108.255 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 tt -122.79 116.24 23.37 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.739 0.816 . . . . 0.0 109.653 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -80.06 107.62 12.99 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 pp -66.83 -30.89 51.13 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -177.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -60.08 -49.46 77.56 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 119.03 0.832 . . . . 0.0 109.295 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -69.89 -36.09 75.16 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.006 177.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -121.25 70.78 22.44 Favored Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 123.907 0.883 . . . . 0.0 112.049 -175.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.94 -52.36 2.25 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.543 2.162 . . . . 0.0 112.616 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -39.03 -44.31 1.98 Allowed Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.438 1.494 . . . . 0.0 114.276 -177.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -53.13 -32.92 50.01 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.813 0.845 . . . . 0.0 112.874 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.78 -68.27 0.76 Allowed Pre-proline 0 CA--C 1.538 0.513 0 CA-C-O 118.072 -0.966 . . . . 0.0 111.662 178.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -59.38 -36.86 93.11 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 121.55 1.5 . . . . 0.0 111.45 177.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -51.58 -40.56 60.01 Favored 'General case' 0 C--N 1.345 0.398 0 CA-C-N 119.558 1.072 . . . . 0.0 111.601 178.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -107.7 21.7 17.06 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 122.704 0.402 . . . . 0.0 111.275 178.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 43.88 43.5 6.82 Favored Glycine 0 C--N 1.338 0.684 0 C-N-CA 125.798 1.666 . . . . 0.0 113.034 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.3 mp -49.02 129.5 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 117.975 0.887 . . . . 0.0 110.839 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.73 -53.86 6.7 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.045 0.938 . . . . 0.0 108.924 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -168.87 150.12 15.15 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 107.062 -2.415 . . . . 0.0 107.062 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 23.8 pt -91.47 149.18 39.02 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-N 117.701 0.75 . . . . 0.0 110.373 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -70.88 137.69 47.89 Favored 'Cis proline' 0 N--CA 1.456 -0.684 0 CA-C-N 119.644 0.908 . . . . 0.0 110.416 -1.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.95 116.69 27.43 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 20.8 mt -98.29 120.83 39.37 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.5 mp -121.08 118.91 30.95 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 177.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.3 tp -93.35 96.11 9.74 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -84.97 101.86 12.71 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.665 1.186 . . . . 0.0 110.002 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -93.45 114.53 26.95 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 173.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 55.89 39.31 30.64 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.8 0.84 . . . . 0.0 110.979 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.51 -0.6 75.26 Favored Glycine 0 CA--C 1.532 1.121 0 CA-C-O 118.758 -1.024 . . . . 0.0 113.738 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -108.24 126.68 53.08 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.346 1.573 . . . . 0.0 109.354 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.7 t -63.57 106.36 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.08 -40.82 30.21 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.026 0.931 . . . . 0.0 109.535 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -156.78 169.46 24.69 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.9 t -151.84 159.63 43.81 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -146.75 131.41 17.87 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.6 t -102.36 125.58 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.26 170.92 38.04 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.21 166.1 16.98 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.685 0.794 . . . . 0.0 112.875 -177.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.0 mt -138.93 153.52 48.24 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 126.228 1.811 . . . . 0.0 107.513 177.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.1 p -84.09 155.54 22.61 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.514 -1.662 . . . . 0.0 106.514 171.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -50.31 -51.36 45.93 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 122.126 -0.359 . . . . 0.0 111.084 -178.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -53.64 -58.45 12.28 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 111.913 -0.475 . . . . 0.0 111.913 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -56.2 -42.34 77.01 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 122.232 -0.569 . . . . 0.0 110.856 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 30.9 tp -62.55 -48.49 79.28 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -54.78 -47.84 73.43 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.558 0.617 . . . . 0.0 110.125 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -57.51 -53.84 53.56 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.541 0.737 . . . . 0.0 110.397 178.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -52.19 -50.16 62.43 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.63 1.172 . . . . 0.0 110.174 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 87.2 mt -60.52 -52.29 65.81 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 119.184 -0.436 . . . . 0.0 110.329 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -52.8 -49.4 65.71 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 118.197 0.453 . . . . 0.0 110.459 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.66 -37.5 70.88 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.546 0.738 . . . . 0.0 111.658 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -78.07 -44.24 26.86 Favored 'General case' 0 N--CA 1.462 0.135 0 O-C-N 122.083 -0.385 . . . . 0.0 110.439 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 53.8 mt -59.05 -48.18 82.53 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.276 0 C-N-CA 123.259 0.623 . . . . 0.0 109.607 177.465 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 7.8 p . . . . . 0 CA--C 1.533 0.323 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -70.78 61.28 0.25 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.703 1.601 . . . . 0.0 111.826 -178.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.4 mtmm -82.23 58.63 4.11 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 177.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.4 mt -131.0 148.21 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 123.875 0.87 . . . . 0.0 109.379 -173.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.8 mm -87.1 106.9 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -82.2 105.67 13.48 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.9 mt -88.24 166.35 14.4 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.854 1.662 . . . . 0.0 112.161 -177.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 44.0 p -137.33 165.72 25.51 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 172.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -59.05 -46.57 87.89 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 118.271 0.487 . . . . 0.0 110.102 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -60.23 -45.36 93.49 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.498 0.719 . . . . 0.0 111.127 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 81.9 p -79.18 -24.24 43.35 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -176.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -37.71 -53.91 1.23 Allowed 'General case' 0 CA--C 1.527 0.073 0 C-N-CA 126.758 2.023 . . . . 0.0 114.359 -178.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -53.19 -60.35 3.4 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.307 0.575 . . . . 0.0 110.637 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.1 m -60.46 -45.54 93.33 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 123.062 0.545 . . . . 0.0 111.601 -178.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -71.63 -36.18 70.65 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -173.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 41.4 t -112.87 -60.92 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 123.619 0.768 . . . . 0.0 110.762 -174.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.4 mt -62.91 -35.51 80.29 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 119.183 -0.437 . . . . 0.0 111.991 -174.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -96.67 15.78 20.83 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.336 0.516 . . . . 0.0 111.765 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -102.87 104.13 14.35 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 118.877 0.762 . . . . 0.0 110.192 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -74.09 65.17 1.1 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.582 0.753 . . . . 0.0 110.995 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -165.84 177.27 41.05 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.56 103.8 14.73 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 125.204 1.402 . . . . 0.0 110.798 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mt -109.98 118.63 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 C-N-CA 123.937 0.895 . . . . 0.0 110.236 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 19.3 tp -89.38 98.06 11.55 Favored 'General case' 0 C--N 1.338 0.068 0 N-CA-C 106.444 -1.688 . . . . 0.0 106.444 175.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.4 t -85.94 110.31 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 123.387 0.675 . . . . 0.0 109.341 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -97.49 108.92 21.74 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.172 0.589 . . . . 0.0 109.679 177.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -81.63 123.25 28.54 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 175.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 37.9 p-90 -136.62 167.43 21.42 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 124.601 1.161 . . . . 0.0 112.122 -177.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -141.39 137.76 32.51 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.976 1.31 . . . . 0.0 107.834 177.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -52.33 -48.23 65.57 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.871 0.868 . . . . 0.0 112.495 -177.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 57.7 p-90 -68.74 -22.42 64.32 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.063 0.545 . . . . 0.0 112.407 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 42.1 t -79.75 77.37 6.39 Favored 'General case' 0 N--CA 1.456 -0.142 0 O-C-N 121.402 -0.811 . . . . 0.0 111.073 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -23.03 -62.69 0.03 OUTLIER Glycine 0 CA--C 1.536 1.401 0 C-N-CA 127.34 2.4 . . . . 0.0 115.499 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -44.16 -31.52 4.19 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 124.511 3.474 . . . . 0.0 114.955 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 88.1 m -55.97 -43.29 77.43 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.613 -0.68 . . . . 0.0 109.724 176.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -66.18 -33.09 74.97 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.703 0.801 . . . . 0.0 110.147 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 46.7 ttm -67.22 -44.36 79.74 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 19.6 pt -77.5 -27.31 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 118.954 -0.546 . . . . 0.0 112.451 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -39.7 -57.45 2.53 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -58.9 -39.44 81.2 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.074 1.849 . . . . 0.0 111.474 177.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 27.9 mt -58.15 -50.78 77.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 177.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 53.2 mt -57.13 -42.85 81.67 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.032 0.533 . . . . 0.0 110.411 177.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -59.0 -48.24 82.29 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.716 0.689 . . . . 0.0 110.492 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -59.63 -49.3 78.3 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.0 mm -55.66 -44.34 76.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 123.597 0.759 . . . . 0.0 109.657 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.18 -41.78 72.35 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.465 0.575 . . . . 0.0 110.355 178.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -66.6 -59.05 3.96 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.122 0.486 . . . . 0.0 110.075 177.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -51.29 -45.45 62.14 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.176 0.99 . . . . 0.0 112.375 -177.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -97.83 22.9 8.56 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.822 0.849 . . . . 0.0 111.78 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.4 130.14 26.64 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.293 0.951 . . . . 0.0 110.525 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.84 -16.54 4.2 Favored Glycine 0 CA--C 1.534 1.23 0 CA-C-O 119.22 -0.767 . . . . 0.0 113.948 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -99.66 -35.32 9.86 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.703 1.251 . . . . 0.0 110.129 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.8 tp -136.42 136.04 39.21 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.269 1.027 . . . . 0.0 108.783 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 85.6 m -97.03 104.73 16.77 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 175.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 63.2 t -79.86 128.15 38.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -129.88 151.85 50.0 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.59 0.756 . . . . 0.0 109.79 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.4 mttm -128.16 142.32 51.22 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.637 1.175 . . . . 0.0 108.135 177.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.4 tt -132.88 115.42 15.23 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -80.72 108.84 14.71 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.9 pt -72.04 -19.08 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -60.88 -47.83 84.61 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 119.342 0.974 . . . . 0.0 108.663 178.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -80.06 -32.85 39.35 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.169 0.988 . . . . 0.0 109.997 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -121.5 64.48 15.49 Favored Pre-proline 0 CA--C 1.533 0.319 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -175.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -65.69 -42.35 12.37 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 121.687 1.591 . . . . 0.0 110.674 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -45.23 -30.15 2.67 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 125.791 1.662 . . . . 0.0 114.922 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.22 -26.75 62.15 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.415 1.108 . . . . 0.0 112.297 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.03 -58.59 15.58 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 119.307 0.958 . . . . 0.0 111.137 178.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -45.68 -45.04 17.05 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 124.031 3.154 . . . . 0.0 113.201 175.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -50.78 -31.15 16.04 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -120.15 19.71 12.18 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.146 0.578 . . . . 0.0 110.781 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 45.92 37.66 7.55 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.527 1.537 . . . . 0.0 112.54 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.4 mt -60.76 140.22 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 117.351 0.575 . . . . 0.0 110.959 -177.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -79.38 -38.39 35.06 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.113 0.965 . . . . 0.0 112.169 -174.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -179.94 -152.27 10.69 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 107.074 -2.41 . . . . 0.0 107.074 -177.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -146.13 157.44 49.82 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-O 117.764 -1.112 . . . . 0.0 108.872 178.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -66.84 135.92 29.14 Favored 'Cis proline' 0 N--CA 1.457 -0.662 0 CA-C-N 120.494 1.212 . . . . 0.0 110.151 -1.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.9 m -132.58 146.76 52.15 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 106.09 -1.818 . . . . 0.0 106.09 175.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.8 mt -127.49 124.86 39.33 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.567 1.547 . . . . 0.0 107.363 -175.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.3 mp -121.3 119.46 32.28 Favored 'General case' 0 CA--C 1.522 -0.106 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 176.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.45 95.62 9.75 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -85.44 101.86 12.97 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.657 1.183 . . . . 0.0 109.207 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -93.78 114.04 26.22 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 174.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 56.16 40.06 30.19 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.676 0.79 . . . . 0.0 111.177 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.68 -1.61 66.56 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 118.734 -1.037 . . . . 0.0 113.521 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -107.01 128.69 54.59 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 119.419 1.609 . . . . 0.0 109.368 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.9 t -66.28 107.87 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.15 -40.94 29.67 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.596 0.758 . . . . 0.0 109.416 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.11 170.75 20.58 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 177.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.9 t -151.32 160.76 43.62 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.7 tptt -148.13 131.1 16.22 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.557 1.543 . . . . 0.0 107.221 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 94.7 t -108.32 133.21 54.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 106.538 -1.652 . . . . 0.0 106.538 177.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.72 173.28 41.17 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.934 -0.867 . . . . 0.0 110.934 -178.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.12 170.37 16.17 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.976 0.511 . . . . 0.0 110.858 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -161.68 164.52 29.12 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.723 1.609 . . . . 0.0 107.614 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 83.8 p -81.26 165.02 21.82 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.067 0.46 . . . . 0.0 110.077 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -57.21 -41.73 79.95 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 174.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.81 -55.24 30.94 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -57.03 -43.73 82.17 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 117.687 0.743 . . . . 0.0 109.94 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 27.6 tp -59.9 -49.69 76.7 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 177.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -53.53 -48.38 69.11 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.011 0.823 . . . . 0.0 111.463 177.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -59.27 -50.57 73.51 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -53.15 -51.82 60.74 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.892 0.877 . . . . 0.0 110.05 178.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.5 mt -57.95 -53.04 62.76 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 122.952 0.501 . . . . 0.0 110.538 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -53.74 -50.45 65.95 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 117.866 0.303 . . . . 0.0 110.637 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.7 -37.56 68.53 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.362 0.665 . . . . 0.0 111.631 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -78.22 -46.16 21.11 Favored 'General case' 0 C--O 1.227 -0.121 0 O-C-N 122.182 -0.324 . . . . 0.0 110.862 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 54.8 mt -60.85 -46.7 89.52 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.265 0.626 . . . . 0.0 109.397 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.282 0 C-N-CA 123.025 0.53 . . . . 0.0 109.75 177.568 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 43.3 m . . . . . 0 N--CA 1.451 -0.385 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -65.37 141.9 58.4 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -69.0 -33.06 73.06 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 175.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.2 mt -80.07 139.25 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 C-N-CA 123.276 0.631 . . . . 0.0 109.357 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.9 mm -89.82 116.2 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 123.763 0.825 . . . . 0.0 109.356 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 -82.27 105.49 13.39 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.1 mt -90.76 155.14 19.02 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.369 0.668 . . . . 0.0 112.143 -177.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.0 p -126.06 158.5 35.25 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 172.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -55.13 -45.14 75.56 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.749 0.82 . . . . 0.0 109.815 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -57.7 -44.55 85.97 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.266 1.026 . . . . 0.0 111.309 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.9 p -78.22 -31.96 49.58 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -176.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -36.79 -48.43 0.73 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.605 1.962 . . . . 0.0 114.321 -176.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -55.3 -39.09 69.5 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -178.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.5 m -90.68 -50.66 5.79 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.348 0.659 . . . . 0.0 110.036 -178.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.87 -29.41 67.71 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -174.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.5 t -114.41 -60.69 2.77 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.076 0 CA-C-N 118.856 0.753 . . . . 0.0 110.723 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 72.1 mt -61.52 -30.94 70.96 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -174.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 42.6 mttp -97.95 16.61 20.43 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.045 0.838 . . . . 0.0 110.596 175.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.64 94.49 4.4 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 121.245 -0.909 . . . . 0.0 111.485 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -75.8 68.98 2.42 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 177.43 -170.56 43.11 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 108.386 -1.885 . . . . 0.0 108.386 -177.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -105.27 118.15 35.82 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.707 1.603 . . . . 0.0 110.783 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.1 mt -122.32 116.75 50.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 125.248 1.419 . . . . 0.0 110.036 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 24.5 tp -84.16 97.07 9.16 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 173.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 51.4 t -86.4 115.57 27.72 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.097 0 C-N-CA 123.361 0.664 . . . . 0.0 109.519 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -100.03 104.45 16.04 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.203 1.001 . . . . 0.0 109.212 177.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -79.57 120.79 24.41 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 105.026 -2.213 . . . . 0.0 105.026 174.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 13.7 p-90 -141.18 164.51 30.07 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -173.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -128.76 139.81 52.03 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.209 1.003 . . . . 0.0 109.215 175.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -54.2 -48.63 70.79 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.977 1.311 . . . . 0.0 111.419 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 54.9 p-90 -69.81 -21.59 63.38 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.794 0.838 . . . . 0.0 112.374 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 42.7 t -79.87 76.93 6.55 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 121.323 -0.861 . . . . 0.0 110.351 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -22.97 -60.99 0.03 OUTLIER Glycine 0 CA--C 1.535 1.315 0 C-N-CA 127.691 2.567 . . . . 0.0 115.632 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -44.21 -35.46 7.99 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 123.921 3.081 . . . . 0.0 114.129 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.8 m -59.12 -48.74 80.5 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 121.721 0.772 . . . . 0.0 109.844 177.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -65.5 -36.91 85.25 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 25.0 ttt -60.77 -45.33 94.78 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 119.622 -0.227 . . . . 0.0 110.715 177.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 34.8 pt -76.35 -25.72 16.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-O 118.635 -0.697 . . . . 0.0 112.49 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -37.26 -58.63 1.15 Allowed Pre-proline 0 CA--C 1.545 0.75 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -56.71 -40.32 85.16 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.241 1.96 . . . . 0.0 112.172 177.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 26.4 mt -59.24 -51.08 76.85 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 177.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 76.8 mt -56.59 -43.44 80.08 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.997 0.519 . . . . 0.0 110.804 178.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -60.22 -48.8 80.19 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.657 0.662 . . . . 0.0 110.215 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -59.25 -50.83 72.49 Favored 'General case' 0 C--O 1.226 -0.183 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.3 mm -54.3 -48.78 67.17 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.38 -49.34 64.61 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 122.975 0.51 . . . . 0.0 109.918 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -61.03 -57.85 10.86 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.785 0.326 . . . . 0.0 110.805 178.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -50.38 -45.96 55.68 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.44 1.096 . . . . 0.0 112.438 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -94.69 22.61 6.14 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -177.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -50.52 127.8 18.61 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.641 1.11 . . . . 0.0 110.384 177.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.48 -20.67 13.12 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-O 119.281 -0.733 . . . . 0.0 113.264 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -99.6 -40.49 7.78 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.566 1.183 . . . . 0.0 110.258 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.3 tp -143.18 136.9 28.61 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.853 0.861 . . . . 0.0 108.703 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 92.8 m -98.13 143.94 28.13 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 173.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 68.7 t -118.43 138.53 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 178.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.34 152.93 50.25 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -177.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.1 mttm -125.83 132.3 52.26 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.875 1.27 . . . . 0.0 107.623 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.8 tt -123.1 106.59 10.92 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -78.14 102.43 7.52 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.202 -177.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 pp -55.59 -30.99 27.6 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.231 0 C-N-CA 124.214 1.006 . . . . 0.0 112.072 -179.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -57.0 -45.36 83.05 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.26 0.482 . . . . 0.0 109.825 178.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -81.94 -35.92 28.57 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.077 0.951 . . . . 0.0 110.581 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -123.49 69.9 43.99 Favored Pre-proline 0 CA--C 1.529 0.15 0 C-N-CA 123.861 0.864 . . . . 0.0 111.182 -176.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -64.97 -41.98 15.72 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.033 1.822 . . . . 0.0 110.898 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -41.78 -41.02 3.27 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.456 1.503 . . . . 0.0 114.765 -178.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.92 -23.81 65.13 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.23 1.015 . . . . 0.0 112.975 -177.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.23 -62.14 6.15 Favored Pre-proline 0 CA--C 1.539 0.557 0 O-C-N 121.388 -0.82 . . . . 0.0 113.035 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -60.74 -37.48 78.4 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.087 1.858 . . . . 0.0 111.651 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -50.96 -36.54 39.38 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 118.836 0.744 . . . . 0.0 112.095 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -112.58 16.41 19.75 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.918 0.487 . . . . 0.0 111.44 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 49.01 43.6 31.73 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 125.043 1.306 . . . . 0.0 112.743 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mp -44.38 118.41 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 117.903 0.852 . . . . 0.0 110.585 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -79.56 -48.28 14.09 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.297 1.039 . . . . 0.0 111.153 -174.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -166.69 141.95 7.28 Favored Glycine 0 C--N 1.334 0.468 0 N-CA-C 107.609 -2.196 . . . . 0.0 107.609 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 22.9 pt -92.96 146.19 31.56 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 123.489 0.716 . . . . 0.0 110.665 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.41 133.19 24.14 Favored 'Cis proline' 0 N--CA 1.459 -0.511 0 CA-C-N 119.963 1.023 . . . . 0.0 110.424 -1.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.94 111.91 23.61 Favored 'General case' 0 C--N 1.338 0.078 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 24.3 mt -93.88 117.72 30.48 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.7 mp -118.17 115.67 25.27 Favored 'General case' 0 C--N 1.334 -0.106 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 177.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 tp -89.99 95.55 10.27 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -84.78 108.61 17.55 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.53 1.132 . . . . 0.0 110.231 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -107.36 122.91 47.53 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 174.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 52.39 47.59 24.41 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.379 0.609 . . . . 0.0 109.99 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.37 -3.0 6.4 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-O 118.181 -1.344 . . . . 0.0 115.687 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -111.99 143.43 43.0 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 120.051 1.925 . . . . 0.0 110.66 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.6 t -70.94 110.49 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.94 -41.41 29.44 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -158.53 169.98 23.22 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 177.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.5 t -150.47 161.25 42.88 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -147.66 131.11 16.68 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.0 t -102.2 121.61 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.38 171.7 38.08 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 121.444 0.469 . . . . 0.0 112.094 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.67 164.22 14.85 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.004 0.922 . . . . 0.0 112.761 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.9 mt -135.52 152.35 51.23 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.972 1.709 . . . . 0.0 108.194 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.9 p -81.77 150.04 28.11 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 170.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -49.84 -48.53 50.95 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -176.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.03 -57.63 17.44 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -55.6 -41.71 73.82 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 122.896 0.478 . . . . 0.0 110.686 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.3 tp -61.12 -51.53 68.71 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -55.41 -45.69 76.67 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.627 0.649 . . . . 0.0 110.906 177.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -57.84 -53.47 57.79 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.18 0.592 . . . . 0.0 110.274 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -52.71 -50.82 62.6 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.92 1.288 . . . . 0.0 110.149 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 98.2 mt -60.32 -51.28 70.18 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 122.592 0.357 . . . . 0.0 110.424 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -53.55 -49.36 67.82 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 117.964 0.347 . . . . 0.0 110.398 178.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.5 -35.67 70.51 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.759 0.823 . . . . 0.0 111.74 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -78.45 -43.65 26.69 Favored 'General case' 0 C--O 1.227 -0.12 0 CA-C-N 118.057 0.39 . . . . 0.0 110.582 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 53.7 mt -62.79 -46.6 87.26 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.241 0.616 . . . . 0.0 109.905 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.164 0 C-N-CA 124.743 1.217 . . . . 0.0 111.739 179.133 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 20.1 p . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -70.3 63.33 0.24 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.488 1.515 . . . . 0.0 111.524 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -82.41 57.74 3.8 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 178.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 32.1 mt -133.64 147.62 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 123.447 0.699 . . . . 0.0 109.64 -174.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.5 mm -87.81 104.61 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 177.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 29.6 m-70 -80.55 95.26 6.45 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 42.9 mt -79.01 162.51 25.89 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.835 1.254 . . . . 0.0 111.922 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 30.0 p -134.16 162.4 32.23 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.38 1.872 . . . . 0.0 106.574 172.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -54.2 -47.63 71.9 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.723 0.809 . . . . 0.0 110.337 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -56.25 -44.83 80.03 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.933 0.893 . . . . 0.0 111.759 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.5 p -78.31 -28.46 47.45 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -176.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -38.99 -49.82 1.73 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.738 1.615 . . . . 0.0 113.879 -176.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -50.81 -63.92 0.98 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.659 0.742 . . . . 0.0 111.0 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.3 m -68.31 -46.89 69.05 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.834 -175.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -75.53 -23.17 56.61 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 -174.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.0 t -118.34 -63.31 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-N 119.432 1.014 . . . . 0.0 110.057 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 72.4 mt -60.21 -37.53 80.58 Favored 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -174.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -93.45 12.28 25.54 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.598 0.636 . . . . 0.0 111.834 177.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.39 102.56 14.66 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 119.098 0.863 . . . . 0.0 110.885 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -76.09 65.7 2.14 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.377 0.671 . . . . 0.0 109.9 177.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -173.84 -175.03 41.2 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.87 124.42 35.97 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.269 1.427 . . . . 0.0 111.052 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.3 mt -133.32 124.07 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 124.811 1.244 . . . . 0.0 109.917 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -93.73 108.57 20.3 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 105.534 -2.025 . . . . 0.0 105.534 174.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.6 t -99.6 107.34 20.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -178.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -91.62 102.86 15.5 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -78.49 121.37 24.48 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 103.758 -2.682 . . . . 0.0 103.758 174.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 25.8 p-90 -137.0 168.54 19.4 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 123.61 0.764 . . . . 0.0 112.631 -174.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -141.48 140.45 33.54 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.813 1.245 . . . . 0.0 108.099 176.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -55.81 -50.76 69.63 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.483 0.713 . . . . 0.0 112.688 -176.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 43.3 p-90 -59.92 -29.68 68.54 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.77 0.828 . . . . 0.0 112.828 -178.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 48.8 t -79.6 80.45 5.98 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 121.432 -0.793 . . . . 0.0 110.507 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -23.06 -61.2 0.03 OUTLIER Glycine 0 CA--C 1.537 1.459 0 C-N-CA 127.422 2.439 . . . . 0.0 115.243 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -41.98 -37.77 4.57 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 124.309 3.34 . . . . 0.0 114.335 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 86.4 m -54.9 -44.23 73.97 Favored 'General case' 0 CA--C 1.527 0.058 0 C-N-CA 123.661 0.785 . . . . 0.0 110.597 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -69.92 -45.21 68.03 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 87.5 mmm -53.69 -42.76 68.31 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 30.7 pt -76.65 -12.06 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.22 -58.35 10.86 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 120.162 1.346 . . . . 0.0 112.79 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -55.43 -41.37 78.72 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.141 1.894 . . . . 0.0 111.377 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 19.2 mt -57.56 -53.65 41.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.3 mt -56.29 -39.19 72.29 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.312 0.645 . . . . 0.0 110.682 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -62.0 -48.84 78.5 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.013 0.824 . . . . 0.0 110.396 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -57.17 -51.73 68.13 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.2 mm -53.05 -48.06 53.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.675 1.19 . . . . 0.0 109.399 177.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.34 -45.76 76.42 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 122.927 0.491 . . . . 0.0 110.645 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -63.2 -53.17 57.4 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 177.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -50.29 -50.15 51.29 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.977 0.911 . . . . 0.0 111.687 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -98.86 30.5 3.33 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.464 0.706 . . . . 0.0 111.347 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -60.35 120.77 10.5 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.491 -0.755 . . . . 0.0 110.005 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.69 3.54 89.06 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 119.615 -0.547 . . . . 0.0 112.487 -177.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.1 mttm -114.03 -41.84 3.47 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.134 1.373 . . . . 0.0 109.281 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.0 tp -133.4 131.54 40.11 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.245 1.018 . . . . 0.0 108.498 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.5 m -86.87 100.35 12.49 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.1 t -79.3 125.07 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -131.74 151.72 51.45 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.58 0.752 . . . . 0.0 110.663 -176.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.7 mttm -127.22 143.76 51.18 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 176.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 tt -133.44 111.34 10.66 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -79.28 110.12 14.26 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.2 pt -71.28 -22.81 22.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 118.94 -0.552 . . . . 0.0 112.276 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -58.79 -46.58 87.22 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 119.352 0.978 . . . . 0.0 108.824 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -80.39 -25.18 39.23 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.282 1.033 . . . . 0.0 110.949 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -127.37 66.95 70.51 Favored Pre-proline 0 CA--C 1.534 0.341 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.48 -55.85 2.99 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.531 2.154 . . . . 0.0 113.265 -178.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -37.8 -46.61 1.69 Allowed Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.872 1.701 . . . . 0.0 114.544 -176.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -53.12 -34.56 57.26 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.489 0.715 . . . . 0.0 112.288 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.72 -68.6 0.57 Allowed Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 118.255 -0.878 . . . . 0.0 112.374 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -58.96 -38.24 89.14 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 CA-C-N 121.085 1.423 . . . . 0.0 110.94 177.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -52.26 -39.92 61.03 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 118.926 0.784 . . . . 0.0 111.732 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -104.59 19.46 20.33 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.106 0.412 . . . . 0.0 111.907 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.7 39.04 54.05 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 124.021 0.82 . . . . 0.0 113.216 177.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.5 mp -56.94 122.33 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -79.81 -47.24 15.51 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.721 0.808 . . . . 0.0 109.364 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -168.92 146.09 10.01 Favored Glycine 0 CA--C 1.521 0.424 0 N-CA-C 106.896 -2.481 . . . . 0.0 106.896 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.6 pp -92.02 150.32 40.32 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 117.382 0.591 . . . . 0.0 110.378 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -70.93 136.5 41.61 Favored 'Cis proline' 0 N--CA 1.457 -0.649 0 CA-C-N 120.107 1.074 . . . . 0.0 111.31 0.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -120.68 113.47 20.26 Favored 'General case' 0 C--O 1.23 0.042 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 178.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.4 mt -95.9 101.17 12.82 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 -178.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -92.79 111.98 23.78 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 176.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 tp -92.77 105.59 17.7 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -93.81 143.66 26.13 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.24 1.416 . . . . 0.0 109.835 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -138.01 121.96 17.78 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 172.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 46.1 m-20 50.18 48.55 21.95 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.858 0.863 . . . . 0.0 110.803 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.57 -5.51 10.83 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 118.527 -1.152 . . . . 0.0 115.389 178.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -106.26 138.47 42.38 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 119.932 1.866 . . . . 0.0 110.163 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 94.2 t -66.55 109.17 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 176.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.75 -43.63 22.22 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 124.526 1.131 . . . . 0.0 109.604 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -150.55 169.32 21.81 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 97.2 m -150.98 139.34 20.36 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -177.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -131.47 137.02 48.4 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.0 t -110.94 122.2 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 177.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.01 171.76 37.09 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 123.38 0.514 . . . . 0.0 112.068 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.83 170.71 10.53 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.105 0.962 . . . . 0.0 112.441 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.1 mt -140.57 162.39 35.48 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 126.227 1.811 . . . . 0.0 108.321 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 99.9 p -83.67 162.11 20.86 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 169.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -57.06 -44.11 82.72 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 177.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -58.05 -57.59 19.01 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 123.37 0.51 . . . . 0.0 111.964 178.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -60.3 -38.64 84.26 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 121.842 -0.799 . . . . 0.0 110.739 -178.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.0 tp -64.17 -49.39 72.26 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 119.153 -0.451 . . . . 0.0 110.013 178.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 10.2 mmmm -52.65 -49.84 64.4 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.667 0.667 . . . . 0.0 109.47 176.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -56.13 -54.82 40.49 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.249 0.62 . . . . 0.0 110.73 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -52.59 -53.37 47.59 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.957 1.303 . . . . 0.0 111.05 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.3 mt -61.96 -52.14 65.25 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -51.92 -50.88 60.23 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.336 0.654 . . . . 0.0 110.842 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.43 -36.75 66.84 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.522 0.729 . . . . 0.0 111.664 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -78.52 -45.21 22.47 Favored 'General case' 0 N--CA 1.458 -0.057 0 O-C-N 122.263 -0.273 . . . . 0.0 110.516 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 53.2 mt -58.3 -47.45 83.63 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.306 0 C-N-CA 123.232 0.613 . . . . 0.0 109.665 177.423 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.1 m . . . . . 0 N--CA 1.451 -0.412 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -74.74 -47.56 30.54 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -140.28 46.1 1.83 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.678 1.191 . . . . 0.0 108.171 177.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 16.0 mt -122.75 139.18 50.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 C-N-CA 123.633 0.773 . . . . 0.0 109.939 -177.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.5 mm -87.89 108.1 18.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -79.78 114.77 18.95 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 64.9 mt -96.35 167.03 11.42 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 124.38 1.072 . . . . 0.0 112.397 -176.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 33.9 p -136.86 164.58 27.97 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 171.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -59.27 -45.97 89.78 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.463 0.574 . . . . 0.0 109.923 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -59.85 -45.64 91.79 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.708 0.803 . . . . 0.0 111.263 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.8 p -78.86 -24.44 44.31 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -176.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -38.25 -49.93 1.41 Allowed 'General case' 0 CA--C 1.527 0.075 0 C-N-CA 126.576 1.95 . . . . 0.0 113.613 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -54.41 -61.18 2.47 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 121.483 0.659 . . . . 0.0 110.888 -178.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.7 m -63.27 -42.06 99.1 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.444 -177.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -71.16 -43.58 67.22 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -174.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.4 t -107.54 -59.12 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 123.861 0.864 . . . . 0.0 110.893 -174.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 64.4 mt -62.41 -35.62 79.78 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -173.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -90.43 7.05 40.71 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.555 0.616 . . . . 0.0 112.253 178.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.86 102.1 14.21 Favored 'General case' 0 C--N 1.341 0.239 0 CA-C-N 119.185 0.902 . . . . 0.0 111.946 -178.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -75.58 73.48 2.59 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 175.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -172.72 178.57 44.71 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.76 115.19 26.11 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.0 1.32 . . . . 0.0 109.943 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.4 mt -122.6 120.18 60.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 124.528 1.131 . . . . 0.0 109.833 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.4 tp -91.08 100.27 13.15 Favored 'General case' 0 CA--C 1.521 -0.159 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 175.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 63.4 t -90.88 114.25 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -101.14 110.19 22.18 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.953 0.901 . . . . 0.0 109.186 177.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -79.79 124.8 28.94 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 175.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 28.6 p-90 -140.17 172.48 12.69 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.731 0.812 . . . . 0.0 112.864 -175.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.4 132.28 17.08 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.549 1.539 . . . . 0.0 108.024 175.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -49.23 -39.52 30.39 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 61.3 p-90 -76.86 -19.98 56.85 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 40.4 t -79.58 77.0 6.2 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 121.372 -0.83 . . . . 0.0 111.511 -175.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -9.72 -71.87 0.01 OUTLIER Glycine 0 CA--C 1.538 1.509 0 C-N-CA 127.729 2.585 . . . . 0.0 116.349 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -47.29 -33.59 16.68 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 124.089 3.193 . . . . 0.0 114.61 -178.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 88.2 m -52.94 -47.98 67.65 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.635 0.774 . . . . 0.0 109.955 176.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -68.89 -29.19 67.42 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.385 0.674 . . . . 0.0 110.611 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 24.2 mmt -70.28 -44.91 67.42 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 34.3 pt -74.17 -30.53 27.26 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 CA-C-O 118.371 -0.823 . . . . 0.0 112.231 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -36.84 -60.1 0.82 Allowed Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -57.79 -40.39 79.37 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.0 1.8 . . . . 0.0 111.414 178.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 15.7 mt -58.68 -49.67 81.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 177.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 76.9 mt -55.63 -44.17 76.85 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.213 0.605 . . . . 0.0 110.071 177.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -60.7 -46.89 88.67 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.76 -0.587 . . . . 0.0 110.746 177.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -57.25 -51.51 69.08 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 23.4 mm -53.03 -49.28 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 124.057 0.943 . . . . 0.0 109.478 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.56 -47.6 73.05 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 117.967 0.349 . . . . 0.0 110.547 178.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -61.17 -44.47 97.26 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 122.284 0.234 . . . . 0.0 111.283 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -65.54 -46.27 80.21 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.364 1.065 . . . . 0.0 112.723 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -100.22 38.68 1.45 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.516 1.127 . . . . 0.0 110.807 -178.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.1 122.13 8.82 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.644 -0.66 . . . . 0.0 111.905 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.62 -5.95 6.76 Favored Glycine 0 CA--C 1.535 1.29 0 CA-C-O 119.487 -0.618 . . . . 0.0 113.7 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 51.7 mttt -99.68 -36.27 9.54 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.964 1.306 . . . . 0.0 108.491 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.3 tp -136.28 122.48 20.4 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 35.3 m -86.58 103.52 15.15 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 177.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 91.8 t -79.67 128.02 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 107.057 -1.461 . . . . 0.0 107.057 178.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -132.53 149.53 52.31 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.373 0.669 . . . . 0.0 110.05 -177.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -129.36 132.49 47.08 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 123.794 0.838 . . . . 0.0 108.89 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.5 tt -120.63 116.13 24.73 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.766 0.826 . . . . 0.0 110.059 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -78.22 108.03 11.24 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 pp -67.33 -29.8 46.99 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 C-N-CA 123.335 0.654 . . . . 0.0 112.701 -177.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -60.49 -47.71 84.93 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 118.934 0.788 . . . . 0.0 109.491 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -74.88 -32.92 61.99 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.147 176.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -121.23 69.95 21.03 Favored Pre-proline 0 CA--C 1.531 0.228 0 C-N-CA 123.651 0.78 . . . . 0.0 112.01 -176.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -64.8 -47.45 5.13 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.977 1.785 . . . . 0.0 111.431 -178.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -42.02 -40.72 3.39 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.358 1.456 . . . . 0.0 114.659 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.43 -29.31 69.86 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.62 -0.929 . . . . 0.0 112.479 -178.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.84 -65.23 1.79 Allowed Pre-proline 0 CA--C 1.537 0.456 0 CA-C-O 118.395 -0.812 . . . . 0.0 112.912 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -59.78 -38.44 80.29 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 121.718 1.612 . . . . 0.0 111.036 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -51.79 -36.38 47.41 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-N 118.683 0.674 . . . . 0.0 112.029 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -111.65 20.59 16.97 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.683 0.393 . . . . 0.0 111.883 178.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 51.09 40.33 43.6 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.043 0.83 . . . . 0.0 113.481 177.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mp -53.94 127.87 12.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 117.883 0.841 . . . . 0.0 109.069 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -92.91 -50.64 5.45 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.75 1.22 . . . . 0.0 110.133 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.02 146.56 13.2 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 107.406 -2.278 . . . . 0.0 107.406 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.7 pt -95.61 148.64 34.92 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 123.715 0.806 . . . . 0.0 110.131 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.96 140.89 60.75 Favored 'Cis proline' 0 N--CA 1.456 -0.71 0 CA-C-N 119.788 0.96 . . . . 0.0 110.72 -1.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.61 118.69 30.8 Favored 'General case' 0 CA--C 1.523 -0.083 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.8 mt -96.82 126.6 42.09 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -120.89 111.57 17.7 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 104.066 -2.568 . . . . 0.0 104.066 175.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.5 tp -93.29 99.54 12.06 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -84.7 142.02 30.16 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.569 1.148 . . . . 0.0 109.676 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -138.13 97.86 3.49 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 175.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.2 t30 55.42 71.52 0.54 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.3 0.64 . . . . 0.0 110.3 -176.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 70.62 -37.68 0.47 Allowed Glycine 0 CA--C 1.531 1.093 0 N-CA-C 116.146 1.218 . . . . 0.0 116.146 176.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -86.6 146.03 26.5 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 119.147 1.474 . . . . 0.0 110.529 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 96.6 t -79.04 115.19 20.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 175.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.3 -42.11 26.5 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.346 0.659 . . . . 0.0 109.448 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -155.34 169.86 23.24 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 177.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.8 t -147.88 168.35 22.46 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.68 146.22 23.15 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.827 1.251 . . . . 0.0 108.327 -177.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.9 t -124.01 124.8 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.26 177.11 37.54 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 123.324 0.487 . . . . 0.0 112.052 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.71 173.58 8.85 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.416 0.686 . . . . 0.0 111.885 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 mt -147.65 160.71 42.37 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 125.679 1.592 . . . . 0.0 108.708 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 44.6 p -90.4 154.15 19.89 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 170.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -51.76 -45.52 63.74 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 122.213 -0.305 . . . . 0.0 110.921 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -57.6 -57.24 20.86 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 111.74 -0.544 . . . . 0.0 111.74 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -58.01 -41.09 82.35 Favored 'General case' 0 N--CA 1.456 -0.168 0 O-C-N 121.996 -0.708 . . . . 0.0 110.739 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 29.3 tp -62.19 -49.21 76.71 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -52.93 -48.66 67.12 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.898 0.479 . . . . 0.0 109.895 176.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -56.98 -53.98 51.84 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.946 0.498 . . . . 0.0 110.617 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -52.25 -51.25 59.49 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.002 0.921 . . . . 0.0 110.437 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 89.7 mt -61.28 -51.49 68.69 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.631 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -52.78 -48.98 66.47 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.941 0.496 . . . . 0.0 110.406 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.05 -36.12 70.13 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.292 0.637 . . . . 0.0 111.832 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -78.89 -44.64 22.34 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 117.783 0.265 . . . . 0.0 111.013 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 56.9 mt -64.7 -43.08 94.66 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.434 0.694 . . . . 0.0 110.211 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.213 0 C-N-CA 124.84 1.256 . . . . 0.0 111.807 179.066 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.6 m . . . . . 0 N--CA 1.451 -0.412 0 CA-C-O 120.531 0.205 . . . . 0.0 111.473 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -74.0 54.74 0.53 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.384 1.074 . . . . 0.0 111.661 -178.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -81.79 56.89 3.2 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 176.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.8 mt -122.83 149.0 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 124.559 1.144 . . . . 0.0 110.854 -172.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.9 mm -87.54 106.7 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 175.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 37.9 m-70 -81.26 95.54 6.99 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 177.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 44.8 mt -79.9 163.44 24.33 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.598 1.159 . . . . 0.0 113.067 -175.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.6 p -139.06 164.73 29.01 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 126.261 1.824 . . . . 0.0 106.459 174.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -57.46 -46.25 83.85 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.673 -0.642 . . . . 0.0 110.14 -178.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -61.87 -38.9 90.02 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.8 p -78.13 -35.52 48.99 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 121.992 -0.443 . . . . 0.0 110.223 -177.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -33.74 -51.17 0.38 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 126.912 2.085 . . . . 0.0 114.019 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -54.92 -48.09 73.54 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.07 0.462 . . . . 0.0 111.636 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.1 m -76.33 -52.09 10.64 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 121.996 -0.44 . . . . 0.0 110.769 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.52 -47.31 64.18 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -173.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.3 t -94.53 -50.09 12.12 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.11 0 C-N-CA 123.33 0.652 . . . . 0.0 111.915 -175.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 70.4 mt -73.67 -48.69 30.38 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.988 -177.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -91.36 42.33 1.1 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.134 0.879 . . . . 0.0 109.252 175.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.03 177.08 2.33 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 125.395 1.478 . . . . 0.0 113.686 -178.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -134.88 101.93 5.07 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.993 2.117 . . . . 0.0 106.594 175.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.09 -162.03 45.98 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-O 121.588 0.549 . . . . 0.0 113.87 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.48 117.9 20.11 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.47 1.508 . . . . 0.0 112.536 -177.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.1 mt -116.53 120.77 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 124.552 1.141 . . . . 0.0 109.049 176.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -91.97 108.08 19.67 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 176.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.9 t -98.53 106.59 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 123.86 0.864 . . . . 0.0 109.954 -177.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -91.35 105.11 17.54 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 176.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -79.59 125.24 29.35 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 174.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 44.7 p-90 -142.39 169.52 17.42 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.828 0.851 . . . . 0.0 112.729 -176.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -146.93 137.97 23.96 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.954 1.302 . . . . 0.0 107.586 174.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -50.55 -48.54 57.33 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.586 0.754 . . . . 0.0 112.759 -176.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 58.5 p-90 -62.7 -26.05 68.47 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 50.8 t -79.8 79.44 6.31 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 121.316 -0.865 . . . . 0.0 109.233 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -25.96 -60.39 0.07 OUTLIER Glycine 0 CA--C 1.536 1.359 0 C-N-CA 127.139 2.304 . . . . 0.0 114.801 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -43.08 -35.06 4.46 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 124.315 3.343 . . . . 0.0 114.586 178.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 78.3 m -57.09 -47.24 81.52 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 121.588 -0.695 . . . . 0.0 109.846 176.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -65.87 -31.18 71.98 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.696 0.799 . . . . 0.0 109.776 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 85.1 mtp -68.5 -45.04 73.36 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 177.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.0 pt -75.39 -27.52 19.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 118.521 0.6 . . . . 0.0 112.33 178.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -37.94 -58.66 1.34 Allowed Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -58.27 -39.01 88.34 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.41 2.073 . . . . 0.0 111.514 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.5 mt -59.51 -51.08 76.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 177.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 44.3 mt -56.44 -42.55 78.3 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.621 0.368 . . . . 0.0 110.505 177.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -59.51 -48.7 80.64 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.674 0.67 . . . . 0.0 110.259 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -58.42 -52.62 64.86 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.677 -0.639 . . . . 0.0 109.606 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 11.2 mm -54.39 -46.29 69.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 124.735 1.214 . . . . 0.0 110.179 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.23 -44.73 68.31 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.361 0.664 . . . . 0.0 110.179 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -66.34 -56.78 9.48 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 176.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -45.71 -50.76 13.39 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.937 0.895 . . . . 0.0 112.423 -178.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -95.44 26.2 4.01 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.663 0.785 . . . . 0.0 112.463 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.58 130.15 23.62 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.264 0.938 . . . . 0.0 109.933 176.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.6 -16.48 5.04 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-O 119.147 -0.807 . . . . 0.0 114.181 -178.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -99.6 -39.08 8.48 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 118.87 1.335 . . . . 0.0 110.214 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 26.0 tp -137.78 126.55 23.87 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.8 m -86.94 102.39 14.32 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 176.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 96.3 t -79.02 137.51 21.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.42 147.41 45.39 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.023 0.929 . . . . 0.0 109.445 -177.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -125.26 135.3 52.39 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.6 tt -127.78 112.57 14.92 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.606 0.763 . . . . 0.0 109.692 -178.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -78.98 104.52 9.67 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 122.902 0.481 . . . . 0.0 109.824 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.2 pt -69.03 -24.25 28.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 118.866 -0.588 . . . . 0.0 112.559 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -53.31 -53.82 45.4 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.061 0.846 . . . . 0.0 109.502 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -78.2 -28.71 48.12 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.961 0.904 . . . . 0.0 110.763 179.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -118.11 67.0 6.26 Favored Pre-proline 0 C--O 1.235 0.315 0 C-N-CA 124.1 0.96 . . . . 0.0 111.495 -176.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -61.14 -53.65 2.36 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.465 2.11 . . . . 0.0 112.383 -176.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -37.97 -47.12 1.85 Allowed Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.631 1.586 . . . . 0.0 114.267 -177.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -51.71 -33.79 35.9 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.23 1.012 . . . . 0.0 112.962 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.27 -68.25 0.79 Allowed Pre-proline 0 CA--C 1.537 0.478 0 CA-C-O 117.987 -1.006 . . . . 0.0 112.017 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -59.32 -35.95 95.65 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.005 1.803 . . . . 0.0 111.358 177.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -51.44 -37.64 49.65 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.526 1.057 . . . . 0.0 111.661 177.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -111.9 22.31 15.04 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.098 0.559 . . . . 0.0 111.187 177.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 42.69 43.24 5.06 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 125.465 1.507 . . . . 0.0 113.04 178.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.5 mp -51.07 118.17 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 118.094 0.947 . . . . 0.0 109.315 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -79.14 -44.38 22.12 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.371 0.669 . . . . 0.0 110.415 -177.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -164.91 141.91 7.39 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 108.451 -1.86 . . . . 0.0 108.451 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.7 pt -95.79 148.88 35.26 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 124.017 0.927 . . . . 0.0 109.997 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.35 141.05 62.81 Favored 'Cis proline' 0 N--CA 1.456 -0.697 0 CA-C-N 119.846 0.981 . . . . 0.0 111.177 -0.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.02 114.81 21.46 Favored 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.7 mt -98.0 102.08 13.73 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.7 mp -96.58 118.59 33.39 Favored 'General case' 0 CA--C 1.523 -0.072 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 177.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 tp -92.19 98.67 11.67 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -89.27 103.33 15.96 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 125.225 1.41 . . . . 0.0 110.413 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -83.61 102.19 12.02 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 172.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 45.76 41.43 7.49 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.069 1.748 . . . . 0.0 113.934 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 106.2 -21.28 33.7 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-O 118.784 -1.009 . . . . 0.0 113.358 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -100.32 128.55 46.36 Favored 'General case' 0 C--O 1.227 -0.085 0 CA-C-N 119.254 1.527 . . . . 0.0 110.948 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 89.7 t -68.04 107.29 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.57 -41.61 26.81 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.884 0.874 . . . . 0.0 109.987 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -155.13 167.49 30.2 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 93.7 m -149.72 140.7 22.89 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -116.5 138.37 51.44 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 177.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 26.3 t -120.96 123.32 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 178.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.92 175.09 45.47 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 111.579 -0.609 . . . . 0.0 111.579 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.38 172.77 8.83 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.22 0.608 . . . . 0.0 110.954 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -162.8 167.99 22.07 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.625 1.17 . . . . 0.0 108.75 -177.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 88.2 p -81.67 160.1 23.8 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -57.48 -40.35 78.41 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 175.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.95 -53.06 42.38 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 176.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -60.46 -39.65 88.34 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 117.616 0.708 . . . . 0.0 111.148 178.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 23.3 tp -62.19 -50.93 69.85 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.586 0.63 . . . . 0.0 109.874 178.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -53.41 -49.52 67.12 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.32 0.648 . . . . 0.0 109.567 176.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -55.56 -55.86 27.03 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.063 0.945 . . . . 0.0 110.424 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -52.93 -54.38 35.64 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.489 1.516 . . . . 0.0 110.828 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.7 mt -61.32 -51.93 66.8 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.44 0.296 . . . . 0.0 110.658 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -53.95 -50.38 66.63 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.028 0.531 . . . . 0.0 110.631 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.02 -36.53 65.58 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.429 0.692 . . . . 0.0 111.623 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -78.64 -48.32 15.31 Favored 'General case' 0 C--O 1.227 -0.115 0 O-C-N 122.238 -0.289 . . . . 0.0 110.406 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 58.0 mt -59.18 -42.78 91.66 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.936 0.494 . . . . 0.0 110.294 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.282 0 C-N-CA 123.097 0.559 . . . . 0.0 109.777 177.889 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.8 p . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -61.84 134.92 57.3 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -72.67 -30.76 64.54 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.574 0.75 . . . . 0.0 109.843 177.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 36.9 mt -79.86 141.15 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 124.28 1.032 . . . . 0.0 110.674 -176.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.2 mm -89.26 120.28 37.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 123.978 0.911 . . . . 0.0 109.492 178.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -85.71 111.39 20.07 Favored 'General case' 0 CA--C 1.528 0.099 0 O-C-N 121.515 -0.741 . . . . 0.0 109.349 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 65.8 mt -95.5 160.87 14.31 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 124.458 1.103 . . . . 0.0 111.203 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 48.9 p -134.68 163.48 29.67 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 174.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -58.48 -47.18 84.91 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.809 0.732 . . . . 0.0 109.601 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -63.69 -41.2 98.17 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.664 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.1 p -78.42 -24.82 45.98 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.38 0.536 . . . . 0.0 111.368 -177.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -41.6 -43.69 2.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 126.602 1.961 . . . . 0.0 113.068 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -52.39 -65.14 0.61 Allowed 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 121.697 0.761 . . . . 0.0 110.251 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.9 m -67.17 -42.53 84.13 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.583 -176.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -70.81 -39.3 73.14 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -174.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.0 t -112.84 -58.48 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 123.446 0.698 . . . . 0.0 110.345 -175.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 67.0 mt -61.43 -35.59 78.0 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -174.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -97.4 16.18 20.88 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.451 0.569 . . . . 0.0 111.73 178.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -102.15 102.43 12.88 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 119.042 0.837 . . . . 0.0 111.724 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -77.25 59.21 1.75 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.949 1.3 . . . . 0.0 110.305 176.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -159.05 168.08 35.01 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.5 114.09 20.68 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.257 0.623 . . . . 0.0 110.817 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.5 mt -120.25 122.44 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 124.537 1.135 . . . . 0.0 109.986 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -91.99 107.55 19.29 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 175.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 67.2 t -96.19 108.09 20.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 123.992 0.917 . . . . 0.0 109.241 -178.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -97.18 105.32 17.44 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.592 1.157 . . . . 0.0 109.514 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -79.16 126.39 30.68 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 177.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 26.4 p-90 -141.47 173.86 11.1 Favored 'General case' 0 C--N 1.343 0.289 0 C-N-CA 124.304 1.042 . . . . 0.0 112.83 -176.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -149.97 156.89 42.52 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.985 1.714 . . . . 0.0 108.221 175.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.1 mp0 -63.3 -48.79 76.59 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.226 0.536 . . . . 0.0 110.688 -178.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 54.2 p-90 -65.73 -20.8 66.41 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.064 0.946 . . . . 0.0 112.562 -178.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 47.6 t -79.36 75.68 5.95 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 121.481 -0.762 . . . . 0.0 110.08 -178.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -25.74 -63.12 0.06 OUTLIER Glycine 0 CA--C 1.536 1.357 0 C-N-CA 126.509 2.004 . . . . 0.0 114.692 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -43.44 -35.83 6.17 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 124.559 3.506 . . . . 0.0 114.881 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 87.5 m -52.59 -40.71 62.94 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.172 0.589 . . . . 0.0 110.188 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -67.28 -30.83 70.8 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.633 0.773 . . . . 0.0 111.311 179.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -74.36 -46.12 42.6 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 28.0 pt -73.7 -29.26 26.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 118.66 -0.686 . . . . 0.0 112.255 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -39.16 -60.88 1.08 Allowed Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -56.59 -40.84 81.69 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.372 2.048 . . . . 0.0 111.673 178.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.8 mt -57.44 -52.35 58.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 177.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 47.6 mt -57.44 -40.52 78.59 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.281 0.632 . . . . 0.0 110.973 178.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -61.86 -47.86 83.12 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.1 0.864 . . . . 0.0 110.262 177.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -57.87 -52.59 64.87 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.6 mm -53.15 -47.5 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 124.035 0.934 . . . . 0.0 109.591 177.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.94 -49.95 62.14 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 122.842 0.457 . . . . 0.0 110.103 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -62.23 -54.29 42.91 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.723 0.296 . . . . 0.0 110.932 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -53.24 -46.74 69.29 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.767 0.827 . . . . 0.0 112.308 -178.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -94.48 26.99 3.15 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.967 0.907 . . . . 0.0 112.37 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -54.45 128.65 32.76 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.169 0.895 . . . . 0.0 109.724 176.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.1 -14.75 25.8 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-O 119.25 -0.75 . . . . 0.0 112.993 -178.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -99.82 -44.06 6.21 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 118.507 1.153 . . . . 0.0 109.881 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 24.6 tp -139.42 132.38 29.41 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.415 0.686 . . . . 0.0 110.431 -176.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 62.5 m -91.69 103.28 15.87 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 175.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 63.1 t -79.86 130.81 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.66 151.81 50.58 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.28 0.632 . . . . 0.0 110.844 -176.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -126.8 139.94 52.74 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.908 1.283 . . . . 0.0 108.948 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.5 tt -127.8 115.86 19.3 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.608 0.763 . . . . 0.0 109.734 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -79.25 107.15 11.8 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.9 pt -69.0 -26.96 33.59 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.29 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -177.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -59.75 -47.04 87.28 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 119.067 0.849 . . . . 0.0 109.744 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -77.18 -30.58 54.94 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.148 0.579 . . . . 0.0 110.241 176.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -121.79 67.42 22.21 Favored Pre-proline 0 C--O 1.234 0.25 0 C-N-CA 123.933 0.893 . . . . 0.0 111.735 -176.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -62.22 -53.43 1.97 Allowed 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 122.534 2.156 . . . . 0.0 112.777 -176.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -38.86 -47.2 2.38 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.189 1.376 . . . . 0.0 113.989 -177.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -50.52 -34.46 25.38 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.427 1.091 . . . . 0.0 112.897 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.71 -68.99 0.57 Allowed Pre-proline 0 CA--C 1.538 0.518 0 CA-C-O 118.241 -0.885 . . . . 0.0 112.168 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -59.19 -37.2 93.14 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.64 1.56 . . . . 0.0 111.149 177.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -50.83 -40.61 56.18 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-N 119.281 0.946 . . . . 0.0 111.67 178.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -106.76 19.83 19.9 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.586 0.354 . . . . 0.0 111.893 178.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 51.0 40.31 42.9 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.097 0.856 . . . . 0.0 113.043 177.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mp -53.24 120.7 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 177.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 55.5 mmt-85 -79.14 -46.89 17.07 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.769 0.828 . . . . 0.0 109.417 -178.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -170.72 145.53 9.07 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 106.601 -2.6 . . . . 0.0 106.601 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.5 pt -90.83 150.95 43.03 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-O 118.907 -0.568 . . . . 0.0 109.842 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -70.08 138.11 48.21 Favored 'Cis proline' 0 N--CA 1.458 -0.609 0 CA-C-N 119.485 0.852 . . . . 0.0 111.285 -0.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -123.62 120.27 32.29 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 178.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.3 mt -103.25 117.39 34.4 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -110.2 116.83 32.22 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 177.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 tp -92.28 101.22 13.71 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -90.83 145.42 24.78 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.096 1.358 . . . . 0.0 111.595 -178.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -141.59 116.86 10.09 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.317 1.847 . . . . 0.0 106.102 174.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 49.66 48.64 21.25 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.678 0.752 . . . . 0.0 110.61 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.51 -9.74 4.33 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-O 118.283 -1.287 . . . . 0.0 115.86 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -98.52 142.38 30.19 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 119.983 1.892 . . . . 0.0 109.851 178.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 89.5 t -76.72 116.84 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 177.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.19 -44.21 22.35 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 177.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -161.88 175.34 11.99 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.3 t -150.82 163.48 38.53 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 54.2 mmtt -141.74 148.5 39.09 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 126.96 2.104 . . . . 0.0 106.672 177.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.9 t -130.52 132.33 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.81 -177.33 46.49 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.82 165.3 24.38 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.978 0.511 . . . . 0.0 111.316 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.3 mt -144.35 157.17 44.4 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.44 1.496 . . . . 0.0 108.28 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 88.2 p -81.52 157.16 24.92 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 170.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -55.68 -44.03 76.94 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -56.29 -56.35 24.79 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 123.671 0.653 . . . . 0.0 111.852 177.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -60.89 -41.25 95.65 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 118.211 1.005 . . . . 0.0 111.298 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 37.6 tp -60.95 -50.99 71.15 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.877 -0.514 . . . . 0.0 109.625 178.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -54.24 -47.75 71.87 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.739 0.7 . . . . 0.0 110.407 176.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -55.05 -53.25 58.29 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.082 0.953 . . . . 0.0 109.919 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -55.21 -54.71 39.91 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.598 1.159 . . . . 0.0 110.894 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 89.8 mt -58.62 -50.17 74.82 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.311 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -55.77 -50.37 70.62 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.17 0.588 . . . . 0.0 110.467 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.8 -35.05 65.89 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.48 0.712 . . . . 0.0 111.479 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -78.03 -50.11 12.72 Favored 'General case' 0 CA--C 1.524 -0.057 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 53.0 mt -56.07 -45.23 79.39 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.049 0.539 . . . . 0.0 110.09 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.251 0 C-N-CA 123.085 0.554 . . . . 0.0 109.693 177.599 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 18.5 m . . . . . 0 CA--C 1.533 0.324 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -23.95 -56.33 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 127.857 2.463 . . . . 0.0 114.877 -177.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -138.45 43.31 2.15 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.205 1.002 . . . . 0.0 108.676 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 13.6 mt -107.52 138.71 32.33 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 C-N-CA 123.573 0.749 . . . . 0.0 111.042 -177.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.0 mm -88.02 107.12 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 123.476 0.71 . . . . 0.0 109.344 177.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -79.58 99.52 7.36 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 76.0 mt -81.85 160.76 23.4 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 122.071 0.939 . . . . 0.0 113.348 -175.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 35.4 p -134.66 163.32 30.02 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 126.951 2.1 . . . . 0.0 106.961 173.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -57.03 -44.09 82.57 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.467 0.707 . . . . 0.0 110.059 179.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -55.84 -46.01 78.27 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.939 0.896 . . . . 0.0 111.458 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.5 p -78.02 -27.26 48.85 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 122.242 -0.286 . . . . 0.0 111.207 -177.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -42.15 -46.79 4.47 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.252 1.421 . . . . 0.0 113.499 -177.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -51.88 -64.83 0.69 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.902 0.858 . . . . 0.0 111.261 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.9 m -68.67 -40.6 80.08 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.106 -174.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -76.53 -55.38 5.58 Favored 'General case' 0 N--CA 1.451 -0.375 0 O-C-N 122.251 -0.281 . . . . 0.0 111.659 -177.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.4 t -91.72 -53.31 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -172.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 68.8 mt -66.26 -37.03 84.51 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 118.924 -1.11 . . . . 0.0 111.163 -176.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -93.68 33.54 1.28 Allowed 'General case' 0 CA--C 1.543 0.711 0 O-C-N 122.064 -0.398 . . . . 0.0 110.048 173.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.94 81.47 0.3 Allowed 'General case' 0 C--N 1.342 0.258 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -77.41 62.87 2.48 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 174.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 163.3 176.47 35.33 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 126.464 1.983 . . . . 0.0 108.432 -177.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.12 123.57 32.92 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 117.605 0.703 . . . . 0.0 109.93 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.2 mt -126.07 120.63 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 124.429 1.092 . . . . 0.0 109.88 -179.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.6 tp -92.18 97.0 10.64 Favored 'General case' 0 N--CA 1.458 -0.064 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 176.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.6 t -86.6 103.88 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 123.757 0.823 . . . . 0.0 108.946 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -95.2 108.18 20.3 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.214 1.005 . . . . 0.0 108.495 177.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -79.72 129.07 34.16 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 176.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 25.8 p-90 -143.53 174.29 10.89 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.293 1.037 . . . . 0.0 112.8 -176.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.49 144.44 20.68 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 125.736 1.615 . . . . 0.0 108.359 176.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -50.09 -49.19 52.38 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.804 0.842 . . . . 0.0 111.981 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 59.8 p-90 -66.55 -22.65 66.15 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -177.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 49.3 t -79.79 69.87 6.21 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 121.439 -0.788 . . . . 0.0 111.233 -176.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -16.64 -65.74 0.01 OUTLIER Glycine 0 CA--C 1.535 1.307 0 C-N-CA 128.128 2.775 . . . . 0.0 115.889 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -44.08 -31.29 3.88 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 124.533 3.489 . . . . 0.0 115.253 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 96.1 m -53.44 -41.62 66.27 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.804 -0.56 . . . . 0.0 109.831 176.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -67.4 -28.24 67.75 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.651 0.781 . . . . 0.0 111.161 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 84.1 mtp -74.76 -45.23 45.19 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 29.9 pt -74.56 -28.02 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.88 177.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -38.09 -59.55 1.18 Allowed Pre-proline 0 CA--C 1.544 0.749 0 CA-C-N 119.899 1.227 . . . . 0.0 114.286 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -56.15 -40.21 86.29 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.179 1.919 . . . . 0.0 111.498 177.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 19.7 mt -59.4 -51.01 77.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 55.5 mt -55.63 -41.62 73.78 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.691 0.396 . . . . 0.0 110.054 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -61.44 -48.55 80.64 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.569 0.622 . . . . 0.0 110.61 177.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -55.94 -51.6 67.09 Favored 'General case' 0 N--CA 1.457 -0.083 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 33.4 mm -55.8 -46.87 80.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 123.377 0.671 . . . . 0.0 110.031 177.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.18 -40.48 67.57 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.212 0.605 . . . . 0.0 110.575 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -71.95 -58.58 3.32 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 176.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -47.54 -48.13 27.72 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.004 1.322 . . . . 0.0 112.921 -178.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -102.39 22.36 13.54 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.726 0.81 . . . . 0.0 111.45 -178.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -54.31 131.66 42.28 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.988 0.813 . . . . 0.0 110.731 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.36 -19.87 9.9 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-O 119.25 -0.75 . . . . 0.0 112.953 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -99.56 -41.17 7.47 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.594 1.197 . . . . 0.0 109.478 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.4 tp -128.38 126.45 40.69 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.78 1.232 . . . . 0.0 108.74 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 45.8 m -88.7 103.55 16.05 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 175.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.2 t -79.53 130.18 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -132.34 145.03 50.96 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 122.802 0.441 . . . . 0.0 110.3 -178.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.7 mtmt -124.05 104.87 9.13 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 124.231 1.012 . . . . 0.0 109.127 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.3 tt -97.54 115.47 27.9 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 121.695 -0.628 . . . . 0.0 110.556 -175.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -79.23 107.96 12.37 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.933 -178.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.2 pt -71.41 -32.14 45.57 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-O 118.997 -0.525 . . . . 0.0 111.969 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -54.97 -27.62 45.23 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.147 0.885 . . . . 0.0 111.749 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -109.84 -0.64 18.26 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.131 0.972 . . . . 0.0 111.406 177.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -146.93 62.5 7.5 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 124.068 0.947 . . . . 0.0 110.853 178.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -56.46 -48.23 20.07 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 121.75 1.633 . . . . 0.0 111.863 -178.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -40.68 -39.99 2.0 Allowed Glycine 0 CA--C 1.529 0.943 0 C-N-CA 126.106 1.812 . . . . 0.0 115.077 -177.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.59 -23.97 67.44 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 118.519 1.16 . . . . 0.0 112.808 -178.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.19 -62.69 5.13 Favored Pre-proline 0 CA--C 1.54 0.569 0 O-C-N 121.112 -0.992 . . . . 0.0 113.348 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -58.05 -34.13 98.09 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 C-N-CA 122.31 2.007 . . . . 0.0 111.906 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -52.58 -29.24 24.71 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.0 0.818 . . . . 0.0 112.024 177.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -119.29 17.72 13.05 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.223 0.609 . . . . 0.0 111.174 177.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 49.17 39.52 27.44 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 124.706 1.146 . . . . 0.0 112.006 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 58.6 mt -64.02 130.72 29.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 121.28 0.562 . . . . 0.0 110.335 -178.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -79.26 -34.72 42.37 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 125.332 1.453 . . . . 0.0 112.602 -175.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -175.92 -157.07 16.27 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 107.41 -2.276 . . . . 0.0 107.41 -178.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.9 pt -147.37 158.44 43.88 Favored Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -70.15 140.29 60.85 Favored 'Cis proline' 0 N--CA 1.458 -0.587 0 N-CA-C 109.289 -1.081 . . . . 0.0 109.289 -1.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 26.6 m -136.85 123.96 21.66 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -179.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.6 mt -100.84 119.24 38.38 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.143 1.777 . . . . 0.0 109.718 -176.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.8 mp -114.55 117.4 30.81 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 173.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 tp -93.38 100.8 13.06 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -90.38 136.67 32.91 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.476 1.11 . . . . 0.0 110.023 -178.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -139.44 119.35 13.38 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.746 1.619 . . . . 0.0 106.663 177.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 54.26 41.55 31.94 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.786 0.721 . . . . 0.0 110.211 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 73.56 -11.84 5.18 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 119.051 -0.861 . . . . 0.0 114.41 -178.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -93.73 136.39 34.07 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 119.139 1.47 . . . . 0.0 109.567 -178.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 95.8 t -73.12 112.85 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 175.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.87 -40.85 31.37 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -158.73 158.71 34.18 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 176.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 89.1 m -134.27 145.21 48.89 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.752 1.221 . . . . 0.0 108.285 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -137.38 122.59 19.26 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 63.5 t -104.11 126.61 58.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.53 166.43 28.55 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.09 0.852 . . . . 0.0 112.219 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.45 170.87 12.35 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.755 0.822 . . . . 0.0 111.542 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -162.96 172.7 14.67 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 124.885 1.274 . . . . 0.0 109.964 -178.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 90.9 p -88.02 162.7 16.68 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.513 0.725 . . . . 0.0 110.101 178.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -54.95 -45.04 74.85 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 175.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.52 -60.61 8.55 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 177.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -54.04 -42.08 68.78 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 117.858 0.829 . . . . 0.0 111.641 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 15.9 tp -59.37 -50.97 71.91 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 176.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -57.87 -42.13 83.89 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.397 -0.814 . . . . 0.0 111.988 178.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -57.92 -52.67 64.52 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.138 0.881 . . . . 0.0 109.493 175.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -52.82 -52.3 57.56 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.887 0.875 . . . . 0.0 110.332 179.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.9 mt -56.99 -53.97 52.03 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.853 0.461 . . . . 0.0 110.399 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -52.57 -51.11 61.32 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 122.754 0.422 . . . . 0.0 110.65 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.15 -39.12 69.11 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.1 0.56 . . . . 0.0 111.733 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -78.71 -42.11 29.21 Favored 'General case' 0 N--CA 1.462 0.128 0 O-C-N 122.223 -0.298 . . . . 0.0 111.567 -178.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 59.4 mt -64.64 -45.09 88.27 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.225 0 C-N-CA 123.016 0.526 . . . . 0.0 109.816 177.921 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.9 p . . . . . 0 N--CA 1.451 -0.422 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -72.83 62.06 0.57 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.037 1.335 . . . . 0.0 110.265 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -80.61 54.74 2.16 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.031 0.932 . . . . 0.0 108.688 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.9 mt -107.19 136.83 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 123.67 0.788 . . . . 0.0 110.514 -177.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.1 mm -87.81 114.39 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-O 121.237 0.542 . . . . 0.0 109.802 177.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 63.0 m80 -83.98 96.97 9.01 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 62.4 mt -86.95 163.57 17.04 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.247 1.019 . . . . 0.0 112.342 -175.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 31.4 p -138.71 165.15 27.7 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.15 1.78 . . . . 0.0 106.517 174.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -55.25 -46.68 76.08 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.034 0.534 . . . . 0.0 109.876 178.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -59.72 -43.54 94.12 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.099 0.959 . . . . 0.0 112.158 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.3 p -78.47 -29.8 47.01 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 122.084 -0.385 . . . . 0.0 111.419 -176.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -37.19 -49.12 0.89 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.244 1.818 . . . . 0.0 113.515 -179.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -50.36 -64.6 0.76 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 121.74 0.781 . . . . 0.0 110.955 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 m -69.83 -46.36 65.8 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.855 -175.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -77.21 -21.55 53.71 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 114.935 1.458 . . . . 0.0 114.935 -173.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.3 t -120.48 -61.37 2.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 119.475 1.034 . . . . 0.0 109.753 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 67.0 mt -60.33 -39.92 88.83 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -174.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -94.89 12.52 27.91 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.281 0.491 . . . . 0.0 111.511 178.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.91 98.61 11.17 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.01 0.823 . . . . 0.0 111.654 -178.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -76.44 67.1 2.58 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.492 0.663 . . . . 0.0 109.742 177.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -164.88 162.84 35.96 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.71 112.1 18.57 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.067 0.547 . . . . 0.0 110.47 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.7 mt -118.65 114.21 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 125.288 1.435 . . . . 0.0 110.666 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.9 tp -83.39 96.63 8.6 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 174.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.2 t -86.33 114.93 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 C-N-CA 123.243 0.617 . . . . 0.0 109.611 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -98.31 105.45 17.59 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.495 1.118 . . . . 0.0 108.501 177.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -79.79 121.64 25.62 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 104.672 -2.344 . . . . 0.0 104.672 174.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 38.5 p-90 -135.11 170.35 16.04 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 124.141 0.976 . . . . 0.0 113.347 -175.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.59 125.55 13.6 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.744 1.618 . . . . 0.0 107.558 177.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -46.65 -45.44 19.22 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.416 1.086 . . . . 0.0 113.915 -177.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 55.5 p-90 -68.93 -23.64 64.19 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.956 0.502 . . . . 0.0 112.316 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 42.4 t -79.86 74.24 6.59 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 121.284 -0.885 . . . . 0.0 111.083 -177.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -13.07 -66.15 0.01 OUTLIER Glycine 0 CA--C 1.535 1.319 0 C-N-CA 128.48 2.943 . . . . 0.0 115.891 178.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -41.27 -36.78 2.72 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 124.264 3.309 . . . . 0.0 114.881 178.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 98.8 m -56.11 -48.01 76.98 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.386 0.674 . . . . 0.0 110.003 177.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -64.77 -38.04 89.65 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.549 0.74 . . . . 0.0 109.345 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 52.6 mtm -64.28 -43.96 93.16 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 119.505 -0.283 . . . . 0.0 111.032 178.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 29.8 pt -76.33 -26.69 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 118.74 0.7 . . . . 0.0 112.494 179.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -38.17 -58.85 1.36 Allowed Pre-proline 0 CA--C 1.545 0.756 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -57.27 -39.71 87.85 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 121.959 1.773 . . . . 0.0 111.654 178.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 19.1 mt -59.35 -50.75 78.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 177.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.6 mt -56.05 -43.38 77.84 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.744 0.418 . . . . 0.0 110.434 178.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -59.58 -49.32 78.23 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.603 0.638 . . . . 0.0 109.683 177.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -56.34 -49.78 73.39 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 28.8 mm -56.02 -49.97 72.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 123.206 0.602 . . . . 0.0 109.709 177.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.77 -45.96 63.94 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.288 0.635 . . . . 0.0 110.296 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -66.3 -58.04 6.2 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.938 -0.119 . . . . 0.0 110.738 177.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -48.19 -49.25 33.49 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.52 1.128 . . . . 0.0 112.748 -177.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -98.05 21.79 10.27 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.231 0.612 . . . . 0.0 111.851 -177.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -52.81 128.35 26.47 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.597 1.089 . . . . 0.0 110.824 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.12 -17.35 23.42 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-O 119.33 -0.705 . . . . 0.0 113.419 -178.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -99.29 -42.95 6.78 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 118.477 1.138 . . . . 0.0 109.065 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.3 tp -136.29 137.7 40.99 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.444 1.497 . . . . 0.0 107.274 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.5 m -98.37 140.77 32.14 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 173.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 96.3 t -113.01 141.31 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 177.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -138.03 152.33 48.74 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -128.37 133.4 48.63 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.5 tt -127.8 115.75 19.13 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.72 0.808 . . . . 0.0 109.104 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -80.25 110.01 15.26 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 pp -67.76 -32.54 57.09 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.149 0 C-N-CA 123.412 0.685 . . . . 0.0 112.808 -177.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -60.36 -47.74 84.74 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 118.963 0.801 . . . . 0.0 109.155 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -69.42 -37.26 77.36 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.92 0.888 . . . . 0.0 110.131 177.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -119.87 72.31 16.55 Favored Pre-proline 0 C--O 1.233 0.231 0 C-N-CA 124.007 0.923 . . . . 0.0 111.779 -175.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -61.49 -53.6 2.22 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 122.361 2.04 . . . . 0.0 112.418 -177.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -38.32 -47.93 2.13 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 125.351 1.453 . . . . 0.0 114.377 -177.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.56 -33.34 45.26 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.299 1.039 . . . . 0.0 113.092 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.88 -68.43 0.72 Allowed Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 118.149 -0.929 . . . . 0.0 112.511 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -59.41 -38.23 85.2 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 121.68 1.587 . . . . 0.0 111.048 178.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -50.92 -39.44 54.61 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-N 118.903 0.774 . . . . 0.0 111.53 178.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -108.8 20.93 17.9 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 122.884 0.474 . . . . 0.0 112.132 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 51.49 38.82 43.5 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 124.128 0.87 . . . . 0.0 113.465 176.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mp -57.43 125.66 13.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 118.092 0.946 . . . . 0.0 108.47 177.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -88.92 -47.59 8.05 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.465 1.106 . . . . 0.0 109.118 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -166.64 145.41 9.92 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 107.363 -2.295 . . . . 0.0 107.363 178.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -91.19 154.71 44.87 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-O 118.834 -0.603 . . . . 0.0 110.306 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.31 129.26 12.46 Favored 'Cis proline' 0 N--CA 1.457 -0.624 0 CA-C-N 119.973 1.026 . . . . 0.0 110.628 -1.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -113.72 109.28 18.31 Favored 'General case' 0 N--CA 1.461 0.076 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 178.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.1 mt -89.75 122.55 32.95 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.0 mp -122.96 114.68 20.75 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 177.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 tp -90.11 95.93 10.44 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -87.02 142.29 28.04 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.688 1.195 . . . . 0.0 111.571 -177.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -137.81 109.61 7.12 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 174.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 52.31 48.67 22.16 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 118.983 0.81 . . . . 0.0 110.073 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.71 -13.21 2.42 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 118.731 -1.038 . . . . 0.0 114.957 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -88.59 125.25 34.71 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 119.637 1.719 . . . . 0.0 108.873 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 73.2 t -71.82 114.07 9.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 175.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.94 -41.25 29.82 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.304 0.641 . . . . 0.0 109.398 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -159.18 170.06 22.78 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 177.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.1 t -149.3 162.77 39.39 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -146.88 119.78 8.71 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.171 1.388 . . . . 0.0 108.08 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.2 t -94.24 120.71 44.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.39 174.92 29.97 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 121.537 0.52 . . . . 0.0 112.211 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.21 172.25 9.59 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.777 0.831 . . . . 0.0 112.156 -178.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.9 mt -144.4 158.47 43.73 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 125.81 1.644 . . . . 0.0 108.506 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.3 p -87.03 152.02 22.74 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 169.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -50.53 -47.93 57.33 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 122.065 -0.397 . . . . 0.0 111.006 -178.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.64 -53.53 38.44 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -62.38 -39.7 94.06 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.98 -0.718 . . . . 0.0 111.291 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 30.6 tp -62.53 -49.43 75.37 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -56.22 -44.92 80.03 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.429 0.559 . . . . 0.0 110.492 176.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -56.27 -54.68 42.46 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.569 0.748 . . . . 0.0 109.887 177.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -53.4 -51.66 61.83 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.669 1.188 . . . . 0.0 110.357 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.9 mt -58.83 -50.77 72.74 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.519 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -55.33 -49.86 71.12 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.8 -36.89 67.92 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.468 0.707 . . . . 0.0 111.601 178.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -78.06 -47.43 18.36 Favored 'General case' 0 C--N 1.337 0.042 0 O-C-N 122.113 -0.367 . . . . 0.0 110.475 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 54.2 mt -59.37 -44.67 92.7 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.227 0.611 . . . . 0.0 109.531 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.244 0 C-N-CA 122.933 0.493 . . . . 0.0 109.707 177.743 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 20.0 m . . . . . 0 CA--C 1.528 0.12 0 CA-C-O 120.691 0.281 . . . . 0.0 111.299 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -74.31 78.65 1.84 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 120.994 0.426 . . . . 0.0 110.614 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -77.4 57.5 1.53 Allowed 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 175.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.7 mt -117.55 147.72 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 C-N-CA 125.631 1.572 . . . . 0.0 109.706 -173.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.2 mm -87.71 108.78 18.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 176.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 27.1 m-70 -79.77 94.69 5.81 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 177.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 66.9 mt -82.09 159.18 23.47 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.832 0.853 . . . . 0.0 112.433 -177.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 26.6 p -134.25 163.15 30.27 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.991 1.716 . . . . 0.0 106.947 173.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -55.62 -46.58 77.37 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.492 0.717 . . . . 0.0 110.656 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -55.98 -45.13 79.07 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.997 0.919 . . . . 0.0 111.468 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.9 p -78.34 -29.78 47.76 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 111.6 0.222 . . . . 0.0 111.6 -177.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -37.62 -53.59 1.2 Allowed 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 125.782 1.633 . . . . 0.0 114.473 -176.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -50.87 -62.2 1.75 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.611 0.719 . . . . 0.0 111.045 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -66.39 -49.53 66.51 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.944 -176.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -74.39 -21.0 59.86 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -173.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.5 t -119.51 -64.99 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.23 0.066 0 CA-C-N 119.326 0.966 . . . . 0.0 110.161 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 67.9 mt -59.66 -37.46 78.79 Favored 'General case' 0 C--N 1.334 -0.082 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 -174.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -98.61 15.75 24.1 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.428 0.558 . . . . 0.0 111.949 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.58 108.39 20.98 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 118.979 0.809 . . . . 0.0 111.047 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -75.38 63.97 1.49 Allowed 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.933 1.293 . . . . 0.0 111.336 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -163.81 178.38 39.29 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.61 105.66 17.9 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.134 1.374 . . . . 0.0 109.44 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.7 mt -112.38 117.35 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 124.144 0.978 . . . . 0.0 110.352 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.5 tp -90.5 97.89 11.45 Favored 'General case' 0 CA--C 1.523 -0.062 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 175.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.8 t -88.78 111.79 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -95.54 106.8 18.93 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.709 1.204 . . . . 0.0 108.601 176.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -80.5 125.17 29.63 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 175.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 31.1 p-90 -143.84 176.2 9.43 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.858 0.863 . . . . 0.0 112.574 -174.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.17 144.71 16.15 Favored 'General case' 0 C--N 1.338 0.092 0 C-N-CA 125.065 1.346 . . . . 0.0 108.476 175.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 -48.93 -50.69 34.15 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.789 1.236 . . . . 0.0 112.099 -178.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 63.9 p-90 -60.41 -29.84 69.22 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -177.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 49.5 t -79.82 77.88 6.45 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 121.514 -0.741 . . . . 0.0 110.52 -178.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -24.66 -62.1 0.05 OUTLIER Glycine 0 CA--C 1.536 1.399 0 C-N-CA 127.094 2.283 . . . . 0.0 115.084 179.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -43.88 -31.16 3.49 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 124.683 3.589 . . . . 0.0 115.192 179.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 98.8 m -55.09 -42.73 73.21 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.688 -0.633 . . . . 0.0 109.705 176.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -67.77 -27.2 66.56 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.712 0.805 . . . . 0.0 111.007 178.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 12.7 tmm? -72.3 -48.99 38.03 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 43.5 pt -70.39 -31.49 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 118.696 -0.668 . . . . 0.0 112.209 178.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -37.53 -60.94 0.8 Allowed Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -57.48 -39.35 89.6 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.374 2.049 . . . . 0.0 111.734 178.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 16.1 mt -59.22 -52.27 62.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.5 mt -55.84 -43.64 77.22 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.652 0.781 . . . . 0.0 110.575 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -58.09 -50.52 73.19 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.121 0.486 . . . . 0.0 109.804 178.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -59.88 -49.98 75.57 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.6 mm -53.37 -46.59 58.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 123.688 0.795 . . . . 0.0 109.585 177.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.56 -45.96 70.08 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.753 0.421 . . . . 0.0 110.608 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -66.43 -55.65 14.73 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 177.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -50.36 -47.82 55.9 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.931 0.892 . . . . 0.0 112.291 -177.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -98.31 23.74 8.04 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.813 0.845 . . . . 0.0 111.614 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -53.82 130.86 38.49 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 119.396 0.998 . . . . 0.0 110.526 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.24 -18.64 12.92 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 119.151 -0.805 . . . . 0.0 113.087 -178.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -99.3 -42.38 7.03 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.788 1.294 . . . . 0.0 109.288 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.0 tp -132.42 131.87 42.22 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.511 1.125 . . . . 0.0 108.667 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 90.4 m -96.27 104.37 16.32 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 176.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 90.7 t -79.74 134.66 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.08 150.02 51.16 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.296 0.639 . . . . 0.0 109.284 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -126.39 136.27 52.48 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 178.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.5 tt -129.45 115.13 17.04 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.412 0.685 . . . . 0.0 109.16 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -80.63 111.11 16.75 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.1 pt -73.19 -25.1 21.19 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.139 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -177.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -61.54 -46.96 87.71 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 177.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -70.6 -40.13 73.41 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.222 1.009 . . . . 0.0 109.894 177.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -120.53 69.77 16.36 Favored Pre-proline 0 CA--C 1.532 0.269 0 C-N-CA 124.06 0.944 . . . . 0.0 112.691 -175.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -65.54 -41.42 15.23 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 121.802 1.668 . . . . 0.0 110.653 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -43.99 -35.99 3.65 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 125.569 1.557 . . . . 0.0 114.913 -178.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.98 -20.41 61.73 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.604 1.202 . . . . 0.0 112.92 -177.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.25 -59.22 13.6 Favored Pre-proline 0 CA--C 1.539 0.538 0 O-C-N 121.111 -0.993 . . . . 0.0 113.226 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -58.17 -33.25 97.29 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.281 1.987 . . . . 0.0 111.805 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -52.98 -29.0 26.48 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.87 0.759 . . . . 0.0 111.929 177.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -122.94 20.47 10.0 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.464 0.705 . . . . 0.0 110.57 177.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 40.3 43.39 2.74 Favored Glycine 0 C--N 1.342 0.875 0 C-N-CA 126.03 1.776 . . . . 0.0 111.535 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.5 mt -54.06 138.39 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -174.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.51 -41.4 32.47 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.55 1.14 . . . . 0.0 111.219 -174.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -178.25 -150.94 9.01 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 106.674 -2.57 . . . . 0.0 106.674 -177.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.3 pt -148.36 154.31 41.75 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 118.856 1.328 . . . . 0.0 108.979 178.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -70.72 141.41 68.38 Favored 'Cis proline' 0 N--CA 1.455 -0.767 0 CA-C-N 119.786 0.959 . . . . 0.0 110.333 -1.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 43.5 m -133.79 125.92 29.5 Favored 'General case' 0 C--O 1.231 0.111 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 178.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.2 mt -103.58 124.96 49.77 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.89 1.276 . . . . 0.0 109.15 -177.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -114.52 117.35 30.69 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 105.064 -2.199 . . . . 0.0 105.064 174.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.5 tp -94.98 95.41 8.6 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -86.88 102.9 14.77 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.162 1.385 . . . . 0.0 110.052 -178.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -97.93 114.68 26.85 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 174.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 54.23 46.99 24.11 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.536 0.734 . . . . 0.0 109.981 -178.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 69.55 -1.8 13.15 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-O 118.62 -1.1 . . . . 0.0 114.414 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -103.46 128.97 50.51 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 119.657 1.728 . . . . 0.0 109.253 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 98.8 t -66.35 102.7 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.17 -38.54 35.64 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.696 0.799 . . . . 0.0 109.652 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -150.76 167.29 27.88 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 97.4 m -147.49 149.92 33.57 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.13 141.31 31.16 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -177.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 36.7 t -125.36 128.44 72.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.38 175.87 37.37 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 123.829 0.728 . . . . 0.0 111.649 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.73 173.16 9.47 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.455 0.702 . . . . 0.0 111.44 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.0 mt -146.4 161.69 39.83 Favored 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 125.28 1.432 . . . . 0.0 109.333 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.6 p -92.47 152.42 19.69 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 169.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -51.1 -47.46 61.93 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 122.138 -0.351 . . . . 0.0 111.522 -177.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.8 -60.31 8.9 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -54.46 -41.36 69.38 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.989 -0.712 . . . . 0.0 111.422 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 30.3 tp -60.79 -48.67 80.74 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -55.65 -48.0 75.73 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 118.903 -0.57 . . . . 0.0 110.298 176.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -56.0 -52.13 65.31 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.975 0.807 . . . . 0.0 110.515 178.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -52.05 -51.34 58.14 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.789 0.835 . . . . 0.0 110.429 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 90.1 mt -61.97 -52.33 64.45 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.503 0.321 . . . . 0.0 110.723 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -50.55 -49.79 55.1 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.67 1.188 . . . . 0.0 110.126 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.47 -36.17 68.78 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.402 0.681 . . . . 0.0 111.906 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -78.88 -45.81 19.86 Favored 'General case' 0 N--CA 1.46 0.043 0 O-C-N 122.23 -0.294 . . . . 0.0 110.538 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 56.2 mt -60.26 -43.66 95.98 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.445 0.698 . . . . 0.0 109.655 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.278 0 C-N-CA 122.948 0.499 . . . . 0.0 109.795 177.827 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 35.8 p . . . . . 0 N--CA 1.452 -0.34 0 N-CA-C 110.512 -0.181 . . . . 0.0 110.512 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 28.1 t70 63.89 -70.81 0.07 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 126.979 2.112 . . . . 0.0 110.408 -177.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -116.38 -21.09 9.43 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.396 1.478 . . . . 0.0 110.796 176.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.3 mt -79.5 136.98 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.9 mm -87.79 111.29 21.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 123.599 0.76 . . . . 0.0 109.073 178.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -83.04 101.21 10.97 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 70.7 mt -83.23 163.49 20.71 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.543 1.137 . . . . 0.0 112.139 -177.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 62.2 p -131.51 162.42 30.29 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 173.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -59.25 -46.09 89.43 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.866 0.757 . . . . 0.0 109.543 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -62.72 -41.62 99.25 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.896 0.478 . . . . 0.0 111.713 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 54.4 p -78.33 -26.16 46.75 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.409 0.55 . . . . 0.0 111.175 -177.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -41.85 -44.9 3.5 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 126.419 1.888 . . . . 0.0 112.415 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -53.25 -63.17 1.23 Allowed 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.535 0.684 . . . . 0.0 110.637 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.0 m -66.79 -42.63 85.65 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.742 -177.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -70.52 -50.14 40.89 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -175.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.0 t -100.07 -57.87 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 123.882 0.873 . . . . 0.0 111.141 -174.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 67.0 mt -63.21 -37.01 85.56 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 120.22 -0.592 . . . . 0.0 112.311 -174.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -94.5 21.94 6.68 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.344 0.52 . . . . 0.0 111.08 175.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.78 159.45 34.52 Favored 'General case' 0 C--N 1.34 0.16 0 O-C-N 121.471 -0.768 . . . . 0.0 110.568 177.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -138.6 58.41 1.66 Allowed 'General case' 0 C--O 1.226 -0.155 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 175.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 175.25 -174.2 46.66 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -178.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -86.55 128.28 34.96 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.595 1.158 . . . . 0.0 110.281 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.7 mt -132.99 121.08 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 124.417 1.087 . . . . 0.0 109.603 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -95.35 109.51 21.66 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 175.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.1 t -100.46 108.59 23.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 123.16 0.584 . . . . 0.0 110.043 -178.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -93.7 105.19 17.24 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.125 0.97 . . . . 0.0 109.745 178.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -79.57 114.25 18.35 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 105.048 -2.204 . . . . 0.0 105.048 174.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 39.4 p-90 -128.25 170.55 12.9 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.836 1.255 . . . . 0.0 112.185 -176.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -146.24 131.56 18.54 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.283 1.433 . . . . 0.0 107.763 176.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 -51.14 -37.05 43.98 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.923 0.889 . . . . 0.0 113.24 -178.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 57.7 p-90 -77.9 -20.49 52.83 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 52.8 t -79.83 74.16 6.56 Favored 'General case' 0 N--CA 1.456 -0.138 0 O-C-N 121.228 -0.92 . . . . 0.0 110.745 -177.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -9.68 -71.39 0.01 OUTLIER Glycine 0 CA--C 1.535 1.329 0 C-N-CA 128.294 2.854 . . . . 0.0 115.699 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -40.91 -32.81 0.97 Allowed 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 125.207 3.938 . . . . 0.0 115.61 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 89.3 m -52.66 -41.82 64.16 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.368 0.667 . . . . 0.0 110.207 177.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -66.23 -30.23 70.63 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.717 0.807 . . . . 0.0 111.234 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -75.61 -45.02 39.83 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.9 pt -73.28 -31.15 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-O 118.712 -0.661 . . . . 0.0 112.333 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -39.32 -60.95 1.09 Allowed Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -58.11 -36.86 97.57 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.376 2.051 . . . . 0.0 111.893 178.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 19.7 mt -60.92 -51.79 69.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 177.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.6 mt -56.31 -41.34 75.84 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.189 0.596 . . . . 0.0 110.117 177.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -60.76 -47.87 84.35 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.841 0.746 . . . . 0.0 110.093 176.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -56.91 -51.88 67.38 Favored 'General case' 0 C--N 1.339 0.117 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 31.4 mm -53.72 -46.12 61.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 123.302 0.641 . . . . 0.0 109.498 177.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.65 -36.75 67.39 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.939 0.496 . . . . 0.0 111.223 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -74.5 -58.14 3.48 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.938 0.399 . . . . 0.0 109.986 176.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -50.36 -41.91 52.36 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.734 1.214 . . . . 0.0 112.532 -177.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -107.07 25.45 11.36 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.642 1.177 . . . . 0.0 111.021 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -56.94 121.84 10.87 Favored 'General case' 0 CA--C 1.529 0.173 0 O-C-N 121.545 -0.722 . . . . 0.0 110.39 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.06 -9.83 55.54 Favored Glycine 0 CA--C 1.531 1.094 0 CA-C-O 119.556 -0.58 . . . . 0.0 112.85 -178.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 47.4 mttt -99.71 -41.3 7.35 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.691 1.196 . . . . 0.0 108.664 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 47.7 tp -131.82 133.6 44.86 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.572 1.149 . . . . 0.0 108.708 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.2 m -88.08 98.49 11.56 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 176.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 80.5 t -79.09 128.95 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 178.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.65 150.64 50.68 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.276 0.56 . . . . 0.0 110.662 -177.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -127.54 143.45 51.18 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.972 1.309 . . . . 0.0 107.597 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 tt -134.2 115.19 13.89 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -80.83 105.05 11.76 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pp -58.97 -33.87 51.25 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.242 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -177.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -63.05 -44.31 96.23 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.704 0.684 . . . . 0.0 110.226 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -72.06 -31.49 66.18 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 177.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -128.53 69.79 79.41 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -176.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.02 -50.89 10.89 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.488 2.792 . . . . 0.0 113.408 -178.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -41.37 -40.1 2.56 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 125.431 1.491 . . . . 0.0 114.34 -176.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.88 -30.64 69.13 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.767 -0.843 . . . . 0.0 113.113 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.11 -64.57 2.19 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-O 118.259 -0.877 . . . . 0.0 112.292 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -60.02 -37.21 86.3 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 121.833 1.689 . . . . 0.0 111.511 177.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -52.34 -37.18 55.35 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 119.386 0.994 . . . . 0.0 111.791 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -111.49 20.9 16.76 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.922 0.489 . . . . 0.0 110.92 177.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 41.9 45.08 4.73 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 125.537 1.541 . . . . 0.0 112.901 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mp -47.89 116.45 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 117.702 0.751 . . . . 0.0 110.411 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.41 -49.62 12.07 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.179 0.992 . . . . 0.0 110.295 -177.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -161.9 144.1 9.43 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 107.419 -2.272 . . . . 0.0 107.419 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.7 pt -96.85 150.8 37.31 Favored Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 123.837 0.855 . . . . 0.0 110.246 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -70.23 137.28 44.1 Favored 'Cis proline' 0 N--CA 1.457 -0.672 0 CA-C-N 119.591 0.89 . . . . 0.0 110.597 -1.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -115.43 118.91 34.51 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.3 mt -102.37 105.51 16.12 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -179.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -94.21 114.36 26.45 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 104.781 -2.304 . . . . 0.0 104.781 175.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.6 tp -97.24 105.53 17.7 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -179.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -94.18 150.01 20.71 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.584 1.554 . . . . 0.0 110.712 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -139.63 107.04 5.54 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 173.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 51.01 70.81 0.49 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.548 0.689 . . . . 0.0 111.457 -179.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 73.4 -37.09 0.82 Allowed Glycine 0 CA--C 1.531 1.04 0 N-CA-C 115.923 1.129 . . . . 0.0 115.923 176.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -90.14 147.88 23.32 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.146 1.473 . . . . 0.0 111.373 -177.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 75.3 t -74.38 114.66 14.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 175.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.04 -46.66 13.63 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.62 1.168 . . . . 0.0 109.852 178.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -148.64 170.85 17.22 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 58.9 m -152.57 144.92 24.0 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -177.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -135.29 143.88 46.46 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.4 t -121.94 120.77 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 178.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.03 169.7 35.05 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -177.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.27 170.53 8.57 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.983 0.913 . . . . 0.0 112.882 -178.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.1 mt -142.63 155.76 44.98 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 125.977 1.711 . . . . 0.0 108.572 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.6 p -87.78 152.51 22.06 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 171.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -48.21 -52.35 21.33 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -176.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -53.71 -57.26 16.63 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 26.8 mm100 -57.74 -40.93 80.79 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 122.194 -0.592 . . . . 0.0 111.122 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 42.2 tp -62.13 -49.4 76.01 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 177.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -54.1 -45.99 71.97 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.387 0.54 . . . . 0.0 110.403 176.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -57.96 -54.87 42.04 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 122.92 0.488 . . . . 0.0 110.453 178.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -51.44 -52.21 48.24 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.757 1.223 . . . . 0.0 110.584 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 85.4 mt -61.24 -53.39 57.45 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.805 0.442 . . . . 0.0 110.418 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -51.54 -50.29 60.3 Favored 'General case' 0 C--N 1.334 -0.083 0 C-N-CA 123.765 0.826 . . . . 0.0 111.067 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.82 -37.65 66.38 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.354 0.662 . . . . 0.0 111.654 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -78.78 -43.52 25.31 Favored 'General case' 0 N--CA 1.46 0.073 0 C-N-CA 122.456 0.302 . . . . 0.0 110.587 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 40.4 mt -58.82 -47.06 86.13 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.289 0 C-N-CA 123.364 0.666 . . . . 0.0 109.69 177.656 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 CA--C 1.531 0.239 0 CA-C-O 120.745 0.307 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 26.1 t0 47.81 42.91 16.59 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.993 1.717 . . . . 0.0 112.183 -178.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -82.02 58.07 3.77 Favored 'General case' 0 N--CA 1.457 -0.125 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 175.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 22.0 mt -135.79 143.87 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 123.858 0.863 . . . . 0.0 109.104 -173.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.5 mm -88.03 112.09 23.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 -80.28 102.4 9.49 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 72.7 mt -90.93 161.96 14.97 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 121.814 0.816 . . . . 0.0 112.258 -177.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 82.6 p -139.96 167.15 22.78 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.733 2.013 . . . . 0.0 106.444 175.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -55.22 -47.77 74.87 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.459 0.704 . . . . 0.0 110.656 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -61.8 -40.15 94.22 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.2 p -78.74 -29.99 45.53 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 122.109 -0.369 . . . . 0.0 110.727 -178.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -39.27 -52.83 1.97 Allowed 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 125.841 1.656 . . . . 0.0 113.436 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -55.6 -59.18 5.2 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 121.868 -0.52 . . . . 0.0 110.908 -179.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.1 m -59.11 -48.85 80.08 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.222 1.009 . . . . 0.0 112.569 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.96 -47.1 16.97 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -174.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.8 t -94.56 -52.39 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 C-N-CA 123.347 0.659 . . . . 0.0 112.504 -174.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 73.6 mt -71.4 -42.72 68.0 Favored 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 119.545 -0.862 . . . . 0.0 111.218 -175.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -91.64 35.32 0.96 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 176.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -78.1 162.1 26.92 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.415 0.686 . . . . 0.0 111.987 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -141.8 94.28 2.66 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 172.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 135.52 -175.51 20.7 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -176.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.05 111.59 23.32 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.374 1.47 . . . . 0.0 109.687 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.0 mt -109.07 115.98 50.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 124.153 0.981 . . . . 0.0 109.686 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.6 tp -90.14 96.97 10.92 Favored 'General case' 0 C--N 1.338 0.076 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 176.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 45.4 t -88.51 114.58 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 123.328 0.651 . . . . 0.0 109.899 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -98.87 106.09 18.31 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 176.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -79.73 120.05 23.49 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 175.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 37.6 p-90 -133.84 170.52 15.47 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.332 1.053 . . . . 0.0 113.152 -175.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -142.76 138.68 30.64 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.192 1.397 . . . . 0.0 107.444 174.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -53.89 -47.64 70.92 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.015 0.526 . . . . 0.0 112.236 -177.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 62.6 p-90 -65.68 -23.75 66.85 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.108 0.563 . . . . 0.0 112.413 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 52.1 t -79.68 80.38 6.07 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 121.34 -0.85 . . . . 0.0 109.75 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -27.06 -59.89 0.09 OUTLIER Glycine 0 CA--C 1.535 1.304 0 C-N-CA 127.078 2.275 . . . . 0.0 114.391 178.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -41.75 -37.16 3.77 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 124.248 3.299 . . . . 0.0 114.699 177.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 75.1 m -58.24 -47.67 82.82 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.689 0.757 . . . . 0.0 109.837 177.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -65.37 -37.28 86.54 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.71 0.804 . . . . 0.0 109.094 178.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 54.3 mtm -63.44 -43.14 98.27 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 119.243 -0.408 . . . . 0.0 111.061 177.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 31.5 pt -75.46 -26.52 18.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 119.139 0.881 . . . . 0.0 112.164 178.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -38.26 -57.8 1.69 Allowed Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -57.42 -40.13 83.71 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.072 1.848 . . . . 0.0 111.499 177.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 16.4 mt -59.32 -49.19 84.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.9 mt -57.22 -43.53 82.89 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.75 0.42 . . . . 0.0 110.763 177.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.46 -50.76 72.58 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.725 0.693 . . . . 0.0 110.16 176.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -56.24 -52.1 65.68 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.4 mm -54.55 -46.88 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 124.891 1.276 . . . . 0.0 110.221 178.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.05 -44.69 79.07 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.723 0.409 . . . . 0.0 110.041 178.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -64.26 -53.34 50.48 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 177.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -49.46 -48.91 47.28 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.177 0.991 . . . . 0.0 111.684 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -100.82 29.63 4.45 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.347 0.659 . . . . 0.0 111.344 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -55.54 123.45 14.04 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.43 -0.794 . . . . 0.0 110.5 -179.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.71 -15.13 43.72 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 119.466 -0.63 . . . . 0.0 112.913 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -99.62 -40.23 7.9 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.371 1.086 . . . . 0.0 109.458 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.7 tp -126.41 132.88 51.41 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.656 1.183 . . . . 0.0 108.83 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.0 m -97.44 101.8 13.42 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 176.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 66.6 t -79.62 135.0 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 178.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.92 150.19 49.22 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.413 0.685 . . . . 0.0 109.732 -178.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 45.2 mttm -127.96 126.62 41.76 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.0 tt -116.66 115.82 26.39 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.442 0.697 . . . . 0.0 109.608 179.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -79.15 108.97 13.04 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 pp -68.37 -32.42 55.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 119.228 -0.415 . . . . 0.0 111.395 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -51.13 -33.19 25.51 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.654 0.661 . . . . 0.0 112.17 -179.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -110.43 1.32 18.26 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.41 1.084 . . . . 0.0 111.563 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -144.19 64.1 12.09 Favored Pre-proline 0 C--O 1.234 0.26 0 C-N-CA 124.42 1.088 . . . . 0.0 109.163 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -60.01 -53.33 3.22 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.646 2.231 . . . . 0.0 112.394 -177.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -38.42 -47.47 2.15 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.392 1.472 . . . . 0.0 114.478 -177.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.86 -33.29 49.14 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.367 1.067 . . . . 0.0 112.753 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.93 -68.32 0.75 Allowed Pre-proline 0 CA--C 1.54 0.564 0 CA-C-O 118.295 -0.859 . . . . 0.0 112.98 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.84 -39.36 82.31 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 121.484 1.456 . . . . 0.0 110.806 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -51.29 -38.48 53.03 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 118.415 0.552 . . . . 0.0 111.826 178.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -107.32 18.87 21.07 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 55.46 40.62 78.14 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 123.106 0.384 . . . . 0.0 113.043 176.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mp -63.52 104.31 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 176.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 47.6 mtt85 -79.62 -43.4 22.96 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.902 1.281 . . . . 0.0 110.186 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -157.49 141.91 8.18 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 107.874 -2.09 . . . . 0.0 107.874 179.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.1 pt -99.45 147.48 33.4 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 124.354 1.062 . . . . 0.0 109.762 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.57 142.41 66.88 Favored 'Cis proline' 0 N--CA 1.457 -0.649 0 CA-C-N 120.112 1.076 . . . . 0.0 111.156 0.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -121.38 110.69 16.4 Favored 'General case' 0 C--N 1.335 -0.062 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.2 mt -88.73 123.05 32.78 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.7 mp -122.32 118.97 29.74 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 176.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.8 tp -95.31 95.08 8.24 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -177.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -86.55 105.23 16.69 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.682 1.193 . . . . 0.0 110.768 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -93.62 111.07 22.67 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 173.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.5 m120 47.87 50.88 15.07 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.718 0.807 . . . . 0.0 111.169 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.38 -11.53 24.06 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 118.851 -0.972 . . . . 0.0 114.676 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -97.36 121.16 38.94 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 119.632 1.716 . . . . 0.0 109.745 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 89.4 t -64.07 106.08 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 175.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.98 -37.51 39.22 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.587 0.755 . . . . 0.0 109.553 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.81 170.04 21.51 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.3 t -149.59 156.89 42.67 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 178.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.2 tmtm? -138.55 116.38 11.54 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.853 1.661 . . . . 0.0 106.764 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 36.5 t -96.35 126.93 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -178.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.01 178.67 47.44 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.27 168.2 12.87 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.104 0.478 . . . . 0.0 110.342 178.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -158.09 165.33 35.28 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.842 0.857 . . . . 0.0 109.154 -178.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 83.1 p -80.2 160.29 25.67 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 177.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -58.62 -38.43 78.01 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 175.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -56.01 -54.73 33.31 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 110.656 -0.977 . . . . 0.0 110.656 176.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -52.91 -50.03 64.75 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 117.241 0.52 . . . . 0.0 110.424 177.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 14.6 tp -59.79 -50.11 75.1 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 121.141 -0.224 . . . . 0.0 110.704 -178.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -55.05 -49.14 72.34 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.185 0.594 . . . . 0.0 111.581 178.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -67.68 -43.81 79.29 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.509 -177.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -52.15 -53.0 48.32 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.655 0.782 . . . . 0.0 109.208 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 84.8 mt -59.42 -54.42 46.87 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 119.116 -0.469 . . . . 0.0 110.78 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -51.43 -50.01 60.55 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.106 0.412 . . . . 0.0 111.022 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.95 -38.8 73.44 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.492 0.717 . . . . 0.0 111.847 179.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -78.3 -40.93 35.31 Favored 'General case' 0 N--CA 1.461 0.117 0 O-C-N 122.092 -0.38 . . . . 0.0 110.995 -178.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 63.0 mt -64.14 -46.59 83.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.266 0 C-N-CA 122.922 0.489 . . . . 0.0 109.82 177.7 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 CA--C 1.532 0.277 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -36.7 -45.2 0.51 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.619 1.968 . . . . 0.0 113.57 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -129.33 35.63 4.23 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.094 0.558 . . . . 0.0 110.881 178.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.4 mt -110.57 137.12 44.32 Favored 'Isoleucine or valine' 0 C--O 1.23 0.059 0 C-N-CA 122.77 0.428 . . . . 0.0 110.077 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.4 mm -87.03 108.2 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -81.68 110.55 17.12 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 177.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.0 mt -88.94 171.9 9.54 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.628 1.171 . . . . 0.0 110.502 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 51.0 p -136.21 164.26 28.48 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 171.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -57.1 -47.77 80.25 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 177.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -59.52 -45.35 91.99 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.674 1.19 . . . . 0.0 111.889 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 86.1 p -79.64 -24.43 41.89 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -176.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -31.7 -60.33 0.25 Allowed 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 127.121 2.169 . . . . 0.0 114.337 -178.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -52.36 -59.19 4.71 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.46 0.648 . . . . 0.0 111.048 -177.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.9 m -60.01 -41.66 92.65 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 123.6 0.76 . . . . 0.0 111.733 -178.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -74.79 -43.14 56.31 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -175.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 45.8 t -105.85 -57.31 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 C-N-CA 124.568 1.147 . . . . 0.0 112.08 -172.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 75.5 mt -61.38 -33.54 73.83 Favored 'General case' 0 N--CA 1.458 -0.037 0 O-C-N 121.702 -0.624 . . . . 0.0 111.876 -174.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -88.91 8.66 28.19 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 118.286 0.493 . . . . 0.0 111.809 177.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.79 100.58 11.02 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 121.253 -0.905 . . . . 0.0 112.489 -178.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -77.06 68.77 3.26 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 174.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -179.84 -172.11 43.5 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -178.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -99.6 115.76 30.14 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.562 1.545 . . . . 0.0 110.857 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 mt -121.53 123.44 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 125.43 1.492 . . . . 0.0 109.116 178.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -92.86 108.32 19.9 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 175.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 32.2 t -97.3 109.91 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -93.57 106.36 18.34 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 177.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -79.66 125.52 29.74 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 175.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 38.0 p-90 -143.79 166.12 25.78 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -174.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -144.59 137.24 26.6 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.168 1.387 . . . . 0.0 108.909 174.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -51.75 -47.82 63.94 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.865 0.866 . . . . 0.0 112.372 -177.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 50.4 p-90 -60.75 -27.04 67.66 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 46.8 t -79.86 81.48 6.12 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 121.42 -0.8 . . . . 0.0 109.098 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -28.14 -59.17 0.13 Allowed Glycine 0 CA--C 1.538 1.525 0 C-N-CA 125.962 1.744 . . . . 0.0 114.27 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -41.89 -39.27 5.27 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 124.311 3.341 . . . . 0.0 114.464 177.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 94.1 m -56.02 -50.52 70.66 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 121.668 0.747 . . . . 0.0 109.985 176.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -64.18 -38.07 89.74 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.319 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 83.9 mtp -61.7 -44.16 97.47 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 119.472 -0.299 . . . . 0.0 110.827 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.5 pt -76.17 -26.96 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 118.741 0.7 . . . . 0.0 112.635 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -37.8 -57.93 1.48 Allowed Pre-proline 0 CA--C 1.546 0.79 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -58.14 -39.7 83.1 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.07 1.847 . . . . 0.0 111.672 178.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 14.0 mt -59.52 -49.65 82.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 177.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 44.2 mt -56.1 -42.33 76.62 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 122.564 0.346 . . . . 0.0 110.161 177.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -61.71 -46.86 87.83 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.994 0.815 . . . . 0.0 111.147 176.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -56.14 -51.12 69.1 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 24.0 mm -55.92 -44.78 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 123.428 0.691 . . . . 0.0 109.831 177.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.86 70.68 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 118.321 0.509 . . . . 0.0 110.787 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -72.55 -57.61 4.01 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 177.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -51.18 -46.09 62.0 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.231 1.012 . . . . 0.0 112.605 -178.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -98.26 19.82 13.6 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.438 1.095 . . . . 0.0 111.426 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -54.93 131.85 45.44 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.25 -0.906 . . . . 0.0 110.085 -178.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.25 -18.76 7.64 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 119.334 -0.703 . . . . 0.0 113.235 -178.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -99.61 -37.42 9.15 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.486 1.143 . . . . 0.0 109.923 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 26.6 tp -136.68 128.01 28.26 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.496 1.118 . . . . 0.0 108.181 178.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 57.6 m -88.55 105.08 17.4 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 91.2 t -79.53 130.36 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.96 153.19 51.94 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.938 0.895 . . . . 0.0 110.45 -177.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -128.74 144.02 51.06 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.658 1.183 . . . . 0.0 108.221 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.0 tt -134.04 117.4 16.61 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -87.19 99.76 12.18 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 122.125 -0.359 . . . . 0.0 110.984 -175.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.9 pt -55.26 -28.11 21.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -56.99 -43.55 81.84 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.828 0.74 . . . . 0.0 110.294 177.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -95.28 -17.5 21.61 Favored 'General case' 0 CA--C 1.53 0.212 0 C-N-CA 124.818 1.247 . . . . 0.0 111.577 -178.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -129.82 59.35 44.3 Favored Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 124.532 1.133 . . . . 0.0 108.822 -175.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -62.42 -52.18 2.77 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.609 2.206 . . . . 0.0 113.768 -174.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -44.75 -42.99 7.93 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.016 0.817 . . . . 0.0 113.466 -175.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.43 -33.35 43.62 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.055 0.942 . . . . 0.0 112.663 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.54 -68.51 0.63 Allowed Pre-proline 0 CA--C 1.538 0.503 0 CA-C-O 118.139 -0.934 . . . . 0.0 112.294 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -59.86 -38.24 80.84 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 121.595 1.53 . . . . 0.0 111.016 177.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -51.44 -41.31 60.74 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.266 0.939 . . . . 0.0 111.458 178.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -104.59 19.43 20.4 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.505 0.322 . . . . 0.0 111.753 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.16 39.07 49.62 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.224 0.916 . . . . 0.0 113.401 176.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.5 mp -57.01 127.6 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 118.102 0.951 . . . . 0.0 108.903 177.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -92.24 -47.02 7.43 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.658 1.183 . . . . 0.0 110.238 -178.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -160.55 144.94 10.45 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 107.999 -2.04 . . . . 0.0 107.999 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 9.1 pt -99.08 149.34 35.68 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 124.111 0.964 . . . . 0.0 110.275 -179.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.15 140.02 52.91 Favored 'Cis proline' 0 N--CA 1.457 -0.65 0 CA-C-N 119.961 1.022 . . . . 0.0 111.268 -0.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.85 109.56 15.72 Favored 'General case' 0 CA--C 1.527 0.096 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 178.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.5 mt -91.31 93.17 8.94 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.913 0.885 . . . . 0.0 108.758 -178.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.7 mp -90.56 114.47 26.7 Favored 'General case' 0 CA--C 1.522 -0.117 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 177.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -91.6 103.43 16.02 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -91.49 115.24 27.88 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.144 1.378 . . . . 0.0 110.15 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -111.64 125.27 53.77 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 173.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 53.08 46.11 27.36 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.57 0.7 . . . . 0.0 109.621 -178.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.2 7.16 23.5 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 118.167 -1.352 . . . . 0.0 115.449 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -118.03 142.0 47.86 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 120.002 1.901 . . . . 0.0 110.175 178.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 87.4 t -65.92 110.3 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.39 -42.62 25.1 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.895 0.878 . . . . 0.0 108.647 176.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -158.88 170.95 20.96 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.076 0.95 . . . . 0.0 108.662 177.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 91.2 m -147.33 129.86 15.89 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -179.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -112.2 112.95 24.92 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.0 t -92.02 123.46 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.69 167.43 35.02 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 123.885 0.755 . . . . 0.0 112.232 178.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.3 170.56 12.86 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.108 0.563 . . . . 0.0 110.589 179.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -161.16 172.93 15.88 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.689 0.795 . . . . 0.0 109.913 -176.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 82.8 p -84.15 163.88 19.51 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -57.83 -40.78 80.87 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 175.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -59.51 -57.62 18.63 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 177.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -56.44 -40.45 74.8 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 117.589 0.695 . . . . 0.0 110.71 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 28.7 tp -61.05 -54.94 38.61 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 177.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -53.67 -46.36 70.61 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.314 0.506 . . . . 0.0 111.108 178.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -57.49 -53.71 55.04 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.581 0.753 . . . . 0.0 110.044 178.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -52.97 -54.02 41.33 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.327 1.051 . . . . 0.0 110.448 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.3 mt -59.27 -51.81 68.36 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.654 -179.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -54.77 -51.09 66.81 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.057 0.543 . . . . 0.0 110.661 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.2 -37.37 67.01 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.586 0.755 . . . . 0.0 111.46 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -78.13 -45.97 21.91 Favored 'General case' 0 C--O 1.227 -0.081 0 O-C-N 122.336 -0.227 . . . . 0.0 110.587 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 51.9 mt -58.23 -47.3 83.94 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.31 0 C-N-CA 123.286 0.634 . . . . 0.0 109.566 177.355 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.4 m . . . . . 0 N--CA 1.453 -0.325 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -73.85 63.4 0.9 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.906 0.882 . . . . 0.0 110.927 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -80.47 53.27 1.79 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.1 mt -113.42 144.86 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 124.206 1.003 . . . . 0.0 109.846 -174.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.7 mm -87.31 107.78 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 -79.74 92.03 5.37 Favored 'General case' 0 N--CA 1.461 0.082 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 177.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.2 mt -75.79 162.53 28.1 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.794 0.838 . . . . 0.0 111.685 -178.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.3 p -137.28 162.1 34.44 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 171.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -53.25 -44.93 68.55 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.368 0.667 . . . . 0.0 109.965 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -56.01 -39.86 72.53 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.853 1.261 . . . . 0.0 111.564 178.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.35 -43.48 27.63 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 122.089 -0.382 . . . . 0.0 109.98 -177.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -31.05 -55.71 0.23 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 127.702 2.401 . . . . 0.0 114.773 -177.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -55.35 -36.37 66.22 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -177.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.0 m -90.26 -53.4 4.47 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.527 0.679 . . . . 0.0 109.305 179.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.21 -50.55 72.65 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 113.08 0.771 . . . . 0.0 113.08 -174.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.0 t -94.14 -60.29 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 123.467 0.707 . . . . 0.0 111.077 -174.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 65.3 mt -62.72 -24.17 67.54 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -174.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -114.82 32.39 6.03 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 174.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.88 143.72 41.57 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -99.52 36.25 1.81 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.776 1.23 . . . . 0.0 110.369 177.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 159.52 -157.17 28.34 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.42 118.46 26.89 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.706 1.602 . . . . 0.0 110.369 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.2 mt -119.72 120.79 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 C-N-CA 124.782 1.233 . . . . 0.0 109.017 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -91.78 106.41 18.45 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 105.788 -1.931 . . . . 0.0 105.788 175.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 53.9 t -98.02 108.74 22.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 123.36 0.664 . . . . 0.0 109.407 -178.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -93.9 110.09 21.77 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 177.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -81.52 119.44 23.76 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 175.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 27.7 p-90 -136.1 173.32 11.84 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.665 1.186 . . . . 0.0 112.049 -175.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.29 150.84 37.38 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.546 1.138 . . . . 0.0 108.721 175.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -56.92 -51.25 69.85 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.682 1.193 . . . . 0.0 111.834 -178.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 63.9 p-90 -68.68 -24.31 64.49 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.006 0.922 . . . . 0.0 112.835 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 51.4 t -79.35 79.26 5.8 Favored 'General case' 0 N--CA 1.456 -0.167 0 O-C-N 121.506 -0.746 . . . . 0.0 110.807 -177.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -26.78 -61.52 0.08 OUTLIER Glycine 0 CA--C 1.536 1.383 0 C-N-CA 127.018 2.246 . . . . 0.0 114.852 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -45.05 -29.54 3.98 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 124.493 3.462 . . . . 0.0 115.227 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 78.4 m -56.35 -40.98 75.37 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 121.219 -0.926 . . . . 0.0 109.615 176.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -71.21 -20.38 62.27 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.972 0.909 . . . . 0.0 111.23 178.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -74.98 -46.63 33.95 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 175.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 35.7 pt -72.49 -31.36 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.785 178.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -37.73 -60.28 0.96 Allowed Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -57.15 -40.27 84.37 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.297 1.998 . . . . 0.0 111.547 178.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.5 mt -58.7 -51.59 70.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.7 mt -56.54 -41.01 76.08 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.059 0.544 . . . . 0.0 110.347 177.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -60.28 -48.98 79.41 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.554 0.616 . . . . 0.0 110.013 177.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -57.06 -51.03 70.89 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 29.8 mm -54.9 -46.31 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 123.089 0.555 . . . . 0.0 109.738 177.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.93 -41.04 70.55 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.327 0.512 . . . . 0.0 110.754 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -69.8 -56.32 7.45 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 176.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -50.31 -49.94 52.19 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.955 0.902 . . . . 0.0 112.544 -178.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -97.08 27.15 4.23 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.444 1.098 . . . . 0.0 111.564 -177.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -55.94 124.38 17.48 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 119.202 0.91 . . . . 0.0 110.626 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.57 -10.47 37.39 Favored Glycine 0 CA--C 1.534 1.241 0 CA-C-O 119.423 -0.654 . . . . 0.0 113.238 -178.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.5 mttm -99.67 -42.15 7.0 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.56 1.144 . . . . 0.0 109.241 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.1 tp -134.72 128.61 33.27 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.282 1.033 . . . . 0.0 108.315 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 55.6 m -87.18 103.76 15.73 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 176.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.7 t -79.48 131.28 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 178.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.99 151.39 49.86 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.604 0.762 . . . . 0.0 110.076 -177.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.8 mttm -128.86 141.83 51.16 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 177.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 tt -132.13 114.84 15.0 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.002 0.921 . . . . 0.0 108.784 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 -80.65 108.32 14.19 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.1 pt -71.63 -23.17 22.29 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -179.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -61.58 -47.75 84.05 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 63.6 mm-40 -75.65 -33.81 60.47 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.347 178.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -119.76 70.79 13.99 Favored Pre-proline 0 N--CA 1.465 0.306 0 C-N-CA 123.954 0.902 . . . . 0.0 112.003 -177.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -61.45 -48.74 8.82 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 121.761 1.641 . . . . 0.0 111.231 -179.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -41.36 -42.68 3.43 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.416 1.484 . . . . 0.0 115.16 -178.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.55 -25.32 67.93 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.193 0.997 . . . . 0.0 112.609 -177.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.66 -64.26 3.09 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-O 118.306 -0.854 . . . . 0.0 112.61 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -59.72 -37.16 89.05 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.075 1.85 . . . . 0.0 111.184 178.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -51.98 -31.12 27.97 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 118.633 0.651 . . . . 0.0 111.865 178.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -119.29 22.2 11.89 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.115 0.566 . . . . 0.0 111.646 176.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 46.0 42.73 12.17 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.46 1.028 . . . . 0.0 113.126 177.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mp -50.17 117.31 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 117.865 0.833 . . . . 0.0 109.447 176.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.3 -36.87 39.0 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.208 1.003 . . . . 0.0 111.279 -175.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -170.74 -174.18 38.48 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 105.339 -3.104 . . . . 0.0 105.339 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.2 pt -140.13 151.61 65.26 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-N 119.503 1.651 . . . . 0.0 109.855 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -67.77 149.65 83.41 Favored 'Cis proline' 0 N--CA 1.457 -0.665 0 CA-C-N 119.593 0.89 . . . . 0.0 111.357 -0.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.5 m -134.07 145.38 49.33 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 175.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.2 mt -121.73 131.79 54.27 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -118.41 117.53 29.29 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 104.47 -2.419 . . . . 0.0 104.47 174.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -93.77 97.32 10.35 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -89.74 107.17 18.94 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.223 1.409 . . . . 0.0 110.935 -177.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -96.12 109.08 21.57 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 173.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 34.6 m120 48.08 47.89 18.73 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.314 1.046 . . . . 0.0 112.079 -179.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 86.0 -17.35 37.41 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 118.636 -1.091 . . . . 0.0 114.275 178.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -95.04 129.72 42.01 Favored 'General case' 0 N--CA 1.457 -0.093 0 CA-C-N 119.576 1.688 . . . . 0.0 110.146 178.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 90.4 t -69.03 109.5 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 176.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.05 -39.14 34.7 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.86 170.87 19.8 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.7 t -145.98 159.04 43.8 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -138.52 146.61 42.15 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 126.374 1.87 . . . . 0.0 106.946 -177.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.0 t -129.23 134.43 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 107.375 -1.342 . . . . 0.0 107.375 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.94 174.64 50.49 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 123.54 0.591 . . . . 0.0 111.687 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.3 167.95 19.35 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 122.783 0.433 . . . . 0.0 109.949 178.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -159.61 165.79 32.04 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.2 1.0 . . . . 0.0 108.487 -179.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 84.6 p -81.14 163.91 22.76 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -58.58 -41.32 85.47 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 174.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -56.88 -55.72 28.68 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 177.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -57.19 -44.73 83.87 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 122.059 -0.671 . . . . 0.0 110.28 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 48.0 tp -60.1 -51.13 70.95 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 117.792 0.269 . . . . 0.0 110.49 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -52.11 -50.26 62.0 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.661 0.784 . . . . 0.0 110.09 178.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -59.99 -51.36 69.98 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.096 0.158 . . . . 0.0 110.637 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -52.15 -53.63 40.57 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.026 0.93 . . . . 0.0 110.564 179.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.2 -53.21 60.37 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 122.872 0.469 . . . . 0.0 110.479 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -52.55 -51.28 60.43 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.05 0.54 . . . . 0.0 111.145 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.28 -37.7 67.65 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.57 0.748 . . . . 0.0 111.733 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -78.43 -43.88 26.2 Favored 'General case' 0 CA--C 1.524 -0.054 0 O-C-N 122.315 -0.24 . . . . 0.0 110.782 -178.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 46.3 mt -59.79 -47.31 86.2 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.261 0 C-N-CA 123.214 0.606 . . . . 0.0 109.642 177.351 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 18.9 m . . . . . 0 N--CA 1.451 -0.423 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -76.6 55.86 1.08 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.26 0.624 . . . . 0.0 110.063 177.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -82.13 58.42 3.97 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.8 mt -115.22 142.74 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 124.011 0.925 . . . . 0.0 111.155 -174.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.8 mm -91.21 104.29 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 175.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -79.52 81.85 5.73 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 77.3 mt -65.46 163.89 14.96 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -173.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 50.6 p -140.26 161.28 38.05 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 126.453 1.901 . . . . 0.0 106.733 175.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -52.62 -48.16 66.52 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.557 1.143 . . . . 0.0 111.29 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -62.35 -38.07 88.07 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.741 0.416 . . . . 0.0 112.029 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.3 m -78.07 -29.54 49.22 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 122.213 -0.304 . . . . 0.0 110.696 -178.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -42.16 -48.68 4.85 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.069 1.747 . . . . 0.0 113.517 -178.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -51.64 -63.8 1.02 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 121.617 0.722 . . . . 0.0 110.916 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.2 m -68.44 -43.84 76.24 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.171 -175.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -74.76 -48.14 27.19 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -174.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.8 t -95.64 -58.96 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.116 0 C-N-CA 123.269 0.628 . . . . 0.0 111.879 -175.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 80.3 mt -64.07 -39.49 94.18 Favored 'General case' 0 C--N 1.334 -0.085 0 C-N-CA 119.681 -0.808 . . . . 0.0 111.435 -174.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -96.83 30.13 2.78 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 176.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.84 156.11 34.31 Favored 'General case' 0 C--N 1.342 0.255 0 O-C-N 121.887 -0.508 . . . . 0.0 111.082 178.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -131.09 56.37 1.8 Allowed 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 124.808 1.243 . . . . 0.0 108.161 176.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 163.91 -173.66 39.98 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -178.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.64 115.17 25.98 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.47 1.508 . . . . 0.0 110.077 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 mt -114.85 116.67 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 124.561 1.144 . . . . 0.0 109.755 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 19.9 tp -88.26 93.67 9.59 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 176.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.8 t -86.21 103.81 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 123.024 0.53 . . . . 0.0 109.705 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -88.32 107.68 18.95 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 175.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -79.68 126.17 30.58 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 174.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 35.7 p-90 -139.45 169.84 17.01 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.347 1.059 . . . . 0.0 113.286 -174.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.41 136.52 21.07 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.27 1.428 . . . . 0.0 108.517 178.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 50.6 mp0 -49.68 -50.92 41.7 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.874 0.869 . . . . 0.0 112.126 -178.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 62.6 p-90 -64.41 -25.61 68.1 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.294 0.638 . . . . 0.0 112.38 -177.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 51.3 t -79.88 78.84 6.46 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 121.575 -0.703 . . . . 0.0 110.243 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -25.02 -61.07 0.06 OUTLIER Glycine 0 CA--C 1.536 1.389 0 C-N-CA 127.2 2.333 . . . . 0.0 114.936 178.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_exo -42.17 -34.92 3.06 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 124.315 3.343 . . . . 0.0 114.581 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 82.9 m -57.34 -48.67 78.4 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 121.44 0.638 . . . . 0.0 109.919 177.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -65.33 -33.93 77.13 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.32 0.648 . . . . 0.0 109.651 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 24.0 mmt -64.74 -44.52 89.87 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 110.083 -0.339 . . . . 0.0 110.083 177.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 30.7 pt -76.47 -26.13 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-O 118.367 -0.825 . . . . 0.0 112.642 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -38.05 -58.08 1.53 Allowed Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 120.092 1.315 . . . . 0.0 114.328 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -57.7 -37.18 97.6 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.207 1.938 . . . . 0.0 111.771 177.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.9 mt -62.6 -49.42 83.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.8 mt -56.61 -41.11 76.49 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 177.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -61.13 -47.85 84.35 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.586 0.63 . . . . 0.0 109.986 176.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -56.18 -51.87 66.47 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.9 mm -54.66 -49.31 68.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 122.946 0.498 . . . . 0.0 110.071 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.09 -42.48 69.41 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.295 0.638 . . . . 0.0 110.431 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -67.9 -58.81 3.95 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.819 0.342 . . . . 0.0 110.2 177.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -50.75 -46.96 59.56 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.006 1.323 . . . . 0.0 112.602 -178.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -100.29 25.54 7.47 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.541 1.137 . . . . 0.0 111.215 -178.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -54.49 126.97 25.65 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.171 0.896 . . . . 0.0 110.749 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.28 -12.79 24.24 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-O 119.189 -0.784 . . . . 0.0 113.333 -178.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -99.59 -41.83 7.16 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 118.657 1.228 . . . . 0.0 109.363 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.3 tp -130.8 130.56 43.84 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.419 1.087 . . . . 0.0 108.134 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 65.0 m -91.23 102.76 15.48 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 176.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 99.2 t -79.24 140.57 16.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -139.17 147.04 41.32 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 121.859 -0.526 . . . . 0.0 109.834 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.4 mtmt -128.68 99.47 5.36 Favored 'General case' 0 N--CA 1.46 0.065 0 C-N-CA 124.512 1.125 . . . . 0.0 109.087 -178.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.4 tt -97.54 115.08 27.15 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 121.795 -0.565 . . . . 0.0 110.771 -175.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -79.9 109.55 14.44 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.257 -178.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.8 pt -72.4 -25.77 23.52 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -61.43 -47.66 84.75 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 119.448 1.022 . . . . 0.0 108.447 178.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -70.96 -38.71 72.8 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 124.787 1.235 . . . . 0.0 110.003 177.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -118.39 71.83 9.57 Favored Pre-proline 0 N--CA 1.464 0.269 0 C-N-CA 124.16 0.984 . . . . 0.0 111.478 -176.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -60.6 -53.8 2.52 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.167 1.912 . . . . 0.0 112.419 -177.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -36.86 -49.03 1.4 Allowed Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.385 1.469 . . . . 0.0 114.45 -177.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -51.73 -34.61 39.81 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.281 1.032 . . . . 0.0 113.095 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.52 -68.34 0.72 Allowed Pre-proline 0 CA--C 1.538 0.497 0 CA-C-O 118.174 -0.917 . . . . 0.0 112.654 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -60.34 -37.66 80.49 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 121.757 1.638 . . . . 0.0 110.988 177.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -51.44 -38.27 52.84 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 119.065 0.848 . . . . 0.0 111.51 178.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -108.97 19.91 19.03 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 122.857 0.463 . . . . 0.0 112.004 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 51.0 39.7 41.46 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.108 0.861 . . . . 0.0 113.323 177.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.44 129.9 19.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 118.02 0.91 . . . . 0.0 108.563 177.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -87.33 -47.7 8.59 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.342 1.057 . . . . 0.0 108.985 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -169.09 142.26 7.24 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 107.73 -2.148 . . . . 0.0 107.73 178.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -88.25 151.96 49.56 Favored Pre-proline 0 N--CA 1.454 -0.265 0 CA-C-O 118.514 -0.755 . . . . 0.0 109.907 179.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.23 134.85 27.89 Favored 'Cis proline' 0 N--CA 1.456 -0.727 0 CA-C-N 120.102 1.072 . . . . 0.0 111.452 -0.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.48 109.92 14.44 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.1 mt -89.56 94.06 9.72 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.212 1.005 . . . . 0.0 109.858 -178.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.1 mp -92.02 112.88 24.98 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 176.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.4 tp -90.02 94.75 9.92 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -86.33 105.96 17.04 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 125.077 1.351 . . . . 0.0 110.617 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -94.74 108.4 20.4 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 173.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 49.98 52.24 15.05 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.87 0.868 . . . . 0.0 110.756 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 79.44 -16.4 10.32 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 118.918 -0.935 . . . . 0.0 114.33 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -94.21 118.89 32.22 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 119.579 1.69 . . . . 0.0 110.31 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 86.5 t -62.99 106.87 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 175.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.4 -42.44 25.51 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.921 0.888 . . . . 0.0 110.222 -179.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -153.4 154.76 35.1 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 58.1 p -132.83 111.46 11.11 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.139 0.976 . . . . 0.0 108.832 -177.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -103.58 113.19 26.5 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-N 118.718 0.69 . . . . 0.0 109.936 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.0 t -88.58 124.51 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 176.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.91 171.66 32.79 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 121.637 0.576 . . . . 0.0 113.017 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.61 173.16 8.43 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.152 0.981 . . . . 0.0 112.291 -178.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 mt -151.28 160.28 43.89 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 125.856 1.662 . . . . 0.0 108.729 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.1 p -91.43 152.9 20.19 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 171.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -52.58 -47.44 66.87 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.892 -0.505 . . . . 0.0 112.341 -176.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.53 -53.37 41.77 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-N 118.42 0.554 . . . . 0.0 112.16 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -60.15 -43.4 95.78 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 122.285 -0.538 . . . . 0.0 110.34 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 33.0 tp -59.99 -50.44 73.73 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -54.56 -46.1 73.6 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 118.609 0.64 . . . . 0.0 110.747 177.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -57.77 -52.85 63.76 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 178.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -52.24 -50.65 61.6 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.147 0.979 . . . . 0.0 110.324 178.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 87.4 mt -59.33 -50.98 71.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 122.927 0.491 . . . . 0.0 110.383 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -54.94 -50.6 68.46 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 118.054 0.388 . . . . 0.0 110.258 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.68 -38.31 69.49 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.452 0.701 . . . . 0.0 111.603 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -77.99 -44.09 27.69 Favored 'General case' 0 C--O 1.227 -0.099 0 O-C-N 122.243 -0.286 . . . . 0.0 110.72 -178.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 46.3 mt -59.73 -48.14 82.85 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.27 0 C-N-CA 123.116 0.566 . . . . 0.0 109.685 177.323 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.454 -0.231 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.16 -104.66 0.12 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.233 1.013 . . . . 0.0 111.155 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -124.55 24.99 7.72 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.218 1.407 . . . . 0.0 110.726 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.1 mt -79.95 139.06 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 123.311 0.644 . . . . 0.0 109.561 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.9 mm -89.27 111.56 23.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 123.616 0.766 . . . . 0.0 109.5 178.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -81.05 110.96 17.08 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 50.1 mt -92.05 170.02 10.18 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.53 1.132 . . . . 0.0 110.78 -178.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 67.7 p -136.67 159.54 41.53 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 171.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -56.75 -42.3 79.09 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.044 0.449 . . . . 0.0 109.793 177.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -60.34 -46.97 88.04 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.825 1.25 . . . . 0.0 111.338 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 90.0 p -79.27 -26.18 42.41 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -176.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -36.84 -47.37 0.68 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 127.329 2.252 . . . . 0.0 114.233 -179.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -55.89 -47.42 77.44 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.662 0.744 . . . . 0.0 111.321 -178.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.0 m -77.42 -45.56 25.46 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 123.57 0.748 . . . . 0.0 109.925 -177.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -69.05 -53.97 17.58 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -175.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 41.2 t -94.84 -56.68 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 124.147 0.979 . . . . 0.0 111.857 -173.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 77.3 mt -63.78 -39.42 94.22 Favored 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 119.216 -0.994 . . . . 0.0 111.398 -175.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -96.22 32.06 2.05 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.305 0.502 . . . . 0.0 110.137 174.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.43 146.02 49.76 Favored 'General case' 0 C--N 1.343 0.289 0 O-C-N 121.627 -0.671 . . . . 0.0 112.262 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -99.7 23.39 9.65 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.796 1.638 . . . . 0.0 111.961 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 171.27 -157.61 28.38 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.758 -0.537 . . . . 0.0 111.758 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.58 112.12 20.67 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 126.033 1.733 . . . . 0.0 110.601 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 mt -112.36 117.94 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 124.41 1.084 . . . . 0.0 110.048 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.8 tp -90.01 97.37 11.15 Favored 'General case' 0 C--N 1.338 0.089 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 175.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 56.6 t -87.41 107.43 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 123.416 0.687 . . . . 0.0 110.303 -178.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -92.41 108.18 19.77 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.009 0.924 . . . . 0.0 109.269 176.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -80.34 125.72 30.25 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 105.831 -1.915 . . . . 0.0 105.831 174.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 31.0 p-90 -145.43 175.16 10.53 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.073 0.949 . . . . 0.0 112.253 -176.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.95 147.61 16.72 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 125.487 1.515 . . . . 0.0 108.728 175.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -49.84 -51.65 38.44 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.681 1.193 . . . . 0.0 112.3 -178.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -60.39 -29.95 69.27 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -177.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 46.9 t -79.84 77.59 6.48 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 121.659 -0.651 . . . . 0.0 110.589 -178.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -24.45 -62.04 0.05 OUTLIER Glycine 0 CA--C 1.536 1.368 0 C-N-CA 127.089 2.281 . . . . 0.0 115.141 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -42.81 -33.21 2.92 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 124.725 3.617 . . . . 0.0 114.933 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 99.4 m -53.74 -43.32 69.0 Favored 'General case' 0 CA--C 1.529 0.172 0 O-C-N 121.808 -0.557 . . . . 0.0 110.061 176.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -66.96 -26.84 67.02 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.632 0.773 . . . . 0.0 111.173 178.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 22.7 mmt -76.1 -43.93 41.03 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 28.8 pt -74.74 -29.73 23.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.854 177.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -38.48 -59.6 1.26 Allowed Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 113.877 1.065 . . . . 0.0 113.877 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -57.38 -39.89 85.86 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.364 2.042 . . . . 0.0 111.733 178.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 20.1 mt -58.77 -52.35 61.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 177.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 72.3 mt -56.27 -42.75 77.94 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.085 0.554 . . . . 0.0 110.684 178.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -60.36 -48.34 82.19 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.402 0.546 . . . . 0.0 110.203 178.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -57.9 -51.35 69.96 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 23.1 mm -54.73 -45.8 73.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.749 0.82 . . . . 0.0 109.666 178.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.75 -44.74 70.23 Favored 'General case' 0 C--O 1.227 -0.089 0 C-N-CA 123.008 0.523 . . . . 0.0 110.391 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -68.84 -55.78 10.05 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 121.162 -0.215 . . . . 0.0 110.767 177.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -49.09 -48.85 44.01 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.784 0.834 . . . . 0.0 111.968 -178.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -98.26 24.68 6.93 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.067 0.947 . . . . 0.0 111.519 -178.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -55.07 125.86 22.26 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.571 1.078 . . . . 0.0 110.758 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.56 -11.36 32.82 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 119.522 -0.599 . . . . 0.0 113.353 -178.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.6 mttp -99.73 -42.86 6.67 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.933 1.293 . . . . 0.0 108.734 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.3 tp -133.97 131.55 39.11 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.164 1.386 . . . . 0.0 107.687 178.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 89.9 m -91.92 101.99 14.56 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 176.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 72.5 t -79.22 132.83 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 177.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.19 152.42 51.81 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 123.073 0.549 . . . . 0.0 110.17 -177.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.9 mttm -126.52 139.43 53.23 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 tt -130.94 119.96 22.87 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -87.79 99.07 11.83 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.048 0.539 . . . . 0.0 110.504 -175.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 20.7 pt -58.52 -29.3 38.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 O-C-N 121.266 -0.896 . . . . 0.0 113.224 -177.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -61.19 -25.94 67.37 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.048 0.84 . . . . 0.0 111.697 177.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -114.02 -10.95 12.81 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.312 1.045 . . . . 0.0 111.038 178.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -133.94 57.57 25.76 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 124.892 1.277 . . . . 0.0 108.524 -177.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.71 -49.22 4.44 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.166 1.91 . . . . 0.0 112.976 -174.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -40.26 -40.55 1.9 Allowed Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.421 1.486 . . . . 0.0 114.564 -177.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.64 -30.37 67.24 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.971 -0.723 . . . . 0.0 112.636 -178.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.28 -65.1 2.32 Favored Pre-proline 0 CA--C 1.539 0.542 0 O-C-N 121.257 -0.902 . . . . 0.0 112.501 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -59.27 -35.09 97.89 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.09 1.86 . . . . 0.0 111.276 178.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -51.75 -32.41 30.66 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.203 0.91 . . . . 0.0 112.131 177.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -115.08 17.84 16.58 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.097 0.559 . . . . 0.0 111.387 176.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 48.29 41.09 23.31 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.658 1.123 . . . . 0.0 111.887 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 53.2 mt -66.05 138.42 23.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-O 121.344 0.592 . . . . 0.0 110.623 -177.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -79.18 -42.37 26.24 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.211 1.404 . . . . 0.0 111.322 -176.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -171.36 -154.83 10.12 Favored Glycine 0 C--N 1.334 0.417 0 N-CA-C 108.17 -1.972 . . . . 0.0 108.17 -178.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.6 pt -146.13 156.6 50.61 Favored Pre-proline 0 CA--C 1.536 0.422 0 CA-C-N 118.19 0.995 . . . . 0.0 108.495 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -70.45 141.85 69.36 Favored 'Cis proline' 0 N--CA 1.456 -0.681 0 CA-C-N 120.156 1.091 . . . . 0.0 109.95 -1.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.4 m -139.06 122.33 17.04 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 mt -103.83 120.15 40.39 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.932 1.293 . . . . 0.0 109.318 -176.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.9 mp -110.5 121.89 46.39 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 175.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 tp -94.64 95.52 8.82 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -88.68 103.99 16.46 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.429 1.492 . . . . 0.0 110.713 -178.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -91.74 106.55 18.56 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 173.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 35.0 m120 49.29 51.19 16.77 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.664 0.786 . . . . 0.0 111.029 -178.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 79.81 -15.45 14.9 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-O 118.839 -0.978 . . . . 0.0 114.369 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -92.62 120.17 32.79 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.503 1.651 . . . . 0.0 109.668 179.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 88.5 t -64.45 106.75 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 175.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.97 -39.28 34.8 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.479 0.712 . . . . 0.0 109.356 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -159.83 171.37 19.59 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.6 m -150.32 149.41 30.07 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -178.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.5 mmtm -135.09 131.25 36.71 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 126.047 1.739 . . . . 0.0 107.648 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.2 t -113.33 125.12 70.54 Favored 'Isoleucine or valine' 0 C--O 1.231 0.1 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 178.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.13 179.06 33.0 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -177.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.6 170.99 15.09 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.065 0.546 . . . . 0.0 111.202 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.2 mt -143.55 154.61 43.78 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 125.138 1.375 . . . . 0.0 108.698 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.9 p -84.47 148.86 26.32 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 170.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -49.47 -47.84 48.15 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 122.143 -0.348 . . . . 0.0 111.728 -177.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.21 -53.09 42.87 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 111.889 -0.484 . . . . 0.0 111.889 179.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -61.37 -42.16 98.26 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.132 -0.628 . . . . 0.0 110.844 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 33.8 tp -60.15 -51.64 68.73 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 177.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -56.49 -44.34 80.55 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.638 -0.664 . . . . 0.0 111.169 177.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -55.87 -54.29 46.37 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.604 0.762 . . . . 0.0 109.685 177.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -53.28 -52.05 60.3 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.947 1.299 . . . . 0.0 110.444 178.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.0 mt -58.7 -50.61 73.26 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 122.647 0.379 . . . . 0.0 110.574 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -55.09 -50.53 68.94 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 178.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.84 -37.95 69.4 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.322 0.649 . . . . 0.0 111.784 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -77.97 -43.22 30.34 Favored 'General case' 0 C--N 1.339 0.125 0 O-C-N 122.129 -0.357 . . . . 0.0 110.708 -178.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 49.1 mt -61.42 -47.21 86.81 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.293 0 C-N-CA 123.094 0.557 . . . . 0.0 109.686 177.441 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.5 mt . . . . . 0 N--CA 1.463 0.178 0 CA-C-O 120.863 0.363 . . . . 0.0 110.45 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.5 mm -88.0 112.67 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 123.324 0.65 . . . . 0.0 109.488 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -83.52 106.43 15.25 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.75 -0.594 . . . . 0.0 109.662 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 43.0 mt -89.15 164.04 15.18 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.799 1.24 . . . . 0.0 111.14 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 35.0 p -136.78 167.16 21.97 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 175.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -58.33 -46.51 86.08 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 177.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -57.26 -46.79 82.71 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.976 0.911 . . . . 0.0 111.322 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.1 p -78.64 -25.63 45.03 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.932 -176.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -43.41 -46.81 6.81 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.59 1.556 . . . . 0.0 113.123 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -49.07 -65.69 0.53 Allowed 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 121.791 0.805 . . . . 0.0 110.48 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -71.37 -44.62 64.65 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.058 -174.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -73.14 -37.36 66.64 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -173.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.8 t -108.99 -60.42 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.058 0 C-N-CA 123.151 0.58 . . . . 0.0 110.706 -176.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 84.0 mt -63.73 -36.38 83.66 Favored 'General case' 0 C--N 1.334 -0.088 0 C-N-CA 120.029 -0.668 . . . . 0.0 112.597 -174.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -99.95 28.03 5.1 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.673 0.669 . . . . 0.0 110.148 176.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -74.84 172.53 12.04 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.959 0.885 . . . . 0.0 112.263 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -141.96 129.63 21.55 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 171.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.4 -172.0 27.21 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -175.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -98.15 120.43 38.54 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.064 1.346 . . . . 0.0 111.206 -177.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.7 mt -118.13 120.22 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 124.863 1.265 . . . . 0.0 109.01 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -93.42 107.77 19.55 Favored 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 176.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.1 t -98.38 109.4 23.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 123.503 0.721 . . . . 0.0 109.415 -178.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -93.59 108.8 20.46 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 123.669 0.788 . . . . 0.0 108.881 176.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -78.78 128.52 33.51 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 25.7 p-90 -145.43 173.7 11.77 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.623 0.769 . . . . 0.0 112.819 -176.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.51 144.37 22.74 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 125.593 1.557 . . . . 0.0 107.81 176.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -47.63 -51.09 22.59 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.533 1.133 . . . . 0.0 112.307 -177.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 62.2 p-90 -65.31 -23.76 67.1 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.819 0.847 . . . . 0.0 112.621 -178.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 35.3 t -79.91 72.83 6.68 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 121.482 -0.761 . . . . 0.0 111.481 -176.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -21.2 -64.17 0.02 OUTLIER Glycine 0 CA--C 1.537 1.462 0 C-N-CA 127.57 2.509 . . . . 0.0 116.043 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -48.55 -29.09 13.24 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 123.419 2.746 . . . . 0.0 114.443 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.8 m -59.26 -44.71 92.39 Favored 'General case' 0 N--CA 1.462 0.154 0 O-C-N 121.508 -0.745 . . . . 0.0 109.558 176.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -66.65 -36.24 82.08 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.562 0.745 . . . . 0.0 109.017 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 26.0 ttt -62.97 -46.34 88.16 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 119.614 -0.232 . . . . 0.0 110.48 177.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 38.3 pt -75.34 -28.02 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-O 118.417 -0.802 . . . . 0.0 112.363 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -37.11 -58.68 1.09 Allowed Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -58.05 -41.42 68.17 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.025 1.817 . . . . 0.0 111.4 177.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.0 mt -57.8 -51.16 73.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.6 mt -55.71 -41.36 73.7 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.108 0.563 . . . . 0.0 110.359 177.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -63.37 -45.95 88.77 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.226 0.921 . . . . 0.0 111.07 176.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -57.18 -50.56 72.46 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 25.8 mm -54.32 -50.18 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 C-N-CA 123.533 0.733 . . . . 0.0 109.303 176.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.16 -48.71 64.79 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 122.096 -0.377 . . . . 0.0 110.268 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -60.37 -55.23 36.13 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 122.448 0.299 . . . . 0.0 110.677 178.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -54.0 -44.96 71.34 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.093 0.957 . . . . 0.0 112.221 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -98.59 29.83 3.52 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.395 1.078 . . . . 0.0 111.943 -177.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -54.24 127.27 26.31 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.363 -0.836 . . . . 0.0 109.901 177.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.52 -13.62 16.02 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 119.234 -0.759 . . . . 0.0 113.188 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -99.61 -39.37 8.33 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 118.567 1.184 . . . . 0.0 109.994 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.9 tp -137.67 129.7 28.92 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 123.134 0.574 . . . . 0.0 110.272 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.8 m -89.83 101.57 14.27 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 175.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 91.8 t -79.83 130.19 36.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.81 154.43 51.2 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 123.673 0.789 . . . . 0.0 111.134 -177.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -127.49 143.78 51.15 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.306 1.442 . . . . 0.0 107.418 177.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.5 tt -132.32 115.01 15.08 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -80.23 104.35 10.73 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 122.38 0.272 . . . . 0.0 110.656 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.0 pt -70.23 -28.72 36.67 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.28 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -57.21 -45.95 83.33 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 119.103 0.865 . . . . 0.0 108.844 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.49 -38.41 59.53 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.221 0.608 . . . . 0.0 109.943 177.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -117.15 67.36 4.48 Favored Pre-proline 0 CA--C 1.534 0.335 0 C-N-CA 124.252 1.021 . . . . 0.0 112.173 -175.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -58.47 -47.8 17.88 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.476 2.117 . . . . 0.0 112.465 -176.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -40.49 -34.95 0.74 Allowed Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.863 1.696 . . . . 0.0 115.237 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 75.2 p -61.4 -38.72 88.09 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 117.795 0.798 . . . . 0.0 111.643 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.486 ' HB3' ' HD3' ' A' ' 68' ' ' PRO 0.284 . . -56.95 -62.76 4.52 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-O 118.071 -0.966 . . . . 0.0 111.571 -179.351 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.486 ' HD3' ' HB3' ' A' ' 67' ' ' ALA . 51.5 Cg_exo -49.07 -50.75 12.03 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.822 2.348 . . . . 0.0 111.525 173.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -51.88 -41.26 61.75 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -104.15 20.69 17.84 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 118.286 0.494 . . . . 0.0 111.75 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 44.79 42.03 7.51 Favored Glycine 0 C--N 1.341 0.844 0 C-N-CA 124.245 0.926 . . . . 0.0 111.624 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.7 mm -57.97 122.66 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-O 121.156 0.503 . . . . 0.0 110.091 -177.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 50.8 mmt-85 -79.7 -40.02 29.93 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.663 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -179.76 146.32 6.95 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 108.335 -1.906 . . . . 0.0 108.335 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.2 pt -93.67 153.43 41.16 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 123.876 0.87 . . . . 0.0 110.769 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.25 139.64 51.1 Favored 'Cis proline' 0 N--CA 1.458 -0.61 0 CA-C-N 119.614 0.898 . . . . 0.0 110.96 -1.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.8 112.98 16.01 Favored 'General case' 0 CA--C 1.523 -0.077 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.2 mt -94.81 122.05 37.03 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -114.61 117.97 32.37 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 177.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.5 tp -94.93 97.85 10.29 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -89.98 110.56 21.53 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.187 1.395 . . . . 0.0 111.288 -177.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -96.68 114.23 25.85 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 171.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.9 m120 47.24 48.66 15.97 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.011 0.524 . . . . 0.0 111.518 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 76.72 -6.8 37.42 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 118.737 -1.035 . . . . 0.0 115.083 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -102.03 126.32 48.94 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 119.575 1.687 . . . . 0.0 109.541 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 92.4 t -66.18 108.55 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.35 -41.07 28.69 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.947 0.899 . . . . 0.0 109.372 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -157.65 171.86 19.57 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.2 t -152.76 164.0 38.63 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -145.04 126.89 15.37 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.467 1.507 . . . . 0.0 107.398 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.2 t -101.58 122.89 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 174.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.49 175.54 32.67 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 -178.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.5 174.25 9.23 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.619 0.767 . . . . 0.0 111.733 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.1 mt -147.04 156.01 42.68 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.708 1.603 . . . . 0.0 107.962 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.9 p -87.09 154.8 20.46 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.357 -1.719 . . . . 0.0 106.357 171.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -49.58 -51.83 34.39 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 122.089 -0.382 . . . . 0.0 111.654 -177.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.05 -58.12 13.96 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -56.1 -41.29 75.0 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 122.411 -0.464 . . . . 0.0 110.927 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 37.2 tp -62.42 -49.37 75.76 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -55.24 -47.1 75.88 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.474 0.579 . . . . 0.0 110.356 177.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -57.11 -53.93 52.56 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.124 0.57 . . . . 0.0 110.397 178.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -52.65 -52.34 56.08 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.899 1.28 . . . . 0.0 110.857 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 76.0 mt -62.51 -50.87 69.66 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 122.176 -0.327 . . . . 0.0 110.305 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -53.57 -48.98 68.67 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.358 0.663 . . . . 0.0 110.771 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.56 -34.51 67.19 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.792 0.837 . . . . 0.0 111.607 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -78.94 -48.06 15.25 Favored 'General case' 0 C--O 1.228 -0.07 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 45.0 mt -58.39 -45.34 88.52 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.415 0.686 . . . . 0.0 110.827 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.172 0 C-N-CA 124.847 1.259 . . . . 0.0 111.711 179.135 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 15.7 mt . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.1 mm -87.4 104.76 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 177.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -79.44 80.6 5.8 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 177.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 77.6 mt -63.88 163.41 11.98 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.049 0.94 . . . . 0.0 113.208 -175.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 47.4 p -138.31 165.8 25.83 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 126.08 1.752 . . . . 0.0 106.506 174.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -55.23 -47.34 75.51 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.476 0.71 . . . . 0.0 110.932 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -63.72 -38.73 92.21 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.0 p -77.98 -32.5 51.35 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.03 0.377 . . . . 0.0 110.482 -177.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -36.61 -48.78 0.72 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.273 1.829 . . . . 0.0 113.364 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -49.36 -65.37 0.58 Allowed 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 121.961 0.886 . . . . 0.0 111.163 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.3 m -72.29 -45.21 61.0 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.569 -174.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -76.2 -21.83 55.99 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -174.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 45.9 t -120.77 -62.86 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.094 0 CA-C-N 119.548 1.067 . . . . 0.0 109.947 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 72.1 mt -58.81 -37.32 76.11 Favored 'General case' 0 CA--C 1.528 0.098 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -174.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -95.72 14.42 23.21 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 118.587 0.63 . . . . 0.0 111.924 177.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.38 103.36 16.01 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 119.073 0.852 . . . . 0.0 112.367 -178.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -76.31 72.67 3.08 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 174.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -174.63 179.39 45.97 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.95 118.76 32.34 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.489 1.516 . . . . 0.0 109.987 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.6 mt -127.57 115.97 41.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 124.796 1.239 . . . . 0.0 110.73 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 35.0 tp -83.53 96.41 8.6 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 174.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.4 t -86.51 105.85 15.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 122.999 0.519 . . . . 0.0 109.872 -179.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -91.35 112.42 24.33 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 176.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -85.05 120.82 26.99 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 173.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 21.9 p-90 -138.88 177.66 7.73 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.983 0.913 . . . . 0.0 112.351 -174.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -150.94 150.16 30.5 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.472 1.509 . . . . 0.0 107.716 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -62.84 -50.3 71.51 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.852 0.358 . . . . 0.0 111.308 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 63.9 p-90 -62.25 -26.25 68.28 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.489 0.716 . . . . 0.0 112.743 -178.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.6 t -79.16 77.68 5.65 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 121.554 -0.716 . . . . 0.0 109.829 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -22.15 -63.12 0.03 OUTLIER Glycine 0 CA--C 1.534 1.276 0 C-N-CA 127.661 2.553 . . . . 0.0 115.198 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -42.58 -36.0 4.4 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 124.503 3.469 . . . . 0.0 114.525 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 80.5 m -53.92 -46.06 71.36 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 121.508 0.67 . . . . 0.0 109.956 176.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.91 -24.47 63.38 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.348 0.659 . . . . 0.0 110.967 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 23.1 mmt -74.2 -43.92 55.33 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 30.4 pt -75.2 -27.23 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 118.905 -0.569 . . . . 0.0 111.694 177.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -36.6 -60.06 0.8 Allowed Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -56.89 -40.6 83.0 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.224 1.949 . . . . 0.0 111.918 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.0 mt -58.79 -50.72 78.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.7 mt -56.12 -43.77 78.5 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.592 0.357 . . . . 0.0 110.201 177.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -58.5 -49.59 76.82 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.255 0.55 . . . . 0.0 109.794 178.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -56.13 -52.07 65.68 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 31.7 mm -54.04 -50.01 56.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 123.066 0.547 . . . . 0.0 109.869 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.24 -46.47 65.73 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.219 0.608 . . . . 0.0 110.603 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -66.13 -56.91 9.1 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 178.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -47.25 -49.89 22.47 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.711 1.204 . . . . 0.0 112.329 -178.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -99.69 26.19 6.45 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.149 0.58 . . . . 0.0 111.705 -178.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.54 111.85 0.99 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.253 0.933 . . . . 0.0 111.022 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.35 -15.84 61.61 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.01 0.814 . . . . 0.0 112.243 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -99.52 -39.17 8.46 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.943 1.297 . . . . 0.0 109.158 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 46.9 tp -140.2 130.64 25.39 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 178.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 91.0 m -91.09 145.92 24.28 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 105.836 -1.912 . . . . 0.0 105.836 174.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 94.9 t -120.54 141.28 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 177.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.86 148.82 50.22 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.127 0.571 . . . . 0.0 109.889 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -127.33 96.57 4.61 Favored 'General case' 0 C--O 1.23 0.066 0 C-N-CA 124.906 1.283 . . . . 0.0 108.91 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 tt -96.7 109.4 22.05 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -176.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -80.45 108.61 14.22 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.934 -178.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.7 pt -64.46 -25.31 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-O 119.1 -0.476 . . . . 0.0 111.644 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -53.65 -25.72 19.19 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.825 0.739 . . . . 0.0 111.966 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -119.01 3.03 11.52 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.015 0.926 . . . . 0.0 110.89 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -147.23 62.75 7.5 Favored Pre-proline 0 CA--C 1.529 0.137 0 C-N-CA 124.614 1.166 . . . . 0.0 109.523 -177.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -61.82 -52.07 3.31 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 121.776 1.651 . . . . 0.0 111.285 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -40.83 -43.11 3.05 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.529 1.538 . . . . 0.0 114.918 -177.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.31 -31.12 67.22 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 117.808 0.804 . . . . 0.0 111.788 -178.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.36 -67.24 0.92 Allowed Pre-proline 0 CA--C 1.539 0.529 0 CA-C-O 118.276 -0.869 . . . . 0.0 112.619 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -60.0 -38.47 78.05 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 121.72 1.613 . . . . 0.0 110.882 178.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -52.25 -38.56 58.5 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 118.874 0.761 . . . . 0.0 111.484 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -106.67 19.77 20.0 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.657 0.383 . . . . 0.0 111.999 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.23 38.05 55.97 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.111 0.862 . . . . 0.0 113.528 176.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.38 129.23 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -89.79 -48.84 6.99 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.45 1.1 . . . . 0.0 110.095 -178.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -162.14 146.5 12.09 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 107.285 -2.326 . . . . 0.0 107.285 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.3 pt -98.55 149.14 35.44 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 123.461 0.704 . . . . 0.0 110.048 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.17 139.47 53.05 Favored 'Cis proline' 0 N--CA 1.455 -0.772 0 CA-C-N 119.873 0.99 . . . . 0.0 111.094 -0.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.77 139.49 52.23 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 176.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.6 mt -118.46 106.07 12.32 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.0 mp -100.16 113.23 25.73 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 176.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.9 tp -90.23 101.8 14.52 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -86.53 143.2 27.83 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.556 1.143 . . . . 0.0 109.166 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -140.96 110.42 6.33 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 175.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.1 t30 55.73 67.93 0.94 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 121.438 0.637 . . . . 0.0 110.337 -177.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.31 -31.76 0.26 Allowed Glycine 0 CA--C 1.533 1.187 0 N-CA-C 117.04 1.576 . . . . 0.0 117.04 176.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -97.71 155.03 17.2 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 119.5 1.65 . . . . 0.0 111.224 -177.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 93.3 t -76.19 118.31 22.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.93 -47.13 15.53 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 123.662 0.785 . . . . 0.0 109.177 177.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -156.77 171.9 19.57 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 123.944 0.898 . . . . 0.0 108.689 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 90.8 m -149.96 148.86 29.59 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 122.01 -0.431 . . . . 0.0 110.111 -178.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -130.59 151.14 51.38 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 126.314 1.846 . . . . 0.0 107.62 177.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.2 t -129.96 131.64 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -178.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.95 -178.58 45.2 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 111.439 -0.665 . . . . 0.0 111.439 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.75 165.72 24.28 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.836 0.454 . . . . 0.0 110.894 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.5 mt -145.05 151.41 38.5 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.662 1.185 . . . . 0.0 108.533 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.4 p -84.52 149.42 25.93 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 172.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -51.71 -45.04 63.42 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-O 119.481 -0.295 . . . . 0.0 111.648 -177.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.92 -55.34 29.58 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 118.343 0.52 . . . . 0.0 111.844 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -56.81 -47.67 79.73 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 122.048 -0.678 . . . . 0.0 110.077 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 48.4 tp -56.77 -51.59 68.3 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 119.539 -0.267 . . . . 0.0 110.489 178.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.1 mmmp? -51.93 -49.45 63.08 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.279 0.631 . . . . 0.0 110.336 177.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -58.87 -50.37 74.27 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 110.558 -0.164 . . . . 0.0 110.558 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -53.9 -53.01 58.58 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.546 0.739 . . . . 0.0 110.865 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.8 mt -59.97 -49.95 75.68 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 122.726 0.41 . . . . 0.0 110.377 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -54.74 -50.73 67.66 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 117.844 0.293 . . . . 0.0 110.353 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.75 -36.92 70.32 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.577 0.751 . . . . 0.0 111.696 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -77.7 -42.98 32.55 Favored 'General case' 0 C--O 1.227 -0.082 0 O-C-N 122.205 -0.309 . . . . 0.0 110.367 -178.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 47.3 mt -61.75 -47.37 85.52 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.29 0 C-N-CA 123.208 0.603 . . . . 0.0 109.644 177.518 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.2 mt . . . . . 0 N--CA 1.45 -0.475 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.5 mm -90.97 111.41 23.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 124.419 1.088 . . . . 0.0 109.387 178.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -82.37 101.44 10.6 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 67.1 mt -85.09 162.9 19.11 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.697 0.799 . . . . 0.0 111.849 -177.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 48.0 p -137.64 165.67 25.79 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 126.042 1.737 . . . . 0.0 106.406 175.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -56.58 -44.02 80.63 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.853 -0.529 . . . . 0.0 110.216 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -59.28 -44.16 92.49 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.025 0.93 . . . . 0.0 112.192 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.1 p -78.79 -30.94 45.79 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 122.107 -0.371 . . . . 0.0 111.003 -177.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -36.36 -56.48 0.78 Allowed 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 126.37 1.868 . . . . 0.0 114.092 -178.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -54.29 -57.59 10.64 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 121.822 -0.549 . . . . 0.0 110.953 -177.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.3 m -62.02 -47.62 83.97 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.708 0.803 . . . . 0.0 112.446 -177.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.16 -50.68 13.92 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -175.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.4 t -90.97 -57.05 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 124.048 0.939 . . . . 0.0 112.533 -173.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 72.2 mt -66.76 -41.06 88.38 Favored 'General case' 0 CA--C 1.523 -0.074 0 C-N-CA 119.564 -0.854 . . . . 0.0 110.918 -174.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -93.0 30.67 1.56 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 122.64 0.376 . . . . 0.0 110.041 176.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.0 156.66 36.82 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.766 -0.584 . . . . 0.0 110.826 177.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -131.69 55.18 1.88 Allowed 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 124.699 1.2 . . . . 0.0 108.109 176.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 164.5 -173.01 40.41 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.506 -1.037 . . . . 0.0 110.506 -178.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.95 113.65 23.81 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.543 1.537 . . . . 0.0 109.947 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.5 mt -113.52 117.46 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 124.258 1.023 . . . . 0.0 109.479 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.7 tp -89.72 96.32 10.64 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 177.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.7 t -89.32 109.35 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 123.427 0.691 . . . . 0.0 109.629 -179.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -93.58 105.36 17.41 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -79.18 123.95 27.88 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 175.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 24.5 p-90 -138.93 172.69 12.49 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 124.292 1.037 . . . . 0.0 111.943 -175.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.99 147.79 32.05 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.297 1.039 . . . . 0.0 108.651 175.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -54.61 -52.23 62.84 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.904 0.882 . . . . 0.0 111.78 -178.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 61.4 p-90 -67.25 -21.58 65.71 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.958 0.903 . . . . 0.0 112.747 -178.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 46.0 t -79.58 70.0 5.98 Favored 'General case' 0 N--CA 1.456 -0.144 0 O-C-N 121.38 -0.825 . . . . 0.0 110.935 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -16.14 -65.59 0.01 OUTLIER Glycine 0 CA--C 1.534 1.266 0 C-N-CA 128.253 2.835 . . . . 0.0 115.903 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -42.95 -32.38 2.65 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 124.532 3.488 . . . . 0.0 115.036 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 99.6 m -53.9 -44.73 70.76 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.221 0.608 . . . . 0.0 110.121 176.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -67.33 -26.6 66.58 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.323 0.649 . . . . 0.0 111.13 178.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 23.3 mmt -74.54 -43.68 54.64 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 19.6 pt -74.95 -28.95 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 119.006 -0.521 . . . . 0.0 111.922 178.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -38.67 -59.45 1.34 Allowed Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -56.6 -40.08 86.91 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.158 1.905 . . . . 0.0 111.441 177.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 16.3 mt -58.85 -48.82 85.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 74.7 mt -57.25 -43.67 83.16 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 119.415 -0.326 . . . . 0.0 110.352 177.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -60.02 -48.09 83.13 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.839 0.745 . . . . 0.0 110.446 177.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -57.01 -52.16 66.38 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.2 mm -55.44 -45.06 78.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 124.102 0.961 . . . . 0.0 110.017 178.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.51 -41.71 73.47 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 123.048 0.539 . . . . 0.0 110.05 178.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -67.67 -55.13 14.44 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 176.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -48.06 -48.99 33.02 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.903 0.881 . . . . 0.0 112.068 -178.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -103.2 28.87 5.95 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.654 0.782 . . . . 0.0 111.594 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -55.37 126.53 25.43 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.152 0.887 . . . . 0.0 111.212 -178.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.36 -13.13 29.16 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 119.237 -0.757 . . . . 0.0 113.21 -178.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -99.8 -43.93 6.26 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.455 1.127 . . . . 0.0 109.357 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.9 tp -125.4 125.5 43.5 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.755 1.222 . . . . 0.0 108.025 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 60.4 m -87.59 101.84 14.02 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 176.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.6 t -79.39 131.74 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.66 151.65 48.49 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 122.635 0.374 . . . . 0.0 110.096 -178.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -128.69 135.43 49.24 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 tt -124.54 113.62 18.33 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.645 0.778 . . . . 0.0 109.223 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -79.39 108.89 13.25 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.1 pt -70.74 -22.59 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -58.16 -48.47 80.17 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.221 0.919 . . . . 0.0 109.092 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -79.88 -31.76 40.34 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.914 0.885 . . . . 0.0 110.367 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -119.26 67.11 8.97 Favored Pre-proline 0 N--CA 1.463 0.219 0 C-N-CA 123.482 0.713 . . . . 0.0 112.082 -176.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.1 -47.04 8.94 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 121.877 1.718 . . . . 0.0 110.966 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -41.2 -41.0 2.7 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.756 1.646 . . . . 0.0 115.038 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.77 -27.08 68.65 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.158 0.979 . . . . 0.0 112.639 -178.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.8 -63.0 4.63 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 118.347 -0.835 . . . . 0.0 113.053 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -60.56 -37.03 83.27 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.151 1.901 . . . . 0.0 111.464 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -51.99 -31.43 29.35 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.813 0.733 . . . . 0.0 112.003 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -118.56 19.34 13.31 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.25 0.62 . . . . 0.0 111.658 177.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 47.35 43.59 19.9 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.46 1.029 . . . . 0.0 113.308 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.6 mp -53.49 117.66 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 117.908 0.854 . . . . 0.0 109.181 177.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 29.3 mmm180 -79.8 -45.48 18.7 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.238 1.015 . . . . 0.0 110.807 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -164.17 147.25 12.5 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 107.819 -2.112 . . . . 0.0 107.819 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.6 pt -100.27 152.82 37.94 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 123.913 0.885 . . . . 0.0 110.101 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -68.66 142.18 66.06 Favored 'Cis proline' 0 N--CA 1.456 -0.697 0 CA-C-N 119.519 0.864 . . . . 0.0 110.454 -1.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.37 109.82 15.35 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.3 mt -89.53 93.08 9.36 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.925 0.89 . . . . 0.0 109.781 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.2 mp -91.28 115.84 28.35 Favored 'General case' 0 CA--C 1.522 -0.105 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.3 tp -92.6 96.0 9.94 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -87.51 104.5 16.53 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.026 1.33 . . . . 0.0 110.226 -178.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -93.42 108.48 20.14 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 174.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 49.95 50.48 18.4 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.707 0.803 . . . . 0.0 110.626 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 79.75 -14.19 20.12 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 118.879 -0.956 . . . . 0.0 114.565 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -94.82 121.34 36.31 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 119.591 1.695 . . . . 0.0 110.141 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 98.3 t -64.15 104.86 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 175.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.31 -38.03 36.26 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.862 0.865 . . . . 0.0 109.813 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -155.44 166.17 34.37 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.71 0.804 . . . . 0.0 108.899 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 69.7 m -147.79 117.96 7.31 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.629 0.772 . . . . 0.0 108.986 -178.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -104.74 112.5 25.63 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.2 t -90.32 124.15 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 177.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.65 168.44 36.79 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 123.804 0.716 . . . . 0.0 112.249 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.62 166.23 19.49 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.082 0.553 . . . . 0.0 110.244 179.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -155.63 170.69 21.43 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.695 0.798 . . . . 0.0 109.863 -177.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 80.9 p -86.18 162.81 18.16 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 177.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.01 -39.01 80.57 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 175.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -57.06 -56.36 25.44 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 177.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -54.22 -46.56 72.54 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.942 0.371 . . . . 0.0 110.225 178.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 22.8 tp -59.06 -50.25 74.79 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 121.283 -0.167 . . . . 0.0 110.765 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.9 mmmm -54.53 -48.84 71.5 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.723 -0.611 . . . . 0.0 111.338 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -65.95 -43.5 87.78 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 119.584 -0.846 . . . . 0.0 111.022 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -53.24 -52.24 59.59 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.158 0.583 . . . . 0.0 109.497 177.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.8 mt -58.73 -55.19 38.27 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 122.743 0.417 . . . . 0.0 110.3 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -51.24 -50.53 59.02 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.04 0.382 . . . . 0.0 111.13 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.14 -38.45 70.84 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.397 0.679 . . . . 0.0 111.807 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -78.5 -43.48 26.83 Favored 'General case' 0 C--O 1.228 -0.048 0 O-C-N 122.199 -0.313 . . . . 0.0 111.049 -178.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 69.5 mt -63.58 -45.63 89.53 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.2 0 C-N-CA 122.909 0.483 . . . . 0.0 109.832 177.745 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 16.6 mt . . . . . 0 N--CA 1.455 -0.2 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.2 mm -90.31 114.43 27.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.433 1.093 . . . . 0.0 109.297 177.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -84.54 104.82 14.86 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.3 mt -87.84 163.79 16.23 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.598 1.159 . . . . 0.0 111.679 -178.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 61.3 p -138.48 165.19 27.46 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 126.257 1.823 . . . . 0.0 106.385 174.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -55.13 -44.69 75.28 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.128 0.571 . . . . 0.0 110.104 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -59.82 -43.83 94.32 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.867 0.867 . . . . 0.0 112.383 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.8 p -78.75 -30.47 45.75 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 122.152 -0.342 . . . . 0.0 111.22 -177.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -36.76 -54.77 0.9 Allowed 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 126.407 1.883 . . . . 0.0 114.017 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -54.07 -57.66 10.23 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.265 0.555 . . . . 0.0 111.132 -178.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.4 m -63.79 -48.07 78.37 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.385 0.674 . . . . 0.0 112.059 -177.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.59 -52.26 12.27 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -175.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.7 t -89.63 -56.22 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 123.891 0.876 . . . . 0.0 112.203 -174.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 66.6 mt -66.15 -42.7 88.7 Favored 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 119.489 -0.884 . . . . 0.0 111.168 -175.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -91.98 31.72 1.22 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 118.045 0.384 . . . . 0.0 110.18 175.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.68 143.67 57.14 Favored 'General case' 0 C--N 1.341 0.208 0 O-C-N 121.538 -0.726 . . . . 0.0 112.172 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -108.7 54.33 0.66 Allowed 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.495 1.118 . . . . 0.0 108.769 176.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 150.46 -160.47 28.58 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 123.759 0.695 . . . . 0.0 111.566 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.51 122.45 34.1 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 126.103 1.761 . . . . 0.0 110.356 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.5 mt -122.62 122.39 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 124.732 1.213 . . . . 0.0 109.18 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.418 HD13 ' C ' ' A' ' 24' ' ' LEU . 2.9 tm? -93.47 106.87 18.8 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 175.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 42.6 t -97.46 110.33 25.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -92.15 103.58 16.05 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 176.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -78.92 118.05 20.57 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 104.046 -2.576 . . . . 0.0 104.046 175.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 34.5 p-90 -130.66 168.71 16.69 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 124.545 1.138 . . . . 0.0 111.933 -175.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -141.49 143.05 33.61 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.087 1.355 . . . . 0.0 108.304 176.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -58.3 -49.13 78.24 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.261 1.024 . . . . 0.0 112.171 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.469 ' CH2' HD11 ' A' ' 75' ' ' ILE . 50.9 p-90 -63.96 -28.11 69.6 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.519 0.728 . . . . 0.0 112.358 -178.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.6 t -79.59 79.18 6.09 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 121.556 -0.715 . . . . 0.0 110.643 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -24.17 -62.88 0.05 OUTLIER Glycine 0 CA--C 1.535 1.324 0 C-N-CA 127.074 2.273 . . . . 0.0 114.44 178.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -40.46 -33.71 1.0 Allowed 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 125.035 3.823 . . . . 0.0 115.503 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 99.8 m -53.67 -43.04 68.54 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.589 0.709 . . . . 0.0 109.995 177.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -69.05 -26.89 65.19 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.411 1.084 . . . . 0.0 110.973 178.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -75.58 -43.15 49.78 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 33.7 pt -72.79 -29.85 31.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.607 177.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -37.81 -60.46 0.94 Allowed Pre-proline 0 CA--C 1.545 0.769 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -56.32 -39.35 91.88 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.363 2.042 . . . . 0.0 111.938 177.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 21.0 mt -59.61 -52.69 57.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 177.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 60.8 mt -55.12 -40.58 70.66 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.961 0.504 . . . . 0.0 110.363 177.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -61.26 -47.8 84.38 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.243 0.928 . . . . 0.0 110.023 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -56.8 -52.35 65.4 Favored 'General case' 0 C--N 1.34 0.18 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.0 mm -53.28 -49.08 54.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 123.37 0.668 . . . . 0.0 109.538 177.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.47 -43.4 68.13 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.506 0.722 . . . . 0.0 110.76 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -69.31 -55.66 9.79 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.71 0.29 . . . . 0.0 110.638 177.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -50.53 -47.66 57.43 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.57 1.148 . . . . 0.0 112.322 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -99.81 24.36 8.5 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.264 1.026 . . . . 0.0 110.795 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -55.39 124.18 16.3 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.516 -0.74 . . . . 0.0 110.122 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.34 -14.24 46.57 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 119.454 -0.637 . . . . 0.0 112.907 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -99.74 -42.27 6.92 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.371 1.069 . . . . 0.0 109.3 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.1 tp -133.01 125.35 29.5 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.726 1.211 . . . . 0.0 108.168 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 56.2 m -85.41 101.84 12.94 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 176.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 85.1 t -79.31 133.62 29.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -138.16 154.04 49.18 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.126 0.57 . . . . 0.0 110.417 -177.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -126.44 137.38 53.4 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.6 tt -127.28 115.15 18.59 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -78.66 104.54 9.34 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 pp -68.54 -29.11 42.82 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.19 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -56.86 -45.18 82.62 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 118.437 0.562 . . . . 0.0 109.752 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -81.48 -31.43 32.94 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.929 0.892 . . . . 0.0 110.395 177.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -119.83 68.91 12.51 Favored Pre-proline 0 C--O 1.235 0.326 0 C-N-CA 123.663 0.785 . . . . 0.0 111.557 -177.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -61.39 -52.64 3.03 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.463 2.109 . . . . 0.0 112.586 -177.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -38.28 -45.43 1.79 Allowed Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.538 1.542 . . . . 0.0 114.556 -177.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.45 -33.91 46.45 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.89 0.876 . . . . 0.0 112.964 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.55 -67.67 0.89 Allowed Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 118.136 -0.935 . . . . 0.0 112.184 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -59.42 -37.18 91.38 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.77 1.646 . . . . 0.0 111.218 177.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -51.35 -38.38 52.89 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.291 0.951 . . . . 0.0 111.778 178.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -110.83 22.53 15.25 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.895 0.478 . . . . 0.0 111.574 178.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 42.9 43.06 5.23 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 126.085 1.802 . . . . 0.0 112.976 178.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.3 mp -43.95 131.98 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 123.69 0.796 . . . . 0.0 112.137 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.15 -51.7 9.84 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.472 1.109 . . . . 0.0 109.218 -177.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -179.53 135.16 2.44 Favored Glycine 0 C--N 1.333 0.409 0 N-CA-C 107.228 -2.349 . . . . 0.0 107.228 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.469 HD11 ' CH2' ' A' ' 31' ' ' TRP . 2.0 pp -79.98 145.37 61.18 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 117.251 0.525 . . . . 0.0 111.511 -176.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.81 135.1 32.25 Favored 'Cis proline' 0 N--CA 1.456 -0.69 0 CA-C-N 119.744 0.944 . . . . 0.0 111.512 -0.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.5 m -123.23 117.51 25.48 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.6 mt -95.64 122.25 38.21 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -114.17 119.58 37.57 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 177.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.15 98.24 10.49 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -90.26 107.67 19.29 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.374 1.47 . . . . 0.0 110.786 -178.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -96.66 108.63 21.28 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 173.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 35.8 m120 48.43 51.59 14.99 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.75 0.82 . . . . 0.0 111.339 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.51 -13.97 14.51 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 118.851 -0.972 . . . . 0.0 114.64 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -94.71 122.59 37.48 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 119.563 1.682 . . . . 0.0 109.557 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 98.9 t -65.53 108.95 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 175.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.93 -39.52 34.5 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -163.16 173.9 12.85 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.5 t -149.73 159.39 44.39 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.7 mmtp -138.79 151.9 47.45 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.534 1.934 . . . . 0.0 107.271 177.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.9 t -129.08 135.22 62.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 124.722 1.209 . . . . 0.0 107.906 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.47 -171.12 51.23 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 112.077 -0.409 . . . . 0.0 112.077 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.63 163.31 27.86 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.051 0.541 . . . . 0.0 111.357 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.7 mt -146.25 154.62 41.92 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.303 1.441 . . . . 0.0 107.823 178.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.1 p -84.98 150.83 24.64 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 172.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -48.95 -49.32 40.93 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.063 0.545 . . . . 0.0 110.768 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.35 -59.13 10.55 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 112.108 -0.397 . . . . 0.0 112.108 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -55.32 -45.15 76.34 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 117.527 0.664 . . . . 0.0 111.077 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.2 tp -59.51 -50.21 74.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 177.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -55.33 -46.35 76.36 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.613 0.642 . . . . 0.0 111.222 177.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -57.11 -52.55 64.83 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.111 0.565 . . . . 0.0 109.769 178.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -53.81 -53.79 47.45 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.053 0.941 . . . . 0.0 110.781 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 88.3 mt -59.2 -49.76 76.63 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.256 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -54.71 -50.52 68.11 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 122.807 0.443 . . . . 0.0 110.489 178.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.3 -36.18 68.37 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.518 0.727 . . . . 0.0 111.651 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -78.04 -44.15 27.27 Favored 'General case' 0 N--CA 1.46 0.068 0 O-C-N 122.157 -0.339 . . . . 0.0 110.162 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 40.4 mt -59.51 -45.73 90.89 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.2 0 C-N-CA 123.183 0.593 . . . . 0.0 109.812 177.727 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 13.4 mt . . . . . 0 N--CA 1.452 -0.331 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 25.7 mm -91.36 116.72 33.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 177.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -82.92 113.29 20.42 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.3 mt -96.18 164.0 12.86 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.896 0.878 . . . . 0.0 112.148 -177.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 32.4 p -135.81 166.34 23.52 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 171.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -59.13 -47.8 83.96 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.446 0.566 . . . . 0.0 109.556 178.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -60.9 -44.56 96.97 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.663 0.785 . . . . 0.0 111.535 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 82.5 p -79.21 -24.41 43.15 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -176.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -34.21 -59.68 0.43 Allowed 'General case' 0 C--N 1.339 0.124 0 C-N-CA 126.598 1.959 . . . . 0.0 113.836 -178.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -51.69 -59.23 4.52 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.288 0.635 . . . . 0.0 110.82 -177.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 m -60.09 -43.69 95.36 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 123.248 0.619 . . . . 0.0 111.732 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -72.69 -36.7 67.92 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -174.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.4 t -112.88 -60.3 2.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 123.807 0.843 . . . . 0.0 111.205 -173.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.5 mt -61.37 -35.9 78.74 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-O 119.257 -0.402 . . . . 0.0 111.736 -175.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -92.22 10.47 29.4 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.368 0.531 . . . . 0.0 112.071 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.67 103.39 15.07 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 119.081 0.855 . . . . 0.0 109.965 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -74.31 65.38 1.2 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.524 0.73 . . . . 0.0 110.592 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -166.01 177.84 40.92 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.03 107.19 18.32 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.994 1.318 . . . . 0.0 111.059 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 mt -113.42 114.14 46.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 124.523 1.129 . . . . 0.0 110.78 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.4 tp -84.05 98.94 10.13 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 107.005 -1.479 . . . . 0.0 107.005 174.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.0 t -87.58 118.74 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 123.125 0.57 . . . . 0.0 109.54 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -102.63 108.19 19.37 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.52 1.128 . . . . 0.0 108.951 177.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -81.29 119.18 23.32 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 175.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 37.4 p-90 -135.28 171.97 13.68 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 124.154 0.981 . . . . 0.0 113.196 -174.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.11 132.05 17.15 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 125.736 1.614 . . . . 0.0 108.036 175.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.3 pm0 -49.42 -39.29 32.22 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -178.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 61.4 p-90 -77.26 -19.95 55.83 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 43.8 t -79.53 76.21 6.15 Favored 'General case' 0 N--CA 1.456 -0.162 0 O-C-N 121.409 -0.807 . . . . 0.0 110.411 -176.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -12.58 -69.75 0.01 OUTLIER Glycine 0 CA--C 1.536 1.39 0 C-N-CA 127.752 2.596 . . . . 0.0 115.565 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -41.63 -38.78 4.43 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 124.683 3.588 . . . . 0.0 114.766 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 87.7 m -50.86 -47.37 60.36 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.331 1.052 . . . . 0.0 110.584 177.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt -70.57 -28.67 65.06 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.582 0.753 . . . . 0.0 110.621 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 84.7 mmm -71.45 -43.29 66.96 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 177.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.3 pt -76.82 -27.91 16.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 CA-C-O 118.536 -0.745 . . . . 0.0 112.102 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -38.07 -59.21 1.25 Allowed Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -56.92 -41.15 78.4 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.208 1.939 . . . . 0.0 111.911 177.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 27.6 mt -58.27 -52.04 63.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 68.6 mt -56.68 -44.04 81.07 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.432 0.693 . . . . 0.0 110.494 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -58.43 -48.46 80.63 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.737 0.415 . . . . 0.0 110.281 178.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -60.7 -52.25 65.9 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.9 mm -50.79 -47.14 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.267 1.027 . . . . 0.0 110.402 177.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.48 -37.35 65.15 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.323 0.649 . . . . 0.0 110.848 178.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -75.04 -55.44 5.74 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 176.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -45.56 -51.4 11.99 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 125.37 1.468 . . . . 0.0 112.28 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -101.26 23.11 11.4 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.96 0.504 . . . . 0.0 111.637 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -55.35 130.26 41.76 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 119.455 1.025 . . . . 0.0 110.643 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.75 -19.68 23.56 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 119.466 -0.63 . . . . 0.0 112.625 -178.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -99.4 -41.24 7.5 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.261 1.024 . . . . 0.0 108.829 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.0 tp -133.29 143.88 49.34 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.243 1.817 . . . . 0.0 107.217 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 94.5 m -107.16 140.27 40.28 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 105.314 -2.106 . . . . 0.0 105.314 173.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.1 t -112.82 140.51 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 178.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.38 149.41 46.95 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -178.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -126.26 131.43 51.91 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.261 1.024 . . . . 0.0 108.255 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 tt -122.79 116.24 23.37 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.739 0.816 . . . . 0.0 109.653 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -80.06 107.62 12.99 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 pp -66.83 -30.89 51.13 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -177.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -60.08 -49.46 77.56 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 119.03 0.832 . . . . 0.0 109.295 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -69.89 -36.09 75.16 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.006 177.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -121.25 70.78 22.44 Favored Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 123.907 0.883 . . . . 0.0 112.049 -175.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.94 -52.36 2.25 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.543 2.162 . . . . 0.0 112.616 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -39.03 -44.31 1.98 Allowed Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.438 1.494 . . . . 0.0 114.276 -177.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -53.13 -32.92 50.01 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.813 0.845 . . . . 0.0 112.874 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.78 -68.27 0.76 Allowed Pre-proline 0 CA--C 1.538 0.513 0 CA-C-O 118.072 -0.966 . . . . 0.0 111.662 178.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -59.38 -36.86 93.11 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 121.55 1.5 . . . . 0.0 111.45 177.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -51.58 -40.56 60.01 Favored 'General case' 0 C--N 1.345 0.398 0 CA-C-N 119.558 1.072 . . . . 0.0 111.601 178.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -107.7 21.7 17.06 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 122.704 0.402 . . . . 0.0 111.275 178.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 43.88 43.5 6.82 Favored Glycine 0 C--N 1.338 0.684 0 C-N-CA 125.798 1.666 . . . . 0.0 113.034 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.3 mp -49.02 129.5 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 117.975 0.887 . . . . 0.0 110.839 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.73 -53.86 6.7 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.045 0.938 . . . . 0.0 108.924 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -168.87 150.12 15.15 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 107.062 -2.415 . . . . 0.0 107.062 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 23.8 pt -91.47 149.18 39.02 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-N 117.701 0.75 . . . . 0.0 110.373 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -70.88 137.69 47.89 Favored 'Cis proline' 0 N--CA 1.456 -0.684 0 CA-C-N 119.644 0.908 . . . . 0.0 110.416 -1.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.95 116.69 27.43 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 20.8 mt -98.29 120.83 39.37 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.5 mp -121.08 118.91 30.95 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 177.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.3 tp -93.35 96.11 9.74 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -84.97 101.86 12.71 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.665 1.186 . . . . 0.0 110.002 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -93.45 114.53 26.95 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 173.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 55.89 39.31 30.64 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.8 0.84 . . . . 0.0 110.979 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.51 -0.6 75.26 Favored Glycine 0 CA--C 1.532 1.121 0 CA-C-O 118.758 -1.024 . . . . 0.0 113.738 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -108.24 126.68 53.08 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.346 1.573 . . . . 0.0 109.354 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.7 t -63.57 106.36 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.08 -40.82 30.21 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.026 0.931 . . . . 0.0 109.535 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -156.78 169.46 24.69 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.9 t -151.84 159.63 43.81 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -146.75 131.41 17.87 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.6 t -102.36 125.58 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.26 170.92 38.04 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.21 166.1 16.98 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.685 0.794 . . . . 0.0 112.875 -177.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.0 mt -138.93 153.52 48.24 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 126.228 1.811 . . . . 0.0 107.513 177.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.1 p -84.09 155.54 22.61 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.514 -1.662 . . . . 0.0 106.514 171.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -50.31 -51.36 45.93 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 122.126 -0.359 . . . . 0.0 111.084 -178.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -53.64 -58.45 12.28 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 111.913 -0.475 . . . . 0.0 111.913 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -56.2 -42.34 77.01 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 122.232 -0.569 . . . . 0.0 110.856 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 30.9 tp -62.55 -48.49 79.28 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -54.78 -47.84 73.43 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.558 0.617 . . . . 0.0 110.125 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -57.51 -53.84 53.56 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.541 0.737 . . . . 0.0 110.397 178.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -52.19 -50.16 62.43 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.63 1.172 . . . . 0.0 110.174 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 87.2 mt -60.52 -52.29 65.81 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 119.184 -0.436 . . . . 0.0 110.329 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -52.8 -49.4 65.71 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 118.197 0.453 . . . . 0.0 110.459 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.66 -37.5 70.88 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.546 0.738 . . . . 0.0 111.658 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -78.07 -44.24 26.86 Favored 'General case' 0 N--CA 1.462 0.135 0 O-C-N 122.083 -0.385 . . . . 0.0 110.439 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 53.8 mt -59.05 -48.18 82.53 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.276 0 C-N-CA 123.259 0.623 . . . . 0.0 109.607 177.465 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.4 mt . . . . . 0 N--CA 1.449 -0.511 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.8 mm -87.1 106.9 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -82.2 105.67 13.48 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.9 mt -88.24 166.35 14.4 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.854 1.662 . . . . 0.0 112.161 -177.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 44.0 p -137.33 165.72 25.51 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 172.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -59.05 -46.57 87.89 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 118.271 0.487 . . . . 0.0 110.102 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -60.23 -45.36 93.49 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.498 0.719 . . . . 0.0 111.127 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 81.9 p -79.18 -24.24 43.35 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -176.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -37.71 -53.91 1.23 Allowed 'General case' 0 CA--C 1.527 0.073 0 C-N-CA 126.758 2.023 . . . . 0.0 114.359 -178.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -53.19 -60.35 3.4 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.307 0.575 . . . . 0.0 110.637 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.1 m -60.46 -45.54 93.33 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 123.062 0.545 . . . . 0.0 111.601 -178.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -71.63 -36.18 70.65 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -173.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 41.4 t -112.87 -60.92 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 123.619 0.768 . . . . 0.0 110.762 -174.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.4 mt -62.91 -35.51 80.29 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 119.183 -0.437 . . . . 0.0 111.991 -174.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -96.67 15.78 20.83 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.336 0.516 . . . . 0.0 111.765 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -102.87 104.13 14.35 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 118.877 0.762 . . . . 0.0 110.192 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -74.09 65.17 1.1 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.582 0.753 . . . . 0.0 110.995 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -165.84 177.27 41.05 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.56 103.8 14.73 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 125.204 1.402 . . . . 0.0 110.798 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mt -109.98 118.63 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 C-N-CA 123.937 0.895 . . . . 0.0 110.236 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 19.3 tp -89.38 98.06 11.55 Favored 'General case' 0 C--N 1.338 0.068 0 N-CA-C 106.444 -1.688 . . . . 0.0 106.444 175.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.4 t -85.94 110.31 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 123.387 0.675 . . . . 0.0 109.341 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -97.49 108.92 21.74 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.172 0.589 . . . . 0.0 109.679 177.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -81.63 123.25 28.54 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 175.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 37.9 p-90 -136.62 167.43 21.42 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 124.601 1.161 . . . . 0.0 112.122 -177.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -141.39 137.76 32.51 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.976 1.31 . . . . 0.0 107.834 177.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -52.33 -48.23 65.57 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.871 0.868 . . . . 0.0 112.495 -177.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 57.7 p-90 -68.74 -22.42 64.32 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.063 0.545 . . . . 0.0 112.407 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 42.1 t -79.75 77.37 6.39 Favored 'General case' 0 N--CA 1.456 -0.142 0 O-C-N 121.402 -0.811 . . . . 0.0 111.073 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -23.03 -62.69 0.03 OUTLIER Glycine 0 CA--C 1.536 1.401 0 C-N-CA 127.34 2.4 . . . . 0.0 115.499 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -44.16 -31.52 4.19 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 124.511 3.474 . . . . 0.0 114.955 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 88.1 m -55.97 -43.29 77.43 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.613 -0.68 . . . . 0.0 109.724 176.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -66.18 -33.09 74.97 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.703 0.801 . . . . 0.0 110.147 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 46.7 ttm -67.22 -44.36 79.74 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 19.6 pt -77.5 -27.31 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 118.954 -0.546 . . . . 0.0 112.451 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -39.7 -57.45 2.53 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -58.9 -39.44 81.2 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.074 1.849 . . . . 0.0 111.474 177.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 27.9 mt -58.15 -50.78 77.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 177.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 53.2 mt -57.13 -42.85 81.67 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.032 0.533 . . . . 0.0 110.411 177.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -59.0 -48.24 82.29 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.716 0.689 . . . . 0.0 110.492 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -59.63 -49.3 78.3 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.0 mm -55.66 -44.34 76.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 123.597 0.759 . . . . 0.0 109.657 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.18 -41.78 72.35 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.465 0.575 . . . . 0.0 110.355 178.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -66.6 -59.05 3.96 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.122 0.486 . . . . 0.0 110.075 177.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -51.29 -45.45 62.14 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.176 0.99 . . . . 0.0 112.375 -177.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -97.83 22.9 8.56 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.822 0.849 . . . . 0.0 111.78 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.4 130.14 26.64 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.293 0.951 . . . . 0.0 110.525 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.84 -16.54 4.2 Favored Glycine 0 CA--C 1.534 1.23 0 CA-C-O 119.22 -0.767 . . . . 0.0 113.948 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -99.66 -35.32 9.86 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.703 1.251 . . . . 0.0 110.129 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.8 tp -136.42 136.04 39.21 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.269 1.027 . . . . 0.0 108.783 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 85.6 m -97.03 104.73 16.77 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 175.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 63.2 t -79.86 128.15 38.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -129.88 151.85 50.0 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.59 0.756 . . . . 0.0 109.79 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.4 mttm -128.16 142.32 51.22 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.637 1.175 . . . . 0.0 108.135 177.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.4 tt -132.88 115.42 15.23 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -80.72 108.84 14.71 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.9 pt -72.04 -19.08 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -60.88 -47.83 84.61 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 119.342 0.974 . . . . 0.0 108.663 178.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -80.06 -32.85 39.35 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.169 0.988 . . . . 0.0 109.997 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -121.5 64.48 15.49 Favored Pre-proline 0 CA--C 1.533 0.319 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -175.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -65.69 -42.35 12.37 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 121.687 1.591 . . . . 0.0 110.674 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -45.23 -30.15 2.67 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 125.791 1.662 . . . . 0.0 114.922 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.22 -26.75 62.15 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.415 1.108 . . . . 0.0 112.297 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.494 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . . . -63.03 -58.59 15.58 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 119.307 0.958 . . . . 0.0 111.137 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.494 ' HD3' ' HB3' ' A' ' 67' ' ' ALA . 80.6 Cg_exo -45.68 -45.04 17.05 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 124.031 3.154 . . . . 0.0 113.201 175.08 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -50.78 -31.15 16.04 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -120.15 19.71 12.18 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.146 0.578 . . . . 0.0 110.781 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 45.92 37.66 7.55 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.527 1.537 . . . . 0.0 112.54 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.4 mt -60.76 140.22 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 117.351 0.575 . . . . 0.0 110.959 -177.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -79.38 -38.39 35.06 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.113 0.965 . . . . 0.0 112.169 -174.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -179.94 -152.27 10.69 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 107.074 -2.41 . . . . 0.0 107.074 -177.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -146.13 157.44 49.82 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-O 117.764 -1.112 . . . . 0.0 108.872 178.267 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -66.84 135.92 29.14 Favored 'Cis proline' 0 N--CA 1.457 -0.662 0 CA-C-N 120.494 1.212 . . . . 0.0 110.151 -1.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.9 m -132.58 146.76 52.15 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 106.09 -1.818 . . . . 0.0 106.09 175.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.8 mt -127.49 124.86 39.33 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.567 1.547 . . . . 0.0 107.363 -175.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.3 mp -121.3 119.46 32.28 Favored 'General case' 0 CA--C 1.522 -0.106 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 176.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.45 95.62 9.75 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -85.44 101.86 12.97 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.657 1.183 . . . . 0.0 109.207 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -93.78 114.04 26.22 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 174.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 56.16 40.06 30.19 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.676 0.79 . . . . 0.0 111.177 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.68 -1.61 66.56 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 118.734 -1.037 . . . . 0.0 113.521 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -107.01 128.69 54.59 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 119.419 1.609 . . . . 0.0 109.368 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.9 t -66.28 107.87 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.15 -40.94 29.67 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.596 0.758 . . . . 0.0 109.416 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.11 170.75 20.58 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 177.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.9 t -151.32 160.76 43.62 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.7 tptt -148.13 131.1 16.22 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.557 1.543 . . . . 0.0 107.221 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 94.7 t -108.32 133.21 54.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 106.538 -1.652 . . . . 0.0 106.538 177.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.72 173.28 41.17 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.934 -0.867 . . . . 0.0 110.934 -178.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.12 170.37 16.17 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.976 0.511 . . . . 0.0 110.858 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -161.68 164.52 29.12 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.723 1.609 . . . . 0.0 107.614 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 83.8 p -81.26 165.02 21.82 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.067 0.46 . . . . 0.0 110.077 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -57.21 -41.73 79.95 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 174.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.81 -55.24 30.94 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -57.03 -43.73 82.17 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 117.687 0.743 . . . . 0.0 109.94 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 27.6 tp -59.9 -49.69 76.7 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 177.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -53.53 -48.38 69.11 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.011 0.823 . . . . 0.0 111.463 177.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -59.27 -50.57 73.51 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -53.15 -51.82 60.74 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.892 0.877 . . . . 0.0 110.05 178.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.5 mt -57.95 -53.04 62.76 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 122.952 0.501 . . . . 0.0 110.538 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -53.74 -50.45 65.95 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 117.866 0.303 . . . . 0.0 110.637 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.7 -37.56 68.53 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.362 0.665 . . . . 0.0 111.631 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -78.22 -46.16 21.11 Favored 'General case' 0 C--O 1.227 -0.121 0 O-C-N 122.182 -0.324 . . . . 0.0 110.862 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 54.8 mt -60.85 -46.7 89.52 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.265 0.626 . . . . 0.0 109.397 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.282 0 C-N-CA 123.025 0.53 . . . . 0.0 109.75 177.568 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.2 mt . . . . . 0 N--CA 1.446 -0.652 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.9 mm -89.82 116.2 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 123.763 0.825 . . . . 0.0 109.356 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 -82.27 105.49 13.39 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.1 mt -90.76 155.14 19.02 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.369 0.668 . . . . 0.0 112.143 -177.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.0 p -126.06 158.5 35.25 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 172.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -55.13 -45.14 75.56 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.749 0.82 . . . . 0.0 109.815 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -57.7 -44.55 85.97 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.266 1.026 . . . . 0.0 111.309 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.9 p -78.22 -31.96 49.58 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -176.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -36.79 -48.43 0.73 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.605 1.962 . . . . 0.0 114.321 -176.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -55.3 -39.09 69.5 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -178.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.5 m -90.68 -50.66 5.79 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.348 0.659 . . . . 0.0 110.036 -178.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.87 -29.41 67.71 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -174.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.5 t -114.41 -60.69 2.77 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.076 0 CA-C-N 118.856 0.753 . . . . 0.0 110.723 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 72.1 mt -61.52 -30.94 70.96 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -174.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 42.6 mttp -97.95 16.61 20.43 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.045 0.838 . . . . 0.0 110.596 175.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.64 94.49 4.4 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 121.245 -0.909 . . . . 0.0 111.485 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -75.8 68.98 2.42 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 177.43 -170.56 43.11 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 108.386 -1.885 . . . . 0.0 108.386 -177.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -105.27 118.15 35.82 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.707 1.603 . . . . 0.0 110.783 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.1 mt -122.32 116.75 50.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 125.248 1.419 . . . . 0.0 110.036 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 24.5 tp -84.16 97.07 9.16 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 173.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 51.4 t -86.4 115.57 27.72 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.097 0 C-N-CA 123.361 0.664 . . . . 0.0 109.519 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -100.03 104.45 16.04 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.203 1.001 . . . . 0.0 109.212 177.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -79.57 120.79 24.41 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 105.026 -2.213 . . . . 0.0 105.026 174.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 13.7 p-90 -141.18 164.51 30.07 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -173.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -128.76 139.81 52.03 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.209 1.003 . . . . 0.0 109.215 175.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -54.2 -48.63 70.79 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.977 1.311 . . . . 0.0 111.419 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 54.9 p-90 -69.81 -21.59 63.38 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.794 0.838 . . . . 0.0 112.374 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 42.7 t -79.87 76.93 6.55 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 121.323 -0.861 . . . . 0.0 110.351 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -22.97 -60.99 0.03 OUTLIER Glycine 0 CA--C 1.535 1.315 0 C-N-CA 127.691 2.567 . . . . 0.0 115.632 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -44.21 -35.46 7.99 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 123.921 3.081 . . . . 0.0 114.129 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.8 m -59.12 -48.74 80.5 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 121.721 0.772 . . . . 0.0 109.844 177.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -65.5 -36.91 85.25 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 25.0 ttt -60.77 -45.33 94.78 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 119.622 -0.227 . . . . 0.0 110.715 177.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 34.8 pt -76.35 -25.72 16.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-O 118.635 -0.697 . . . . 0.0 112.49 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -37.26 -58.63 1.15 Allowed Pre-proline 0 CA--C 1.545 0.75 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -56.71 -40.32 85.16 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.241 1.96 . . . . 0.0 112.172 177.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 26.4 mt -59.24 -51.08 76.85 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 177.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 76.8 mt -56.59 -43.44 80.08 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.997 0.519 . . . . 0.0 110.804 178.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -60.22 -48.8 80.19 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.657 0.662 . . . . 0.0 110.215 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -59.25 -50.83 72.49 Favored 'General case' 0 C--O 1.226 -0.183 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.3 mm -54.3 -48.78 67.17 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.38 -49.34 64.61 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 122.975 0.51 . . . . 0.0 109.918 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -61.03 -57.85 10.86 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.785 0.326 . . . . 0.0 110.805 178.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -50.38 -45.96 55.68 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.44 1.096 . . . . 0.0 112.438 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -94.69 22.61 6.14 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -177.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -50.52 127.8 18.61 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.641 1.11 . . . . 0.0 110.384 177.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.48 -20.67 13.12 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-O 119.281 -0.733 . . . . 0.0 113.264 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -99.6 -40.49 7.78 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.566 1.183 . . . . 0.0 110.258 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.3 tp -143.18 136.9 28.61 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.853 0.861 . . . . 0.0 108.703 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 92.8 m -98.13 143.94 28.13 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 173.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 68.7 t -118.43 138.53 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 178.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.34 152.93 50.25 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -177.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.1 mttm -125.83 132.3 52.26 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.875 1.27 . . . . 0.0 107.623 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.8 tt -123.1 106.59 10.92 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -78.14 102.43 7.52 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.202 -177.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 pp -55.59 -30.99 27.6 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.231 0 C-N-CA 124.214 1.006 . . . . 0.0 112.072 -179.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -57.0 -45.36 83.05 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.26 0.482 . . . . 0.0 109.825 178.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -81.94 -35.92 28.57 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.077 0.951 . . . . 0.0 110.581 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -123.49 69.9 43.99 Favored Pre-proline 0 CA--C 1.529 0.15 0 C-N-CA 123.861 0.864 . . . . 0.0 111.182 -176.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -64.97 -41.98 15.72 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.033 1.822 . . . . 0.0 110.898 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -41.78 -41.02 3.27 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.456 1.503 . . . . 0.0 114.765 -178.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.92 -23.81 65.13 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.23 1.015 . . . . 0.0 112.975 -177.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.23 -62.14 6.15 Favored Pre-proline 0 CA--C 1.539 0.557 0 O-C-N 121.388 -0.82 . . . . 0.0 113.035 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -60.74 -37.48 78.4 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.087 1.858 . . . . 0.0 111.651 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -50.96 -36.54 39.38 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 118.836 0.744 . . . . 0.0 112.095 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -112.58 16.41 19.75 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.918 0.487 . . . . 0.0 111.44 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 49.01 43.6 31.73 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 125.043 1.306 . . . . 0.0 112.743 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mp -44.38 118.41 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 117.903 0.852 . . . . 0.0 110.585 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -79.56 -48.28 14.09 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.297 1.039 . . . . 0.0 111.153 -174.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -166.69 141.95 7.28 Favored Glycine 0 C--N 1.334 0.468 0 N-CA-C 107.609 -2.196 . . . . 0.0 107.609 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 22.9 pt -92.96 146.19 31.56 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 123.489 0.716 . . . . 0.0 110.665 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.41 133.19 24.14 Favored 'Cis proline' 0 N--CA 1.459 -0.511 0 CA-C-N 119.963 1.023 . . . . 0.0 110.424 -1.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.94 111.91 23.61 Favored 'General case' 0 C--N 1.338 0.078 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 24.3 mt -93.88 117.72 30.48 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.7 mp -118.17 115.67 25.27 Favored 'General case' 0 C--N 1.334 -0.106 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 177.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 tp -89.99 95.55 10.27 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -84.78 108.61 17.55 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.53 1.132 . . . . 0.0 110.231 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -107.36 122.91 47.53 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 174.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 52.39 47.59 24.41 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.379 0.609 . . . . 0.0 109.99 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.37 -3.0 6.4 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-O 118.181 -1.344 . . . . 0.0 115.687 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -111.99 143.43 43.0 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 120.051 1.925 . . . . 0.0 110.66 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.6 t -70.94 110.49 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.94 -41.41 29.44 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -158.53 169.98 23.22 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 177.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.5 t -150.47 161.25 42.88 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -147.66 131.11 16.68 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.0 t -102.2 121.61 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.38 171.7 38.08 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 121.444 0.469 . . . . 0.0 112.094 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.67 164.22 14.85 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.004 0.922 . . . . 0.0 112.761 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.9 mt -135.52 152.35 51.23 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.972 1.709 . . . . 0.0 108.194 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.9 p -81.77 150.04 28.11 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 170.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -49.84 -48.53 50.95 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -176.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.03 -57.63 17.44 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -55.6 -41.71 73.82 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 122.896 0.478 . . . . 0.0 110.686 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.3 tp -61.12 -51.53 68.71 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -55.41 -45.69 76.67 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.627 0.649 . . . . 0.0 110.906 177.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -57.84 -53.47 57.79 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.18 0.592 . . . . 0.0 110.274 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -52.71 -50.82 62.6 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.92 1.288 . . . . 0.0 110.149 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 98.2 mt -60.32 -51.28 70.18 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 122.592 0.357 . . . . 0.0 110.424 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -53.55 -49.36 67.82 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 117.964 0.347 . . . . 0.0 110.398 178.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.5 -35.67 70.51 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.759 0.823 . . . . 0.0 111.74 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -78.45 -43.65 26.69 Favored 'General case' 0 C--O 1.227 -0.12 0 CA-C-N 118.057 0.39 . . . . 0.0 110.582 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 53.7 mt -62.79 -46.6 87.26 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.241 0.616 . . . . 0.0 109.905 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.164 0 C-N-CA 124.743 1.217 . . . . 0.0 111.739 179.133 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 32.1 mt . . . . . 0 N--CA 1.45 -0.459 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.5 mm -87.81 104.61 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 177.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 29.6 m-70 -80.55 95.26 6.45 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 42.9 mt -79.01 162.51 25.89 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.835 1.254 . . . . 0.0 111.922 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 30.0 p -134.16 162.4 32.23 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.38 1.872 . . . . 0.0 106.574 172.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -54.2 -47.63 71.9 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.723 0.809 . . . . 0.0 110.337 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -56.25 -44.83 80.03 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.933 0.893 . . . . 0.0 111.759 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.5 p -78.31 -28.46 47.45 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -176.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -38.99 -49.82 1.73 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.738 1.615 . . . . 0.0 113.879 -176.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -50.81 -63.92 0.98 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.659 0.742 . . . . 0.0 111.0 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.3 m -68.31 -46.89 69.05 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.834 -175.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -75.53 -23.17 56.61 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 -174.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.0 t -118.34 -63.31 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-N 119.432 1.014 . . . . 0.0 110.057 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 72.4 mt -60.21 -37.53 80.58 Favored 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -174.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -93.45 12.28 25.54 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.598 0.636 . . . . 0.0 111.834 177.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.39 102.56 14.66 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 119.098 0.863 . . . . 0.0 110.885 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -76.09 65.7 2.14 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.377 0.671 . . . . 0.0 109.9 177.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -173.84 -175.03 41.2 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.87 124.42 35.97 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.269 1.427 . . . . 0.0 111.052 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.3 mt -133.32 124.07 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 124.811 1.244 . . . . 0.0 109.917 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -93.73 108.57 20.3 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 105.534 -2.025 . . . . 0.0 105.534 174.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.6 t -99.6 107.34 20.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -178.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -91.62 102.86 15.5 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -78.49 121.37 24.48 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 103.758 -2.682 . . . . 0.0 103.758 174.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 25.8 p-90 -137.0 168.54 19.4 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 123.61 0.764 . . . . 0.0 112.631 -174.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -141.48 140.45 33.54 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.813 1.245 . . . . 0.0 108.099 176.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -55.81 -50.76 69.63 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.483 0.713 . . . . 0.0 112.688 -176.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 43.3 p-90 -59.92 -29.68 68.54 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.77 0.828 . . . . 0.0 112.828 -178.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 48.8 t -79.6 80.45 5.98 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 121.432 -0.793 . . . . 0.0 110.507 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -23.06 -61.2 0.03 OUTLIER Glycine 0 CA--C 1.537 1.459 0 C-N-CA 127.422 2.439 . . . . 0.0 115.243 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -41.98 -37.77 4.57 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 124.309 3.34 . . . . 0.0 114.335 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 86.4 m -54.9 -44.23 73.97 Favored 'General case' 0 CA--C 1.527 0.058 0 C-N-CA 123.661 0.785 . . . . 0.0 110.597 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -69.92 -45.21 68.03 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 87.5 mmm -53.69 -42.76 68.31 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 30.7 pt -76.65 -12.06 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.22 -58.35 10.86 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 120.162 1.346 . . . . 0.0 112.79 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -55.43 -41.37 78.72 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.141 1.894 . . . . 0.0 111.377 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 19.2 mt -57.56 -53.65 41.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.3 mt -56.29 -39.19 72.29 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.312 0.645 . . . . 0.0 110.682 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -62.0 -48.84 78.5 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.013 0.824 . . . . 0.0 110.396 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -57.17 -51.73 68.13 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.2 mm -53.05 -48.06 53.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.675 1.19 . . . . 0.0 109.399 177.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.34 -45.76 76.42 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 122.927 0.491 . . . . 0.0 110.645 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -63.2 -53.17 57.4 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 177.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -50.29 -50.15 51.29 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.977 0.911 . . . . 0.0 111.687 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -98.86 30.5 3.33 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.464 0.706 . . . . 0.0 111.347 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -60.35 120.77 10.5 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.491 -0.755 . . . . 0.0 110.005 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.69 3.54 89.06 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 119.615 -0.547 . . . . 0.0 112.487 -177.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.1 mttm -114.03 -41.84 3.47 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.134 1.373 . . . . 0.0 109.281 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.0 tp -133.4 131.54 40.11 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.245 1.018 . . . . 0.0 108.498 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.5 m -86.87 100.35 12.49 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.1 t -79.3 125.07 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -131.74 151.72 51.45 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.58 0.752 . . . . 0.0 110.663 -176.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.7 mttm -127.22 143.76 51.18 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 176.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 tt -133.44 111.34 10.66 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -79.28 110.12 14.26 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.2 pt -71.28 -22.81 22.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 118.94 -0.552 . . . . 0.0 112.276 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -58.79 -46.58 87.22 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 119.352 0.978 . . . . 0.0 108.824 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -80.39 -25.18 39.23 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.282 1.033 . . . . 0.0 110.949 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -127.37 66.95 70.51 Favored Pre-proline 0 CA--C 1.534 0.341 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.48 -55.85 2.99 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.531 2.154 . . . . 0.0 113.265 -178.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -37.8 -46.61 1.69 Allowed Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.872 1.701 . . . . 0.0 114.544 -176.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -53.12 -34.56 57.26 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.489 0.715 . . . . 0.0 112.288 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.72 -68.6 0.57 Allowed Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 118.255 -0.878 . . . . 0.0 112.374 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -58.96 -38.24 89.14 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 CA-C-N 121.085 1.423 . . . . 0.0 110.94 177.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -52.26 -39.92 61.03 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 118.926 0.784 . . . . 0.0 111.732 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -104.59 19.46 20.33 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.106 0.412 . . . . 0.0 111.907 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.7 39.04 54.05 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 124.021 0.82 . . . . 0.0 113.216 177.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.5 mp -56.94 122.33 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -79.81 -47.24 15.51 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.721 0.808 . . . . 0.0 109.364 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -168.92 146.09 10.01 Favored Glycine 0 CA--C 1.521 0.424 0 N-CA-C 106.896 -2.481 . . . . 0.0 106.896 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.411 ' O ' HD12 ' A' ' 75' ' ' ILE . 1.6 pp -92.02 150.32 40.32 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 117.382 0.591 . . . . 0.0 110.378 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -70.93 136.5 41.61 Favored 'Cis proline' 0 N--CA 1.457 -0.649 0 CA-C-N 120.107 1.074 . . . . 0.0 111.31 0.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -120.68 113.47 20.26 Favored 'General case' 0 C--O 1.23 0.042 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 178.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.4 mt -95.9 101.17 12.82 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 -178.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -92.79 111.98 23.78 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 176.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 tp -92.77 105.59 17.7 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -93.81 143.66 26.13 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.24 1.416 . . . . 0.0 109.835 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -138.01 121.96 17.78 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 172.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 46.1 m-20 50.18 48.55 21.95 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.858 0.863 . . . . 0.0 110.803 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.57 -5.51 10.83 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 118.527 -1.152 . . . . 0.0 115.389 178.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -106.26 138.47 42.38 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 119.932 1.866 . . . . 0.0 110.163 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 94.2 t -66.55 109.17 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 176.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.75 -43.63 22.22 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 124.526 1.131 . . . . 0.0 109.604 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -150.55 169.32 21.81 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 97.2 m -150.98 139.34 20.36 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -177.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -131.47 137.02 48.4 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.0 t -110.94 122.2 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 177.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.01 171.76 37.09 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 123.38 0.514 . . . . 0.0 112.068 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.83 170.71 10.53 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.105 0.962 . . . . 0.0 112.441 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.1 mt -140.57 162.39 35.48 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 126.227 1.811 . . . . 0.0 108.321 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 99.9 p -83.67 162.11 20.86 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 169.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -57.06 -44.11 82.72 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 177.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -58.05 -57.59 19.01 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 123.37 0.51 . . . . 0.0 111.964 178.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -60.3 -38.64 84.26 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 121.842 -0.799 . . . . 0.0 110.739 -178.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.0 tp -64.17 -49.39 72.26 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 119.153 -0.451 . . . . 0.0 110.013 178.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 10.2 mmmm -52.65 -49.84 64.4 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.667 0.667 . . . . 0.0 109.47 176.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -56.13 -54.82 40.49 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.249 0.62 . . . . 0.0 110.73 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -52.59 -53.37 47.59 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.957 1.303 . . . . 0.0 111.05 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.3 mt -61.96 -52.14 65.25 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -51.92 -50.88 60.23 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.336 0.654 . . . . 0.0 110.842 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.43 -36.75 66.84 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.522 0.729 . . . . 0.0 111.664 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -78.52 -45.21 22.47 Favored 'General case' 0 N--CA 1.458 -0.057 0 O-C-N 122.263 -0.273 . . . . 0.0 110.516 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 53.2 mt -58.3 -47.45 83.63 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.306 0 C-N-CA 123.232 0.613 . . . . 0.0 109.665 177.423 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 16.0 mt . . . . . 0 C--O 1.232 0.135 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.5 mm -87.89 108.1 18.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -79.78 114.77 18.95 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 64.9 mt -96.35 167.03 11.42 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 124.38 1.072 . . . . 0.0 112.397 -176.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 33.9 p -136.86 164.58 27.97 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 171.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -59.27 -45.97 89.78 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.463 0.574 . . . . 0.0 109.923 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -59.85 -45.64 91.79 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.708 0.803 . . . . 0.0 111.263 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.8 p -78.86 -24.44 44.31 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -176.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -38.25 -49.93 1.41 Allowed 'General case' 0 CA--C 1.527 0.075 0 C-N-CA 126.576 1.95 . . . . 0.0 113.613 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -54.41 -61.18 2.47 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 121.483 0.659 . . . . 0.0 110.888 -178.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.7 m -63.27 -42.06 99.1 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.444 -177.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -71.16 -43.58 67.22 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -174.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.4 t -107.54 -59.12 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 123.861 0.864 . . . . 0.0 110.893 -174.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 64.4 mt -62.41 -35.62 79.78 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -173.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -90.43 7.05 40.71 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.555 0.616 . . . . 0.0 112.253 178.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.86 102.1 14.21 Favored 'General case' 0 C--N 1.341 0.239 0 CA-C-N 119.185 0.902 . . . . 0.0 111.946 -178.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -75.58 73.48 2.59 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 175.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -172.72 178.57 44.71 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.76 115.19 26.11 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.0 1.32 . . . . 0.0 109.943 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.4 mt -122.6 120.18 60.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 124.528 1.131 . . . . 0.0 109.833 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.4 tp -91.08 100.27 13.15 Favored 'General case' 0 CA--C 1.521 -0.159 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 175.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 63.4 t -90.88 114.25 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -101.14 110.19 22.18 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.953 0.901 . . . . 0.0 109.186 177.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -79.79 124.8 28.94 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 175.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 28.6 p-90 -140.17 172.48 12.69 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.731 0.812 . . . . 0.0 112.864 -175.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.4 132.28 17.08 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.549 1.539 . . . . 0.0 108.024 175.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -49.23 -39.52 30.39 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 61.3 p-90 -76.86 -19.98 56.85 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 40.4 t -79.58 77.0 6.2 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 121.372 -0.83 . . . . 0.0 111.511 -175.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -9.72 -71.87 0.01 OUTLIER Glycine 0 CA--C 1.538 1.509 0 C-N-CA 127.729 2.585 . . . . 0.0 116.349 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -47.29 -33.59 16.68 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 124.089 3.193 . . . . 0.0 114.61 -178.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 88.2 m -52.94 -47.98 67.65 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.635 0.774 . . . . 0.0 109.955 176.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -68.89 -29.19 67.42 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.385 0.674 . . . . 0.0 110.611 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 24.2 mmt -70.28 -44.91 67.42 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 34.3 pt -74.17 -30.53 27.26 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 CA-C-O 118.371 -0.823 . . . . 0.0 112.231 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -36.84 -60.1 0.82 Allowed Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -57.79 -40.39 79.37 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.0 1.8 . . . . 0.0 111.414 178.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 15.7 mt -58.68 -49.67 81.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 177.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 76.9 mt -55.63 -44.17 76.85 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.213 0.605 . . . . 0.0 110.071 177.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -60.7 -46.89 88.67 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.76 -0.587 . . . . 0.0 110.746 177.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -57.25 -51.51 69.08 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 23.4 mm -53.03 -49.28 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 124.057 0.943 . . . . 0.0 109.478 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.56 -47.6 73.05 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 117.967 0.349 . . . . 0.0 110.547 178.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -61.17 -44.47 97.26 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 122.284 0.234 . . . . 0.0 111.283 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -65.54 -46.27 80.21 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.364 1.065 . . . . 0.0 112.723 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -100.22 38.68 1.45 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.516 1.127 . . . . 0.0 110.807 -178.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.402 ' H ' ' NE2' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -53.1 122.13 8.82 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.644 -0.66 . . . . 0.0 111.905 -179.265 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.62 -5.95 6.76 Favored Glycine 0 CA--C 1.535 1.29 0 CA-C-O 119.487 -0.618 . . . . 0.0 113.7 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 51.7 mttt -99.68 -36.27 9.54 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.964 1.306 . . . . 0.0 108.491 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.3 tp -136.28 122.48 20.4 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 35.3 m -86.58 103.52 15.15 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 177.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 91.8 t -79.67 128.02 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 107.057 -1.461 . . . . 0.0 107.057 178.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -132.53 149.53 52.31 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.373 0.669 . . . . 0.0 110.05 -177.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -129.36 132.49 47.08 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 123.794 0.838 . . . . 0.0 108.89 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.5 tt -120.63 116.13 24.73 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.766 0.826 . . . . 0.0 110.059 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -78.22 108.03 11.24 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 pp -67.33 -29.8 46.99 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 C-N-CA 123.335 0.654 . . . . 0.0 112.701 -177.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -60.49 -47.71 84.93 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 118.934 0.788 . . . . 0.0 109.491 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -74.88 -32.92 61.99 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.147 176.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -121.23 69.95 21.03 Favored Pre-proline 0 CA--C 1.531 0.228 0 C-N-CA 123.651 0.78 . . . . 0.0 112.01 -176.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -64.8 -47.45 5.13 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.977 1.785 . . . . 0.0 111.431 -178.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -42.02 -40.72 3.39 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.358 1.456 . . . . 0.0 114.659 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.43 -29.31 69.86 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.62 -0.929 . . . . 0.0 112.479 -178.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.84 -65.23 1.79 Allowed Pre-proline 0 CA--C 1.537 0.456 0 CA-C-O 118.395 -0.812 . . . . 0.0 112.912 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -59.78 -38.44 80.29 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 121.718 1.612 . . . . 0.0 111.036 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -51.79 -36.38 47.41 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-N 118.683 0.674 . . . . 0.0 112.029 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -111.65 20.59 16.97 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.683 0.393 . . . . 0.0 111.883 178.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 51.09 40.33 43.6 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.043 0.83 . . . . 0.0 113.481 177.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mp -53.94 127.87 12.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 117.883 0.841 . . . . 0.0 109.069 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -92.91 -50.64 5.45 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.75 1.22 . . . . 0.0 110.133 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.02 146.56 13.2 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 107.406 -2.278 . . . . 0.0 107.406 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.7 pt -95.61 148.64 34.92 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 123.715 0.806 . . . . 0.0 110.131 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.96 140.89 60.75 Favored 'Cis proline' 0 N--CA 1.456 -0.71 0 CA-C-N 119.788 0.96 . . . . 0.0 110.72 -1.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.61 118.69 30.8 Favored 'General case' 0 CA--C 1.523 -0.083 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.8 mt -96.82 126.6 42.09 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -120.89 111.57 17.7 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 104.066 -2.568 . . . . 0.0 104.066 175.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.5 tp -93.29 99.54 12.06 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -84.7 142.02 30.16 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.569 1.148 . . . . 0.0 109.676 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -138.13 97.86 3.49 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 175.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.2 t30 55.42 71.52 0.54 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.3 0.64 . . . . 0.0 110.3 -176.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 70.62 -37.68 0.47 Allowed Glycine 0 CA--C 1.531 1.093 0 N-CA-C 116.146 1.218 . . . . 0.0 116.146 176.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -86.6 146.03 26.5 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 119.147 1.474 . . . . 0.0 110.529 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 96.6 t -79.04 115.19 20.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 175.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.3 -42.11 26.5 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.346 0.659 . . . . 0.0 109.448 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -155.34 169.86 23.24 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 177.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.8 t -147.88 168.35 22.46 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.68 146.22 23.15 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.827 1.251 . . . . 0.0 108.327 -177.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.9 t -124.01 124.8 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.26 177.11 37.54 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 123.324 0.487 . . . . 0.0 112.052 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.71 173.58 8.85 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.416 0.686 . . . . 0.0 111.885 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 mt -147.65 160.71 42.37 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 125.679 1.592 . . . . 0.0 108.708 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 44.6 p -90.4 154.15 19.89 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 170.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -51.76 -45.52 63.74 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 122.213 -0.305 . . . . 0.0 110.921 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -57.6 -57.24 20.86 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 111.74 -0.544 . . . . 0.0 111.74 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -58.01 -41.09 82.35 Favored 'General case' 0 N--CA 1.456 -0.168 0 O-C-N 121.996 -0.708 . . . . 0.0 110.739 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 29.3 tp -62.19 -49.21 76.71 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -52.93 -48.66 67.12 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.898 0.479 . . . . 0.0 109.895 176.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -56.98 -53.98 51.84 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.946 0.498 . . . . 0.0 110.617 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -52.25 -51.25 59.49 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.002 0.921 . . . . 0.0 110.437 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 89.7 mt -61.28 -51.49 68.69 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.631 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -52.78 -48.98 66.47 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.941 0.496 . . . . 0.0 110.406 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.05 -36.12 70.13 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.292 0.637 . . . . 0.0 111.832 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -78.89 -44.64 22.34 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 117.783 0.265 . . . . 0.0 111.013 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 56.9 mt -64.7 -43.08 94.66 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.434 0.694 . . . . 0.0 110.211 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.213 0 C-N-CA 124.84 1.256 . . . . 0.0 111.807 179.066 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.8 mt . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 120.678 0.275 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.9 mm -87.54 106.7 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 175.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 37.9 m-70 -81.26 95.54 6.99 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 177.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 44.8 mt -79.9 163.44 24.33 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.598 1.159 . . . . 0.0 113.067 -175.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.6 p -139.06 164.73 29.01 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 126.261 1.824 . . . . 0.0 106.459 174.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -57.46 -46.25 83.85 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.673 -0.642 . . . . 0.0 110.14 -178.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -61.87 -38.9 90.02 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.8 p -78.13 -35.52 48.99 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 121.992 -0.443 . . . . 0.0 110.223 -177.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -33.74 -51.17 0.38 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 126.912 2.085 . . . . 0.0 114.019 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -54.92 -48.09 73.54 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.07 0.462 . . . . 0.0 111.636 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.1 m -76.33 -52.09 10.64 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 121.996 -0.44 . . . . 0.0 110.769 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.52 -47.31 64.18 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -173.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.3 t -94.53 -50.09 12.12 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.11 0 C-N-CA 123.33 0.652 . . . . 0.0 111.915 -175.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 70.4 mt -73.67 -48.69 30.38 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.988 -177.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -91.36 42.33 1.1 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.134 0.879 . . . . 0.0 109.252 175.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.03 177.08 2.33 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 125.395 1.478 . . . . 0.0 113.686 -178.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -134.88 101.93 5.07 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.993 2.117 . . . . 0.0 106.594 175.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.09 -162.03 45.98 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-O 121.588 0.549 . . . . 0.0 113.87 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.48 117.9 20.11 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.47 1.508 . . . . 0.0 112.536 -177.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.1 mt -116.53 120.77 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 124.552 1.141 . . . . 0.0 109.049 176.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.409 HD13 ' C ' ' A' ' 24' ' ' LEU . 2.9 tm? -91.97 108.08 19.67 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 176.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.9 t -98.53 106.59 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 123.86 0.864 . . . . 0.0 109.954 -177.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -91.35 105.11 17.54 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 176.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -79.59 125.24 29.35 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 174.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 44.7 p-90 -142.39 169.52 17.42 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.828 0.851 . . . . 0.0 112.729 -176.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -146.93 137.97 23.96 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.954 1.302 . . . . 0.0 107.586 174.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -50.55 -48.54 57.33 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.586 0.754 . . . . 0.0 112.759 -176.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 58.5 p-90 -62.7 -26.05 68.47 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 50.8 t -79.8 79.44 6.31 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 121.316 -0.865 . . . . 0.0 109.233 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -25.96 -60.39 0.07 OUTLIER Glycine 0 CA--C 1.536 1.359 0 C-N-CA 127.139 2.304 . . . . 0.0 114.801 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -43.08 -35.06 4.46 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 124.315 3.343 . . . . 0.0 114.586 178.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 78.3 m -57.09 -47.24 81.52 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 121.588 -0.695 . . . . 0.0 109.846 176.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -65.87 -31.18 71.98 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.696 0.799 . . . . 0.0 109.776 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 85.1 mtp -68.5 -45.04 73.36 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 177.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.0 pt -75.39 -27.52 19.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 118.521 0.6 . . . . 0.0 112.33 178.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -37.94 -58.66 1.34 Allowed Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -58.27 -39.01 88.34 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.41 2.073 . . . . 0.0 111.514 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.5 mt -59.51 -51.08 76.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 177.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 44.3 mt -56.44 -42.55 78.3 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.621 0.368 . . . . 0.0 110.505 177.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -59.51 -48.7 80.64 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.674 0.67 . . . . 0.0 110.259 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -58.42 -52.62 64.86 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.677 -0.639 . . . . 0.0 109.606 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 11.2 mm -54.39 -46.29 69.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 124.735 1.214 . . . . 0.0 110.179 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.23 -44.73 68.31 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.361 0.664 . . . . 0.0 110.179 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -66.34 -56.78 9.48 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 176.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -45.71 -50.76 13.39 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.937 0.895 . . . . 0.0 112.423 -178.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -95.44 26.2 4.01 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.663 0.785 . . . . 0.0 112.463 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.58 130.15 23.62 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.264 0.938 . . . . 0.0 109.933 176.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.6 -16.48 5.04 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-O 119.147 -0.807 . . . . 0.0 114.181 -178.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -99.6 -39.08 8.48 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 118.87 1.335 . . . . 0.0 110.214 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 26.0 tp -137.78 126.55 23.87 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.8 m -86.94 102.39 14.32 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 176.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 96.3 t -79.02 137.51 21.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.42 147.41 45.39 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.023 0.929 . . . . 0.0 109.445 -177.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -125.26 135.3 52.39 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.6 tt -127.78 112.57 14.92 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.606 0.763 . . . . 0.0 109.692 -178.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -78.98 104.52 9.67 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 122.902 0.481 . . . . 0.0 109.824 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.2 pt -69.03 -24.25 28.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 118.866 -0.588 . . . . 0.0 112.559 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -53.31 -53.82 45.4 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.061 0.846 . . . . 0.0 109.502 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -78.2 -28.71 48.12 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.961 0.904 . . . . 0.0 110.763 179.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -118.11 67.0 6.26 Favored Pre-proline 0 C--O 1.235 0.315 0 C-N-CA 124.1 0.96 . . . . 0.0 111.495 -176.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -61.14 -53.65 2.36 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.465 2.11 . . . . 0.0 112.383 -176.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -37.97 -47.12 1.85 Allowed Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.631 1.586 . . . . 0.0 114.267 -177.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -51.71 -33.79 35.9 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.23 1.012 . . . . 0.0 112.962 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.27 -68.25 0.79 Allowed Pre-proline 0 CA--C 1.537 0.478 0 CA-C-O 117.987 -1.006 . . . . 0.0 112.017 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -59.32 -35.95 95.65 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.005 1.803 . . . . 0.0 111.358 177.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -51.44 -37.64 49.65 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.526 1.057 . . . . 0.0 111.661 177.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -111.9 22.31 15.04 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.098 0.559 . . . . 0.0 111.187 177.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 42.69 43.24 5.06 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 125.465 1.507 . . . . 0.0 113.04 178.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.5 mp -51.07 118.17 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 118.094 0.947 . . . . 0.0 109.315 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -79.14 -44.38 22.12 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.371 0.669 . . . . 0.0 110.415 -177.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -164.91 141.91 7.39 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 108.451 -1.86 . . . . 0.0 108.451 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.7 pt -95.79 148.88 35.26 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 124.017 0.927 . . . . 0.0 109.997 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.35 141.05 62.81 Favored 'Cis proline' 0 N--CA 1.456 -0.697 0 CA-C-N 119.846 0.981 . . . . 0.0 111.177 -0.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.02 114.81 21.46 Favored 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.7 mt -98.0 102.08 13.73 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.7 mp -96.58 118.59 33.39 Favored 'General case' 0 CA--C 1.523 -0.072 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 177.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 tp -92.19 98.67 11.67 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -89.27 103.33 15.96 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 125.225 1.41 . . . . 0.0 110.413 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -83.61 102.19 12.02 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 172.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 45.76 41.43 7.49 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.069 1.748 . . . . 0.0 113.934 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 106.2 -21.28 33.7 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-O 118.784 -1.009 . . . . 0.0 113.358 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -100.32 128.55 46.36 Favored 'General case' 0 C--O 1.227 -0.085 0 CA-C-N 119.254 1.527 . . . . 0.0 110.948 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 89.7 t -68.04 107.29 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.57 -41.61 26.81 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.884 0.874 . . . . 0.0 109.987 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -155.13 167.49 30.2 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 93.7 m -149.72 140.7 22.89 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -116.5 138.37 51.44 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 177.179 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 26.3 t -120.96 123.32 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 178.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.92 175.09 45.47 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 111.579 -0.609 . . . . 0.0 111.579 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.38 172.77 8.83 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.22 0.608 . . . . 0.0 110.954 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -162.8 167.99 22.07 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.625 1.17 . . . . 0.0 108.75 -177.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 88.2 p -81.67 160.1 23.8 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -57.48 -40.35 78.41 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 175.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.95 -53.06 42.38 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 176.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -60.46 -39.65 88.34 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 117.616 0.708 . . . . 0.0 111.148 178.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 23.3 tp -62.19 -50.93 69.85 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.586 0.63 . . . . 0.0 109.874 178.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -53.41 -49.52 67.12 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.32 0.648 . . . . 0.0 109.567 176.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -55.56 -55.86 27.03 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.063 0.945 . . . . 0.0 110.424 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -52.93 -54.38 35.64 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.489 1.516 . . . . 0.0 110.828 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.7 mt -61.32 -51.93 66.8 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.44 0.296 . . . . 0.0 110.658 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -53.95 -50.38 66.63 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.028 0.531 . . . . 0.0 110.631 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.02 -36.53 65.58 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.429 0.692 . . . . 0.0 111.623 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -78.64 -48.32 15.31 Favored 'General case' 0 C--O 1.227 -0.115 0 O-C-N 122.238 -0.289 . . . . 0.0 110.406 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 58.0 mt -59.18 -42.78 91.66 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.936 0.494 . . . . 0.0 110.294 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.282 0 C-N-CA 123.097 0.559 . . . . 0.0 109.777 177.889 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 36.9 mt . . . . . 0 N--CA 1.446 -0.648 0 CA-C-O 120.969 0.414 . . . . 0.0 110.674 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.2 mm -89.26 120.28 37.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 123.978 0.911 . . . . 0.0 109.492 178.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -85.71 111.39 20.07 Favored 'General case' 0 CA--C 1.528 0.099 0 O-C-N 121.515 -0.741 . . . . 0.0 109.349 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 65.8 mt -95.5 160.87 14.31 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 124.458 1.103 . . . . 0.0 111.203 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 48.9 p -134.68 163.48 29.67 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 174.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -58.48 -47.18 84.91 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.809 0.732 . . . . 0.0 109.601 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -63.69 -41.2 98.17 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.664 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.1 p -78.42 -24.82 45.98 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.38 0.536 . . . . 0.0 111.368 -177.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -41.6 -43.69 2.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 126.602 1.961 . . . . 0.0 113.068 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -52.39 -65.14 0.61 Allowed 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 121.697 0.761 . . . . 0.0 110.251 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.9 m -67.17 -42.53 84.13 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.583 -176.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -70.81 -39.3 73.14 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -174.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.0 t -112.84 -58.48 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 123.446 0.698 . . . . 0.0 110.345 -175.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 67.0 mt -61.43 -35.59 78.0 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -174.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -97.4 16.18 20.88 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.451 0.569 . . . . 0.0 111.73 178.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -102.15 102.43 12.88 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 119.042 0.837 . . . . 0.0 111.724 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -77.25 59.21 1.75 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.949 1.3 . . . . 0.0 110.305 176.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -159.05 168.08 35.01 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.5 114.09 20.68 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.257 0.623 . . . . 0.0 110.817 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.5 mt -120.25 122.44 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 124.537 1.135 . . . . 0.0 109.986 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.4 ' C ' HD13 ' A' ' 24' ' ' LEU . 3.0 tm? -91.99 107.55 19.29 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 175.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 67.2 t -96.19 108.09 20.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 123.992 0.917 . . . . 0.0 109.241 -178.178 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -97.18 105.32 17.44 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.592 1.157 . . . . 0.0 109.514 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -79.16 126.39 30.68 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 177.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 26.4 p-90 -141.47 173.86 11.1 Favored 'General case' 0 C--N 1.343 0.289 0 C-N-CA 124.304 1.042 . . . . 0.0 112.83 -176.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -149.97 156.89 42.52 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.985 1.714 . . . . 0.0 108.221 175.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.1 mp0 -63.3 -48.79 76.59 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.226 0.536 . . . . 0.0 110.688 -178.221 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 54.2 p-90 -65.73 -20.8 66.41 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.064 0.946 . . . . 0.0 112.562 -178.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 47.6 t -79.36 75.68 5.95 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 121.481 -0.762 . . . . 0.0 110.08 -178.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -25.74 -63.12 0.06 OUTLIER Glycine 0 CA--C 1.536 1.357 0 C-N-CA 126.509 2.004 . . . . 0.0 114.692 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -43.44 -35.83 6.17 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 124.559 3.506 . . . . 0.0 114.881 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 87.5 m -52.59 -40.71 62.94 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.172 0.589 . . . . 0.0 110.188 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -67.28 -30.83 70.8 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.633 0.773 . . . . 0.0 111.311 179.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -74.36 -46.12 42.6 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 28.0 pt -73.7 -29.26 26.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 118.66 -0.686 . . . . 0.0 112.255 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -39.16 -60.88 1.08 Allowed Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -56.59 -40.84 81.69 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.372 2.048 . . . . 0.0 111.673 178.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.8 mt -57.44 -52.35 58.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 177.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 47.6 mt -57.44 -40.52 78.59 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.281 0.632 . . . . 0.0 110.973 178.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -61.86 -47.86 83.12 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.1 0.864 . . . . 0.0 110.262 177.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -57.87 -52.59 64.87 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.6 mm -53.15 -47.5 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 124.035 0.934 . . . . 0.0 109.591 177.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.94 -49.95 62.14 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 122.842 0.457 . . . . 0.0 110.103 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -62.23 -54.29 42.91 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.723 0.296 . . . . 0.0 110.932 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -53.24 -46.74 69.29 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.767 0.827 . . . . 0.0 112.308 -178.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -94.48 26.99 3.15 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.967 0.907 . . . . 0.0 112.37 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -54.45 128.65 32.76 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.169 0.895 . . . . 0.0 109.724 176.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.1 -14.75 25.8 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-O 119.25 -0.75 . . . . 0.0 112.993 -178.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -99.82 -44.06 6.21 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 118.507 1.153 . . . . 0.0 109.881 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 24.6 tp -139.42 132.38 29.41 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.415 0.686 . . . . 0.0 110.431 -176.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 62.5 m -91.69 103.28 15.87 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 175.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 63.1 t -79.86 130.81 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.66 151.81 50.58 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.28 0.632 . . . . 0.0 110.844 -176.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -126.8 139.94 52.74 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.908 1.283 . . . . 0.0 108.948 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.5 tt -127.8 115.86 19.3 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.608 0.763 . . . . 0.0 109.734 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -79.25 107.15 11.8 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.9 pt -69.0 -26.96 33.59 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.29 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -177.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -59.75 -47.04 87.28 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 119.067 0.849 . . . . 0.0 109.744 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -77.18 -30.58 54.94 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.148 0.579 . . . . 0.0 110.241 176.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -121.79 67.42 22.21 Favored Pre-proline 0 C--O 1.234 0.25 0 C-N-CA 123.933 0.893 . . . . 0.0 111.735 -176.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -62.22 -53.43 1.97 Allowed 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 122.534 2.156 . . . . 0.0 112.777 -176.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -38.86 -47.2 2.38 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.189 1.376 . . . . 0.0 113.989 -177.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -50.52 -34.46 25.38 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.427 1.091 . . . . 0.0 112.897 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.71 -68.99 0.57 Allowed Pre-proline 0 CA--C 1.538 0.518 0 CA-C-O 118.241 -0.885 . . . . 0.0 112.168 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -59.19 -37.2 93.14 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.64 1.56 . . . . 0.0 111.149 177.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -50.83 -40.61 56.18 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-N 119.281 0.946 . . . . 0.0 111.67 178.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -106.76 19.83 19.9 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.586 0.354 . . . . 0.0 111.893 178.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 51.0 40.31 42.9 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.097 0.856 . . . . 0.0 113.043 177.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mp -53.24 120.7 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 177.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 55.5 mmt-85 -79.14 -46.89 17.07 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.769 0.828 . . . . 0.0 109.417 -178.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -170.72 145.53 9.07 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 106.601 -2.6 . . . . 0.0 106.601 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.5 pt -90.83 150.95 43.03 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-O 118.907 -0.568 . . . . 0.0 109.842 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -70.08 138.11 48.21 Favored 'Cis proline' 0 N--CA 1.458 -0.609 0 CA-C-N 119.485 0.852 . . . . 0.0 111.285 -0.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -123.62 120.27 32.29 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 178.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.3 mt -103.25 117.39 34.4 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -110.2 116.83 32.22 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 177.064 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 tp -92.28 101.22 13.71 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -90.83 145.42 24.78 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.096 1.358 . . . . 0.0 111.595 -178.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -141.59 116.86 10.09 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.317 1.847 . . . . 0.0 106.102 174.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 49.66 48.64 21.25 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.678 0.752 . . . . 0.0 110.61 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.51 -9.74 4.33 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-O 118.283 -1.287 . . . . 0.0 115.86 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -98.52 142.38 30.19 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 119.983 1.892 . . . . 0.0 109.851 178.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 89.5 t -76.72 116.84 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 177.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.19 -44.21 22.35 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 177.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -161.88 175.34 11.99 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.3 t -150.82 163.48 38.53 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 54.2 mmtt -141.74 148.5 39.09 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 126.96 2.104 . . . . 0.0 106.672 177.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.9 t -130.52 132.33 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.81 -177.33 46.49 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.82 165.3 24.38 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.978 0.511 . . . . 0.0 111.316 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.3 mt -144.35 157.17 44.4 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.44 1.496 . . . . 0.0 108.28 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 88.2 p -81.52 157.16 24.92 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 170.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -55.68 -44.03 76.94 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -56.29 -56.35 24.79 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 123.671 0.653 . . . . 0.0 111.852 177.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -60.89 -41.25 95.65 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 118.211 1.005 . . . . 0.0 111.298 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 37.6 tp -60.95 -50.99 71.15 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.877 -0.514 . . . . 0.0 109.625 178.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -54.24 -47.75 71.87 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.739 0.7 . . . . 0.0 110.407 176.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -55.05 -53.25 58.29 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.082 0.953 . . . . 0.0 109.919 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -55.21 -54.71 39.91 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.598 1.159 . . . . 0.0 110.894 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 89.8 mt -58.62 -50.17 74.82 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.311 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -55.77 -50.37 70.62 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.17 0.588 . . . . 0.0 110.467 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.8 -35.05 65.89 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.48 0.712 . . . . 0.0 111.479 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -78.03 -50.11 12.72 Favored 'General case' 0 CA--C 1.524 -0.057 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 53.0 mt -56.07 -45.23 79.39 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.049 0.539 . . . . 0.0 110.09 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.251 0 C-N-CA 123.085 0.554 . . . . 0.0 109.693 177.599 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 13.6 mt . . . . . 0 CA--C 1.527 0.076 0 CA-C-O 120.776 0.322 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.0 mm -88.02 107.12 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 123.476 0.71 . . . . 0.0 109.344 177.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -79.58 99.52 7.36 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 76.0 mt -81.85 160.76 23.4 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 122.071 0.939 . . . . 0.0 113.348 -175.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 35.4 p -134.66 163.32 30.02 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 126.951 2.1 . . . . 0.0 106.961 173.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -57.03 -44.09 82.57 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.467 0.707 . . . . 0.0 110.059 179.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -55.84 -46.01 78.27 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.939 0.896 . . . . 0.0 111.458 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.5 p -78.02 -27.26 48.85 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 122.242 -0.286 . . . . 0.0 111.207 -177.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -42.15 -46.79 4.47 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.252 1.421 . . . . 0.0 113.499 -177.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -51.88 -64.83 0.69 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.902 0.858 . . . . 0.0 111.261 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.9 m -68.67 -40.6 80.08 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.106 -174.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -76.53 -55.38 5.58 Favored 'General case' 0 N--CA 1.451 -0.375 0 O-C-N 122.251 -0.281 . . . . 0.0 111.659 -177.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.4 t -91.72 -53.31 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -172.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 68.8 mt -66.26 -37.03 84.51 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 118.924 -1.11 . . . . 0.0 111.163 -176.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -93.68 33.54 1.28 Allowed 'General case' 0 CA--C 1.543 0.711 0 O-C-N 122.064 -0.398 . . . . 0.0 110.048 173.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.94 81.47 0.3 Allowed 'General case' 0 C--N 1.342 0.258 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -77.41 62.87 2.48 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 174.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 163.3 176.47 35.33 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 126.464 1.983 . . . . 0.0 108.432 -177.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.12 123.57 32.92 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 117.605 0.703 . . . . 0.0 109.93 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.2 mt -126.07 120.63 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 124.429 1.092 . . . . 0.0 109.88 -179.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.6 tp -92.18 97.0 10.64 Favored 'General case' 0 N--CA 1.458 -0.064 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 176.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.6 t -86.6 103.88 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 123.757 0.823 . . . . 0.0 108.946 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -95.2 108.18 20.3 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.214 1.005 . . . . 0.0 108.495 177.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -79.72 129.07 34.16 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 176.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 25.8 p-90 -143.53 174.29 10.89 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.293 1.037 . . . . 0.0 112.8 -176.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.49 144.44 20.68 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 125.736 1.615 . . . . 0.0 108.359 176.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -50.09 -49.19 52.38 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.804 0.842 . . . . 0.0 111.981 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 59.8 p-90 -66.55 -22.65 66.15 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -177.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 49.3 t -79.79 69.87 6.21 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 121.439 -0.788 . . . . 0.0 111.233 -176.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -16.64 -65.74 0.01 OUTLIER Glycine 0 CA--C 1.535 1.307 0 C-N-CA 128.128 2.775 . . . . 0.0 115.889 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -44.08 -31.29 3.88 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 124.533 3.489 . . . . 0.0 115.253 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 96.1 m -53.44 -41.62 66.27 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.804 -0.56 . . . . 0.0 109.831 176.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -67.4 -28.24 67.75 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.651 0.781 . . . . 0.0 111.161 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 84.1 mtp -74.76 -45.23 45.19 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 29.9 pt -74.56 -28.02 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.88 177.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -38.09 -59.55 1.18 Allowed Pre-proline 0 CA--C 1.544 0.749 0 CA-C-N 119.899 1.227 . . . . 0.0 114.286 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -56.15 -40.21 86.29 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.179 1.919 . . . . 0.0 111.498 177.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 19.7 mt -59.4 -51.01 77.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 55.5 mt -55.63 -41.62 73.78 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.691 0.396 . . . . 0.0 110.054 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -61.44 -48.55 80.64 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.569 0.622 . . . . 0.0 110.61 177.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -55.94 -51.6 67.09 Favored 'General case' 0 N--CA 1.457 -0.083 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 33.4 mm -55.8 -46.87 80.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 123.377 0.671 . . . . 0.0 110.031 177.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.18 -40.48 67.57 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.212 0.605 . . . . 0.0 110.575 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -71.95 -58.58 3.32 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 176.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -47.54 -48.13 27.72 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.004 1.322 . . . . 0.0 112.921 -178.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -102.39 22.36 13.54 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.726 0.81 . . . . 0.0 111.45 -178.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -54.31 131.66 42.28 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.988 0.813 . . . . 0.0 110.731 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.36 -19.87 9.9 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-O 119.25 -0.75 . . . . 0.0 112.953 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -99.56 -41.17 7.47 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.594 1.197 . . . . 0.0 109.478 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.4 tp -128.38 126.45 40.69 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.78 1.232 . . . . 0.0 108.74 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 45.8 m -88.7 103.55 16.05 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 175.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.2 t -79.53 130.18 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -132.34 145.03 50.96 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 122.802 0.441 . . . . 0.0 110.3 -178.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.7 mtmt -124.05 104.87 9.13 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 124.231 1.012 . . . . 0.0 109.127 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.3 tt -97.54 115.47 27.9 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 121.695 -0.628 . . . . 0.0 110.556 -175.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -79.23 107.96 12.37 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.933 -178.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.2 pt -71.41 -32.14 45.57 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-O 118.997 -0.525 . . . . 0.0 111.969 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -54.97 -27.62 45.23 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.147 0.885 . . . . 0.0 111.749 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -109.84 -0.64 18.26 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.131 0.972 . . . . 0.0 111.406 177.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -146.93 62.5 7.5 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 124.068 0.947 . . . . 0.0 110.853 178.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -56.46 -48.23 20.07 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 121.75 1.633 . . . . 0.0 111.863 -178.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -40.68 -39.99 2.0 Allowed Glycine 0 CA--C 1.529 0.943 0 C-N-CA 126.106 1.812 . . . . 0.0 115.077 -177.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.59 -23.97 67.44 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 118.519 1.16 . . . . 0.0 112.808 -178.16 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.19 -62.69 5.13 Favored Pre-proline 0 CA--C 1.54 0.569 0 O-C-N 121.112 -0.992 . . . . 0.0 113.348 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -58.05 -34.13 98.09 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 C-N-CA 122.31 2.007 . . . . 0.0 111.906 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -52.58 -29.24 24.71 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.0 0.818 . . . . 0.0 112.024 177.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -119.29 17.72 13.05 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.223 0.609 . . . . 0.0 111.174 177.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 49.17 39.52 27.44 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 124.706 1.146 . . . . 0.0 112.006 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 58.6 mt -64.02 130.72 29.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 121.28 0.562 . . . . 0.0 110.335 -178.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -79.26 -34.72 42.37 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 125.332 1.453 . . . . 0.0 112.602 -175.035 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -175.92 -157.07 16.27 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 107.41 -2.276 . . . . 0.0 107.41 -178.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.9 pt -147.37 158.44 43.88 Favored Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -70.15 140.29 60.85 Favored 'Cis proline' 0 N--CA 1.458 -0.587 0 N-CA-C 109.289 -1.081 . . . . 0.0 109.289 -1.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 26.6 m -136.85 123.96 21.66 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -179.022 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.6 mt -100.84 119.24 38.38 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.143 1.777 . . . . 0.0 109.718 -176.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.8 mp -114.55 117.4 30.81 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 173.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 tp -93.38 100.8 13.06 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -90.38 136.67 32.91 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.476 1.11 . . . . 0.0 110.023 -178.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -139.44 119.35 13.38 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.746 1.619 . . . . 0.0 106.663 177.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 54.26 41.55 31.94 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.786 0.721 . . . . 0.0 110.211 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 73.56 -11.84 5.18 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 119.051 -0.861 . . . . 0.0 114.41 -178.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -93.73 136.39 34.07 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 119.139 1.47 . . . . 0.0 109.567 -178.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 95.8 t -73.12 112.85 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 175.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.87 -40.85 31.37 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -158.73 158.71 34.18 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 176.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 89.1 m -134.27 145.21 48.89 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.752 1.221 . . . . 0.0 108.285 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -137.38 122.59 19.26 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 63.5 t -104.11 126.61 58.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.53 166.43 28.55 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.09 0.852 . . . . 0.0 112.219 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.45 170.87 12.35 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.755 0.822 . . . . 0.0 111.542 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -162.96 172.7 14.67 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 124.885 1.274 . . . . 0.0 109.964 -178.143 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 90.9 p -88.02 162.7 16.68 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.513 0.725 . . . . 0.0 110.101 178.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -54.95 -45.04 74.85 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 175.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.52 -60.61 8.55 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 177.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -54.04 -42.08 68.78 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 117.858 0.829 . . . . 0.0 111.641 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 15.9 tp -59.37 -50.97 71.91 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 176.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -57.87 -42.13 83.89 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.397 -0.814 . . . . 0.0 111.988 178.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -57.92 -52.67 64.52 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.138 0.881 . . . . 0.0 109.493 175.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -52.82 -52.3 57.56 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.887 0.875 . . . . 0.0 110.332 179.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.9 mt -56.99 -53.97 52.03 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.853 0.461 . . . . 0.0 110.399 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -52.57 -51.11 61.32 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 122.754 0.422 . . . . 0.0 110.65 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.15 -39.12 69.11 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.1 0.56 . . . . 0.0 111.733 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -78.71 -42.11 29.21 Favored 'General case' 0 N--CA 1.462 0.128 0 O-C-N 122.223 -0.298 . . . . 0.0 111.567 -178.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 59.4 mt -64.64 -45.09 88.27 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.225 0 C-N-CA 123.016 0.526 . . . . 0.0 109.816 177.921 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.9 mt . . . . . 0 N--CA 1.453 -0.321 0 CA-C-O 120.84 0.352 . . . . 0.0 110.514 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.1 mm -87.81 114.39 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-O 121.237 0.542 . . . . 0.0 109.802 177.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 63.0 m80 -83.98 96.97 9.01 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 62.4 mt -86.95 163.57 17.04 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.247 1.019 . . . . 0.0 112.342 -175.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 31.4 p -138.71 165.15 27.7 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.15 1.78 . . . . 0.0 106.517 174.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -55.25 -46.68 76.08 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.034 0.534 . . . . 0.0 109.876 178.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -59.72 -43.54 94.12 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.099 0.959 . . . . 0.0 112.158 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.3 p -78.47 -29.8 47.01 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 122.084 -0.385 . . . . 0.0 111.419 -176.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -37.19 -49.12 0.89 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.244 1.818 . . . . 0.0 113.515 -179.211 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -50.36 -64.6 0.76 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 121.74 0.781 . . . . 0.0 110.955 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 m -69.83 -46.36 65.8 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.855 -175.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -77.21 -21.55 53.71 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 114.935 1.458 . . . . 0.0 114.935 -173.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.3 t -120.48 -61.37 2.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 119.475 1.034 . . . . 0.0 109.753 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 67.0 mt -60.33 -39.92 88.83 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -174.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -94.89 12.52 27.91 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.281 0.491 . . . . 0.0 111.511 178.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.91 98.61 11.17 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.01 0.823 . . . . 0.0 111.654 -178.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -76.44 67.1 2.58 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.492 0.663 . . . . 0.0 109.742 177.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -164.88 162.84 35.96 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.71 112.1 18.57 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.067 0.547 . . . . 0.0 110.47 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.7 mt -118.65 114.21 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 125.288 1.435 . . . . 0.0 110.666 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.9 tp -83.39 96.63 8.6 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 174.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.2 t -86.33 114.93 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 C-N-CA 123.243 0.617 . . . . 0.0 109.611 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -98.31 105.45 17.59 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.495 1.118 . . . . 0.0 108.501 177.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -79.79 121.64 25.62 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 104.672 -2.344 . . . . 0.0 104.672 174.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 38.5 p-90 -135.11 170.35 16.04 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 124.141 0.976 . . . . 0.0 113.347 -175.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.59 125.55 13.6 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.744 1.618 . . . . 0.0 107.558 177.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -46.65 -45.44 19.22 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.416 1.086 . . . . 0.0 113.915 -177.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 55.5 p-90 -68.93 -23.64 64.19 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.956 0.502 . . . . 0.0 112.316 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 42.4 t -79.86 74.24 6.59 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 121.284 -0.885 . . . . 0.0 111.083 -177.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -13.07 -66.15 0.01 OUTLIER Glycine 0 CA--C 1.535 1.319 0 C-N-CA 128.48 2.943 . . . . 0.0 115.891 178.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -41.27 -36.78 2.72 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 124.264 3.309 . . . . 0.0 114.881 178.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 98.8 m -56.11 -48.01 76.98 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.386 0.674 . . . . 0.0 110.003 177.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -64.77 -38.04 89.65 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.549 0.74 . . . . 0.0 109.345 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 52.6 mtm -64.28 -43.96 93.16 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 119.505 -0.283 . . . . 0.0 111.032 178.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 29.8 pt -76.33 -26.69 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 118.74 0.7 . . . . 0.0 112.494 179.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -38.17 -58.85 1.36 Allowed Pre-proline 0 CA--C 1.545 0.756 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -57.27 -39.71 87.85 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 121.959 1.773 . . . . 0.0 111.654 178.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 19.1 mt -59.35 -50.75 78.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 177.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.6 mt -56.05 -43.38 77.84 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.744 0.418 . . . . 0.0 110.434 178.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -59.58 -49.32 78.23 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.603 0.638 . . . . 0.0 109.683 177.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -56.34 -49.78 73.39 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 28.8 mm -56.02 -49.97 72.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 123.206 0.602 . . . . 0.0 109.709 177.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.77 -45.96 63.94 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.288 0.635 . . . . 0.0 110.296 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -66.3 -58.04 6.2 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.938 -0.119 . . . . 0.0 110.738 177.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -48.19 -49.25 33.49 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.52 1.128 . . . . 0.0 112.748 -177.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -98.05 21.79 10.27 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.231 0.612 . . . . 0.0 111.851 -177.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -52.81 128.35 26.47 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.597 1.089 . . . . 0.0 110.824 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.12 -17.35 23.42 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-O 119.33 -0.705 . . . . 0.0 113.419 -178.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -99.29 -42.95 6.78 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 118.477 1.138 . . . . 0.0 109.065 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.3 tp -136.29 137.7 40.99 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.444 1.497 . . . . 0.0 107.274 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.5 m -98.37 140.77 32.14 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 173.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 96.3 t -113.01 141.31 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 177.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -138.03 152.33 48.74 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -128.37 133.4 48.63 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.5 tt -127.8 115.75 19.13 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.72 0.808 . . . . 0.0 109.104 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -80.25 110.01 15.26 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 pp -67.76 -32.54 57.09 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.149 0 C-N-CA 123.412 0.685 . . . . 0.0 112.808 -177.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -60.36 -47.74 84.74 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 118.963 0.801 . . . . 0.0 109.155 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -69.42 -37.26 77.36 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.92 0.888 . . . . 0.0 110.131 177.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -119.87 72.31 16.55 Favored Pre-proline 0 C--O 1.233 0.231 0 C-N-CA 124.007 0.923 . . . . 0.0 111.779 -175.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -61.49 -53.6 2.22 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 122.361 2.04 . . . . 0.0 112.418 -177.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -38.32 -47.93 2.13 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 125.351 1.453 . . . . 0.0 114.377 -177.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.56 -33.34 45.26 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.299 1.039 . . . . 0.0 113.092 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.88 -68.43 0.72 Allowed Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 118.149 -0.929 . . . . 0.0 112.511 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -59.41 -38.23 85.2 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 121.68 1.587 . . . . 0.0 111.048 178.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -50.92 -39.44 54.61 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-N 118.903 0.774 . . . . 0.0 111.53 178.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -108.8 20.93 17.9 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 122.884 0.474 . . . . 0.0 112.132 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 51.49 38.82 43.5 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 124.128 0.87 . . . . 0.0 113.465 176.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mp -57.43 125.66 13.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 118.092 0.946 . . . . 0.0 108.47 177.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -88.92 -47.59 8.05 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.465 1.106 . . . . 0.0 109.118 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -166.64 145.41 9.92 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 107.363 -2.295 . . . . 0.0 107.363 178.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.497 ' H ' HD13 ' A' ' 75' ' ' ILE . 0.2 OUTLIER -91.19 154.71 44.87 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-O 118.834 -0.603 . . . . 0.0 110.306 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.31 129.26 12.46 Favored 'Cis proline' 0 N--CA 1.457 -0.624 0 CA-C-N 119.973 1.026 . . . . 0.0 110.628 -1.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -113.72 109.28 18.31 Favored 'General case' 0 N--CA 1.461 0.076 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 178.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.1 mt -89.75 122.55 32.95 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.0 mp -122.96 114.68 20.75 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 177.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 tp -90.11 95.93 10.44 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -87.02 142.29 28.04 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.688 1.195 . . . . 0.0 111.571 -177.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -137.81 109.61 7.12 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 174.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 52.31 48.67 22.16 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 118.983 0.81 . . . . 0.0 110.073 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.71 -13.21 2.42 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 118.731 -1.038 . . . . 0.0 114.957 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -88.59 125.25 34.71 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 119.637 1.719 . . . . 0.0 108.873 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 73.2 t -71.82 114.07 9.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 175.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.94 -41.25 29.82 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.304 0.641 . . . . 0.0 109.398 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -159.18 170.06 22.78 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 177.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.1 t -149.3 162.77 39.39 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -146.88 119.78 8.71 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.171 1.388 . . . . 0.0 108.08 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.2 t -94.24 120.71 44.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.39 174.92 29.97 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 121.537 0.52 . . . . 0.0 112.211 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.21 172.25 9.59 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.777 0.831 . . . . 0.0 112.156 -178.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.9 mt -144.4 158.47 43.73 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 125.81 1.644 . . . . 0.0 108.506 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.3 p -87.03 152.02 22.74 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 169.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -50.53 -47.93 57.33 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 122.065 -0.397 . . . . 0.0 111.006 -178.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.64 -53.53 38.44 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -62.38 -39.7 94.06 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.98 -0.718 . . . . 0.0 111.291 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 30.6 tp -62.53 -49.43 75.37 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -56.22 -44.92 80.03 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.429 0.559 . . . . 0.0 110.492 176.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -56.27 -54.68 42.46 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.569 0.748 . . . . 0.0 109.887 177.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -53.4 -51.66 61.83 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.669 1.188 . . . . 0.0 110.357 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.9 mt -58.83 -50.77 72.74 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.519 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -55.33 -49.86 71.12 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.8 -36.89 67.92 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.468 0.707 . . . . 0.0 111.601 178.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -78.06 -47.43 18.36 Favored 'General case' 0 C--N 1.337 0.042 0 O-C-N 122.113 -0.367 . . . . 0.0 110.475 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 54.2 mt -59.37 -44.67 92.7 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.227 0.611 . . . . 0.0 109.531 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.244 0 C-N-CA 122.933 0.493 . . . . 0.0 109.707 177.743 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.7 mt . . . . . 0 N--CA 1.447 -0.614 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.2 mm -87.71 108.78 18.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 176.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 27.1 m-70 -79.77 94.69 5.81 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 177.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 66.9 mt -82.09 159.18 23.47 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.832 0.853 . . . . 0.0 112.433 -177.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 26.6 p -134.25 163.15 30.27 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.991 1.716 . . . . 0.0 106.947 173.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -55.62 -46.58 77.37 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.492 0.717 . . . . 0.0 110.656 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -55.98 -45.13 79.07 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.997 0.919 . . . . 0.0 111.468 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.9 p -78.34 -29.78 47.76 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 111.6 0.222 . . . . 0.0 111.6 -177.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -37.62 -53.59 1.2 Allowed 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 125.782 1.633 . . . . 0.0 114.473 -176.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -50.87 -62.2 1.75 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.611 0.719 . . . . 0.0 111.045 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -66.39 -49.53 66.51 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.944 -176.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -74.39 -21.0 59.86 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -173.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.5 t -119.51 -64.99 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.23 0.066 0 CA-C-N 119.326 0.966 . . . . 0.0 110.161 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 67.9 mt -59.66 -37.46 78.79 Favored 'General case' 0 C--N 1.334 -0.082 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 -174.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -98.61 15.75 24.1 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.428 0.558 . . . . 0.0 111.949 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.58 108.39 20.98 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 118.979 0.809 . . . . 0.0 111.047 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -75.38 63.97 1.49 Allowed 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.933 1.293 . . . . 0.0 111.336 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -163.81 178.38 39.29 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.61 105.66 17.9 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.134 1.374 . . . . 0.0 109.44 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.7 mt -112.38 117.35 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 124.144 0.978 . . . . 0.0 110.352 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.5 tp -90.5 97.89 11.45 Favored 'General case' 0 CA--C 1.523 -0.062 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 175.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.8 t -88.78 111.79 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -95.54 106.8 18.93 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.709 1.204 . . . . 0.0 108.601 176.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -80.5 125.17 29.63 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 175.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 31.1 p-90 -143.84 176.2 9.43 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.858 0.863 . . . . 0.0 112.574 -174.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.17 144.71 16.15 Favored 'General case' 0 C--N 1.338 0.092 0 C-N-CA 125.065 1.346 . . . . 0.0 108.476 175.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 -48.93 -50.69 34.15 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.789 1.236 . . . . 0.0 112.099 -178.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 63.9 p-90 -60.41 -29.84 69.22 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -177.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 49.5 t -79.82 77.88 6.45 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 121.514 -0.741 . . . . 0.0 110.52 -178.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -24.66 -62.1 0.05 OUTLIER Glycine 0 CA--C 1.536 1.399 0 C-N-CA 127.094 2.283 . . . . 0.0 115.084 179.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -43.88 -31.16 3.49 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 124.683 3.589 . . . . 0.0 115.192 179.162 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 98.8 m -55.09 -42.73 73.21 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.688 -0.633 . . . . 0.0 109.705 176.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -67.77 -27.2 66.56 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.712 0.805 . . . . 0.0 111.007 178.037 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 12.7 tmm? -72.3 -48.99 38.03 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 43.5 pt -70.39 -31.49 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 118.696 -0.668 . . . . 0.0 112.209 178.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -37.53 -60.94 0.8 Allowed Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -57.48 -39.35 89.6 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.374 2.049 . . . . 0.0 111.734 178.12 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 16.1 mt -59.22 -52.27 62.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.5 mt -55.84 -43.64 77.22 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.652 0.781 . . . . 0.0 110.575 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -58.09 -50.52 73.19 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.121 0.486 . . . . 0.0 109.804 178.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -59.88 -49.98 75.57 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.6 mm -53.37 -46.59 58.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 123.688 0.795 . . . . 0.0 109.585 177.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.56 -45.96 70.08 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.753 0.421 . . . . 0.0 110.608 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -66.43 -55.65 14.73 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 177.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -50.36 -47.82 55.9 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.931 0.892 . . . . 0.0 112.291 -177.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -98.31 23.74 8.04 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.813 0.845 . . . . 0.0 111.614 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -53.82 130.86 38.49 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 119.396 0.998 . . . . 0.0 110.526 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.24 -18.64 12.92 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 119.151 -0.805 . . . . 0.0 113.087 -178.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -99.3 -42.38 7.03 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.788 1.294 . . . . 0.0 109.288 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.0 tp -132.42 131.87 42.22 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.511 1.125 . . . . 0.0 108.667 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 90.4 m -96.27 104.37 16.32 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 176.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 90.7 t -79.74 134.66 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.08 150.02 51.16 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.296 0.639 . . . . 0.0 109.284 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -126.39 136.27 52.48 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 178.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.5 tt -129.45 115.13 17.04 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.412 0.685 . . . . 0.0 109.16 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -80.63 111.11 16.75 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.1 pt -73.19 -25.1 21.19 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.139 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -177.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -61.54 -46.96 87.71 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 177.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -70.6 -40.13 73.41 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.222 1.009 . . . . 0.0 109.894 177.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -120.53 69.77 16.36 Favored Pre-proline 0 CA--C 1.532 0.269 0 C-N-CA 124.06 0.944 . . . . 0.0 112.691 -175.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -65.54 -41.42 15.23 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 121.802 1.668 . . . . 0.0 110.653 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -43.99 -35.99 3.65 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 125.569 1.557 . . . . 0.0 114.913 -178.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.98 -20.41 61.73 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.604 1.202 . . . . 0.0 112.92 -177.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.25 -59.22 13.6 Favored Pre-proline 0 CA--C 1.539 0.538 0 O-C-N 121.111 -0.993 . . . . 0.0 113.226 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -58.17 -33.25 97.29 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.281 1.987 . . . . 0.0 111.805 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -52.98 -29.0 26.48 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.87 0.759 . . . . 0.0 111.929 177.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -122.94 20.47 10.0 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.464 0.705 . . . . 0.0 110.57 177.024 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 40.3 43.39 2.74 Favored Glycine 0 C--N 1.342 0.875 0 C-N-CA 126.03 1.776 . . . . 0.0 111.535 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.5 mt -54.06 138.39 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -174.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.51 -41.4 32.47 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.55 1.14 . . . . 0.0 111.219 -174.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -178.25 -150.94 9.01 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 106.674 -2.57 . . . . 0.0 106.674 -177.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.3 pt -148.36 154.31 41.75 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 118.856 1.328 . . . . 0.0 108.979 178.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -70.72 141.41 68.38 Favored 'Cis proline' 0 N--CA 1.455 -0.767 0 CA-C-N 119.786 0.959 . . . . 0.0 110.333 -1.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 43.5 m -133.79 125.92 29.5 Favored 'General case' 0 C--O 1.231 0.111 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 178.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.2 mt -103.58 124.96 49.77 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.89 1.276 . . . . 0.0 109.15 -177.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -114.52 117.35 30.69 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 105.064 -2.199 . . . . 0.0 105.064 174.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.5 tp -94.98 95.41 8.6 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -86.88 102.9 14.77 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.162 1.385 . . . . 0.0 110.052 -178.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -97.93 114.68 26.85 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 174.032 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 54.23 46.99 24.11 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.536 0.734 . . . . 0.0 109.981 -178.038 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 69.55 -1.8 13.15 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-O 118.62 -1.1 . . . . 0.0 114.414 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -103.46 128.97 50.51 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 119.657 1.728 . . . . 0.0 109.253 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 98.8 t -66.35 102.7 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.17 -38.54 35.64 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.696 0.799 . . . . 0.0 109.652 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -150.76 167.29 27.88 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 97.4 m -147.49 149.92 33.57 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.13 141.31 31.16 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -177.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 36.7 t -125.36 128.44 72.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.38 175.87 37.37 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 123.829 0.728 . . . . 0.0 111.649 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.73 173.16 9.47 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.455 0.702 . . . . 0.0 111.44 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.0 mt -146.4 161.69 39.83 Favored 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 125.28 1.432 . . . . 0.0 109.333 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.6 p -92.47 152.42 19.69 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 169.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -51.1 -47.46 61.93 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 122.138 -0.351 . . . . 0.0 111.522 -177.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.8 -60.31 8.9 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -54.46 -41.36 69.38 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.989 -0.712 . . . . 0.0 111.422 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 30.3 tp -60.79 -48.67 80.74 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -55.65 -48.0 75.73 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 118.903 -0.57 . . . . 0.0 110.298 176.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -56.0 -52.13 65.31 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.975 0.807 . . . . 0.0 110.515 178.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -52.05 -51.34 58.14 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.789 0.835 . . . . 0.0 110.429 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 90.1 mt -61.97 -52.33 64.45 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.503 0.321 . . . . 0.0 110.723 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -50.55 -49.79 55.1 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.67 1.188 . . . . 0.0 110.126 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.47 -36.17 68.78 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.402 0.681 . . . . 0.0 111.906 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -78.88 -45.81 19.86 Favored 'General case' 0 N--CA 1.46 0.043 0 O-C-N 122.23 -0.294 . . . . 0.0 110.538 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 56.2 mt -60.26 -43.66 95.98 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.445 0.698 . . . . 0.0 109.655 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.278 0 C-N-CA 122.948 0.499 . . . . 0.0 109.795 177.827 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.3 mt . . . . . 0 N--CA 1.449 -0.505 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.9 mm -87.79 111.29 21.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 123.599 0.76 . . . . 0.0 109.073 178.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -83.04 101.21 10.97 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 70.7 mt -83.23 163.49 20.71 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.543 1.137 . . . . 0.0 112.139 -177.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 62.2 p -131.51 162.42 30.29 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 173.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -59.25 -46.09 89.43 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.866 0.757 . . . . 0.0 109.543 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -62.72 -41.62 99.25 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.896 0.478 . . . . 0.0 111.713 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 54.4 p -78.33 -26.16 46.75 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.409 0.55 . . . . 0.0 111.175 -177.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -41.85 -44.9 3.5 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 126.419 1.888 . . . . 0.0 112.415 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -53.25 -63.17 1.23 Allowed 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.535 0.684 . . . . 0.0 110.637 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.0 m -66.79 -42.63 85.65 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.742 -177.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -70.52 -50.14 40.89 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -175.004 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.0 t -100.07 -57.87 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 123.882 0.873 . . . . 0.0 111.141 -174.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 67.0 mt -63.21 -37.01 85.56 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 120.22 -0.592 . . . . 0.0 112.311 -174.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -94.5 21.94 6.68 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.344 0.52 . . . . 0.0 111.08 175.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.78 159.45 34.52 Favored 'General case' 0 C--N 1.34 0.16 0 O-C-N 121.471 -0.768 . . . . 0.0 110.568 177.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -138.6 58.41 1.66 Allowed 'General case' 0 C--O 1.226 -0.155 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 175.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 175.25 -174.2 46.66 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -178.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -86.55 128.28 34.96 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.595 1.158 . . . . 0.0 110.281 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.7 mt -132.99 121.08 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 124.417 1.087 . . . . 0.0 109.603 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -95.35 109.51 21.66 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 175.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.1 t -100.46 108.59 23.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 123.16 0.584 . . . . 0.0 110.043 -178.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -93.7 105.19 17.24 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.125 0.97 . . . . 0.0 109.745 178.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -79.57 114.25 18.35 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 105.048 -2.204 . . . . 0.0 105.048 174.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 39.4 p-90 -128.25 170.55 12.9 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.836 1.255 . . . . 0.0 112.185 -176.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -146.24 131.56 18.54 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.283 1.433 . . . . 0.0 107.763 176.251 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 -51.14 -37.05 43.98 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.923 0.889 . . . . 0.0 113.24 -178.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 57.7 p-90 -77.9 -20.49 52.83 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 52.8 t -79.83 74.16 6.56 Favored 'General case' 0 N--CA 1.456 -0.138 0 O-C-N 121.228 -0.92 . . . . 0.0 110.745 -177.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -9.68 -71.39 0.01 OUTLIER Glycine 0 CA--C 1.535 1.329 0 C-N-CA 128.294 2.854 . . . . 0.0 115.699 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -40.91 -32.81 0.97 Allowed 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 125.207 3.938 . . . . 0.0 115.61 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 89.3 m -52.66 -41.82 64.16 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.368 0.667 . . . . 0.0 110.207 177.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -66.23 -30.23 70.63 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.717 0.807 . . . . 0.0 111.234 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -75.61 -45.02 39.83 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.9 pt -73.28 -31.15 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-O 118.712 -0.661 . . . . 0.0 112.333 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -39.32 -60.95 1.09 Allowed Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -58.11 -36.86 97.57 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.376 2.051 . . . . 0.0 111.893 178.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 19.7 mt -60.92 -51.79 69.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 177.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.6 mt -56.31 -41.34 75.84 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.189 0.596 . . . . 0.0 110.117 177.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -60.76 -47.87 84.35 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.841 0.746 . . . . 0.0 110.093 176.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -56.91 -51.88 67.38 Favored 'General case' 0 C--N 1.339 0.117 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 31.4 mm -53.72 -46.12 61.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 123.302 0.641 . . . . 0.0 109.498 177.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.65 -36.75 67.39 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.939 0.496 . . . . 0.0 111.223 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -74.5 -58.14 3.48 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.938 0.399 . . . . 0.0 109.986 176.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -50.36 -41.91 52.36 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.734 1.214 . . . . 0.0 112.532 -177.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -107.07 25.45 11.36 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.642 1.177 . . . . 0.0 111.021 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -56.94 121.84 10.87 Favored 'General case' 0 CA--C 1.529 0.173 0 O-C-N 121.545 -0.722 . . . . 0.0 110.39 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.06 -9.83 55.54 Favored Glycine 0 CA--C 1.531 1.094 0 CA-C-O 119.556 -0.58 . . . . 0.0 112.85 -178.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 47.4 mttt -99.71 -41.3 7.35 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.691 1.196 . . . . 0.0 108.664 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 47.7 tp -131.82 133.6 44.86 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.572 1.149 . . . . 0.0 108.708 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.2 m -88.08 98.49 11.56 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 176.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 80.5 t -79.09 128.95 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 178.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.65 150.64 50.68 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.276 0.56 . . . . 0.0 110.662 -177.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -127.54 143.45 51.18 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.972 1.309 . . . . 0.0 107.597 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 tt -134.2 115.19 13.89 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -80.83 105.05 11.76 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pp -58.97 -33.87 51.25 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.242 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -177.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -63.05 -44.31 96.23 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.704 0.684 . . . . 0.0 110.226 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -72.06 -31.49 66.18 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 177.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -128.53 69.79 79.41 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -176.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.02 -50.89 10.89 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.488 2.792 . . . . 0.0 113.408 -178.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -41.37 -40.1 2.56 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 125.431 1.491 . . . . 0.0 114.34 -176.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.88 -30.64 69.13 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.767 -0.843 . . . . 0.0 113.113 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.11 -64.57 2.19 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-O 118.259 -0.877 . . . . 0.0 112.292 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -60.02 -37.21 86.3 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 121.833 1.689 . . . . 0.0 111.511 177.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -52.34 -37.18 55.35 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 119.386 0.994 . . . . 0.0 111.791 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -111.49 20.9 16.76 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.922 0.489 . . . . 0.0 110.92 177.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 41.9 45.08 4.73 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 125.537 1.541 . . . . 0.0 112.901 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mp -47.89 116.45 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 117.702 0.751 . . . . 0.0 110.411 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.41 -49.62 12.07 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.179 0.992 . . . . 0.0 110.295 -177.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -161.9 144.1 9.43 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 107.419 -2.272 . . . . 0.0 107.419 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.7 pt -96.85 150.8 37.31 Favored Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 123.837 0.855 . . . . 0.0 110.246 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -70.23 137.28 44.1 Favored 'Cis proline' 0 N--CA 1.457 -0.672 0 CA-C-N 119.591 0.89 . . . . 0.0 110.597 -1.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -115.43 118.91 34.51 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.3 mt -102.37 105.51 16.12 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -179.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -94.21 114.36 26.45 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 104.781 -2.304 . . . . 0.0 104.781 175.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.6 tp -97.24 105.53 17.7 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -179.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -94.18 150.01 20.71 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.584 1.554 . . . . 0.0 110.712 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -139.63 107.04 5.54 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 173.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 51.01 70.81 0.49 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.548 0.689 . . . . 0.0 111.457 -179.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 73.4 -37.09 0.82 Allowed Glycine 0 CA--C 1.531 1.04 0 N-CA-C 115.923 1.129 . . . . 0.0 115.923 176.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -90.14 147.88 23.32 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.146 1.473 . . . . 0.0 111.373 -177.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 75.3 t -74.38 114.66 14.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 175.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.04 -46.66 13.63 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.62 1.168 . . . . 0.0 109.852 178.405 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -148.64 170.85 17.22 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 58.9 m -152.57 144.92 24.0 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -177.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -135.29 143.88 46.46 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.4 t -121.94 120.77 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 178.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.03 169.7 35.05 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -177.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.27 170.53 8.57 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.983 0.913 . . . . 0.0 112.882 -178.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.1 mt -142.63 155.76 44.98 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 125.977 1.711 . . . . 0.0 108.572 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.6 p -87.78 152.51 22.06 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 171.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -48.21 -52.35 21.33 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -176.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -53.71 -57.26 16.63 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 26.8 mm100 -57.74 -40.93 80.79 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 122.194 -0.592 . . . . 0.0 111.122 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 42.2 tp -62.13 -49.4 76.01 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 177.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -54.1 -45.99 71.97 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.387 0.54 . . . . 0.0 110.403 176.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -57.96 -54.87 42.04 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 122.92 0.488 . . . . 0.0 110.453 178.034 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -51.44 -52.21 48.24 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.757 1.223 . . . . 0.0 110.584 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 85.4 mt -61.24 -53.39 57.45 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.805 0.442 . . . . 0.0 110.418 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -51.54 -50.29 60.3 Favored 'General case' 0 C--N 1.334 -0.083 0 C-N-CA 123.765 0.826 . . . . 0.0 111.067 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.82 -37.65 66.38 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.354 0.662 . . . . 0.0 111.654 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -78.78 -43.52 25.31 Favored 'General case' 0 N--CA 1.46 0.073 0 C-N-CA 122.456 0.302 . . . . 0.0 110.587 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 40.4 mt -58.82 -47.06 86.13 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.289 0 C-N-CA 123.364 0.666 . . . . 0.0 109.69 177.656 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 22.0 mt . . . . . 0 N--CA 1.447 -0.583 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.5 mm -88.03 112.09 23.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 -80.28 102.4 9.49 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 72.7 mt -90.93 161.96 14.97 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 121.814 0.816 . . . . 0.0 112.258 -177.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 82.6 p -139.96 167.15 22.78 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.733 2.013 . . . . 0.0 106.444 175.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -55.22 -47.77 74.87 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.459 0.704 . . . . 0.0 110.656 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -61.8 -40.15 94.22 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.2 p -78.74 -29.99 45.53 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 122.109 -0.369 . . . . 0.0 110.727 -178.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -39.27 -52.83 1.97 Allowed 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 125.841 1.656 . . . . 0.0 113.436 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -55.6 -59.18 5.2 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 121.868 -0.52 . . . . 0.0 110.908 -179.046 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.1 m -59.11 -48.85 80.08 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.222 1.009 . . . . 0.0 112.569 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.96 -47.1 16.97 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -174.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.8 t -94.56 -52.39 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 C-N-CA 123.347 0.659 . . . . 0.0 112.504 -174.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 73.6 mt -71.4 -42.72 68.0 Favored 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 119.545 -0.862 . . . . 0.0 111.218 -175.19 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -91.64 35.32 0.96 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 176.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -78.1 162.1 26.92 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.415 0.686 . . . . 0.0 111.987 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -141.8 94.28 2.66 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 172.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 135.52 -175.51 20.7 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -176.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.05 111.59 23.32 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.374 1.47 . . . . 0.0 109.687 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.0 mt -109.07 115.98 50.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 124.153 0.981 . . . . 0.0 109.686 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.6 tp -90.14 96.97 10.92 Favored 'General case' 0 C--N 1.338 0.076 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 176.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 45.4 t -88.51 114.58 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 123.328 0.651 . . . . 0.0 109.899 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -98.87 106.09 18.31 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 176.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -79.73 120.05 23.49 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 175.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 37.6 p-90 -133.84 170.52 15.47 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.332 1.053 . . . . 0.0 113.152 -175.038 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -142.76 138.68 30.64 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.192 1.397 . . . . 0.0 107.444 174.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -53.89 -47.64 70.92 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.015 0.526 . . . . 0.0 112.236 -177.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 62.6 p-90 -65.68 -23.75 66.85 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.108 0.563 . . . . 0.0 112.413 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 52.1 t -79.68 80.38 6.07 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 121.34 -0.85 . . . . 0.0 109.75 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -27.06 -59.89 0.09 OUTLIER Glycine 0 CA--C 1.535 1.304 0 C-N-CA 127.078 2.275 . . . . 0.0 114.391 178.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -41.75 -37.16 3.77 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 124.248 3.299 . . . . 0.0 114.699 177.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 75.1 m -58.24 -47.67 82.82 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.689 0.757 . . . . 0.0 109.837 177.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -65.37 -37.28 86.54 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.71 0.804 . . . . 0.0 109.094 178.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 54.3 mtm -63.44 -43.14 98.27 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 119.243 -0.408 . . . . 0.0 111.061 177.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 31.5 pt -75.46 -26.52 18.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 119.139 0.881 . . . . 0.0 112.164 178.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -38.26 -57.8 1.69 Allowed Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -57.42 -40.13 83.71 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.072 1.848 . . . . 0.0 111.499 177.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 16.4 mt -59.32 -49.19 84.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.9 mt -57.22 -43.53 82.89 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.75 0.42 . . . . 0.0 110.763 177.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.46 -50.76 72.58 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.725 0.693 . . . . 0.0 110.16 176.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -56.24 -52.1 65.68 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.4 mm -54.55 -46.88 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 124.891 1.276 . . . . 0.0 110.221 178.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.05 -44.69 79.07 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.723 0.409 . . . . 0.0 110.041 178.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -64.26 -53.34 50.48 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 177.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -49.46 -48.91 47.28 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.177 0.991 . . . . 0.0 111.684 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -100.82 29.63 4.45 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.347 0.659 . . . . 0.0 111.344 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -55.54 123.45 14.04 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.43 -0.794 . . . . 0.0 110.5 -179.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.71 -15.13 43.72 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 119.466 -0.63 . . . . 0.0 112.913 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -99.62 -40.23 7.9 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.371 1.086 . . . . 0.0 109.458 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.7 tp -126.41 132.88 51.41 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.656 1.183 . . . . 0.0 108.83 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.0 m -97.44 101.8 13.42 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 176.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 66.6 t -79.62 135.0 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 178.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.92 150.19 49.22 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.413 0.685 . . . . 0.0 109.732 -178.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 45.2 mttm -127.96 126.62 41.76 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.0 tt -116.66 115.82 26.39 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.442 0.697 . . . . 0.0 109.608 179.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -79.15 108.97 13.04 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 pp -68.37 -32.42 55.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 119.228 -0.415 . . . . 0.0 111.395 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -51.13 -33.19 25.51 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.654 0.661 . . . . 0.0 112.17 -179.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -110.43 1.32 18.26 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.41 1.084 . . . . 0.0 111.563 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -144.19 64.1 12.09 Favored Pre-proline 0 C--O 1.234 0.26 0 C-N-CA 124.42 1.088 . . . . 0.0 109.163 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -60.01 -53.33 3.22 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.646 2.231 . . . . 0.0 112.394 -177.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -38.42 -47.47 2.15 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.392 1.472 . . . . 0.0 114.478 -177.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.86 -33.29 49.14 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.367 1.067 . . . . 0.0 112.753 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.93 -68.32 0.75 Allowed Pre-proline 0 CA--C 1.54 0.564 0 CA-C-O 118.295 -0.859 . . . . 0.0 112.98 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.84 -39.36 82.31 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 121.484 1.456 . . . . 0.0 110.806 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -51.29 -38.48 53.03 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 118.415 0.552 . . . . 0.0 111.826 178.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -107.32 18.87 21.07 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 55.46 40.62 78.14 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 123.106 0.384 . . . . 0.0 113.043 176.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mp -63.52 104.31 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 176.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 47.6 mtt85 -79.62 -43.4 22.96 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.902 1.281 . . . . 0.0 110.186 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -157.49 141.91 8.18 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 107.874 -2.09 . . . . 0.0 107.874 179.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.1 pt -99.45 147.48 33.4 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 124.354 1.062 . . . . 0.0 109.762 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.57 142.41 66.88 Favored 'Cis proline' 0 N--CA 1.457 -0.649 0 CA-C-N 120.112 1.076 . . . . 0.0 111.156 0.132 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -121.38 110.69 16.4 Favored 'General case' 0 C--N 1.335 -0.062 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.2 mt -88.73 123.05 32.78 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.7 mp -122.32 118.97 29.74 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 176.08 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.8 tp -95.31 95.08 8.24 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -177.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -86.55 105.23 16.69 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.682 1.193 . . . . 0.0 110.768 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -93.62 111.07 22.67 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 173.099 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.5 m120 47.87 50.88 15.07 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.718 0.807 . . . . 0.0 111.169 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.38 -11.53 24.06 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 118.851 -0.972 . . . . 0.0 114.676 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -97.36 121.16 38.94 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 119.632 1.716 . . . . 0.0 109.745 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 89.4 t -64.07 106.08 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 175.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.98 -37.51 39.22 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.587 0.755 . . . . 0.0 109.553 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.81 170.04 21.51 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.3 t -149.59 156.89 42.67 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 178.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.2 tmtm? -138.55 116.38 11.54 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.853 1.661 . . . . 0.0 106.764 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 36.5 t -96.35 126.93 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -178.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.01 178.67 47.44 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.27 168.2 12.87 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.104 0.478 . . . . 0.0 110.342 178.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -158.09 165.33 35.28 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.842 0.857 . . . . 0.0 109.154 -178.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 83.1 p -80.2 160.29 25.67 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 177.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -58.62 -38.43 78.01 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 175.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -56.01 -54.73 33.31 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 110.656 -0.977 . . . . 0.0 110.656 176.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -52.91 -50.03 64.75 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 117.241 0.52 . . . . 0.0 110.424 177.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 14.6 tp -59.79 -50.11 75.1 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 121.141 -0.224 . . . . 0.0 110.704 -178.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -55.05 -49.14 72.34 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.185 0.594 . . . . 0.0 111.581 178.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -67.68 -43.81 79.29 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.509 -177.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -52.15 -53.0 48.32 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.655 0.782 . . . . 0.0 109.208 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 84.8 mt -59.42 -54.42 46.87 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 119.116 -0.469 . . . . 0.0 110.78 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -51.43 -50.01 60.55 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.106 0.412 . . . . 0.0 111.022 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.95 -38.8 73.44 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.492 0.717 . . . . 0.0 111.847 179.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -78.3 -40.93 35.31 Favored 'General case' 0 N--CA 1.461 0.117 0 O-C-N 122.092 -0.38 . . . . 0.0 110.995 -178.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 63.0 mt -64.14 -46.59 83.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.107 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.266 0 C-N-CA 122.922 0.489 . . . . 0.0 109.82 177.7 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.4 mt . . . . . 0 C--O 1.23 0.059 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.4 mm -87.03 108.2 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -81.68 110.55 17.12 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 177.321 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.0 mt -88.94 171.9 9.54 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.628 1.171 . . . . 0.0 110.502 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 51.0 p -136.21 164.26 28.48 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 171.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -57.1 -47.77 80.25 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 177.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -59.52 -45.35 91.99 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.674 1.19 . . . . 0.0 111.889 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 86.1 p -79.64 -24.43 41.89 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -176.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -31.7 -60.33 0.25 Allowed 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 127.121 2.169 . . . . 0.0 114.337 -178.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -52.36 -59.19 4.71 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.46 0.648 . . . . 0.0 111.048 -177.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.9 m -60.01 -41.66 92.65 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 123.6 0.76 . . . . 0.0 111.733 -178.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -74.79 -43.14 56.31 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -175.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 45.8 t -105.85 -57.31 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 C-N-CA 124.568 1.147 . . . . 0.0 112.08 -172.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 75.5 mt -61.38 -33.54 73.83 Favored 'General case' 0 N--CA 1.458 -0.037 0 O-C-N 121.702 -0.624 . . . . 0.0 111.876 -174.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -88.91 8.66 28.19 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 118.286 0.493 . . . . 0.0 111.809 177.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.79 100.58 11.02 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 121.253 -0.905 . . . . 0.0 112.489 -178.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -77.06 68.77 3.26 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 174.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -179.84 -172.11 43.5 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -178.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -99.6 115.76 30.14 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.562 1.545 . . . . 0.0 110.857 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 mt -121.53 123.44 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 125.43 1.492 . . . . 0.0 109.116 178.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.423 HD13 ' C ' ' A' ' 24' ' ' LEU . 2.9 tm? -92.86 108.32 19.9 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 175.177 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 32.2 t -97.3 109.91 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -93.57 106.36 18.34 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 177.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -79.66 125.52 29.74 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 175.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 38.0 p-90 -143.79 166.12 25.78 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -174.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -144.59 137.24 26.6 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.168 1.387 . . . . 0.0 108.909 174.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -51.75 -47.82 63.94 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.865 0.866 . . . . 0.0 112.372 -177.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 50.4 p-90 -60.75 -27.04 67.66 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 46.8 t -79.86 81.48 6.12 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 121.42 -0.8 . . . . 0.0 109.098 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -28.14 -59.17 0.13 Allowed Glycine 0 CA--C 1.538 1.525 0 C-N-CA 125.962 1.744 . . . . 0.0 114.27 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -41.89 -39.27 5.27 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 124.311 3.341 . . . . 0.0 114.464 177.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 94.1 m -56.02 -50.52 70.66 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 121.668 0.747 . . . . 0.0 109.985 176.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -64.18 -38.07 89.74 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.319 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 83.9 mtp -61.7 -44.16 97.47 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 119.472 -0.299 . . . . 0.0 110.827 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.5 pt -76.17 -26.96 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 118.741 0.7 . . . . 0.0 112.635 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -37.8 -57.93 1.48 Allowed Pre-proline 0 CA--C 1.546 0.79 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -58.14 -39.7 83.1 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.07 1.847 . . . . 0.0 111.672 178.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 14.0 mt -59.52 -49.65 82.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 177.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 44.2 mt -56.1 -42.33 76.62 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 122.564 0.346 . . . . 0.0 110.161 177.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -61.71 -46.86 87.83 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.994 0.815 . . . . 0.0 111.147 176.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -56.14 -51.12 69.1 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 24.0 mm -55.92 -44.78 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 123.428 0.691 . . . . 0.0 109.831 177.226 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.86 70.68 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 118.321 0.509 . . . . 0.0 110.787 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -72.55 -57.61 4.01 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 177.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -51.18 -46.09 62.0 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.231 1.012 . . . . 0.0 112.605 -178.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -98.26 19.82 13.6 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.438 1.095 . . . . 0.0 111.426 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -54.93 131.85 45.44 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.25 -0.906 . . . . 0.0 110.085 -178.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.25 -18.76 7.64 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 119.334 -0.703 . . . . 0.0 113.235 -178.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -99.61 -37.42 9.15 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.486 1.143 . . . . 0.0 109.923 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 26.6 tp -136.68 128.01 28.26 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.496 1.118 . . . . 0.0 108.181 178.098 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 57.6 m -88.55 105.08 17.4 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 91.2 t -79.53 130.36 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.96 153.19 51.94 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.938 0.895 . . . . 0.0 110.45 -177.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -128.74 144.02 51.06 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.658 1.183 . . . . 0.0 108.221 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.0 tt -134.04 117.4 16.61 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -87.19 99.76 12.18 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 122.125 -0.359 . . . . 0.0 110.984 -175.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.9 pt -55.26 -28.11 21.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -56.99 -43.55 81.84 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.828 0.74 . . . . 0.0 110.294 177.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -95.28 -17.5 21.61 Favored 'General case' 0 CA--C 1.53 0.212 0 C-N-CA 124.818 1.247 . . . . 0.0 111.577 -178.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -129.82 59.35 44.3 Favored Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 124.532 1.133 . . . . 0.0 108.822 -175.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -62.42 -52.18 2.77 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.609 2.206 . . . . 0.0 113.768 -174.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -44.75 -42.99 7.93 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.016 0.817 . . . . 0.0 113.466 -175.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.43 -33.35 43.62 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.055 0.942 . . . . 0.0 112.663 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.54 -68.51 0.63 Allowed Pre-proline 0 CA--C 1.538 0.503 0 CA-C-O 118.139 -0.934 . . . . 0.0 112.294 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -59.86 -38.24 80.84 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 121.595 1.53 . . . . 0.0 111.016 177.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -51.44 -41.31 60.74 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.266 0.939 . . . . 0.0 111.458 178.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -104.59 19.43 20.4 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.505 0.322 . . . . 0.0 111.753 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.16 39.07 49.62 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.224 0.916 . . . . 0.0 113.401 176.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.5 mp -57.01 127.6 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 118.102 0.951 . . . . 0.0 108.903 177.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -92.24 -47.02 7.43 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.658 1.183 . . . . 0.0 110.238 -178.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -160.55 144.94 10.45 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 107.999 -2.04 . . . . 0.0 107.999 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 9.1 pt -99.08 149.34 35.68 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 124.111 0.964 . . . . 0.0 110.275 -179.03 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.15 140.02 52.91 Favored 'Cis proline' 0 N--CA 1.457 -0.65 0 CA-C-N 119.961 1.022 . . . . 0.0 111.268 -0.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.85 109.56 15.72 Favored 'General case' 0 CA--C 1.527 0.096 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 178.611 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.5 mt -91.31 93.17 8.94 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.913 0.885 . . . . 0.0 108.758 -178.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.7 mp -90.56 114.47 26.7 Favored 'General case' 0 CA--C 1.522 -0.117 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 177.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -91.6 103.43 16.02 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -91.49 115.24 27.88 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.144 1.378 . . . . 0.0 110.15 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -111.64 125.27 53.77 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 173.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 53.08 46.11 27.36 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.57 0.7 . . . . 0.0 109.621 -178.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.2 7.16 23.5 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 118.167 -1.352 . . . . 0.0 115.449 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -118.03 142.0 47.86 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 120.002 1.901 . . . . 0.0 110.175 178.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 87.4 t -65.92 110.3 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.39 -42.62 25.1 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.895 0.878 . . . . 0.0 108.647 176.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -158.88 170.95 20.96 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.076 0.95 . . . . 0.0 108.662 177.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 91.2 m -147.33 129.86 15.89 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -179.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -112.2 112.95 24.92 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.076 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.0 t -92.02 123.46 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.69 167.43 35.02 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 123.885 0.755 . . . . 0.0 112.232 178.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.3 170.56 12.86 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.108 0.563 . . . . 0.0 110.589 179.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -161.16 172.93 15.88 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.689 0.795 . . . . 0.0 109.913 -176.484 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 82.8 p -84.15 163.88 19.51 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -57.83 -40.78 80.87 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 175.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -59.51 -57.62 18.63 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 177.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -56.44 -40.45 74.8 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 117.589 0.695 . . . . 0.0 110.71 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 28.7 tp -61.05 -54.94 38.61 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 177.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -53.67 -46.36 70.61 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.314 0.506 . . . . 0.0 111.108 178.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -57.49 -53.71 55.04 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.581 0.753 . . . . 0.0 110.044 178.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -52.97 -54.02 41.33 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.327 1.051 . . . . 0.0 110.448 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.3 mt -59.27 -51.81 68.36 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.654 -179.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -54.77 -51.09 66.81 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.057 0.543 . . . . 0.0 110.661 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.2 -37.37 67.01 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.586 0.755 . . . . 0.0 111.46 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -78.13 -45.97 21.91 Favored 'General case' 0 C--O 1.227 -0.081 0 O-C-N 122.336 -0.227 . . . . 0.0 110.587 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 51.9 mt -58.23 -47.3 83.94 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.31 0 C-N-CA 123.286 0.634 . . . . 0.0 109.566 177.355 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.1 mt . . . . . 0 N--CA 1.45 -0.466 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.7 mm -87.31 107.78 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 -79.74 92.03 5.37 Favored 'General case' 0 N--CA 1.461 0.082 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 177.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.2 mt -75.79 162.53 28.1 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.794 0.838 . . . . 0.0 111.685 -178.087 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.3 p -137.28 162.1 34.44 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 171.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -53.25 -44.93 68.55 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.368 0.667 . . . . 0.0 109.965 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -56.01 -39.86 72.53 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.853 1.261 . . . . 0.0 111.564 178.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.35 -43.48 27.63 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 122.089 -0.382 . . . . 0.0 109.98 -177.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -31.05 -55.71 0.23 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 127.702 2.401 . . . . 0.0 114.773 -177.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -55.35 -36.37 66.22 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -177.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.0 m -90.26 -53.4 4.47 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.527 0.679 . . . . 0.0 109.305 179.091 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.21 -50.55 72.65 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 113.08 0.771 . . . . 0.0 113.08 -174.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.0 t -94.14 -60.29 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 123.467 0.707 . . . . 0.0 111.077 -174.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 65.3 mt -62.72 -24.17 67.54 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -174.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -114.82 32.39 6.03 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 174.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.88 143.72 41.57 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -99.52 36.25 1.81 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.776 1.23 . . . . 0.0 110.369 177.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 159.52 -157.17 28.34 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.42 118.46 26.89 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.706 1.602 . . . . 0.0 110.369 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.2 mt -119.72 120.79 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 C-N-CA 124.782 1.233 . . . . 0.0 109.017 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.41 HD13 ' C ' ' A' ' 24' ' ' LEU . 3.1 tm? -91.78 106.41 18.45 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 105.788 -1.931 . . . . 0.0 105.788 175.396 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 53.9 t -98.02 108.74 22.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 123.36 0.664 . . . . 0.0 109.407 -178.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -93.9 110.09 21.77 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 177.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -81.52 119.44 23.76 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 175.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 27.7 p-90 -136.1 173.32 11.84 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.665 1.186 . . . . 0.0 112.049 -175.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.29 150.84 37.38 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.546 1.138 . . . . 0.0 108.721 175.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -56.92 -51.25 69.85 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.682 1.193 . . . . 0.0 111.834 -178.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 63.9 p-90 -68.68 -24.31 64.49 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.006 0.922 . . . . 0.0 112.835 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 51.4 t -79.35 79.26 5.8 Favored 'General case' 0 N--CA 1.456 -0.167 0 O-C-N 121.506 -0.746 . . . . 0.0 110.807 -177.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -26.78 -61.52 0.08 OUTLIER Glycine 0 CA--C 1.536 1.383 0 C-N-CA 127.018 2.246 . . . . 0.0 114.852 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -45.05 -29.54 3.98 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 124.493 3.462 . . . . 0.0 115.227 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 78.4 m -56.35 -40.98 75.37 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 121.219 -0.926 . . . . 0.0 109.615 176.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -71.21 -20.38 62.27 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.972 0.909 . . . . 0.0 111.23 178.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -74.98 -46.63 33.95 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 175.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 35.7 pt -72.49 -31.36 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.785 178.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -37.73 -60.28 0.96 Allowed Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -57.15 -40.27 84.37 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.297 1.998 . . . . 0.0 111.547 178.121 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.5 mt -58.7 -51.59 70.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.7 mt -56.54 -41.01 76.08 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.059 0.544 . . . . 0.0 110.347 177.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -60.28 -48.98 79.41 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.554 0.616 . . . . 0.0 110.013 177.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -57.06 -51.03 70.89 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 29.8 mm -54.9 -46.31 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 123.089 0.555 . . . . 0.0 109.738 177.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.93 -41.04 70.55 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.327 0.512 . . . . 0.0 110.754 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -69.8 -56.32 7.45 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 176.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -50.31 -49.94 52.19 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.955 0.902 . . . . 0.0 112.544 -178.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -97.08 27.15 4.23 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.444 1.098 . . . . 0.0 111.564 -177.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -55.94 124.38 17.48 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 119.202 0.91 . . . . 0.0 110.626 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.57 -10.47 37.39 Favored Glycine 0 CA--C 1.534 1.241 0 CA-C-O 119.423 -0.654 . . . . 0.0 113.238 -178.021 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.5 mttm -99.67 -42.15 7.0 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.56 1.144 . . . . 0.0 109.241 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.1 tp -134.72 128.61 33.27 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.282 1.033 . . . . 0.0 108.315 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 55.6 m -87.18 103.76 15.73 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 176.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.7 t -79.48 131.28 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 178.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.99 151.39 49.86 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.604 0.762 . . . . 0.0 110.076 -177.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.8 mttm -128.86 141.83 51.16 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 177.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 tt -132.13 114.84 15.0 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.002 0.921 . . . . 0.0 108.784 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 -80.65 108.32 14.19 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.1 pt -71.63 -23.17 22.29 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -179.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -61.58 -47.75 84.05 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 63.6 mm-40 -75.65 -33.81 60.47 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.347 178.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -119.76 70.79 13.99 Favored Pre-proline 0 N--CA 1.465 0.306 0 C-N-CA 123.954 0.902 . . . . 0.0 112.003 -177.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -61.45 -48.74 8.82 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 121.761 1.641 . . . . 0.0 111.231 -179.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -41.36 -42.68 3.43 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.416 1.484 . . . . 0.0 115.16 -178.08 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.55 -25.32 67.93 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.193 0.997 . . . . 0.0 112.609 -177.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.66 -64.26 3.09 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-O 118.306 -0.854 . . . . 0.0 112.61 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -59.72 -37.16 89.05 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.075 1.85 . . . . 0.0 111.184 178.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -51.98 -31.12 27.97 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 118.633 0.651 . . . . 0.0 111.865 178.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -119.29 22.2 11.89 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.115 0.566 . . . . 0.0 111.646 176.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 46.0 42.73 12.17 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.46 1.028 . . . . 0.0 113.126 177.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mp -50.17 117.31 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 117.865 0.833 . . . . 0.0 109.447 176.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.3 -36.87 39.0 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.208 1.003 . . . . 0.0 111.279 -175.553 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -170.74 -174.18 38.48 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 105.339 -3.104 . . . . 0.0 105.339 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.2 pt -140.13 151.61 65.26 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-N 119.503 1.651 . . . . 0.0 109.855 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -67.77 149.65 83.41 Favored 'Cis proline' 0 N--CA 1.457 -0.665 0 CA-C-N 119.593 0.89 . . . . 0.0 111.357 -0.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.5 m -134.07 145.38 49.33 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 175.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.2 mt -121.73 131.79 54.27 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -118.41 117.53 29.29 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 104.47 -2.419 . . . . 0.0 104.47 174.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -93.77 97.32 10.35 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -89.74 107.17 18.94 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.223 1.409 . . . . 0.0 110.935 -177.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -96.12 109.08 21.57 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 173.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 34.6 m120 48.08 47.89 18.73 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.314 1.046 . . . . 0.0 112.079 -179.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 86.0 -17.35 37.41 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 118.636 -1.091 . . . . 0.0 114.275 178.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -95.04 129.72 42.01 Favored 'General case' 0 N--CA 1.457 -0.093 0 CA-C-N 119.576 1.688 . . . . 0.0 110.146 178.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 90.4 t -69.03 109.5 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 176.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.05 -39.14 34.7 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.86 170.87 19.8 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.7 t -145.98 159.04 43.8 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.242 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -138.52 146.61 42.15 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 126.374 1.87 . . . . 0.0 106.946 -177.467 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.0 t -129.23 134.43 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 107.375 -1.342 . . . . 0.0 107.375 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.94 174.64 50.49 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 123.54 0.591 . . . . 0.0 111.687 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.3 167.95 19.35 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 122.783 0.433 . . . . 0.0 109.949 178.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -159.61 165.79 32.04 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.2 1.0 . . . . 0.0 108.487 -179.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 84.6 p -81.14 163.91 22.76 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -58.58 -41.32 85.47 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 174.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -56.88 -55.72 28.68 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 177.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -57.19 -44.73 83.87 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 122.059 -0.671 . . . . 0.0 110.28 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 48.0 tp -60.1 -51.13 70.95 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 117.792 0.269 . . . . 0.0 110.49 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -52.11 -50.26 62.0 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.661 0.784 . . . . 0.0 110.09 178.122 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -59.99 -51.36 69.98 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.096 0.158 . . . . 0.0 110.637 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -52.15 -53.63 40.57 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.026 0.93 . . . . 0.0 110.564 179.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.2 -53.21 60.37 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 122.872 0.469 . . . . 0.0 110.479 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -52.55 -51.28 60.43 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.05 0.54 . . . . 0.0 111.145 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.28 -37.7 67.65 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.57 0.748 . . . . 0.0 111.733 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -78.43 -43.88 26.2 Favored 'General case' 0 CA--C 1.524 -0.054 0 O-C-N 122.315 -0.24 . . . . 0.0 110.782 -178.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 46.3 mt -59.79 -47.31 86.2 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.261 0 C-N-CA 123.214 0.606 . . . . 0.0 109.642 177.351 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.8 mt . . . . . 0 N--CA 1.452 -0.338 0 CA-C-O 120.714 0.292 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.8 mm -91.21 104.29 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 175.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -79.52 81.85 5.73 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 77.3 mt -65.46 163.89 14.96 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -173.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 50.6 p -140.26 161.28 38.05 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 126.453 1.901 . . . . 0.0 106.733 175.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -52.62 -48.16 66.52 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.557 1.143 . . . . 0.0 111.29 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -62.35 -38.07 88.07 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.741 0.416 . . . . 0.0 112.029 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.3 m -78.07 -29.54 49.22 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 122.213 -0.304 . . . . 0.0 110.696 -178.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -42.16 -48.68 4.85 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.069 1.747 . . . . 0.0 113.517 -178.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -51.64 -63.8 1.02 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 121.617 0.722 . . . . 0.0 110.916 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.2 m -68.44 -43.84 76.24 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.171 -175.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -74.76 -48.14 27.19 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -174.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.8 t -95.64 -58.96 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.116 0 C-N-CA 123.269 0.628 . . . . 0.0 111.879 -175.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 80.3 mt -64.07 -39.49 94.18 Favored 'General case' 0 C--N 1.334 -0.085 0 C-N-CA 119.681 -0.808 . . . . 0.0 111.435 -174.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -96.83 30.13 2.78 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 176.263 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.84 156.11 34.31 Favored 'General case' 0 C--N 1.342 0.255 0 O-C-N 121.887 -0.508 . . . . 0.0 111.082 178.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -131.09 56.37 1.8 Allowed 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 124.808 1.243 . . . . 0.0 108.161 176.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 163.91 -173.66 39.98 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -178.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.64 115.17 25.98 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.47 1.508 . . . . 0.0 110.077 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 mt -114.85 116.67 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 124.561 1.144 . . . . 0.0 109.755 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 19.9 tp -88.26 93.67 9.59 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 176.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.8 t -86.21 103.81 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 123.024 0.53 . . . . 0.0 109.705 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -88.32 107.68 18.95 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 175.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -79.68 126.17 30.58 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 174.257 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 35.7 p-90 -139.45 169.84 17.01 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.347 1.059 . . . . 0.0 113.286 -174.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.41 136.52 21.07 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.27 1.428 . . . . 0.0 108.517 178.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 50.6 mp0 -49.68 -50.92 41.7 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.874 0.869 . . . . 0.0 112.126 -178.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 62.6 p-90 -64.41 -25.61 68.1 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.294 0.638 . . . . 0.0 112.38 -177.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 51.3 t -79.88 78.84 6.46 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 121.575 -0.703 . . . . 0.0 110.243 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -25.02 -61.07 0.06 OUTLIER Glycine 0 CA--C 1.536 1.389 0 C-N-CA 127.2 2.333 . . . . 0.0 114.936 178.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_exo -42.17 -34.92 3.06 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 124.315 3.343 . . . . 0.0 114.581 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 82.9 m -57.34 -48.67 78.4 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 121.44 0.638 . . . . 0.0 109.919 177.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -65.33 -33.93 77.13 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.32 0.648 . . . . 0.0 109.651 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 24.0 mmt -64.74 -44.52 89.87 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 110.083 -0.339 . . . . 0.0 110.083 177.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 30.7 pt -76.47 -26.13 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-O 118.367 -0.825 . . . . 0.0 112.642 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -38.05 -58.08 1.53 Allowed Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 120.092 1.315 . . . . 0.0 114.328 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -57.7 -37.18 97.6 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.207 1.938 . . . . 0.0 111.771 177.263 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.9 mt -62.6 -49.42 83.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.8 mt -56.61 -41.11 76.49 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 177.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -61.13 -47.85 84.35 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.586 0.63 . . . . 0.0 109.986 176.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -56.18 -51.87 66.47 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.015 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.9 mm -54.66 -49.31 68.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 122.946 0.498 . . . . 0.0 110.071 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.09 -42.48 69.41 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.295 0.638 . . . . 0.0 110.431 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -67.9 -58.81 3.95 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.819 0.342 . . . . 0.0 110.2 177.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -50.75 -46.96 59.56 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.006 1.323 . . . . 0.0 112.602 -178.071 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -100.29 25.54 7.47 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.541 1.137 . . . . 0.0 111.215 -178.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -54.49 126.97 25.65 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.171 0.896 . . . . 0.0 110.749 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.28 -12.79 24.24 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-O 119.189 -0.784 . . . . 0.0 113.333 -178.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -99.59 -41.83 7.16 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 118.657 1.228 . . . . 0.0 109.363 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.3 tp -130.8 130.56 43.84 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.419 1.087 . . . . 0.0 108.134 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 65.0 m -91.23 102.76 15.48 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 176.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 99.2 t -79.24 140.57 16.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -139.17 147.04 41.32 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 121.859 -0.526 . . . . 0.0 109.834 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.4 mtmt -128.68 99.47 5.36 Favored 'General case' 0 N--CA 1.46 0.065 0 C-N-CA 124.512 1.125 . . . . 0.0 109.087 -178.351 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.4 tt -97.54 115.08 27.15 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 121.795 -0.565 . . . . 0.0 110.771 -175.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -79.9 109.55 14.44 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.257 -178.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.8 pt -72.4 -25.77 23.52 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -61.43 -47.66 84.75 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 119.448 1.022 . . . . 0.0 108.447 178.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -70.96 -38.71 72.8 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 124.787 1.235 . . . . 0.0 110.003 177.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -118.39 71.83 9.57 Favored Pre-proline 0 N--CA 1.464 0.269 0 C-N-CA 124.16 0.984 . . . . 0.0 111.478 -176.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -60.6 -53.8 2.52 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.167 1.912 . . . . 0.0 112.419 -177.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -36.86 -49.03 1.4 Allowed Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.385 1.469 . . . . 0.0 114.45 -177.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -51.73 -34.61 39.81 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.281 1.032 . . . . 0.0 113.095 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.52 -68.34 0.72 Allowed Pre-proline 0 CA--C 1.538 0.497 0 CA-C-O 118.174 -0.917 . . . . 0.0 112.654 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -60.34 -37.66 80.49 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 121.757 1.638 . . . . 0.0 110.988 177.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -51.44 -38.27 52.84 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 119.065 0.848 . . . . 0.0 111.51 178.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -108.97 19.91 19.03 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 122.857 0.463 . . . . 0.0 112.004 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 51.0 39.7 41.46 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.108 0.861 . . . . 0.0 113.323 177.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.44 129.9 19.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 118.02 0.91 . . . . 0.0 108.563 177.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -87.33 -47.7 8.59 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.342 1.057 . . . . 0.0 108.985 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -169.09 142.26 7.24 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 107.73 -2.148 . . . . 0.0 107.73 178.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.453 ' H ' HD13 ' A' ' 75' ' ' ILE . 0.2 OUTLIER -88.25 151.96 49.56 Favored Pre-proline 0 N--CA 1.454 -0.265 0 CA-C-O 118.514 -0.755 . . . . 0.0 109.907 179.373 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.23 134.85 27.89 Favored 'Cis proline' 0 N--CA 1.456 -0.727 0 CA-C-N 120.102 1.072 . . . . 0.0 111.452 -0.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.48 109.92 14.44 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.354 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.1 mt -89.56 94.06 9.72 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.212 1.005 . . . . 0.0 109.858 -178.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.1 mp -92.02 112.88 24.98 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 176.02 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.4 tp -90.02 94.75 9.92 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -86.33 105.96 17.04 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 125.077 1.351 . . . . 0.0 110.617 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -94.74 108.4 20.4 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 173.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 49.98 52.24 15.05 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.87 0.868 . . . . 0.0 110.756 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 79.44 -16.4 10.32 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 118.918 -0.935 . . . . 0.0 114.33 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -94.21 118.89 32.22 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 119.579 1.69 . . . . 0.0 110.31 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 86.5 t -62.99 106.87 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 175.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.4 -42.44 25.51 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.921 0.888 . . . . 0.0 110.222 -179.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -153.4 154.76 35.1 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 58.1 p -132.83 111.46 11.11 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.139 0.976 . . . . 0.0 108.832 -177.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -103.58 113.19 26.5 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-N 118.718 0.69 . . . . 0.0 109.936 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.0 t -88.58 124.51 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 176.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.91 171.66 32.79 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 121.637 0.576 . . . . 0.0 113.017 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.61 173.16 8.43 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.152 0.981 . . . . 0.0 112.291 -178.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 mt -151.28 160.28 43.89 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 125.856 1.662 . . . . 0.0 108.729 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.1 p -91.43 152.9 20.19 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 171.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -52.58 -47.44 66.87 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.892 -0.505 . . . . 0.0 112.341 -176.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.53 -53.37 41.77 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-N 118.42 0.554 . . . . 0.0 112.16 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -60.15 -43.4 95.78 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 122.285 -0.538 . . . . 0.0 110.34 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 33.0 tp -59.99 -50.44 73.73 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -54.56 -46.1 73.6 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 118.609 0.64 . . . . 0.0 110.747 177.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -57.77 -52.85 63.76 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 178.057 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -52.24 -50.65 61.6 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.147 0.979 . . . . 0.0 110.324 178.02 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 87.4 mt -59.33 -50.98 71.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 122.927 0.491 . . . . 0.0 110.383 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -54.94 -50.6 68.46 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 118.054 0.388 . . . . 0.0 110.258 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.68 -38.31 69.49 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.452 0.701 . . . . 0.0 111.603 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -77.99 -44.09 27.69 Favored 'General case' 0 C--O 1.227 -0.099 0 O-C-N 122.243 -0.286 . . . . 0.0 110.72 -178.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 46.3 mt -59.73 -48.14 82.85 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.27 0 C-N-CA 123.116 0.566 . . . . 0.0 109.685 177.323 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.1 mt . . . . . 0 N--CA 1.454 -0.27 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.9 mm -89.27 111.56 23.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 123.616 0.766 . . . . 0.0 109.5 178.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -81.05 110.96 17.08 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 50.1 mt -92.05 170.02 10.18 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.53 1.132 . . . . 0.0 110.78 -178.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 67.7 p -136.67 159.54 41.53 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 171.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -56.75 -42.3 79.09 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.044 0.449 . . . . 0.0 109.793 177.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -60.34 -46.97 88.04 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.825 1.25 . . . . 0.0 111.338 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 90.0 p -79.27 -26.18 42.41 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -176.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -36.84 -47.37 0.68 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 127.329 2.252 . . . . 0.0 114.233 -179.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -55.89 -47.42 77.44 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.662 0.744 . . . . 0.0 111.321 -178.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.0 m -77.42 -45.56 25.46 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 123.57 0.748 . . . . 0.0 109.925 -177.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -69.05 -53.97 17.58 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -175.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 41.2 t -94.84 -56.68 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 124.147 0.979 . . . . 0.0 111.857 -173.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 77.3 mt -63.78 -39.42 94.22 Favored 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 119.216 -0.994 . . . . 0.0 111.398 -175.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -96.22 32.06 2.05 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.305 0.502 . . . . 0.0 110.137 174.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.43 146.02 49.76 Favored 'General case' 0 C--N 1.343 0.289 0 O-C-N 121.627 -0.671 . . . . 0.0 112.262 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -99.7 23.39 9.65 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.796 1.638 . . . . 0.0 111.961 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 171.27 -157.61 28.38 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.758 -0.537 . . . . 0.0 111.758 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.58 112.12 20.67 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 126.033 1.733 . . . . 0.0 110.601 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 mt -112.36 117.94 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 124.41 1.084 . . . . 0.0 110.048 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.8 tp -90.01 97.37 11.15 Favored 'General case' 0 C--N 1.338 0.089 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 175.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 56.6 t -87.41 107.43 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 123.416 0.687 . . . . 0.0 110.303 -178.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -92.41 108.18 19.77 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.009 0.924 . . . . 0.0 109.269 176.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -80.34 125.72 30.25 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 105.831 -1.915 . . . . 0.0 105.831 174.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 31.0 p-90 -145.43 175.16 10.53 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.073 0.949 . . . . 0.0 112.253 -176.008 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.95 147.61 16.72 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 125.487 1.515 . . . . 0.0 108.728 175.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -49.84 -51.65 38.44 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.681 1.193 . . . . 0.0 112.3 -178.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -60.39 -29.95 69.27 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -177.068 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 46.9 t -79.84 77.59 6.48 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 121.659 -0.651 . . . . 0.0 110.589 -178.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -24.45 -62.04 0.05 OUTLIER Glycine 0 CA--C 1.536 1.368 0 C-N-CA 127.089 2.281 . . . . 0.0 115.141 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -42.81 -33.21 2.92 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 124.725 3.617 . . . . 0.0 114.933 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 99.4 m -53.74 -43.32 69.0 Favored 'General case' 0 CA--C 1.529 0.172 0 O-C-N 121.808 -0.557 . . . . 0.0 110.061 176.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -66.96 -26.84 67.02 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.632 0.773 . . . . 0.0 111.173 178.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 22.7 mmt -76.1 -43.93 41.03 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 28.8 pt -74.74 -29.73 23.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.854 177.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -38.48 -59.6 1.26 Allowed Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 113.877 1.065 . . . . 0.0 113.877 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -57.38 -39.89 85.86 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.364 2.042 . . . . 0.0 111.733 178.009 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 20.1 mt -58.77 -52.35 61.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 177.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 72.3 mt -56.27 -42.75 77.94 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.085 0.554 . . . . 0.0 110.684 178.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -60.36 -48.34 82.19 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.402 0.546 . . . . 0.0 110.203 178.026 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -57.9 -51.35 69.96 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 23.1 mm -54.73 -45.8 73.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.749 0.82 . . . . 0.0 109.666 178.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.75 -44.74 70.23 Favored 'General case' 0 C--O 1.227 -0.089 0 C-N-CA 123.008 0.523 . . . . 0.0 110.391 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -68.84 -55.78 10.05 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 121.162 -0.215 . . . . 0.0 110.767 177.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -49.09 -48.85 44.01 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.784 0.834 . . . . 0.0 111.968 -178.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -98.26 24.68 6.93 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.067 0.947 . . . . 0.0 111.519 -178.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -55.07 125.86 22.26 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.571 1.078 . . . . 0.0 110.758 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.56 -11.36 32.82 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 119.522 -0.599 . . . . 0.0 113.353 -178.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.6 mttp -99.73 -42.86 6.67 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.933 1.293 . . . . 0.0 108.734 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.3 tp -133.97 131.55 39.11 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.164 1.386 . . . . 0.0 107.687 178.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 89.9 m -91.92 101.99 14.56 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 176.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 72.5 t -79.22 132.83 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 177.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.19 152.42 51.81 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 123.073 0.549 . . . . 0.0 110.17 -177.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.9 mttm -126.52 139.43 53.23 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 tt -130.94 119.96 22.87 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -87.79 99.07 11.83 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.048 0.539 . . . . 0.0 110.504 -175.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 20.7 pt -58.52 -29.3 38.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 O-C-N 121.266 -0.896 . . . . 0.0 113.224 -177.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -61.19 -25.94 67.37 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.048 0.84 . . . . 0.0 111.697 177.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -114.02 -10.95 12.81 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.312 1.045 . . . . 0.0 111.038 178.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -133.94 57.57 25.76 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 124.892 1.277 . . . . 0.0 108.524 -177.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.71 -49.22 4.44 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.166 1.91 . . . . 0.0 112.976 -174.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -40.26 -40.55 1.9 Allowed Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.421 1.486 . . . . 0.0 114.564 -177.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.64 -30.37 67.24 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.971 -0.723 . . . . 0.0 112.636 -178.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.28 -65.1 2.32 Favored Pre-proline 0 CA--C 1.539 0.542 0 O-C-N 121.257 -0.902 . . . . 0.0 112.501 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -59.27 -35.09 97.89 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.09 1.86 . . . . 0.0 111.276 178.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -51.75 -32.41 30.66 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.203 0.91 . . . . 0.0 112.131 177.215 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -115.08 17.84 16.58 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.097 0.559 . . . . 0.0 111.387 176.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 48.29 41.09 23.31 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.658 1.123 . . . . 0.0 111.887 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 53.2 mt -66.05 138.42 23.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-O 121.344 0.592 . . . . 0.0 110.623 -177.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -79.18 -42.37 26.24 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.211 1.404 . . . . 0.0 111.322 -176.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -171.36 -154.83 10.12 Favored Glycine 0 C--N 1.334 0.417 0 N-CA-C 108.17 -1.972 . . . . 0.0 108.17 -178.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.6 pt -146.13 156.6 50.61 Favored Pre-proline 0 CA--C 1.536 0.422 0 CA-C-N 118.19 0.995 . . . . 0.0 108.495 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -70.45 141.85 69.36 Favored 'Cis proline' 0 N--CA 1.456 -0.681 0 CA-C-N 120.156 1.091 . . . . 0.0 109.95 -1.116 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.4 m -139.06 122.33 17.04 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 mt -103.83 120.15 40.39 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.932 1.293 . . . . 0.0 109.318 -176.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.9 mp -110.5 121.89 46.39 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 175.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 tp -94.64 95.52 8.82 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -88.68 103.99 16.46 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.429 1.492 . . . . 0.0 110.713 -178.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -91.74 106.55 18.56 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 173.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 35.0 m120 49.29 51.19 16.77 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.664 0.786 . . . . 0.0 111.029 -178.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 79.81 -15.45 14.9 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-O 118.839 -0.978 . . . . 0.0 114.369 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -92.62 120.17 32.79 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.503 1.651 . . . . 0.0 109.668 179.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 88.5 t -64.45 106.75 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 175.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.97 -39.28 34.8 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.479 0.712 . . . . 0.0 109.356 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -159.83 171.37 19.59 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.6 m -150.32 149.41 30.07 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -178.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.5 mmtm -135.09 131.25 36.71 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 126.047 1.739 . . . . 0.0 107.648 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.2 t -113.33 125.12 70.54 Favored 'Isoleucine or valine' 0 C--O 1.231 0.1 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 178.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.13 179.06 33.0 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -177.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.6 170.99 15.09 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.065 0.546 . . . . 0.0 111.202 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.2 mt -143.55 154.61 43.78 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 125.138 1.375 . . . . 0.0 108.698 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.9 p -84.47 148.86 26.32 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 170.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -49.47 -47.84 48.15 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 122.143 -0.348 . . . . 0.0 111.728 -177.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.21 -53.09 42.87 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 111.889 -0.484 . . . . 0.0 111.889 179.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -61.37 -42.16 98.26 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.132 -0.628 . . . . 0.0 110.844 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 33.8 tp -60.15 -51.64 68.73 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 177.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -56.49 -44.34 80.55 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.638 -0.664 . . . . 0.0 111.169 177.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -55.87 -54.29 46.37 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.604 0.762 . . . . 0.0 109.685 177.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -53.28 -52.05 60.3 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.947 1.299 . . . . 0.0 110.444 178.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.0 mt -58.7 -50.61 73.26 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 122.647 0.379 . . . . 0.0 110.574 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -55.09 -50.53 68.94 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 178.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.84 -37.95 69.4 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.322 0.649 . . . . 0.0 111.784 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -77.97 -43.22 30.34 Favored 'General case' 0 C--N 1.339 0.125 0 O-C-N 122.129 -0.357 . . . . 0.0 110.708 -178.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 49.1 mt -61.42 -47.21 86.81 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.293 0 C-N-CA 123.094 0.557 . . . . 0.0 109.686 177.441 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.4 m . . . . . 0 CA--C 1.532 0.254 0 N-CA-C 113.024 0.749 . . . . 0.0 113.024 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -34.91 -47.31 0.35 Allowed 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 127.003 2.121 . . . . 0.0 112.798 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -129.37 44.51 2.96 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.336 0.654 . . . . 0.0 110.51 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.5 mt -121.15 139.13 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 O-C-N 121.947 -0.471 . . . . 0.0 110.45 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.5 mm -88.0 112.67 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 123.324 0.65 . . . . 0.0 109.488 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -83.52 106.43 15.25 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.75 -0.594 . . . . 0.0 109.662 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 43.0 mt -89.15 164.04 15.18 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.799 1.24 . . . . 0.0 111.14 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 35.0 p -136.78 167.16 21.97 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 175.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -58.33 -46.51 86.08 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 177.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -57.26 -46.79 82.71 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.976 0.911 . . . . 0.0 111.322 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.1 p -78.64 -25.63 45.03 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.932 -176.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -43.41 -46.81 6.81 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.59 1.556 . . . . 0.0 113.123 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -49.07 -65.69 0.53 Allowed 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 121.791 0.805 . . . . 0.0 110.48 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -71.37 -44.62 64.65 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.058 -174.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -73.14 -37.36 66.64 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -173.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.8 t -108.99 -60.42 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.058 0 C-N-CA 123.151 0.58 . . . . 0.0 110.706 -176.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 84.0 mt -63.73 -36.38 83.66 Favored 'General case' 0 C--N 1.334 -0.088 0 C-N-CA 120.029 -0.668 . . . . 0.0 112.597 -174.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -99.95 28.03 5.1 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.673 0.669 . . . . 0.0 110.148 176.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -74.84 172.53 12.04 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.959 0.885 . . . . 0.0 112.263 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -141.96 129.63 21.55 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 171.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.4 -172.0 27.21 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -175.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -98.15 120.43 38.54 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.064 1.346 . . . . 0.0 111.206 -177.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.7 mt -118.13 120.22 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 124.863 1.265 . . . . 0.0 109.01 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -93.42 107.77 19.55 Favored 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 176.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.1 t -98.38 109.4 23.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 123.503 0.721 . . . . 0.0 109.415 -178.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -93.59 108.8 20.46 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 123.669 0.788 . . . . 0.0 108.881 176.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -78.78 128.52 33.51 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 25.7 p-90 -145.43 173.7 11.77 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.623 0.769 . . . . 0.0 112.819 -176.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.51 144.37 22.74 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 125.593 1.557 . . . . 0.0 107.81 176.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -47.63 -51.09 22.59 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.533 1.133 . . . . 0.0 112.307 -177.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 62.2 p-90 -65.31 -23.76 67.1 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.819 0.847 . . . . 0.0 112.621 -178.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 35.3 t -79.91 72.83 6.68 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 121.482 -0.761 . . . . 0.0 111.481 -176.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -21.2 -64.17 0.02 OUTLIER Glycine 0 CA--C 1.537 1.462 0 C-N-CA 127.57 2.509 . . . . 0.0 116.043 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -48.55 -29.09 13.24 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 123.419 2.746 . . . . 0.0 114.443 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.8 m -59.26 -44.71 92.39 Favored 'General case' 0 N--CA 1.462 0.154 0 O-C-N 121.508 -0.745 . . . . 0.0 109.558 176.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -66.65 -36.24 82.08 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.562 0.745 . . . . 0.0 109.017 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 26.0 ttt -62.97 -46.34 88.16 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 119.614 -0.232 . . . . 0.0 110.48 177.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 38.3 pt -75.34 -28.02 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-O 118.417 -0.802 . . . . 0.0 112.363 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -37.11 -58.68 1.09 Allowed Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -58.05 -41.42 68.17 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.025 1.817 . . . . 0.0 111.4 177.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.0 mt -57.8 -51.16 73.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.6 mt -55.71 -41.36 73.7 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.108 0.563 . . . . 0.0 110.359 177.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -63.37 -45.95 88.77 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.226 0.921 . . . . 0.0 111.07 176.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -57.18 -50.56 72.46 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 25.8 mm -54.32 -50.18 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 C-N-CA 123.533 0.733 . . . . 0.0 109.303 176.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.16 -48.71 64.79 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 122.096 -0.377 . . . . 0.0 110.268 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -60.37 -55.23 36.13 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 122.448 0.299 . . . . 0.0 110.677 178.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -54.0 -44.96 71.34 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.093 0.957 . . . . 0.0 112.221 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -98.59 29.83 3.52 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.395 1.078 . . . . 0.0 111.943 -177.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -54.24 127.27 26.31 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.363 -0.836 . . . . 0.0 109.901 177.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.52 -13.62 16.02 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 119.234 -0.759 . . . . 0.0 113.188 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -99.61 -39.37 8.33 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 118.567 1.184 . . . . 0.0 109.994 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.9 tp -137.67 129.7 28.92 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 123.134 0.574 . . . . 0.0 110.272 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.8 m -89.83 101.57 14.27 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 175.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 91.8 t -79.83 130.19 36.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.81 154.43 51.2 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 123.673 0.789 . . . . 0.0 111.134 -177.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -127.49 143.78 51.15 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.306 1.442 . . . . 0.0 107.418 177.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.5 tt -132.32 115.01 15.08 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -80.23 104.35 10.73 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 122.38 0.272 . . . . 0.0 110.656 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.0 pt -70.23 -28.72 36.67 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.28 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -57.21 -45.95 83.33 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 119.103 0.865 . . . . 0.0 108.844 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.49 -38.41 59.53 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.221 0.608 . . . . 0.0 109.943 177.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -117.15 67.36 4.48 Favored Pre-proline 0 CA--C 1.534 0.335 0 C-N-CA 124.252 1.021 . . . . 0.0 112.173 -175.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -58.47 -47.8 17.88 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.476 2.117 . . . . 0.0 112.465 -176.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -40.49 -34.95 0.74 Allowed Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.863 1.696 . . . . 0.0 115.237 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 75.2 p -61.4 -38.72 88.09 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 117.795 0.798 . . . . 0.0 111.643 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.486 ' HB3' ' HD3' ' A' ' 68' ' ' PRO 0.284 . . -56.95 -62.76 4.52 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-O 118.071 -0.966 . . . . 0.0 111.571 -179.351 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.486 ' HD3' ' HB3' ' A' ' 67' ' ' ALA . 51.5 Cg_exo -49.07 -50.75 12.03 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.822 2.348 . . . . 0.0 111.525 173.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -51.88 -41.26 61.75 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -104.15 20.69 17.84 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 118.286 0.494 . . . . 0.0 111.75 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 44.79 42.03 7.51 Favored Glycine 0 C--N 1.341 0.844 0 C-N-CA 124.245 0.926 . . . . 0.0 111.624 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.7 mm -57.97 122.66 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-O 121.156 0.503 . . . . 0.0 110.091 -177.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 50.8 mmt-85 -79.7 -40.02 29.93 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.663 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -179.76 146.32 6.95 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 108.335 -1.906 . . . . 0.0 108.335 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.2 pt -93.67 153.43 41.16 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 123.876 0.87 . . . . 0.0 110.769 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.25 139.64 51.1 Favored 'Cis proline' 0 N--CA 1.458 -0.61 0 CA-C-N 119.614 0.898 . . . . 0.0 110.96 -1.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.8 112.98 16.01 Favored 'General case' 0 CA--C 1.523 -0.077 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.2 mt -94.81 122.05 37.03 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -114.61 117.97 32.37 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 177.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.5 tp -94.93 97.85 10.29 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -89.98 110.56 21.53 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.187 1.395 . . . . 0.0 111.288 -177.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -96.68 114.23 25.85 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 171.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.9 m120 47.24 48.66 15.97 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.011 0.524 . . . . 0.0 111.518 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 76.72 -6.8 37.42 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 118.737 -1.035 . . . . 0.0 115.083 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -102.03 126.32 48.94 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 119.575 1.687 . . . . 0.0 109.541 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 92.4 t -66.18 108.55 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.35 -41.07 28.69 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.947 0.899 . . . . 0.0 109.372 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -157.65 171.86 19.57 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.2 t -152.76 164.0 38.63 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -145.04 126.89 15.37 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.467 1.507 . . . . 0.0 107.398 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.2 t -101.58 122.89 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 174.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.49 175.54 32.67 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 -178.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.5 174.25 9.23 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.619 0.767 . . . . 0.0 111.733 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.1 mt -147.04 156.01 42.68 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.708 1.603 . . . . 0.0 107.962 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.9 p -87.09 154.8 20.46 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.357 -1.719 . . . . 0.0 106.357 171.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -49.58 -51.83 34.39 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 122.089 -0.382 . . . . 0.0 111.654 -177.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.05 -58.12 13.96 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -56.1 -41.29 75.0 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 122.411 -0.464 . . . . 0.0 110.927 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 37.2 tp -62.42 -49.37 75.76 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -55.24 -47.1 75.88 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.474 0.579 . . . . 0.0 110.356 177.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -57.11 -53.93 52.56 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.124 0.57 . . . . 0.0 110.397 178.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -52.65 -52.34 56.08 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.899 1.28 . . . . 0.0 110.857 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 76.0 mt -62.51 -50.87 69.66 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 122.176 -0.327 . . . . 0.0 110.305 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -53.57 -48.98 68.67 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.358 0.663 . . . . 0.0 110.771 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.56 -34.51 67.19 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.792 0.837 . . . . 0.0 111.607 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -78.94 -48.06 15.25 Favored 'General case' 0 C--O 1.228 -0.07 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 45.0 mt -58.39 -45.34 88.52 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.415 0.686 . . . . 0.0 110.827 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.172 0 C-N-CA 124.847 1.259 . . . . 0.0 111.711 179.135 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 37.3 p . . . . . 0 N--CA 1.454 -0.231 0 CA-C-O 120.765 0.317 . . . . 0.0 110.822 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -166.87 -136.88 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.76 1.624 . . . . 0.0 107.392 -177.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -81.67 54.47 2.4 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 119.3 0.955 . . . . 0.0 108.665 178.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 15.7 mt -125.02 140.62 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 C-N-CA 124.138 0.975 . . . . 0.0 108.701 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.1 mm -87.4 104.76 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 177.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -79.44 80.6 5.8 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 177.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 77.6 mt -63.88 163.41 11.98 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.049 0.94 . . . . 0.0 113.208 -175.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 47.4 p -138.31 165.8 25.83 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 126.08 1.752 . . . . 0.0 106.506 174.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -55.23 -47.34 75.51 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.476 0.71 . . . . 0.0 110.932 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -63.72 -38.73 92.21 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.0 p -77.98 -32.5 51.35 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.03 0.377 . . . . 0.0 110.482 -177.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -36.61 -48.78 0.72 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.273 1.829 . . . . 0.0 113.364 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -49.36 -65.37 0.58 Allowed 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 121.961 0.886 . . . . 0.0 111.163 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.3 m -72.29 -45.21 61.0 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.569 -174.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -76.2 -21.83 55.99 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -174.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 45.9 t -120.77 -62.86 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.094 0 CA-C-N 119.548 1.067 . . . . 0.0 109.947 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 72.1 mt -58.81 -37.32 76.11 Favored 'General case' 0 CA--C 1.528 0.098 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -174.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -95.72 14.42 23.21 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 118.587 0.63 . . . . 0.0 111.924 177.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.38 103.36 16.01 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 119.073 0.852 . . . . 0.0 112.367 -178.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -76.31 72.67 3.08 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 174.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -174.63 179.39 45.97 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.95 118.76 32.34 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.489 1.516 . . . . 0.0 109.987 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.6 mt -127.57 115.97 41.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 124.796 1.239 . . . . 0.0 110.73 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 35.0 tp -83.53 96.41 8.6 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 174.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.4 t -86.51 105.85 15.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 122.999 0.519 . . . . 0.0 109.872 -179.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -91.35 112.42 24.33 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 176.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -85.05 120.82 26.99 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 173.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 21.9 p-90 -138.88 177.66 7.73 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.983 0.913 . . . . 0.0 112.351 -174.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -150.94 150.16 30.5 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.472 1.509 . . . . 0.0 107.716 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -62.84 -50.3 71.51 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.852 0.358 . . . . 0.0 111.308 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 63.9 p-90 -62.25 -26.25 68.28 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.489 0.716 . . . . 0.0 112.743 -178.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.6 t -79.16 77.68 5.65 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 121.554 -0.716 . . . . 0.0 109.829 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -22.15 -63.12 0.03 OUTLIER Glycine 0 CA--C 1.534 1.276 0 C-N-CA 127.661 2.553 . . . . 0.0 115.198 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -42.58 -36.0 4.4 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 124.503 3.469 . . . . 0.0 114.525 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 80.5 m -53.92 -46.06 71.36 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 121.508 0.67 . . . . 0.0 109.956 176.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.91 -24.47 63.38 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.348 0.659 . . . . 0.0 110.967 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 23.1 mmt -74.2 -43.92 55.33 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 30.4 pt -75.2 -27.23 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 118.905 -0.569 . . . . 0.0 111.694 177.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -36.6 -60.06 0.8 Allowed Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -56.89 -40.6 83.0 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.224 1.949 . . . . 0.0 111.918 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.0 mt -58.79 -50.72 78.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.7 mt -56.12 -43.77 78.5 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.592 0.357 . . . . 0.0 110.201 177.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -58.5 -49.59 76.82 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.255 0.55 . . . . 0.0 109.794 178.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -56.13 -52.07 65.68 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 31.7 mm -54.04 -50.01 56.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 123.066 0.547 . . . . 0.0 109.869 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.24 -46.47 65.73 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.219 0.608 . . . . 0.0 110.603 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -66.13 -56.91 9.1 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 178.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -47.25 -49.89 22.47 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.711 1.204 . . . . 0.0 112.329 -178.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -99.69 26.19 6.45 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.149 0.58 . . . . 0.0 111.705 -178.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.54 111.85 0.99 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.253 0.933 . . . . 0.0 111.022 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.35 -15.84 61.61 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.01 0.814 . . . . 0.0 112.243 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -99.52 -39.17 8.46 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.943 1.297 . . . . 0.0 109.158 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 46.9 tp -140.2 130.64 25.39 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 178.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 91.0 m -91.09 145.92 24.28 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 105.836 -1.912 . . . . 0.0 105.836 174.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 94.9 t -120.54 141.28 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 177.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.86 148.82 50.22 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.127 0.571 . . . . 0.0 109.889 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -127.33 96.57 4.61 Favored 'General case' 0 C--O 1.23 0.066 0 C-N-CA 124.906 1.283 . . . . 0.0 108.91 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 tt -96.7 109.4 22.05 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -176.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -80.45 108.61 14.22 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.934 -178.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.7 pt -64.46 -25.31 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-O 119.1 -0.476 . . . . 0.0 111.644 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -53.65 -25.72 19.19 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.825 0.739 . . . . 0.0 111.966 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -119.01 3.03 11.52 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.015 0.926 . . . . 0.0 110.89 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -147.23 62.75 7.5 Favored Pre-proline 0 CA--C 1.529 0.137 0 C-N-CA 124.614 1.166 . . . . 0.0 109.523 -177.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -61.82 -52.07 3.31 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 121.776 1.651 . . . . 0.0 111.285 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -40.83 -43.11 3.05 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.529 1.538 . . . . 0.0 114.918 -177.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.31 -31.12 67.22 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 117.808 0.804 . . . . 0.0 111.788 -178.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.36 -67.24 0.92 Allowed Pre-proline 0 CA--C 1.539 0.529 0 CA-C-O 118.276 -0.869 . . . . 0.0 112.619 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -60.0 -38.47 78.05 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 121.72 1.613 . . . . 0.0 110.882 178.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -52.25 -38.56 58.5 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 118.874 0.761 . . . . 0.0 111.484 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -106.67 19.77 20.0 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.657 0.383 . . . . 0.0 111.999 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.23 38.05 55.97 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.111 0.862 . . . . 0.0 113.528 176.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.38 129.23 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -89.79 -48.84 6.99 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.45 1.1 . . . . 0.0 110.095 -178.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -162.14 146.5 12.09 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 107.285 -2.326 . . . . 0.0 107.285 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.3 pt -98.55 149.14 35.44 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 123.461 0.704 . . . . 0.0 110.048 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.17 139.47 53.05 Favored 'Cis proline' 0 N--CA 1.455 -0.772 0 CA-C-N 119.873 0.99 . . . . 0.0 111.094 -0.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.77 139.49 52.23 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 176.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.6 mt -118.46 106.07 12.32 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.0 mp -100.16 113.23 25.73 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 176.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.9 tp -90.23 101.8 14.52 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -86.53 143.2 27.83 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.556 1.143 . . . . 0.0 109.166 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -140.96 110.42 6.33 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 175.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.1 t30 55.73 67.93 0.94 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 121.438 0.637 . . . . 0.0 110.337 -177.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.31 -31.76 0.26 Allowed Glycine 0 CA--C 1.533 1.187 0 N-CA-C 117.04 1.576 . . . . 0.0 117.04 176.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -97.71 155.03 17.2 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 119.5 1.65 . . . . 0.0 111.224 -177.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 93.3 t -76.19 118.31 22.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.93 -47.13 15.53 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 123.662 0.785 . . . . 0.0 109.177 177.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -156.77 171.9 19.57 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 123.944 0.898 . . . . 0.0 108.689 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 90.8 m -149.96 148.86 29.59 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 122.01 -0.431 . . . . 0.0 110.111 -178.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -130.59 151.14 51.38 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 126.314 1.846 . . . . 0.0 107.62 177.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.2 t -129.96 131.64 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -178.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.95 -178.58 45.2 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 111.439 -0.665 . . . . 0.0 111.439 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.75 165.72 24.28 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.836 0.454 . . . . 0.0 110.894 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.5 mt -145.05 151.41 38.5 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.662 1.185 . . . . 0.0 108.533 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.4 p -84.52 149.42 25.93 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 172.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -51.71 -45.04 63.42 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-O 119.481 -0.295 . . . . 0.0 111.648 -177.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.92 -55.34 29.58 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 118.343 0.52 . . . . 0.0 111.844 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -56.81 -47.67 79.73 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 122.048 -0.678 . . . . 0.0 110.077 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 48.4 tp -56.77 -51.59 68.3 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 119.539 -0.267 . . . . 0.0 110.489 178.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.1 mmmp? -51.93 -49.45 63.08 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.279 0.631 . . . . 0.0 110.336 177.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -58.87 -50.37 74.27 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 110.558 -0.164 . . . . 0.0 110.558 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -53.9 -53.01 58.58 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.546 0.739 . . . . 0.0 110.865 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.8 mt -59.97 -49.95 75.68 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 122.726 0.41 . . . . 0.0 110.377 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -54.74 -50.73 67.66 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 117.844 0.293 . . . . 0.0 110.353 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.75 -36.92 70.32 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.577 0.751 . . . . 0.0 111.696 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -77.7 -42.98 32.55 Favored 'General case' 0 C--O 1.227 -0.082 0 O-C-N 122.205 -0.309 . . . . 0.0 110.367 -178.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 47.3 mt -61.75 -47.37 85.52 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.29 0 C-N-CA 123.208 0.603 . . . . 0.0 109.644 177.518 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.454 -0.263 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 21.6 t0 60.79 -73.53 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 126.38 1.872 . . . . 0.0 112.002 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -102.42 -19.99 14.73 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.677 1.191 . . . . 0.0 110.955 177.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.2 mt -79.45 133.7 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-N 118.118 0.417 . . . . 0.0 110.129 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.5 mm -90.97 111.41 23.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 124.419 1.088 . . . . 0.0 109.387 178.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -82.37 101.44 10.6 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 67.1 mt -85.09 162.9 19.11 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.697 0.799 . . . . 0.0 111.849 -177.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 48.0 p -137.64 165.67 25.79 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 126.042 1.737 . . . . 0.0 106.406 175.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -56.58 -44.02 80.63 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.853 -0.529 . . . . 0.0 110.216 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -59.28 -44.16 92.49 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.025 0.93 . . . . 0.0 112.192 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.1 p -78.79 -30.94 45.79 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 122.107 -0.371 . . . . 0.0 111.003 -177.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -36.36 -56.48 0.78 Allowed 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 126.37 1.868 . . . . 0.0 114.092 -178.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -54.29 -57.59 10.64 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 121.822 -0.549 . . . . 0.0 110.953 -177.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.3 m -62.02 -47.62 83.97 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.708 0.803 . . . . 0.0 112.446 -177.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.16 -50.68 13.92 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -175.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.4 t -90.97 -57.05 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 124.048 0.939 . . . . 0.0 112.533 -173.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 72.2 mt -66.76 -41.06 88.38 Favored 'General case' 0 CA--C 1.523 -0.074 0 C-N-CA 119.564 -0.854 . . . . 0.0 110.918 -174.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -93.0 30.67 1.56 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 122.64 0.376 . . . . 0.0 110.041 176.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.0 156.66 36.82 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.766 -0.584 . . . . 0.0 110.826 177.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -131.69 55.18 1.88 Allowed 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 124.699 1.2 . . . . 0.0 108.109 176.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 164.5 -173.01 40.41 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.506 -1.037 . . . . 0.0 110.506 -178.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.95 113.65 23.81 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.543 1.537 . . . . 0.0 109.947 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.5 mt -113.52 117.46 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 124.258 1.023 . . . . 0.0 109.479 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.7 tp -89.72 96.32 10.64 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 177.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.7 t -89.32 109.35 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 123.427 0.691 . . . . 0.0 109.629 -179.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -93.58 105.36 17.41 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -79.18 123.95 27.88 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 175.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 24.5 p-90 -138.93 172.69 12.49 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 124.292 1.037 . . . . 0.0 111.943 -175.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.99 147.79 32.05 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.297 1.039 . . . . 0.0 108.651 175.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -54.61 -52.23 62.84 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.904 0.882 . . . . 0.0 111.78 -178.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 61.4 p-90 -67.25 -21.58 65.71 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.958 0.903 . . . . 0.0 112.747 -178.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 46.0 t -79.58 70.0 5.98 Favored 'General case' 0 N--CA 1.456 -0.144 0 O-C-N 121.38 -0.825 . . . . 0.0 110.935 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -16.14 -65.59 0.01 OUTLIER Glycine 0 CA--C 1.534 1.266 0 C-N-CA 128.253 2.835 . . . . 0.0 115.903 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -42.95 -32.38 2.65 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 124.532 3.488 . . . . 0.0 115.036 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 99.6 m -53.9 -44.73 70.76 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.221 0.608 . . . . 0.0 110.121 176.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -67.33 -26.6 66.58 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.323 0.649 . . . . 0.0 111.13 178.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 23.3 mmt -74.54 -43.68 54.64 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 19.6 pt -74.95 -28.95 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 119.006 -0.521 . . . . 0.0 111.922 178.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -38.67 -59.45 1.34 Allowed Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -56.6 -40.08 86.91 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.158 1.905 . . . . 0.0 111.441 177.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 16.3 mt -58.85 -48.82 85.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 74.7 mt -57.25 -43.67 83.16 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 119.415 -0.326 . . . . 0.0 110.352 177.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -60.02 -48.09 83.13 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.839 0.745 . . . . 0.0 110.446 177.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -57.01 -52.16 66.38 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.2 mm -55.44 -45.06 78.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 124.102 0.961 . . . . 0.0 110.017 178.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.51 -41.71 73.47 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 123.048 0.539 . . . . 0.0 110.05 178.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -67.67 -55.13 14.44 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 176.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -48.06 -48.99 33.02 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.903 0.881 . . . . 0.0 112.068 -178.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -103.2 28.87 5.95 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.654 0.782 . . . . 0.0 111.594 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -55.37 126.53 25.43 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.152 0.887 . . . . 0.0 111.212 -178.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.36 -13.13 29.16 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 119.237 -0.757 . . . . 0.0 113.21 -178.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -99.8 -43.93 6.26 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.455 1.127 . . . . 0.0 109.357 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.9 tp -125.4 125.5 43.5 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.755 1.222 . . . . 0.0 108.025 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 60.4 m -87.59 101.84 14.02 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 176.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.6 t -79.39 131.74 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.66 151.65 48.49 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 122.635 0.374 . . . . 0.0 110.096 -178.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -128.69 135.43 49.24 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 tt -124.54 113.62 18.33 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.645 0.778 . . . . 0.0 109.223 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -79.39 108.89 13.25 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.1 pt -70.74 -22.59 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -58.16 -48.47 80.17 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.221 0.919 . . . . 0.0 109.092 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -79.88 -31.76 40.34 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.914 0.885 . . . . 0.0 110.367 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -119.26 67.11 8.97 Favored Pre-proline 0 N--CA 1.463 0.219 0 C-N-CA 123.482 0.713 . . . . 0.0 112.082 -176.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.1 -47.04 8.94 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 121.877 1.718 . . . . 0.0 110.966 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -41.2 -41.0 2.7 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.756 1.646 . . . . 0.0 115.038 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.77 -27.08 68.65 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.158 0.979 . . . . 0.0 112.639 -178.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.8 -63.0 4.63 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 118.347 -0.835 . . . . 0.0 113.053 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -60.56 -37.03 83.27 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.151 1.901 . . . . 0.0 111.464 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -51.99 -31.43 29.35 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.813 0.733 . . . . 0.0 112.003 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -118.56 19.34 13.31 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.25 0.62 . . . . 0.0 111.658 177.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 47.35 43.59 19.9 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.46 1.029 . . . . 0.0 113.308 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.6 mp -53.49 117.66 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 117.908 0.854 . . . . 0.0 109.181 177.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 29.3 mmm180 -79.8 -45.48 18.7 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.238 1.015 . . . . 0.0 110.807 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -164.17 147.25 12.5 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 107.819 -2.112 . . . . 0.0 107.819 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.6 pt -100.27 152.82 37.94 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 123.913 0.885 . . . . 0.0 110.101 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -68.66 142.18 66.06 Favored 'Cis proline' 0 N--CA 1.456 -0.697 0 CA-C-N 119.519 0.864 . . . . 0.0 110.454 -1.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.37 109.82 15.35 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.3 mt -89.53 93.08 9.36 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.925 0.89 . . . . 0.0 109.781 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.2 mp -91.28 115.84 28.35 Favored 'General case' 0 CA--C 1.522 -0.105 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.3 tp -92.6 96.0 9.94 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -87.51 104.5 16.53 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.026 1.33 . . . . 0.0 110.226 -178.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -93.42 108.48 20.14 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 174.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 49.95 50.48 18.4 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.707 0.803 . . . . 0.0 110.626 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 79.75 -14.19 20.12 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 118.879 -0.956 . . . . 0.0 114.565 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -94.82 121.34 36.31 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 119.591 1.695 . . . . 0.0 110.141 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 98.3 t -64.15 104.86 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 175.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.31 -38.03 36.26 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.862 0.865 . . . . 0.0 109.813 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -155.44 166.17 34.37 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.71 0.804 . . . . 0.0 108.899 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 69.7 m -147.79 117.96 7.31 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.629 0.772 . . . . 0.0 108.986 -178.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -104.74 112.5 25.63 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.2 t -90.32 124.15 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 177.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.65 168.44 36.79 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 123.804 0.716 . . . . 0.0 112.249 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.62 166.23 19.49 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.082 0.553 . . . . 0.0 110.244 179.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -155.63 170.69 21.43 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.695 0.798 . . . . 0.0 109.863 -177.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 80.9 p -86.18 162.81 18.16 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 177.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.01 -39.01 80.57 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 175.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -57.06 -56.36 25.44 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 177.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -54.22 -46.56 72.54 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.942 0.371 . . . . 0.0 110.225 178.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 22.8 tp -59.06 -50.25 74.79 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 121.283 -0.167 . . . . 0.0 110.765 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.9 mmmm -54.53 -48.84 71.5 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.723 -0.611 . . . . 0.0 111.338 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -65.95 -43.5 87.78 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 119.584 -0.846 . . . . 0.0 111.022 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -53.24 -52.24 59.59 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.158 0.583 . . . . 0.0 109.497 177.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.8 mt -58.73 -55.19 38.27 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 122.743 0.417 . . . . 0.0 110.3 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -51.24 -50.53 59.02 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.04 0.382 . . . . 0.0 111.13 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.14 -38.45 70.84 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.397 0.679 . . . . 0.0 111.807 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -78.5 -43.48 26.83 Favored 'General case' 0 C--O 1.228 -0.048 0 O-C-N 122.199 -0.313 . . . . 0.0 111.049 -178.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 69.5 mt -63.58 -45.63 89.53 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.2 0 C-N-CA 122.909 0.483 . . . . 0.0 109.832 177.745 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.415 ' H1 ' ' CD2' ' A' ' 6' ' ' HIS . 13.2 m . . . . . 0 N--CA 1.452 -0.356 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 36.0 t70 58.6 -71.79 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 127.244 2.218 . . . . 0.0 112.267 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -84.91 -33.04 22.81 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.991 0.917 . . . . 0.0 109.791 176.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 16.6 mt -79.82 135.8 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.2 mm -90.31 114.43 27.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.433 1.093 . . . . 0.0 109.297 177.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.415 ' CD2' ' H1 ' ' A' ' 1' ' ' SER . 11.1 m-70 -84.54 104.82 14.86 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.3 mt -87.84 163.79 16.23 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.598 1.159 . . . . 0.0 111.679 -178.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 61.3 p -138.48 165.19 27.46 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 126.257 1.823 . . . . 0.0 106.385 174.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -55.13 -44.69 75.28 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.128 0.571 . . . . 0.0 110.104 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -59.82 -43.83 94.32 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.867 0.867 . . . . 0.0 112.383 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.8 p -78.75 -30.47 45.75 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 122.152 -0.342 . . . . 0.0 111.22 -177.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -36.76 -54.77 0.9 Allowed 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 126.407 1.883 . . . . 0.0 114.017 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -54.07 -57.66 10.23 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.265 0.555 . . . . 0.0 111.132 -178.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.4 m -63.79 -48.07 78.37 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.385 0.674 . . . . 0.0 112.059 -177.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.59 -52.26 12.27 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -175.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.7 t -89.63 -56.22 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 123.891 0.876 . . . . 0.0 112.203 -174.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 66.6 mt -66.15 -42.7 88.7 Favored 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 119.489 -0.884 . . . . 0.0 111.168 -175.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -91.98 31.72 1.22 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 118.045 0.384 . . . . 0.0 110.18 175.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.68 143.67 57.14 Favored 'General case' 0 C--N 1.341 0.208 0 O-C-N 121.538 -0.726 . . . . 0.0 112.172 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -108.7 54.33 0.66 Allowed 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.495 1.118 . . . . 0.0 108.769 176.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 150.46 -160.47 28.58 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 123.759 0.695 . . . . 0.0 111.566 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.51 122.45 34.1 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 126.103 1.761 . . . . 0.0 110.356 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.5 mt -122.62 122.39 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 124.732 1.213 . . . . 0.0 109.18 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.418 HD13 ' C ' ' A' ' 24' ' ' LEU . 2.9 tm? -93.47 106.87 18.8 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 175.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 42.6 t -97.46 110.33 25.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -92.15 103.58 16.05 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 176.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -78.92 118.05 20.57 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 104.046 -2.576 . . . . 0.0 104.046 175.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 34.5 p-90 -130.66 168.71 16.69 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 124.545 1.138 . . . . 0.0 111.933 -175.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -141.49 143.05 33.61 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.087 1.355 . . . . 0.0 108.304 176.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -58.3 -49.13 78.24 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.261 1.024 . . . . 0.0 112.171 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.469 ' CH2' HD11 ' A' ' 75' ' ' ILE . 50.9 p-90 -63.96 -28.11 69.6 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.519 0.728 . . . . 0.0 112.358 -178.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.6 t -79.59 79.18 6.09 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 121.556 -0.715 . . . . 0.0 110.643 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -24.17 -62.88 0.05 OUTLIER Glycine 0 CA--C 1.535 1.324 0 C-N-CA 127.074 2.273 . . . . 0.0 114.44 178.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -40.46 -33.71 1.0 Allowed 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 125.035 3.823 . . . . 0.0 115.503 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 99.8 m -53.67 -43.04 68.54 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.589 0.709 . . . . 0.0 109.995 177.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -69.05 -26.89 65.19 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.411 1.084 . . . . 0.0 110.973 178.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -75.58 -43.15 49.78 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 33.7 pt -72.79 -29.85 31.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.607 177.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -37.81 -60.46 0.94 Allowed Pre-proline 0 CA--C 1.545 0.769 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -56.32 -39.35 91.88 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.363 2.042 . . . . 0.0 111.938 177.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 21.0 mt -59.61 -52.69 57.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 177.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 60.8 mt -55.12 -40.58 70.66 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.961 0.504 . . . . 0.0 110.363 177.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -61.26 -47.8 84.38 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.243 0.928 . . . . 0.0 110.023 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -56.8 -52.35 65.4 Favored 'General case' 0 C--N 1.34 0.18 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.0 mm -53.28 -49.08 54.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 123.37 0.668 . . . . 0.0 109.538 177.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.47 -43.4 68.13 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.506 0.722 . . . . 0.0 110.76 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -69.31 -55.66 9.79 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.71 0.29 . . . . 0.0 110.638 177.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -50.53 -47.66 57.43 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.57 1.148 . . . . 0.0 112.322 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -99.81 24.36 8.5 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.264 1.026 . . . . 0.0 110.795 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -55.39 124.18 16.3 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.516 -0.74 . . . . 0.0 110.122 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.34 -14.24 46.57 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 119.454 -0.637 . . . . 0.0 112.907 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -99.74 -42.27 6.92 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.371 1.069 . . . . 0.0 109.3 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.1 tp -133.01 125.35 29.5 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.726 1.211 . . . . 0.0 108.168 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 56.2 m -85.41 101.84 12.94 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 176.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 85.1 t -79.31 133.62 29.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -138.16 154.04 49.18 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.126 0.57 . . . . 0.0 110.417 -177.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -126.44 137.38 53.4 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.6 tt -127.28 115.15 18.59 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -78.66 104.54 9.34 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 pp -68.54 -29.11 42.82 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.19 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -56.86 -45.18 82.62 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 118.437 0.562 . . . . 0.0 109.752 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -81.48 -31.43 32.94 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.929 0.892 . . . . 0.0 110.395 177.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -119.83 68.91 12.51 Favored Pre-proline 0 C--O 1.235 0.326 0 C-N-CA 123.663 0.785 . . . . 0.0 111.557 -177.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -61.39 -52.64 3.03 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.463 2.109 . . . . 0.0 112.586 -177.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -38.28 -45.43 1.79 Allowed Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.538 1.542 . . . . 0.0 114.556 -177.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.45 -33.91 46.45 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.89 0.876 . . . . 0.0 112.964 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.55 -67.67 0.89 Allowed Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 118.136 -0.935 . . . . 0.0 112.184 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -59.42 -37.18 91.38 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.77 1.646 . . . . 0.0 111.218 177.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -51.35 -38.38 52.89 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.291 0.951 . . . . 0.0 111.778 178.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -110.83 22.53 15.25 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.895 0.478 . . . . 0.0 111.574 178.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 42.9 43.06 5.23 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 126.085 1.802 . . . . 0.0 112.976 178.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.3 mp -43.95 131.98 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 123.69 0.796 . . . . 0.0 112.137 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.15 -51.7 9.84 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.472 1.109 . . . . 0.0 109.218 -177.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -179.53 135.16 2.44 Favored Glycine 0 C--N 1.333 0.409 0 N-CA-C 107.228 -2.349 . . . . 0.0 107.228 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.469 HD11 ' CH2' ' A' ' 31' ' ' TRP . 2.0 pp -79.98 145.37 61.18 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 117.251 0.525 . . . . 0.0 111.511 -176.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.81 135.1 32.25 Favored 'Cis proline' 0 N--CA 1.456 -0.69 0 CA-C-N 119.744 0.944 . . . . 0.0 111.512 -0.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.5 m -123.23 117.51 25.48 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.6 mt -95.64 122.25 38.21 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -114.17 119.58 37.57 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 177.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.15 98.24 10.49 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -90.26 107.67 19.29 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.374 1.47 . . . . 0.0 110.786 -178.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -96.66 108.63 21.28 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 173.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 35.8 m120 48.43 51.59 14.99 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.75 0.82 . . . . 0.0 111.339 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.51 -13.97 14.51 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 118.851 -0.972 . . . . 0.0 114.64 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -94.71 122.59 37.48 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 119.563 1.682 . . . . 0.0 109.557 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 98.9 t -65.53 108.95 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 175.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.93 -39.52 34.5 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -163.16 173.9 12.85 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.5 t -149.73 159.39 44.39 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.7 mmtp -138.79 151.9 47.45 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.534 1.934 . . . . 0.0 107.271 177.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.9 t -129.08 135.22 62.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 124.722 1.209 . . . . 0.0 107.906 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.47 -171.12 51.23 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 112.077 -0.409 . . . . 0.0 112.077 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.63 163.31 27.86 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.051 0.541 . . . . 0.0 111.357 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.7 mt -146.25 154.62 41.92 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.303 1.441 . . . . 0.0 107.823 178.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.1 p -84.98 150.83 24.64 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 172.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -48.95 -49.32 40.93 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.063 0.545 . . . . 0.0 110.768 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.35 -59.13 10.55 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 112.108 -0.397 . . . . 0.0 112.108 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -55.32 -45.15 76.34 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 117.527 0.664 . . . . 0.0 111.077 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.2 tp -59.51 -50.21 74.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 177.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -55.33 -46.35 76.36 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.613 0.642 . . . . 0.0 111.222 177.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -57.11 -52.55 64.83 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.111 0.565 . . . . 0.0 109.769 178.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -53.81 -53.79 47.45 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.053 0.941 . . . . 0.0 110.781 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 88.3 mt -59.2 -49.76 76.63 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.256 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -54.71 -50.52 68.11 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 122.807 0.443 . . . . 0.0 110.489 178.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.3 -36.18 68.37 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.518 0.727 . . . . 0.0 111.651 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -78.04 -44.15 27.27 Favored 'General case' 0 N--CA 1.46 0.068 0 O-C-N 122.157 -0.339 . . . . 0.0 110.162 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 40.4 mt -59.51 -45.73 90.89 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.2 0 C-N-CA 123.183 0.593 . . . . 0.0 109.812 177.727 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.449 -0.507 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 43.56 42.31 3.95 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.145 1.778 . . . . 0.0 112.962 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -80.77 57.79 3.11 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.386 1.075 . . . . 0.0 108.872 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 13.4 mt -103.99 139.7 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 124.794 1.238 . . . . 0.0 110.355 -177.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 25.7 mm -91.36 116.72 33.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 177.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -82.92 113.29 20.42 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.3 mt -96.18 164.0 12.86 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.896 0.878 . . . . 0.0 112.148 -177.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 32.4 p -135.81 166.34 23.52 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 171.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -59.13 -47.8 83.96 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.446 0.566 . . . . 0.0 109.556 178.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -60.9 -44.56 96.97 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.663 0.785 . . . . 0.0 111.535 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 82.5 p -79.21 -24.41 43.15 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -176.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -34.21 -59.68 0.43 Allowed 'General case' 0 C--N 1.339 0.124 0 C-N-CA 126.598 1.959 . . . . 0.0 113.836 -178.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -51.69 -59.23 4.52 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.288 0.635 . . . . 0.0 110.82 -177.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 m -60.09 -43.69 95.36 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 123.248 0.619 . . . . 0.0 111.732 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -72.69 -36.7 67.92 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -174.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.4 t -112.88 -60.3 2.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 123.807 0.843 . . . . 0.0 111.205 -173.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.5 mt -61.37 -35.9 78.74 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-O 119.257 -0.402 . . . . 0.0 111.736 -175.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -92.22 10.47 29.4 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.368 0.531 . . . . 0.0 112.071 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.67 103.39 15.07 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 119.081 0.855 . . . . 0.0 109.965 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -74.31 65.38 1.2 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.524 0.73 . . . . 0.0 110.592 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -166.01 177.84 40.92 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.03 107.19 18.32 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.994 1.318 . . . . 0.0 111.059 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 mt -113.42 114.14 46.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 124.523 1.129 . . . . 0.0 110.78 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.4 tp -84.05 98.94 10.13 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 107.005 -1.479 . . . . 0.0 107.005 174.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.0 t -87.58 118.74 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 123.125 0.57 . . . . 0.0 109.54 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -102.63 108.19 19.37 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.52 1.128 . . . . 0.0 108.951 177.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -81.29 119.18 23.32 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 175.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 37.4 p-90 -135.28 171.97 13.68 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 124.154 0.981 . . . . 0.0 113.196 -174.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.11 132.05 17.15 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 125.736 1.614 . . . . 0.0 108.036 175.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.3 pm0 -49.42 -39.29 32.22 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -178.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 61.4 p-90 -77.26 -19.95 55.83 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 43.8 t -79.53 76.21 6.15 Favored 'General case' 0 N--CA 1.456 -0.162 0 O-C-N 121.409 -0.807 . . . . 0.0 110.411 -176.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -12.58 -69.75 0.01 OUTLIER Glycine 0 CA--C 1.536 1.39 0 C-N-CA 127.752 2.596 . . . . 0.0 115.565 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -41.63 -38.78 4.43 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 124.683 3.588 . . . . 0.0 114.766 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 87.7 m -50.86 -47.37 60.36 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.331 1.052 . . . . 0.0 110.584 177.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt -70.57 -28.67 65.06 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.582 0.753 . . . . 0.0 110.621 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 84.7 mmm -71.45 -43.29 66.96 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 177.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.3 pt -76.82 -27.91 16.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 CA-C-O 118.536 -0.745 . . . . 0.0 112.102 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -38.07 -59.21 1.25 Allowed Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -56.92 -41.15 78.4 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.208 1.939 . . . . 0.0 111.911 177.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 27.6 mt -58.27 -52.04 63.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 68.6 mt -56.68 -44.04 81.07 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.432 0.693 . . . . 0.0 110.494 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -58.43 -48.46 80.63 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.737 0.415 . . . . 0.0 110.281 178.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -60.7 -52.25 65.9 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.9 mm -50.79 -47.14 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.267 1.027 . . . . 0.0 110.402 177.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.48 -37.35 65.15 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.323 0.649 . . . . 0.0 110.848 178.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -75.04 -55.44 5.74 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 176.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -45.56 -51.4 11.99 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 125.37 1.468 . . . . 0.0 112.28 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -101.26 23.11 11.4 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.96 0.504 . . . . 0.0 111.637 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -55.35 130.26 41.76 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 119.455 1.025 . . . . 0.0 110.643 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.75 -19.68 23.56 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 119.466 -0.63 . . . . 0.0 112.625 -178.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -99.4 -41.24 7.5 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.261 1.024 . . . . 0.0 108.829 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.0 tp -133.29 143.88 49.34 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.243 1.817 . . . . 0.0 107.217 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 94.5 m -107.16 140.27 40.28 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 105.314 -2.106 . . . . 0.0 105.314 173.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.1 t -112.82 140.51 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 178.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.38 149.41 46.95 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -178.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -126.26 131.43 51.91 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.261 1.024 . . . . 0.0 108.255 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 tt -122.79 116.24 23.37 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.739 0.816 . . . . 0.0 109.653 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -80.06 107.62 12.99 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 pp -66.83 -30.89 51.13 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -177.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -60.08 -49.46 77.56 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 119.03 0.832 . . . . 0.0 109.295 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -69.89 -36.09 75.16 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.006 177.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -121.25 70.78 22.44 Favored Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 123.907 0.883 . . . . 0.0 112.049 -175.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.94 -52.36 2.25 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.543 2.162 . . . . 0.0 112.616 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -39.03 -44.31 1.98 Allowed Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.438 1.494 . . . . 0.0 114.276 -177.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -53.13 -32.92 50.01 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.813 0.845 . . . . 0.0 112.874 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.78 -68.27 0.76 Allowed Pre-proline 0 CA--C 1.538 0.513 0 CA-C-O 118.072 -0.966 . . . . 0.0 111.662 178.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -59.38 -36.86 93.11 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 121.55 1.5 . . . . 0.0 111.45 177.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -51.58 -40.56 60.01 Favored 'General case' 0 C--N 1.345 0.398 0 CA-C-N 119.558 1.072 . . . . 0.0 111.601 178.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -107.7 21.7 17.06 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 122.704 0.402 . . . . 0.0 111.275 178.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 43.88 43.5 6.82 Favored Glycine 0 C--N 1.338 0.684 0 C-N-CA 125.798 1.666 . . . . 0.0 113.034 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.3 mp -49.02 129.5 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 117.975 0.887 . . . . 0.0 110.839 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.73 -53.86 6.7 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.045 0.938 . . . . 0.0 108.924 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -168.87 150.12 15.15 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 107.062 -2.415 . . . . 0.0 107.062 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 23.8 pt -91.47 149.18 39.02 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-N 117.701 0.75 . . . . 0.0 110.373 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -70.88 137.69 47.89 Favored 'Cis proline' 0 N--CA 1.456 -0.684 0 CA-C-N 119.644 0.908 . . . . 0.0 110.416 -1.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.95 116.69 27.43 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 20.8 mt -98.29 120.83 39.37 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.5 mp -121.08 118.91 30.95 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 177.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.3 tp -93.35 96.11 9.74 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -84.97 101.86 12.71 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.665 1.186 . . . . 0.0 110.002 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -93.45 114.53 26.95 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 173.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 55.89 39.31 30.64 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.8 0.84 . . . . 0.0 110.979 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.51 -0.6 75.26 Favored Glycine 0 CA--C 1.532 1.121 0 CA-C-O 118.758 -1.024 . . . . 0.0 113.738 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -108.24 126.68 53.08 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.346 1.573 . . . . 0.0 109.354 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.7 t -63.57 106.36 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.08 -40.82 30.21 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.026 0.931 . . . . 0.0 109.535 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -156.78 169.46 24.69 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.9 t -151.84 159.63 43.81 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -146.75 131.41 17.87 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.6 t -102.36 125.58 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.26 170.92 38.04 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.21 166.1 16.98 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.685 0.794 . . . . 0.0 112.875 -177.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.0 mt -138.93 153.52 48.24 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 126.228 1.811 . . . . 0.0 107.513 177.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.1 p -84.09 155.54 22.61 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.514 -1.662 . . . . 0.0 106.514 171.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -50.31 -51.36 45.93 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 122.126 -0.359 . . . . 0.0 111.084 -178.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -53.64 -58.45 12.28 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 111.913 -0.475 . . . . 0.0 111.913 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -56.2 -42.34 77.01 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 122.232 -0.569 . . . . 0.0 110.856 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 30.9 tp -62.55 -48.49 79.28 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -54.78 -47.84 73.43 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.558 0.617 . . . . 0.0 110.125 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -57.51 -53.84 53.56 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.541 0.737 . . . . 0.0 110.397 178.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -52.19 -50.16 62.43 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.63 1.172 . . . . 0.0 110.174 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 87.2 mt -60.52 -52.29 65.81 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 119.184 -0.436 . . . . 0.0 110.329 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -52.8 -49.4 65.71 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 118.197 0.453 . . . . 0.0 110.459 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.66 -37.5 70.88 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.546 0.738 . . . . 0.0 111.658 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -78.07 -44.24 26.86 Favored 'General case' 0 N--CA 1.462 0.135 0 O-C-N 122.083 -0.385 . . . . 0.0 110.439 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 53.8 mt -59.05 -48.18 82.53 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.276 0 C-N-CA 123.259 0.623 . . . . 0.0 109.607 177.465 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 7.8 p . . . . . 0 CA--C 1.533 0.323 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -70.78 61.28 0.25 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.703 1.601 . . . . 0.0 111.826 -178.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.4 mtmm -82.23 58.63 4.11 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 177.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.4 mt -131.0 148.21 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 123.875 0.87 . . . . 0.0 109.379 -173.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.8 mm -87.1 106.9 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -82.2 105.67 13.48 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.9 mt -88.24 166.35 14.4 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.854 1.662 . . . . 0.0 112.161 -177.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 44.0 p -137.33 165.72 25.51 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 172.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -59.05 -46.57 87.89 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 118.271 0.487 . . . . 0.0 110.102 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -60.23 -45.36 93.49 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.498 0.719 . . . . 0.0 111.127 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 81.9 p -79.18 -24.24 43.35 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -176.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -37.71 -53.91 1.23 Allowed 'General case' 0 CA--C 1.527 0.073 0 C-N-CA 126.758 2.023 . . . . 0.0 114.359 -178.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -53.19 -60.35 3.4 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.307 0.575 . . . . 0.0 110.637 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.1 m -60.46 -45.54 93.33 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 123.062 0.545 . . . . 0.0 111.601 -178.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -71.63 -36.18 70.65 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -173.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 41.4 t -112.87 -60.92 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 123.619 0.768 . . . . 0.0 110.762 -174.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.4 mt -62.91 -35.51 80.29 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 119.183 -0.437 . . . . 0.0 111.991 -174.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -96.67 15.78 20.83 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.336 0.516 . . . . 0.0 111.765 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -102.87 104.13 14.35 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 118.877 0.762 . . . . 0.0 110.192 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -74.09 65.17 1.1 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.582 0.753 . . . . 0.0 110.995 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -165.84 177.27 41.05 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.56 103.8 14.73 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 125.204 1.402 . . . . 0.0 110.798 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mt -109.98 118.63 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 C-N-CA 123.937 0.895 . . . . 0.0 110.236 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 19.3 tp -89.38 98.06 11.55 Favored 'General case' 0 C--N 1.338 0.068 0 N-CA-C 106.444 -1.688 . . . . 0.0 106.444 175.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.4 t -85.94 110.31 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 123.387 0.675 . . . . 0.0 109.341 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -97.49 108.92 21.74 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.172 0.589 . . . . 0.0 109.679 177.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -81.63 123.25 28.54 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 175.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 37.9 p-90 -136.62 167.43 21.42 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 124.601 1.161 . . . . 0.0 112.122 -177.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -141.39 137.76 32.51 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.976 1.31 . . . . 0.0 107.834 177.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -52.33 -48.23 65.57 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.871 0.868 . . . . 0.0 112.495 -177.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 57.7 p-90 -68.74 -22.42 64.32 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.063 0.545 . . . . 0.0 112.407 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 42.1 t -79.75 77.37 6.39 Favored 'General case' 0 N--CA 1.456 -0.142 0 O-C-N 121.402 -0.811 . . . . 0.0 111.073 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -23.03 -62.69 0.03 OUTLIER Glycine 0 CA--C 1.536 1.401 0 C-N-CA 127.34 2.4 . . . . 0.0 115.499 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -44.16 -31.52 4.19 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 124.511 3.474 . . . . 0.0 114.955 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 88.1 m -55.97 -43.29 77.43 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.613 -0.68 . . . . 0.0 109.724 176.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -66.18 -33.09 74.97 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.703 0.801 . . . . 0.0 110.147 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 46.7 ttm -67.22 -44.36 79.74 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 19.6 pt -77.5 -27.31 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 118.954 -0.546 . . . . 0.0 112.451 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -39.7 -57.45 2.53 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -58.9 -39.44 81.2 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.074 1.849 . . . . 0.0 111.474 177.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 27.9 mt -58.15 -50.78 77.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 177.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 53.2 mt -57.13 -42.85 81.67 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.032 0.533 . . . . 0.0 110.411 177.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -59.0 -48.24 82.29 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.716 0.689 . . . . 0.0 110.492 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -59.63 -49.3 78.3 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.0 mm -55.66 -44.34 76.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 123.597 0.759 . . . . 0.0 109.657 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.18 -41.78 72.35 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.465 0.575 . . . . 0.0 110.355 178.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -66.6 -59.05 3.96 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.122 0.486 . . . . 0.0 110.075 177.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -51.29 -45.45 62.14 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.176 0.99 . . . . 0.0 112.375 -177.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -97.83 22.9 8.56 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.822 0.849 . . . . 0.0 111.78 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.4 130.14 26.64 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.293 0.951 . . . . 0.0 110.525 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.84 -16.54 4.2 Favored Glycine 0 CA--C 1.534 1.23 0 CA-C-O 119.22 -0.767 . . . . 0.0 113.948 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -99.66 -35.32 9.86 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.703 1.251 . . . . 0.0 110.129 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.8 tp -136.42 136.04 39.21 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.269 1.027 . . . . 0.0 108.783 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 85.6 m -97.03 104.73 16.77 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 175.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 63.2 t -79.86 128.15 38.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -129.88 151.85 50.0 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.59 0.756 . . . . 0.0 109.79 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.4 mttm -128.16 142.32 51.22 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.637 1.175 . . . . 0.0 108.135 177.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.4 tt -132.88 115.42 15.23 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -80.72 108.84 14.71 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.9 pt -72.04 -19.08 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -60.88 -47.83 84.61 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 119.342 0.974 . . . . 0.0 108.663 178.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -80.06 -32.85 39.35 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.169 0.988 . . . . 0.0 109.997 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -121.5 64.48 15.49 Favored Pre-proline 0 CA--C 1.533 0.319 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -175.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -65.69 -42.35 12.37 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 121.687 1.591 . . . . 0.0 110.674 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -45.23 -30.15 2.67 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 125.791 1.662 . . . . 0.0 114.922 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.22 -26.75 62.15 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.415 1.108 . . . . 0.0 112.297 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.494 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . . . -63.03 -58.59 15.58 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 119.307 0.958 . . . . 0.0 111.137 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.494 ' HD3' ' HB3' ' A' ' 67' ' ' ALA . 80.6 Cg_exo -45.68 -45.04 17.05 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 124.031 3.154 . . . . 0.0 113.201 175.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -50.78 -31.15 16.04 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -120.15 19.71 12.18 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.146 0.578 . . . . 0.0 110.781 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 45.92 37.66 7.55 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.527 1.537 . . . . 0.0 112.54 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.4 mt -60.76 140.22 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 117.351 0.575 . . . . 0.0 110.959 -177.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -79.38 -38.39 35.06 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.113 0.965 . . . . 0.0 112.169 -174.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -179.94 -152.27 10.69 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 107.074 -2.41 . . . . 0.0 107.074 -177.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -146.13 157.44 49.82 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-O 117.764 -1.112 . . . . 0.0 108.872 178.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -66.84 135.92 29.14 Favored 'Cis proline' 0 N--CA 1.457 -0.662 0 CA-C-N 120.494 1.212 . . . . 0.0 110.151 -1.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.9 m -132.58 146.76 52.15 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 106.09 -1.818 . . . . 0.0 106.09 175.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.8 mt -127.49 124.86 39.33 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.567 1.547 . . . . 0.0 107.363 -175.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.3 mp -121.3 119.46 32.28 Favored 'General case' 0 CA--C 1.522 -0.106 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 176.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.45 95.62 9.75 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -85.44 101.86 12.97 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.657 1.183 . . . . 0.0 109.207 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -93.78 114.04 26.22 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 174.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 56.16 40.06 30.19 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.676 0.79 . . . . 0.0 111.177 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.68 -1.61 66.56 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 118.734 -1.037 . . . . 0.0 113.521 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -107.01 128.69 54.59 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 119.419 1.609 . . . . 0.0 109.368 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.9 t -66.28 107.87 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.15 -40.94 29.67 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.596 0.758 . . . . 0.0 109.416 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.11 170.75 20.58 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 177.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.9 t -151.32 160.76 43.62 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.7 tptt -148.13 131.1 16.22 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.557 1.543 . . . . 0.0 107.221 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 94.7 t -108.32 133.21 54.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 106.538 -1.652 . . . . 0.0 106.538 177.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.72 173.28 41.17 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.934 -0.867 . . . . 0.0 110.934 -178.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.12 170.37 16.17 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.976 0.511 . . . . 0.0 110.858 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -161.68 164.52 29.12 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.723 1.609 . . . . 0.0 107.614 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 83.8 p -81.26 165.02 21.82 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.067 0.46 . . . . 0.0 110.077 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -57.21 -41.73 79.95 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 174.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.81 -55.24 30.94 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -57.03 -43.73 82.17 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 117.687 0.743 . . . . 0.0 109.94 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 27.6 tp -59.9 -49.69 76.7 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 177.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -53.53 -48.38 69.11 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.011 0.823 . . . . 0.0 111.463 177.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -59.27 -50.57 73.51 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -53.15 -51.82 60.74 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.892 0.877 . . . . 0.0 110.05 178.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.5 mt -57.95 -53.04 62.76 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 122.952 0.501 . . . . 0.0 110.538 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -53.74 -50.45 65.95 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 117.866 0.303 . . . . 0.0 110.637 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.7 -37.56 68.53 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.362 0.665 . . . . 0.0 111.631 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -78.22 -46.16 21.11 Favored 'General case' 0 C--O 1.227 -0.121 0 O-C-N 122.182 -0.324 . . . . 0.0 110.862 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 54.8 mt -60.85 -46.7 89.52 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.265 0.626 . . . . 0.0 109.397 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.282 0 C-N-CA 123.025 0.53 . . . . 0.0 109.75 177.568 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 43.3 m . . . . . 0 N--CA 1.451 -0.385 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -65.37 141.9 58.4 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -69.0 -33.06 73.06 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 175.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.2 mt -80.07 139.25 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 C-N-CA 123.276 0.631 . . . . 0.0 109.357 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.9 mm -89.82 116.2 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 123.763 0.825 . . . . 0.0 109.356 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 -82.27 105.49 13.39 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.1 mt -90.76 155.14 19.02 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.369 0.668 . . . . 0.0 112.143 -177.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.0 p -126.06 158.5 35.25 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 172.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -55.13 -45.14 75.56 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.749 0.82 . . . . 0.0 109.815 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -57.7 -44.55 85.97 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.266 1.026 . . . . 0.0 111.309 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.9 p -78.22 -31.96 49.58 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -176.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -36.79 -48.43 0.73 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.605 1.962 . . . . 0.0 114.321 -176.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -55.3 -39.09 69.5 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -178.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.5 m -90.68 -50.66 5.79 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.348 0.659 . . . . 0.0 110.036 -178.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.87 -29.41 67.71 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -174.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.5 t -114.41 -60.69 2.77 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.076 0 CA-C-N 118.856 0.753 . . . . 0.0 110.723 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 72.1 mt -61.52 -30.94 70.96 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -174.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 42.6 mttp -97.95 16.61 20.43 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.045 0.838 . . . . 0.0 110.596 175.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.64 94.49 4.4 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 121.245 -0.909 . . . . 0.0 111.485 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -75.8 68.98 2.42 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 177.43 -170.56 43.11 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 108.386 -1.885 . . . . 0.0 108.386 -177.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -105.27 118.15 35.82 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.707 1.603 . . . . 0.0 110.783 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.1 mt -122.32 116.75 50.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 125.248 1.419 . . . . 0.0 110.036 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 24.5 tp -84.16 97.07 9.16 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 173.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 51.4 t -86.4 115.57 27.72 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.097 0 C-N-CA 123.361 0.664 . . . . 0.0 109.519 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -100.03 104.45 16.04 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.203 1.001 . . . . 0.0 109.212 177.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -79.57 120.79 24.41 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 105.026 -2.213 . . . . 0.0 105.026 174.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 13.7 p-90 -141.18 164.51 30.07 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -173.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -128.76 139.81 52.03 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.209 1.003 . . . . 0.0 109.215 175.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -54.2 -48.63 70.79 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.977 1.311 . . . . 0.0 111.419 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 54.9 p-90 -69.81 -21.59 63.38 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.794 0.838 . . . . 0.0 112.374 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 42.7 t -79.87 76.93 6.55 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 121.323 -0.861 . . . . 0.0 110.351 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -22.97 -60.99 0.03 OUTLIER Glycine 0 CA--C 1.535 1.315 0 C-N-CA 127.691 2.567 . . . . 0.0 115.632 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -44.21 -35.46 7.99 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 123.921 3.081 . . . . 0.0 114.129 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.8 m -59.12 -48.74 80.5 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 121.721 0.772 . . . . 0.0 109.844 177.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -65.5 -36.91 85.25 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 25.0 ttt -60.77 -45.33 94.78 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 119.622 -0.227 . . . . 0.0 110.715 177.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 34.8 pt -76.35 -25.72 16.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-O 118.635 -0.697 . . . . 0.0 112.49 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -37.26 -58.63 1.15 Allowed Pre-proline 0 CA--C 1.545 0.75 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -56.71 -40.32 85.16 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.241 1.96 . . . . 0.0 112.172 177.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 26.4 mt -59.24 -51.08 76.85 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 177.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 76.8 mt -56.59 -43.44 80.08 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.997 0.519 . . . . 0.0 110.804 178.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -60.22 -48.8 80.19 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.657 0.662 . . . . 0.0 110.215 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -59.25 -50.83 72.49 Favored 'General case' 0 C--O 1.226 -0.183 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.3 mm -54.3 -48.78 67.17 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.38 -49.34 64.61 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 122.975 0.51 . . . . 0.0 109.918 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -61.03 -57.85 10.86 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.785 0.326 . . . . 0.0 110.805 178.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -50.38 -45.96 55.68 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.44 1.096 . . . . 0.0 112.438 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -94.69 22.61 6.14 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -177.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -50.52 127.8 18.61 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.641 1.11 . . . . 0.0 110.384 177.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.48 -20.67 13.12 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-O 119.281 -0.733 . . . . 0.0 113.264 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -99.6 -40.49 7.78 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.566 1.183 . . . . 0.0 110.258 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.3 tp -143.18 136.9 28.61 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.853 0.861 . . . . 0.0 108.703 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 92.8 m -98.13 143.94 28.13 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 173.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 68.7 t -118.43 138.53 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 178.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.34 152.93 50.25 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -177.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.1 mttm -125.83 132.3 52.26 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.875 1.27 . . . . 0.0 107.623 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.8 tt -123.1 106.59 10.92 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -78.14 102.43 7.52 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.202 -177.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 pp -55.59 -30.99 27.6 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.231 0 C-N-CA 124.214 1.006 . . . . 0.0 112.072 -179.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -57.0 -45.36 83.05 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.26 0.482 . . . . 0.0 109.825 178.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -81.94 -35.92 28.57 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.077 0.951 . . . . 0.0 110.581 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -123.49 69.9 43.99 Favored Pre-proline 0 CA--C 1.529 0.15 0 C-N-CA 123.861 0.864 . . . . 0.0 111.182 -176.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -64.97 -41.98 15.72 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.033 1.822 . . . . 0.0 110.898 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -41.78 -41.02 3.27 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.456 1.503 . . . . 0.0 114.765 -178.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.92 -23.81 65.13 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.23 1.015 . . . . 0.0 112.975 -177.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.23 -62.14 6.15 Favored Pre-proline 0 CA--C 1.539 0.557 0 O-C-N 121.388 -0.82 . . . . 0.0 113.035 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -60.74 -37.48 78.4 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.087 1.858 . . . . 0.0 111.651 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -50.96 -36.54 39.38 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 118.836 0.744 . . . . 0.0 112.095 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -112.58 16.41 19.75 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.918 0.487 . . . . 0.0 111.44 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 49.01 43.6 31.73 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 125.043 1.306 . . . . 0.0 112.743 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mp -44.38 118.41 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 117.903 0.852 . . . . 0.0 110.585 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -79.56 -48.28 14.09 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.297 1.039 . . . . 0.0 111.153 -174.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -166.69 141.95 7.28 Favored Glycine 0 C--N 1.334 0.468 0 N-CA-C 107.609 -2.196 . . . . 0.0 107.609 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 22.9 pt -92.96 146.19 31.56 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 123.489 0.716 . . . . 0.0 110.665 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.41 133.19 24.14 Favored 'Cis proline' 0 N--CA 1.459 -0.511 0 CA-C-N 119.963 1.023 . . . . 0.0 110.424 -1.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.94 111.91 23.61 Favored 'General case' 0 C--N 1.338 0.078 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 24.3 mt -93.88 117.72 30.48 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.7 mp -118.17 115.67 25.27 Favored 'General case' 0 C--N 1.334 -0.106 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 177.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 tp -89.99 95.55 10.27 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -84.78 108.61 17.55 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.53 1.132 . . . . 0.0 110.231 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -107.36 122.91 47.53 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 174.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 52.39 47.59 24.41 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.379 0.609 . . . . 0.0 109.99 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.37 -3.0 6.4 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-O 118.181 -1.344 . . . . 0.0 115.687 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -111.99 143.43 43.0 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 120.051 1.925 . . . . 0.0 110.66 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.6 t -70.94 110.49 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.94 -41.41 29.44 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -158.53 169.98 23.22 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 177.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.5 t -150.47 161.25 42.88 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -147.66 131.11 16.68 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.0 t -102.2 121.61 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.38 171.7 38.08 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 121.444 0.469 . . . . 0.0 112.094 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.67 164.22 14.85 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.004 0.922 . . . . 0.0 112.761 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.9 mt -135.52 152.35 51.23 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.972 1.709 . . . . 0.0 108.194 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.9 p -81.77 150.04 28.11 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 170.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -49.84 -48.53 50.95 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -176.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.03 -57.63 17.44 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -55.6 -41.71 73.82 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 122.896 0.478 . . . . 0.0 110.686 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.3 tp -61.12 -51.53 68.71 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -55.41 -45.69 76.67 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.627 0.649 . . . . 0.0 110.906 177.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -57.84 -53.47 57.79 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.18 0.592 . . . . 0.0 110.274 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -52.71 -50.82 62.6 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.92 1.288 . . . . 0.0 110.149 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 98.2 mt -60.32 -51.28 70.18 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 122.592 0.357 . . . . 0.0 110.424 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -53.55 -49.36 67.82 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 117.964 0.347 . . . . 0.0 110.398 178.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.5 -35.67 70.51 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.759 0.823 . . . . 0.0 111.74 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -78.45 -43.65 26.69 Favored 'General case' 0 C--O 1.227 -0.12 0 CA-C-N 118.057 0.39 . . . . 0.0 110.582 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 53.7 mt -62.79 -46.6 87.26 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.241 0.616 . . . . 0.0 109.905 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.164 0 C-N-CA 124.743 1.217 . . . . 0.0 111.739 179.133 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 20.1 p . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -70.3 63.33 0.24 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.488 1.515 . . . . 0.0 111.524 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -82.41 57.74 3.8 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 178.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 32.1 mt -133.64 147.62 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 123.447 0.699 . . . . 0.0 109.64 -174.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.5 mm -87.81 104.61 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 177.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 29.6 m-70 -80.55 95.26 6.45 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 42.9 mt -79.01 162.51 25.89 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.835 1.254 . . . . 0.0 111.922 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 30.0 p -134.16 162.4 32.23 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.38 1.872 . . . . 0.0 106.574 172.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -54.2 -47.63 71.9 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.723 0.809 . . . . 0.0 110.337 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -56.25 -44.83 80.03 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.933 0.893 . . . . 0.0 111.759 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.5 p -78.31 -28.46 47.45 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -176.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -38.99 -49.82 1.73 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.738 1.615 . . . . 0.0 113.879 -176.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -50.81 -63.92 0.98 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.659 0.742 . . . . 0.0 111.0 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.3 m -68.31 -46.89 69.05 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.834 -175.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -75.53 -23.17 56.61 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 -174.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.0 t -118.34 -63.31 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-N 119.432 1.014 . . . . 0.0 110.057 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 72.4 mt -60.21 -37.53 80.58 Favored 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -174.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -93.45 12.28 25.54 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.598 0.636 . . . . 0.0 111.834 177.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.39 102.56 14.66 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 119.098 0.863 . . . . 0.0 110.885 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -76.09 65.7 2.14 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.377 0.671 . . . . 0.0 109.9 177.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -173.84 -175.03 41.2 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.87 124.42 35.97 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.269 1.427 . . . . 0.0 111.052 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.3 mt -133.32 124.07 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 124.811 1.244 . . . . 0.0 109.917 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -93.73 108.57 20.3 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 105.534 -2.025 . . . . 0.0 105.534 174.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.6 t -99.6 107.34 20.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -178.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -91.62 102.86 15.5 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -78.49 121.37 24.48 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 103.758 -2.682 . . . . 0.0 103.758 174.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 25.8 p-90 -137.0 168.54 19.4 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 123.61 0.764 . . . . 0.0 112.631 -174.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -141.48 140.45 33.54 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.813 1.245 . . . . 0.0 108.099 176.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -55.81 -50.76 69.63 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.483 0.713 . . . . 0.0 112.688 -176.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 43.3 p-90 -59.92 -29.68 68.54 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.77 0.828 . . . . 0.0 112.828 -178.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 48.8 t -79.6 80.45 5.98 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 121.432 -0.793 . . . . 0.0 110.507 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -23.06 -61.2 0.03 OUTLIER Glycine 0 CA--C 1.537 1.459 0 C-N-CA 127.422 2.439 . . . . 0.0 115.243 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -41.98 -37.77 4.57 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 124.309 3.34 . . . . 0.0 114.335 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 86.4 m -54.9 -44.23 73.97 Favored 'General case' 0 CA--C 1.527 0.058 0 C-N-CA 123.661 0.785 . . . . 0.0 110.597 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -69.92 -45.21 68.03 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 87.5 mmm -53.69 -42.76 68.31 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 30.7 pt -76.65 -12.06 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.22 -58.35 10.86 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 120.162 1.346 . . . . 0.0 112.79 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -55.43 -41.37 78.72 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.141 1.894 . . . . 0.0 111.377 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 19.2 mt -57.56 -53.65 41.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.3 mt -56.29 -39.19 72.29 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.312 0.645 . . . . 0.0 110.682 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -62.0 -48.84 78.5 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.013 0.824 . . . . 0.0 110.396 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -57.17 -51.73 68.13 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.2 mm -53.05 -48.06 53.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.675 1.19 . . . . 0.0 109.399 177.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.34 -45.76 76.42 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 122.927 0.491 . . . . 0.0 110.645 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -63.2 -53.17 57.4 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 177.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -50.29 -50.15 51.29 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.977 0.911 . . . . 0.0 111.687 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -98.86 30.5 3.33 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.464 0.706 . . . . 0.0 111.347 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -60.35 120.77 10.5 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.491 -0.755 . . . . 0.0 110.005 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.69 3.54 89.06 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 119.615 -0.547 . . . . 0.0 112.487 -177.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.1 mttm -114.03 -41.84 3.47 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.134 1.373 . . . . 0.0 109.281 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.0 tp -133.4 131.54 40.11 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.245 1.018 . . . . 0.0 108.498 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.5 m -86.87 100.35 12.49 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.1 t -79.3 125.07 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -131.74 151.72 51.45 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.58 0.752 . . . . 0.0 110.663 -176.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.7 mttm -127.22 143.76 51.18 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 176.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 tt -133.44 111.34 10.66 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -79.28 110.12 14.26 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.2 pt -71.28 -22.81 22.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 118.94 -0.552 . . . . 0.0 112.276 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -58.79 -46.58 87.22 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 119.352 0.978 . . . . 0.0 108.824 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -80.39 -25.18 39.23 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.282 1.033 . . . . 0.0 110.949 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -127.37 66.95 70.51 Favored Pre-proline 0 CA--C 1.534 0.341 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.48 -55.85 2.99 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.531 2.154 . . . . 0.0 113.265 -178.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -37.8 -46.61 1.69 Allowed Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.872 1.701 . . . . 0.0 114.544 -176.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -53.12 -34.56 57.26 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.489 0.715 . . . . 0.0 112.288 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.72 -68.6 0.57 Allowed Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 118.255 -0.878 . . . . 0.0 112.374 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -58.96 -38.24 89.14 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 CA-C-N 121.085 1.423 . . . . 0.0 110.94 177.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -52.26 -39.92 61.03 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 118.926 0.784 . . . . 0.0 111.732 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -104.59 19.46 20.33 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.106 0.412 . . . . 0.0 111.907 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.7 39.04 54.05 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 124.021 0.82 . . . . 0.0 113.216 177.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.5 mp -56.94 122.33 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -79.81 -47.24 15.51 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.721 0.808 . . . . 0.0 109.364 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -168.92 146.09 10.01 Favored Glycine 0 CA--C 1.521 0.424 0 N-CA-C 106.896 -2.481 . . . . 0.0 106.896 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.411 ' O ' HD12 ' A' ' 75' ' ' ILE . 1.6 pp -92.02 150.32 40.32 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 117.382 0.591 . . . . 0.0 110.378 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -70.93 136.5 41.61 Favored 'Cis proline' 0 N--CA 1.457 -0.649 0 CA-C-N 120.107 1.074 . . . . 0.0 111.31 0.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -120.68 113.47 20.26 Favored 'General case' 0 C--O 1.23 0.042 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 178.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.4 mt -95.9 101.17 12.82 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 -178.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -92.79 111.98 23.78 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 176.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 tp -92.77 105.59 17.7 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -93.81 143.66 26.13 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.24 1.416 . . . . 0.0 109.835 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -138.01 121.96 17.78 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 172.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 46.1 m-20 50.18 48.55 21.95 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.858 0.863 . . . . 0.0 110.803 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.57 -5.51 10.83 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 118.527 -1.152 . . . . 0.0 115.389 178.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -106.26 138.47 42.38 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 119.932 1.866 . . . . 0.0 110.163 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 94.2 t -66.55 109.17 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 176.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.75 -43.63 22.22 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 124.526 1.131 . . . . 0.0 109.604 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -150.55 169.32 21.81 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 97.2 m -150.98 139.34 20.36 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -177.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -131.47 137.02 48.4 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.0 t -110.94 122.2 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 177.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.01 171.76 37.09 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 123.38 0.514 . . . . 0.0 112.068 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.83 170.71 10.53 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.105 0.962 . . . . 0.0 112.441 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.1 mt -140.57 162.39 35.48 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 126.227 1.811 . . . . 0.0 108.321 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 99.9 p -83.67 162.11 20.86 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 169.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -57.06 -44.11 82.72 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 177.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -58.05 -57.59 19.01 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 123.37 0.51 . . . . 0.0 111.964 178.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -60.3 -38.64 84.26 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 121.842 -0.799 . . . . 0.0 110.739 -178.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.0 tp -64.17 -49.39 72.26 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 119.153 -0.451 . . . . 0.0 110.013 178.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 10.2 mmmm -52.65 -49.84 64.4 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.667 0.667 . . . . 0.0 109.47 176.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -56.13 -54.82 40.49 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.249 0.62 . . . . 0.0 110.73 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -52.59 -53.37 47.59 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.957 1.303 . . . . 0.0 111.05 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.3 mt -61.96 -52.14 65.25 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -51.92 -50.88 60.23 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.336 0.654 . . . . 0.0 110.842 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.43 -36.75 66.84 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.522 0.729 . . . . 0.0 111.664 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -78.52 -45.21 22.47 Favored 'General case' 0 N--CA 1.458 -0.057 0 O-C-N 122.263 -0.273 . . . . 0.0 110.516 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 53.2 mt -58.3 -47.45 83.63 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.306 0 C-N-CA 123.232 0.613 . . . . 0.0 109.665 177.423 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.1 m . . . . . 0 N--CA 1.451 -0.412 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -74.74 -47.56 30.54 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -140.28 46.1 1.83 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.678 1.191 . . . . 0.0 108.171 177.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 16.0 mt -122.75 139.18 50.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 C-N-CA 123.633 0.773 . . . . 0.0 109.939 -177.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.5 mm -87.89 108.1 18.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -79.78 114.77 18.95 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 64.9 mt -96.35 167.03 11.42 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 124.38 1.072 . . . . 0.0 112.397 -176.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 33.9 p -136.86 164.58 27.97 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 171.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -59.27 -45.97 89.78 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.463 0.574 . . . . 0.0 109.923 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -59.85 -45.64 91.79 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.708 0.803 . . . . 0.0 111.263 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.8 p -78.86 -24.44 44.31 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -176.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -38.25 -49.93 1.41 Allowed 'General case' 0 CA--C 1.527 0.075 0 C-N-CA 126.576 1.95 . . . . 0.0 113.613 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -54.41 -61.18 2.47 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 121.483 0.659 . . . . 0.0 110.888 -178.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.7 m -63.27 -42.06 99.1 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.444 -177.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -71.16 -43.58 67.22 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -174.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.4 t -107.54 -59.12 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 123.861 0.864 . . . . 0.0 110.893 -174.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 64.4 mt -62.41 -35.62 79.78 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -173.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -90.43 7.05 40.71 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.555 0.616 . . . . 0.0 112.253 178.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.86 102.1 14.21 Favored 'General case' 0 C--N 1.341 0.239 0 CA-C-N 119.185 0.902 . . . . 0.0 111.946 -178.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -75.58 73.48 2.59 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 175.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -172.72 178.57 44.71 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.76 115.19 26.11 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.0 1.32 . . . . 0.0 109.943 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.4 mt -122.6 120.18 60.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 124.528 1.131 . . . . 0.0 109.833 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.4 tp -91.08 100.27 13.15 Favored 'General case' 0 CA--C 1.521 -0.159 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 175.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 63.4 t -90.88 114.25 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -101.14 110.19 22.18 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.953 0.901 . . . . 0.0 109.186 177.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -79.79 124.8 28.94 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 175.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 28.6 p-90 -140.17 172.48 12.69 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.731 0.812 . . . . 0.0 112.864 -175.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.4 132.28 17.08 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.549 1.539 . . . . 0.0 108.024 175.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -49.23 -39.52 30.39 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 61.3 p-90 -76.86 -19.98 56.85 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 40.4 t -79.58 77.0 6.2 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 121.372 -0.83 . . . . 0.0 111.511 -175.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -9.72 -71.87 0.01 OUTLIER Glycine 0 CA--C 1.538 1.509 0 C-N-CA 127.729 2.585 . . . . 0.0 116.349 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -47.29 -33.59 16.68 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 124.089 3.193 . . . . 0.0 114.61 -178.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 88.2 m -52.94 -47.98 67.65 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.635 0.774 . . . . 0.0 109.955 176.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -68.89 -29.19 67.42 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.385 0.674 . . . . 0.0 110.611 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 24.2 mmt -70.28 -44.91 67.42 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 34.3 pt -74.17 -30.53 27.26 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 CA-C-O 118.371 -0.823 . . . . 0.0 112.231 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -36.84 -60.1 0.82 Allowed Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -57.79 -40.39 79.37 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.0 1.8 . . . . 0.0 111.414 178.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 15.7 mt -58.68 -49.67 81.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 177.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 76.9 mt -55.63 -44.17 76.85 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.213 0.605 . . . . 0.0 110.071 177.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -60.7 -46.89 88.67 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.76 -0.587 . . . . 0.0 110.746 177.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -57.25 -51.51 69.08 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 23.4 mm -53.03 -49.28 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 124.057 0.943 . . . . 0.0 109.478 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.56 -47.6 73.05 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 117.967 0.349 . . . . 0.0 110.547 178.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -61.17 -44.47 97.26 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 122.284 0.234 . . . . 0.0 111.283 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -65.54 -46.27 80.21 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.364 1.065 . . . . 0.0 112.723 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -100.22 38.68 1.45 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.516 1.127 . . . . 0.0 110.807 -178.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.402 ' H ' ' NE2' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -53.1 122.13 8.82 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.644 -0.66 . . . . 0.0 111.905 -179.265 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.62 -5.95 6.76 Favored Glycine 0 CA--C 1.535 1.29 0 CA-C-O 119.487 -0.618 . . . . 0.0 113.7 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 51.7 mttt -99.68 -36.27 9.54 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.964 1.306 . . . . 0.0 108.491 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.3 tp -136.28 122.48 20.4 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 35.3 m -86.58 103.52 15.15 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 177.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 91.8 t -79.67 128.02 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 107.057 -1.461 . . . . 0.0 107.057 178.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -132.53 149.53 52.31 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.373 0.669 . . . . 0.0 110.05 -177.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -129.36 132.49 47.08 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 123.794 0.838 . . . . 0.0 108.89 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.5 tt -120.63 116.13 24.73 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.766 0.826 . . . . 0.0 110.059 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -78.22 108.03 11.24 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 pp -67.33 -29.8 46.99 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 C-N-CA 123.335 0.654 . . . . 0.0 112.701 -177.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -60.49 -47.71 84.93 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 118.934 0.788 . . . . 0.0 109.491 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -74.88 -32.92 61.99 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.147 176.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -121.23 69.95 21.03 Favored Pre-proline 0 CA--C 1.531 0.228 0 C-N-CA 123.651 0.78 . . . . 0.0 112.01 -176.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -64.8 -47.45 5.13 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.977 1.785 . . . . 0.0 111.431 -178.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -42.02 -40.72 3.39 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.358 1.456 . . . . 0.0 114.659 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.43 -29.31 69.86 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.62 -0.929 . . . . 0.0 112.479 -178.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.84 -65.23 1.79 Allowed Pre-proline 0 CA--C 1.537 0.456 0 CA-C-O 118.395 -0.812 . . . . 0.0 112.912 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -59.78 -38.44 80.29 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 121.718 1.612 . . . . 0.0 111.036 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -51.79 -36.38 47.41 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-N 118.683 0.674 . . . . 0.0 112.029 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -111.65 20.59 16.97 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.683 0.393 . . . . 0.0 111.883 178.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 51.09 40.33 43.6 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.043 0.83 . . . . 0.0 113.481 177.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mp -53.94 127.87 12.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 117.883 0.841 . . . . 0.0 109.069 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -92.91 -50.64 5.45 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.75 1.22 . . . . 0.0 110.133 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.02 146.56 13.2 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 107.406 -2.278 . . . . 0.0 107.406 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.7 pt -95.61 148.64 34.92 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 123.715 0.806 . . . . 0.0 110.131 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.96 140.89 60.75 Favored 'Cis proline' 0 N--CA 1.456 -0.71 0 CA-C-N 119.788 0.96 . . . . 0.0 110.72 -1.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.61 118.69 30.8 Favored 'General case' 0 CA--C 1.523 -0.083 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.8 mt -96.82 126.6 42.09 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -120.89 111.57 17.7 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 104.066 -2.568 . . . . 0.0 104.066 175.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.5 tp -93.29 99.54 12.06 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -84.7 142.02 30.16 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.569 1.148 . . . . 0.0 109.676 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -138.13 97.86 3.49 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 175.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.2 t30 55.42 71.52 0.54 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.3 0.64 . . . . 0.0 110.3 -176.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 70.62 -37.68 0.47 Allowed Glycine 0 CA--C 1.531 1.093 0 N-CA-C 116.146 1.218 . . . . 0.0 116.146 176.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -86.6 146.03 26.5 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 119.147 1.474 . . . . 0.0 110.529 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 96.6 t -79.04 115.19 20.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 175.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.3 -42.11 26.5 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.346 0.659 . . . . 0.0 109.448 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -155.34 169.86 23.24 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 177.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.8 t -147.88 168.35 22.46 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.68 146.22 23.15 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.827 1.251 . . . . 0.0 108.327 -177.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.9 t -124.01 124.8 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.26 177.11 37.54 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 123.324 0.487 . . . . 0.0 112.052 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.71 173.58 8.85 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.416 0.686 . . . . 0.0 111.885 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 mt -147.65 160.71 42.37 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 125.679 1.592 . . . . 0.0 108.708 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 44.6 p -90.4 154.15 19.89 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 170.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -51.76 -45.52 63.74 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 122.213 -0.305 . . . . 0.0 110.921 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -57.6 -57.24 20.86 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 111.74 -0.544 . . . . 0.0 111.74 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -58.01 -41.09 82.35 Favored 'General case' 0 N--CA 1.456 -0.168 0 O-C-N 121.996 -0.708 . . . . 0.0 110.739 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 29.3 tp -62.19 -49.21 76.71 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -52.93 -48.66 67.12 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.898 0.479 . . . . 0.0 109.895 176.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -56.98 -53.98 51.84 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.946 0.498 . . . . 0.0 110.617 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -52.25 -51.25 59.49 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.002 0.921 . . . . 0.0 110.437 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 89.7 mt -61.28 -51.49 68.69 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.631 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -52.78 -48.98 66.47 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.941 0.496 . . . . 0.0 110.406 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.05 -36.12 70.13 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.292 0.637 . . . . 0.0 111.832 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -78.89 -44.64 22.34 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 117.783 0.265 . . . . 0.0 111.013 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 56.9 mt -64.7 -43.08 94.66 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.434 0.694 . . . . 0.0 110.211 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.213 0 C-N-CA 124.84 1.256 . . . . 0.0 111.807 179.066 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.6 m . . . . . 0 N--CA 1.451 -0.412 0 CA-C-O 120.531 0.205 . . . . 0.0 111.473 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -74.0 54.74 0.53 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.384 1.074 . . . . 0.0 111.661 -178.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -81.79 56.89 3.2 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 176.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.8 mt -122.83 149.0 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 124.559 1.144 . . . . 0.0 110.854 -172.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.9 mm -87.54 106.7 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 175.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 37.9 m-70 -81.26 95.54 6.99 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 177.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 44.8 mt -79.9 163.44 24.33 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.598 1.159 . . . . 0.0 113.067 -175.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.6 p -139.06 164.73 29.01 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 126.261 1.824 . . . . 0.0 106.459 174.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -57.46 -46.25 83.85 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.673 -0.642 . . . . 0.0 110.14 -178.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -61.87 -38.9 90.02 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.8 p -78.13 -35.52 48.99 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 121.992 -0.443 . . . . 0.0 110.223 -177.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -33.74 -51.17 0.38 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 126.912 2.085 . . . . 0.0 114.019 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -54.92 -48.09 73.54 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.07 0.462 . . . . 0.0 111.636 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.1 m -76.33 -52.09 10.64 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 121.996 -0.44 . . . . 0.0 110.769 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.52 -47.31 64.18 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -173.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.3 t -94.53 -50.09 12.12 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.11 0 C-N-CA 123.33 0.652 . . . . 0.0 111.915 -175.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 70.4 mt -73.67 -48.69 30.38 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.988 -177.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -91.36 42.33 1.1 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.134 0.879 . . . . 0.0 109.252 175.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.03 177.08 2.33 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 125.395 1.478 . . . . 0.0 113.686 -178.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -134.88 101.93 5.07 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.993 2.117 . . . . 0.0 106.594 175.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.09 -162.03 45.98 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-O 121.588 0.549 . . . . 0.0 113.87 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.48 117.9 20.11 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.47 1.508 . . . . 0.0 112.536 -177.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.1 mt -116.53 120.77 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 124.552 1.141 . . . . 0.0 109.049 176.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.409 HD13 ' C ' ' A' ' 24' ' ' LEU . 2.9 tm? -91.97 108.08 19.67 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 176.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.9 t -98.53 106.59 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 123.86 0.864 . . . . 0.0 109.954 -177.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -91.35 105.11 17.54 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 176.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -79.59 125.24 29.35 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 174.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 44.7 p-90 -142.39 169.52 17.42 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.828 0.851 . . . . 0.0 112.729 -176.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -146.93 137.97 23.96 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.954 1.302 . . . . 0.0 107.586 174.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -50.55 -48.54 57.33 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.586 0.754 . . . . 0.0 112.759 -176.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 58.5 p-90 -62.7 -26.05 68.47 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 50.8 t -79.8 79.44 6.31 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 121.316 -0.865 . . . . 0.0 109.233 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -25.96 -60.39 0.07 OUTLIER Glycine 0 CA--C 1.536 1.359 0 C-N-CA 127.139 2.304 . . . . 0.0 114.801 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -43.08 -35.06 4.46 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 124.315 3.343 . . . . 0.0 114.586 178.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 78.3 m -57.09 -47.24 81.52 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 121.588 -0.695 . . . . 0.0 109.846 176.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -65.87 -31.18 71.98 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.696 0.799 . . . . 0.0 109.776 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 85.1 mtp -68.5 -45.04 73.36 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 177.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.0 pt -75.39 -27.52 19.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 118.521 0.6 . . . . 0.0 112.33 178.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -37.94 -58.66 1.34 Allowed Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -58.27 -39.01 88.34 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.41 2.073 . . . . 0.0 111.514 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.5 mt -59.51 -51.08 76.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 177.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 44.3 mt -56.44 -42.55 78.3 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.621 0.368 . . . . 0.0 110.505 177.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -59.51 -48.7 80.64 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.674 0.67 . . . . 0.0 110.259 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -58.42 -52.62 64.86 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.677 -0.639 . . . . 0.0 109.606 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 11.2 mm -54.39 -46.29 69.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 124.735 1.214 . . . . 0.0 110.179 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.23 -44.73 68.31 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.361 0.664 . . . . 0.0 110.179 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -66.34 -56.78 9.48 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 176.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -45.71 -50.76 13.39 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.937 0.895 . . . . 0.0 112.423 -178.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -95.44 26.2 4.01 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.663 0.785 . . . . 0.0 112.463 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.58 130.15 23.62 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.264 0.938 . . . . 0.0 109.933 176.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.6 -16.48 5.04 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-O 119.147 -0.807 . . . . 0.0 114.181 -178.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -99.6 -39.08 8.48 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 118.87 1.335 . . . . 0.0 110.214 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 26.0 tp -137.78 126.55 23.87 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.8 m -86.94 102.39 14.32 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 176.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 96.3 t -79.02 137.51 21.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.42 147.41 45.39 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.023 0.929 . . . . 0.0 109.445 -177.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -125.26 135.3 52.39 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.6 tt -127.78 112.57 14.92 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.606 0.763 . . . . 0.0 109.692 -178.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -78.98 104.52 9.67 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 122.902 0.481 . . . . 0.0 109.824 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.2 pt -69.03 -24.25 28.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 118.866 -0.588 . . . . 0.0 112.559 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -53.31 -53.82 45.4 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.061 0.846 . . . . 0.0 109.502 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -78.2 -28.71 48.12 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.961 0.904 . . . . 0.0 110.763 179.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -118.11 67.0 6.26 Favored Pre-proline 0 C--O 1.235 0.315 0 C-N-CA 124.1 0.96 . . . . 0.0 111.495 -176.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -61.14 -53.65 2.36 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.465 2.11 . . . . 0.0 112.383 -176.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -37.97 -47.12 1.85 Allowed Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.631 1.586 . . . . 0.0 114.267 -177.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -51.71 -33.79 35.9 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.23 1.012 . . . . 0.0 112.962 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.27 -68.25 0.79 Allowed Pre-proline 0 CA--C 1.537 0.478 0 CA-C-O 117.987 -1.006 . . . . 0.0 112.017 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -59.32 -35.95 95.65 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.005 1.803 . . . . 0.0 111.358 177.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -51.44 -37.64 49.65 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.526 1.057 . . . . 0.0 111.661 177.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -111.9 22.31 15.04 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.098 0.559 . . . . 0.0 111.187 177.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 42.69 43.24 5.06 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 125.465 1.507 . . . . 0.0 113.04 178.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.5 mp -51.07 118.17 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 118.094 0.947 . . . . 0.0 109.315 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -79.14 -44.38 22.12 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.371 0.669 . . . . 0.0 110.415 -177.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -164.91 141.91 7.39 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 108.451 -1.86 . . . . 0.0 108.451 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.7 pt -95.79 148.88 35.26 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 124.017 0.927 . . . . 0.0 109.997 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.35 141.05 62.81 Favored 'Cis proline' 0 N--CA 1.456 -0.697 0 CA-C-N 119.846 0.981 . . . . 0.0 111.177 -0.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.02 114.81 21.46 Favored 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.7 mt -98.0 102.08 13.73 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.7 mp -96.58 118.59 33.39 Favored 'General case' 0 CA--C 1.523 -0.072 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 177.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 tp -92.19 98.67 11.67 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -89.27 103.33 15.96 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 125.225 1.41 . . . . 0.0 110.413 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -83.61 102.19 12.02 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 172.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 45.76 41.43 7.49 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.069 1.748 . . . . 0.0 113.934 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 106.2 -21.28 33.7 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-O 118.784 -1.009 . . . . 0.0 113.358 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -100.32 128.55 46.36 Favored 'General case' 0 C--O 1.227 -0.085 0 CA-C-N 119.254 1.527 . . . . 0.0 110.948 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 89.7 t -68.04 107.29 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.57 -41.61 26.81 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.884 0.874 . . . . 0.0 109.987 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -155.13 167.49 30.2 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 93.7 m -149.72 140.7 22.89 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -116.5 138.37 51.44 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 177.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 26.3 t -120.96 123.32 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 178.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.92 175.09 45.47 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 111.579 -0.609 . . . . 0.0 111.579 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.38 172.77 8.83 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.22 0.608 . . . . 0.0 110.954 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -162.8 167.99 22.07 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.625 1.17 . . . . 0.0 108.75 -177.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 88.2 p -81.67 160.1 23.8 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -57.48 -40.35 78.41 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 175.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.95 -53.06 42.38 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 176.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -60.46 -39.65 88.34 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 117.616 0.708 . . . . 0.0 111.148 178.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 23.3 tp -62.19 -50.93 69.85 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.586 0.63 . . . . 0.0 109.874 178.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -53.41 -49.52 67.12 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.32 0.648 . . . . 0.0 109.567 176.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -55.56 -55.86 27.03 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.063 0.945 . . . . 0.0 110.424 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -52.93 -54.38 35.64 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.489 1.516 . . . . 0.0 110.828 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.7 mt -61.32 -51.93 66.8 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.44 0.296 . . . . 0.0 110.658 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -53.95 -50.38 66.63 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.028 0.531 . . . . 0.0 110.631 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.02 -36.53 65.58 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.429 0.692 . . . . 0.0 111.623 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -78.64 -48.32 15.31 Favored 'General case' 0 C--O 1.227 -0.115 0 O-C-N 122.238 -0.289 . . . . 0.0 110.406 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 58.0 mt -59.18 -42.78 91.66 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.936 0.494 . . . . 0.0 110.294 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.282 0 C-N-CA 123.097 0.559 . . . . 0.0 109.777 177.889 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.8 p . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -61.84 134.92 57.3 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -72.67 -30.76 64.54 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.574 0.75 . . . . 0.0 109.843 177.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 36.9 mt -79.86 141.15 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 124.28 1.032 . . . . 0.0 110.674 -176.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.2 mm -89.26 120.28 37.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 123.978 0.911 . . . . 0.0 109.492 178.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -85.71 111.39 20.07 Favored 'General case' 0 CA--C 1.528 0.099 0 O-C-N 121.515 -0.741 . . . . 0.0 109.349 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 65.8 mt -95.5 160.87 14.31 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 124.458 1.103 . . . . 0.0 111.203 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 48.9 p -134.68 163.48 29.67 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 174.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -58.48 -47.18 84.91 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.809 0.732 . . . . 0.0 109.601 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -63.69 -41.2 98.17 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.664 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.1 p -78.42 -24.82 45.98 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.38 0.536 . . . . 0.0 111.368 -177.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -41.6 -43.69 2.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 126.602 1.961 . . . . 0.0 113.068 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -52.39 -65.14 0.61 Allowed 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 121.697 0.761 . . . . 0.0 110.251 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.9 m -67.17 -42.53 84.13 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.583 -176.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -70.81 -39.3 73.14 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -174.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.0 t -112.84 -58.48 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 123.446 0.698 . . . . 0.0 110.345 -175.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 67.0 mt -61.43 -35.59 78.0 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -174.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -97.4 16.18 20.88 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.451 0.569 . . . . 0.0 111.73 178.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -102.15 102.43 12.88 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 119.042 0.837 . . . . 0.0 111.724 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -77.25 59.21 1.75 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.949 1.3 . . . . 0.0 110.305 176.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -159.05 168.08 35.01 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.5 114.09 20.68 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.257 0.623 . . . . 0.0 110.817 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.5 mt -120.25 122.44 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 124.537 1.135 . . . . 0.0 109.986 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.4 ' C ' HD13 ' A' ' 24' ' ' LEU . 3.0 tm? -91.99 107.55 19.29 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 175.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 67.2 t -96.19 108.09 20.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 123.992 0.917 . . . . 0.0 109.241 -178.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -97.18 105.32 17.44 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.592 1.157 . . . . 0.0 109.514 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -79.16 126.39 30.68 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 177.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 26.4 p-90 -141.47 173.86 11.1 Favored 'General case' 0 C--N 1.343 0.289 0 C-N-CA 124.304 1.042 . . . . 0.0 112.83 -176.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -149.97 156.89 42.52 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.985 1.714 . . . . 0.0 108.221 175.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.1 mp0 -63.3 -48.79 76.59 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.226 0.536 . . . . 0.0 110.688 -178.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 54.2 p-90 -65.73 -20.8 66.41 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.064 0.946 . . . . 0.0 112.562 -178.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 47.6 t -79.36 75.68 5.95 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 121.481 -0.762 . . . . 0.0 110.08 -178.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -25.74 -63.12 0.06 OUTLIER Glycine 0 CA--C 1.536 1.357 0 C-N-CA 126.509 2.004 . . . . 0.0 114.692 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -43.44 -35.83 6.17 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 124.559 3.506 . . . . 0.0 114.881 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 87.5 m -52.59 -40.71 62.94 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.172 0.589 . . . . 0.0 110.188 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -67.28 -30.83 70.8 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.633 0.773 . . . . 0.0 111.311 179.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -74.36 -46.12 42.6 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 28.0 pt -73.7 -29.26 26.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 118.66 -0.686 . . . . 0.0 112.255 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -39.16 -60.88 1.08 Allowed Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -56.59 -40.84 81.69 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.372 2.048 . . . . 0.0 111.673 178.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.8 mt -57.44 -52.35 58.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 177.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 47.6 mt -57.44 -40.52 78.59 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.281 0.632 . . . . 0.0 110.973 178.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -61.86 -47.86 83.12 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.1 0.864 . . . . 0.0 110.262 177.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -57.87 -52.59 64.87 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.6 mm -53.15 -47.5 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 124.035 0.934 . . . . 0.0 109.591 177.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.94 -49.95 62.14 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 122.842 0.457 . . . . 0.0 110.103 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -62.23 -54.29 42.91 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.723 0.296 . . . . 0.0 110.932 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -53.24 -46.74 69.29 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.767 0.827 . . . . 0.0 112.308 -178.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -94.48 26.99 3.15 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.967 0.907 . . . . 0.0 112.37 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -54.45 128.65 32.76 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.169 0.895 . . . . 0.0 109.724 176.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.1 -14.75 25.8 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-O 119.25 -0.75 . . . . 0.0 112.993 -178.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -99.82 -44.06 6.21 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 118.507 1.153 . . . . 0.0 109.881 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 24.6 tp -139.42 132.38 29.41 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.415 0.686 . . . . 0.0 110.431 -176.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 62.5 m -91.69 103.28 15.87 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 175.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 63.1 t -79.86 130.81 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.66 151.81 50.58 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.28 0.632 . . . . 0.0 110.844 -176.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -126.8 139.94 52.74 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.908 1.283 . . . . 0.0 108.948 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.5 tt -127.8 115.86 19.3 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.608 0.763 . . . . 0.0 109.734 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -79.25 107.15 11.8 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.9 pt -69.0 -26.96 33.59 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.29 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -177.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -59.75 -47.04 87.28 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 119.067 0.849 . . . . 0.0 109.744 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -77.18 -30.58 54.94 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.148 0.579 . . . . 0.0 110.241 176.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -121.79 67.42 22.21 Favored Pre-proline 0 C--O 1.234 0.25 0 C-N-CA 123.933 0.893 . . . . 0.0 111.735 -176.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -62.22 -53.43 1.97 Allowed 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 122.534 2.156 . . . . 0.0 112.777 -176.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -38.86 -47.2 2.38 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.189 1.376 . . . . 0.0 113.989 -177.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -50.52 -34.46 25.38 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.427 1.091 . . . . 0.0 112.897 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.71 -68.99 0.57 Allowed Pre-proline 0 CA--C 1.538 0.518 0 CA-C-O 118.241 -0.885 . . . . 0.0 112.168 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -59.19 -37.2 93.14 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.64 1.56 . . . . 0.0 111.149 177.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -50.83 -40.61 56.18 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-N 119.281 0.946 . . . . 0.0 111.67 178.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -106.76 19.83 19.9 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.586 0.354 . . . . 0.0 111.893 178.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 51.0 40.31 42.9 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.097 0.856 . . . . 0.0 113.043 177.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mp -53.24 120.7 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 177.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 55.5 mmt-85 -79.14 -46.89 17.07 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.769 0.828 . . . . 0.0 109.417 -178.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -170.72 145.53 9.07 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 106.601 -2.6 . . . . 0.0 106.601 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.5 pt -90.83 150.95 43.03 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-O 118.907 -0.568 . . . . 0.0 109.842 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -70.08 138.11 48.21 Favored 'Cis proline' 0 N--CA 1.458 -0.609 0 CA-C-N 119.485 0.852 . . . . 0.0 111.285 -0.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -123.62 120.27 32.29 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 178.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.3 mt -103.25 117.39 34.4 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -110.2 116.83 32.22 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 177.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 tp -92.28 101.22 13.71 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -90.83 145.42 24.78 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.096 1.358 . . . . 0.0 111.595 -178.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -141.59 116.86 10.09 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.317 1.847 . . . . 0.0 106.102 174.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 49.66 48.64 21.25 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.678 0.752 . . . . 0.0 110.61 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.51 -9.74 4.33 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-O 118.283 -1.287 . . . . 0.0 115.86 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -98.52 142.38 30.19 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 119.983 1.892 . . . . 0.0 109.851 178.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 89.5 t -76.72 116.84 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 177.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.19 -44.21 22.35 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 177.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -161.88 175.34 11.99 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.3 t -150.82 163.48 38.53 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 54.2 mmtt -141.74 148.5 39.09 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 126.96 2.104 . . . . 0.0 106.672 177.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.9 t -130.52 132.33 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.81 -177.33 46.49 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.82 165.3 24.38 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.978 0.511 . . . . 0.0 111.316 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.3 mt -144.35 157.17 44.4 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.44 1.496 . . . . 0.0 108.28 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 88.2 p -81.52 157.16 24.92 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 170.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -55.68 -44.03 76.94 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -56.29 -56.35 24.79 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 123.671 0.653 . . . . 0.0 111.852 177.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -60.89 -41.25 95.65 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 118.211 1.005 . . . . 0.0 111.298 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 37.6 tp -60.95 -50.99 71.15 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.877 -0.514 . . . . 0.0 109.625 178.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -54.24 -47.75 71.87 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.739 0.7 . . . . 0.0 110.407 176.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -55.05 -53.25 58.29 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.082 0.953 . . . . 0.0 109.919 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -55.21 -54.71 39.91 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.598 1.159 . . . . 0.0 110.894 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 89.8 mt -58.62 -50.17 74.82 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.311 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -55.77 -50.37 70.62 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.17 0.588 . . . . 0.0 110.467 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.8 -35.05 65.89 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.48 0.712 . . . . 0.0 111.479 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -78.03 -50.11 12.72 Favored 'General case' 0 CA--C 1.524 -0.057 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 53.0 mt -56.07 -45.23 79.39 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.049 0.539 . . . . 0.0 110.09 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.251 0 C-N-CA 123.085 0.554 . . . . 0.0 109.693 177.599 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 18.5 m . . . . . 0 CA--C 1.533 0.324 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -23.95 -56.33 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 127.857 2.463 . . . . 0.0 114.877 -177.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -138.45 43.31 2.15 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.205 1.002 . . . . 0.0 108.676 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 13.6 mt -107.52 138.71 32.33 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 C-N-CA 123.573 0.749 . . . . 0.0 111.042 -177.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.0 mm -88.02 107.12 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 123.476 0.71 . . . . 0.0 109.344 177.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -79.58 99.52 7.36 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 76.0 mt -81.85 160.76 23.4 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 122.071 0.939 . . . . 0.0 113.348 -175.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 35.4 p -134.66 163.32 30.02 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 126.951 2.1 . . . . 0.0 106.961 173.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -57.03 -44.09 82.57 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.467 0.707 . . . . 0.0 110.059 179.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -55.84 -46.01 78.27 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.939 0.896 . . . . 0.0 111.458 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.5 p -78.02 -27.26 48.85 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 122.242 -0.286 . . . . 0.0 111.207 -177.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -42.15 -46.79 4.47 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.252 1.421 . . . . 0.0 113.499 -177.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -51.88 -64.83 0.69 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.902 0.858 . . . . 0.0 111.261 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.9 m -68.67 -40.6 80.08 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.106 -174.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -76.53 -55.38 5.58 Favored 'General case' 0 N--CA 1.451 -0.375 0 O-C-N 122.251 -0.281 . . . . 0.0 111.659 -177.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.4 t -91.72 -53.31 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -172.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 68.8 mt -66.26 -37.03 84.51 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 118.924 -1.11 . . . . 0.0 111.163 -176.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -93.68 33.54 1.28 Allowed 'General case' 0 CA--C 1.543 0.711 0 O-C-N 122.064 -0.398 . . . . 0.0 110.048 173.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.94 81.47 0.3 Allowed 'General case' 0 C--N 1.342 0.258 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -77.41 62.87 2.48 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 174.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 163.3 176.47 35.33 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 126.464 1.983 . . . . 0.0 108.432 -177.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.12 123.57 32.92 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 117.605 0.703 . . . . 0.0 109.93 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.2 mt -126.07 120.63 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 124.429 1.092 . . . . 0.0 109.88 -179.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.6 tp -92.18 97.0 10.64 Favored 'General case' 0 N--CA 1.458 -0.064 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 176.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.6 t -86.6 103.88 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 123.757 0.823 . . . . 0.0 108.946 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -95.2 108.18 20.3 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.214 1.005 . . . . 0.0 108.495 177.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -79.72 129.07 34.16 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 176.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 25.8 p-90 -143.53 174.29 10.89 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.293 1.037 . . . . 0.0 112.8 -176.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.49 144.44 20.68 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 125.736 1.615 . . . . 0.0 108.359 176.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -50.09 -49.19 52.38 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.804 0.842 . . . . 0.0 111.981 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 59.8 p-90 -66.55 -22.65 66.15 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -177.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 49.3 t -79.79 69.87 6.21 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 121.439 -0.788 . . . . 0.0 111.233 -176.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -16.64 -65.74 0.01 OUTLIER Glycine 0 CA--C 1.535 1.307 0 C-N-CA 128.128 2.775 . . . . 0.0 115.889 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -44.08 -31.29 3.88 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 124.533 3.489 . . . . 0.0 115.253 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 96.1 m -53.44 -41.62 66.27 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.804 -0.56 . . . . 0.0 109.831 176.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -67.4 -28.24 67.75 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.651 0.781 . . . . 0.0 111.161 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 84.1 mtp -74.76 -45.23 45.19 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 29.9 pt -74.56 -28.02 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.88 177.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -38.09 -59.55 1.18 Allowed Pre-proline 0 CA--C 1.544 0.749 0 CA-C-N 119.899 1.227 . . . . 0.0 114.286 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -56.15 -40.21 86.29 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.179 1.919 . . . . 0.0 111.498 177.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 19.7 mt -59.4 -51.01 77.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 55.5 mt -55.63 -41.62 73.78 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.691 0.396 . . . . 0.0 110.054 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -61.44 -48.55 80.64 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.569 0.622 . . . . 0.0 110.61 177.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -55.94 -51.6 67.09 Favored 'General case' 0 N--CA 1.457 -0.083 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 33.4 mm -55.8 -46.87 80.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 123.377 0.671 . . . . 0.0 110.031 177.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.18 -40.48 67.57 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.212 0.605 . . . . 0.0 110.575 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -71.95 -58.58 3.32 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 176.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -47.54 -48.13 27.72 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.004 1.322 . . . . 0.0 112.921 -178.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -102.39 22.36 13.54 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.726 0.81 . . . . 0.0 111.45 -178.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -54.31 131.66 42.28 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.988 0.813 . . . . 0.0 110.731 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.36 -19.87 9.9 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-O 119.25 -0.75 . . . . 0.0 112.953 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -99.56 -41.17 7.47 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.594 1.197 . . . . 0.0 109.478 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.4 tp -128.38 126.45 40.69 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.78 1.232 . . . . 0.0 108.74 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 45.8 m -88.7 103.55 16.05 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 175.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.2 t -79.53 130.18 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -132.34 145.03 50.96 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 122.802 0.441 . . . . 0.0 110.3 -178.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.7 mtmt -124.05 104.87 9.13 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 124.231 1.012 . . . . 0.0 109.127 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.3 tt -97.54 115.47 27.9 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 121.695 -0.628 . . . . 0.0 110.556 -175.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -79.23 107.96 12.37 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.933 -178.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.2 pt -71.41 -32.14 45.57 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-O 118.997 -0.525 . . . . 0.0 111.969 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -54.97 -27.62 45.23 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.147 0.885 . . . . 0.0 111.749 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -109.84 -0.64 18.26 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.131 0.972 . . . . 0.0 111.406 177.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -146.93 62.5 7.5 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 124.068 0.947 . . . . 0.0 110.853 178.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -56.46 -48.23 20.07 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 121.75 1.633 . . . . 0.0 111.863 -178.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -40.68 -39.99 2.0 Allowed Glycine 0 CA--C 1.529 0.943 0 C-N-CA 126.106 1.812 . . . . 0.0 115.077 -177.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.59 -23.97 67.44 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 118.519 1.16 . . . . 0.0 112.808 -178.16 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.19 -62.69 5.13 Favored Pre-proline 0 CA--C 1.54 0.569 0 O-C-N 121.112 -0.992 . . . . 0.0 113.348 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -58.05 -34.13 98.09 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 C-N-CA 122.31 2.007 . . . . 0.0 111.906 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -52.58 -29.24 24.71 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.0 0.818 . . . . 0.0 112.024 177.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -119.29 17.72 13.05 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.223 0.609 . . . . 0.0 111.174 177.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 49.17 39.52 27.44 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 124.706 1.146 . . . . 0.0 112.006 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 58.6 mt -64.02 130.72 29.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 121.28 0.562 . . . . 0.0 110.335 -178.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -79.26 -34.72 42.37 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 125.332 1.453 . . . . 0.0 112.602 -175.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -175.92 -157.07 16.27 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 107.41 -2.276 . . . . 0.0 107.41 -178.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.9 pt -147.37 158.44 43.88 Favored Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -70.15 140.29 60.85 Favored 'Cis proline' 0 N--CA 1.458 -0.587 0 N-CA-C 109.289 -1.081 . . . . 0.0 109.289 -1.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 26.6 m -136.85 123.96 21.66 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -179.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.6 mt -100.84 119.24 38.38 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.143 1.777 . . . . 0.0 109.718 -176.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.8 mp -114.55 117.4 30.81 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 173.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 tp -93.38 100.8 13.06 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -90.38 136.67 32.91 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.476 1.11 . . . . 0.0 110.023 -178.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -139.44 119.35 13.38 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.746 1.619 . . . . 0.0 106.663 177.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 54.26 41.55 31.94 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.786 0.721 . . . . 0.0 110.211 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 73.56 -11.84 5.18 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 119.051 -0.861 . . . . 0.0 114.41 -178.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -93.73 136.39 34.07 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 119.139 1.47 . . . . 0.0 109.567 -178.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 95.8 t -73.12 112.85 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 175.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.87 -40.85 31.37 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -158.73 158.71 34.18 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 176.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 89.1 m -134.27 145.21 48.89 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.752 1.221 . . . . 0.0 108.285 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -137.38 122.59 19.26 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 63.5 t -104.11 126.61 58.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.53 166.43 28.55 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.09 0.852 . . . . 0.0 112.219 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.45 170.87 12.35 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.755 0.822 . . . . 0.0 111.542 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -162.96 172.7 14.67 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 124.885 1.274 . . . . 0.0 109.964 -178.143 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 90.9 p -88.02 162.7 16.68 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.513 0.725 . . . . 0.0 110.101 178.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -54.95 -45.04 74.85 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 175.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.52 -60.61 8.55 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 177.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -54.04 -42.08 68.78 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 117.858 0.829 . . . . 0.0 111.641 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 15.9 tp -59.37 -50.97 71.91 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 176.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -57.87 -42.13 83.89 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.397 -0.814 . . . . 0.0 111.988 178.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -57.92 -52.67 64.52 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.138 0.881 . . . . 0.0 109.493 175.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -52.82 -52.3 57.56 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.887 0.875 . . . . 0.0 110.332 179.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.9 mt -56.99 -53.97 52.03 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.853 0.461 . . . . 0.0 110.399 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -52.57 -51.11 61.32 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 122.754 0.422 . . . . 0.0 110.65 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.15 -39.12 69.11 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.1 0.56 . . . . 0.0 111.733 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -78.71 -42.11 29.21 Favored 'General case' 0 N--CA 1.462 0.128 0 O-C-N 122.223 -0.298 . . . . 0.0 111.567 -178.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 59.4 mt -64.64 -45.09 88.27 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.225 0 C-N-CA 123.016 0.526 . . . . 0.0 109.816 177.921 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.9 p . . . . . 0 N--CA 1.451 -0.422 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -72.83 62.06 0.57 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.037 1.335 . . . . 0.0 110.265 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -80.61 54.74 2.16 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.031 0.932 . . . . 0.0 108.688 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.9 mt -107.19 136.83 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 123.67 0.788 . . . . 0.0 110.514 -177.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.1 mm -87.81 114.39 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-O 121.237 0.542 . . . . 0.0 109.802 177.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 63.0 m80 -83.98 96.97 9.01 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 62.4 mt -86.95 163.57 17.04 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.247 1.019 . . . . 0.0 112.342 -175.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 31.4 p -138.71 165.15 27.7 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.15 1.78 . . . . 0.0 106.517 174.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -55.25 -46.68 76.08 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.034 0.534 . . . . 0.0 109.876 178.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -59.72 -43.54 94.12 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.099 0.959 . . . . 0.0 112.158 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.3 p -78.47 -29.8 47.01 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 122.084 -0.385 . . . . 0.0 111.419 -176.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -37.19 -49.12 0.89 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.244 1.818 . . . . 0.0 113.515 -179.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -50.36 -64.6 0.76 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 121.74 0.781 . . . . 0.0 110.955 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 m -69.83 -46.36 65.8 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.855 -175.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -77.21 -21.55 53.71 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 114.935 1.458 . . . . 0.0 114.935 -173.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.3 t -120.48 -61.37 2.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 119.475 1.034 . . . . 0.0 109.753 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 67.0 mt -60.33 -39.92 88.83 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -174.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -94.89 12.52 27.91 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.281 0.491 . . . . 0.0 111.511 178.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.91 98.61 11.17 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.01 0.823 . . . . 0.0 111.654 -178.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -76.44 67.1 2.58 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.492 0.663 . . . . 0.0 109.742 177.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -164.88 162.84 35.96 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.71 112.1 18.57 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.067 0.547 . . . . 0.0 110.47 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.7 mt -118.65 114.21 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 125.288 1.435 . . . . 0.0 110.666 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.9 tp -83.39 96.63 8.6 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 174.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.2 t -86.33 114.93 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 C-N-CA 123.243 0.617 . . . . 0.0 109.611 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -98.31 105.45 17.59 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.495 1.118 . . . . 0.0 108.501 177.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -79.79 121.64 25.62 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 104.672 -2.344 . . . . 0.0 104.672 174.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 38.5 p-90 -135.11 170.35 16.04 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 124.141 0.976 . . . . 0.0 113.347 -175.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.59 125.55 13.6 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.744 1.618 . . . . 0.0 107.558 177.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -46.65 -45.44 19.22 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.416 1.086 . . . . 0.0 113.915 -177.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 55.5 p-90 -68.93 -23.64 64.19 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.956 0.502 . . . . 0.0 112.316 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 42.4 t -79.86 74.24 6.59 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 121.284 -0.885 . . . . 0.0 111.083 -177.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -13.07 -66.15 0.01 OUTLIER Glycine 0 CA--C 1.535 1.319 0 C-N-CA 128.48 2.943 . . . . 0.0 115.891 178.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -41.27 -36.78 2.72 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 124.264 3.309 . . . . 0.0 114.881 178.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 98.8 m -56.11 -48.01 76.98 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.386 0.674 . . . . 0.0 110.003 177.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -64.77 -38.04 89.65 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.549 0.74 . . . . 0.0 109.345 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 52.6 mtm -64.28 -43.96 93.16 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 119.505 -0.283 . . . . 0.0 111.032 178.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 29.8 pt -76.33 -26.69 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 118.74 0.7 . . . . 0.0 112.494 179.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -38.17 -58.85 1.36 Allowed Pre-proline 0 CA--C 1.545 0.756 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -57.27 -39.71 87.85 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 121.959 1.773 . . . . 0.0 111.654 178.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 19.1 mt -59.35 -50.75 78.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 177.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.6 mt -56.05 -43.38 77.84 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.744 0.418 . . . . 0.0 110.434 178.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -59.58 -49.32 78.23 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.603 0.638 . . . . 0.0 109.683 177.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -56.34 -49.78 73.39 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 28.8 mm -56.02 -49.97 72.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 123.206 0.602 . . . . 0.0 109.709 177.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.77 -45.96 63.94 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.288 0.635 . . . . 0.0 110.296 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -66.3 -58.04 6.2 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.938 -0.119 . . . . 0.0 110.738 177.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -48.19 -49.25 33.49 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.52 1.128 . . . . 0.0 112.748 -177.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -98.05 21.79 10.27 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.231 0.612 . . . . 0.0 111.851 -177.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -52.81 128.35 26.47 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.597 1.089 . . . . 0.0 110.824 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.12 -17.35 23.42 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-O 119.33 -0.705 . . . . 0.0 113.419 -178.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -99.29 -42.95 6.78 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 118.477 1.138 . . . . 0.0 109.065 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.3 tp -136.29 137.7 40.99 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.444 1.497 . . . . 0.0 107.274 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.5 m -98.37 140.77 32.14 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 173.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 96.3 t -113.01 141.31 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 177.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -138.03 152.33 48.74 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -128.37 133.4 48.63 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.5 tt -127.8 115.75 19.13 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.72 0.808 . . . . 0.0 109.104 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -80.25 110.01 15.26 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 pp -67.76 -32.54 57.09 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.149 0 C-N-CA 123.412 0.685 . . . . 0.0 112.808 -177.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -60.36 -47.74 84.74 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 118.963 0.801 . . . . 0.0 109.155 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -69.42 -37.26 77.36 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.92 0.888 . . . . 0.0 110.131 177.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -119.87 72.31 16.55 Favored Pre-proline 0 C--O 1.233 0.231 0 C-N-CA 124.007 0.923 . . . . 0.0 111.779 -175.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -61.49 -53.6 2.22 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 122.361 2.04 . . . . 0.0 112.418 -177.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -38.32 -47.93 2.13 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 125.351 1.453 . . . . 0.0 114.377 -177.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.56 -33.34 45.26 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.299 1.039 . . . . 0.0 113.092 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.88 -68.43 0.72 Allowed Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 118.149 -0.929 . . . . 0.0 112.511 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -59.41 -38.23 85.2 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 121.68 1.587 . . . . 0.0 111.048 178.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -50.92 -39.44 54.61 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-N 118.903 0.774 . . . . 0.0 111.53 178.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -108.8 20.93 17.9 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 122.884 0.474 . . . . 0.0 112.132 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 51.49 38.82 43.5 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 124.128 0.87 . . . . 0.0 113.465 176.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mp -57.43 125.66 13.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 118.092 0.946 . . . . 0.0 108.47 177.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -88.92 -47.59 8.05 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.465 1.106 . . . . 0.0 109.118 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -166.64 145.41 9.92 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 107.363 -2.295 . . . . 0.0 107.363 178.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.497 ' H ' HD13 ' A' ' 75' ' ' ILE . 0.2 OUTLIER -91.19 154.71 44.87 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-O 118.834 -0.603 . . . . 0.0 110.306 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.31 129.26 12.46 Favored 'Cis proline' 0 N--CA 1.457 -0.624 0 CA-C-N 119.973 1.026 . . . . 0.0 110.628 -1.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -113.72 109.28 18.31 Favored 'General case' 0 N--CA 1.461 0.076 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 178.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.1 mt -89.75 122.55 32.95 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.0 mp -122.96 114.68 20.75 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 177.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 tp -90.11 95.93 10.44 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -87.02 142.29 28.04 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.688 1.195 . . . . 0.0 111.571 -177.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -137.81 109.61 7.12 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 174.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 52.31 48.67 22.16 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 118.983 0.81 . . . . 0.0 110.073 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.71 -13.21 2.42 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 118.731 -1.038 . . . . 0.0 114.957 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -88.59 125.25 34.71 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 119.637 1.719 . . . . 0.0 108.873 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 73.2 t -71.82 114.07 9.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 175.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.94 -41.25 29.82 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.304 0.641 . . . . 0.0 109.398 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -159.18 170.06 22.78 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 177.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.1 t -149.3 162.77 39.39 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -146.88 119.78 8.71 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.171 1.388 . . . . 0.0 108.08 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.2 t -94.24 120.71 44.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.39 174.92 29.97 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 121.537 0.52 . . . . 0.0 112.211 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.21 172.25 9.59 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.777 0.831 . . . . 0.0 112.156 -178.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.9 mt -144.4 158.47 43.73 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 125.81 1.644 . . . . 0.0 108.506 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.3 p -87.03 152.02 22.74 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 169.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -50.53 -47.93 57.33 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 122.065 -0.397 . . . . 0.0 111.006 -178.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.64 -53.53 38.44 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -62.38 -39.7 94.06 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.98 -0.718 . . . . 0.0 111.291 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 30.6 tp -62.53 -49.43 75.37 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -56.22 -44.92 80.03 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.429 0.559 . . . . 0.0 110.492 176.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -56.27 -54.68 42.46 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.569 0.748 . . . . 0.0 109.887 177.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -53.4 -51.66 61.83 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.669 1.188 . . . . 0.0 110.357 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.9 mt -58.83 -50.77 72.74 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.519 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -55.33 -49.86 71.12 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.8 -36.89 67.92 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.468 0.707 . . . . 0.0 111.601 178.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -78.06 -47.43 18.36 Favored 'General case' 0 C--N 1.337 0.042 0 O-C-N 122.113 -0.367 . . . . 0.0 110.475 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 54.2 mt -59.37 -44.67 92.7 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.227 0.611 . . . . 0.0 109.531 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.244 0 C-N-CA 122.933 0.493 . . . . 0.0 109.707 177.743 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 20.0 m . . . . . 0 CA--C 1.528 0.12 0 CA-C-O 120.691 0.281 . . . . 0.0 111.299 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -74.31 78.65 1.84 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 120.994 0.426 . . . . 0.0 110.614 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -77.4 57.5 1.53 Allowed 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 175.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.7 mt -117.55 147.72 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 C-N-CA 125.631 1.572 . . . . 0.0 109.706 -173.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.2 mm -87.71 108.78 18.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 176.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 27.1 m-70 -79.77 94.69 5.81 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 177.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 66.9 mt -82.09 159.18 23.47 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.832 0.853 . . . . 0.0 112.433 -177.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 26.6 p -134.25 163.15 30.27 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.991 1.716 . . . . 0.0 106.947 173.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -55.62 -46.58 77.37 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.492 0.717 . . . . 0.0 110.656 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -55.98 -45.13 79.07 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.997 0.919 . . . . 0.0 111.468 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.9 p -78.34 -29.78 47.76 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 111.6 0.222 . . . . 0.0 111.6 -177.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -37.62 -53.59 1.2 Allowed 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 125.782 1.633 . . . . 0.0 114.473 -176.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -50.87 -62.2 1.75 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.611 0.719 . . . . 0.0 111.045 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -66.39 -49.53 66.51 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.944 -176.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -74.39 -21.0 59.86 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -173.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.5 t -119.51 -64.99 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.23 0.066 0 CA-C-N 119.326 0.966 . . . . 0.0 110.161 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 67.9 mt -59.66 -37.46 78.79 Favored 'General case' 0 C--N 1.334 -0.082 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 -174.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -98.61 15.75 24.1 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.428 0.558 . . . . 0.0 111.949 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.58 108.39 20.98 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 118.979 0.809 . . . . 0.0 111.047 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -75.38 63.97 1.49 Allowed 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.933 1.293 . . . . 0.0 111.336 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -163.81 178.38 39.29 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.61 105.66 17.9 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.134 1.374 . . . . 0.0 109.44 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.7 mt -112.38 117.35 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 124.144 0.978 . . . . 0.0 110.352 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.5 tp -90.5 97.89 11.45 Favored 'General case' 0 CA--C 1.523 -0.062 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 175.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.8 t -88.78 111.79 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -95.54 106.8 18.93 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.709 1.204 . . . . 0.0 108.601 176.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -80.5 125.17 29.63 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 175.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 31.1 p-90 -143.84 176.2 9.43 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.858 0.863 . . . . 0.0 112.574 -174.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.17 144.71 16.15 Favored 'General case' 0 C--N 1.338 0.092 0 C-N-CA 125.065 1.346 . . . . 0.0 108.476 175.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 -48.93 -50.69 34.15 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.789 1.236 . . . . 0.0 112.099 -178.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 63.9 p-90 -60.41 -29.84 69.22 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -177.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 49.5 t -79.82 77.88 6.45 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 121.514 -0.741 . . . . 0.0 110.52 -178.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -24.66 -62.1 0.05 OUTLIER Glycine 0 CA--C 1.536 1.399 0 C-N-CA 127.094 2.283 . . . . 0.0 115.084 179.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -43.88 -31.16 3.49 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 124.683 3.589 . . . . 0.0 115.192 179.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 98.8 m -55.09 -42.73 73.21 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.688 -0.633 . . . . 0.0 109.705 176.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -67.77 -27.2 66.56 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.712 0.805 . . . . 0.0 111.007 178.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 12.7 tmm? -72.3 -48.99 38.03 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 43.5 pt -70.39 -31.49 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 118.696 -0.668 . . . . 0.0 112.209 178.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -37.53 -60.94 0.8 Allowed Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -57.48 -39.35 89.6 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.374 2.049 . . . . 0.0 111.734 178.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 16.1 mt -59.22 -52.27 62.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.5 mt -55.84 -43.64 77.22 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.652 0.781 . . . . 0.0 110.575 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -58.09 -50.52 73.19 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.121 0.486 . . . . 0.0 109.804 178.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -59.88 -49.98 75.57 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.6 mm -53.37 -46.59 58.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 123.688 0.795 . . . . 0.0 109.585 177.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.56 -45.96 70.08 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.753 0.421 . . . . 0.0 110.608 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -66.43 -55.65 14.73 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 177.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -50.36 -47.82 55.9 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.931 0.892 . . . . 0.0 112.291 -177.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -98.31 23.74 8.04 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.813 0.845 . . . . 0.0 111.614 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -53.82 130.86 38.49 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 119.396 0.998 . . . . 0.0 110.526 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.24 -18.64 12.92 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 119.151 -0.805 . . . . 0.0 113.087 -178.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -99.3 -42.38 7.03 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.788 1.294 . . . . 0.0 109.288 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.0 tp -132.42 131.87 42.22 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.511 1.125 . . . . 0.0 108.667 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 90.4 m -96.27 104.37 16.32 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 176.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 90.7 t -79.74 134.66 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.08 150.02 51.16 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.296 0.639 . . . . 0.0 109.284 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -126.39 136.27 52.48 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 178.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.5 tt -129.45 115.13 17.04 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.412 0.685 . . . . 0.0 109.16 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -80.63 111.11 16.75 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.1 pt -73.19 -25.1 21.19 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.139 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -177.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -61.54 -46.96 87.71 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 177.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -70.6 -40.13 73.41 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.222 1.009 . . . . 0.0 109.894 177.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -120.53 69.77 16.36 Favored Pre-proline 0 CA--C 1.532 0.269 0 C-N-CA 124.06 0.944 . . . . 0.0 112.691 -175.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -65.54 -41.42 15.23 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 121.802 1.668 . . . . 0.0 110.653 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -43.99 -35.99 3.65 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 125.569 1.557 . . . . 0.0 114.913 -178.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.98 -20.41 61.73 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.604 1.202 . . . . 0.0 112.92 -177.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.25 -59.22 13.6 Favored Pre-proline 0 CA--C 1.539 0.538 0 O-C-N 121.111 -0.993 . . . . 0.0 113.226 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -58.17 -33.25 97.29 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.281 1.987 . . . . 0.0 111.805 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -52.98 -29.0 26.48 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.87 0.759 . . . . 0.0 111.929 177.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -122.94 20.47 10.0 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.464 0.705 . . . . 0.0 110.57 177.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 40.3 43.39 2.74 Favored Glycine 0 C--N 1.342 0.875 0 C-N-CA 126.03 1.776 . . . . 0.0 111.535 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.5 mt -54.06 138.39 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -174.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.51 -41.4 32.47 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.55 1.14 . . . . 0.0 111.219 -174.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -178.25 -150.94 9.01 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 106.674 -2.57 . . . . 0.0 106.674 -177.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.3 pt -148.36 154.31 41.75 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 118.856 1.328 . . . . 0.0 108.979 178.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -70.72 141.41 68.38 Favored 'Cis proline' 0 N--CA 1.455 -0.767 0 CA-C-N 119.786 0.959 . . . . 0.0 110.333 -1.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 43.5 m -133.79 125.92 29.5 Favored 'General case' 0 C--O 1.231 0.111 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 178.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.2 mt -103.58 124.96 49.77 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.89 1.276 . . . . 0.0 109.15 -177.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -114.52 117.35 30.69 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 105.064 -2.199 . . . . 0.0 105.064 174.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.5 tp -94.98 95.41 8.6 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -86.88 102.9 14.77 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.162 1.385 . . . . 0.0 110.052 -178.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -97.93 114.68 26.85 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 174.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 54.23 46.99 24.11 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.536 0.734 . . . . 0.0 109.981 -178.038 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 69.55 -1.8 13.15 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-O 118.62 -1.1 . . . . 0.0 114.414 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -103.46 128.97 50.51 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 119.657 1.728 . . . . 0.0 109.253 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 98.8 t -66.35 102.7 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.17 -38.54 35.64 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.696 0.799 . . . . 0.0 109.652 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -150.76 167.29 27.88 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 97.4 m -147.49 149.92 33.57 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.13 141.31 31.16 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -177.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 36.7 t -125.36 128.44 72.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.38 175.87 37.37 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 123.829 0.728 . . . . 0.0 111.649 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.73 173.16 9.47 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.455 0.702 . . . . 0.0 111.44 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.0 mt -146.4 161.69 39.83 Favored 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 125.28 1.432 . . . . 0.0 109.333 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.6 p -92.47 152.42 19.69 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 169.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -51.1 -47.46 61.93 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 122.138 -0.351 . . . . 0.0 111.522 -177.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.8 -60.31 8.9 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -54.46 -41.36 69.38 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.989 -0.712 . . . . 0.0 111.422 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 30.3 tp -60.79 -48.67 80.74 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -55.65 -48.0 75.73 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 118.903 -0.57 . . . . 0.0 110.298 176.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -56.0 -52.13 65.31 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.975 0.807 . . . . 0.0 110.515 178.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -52.05 -51.34 58.14 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.789 0.835 . . . . 0.0 110.429 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 90.1 mt -61.97 -52.33 64.45 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.503 0.321 . . . . 0.0 110.723 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -50.55 -49.79 55.1 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.67 1.188 . . . . 0.0 110.126 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.47 -36.17 68.78 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.402 0.681 . . . . 0.0 111.906 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -78.88 -45.81 19.86 Favored 'General case' 0 N--CA 1.46 0.043 0 O-C-N 122.23 -0.294 . . . . 0.0 110.538 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 56.2 mt -60.26 -43.66 95.98 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.445 0.698 . . . . 0.0 109.655 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.278 0 C-N-CA 122.948 0.499 . . . . 0.0 109.795 177.827 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 35.8 p . . . . . 0 N--CA 1.452 -0.34 0 N-CA-C 110.512 -0.181 . . . . 0.0 110.512 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 28.1 t70 63.89 -70.81 0.07 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 126.979 2.112 . . . . 0.0 110.408 -177.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -116.38 -21.09 9.43 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.396 1.478 . . . . 0.0 110.796 176.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.3 mt -79.5 136.98 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.9 mm -87.79 111.29 21.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 123.599 0.76 . . . . 0.0 109.073 178.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -83.04 101.21 10.97 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 70.7 mt -83.23 163.49 20.71 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.543 1.137 . . . . 0.0 112.139 -177.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 62.2 p -131.51 162.42 30.29 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 173.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -59.25 -46.09 89.43 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.866 0.757 . . . . 0.0 109.543 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -62.72 -41.62 99.25 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.896 0.478 . . . . 0.0 111.713 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 54.4 p -78.33 -26.16 46.75 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.409 0.55 . . . . 0.0 111.175 -177.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -41.85 -44.9 3.5 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 126.419 1.888 . . . . 0.0 112.415 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -53.25 -63.17 1.23 Allowed 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.535 0.684 . . . . 0.0 110.637 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.0 m -66.79 -42.63 85.65 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.742 -177.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -70.52 -50.14 40.89 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -175.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.0 t -100.07 -57.87 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 123.882 0.873 . . . . 0.0 111.141 -174.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 67.0 mt -63.21 -37.01 85.56 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 120.22 -0.592 . . . . 0.0 112.311 -174.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -94.5 21.94 6.68 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.344 0.52 . . . . 0.0 111.08 175.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.78 159.45 34.52 Favored 'General case' 0 C--N 1.34 0.16 0 O-C-N 121.471 -0.768 . . . . 0.0 110.568 177.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -138.6 58.41 1.66 Allowed 'General case' 0 C--O 1.226 -0.155 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 175.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 175.25 -174.2 46.66 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -178.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -86.55 128.28 34.96 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.595 1.158 . . . . 0.0 110.281 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.7 mt -132.99 121.08 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 124.417 1.087 . . . . 0.0 109.603 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -95.35 109.51 21.66 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 175.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.1 t -100.46 108.59 23.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 123.16 0.584 . . . . 0.0 110.043 -178.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -93.7 105.19 17.24 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.125 0.97 . . . . 0.0 109.745 178.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -79.57 114.25 18.35 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 105.048 -2.204 . . . . 0.0 105.048 174.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 39.4 p-90 -128.25 170.55 12.9 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.836 1.255 . . . . 0.0 112.185 -176.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -146.24 131.56 18.54 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.283 1.433 . . . . 0.0 107.763 176.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 -51.14 -37.05 43.98 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.923 0.889 . . . . 0.0 113.24 -178.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 57.7 p-90 -77.9 -20.49 52.83 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 52.8 t -79.83 74.16 6.56 Favored 'General case' 0 N--CA 1.456 -0.138 0 O-C-N 121.228 -0.92 . . . . 0.0 110.745 -177.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -9.68 -71.39 0.01 OUTLIER Glycine 0 CA--C 1.535 1.329 0 C-N-CA 128.294 2.854 . . . . 0.0 115.699 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -40.91 -32.81 0.97 Allowed 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 125.207 3.938 . . . . 0.0 115.61 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 89.3 m -52.66 -41.82 64.16 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.368 0.667 . . . . 0.0 110.207 177.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -66.23 -30.23 70.63 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.717 0.807 . . . . 0.0 111.234 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -75.61 -45.02 39.83 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.9 pt -73.28 -31.15 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-O 118.712 -0.661 . . . . 0.0 112.333 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -39.32 -60.95 1.09 Allowed Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -58.11 -36.86 97.57 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.376 2.051 . . . . 0.0 111.893 178.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 19.7 mt -60.92 -51.79 69.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 177.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.6 mt -56.31 -41.34 75.84 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.189 0.596 . . . . 0.0 110.117 177.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -60.76 -47.87 84.35 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.841 0.746 . . . . 0.0 110.093 176.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -56.91 -51.88 67.38 Favored 'General case' 0 C--N 1.339 0.117 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 31.4 mm -53.72 -46.12 61.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 123.302 0.641 . . . . 0.0 109.498 177.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.65 -36.75 67.39 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.939 0.496 . . . . 0.0 111.223 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -74.5 -58.14 3.48 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.938 0.399 . . . . 0.0 109.986 176.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -50.36 -41.91 52.36 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.734 1.214 . . . . 0.0 112.532 -177.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -107.07 25.45 11.36 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.642 1.177 . . . . 0.0 111.021 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -56.94 121.84 10.87 Favored 'General case' 0 CA--C 1.529 0.173 0 O-C-N 121.545 -0.722 . . . . 0.0 110.39 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.06 -9.83 55.54 Favored Glycine 0 CA--C 1.531 1.094 0 CA-C-O 119.556 -0.58 . . . . 0.0 112.85 -178.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 47.4 mttt -99.71 -41.3 7.35 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.691 1.196 . . . . 0.0 108.664 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 47.7 tp -131.82 133.6 44.86 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.572 1.149 . . . . 0.0 108.708 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.2 m -88.08 98.49 11.56 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 176.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 80.5 t -79.09 128.95 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 178.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.65 150.64 50.68 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.276 0.56 . . . . 0.0 110.662 -177.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -127.54 143.45 51.18 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.972 1.309 . . . . 0.0 107.597 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 tt -134.2 115.19 13.89 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -80.83 105.05 11.76 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pp -58.97 -33.87 51.25 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.242 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -177.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -63.05 -44.31 96.23 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.704 0.684 . . . . 0.0 110.226 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -72.06 -31.49 66.18 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 177.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -128.53 69.79 79.41 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -176.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.02 -50.89 10.89 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.488 2.792 . . . . 0.0 113.408 -178.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -41.37 -40.1 2.56 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 125.431 1.491 . . . . 0.0 114.34 -176.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.88 -30.64 69.13 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.767 -0.843 . . . . 0.0 113.113 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.11 -64.57 2.19 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-O 118.259 -0.877 . . . . 0.0 112.292 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -60.02 -37.21 86.3 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 121.833 1.689 . . . . 0.0 111.511 177.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -52.34 -37.18 55.35 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 119.386 0.994 . . . . 0.0 111.791 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -111.49 20.9 16.76 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.922 0.489 . . . . 0.0 110.92 177.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 41.9 45.08 4.73 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 125.537 1.541 . . . . 0.0 112.901 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mp -47.89 116.45 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 117.702 0.751 . . . . 0.0 110.411 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.41 -49.62 12.07 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.179 0.992 . . . . 0.0 110.295 -177.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -161.9 144.1 9.43 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 107.419 -2.272 . . . . 0.0 107.419 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.7 pt -96.85 150.8 37.31 Favored Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 123.837 0.855 . . . . 0.0 110.246 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -70.23 137.28 44.1 Favored 'Cis proline' 0 N--CA 1.457 -0.672 0 CA-C-N 119.591 0.89 . . . . 0.0 110.597 -1.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -115.43 118.91 34.51 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.3 mt -102.37 105.51 16.12 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -179.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -94.21 114.36 26.45 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 104.781 -2.304 . . . . 0.0 104.781 175.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.6 tp -97.24 105.53 17.7 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -179.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -94.18 150.01 20.71 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.584 1.554 . . . . 0.0 110.712 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -139.63 107.04 5.54 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 173.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 51.01 70.81 0.49 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.548 0.689 . . . . 0.0 111.457 -179.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 73.4 -37.09 0.82 Allowed Glycine 0 CA--C 1.531 1.04 0 N-CA-C 115.923 1.129 . . . . 0.0 115.923 176.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -90.14 147.88 23.32 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.146 1.473 . . . . 0.0 111.373 -177.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 75.3 t -74.38 114.66 14.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 175.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.04 -46.66 13.63 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.62 1.168 . . . . 0.0 109.852 178.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -148.64 170.85 17.22 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 58.9 m -152.57 144.92 24.0 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -177.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -135.29 143.88 46.46 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.4 t -121.94 120.77 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 178.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.03 169.7 35.05 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -177.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.27 170.53 8.57 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.983 0.913 . . . . 0.0 112.882 -178.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.1 mt -142.63 155.76 44.98 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 125.977 1.711 . . . . 0.0 108.572 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.6 p -87.78 152.51 22.06 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 171.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -48.21 -52.35 21.33 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -176.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -53.71 -57.26 16.63 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 26.8 mm100 -57.74 -40.93 80.79 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 122.194 -0.592 . . . . 0.0 111.122 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 42.2 tp -62.13 -49.4 76.01 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 177.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -54.1 -45.99 71.97 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.387 0.54 . . . . 0.0 110.403 176.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -57.96 -54.87 42.04 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 122.92 0.488 . . . . 0.0 110.453 178.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -51.44 -52.21 48.24 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.757 1.223 . . . . 0.0 110.584 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 85.4 mt -61.24 -53.39 57.45 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.805 0.442 . . . . 0.0 110.418 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -51.54 -50.29 60.3 Favored 'General case' 0 C--N 1.334 -0.083 0 C-N-CA 123.765 0.826 . . . . 0.0 111.067 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.82 -37.65 66.38 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.354 0.662 . . . . 0.0 111.654 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -78.78 -43.52 25.31 Favored 'General case' 0 N--CA 1.46 0.073 0 C-N-CA 122.456 0.302 . . . . 0.0 110.587 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 40.4 mt -58.82 -47.06 86.13 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.289 0 C-N-CA 123.364 0.666 . . . . 0.0 109.69 177.656 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 CA--C 1.531 0.239 0 CA-C-O 120.745 0.307 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 26.1 t0 47.81 42.91 16.59 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.993 1.717 . . . . 0.0 112.183 -178.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -82.02 58.07 3.77 Favored 'General case' 0 N--CA 1.457 -0.125 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 175.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 22.0 mt -135.79 143.87 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 123.858 0.863 . . . . 0.0 109.104 -173.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.5 mm -88.03 112.09 23.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 -80.28 102.4 9.49 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 72.7 mt -90.93 161.96 14.97 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 121.814 0.816 . . . . 0.0 112.258 -177.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 82.6 p -139.96 167.15 22.78 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.733 2.013 . . . . 0.0 106.444 175.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -55.22 -47.77 74.87 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.459 0.704 . . . . 0.0 110.656 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -61.8 -40.15 94.22 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.2 p -78.74 -29.99 45.53 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 122.109 -0.369 . . . . 0.0 110.727 -178.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -39.27 -52.83 1.97 Allowed 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 125.841 1.656 . . . . 0.0 113.436 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -55.6 -59.18 5.2 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 121.868 -0.52 . . . . 0.0 110.908 -179.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.1 m -59.11 -48.85 80.08 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.222 1.009 . . . . 0.0 112.569 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.96 -47.1 16.97 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -174.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.8 t -94.56 -52.39 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 C-N-CA 123.347 0.659 . . . . 0.0 112.504 -174.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 73.6 mt -71.4 -42.72 68.0 Favored 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 119.545 -0.862 . . . . 0.0 111.218 -175.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -91.64 35.32 0.96 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 176.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -78.1 162.1 26.92 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.415 0.686 . . . . 0.0 111.987 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -141.8 94.28 2.66 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 172.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 135.52 -175.51 20.7 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -176.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.05 111.59 23.32 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.374 1.47 . . . . 0.0 109.687 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.0 mt -109.07 115.98 50.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 124.153 0.981 . . . . 0.0 109.686 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.6 tp -90.14 96.97 10.92 Favored 'General case' 0 C--N 1.338 0.076 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 176.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 45.4 t -88.51 114.58 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 123.328 0.651 . . . . 0.0 109.899 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -98.87 106.09 18.31 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 176.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -79.73 120.05 23.49 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 175.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 37.6 p-90 -133.84 170.52 15.47 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.332 1.053 . . . . 0.0 113.152 -175.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -142.76 138.68 30.64 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.192 1.397 . . . . 0.0 107.444 174.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -53.89 -47.64 70.92 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.015 0.526 . . . . 0.0 112.236 -177.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 62.6 p-90 -65.68 -23.75 66.85 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.108 0.563 . . . . 0.0 112.413 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 52.1 t -79.68 80.38 6.07 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 121.34 -0.85 . . . . 0.0 109.75 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -27.06 -59.89 0.09 OUTLIER Glycine 0 CA--C 1.535 1.304 0 C-N-CA 127.078 2.275 . . . . 0.0 114.391 178.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -41.75 -37.16 3.77 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 124.248 3.299 . . . . 0.0 114.699 177.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 75.1 m -58.24 -47.67 82.82 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.689 0.757 . . . . 0.0 109.837 177.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -65.37 -37.28 86.54 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.71 0.804 . . . . 0.0 109.094 178.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 54.3 mtm -63.44 -43.14 98.27 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 119.243 -0.408 . . . . 0.0 111.061 177.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 31.5 pt -75.46 -26.52 18.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 119.139 0.881 . . . . 0.0 112.164 178.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -38.26 -57.8 1.69 Allowed Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -57.42 -40.13 83.71 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.072 1.848 . . . . 0.0 111.499 177.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 16.4 mt -59.32 -49.19 84.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.9 mt -57.22 -43.53 82.89 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.75 0.42 . . . . 0.0 110.763 177.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.46 -50.76 72.58 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.725 0.693 . . . . 0.0 110.16 176.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -56.24 -52.1 65.68 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.4 mm -54.55 -46.88 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 124.891 1.276 . . . . 0.0 110.221 178.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.05 -44.69 79.07 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.723 0.409 . . . . 0.0 110.041 178.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -64.26 -53.34 50.48 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 177.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -49.46 -48.91 47.28 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.177 0.991 . . . . 0.0 111.684 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -100.82 29.63 4.45 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.347 0.659 . . . . 0.0 111.344 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -55.54 123.45 14.04 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.43 -0.794 . . . . 0.0 110.5 -179.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.71 -15.13 43.72 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 119.466 -0.63 . . . . 0.0 112.913 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -99.62 -40.23 7.9 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.371 1.086 . . . . 0.0 109.458 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.7 tp -126.41 132.88 51.41 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.656 1.183 . . . . 0.0 108.83 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.0 m -97.44 101.8 13.42 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 176.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 66.6 t -79.62 135.0 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 178.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.92 150.19 49.22 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.413 0.685 . . . . 0.0 109.732 -178.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 45.2 mttm -127.96 126.62 41.76 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.0 tt -116.66 115.82 26.39 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.442 0.697 . . . . 0.0 109.608 179.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -79.15 108.97 13.04 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 pp -68.37 -32.42 55.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 119.228 -0.415 . . . . 0.0 111.395 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -51.13 -33.19 25.51 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.654 0.661 . . . . 0.0 112.17 -179.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -110.43 1.32 18.26 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.41 1.084 . . . . 0.0 111.563 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -144.19 64.1 12.09 Favored Pre-proline 0 C--O 1.234 0.26 0 C-N-CA 124.42 1.088 . . . . 0.0 109.163 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -60.01 -53.33 3.22 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.646 2.231 . . . . 0.0 112.394 -177.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -38.42 -47.47 2.15 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.392 1.472 . . . . 0.0 114.478 -177.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.86 -33.29 49.14 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.367 1.067 . . . . 0.0 112.753 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.93 -68.32 0.75 Allowed Pre-proline 0 CA--C 1.54 0.564 0 CA-C-O 118.295 -0.859 . . . . 0.0 112.98 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.84 -39.36 82.31 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 121.484 1.456 . . . . 0.0 110.806 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -51.29 -38.48 53.03 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 118.415 0.552 . . . . 0.0 111.826 178.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -107.32 18.87 21.07 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 55.46 40.62 78.14 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 123.106 0.384 . . . . 0.0 113.043 176.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mp -63.52 104.31 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 176.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 47.6 mtt85 -79.62 -43.4 22.96 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.902 1.281 . . . . 0.0 110.186 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -157.49 141.91 8.18 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 107.874 -2.09 . . . . 0.0 107.874 179.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.1 pt -99.45 147.48 33.4 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 124.354 1.062 . . . . 0.0 109.762 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.57 142.41 66.88 Favored 'Cis proline' 0 N--CA 1.457 -0.649 0 CA-C-N 120.112 1.076 . . . . 0.0 111.156 0.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -121.38 110.69 16.4 Favored 'General case' 0 C--N 1.335 -0.062 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.2 mt -88.73 123.05 32.78 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.7 mp -122.32 118.97 29.74 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 176.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.8 tp -95.31 95.08 8.24 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -177.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -86.55 105.23 16.69 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.682 1.193 . . . . 0.0 110.768 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -93.62 111.07 22.67 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 173.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.5 m120 47.87 50.88 15.07 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.718 0.807 . . . . 0.0 111.169 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.38 -11.53 24.06 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 118.851 -0.972 . . . . 0.0 114.676 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -97.36 121.16 38.94 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 119.632 1.716 . . . . 0.0 109.745 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 89.4 t -64.07 106.08 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 175.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.98 -37.51 39.22 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.587 0.755 . . . . 0.0 109.553 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.81 170.04 21.51 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.3 t -149.59 156.89 42.67 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 178.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.2 tmtm? -138.55 116.38 11.54 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.853 1.661 . . . . 0.0 106.764 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 36.5 t -96.35 126.93 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -178.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.01 178.67 47.44 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.27 168.2 12.87 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.104 0.478 . . . . 0.0 110.342 178.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -158.09 165.33 35.28 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.842 0.857 . . . . 0.0 109.154 -178.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 83.1 p -80.2 160.29 25.67 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 177.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -58.62 -38.43 78.01 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 175.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -56.01 -54.73 33.31 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 110.656 -0.977 . . . . 0.0 110.656 176.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -52.91 -50.03 64.75 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 117.241 0.52 . . . . 0.0 110.424 177.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 14.6 tp -59.79 -50.11 75.1 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 121.141 -0.224 . . . . 0.0 110.704 -178.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -55.05 -49.14 72.34 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.185 0.594 . . . . 0.0 111.581 178.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -67.68 -43.81 79.29 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.509 -177.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -52.15 -53.0 48.32 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.655 0.782 . . . . 0.0 109.208 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 84.8 mt -59.42 -54.42 46.87 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 119.116 -0.469 . . . . 0.0 110.78 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -51.43 -50.01 60.55 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.106 0.412 . . . . 0.0 111.022 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.95 -38.8 73.44 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.492 0.717 . . . . 0.0 111.847 179.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -78.3 -40.93 35.31 Favored 'General case' 0 N--CA 1.461 0.117 0 O-C-N 122.092 -0.38 . . . . 0.0 110.995 -178.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 63.0 mt -64.14 -46.59 83.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.266 0 C-N-CA 122.922 0.489 . . . . 0.0 109.82 177.7 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 CA--C 1.532 0.277 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -36.7 -45.2 0.51 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.619 1.968 . . . . 0.0 113.57 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -129.33 35.63 4.23 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.094 0.558 . . . . 0.0 110.881 178.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.4 mt -110.57 137.12 44.32 Favored 'Isoleucine or valine' 0 C--O 1.23 0.059 0 C-N-CA 122.77 0.428 . . . . 0.0 110.077 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.4 mm -87.03 108.2 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -81.68 110.55 17.12 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 177.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.0 mt -88.94 171.9 9.54 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.628 1.171 . . . . 0.0 110.502 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 51.0 p -136.21 164.26 28.48 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 171.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -57.1 -47.77 80.25 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 177.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -59.52 -45.35 91.99 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.674 1.19 . . . . 0.0 111.889 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 86.1 p -79.64 -24.43 41.89 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -176.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -31.7 -60.33 0.25 Allowed 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 127.121 2.169 . . . . 0.0 114.337 -178.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -52.36 -59.19 4.71 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.46 0.648 . . . . 0.0 111.048 -177.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.9 m -60.01 -41.66 92.65 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 123.6 0.76 . . . . 0.0 111.733 -178.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -74.79 -43.14 56.31 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -175.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 45.8 t -105.85 -57.31 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 C-N-CA 124.568 1.147 . . . . 0.0 112.08 -172.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 75.5 mt -61.38 -33.54 73.83 Favored 'General case' 0 N--CA 1.458 -0.037 0 O-C-N 121.702 -0.624 . . . . 0.0 111.876 -174.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -88.91 8.66 28.19 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 118.286 0.493 . . . . 0.0 111.809 177.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.79 100.58 11.02 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 121.253 -0.905 . . . . 0.0 112.489 -178.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -77.06 68.77 3.26 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 174.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -179.84 -172.11 43.5 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -178.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -99.6 115.76 30.14 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.562 1.545 . . . . 0.0 110.857 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 mt -121.53 123.44 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 125.43 1.492 . . . . 0.0 109.116 178.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.423 HD13 ' C ' ' A' ' 24' ' ' LEU . 2.9 tm? -92.86 108.32 19.9 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 175.177 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 32.2 t -97.3 109.91 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -93.57 106.36 18.34 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 177.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -79.66 125.52 29.74 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 175.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 38.0 p-90 -143.79 166.12 25.78 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -174.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -144.59 137.24 26.6 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.168 1.387 . . . . 0.0 108.909 174.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -51.75 -47.82 63.94 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.865 0.866 . . . . 0.0 112.372 -177.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 50.4 p-90 -60.75 -27.04 67.66 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 46.8 t -79.86 81.48 6.12 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 121.42 -0.8 . . . . 0.0 109.098 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -28.14 -59.17 0.13 Allowed Glycine 0 CA--C 1.538 1.525 0 C-N-CA 125.962 1.744 . . . . 0.0 114.27 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -41.89 -39.27 5.27 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 124.311 3.341 . . . . 0.0 114.464 177.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 94.1 m -56.02 -50.52 70.66 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 121.668 0.747 . . . . 0.0 109.985 176.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -64.18 -38.07 89.74 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.319 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 83.9 mtp -61.7 -44.16 97.47 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 119.472 -0.299 . . . . 0.0 110.827 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.5 pt -76.17 -26.96 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 118.741 0.7 . . . . 0.0 112.635 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -37.8 -57.93 1.48 Allowed Pre-proline 0 CA--C 1.546 0.79 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -58.14 -39.7 83.1 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.07 1.847 . . . . 0.0 111.672 178.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 14.0 mt -59.52 -49.65 82.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 177.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 44.2 mt -56.1 -42.33 76.62 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 122.564 0.346 . . . . 0.0 110.161 177.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -61.71 -46.86 87.83 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.994 0.815 . . . . 0.0 111.147 176.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -56.14 -51.12 69.1 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 24.0 mm -55.92 -44.78 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 123.428 0.691 . . . . 0.0 109.831 177.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.86 70.68 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 118.321 0.509 . . . . 0.0 110.787 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -72.55 -57.61 4.01 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 177.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -51.18 -46.09 62.0 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.231 1.012 . . . . 0.0 112.605 -178.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -98.26 19.82 13.6 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.438 1.095 . . . . 0.0 111.426 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -54.93 131.85 45.44 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.25 -0.906 . . . . 0.0 110.085 -178.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.25 -18.76 7.64 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 119.334 -0.703 . . . . 0.0 113.235 -178.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -99.61 -37.42 9.15 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.486 1.143 . . . . 0.0 109.923 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 26.6 tp -136.68 128.01 28.26 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.496 1.118 . . . . 0.0 108.181 178.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 57.6 m -88.55 105.08 17.4 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 91.2 t -79.53 130.36 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.96 153.19 51.94 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.938 0.895 . . . . 0.0 110.45 -177.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -128.74 144.02 51.06 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.658 1.183 . . . . 0.0 108.221 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.0 tt -134.04 117.4 16.61 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -87.19 99.76 12.18 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 122.125 -0.359 . . . . 0.0 110.984 -175.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.9 pt -55.26 -28.11 21.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -56.99 -43.55 81.84 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.828 0.74 . . . . 0.0 110.294 177.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -95.28 -17.5 21.61 Favored 'General case' 0 CA--C 1.53 0.212 0 C-N-CA 124.818 1.247 . . . . 0.0 111.577 -178.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -129.82 59.35 44.3 Favored Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 124.532 1.133 . . . . 0.0 108.822 -175.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -62.42 -52.18 2.77 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.609 2.206 . . . . 0.0 113.768 -174.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -44.75 -42.99 7.93 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.016 0.817 . . . . 0.0 113.466 -175.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.43 -33.35 43.62 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.055 0.942 . . . . 0.0 112.663 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.54 -68.51 0.63 Allowed Pre-proline 0 CA--C 1.538 0.503 0 CA-C-O 118.139 -0.934 . . . . 0.0 112.294 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -59.86 -38.24 80.84 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 121.595 1.53 . . . . 0.0 111.016 177.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -51.44 -41.31 60.74 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.266 0.939 . . . . 0.0 111.458 178.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -104.59 19.43 20.4 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.505 0.322 . . . . 0.0 111.753 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.16 39.07 49.62 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.224 0.916 . . . . 0.0 113.401 176.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.5 mp -57.01 127.6 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 118.102 0.951 . . . . 0.0 108.903 177.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -92.24 -47.02 7.43 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.658 1.183 . . . . 0.0 110.238 -178.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -160.55 144.94 10.45 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 107.999 -2.04 . . . . 0.0 107.999 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 9.1 pt -99.08 149.34 35.68 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 124.111 0.964 . . . . 0.0 110.275 -179.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.15 140.02 52.91 Favored 'Cis proline' 0 N--CA 1.457 -0.65 0 CA-C-N 119.961 1.022 . . . . 0.0 111.268 -0.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.85 109.56 15.72 Favored 'General case' 0 CA--C 1.527 0.096 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 178.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.5 mt -91.31 93.17 8.94 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.913 0.885 . . . . 0.0 108.758 -178.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.7 mp -90.56 114.47 26.7 Favored 'General case' 0 CA--C 1.522 -0.117 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 177.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -91.6 103.43 16.02 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -91.49 115.24 27.88 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.144 1.378 . . . . 0.0 110.15 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -111.64 125.27 53.77 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 173.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 53.08 46.11 27.36 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.57 0.7 . . . . 0.0 109.621 -178.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.2 7.16 23.5 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 118.167 -1.352 . . . . 0.0 115.449 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -118.03 142.0 47.86 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 120.002 1.901 . . . . 0.0 110.175 178.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 87.4 t -65.92 110.3 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.39 -42.62 25.1 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.895 0.878 . . . . 0.0 108.647 176.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -158.88 170.95 20.96 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.076 0.95 . . . . 0.0 108.662 177.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 91.2 m -147.33 129.86 15.89 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -179.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -112.2 112.95 24.92 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.0 t -92.02 123.46 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.69 167.43 35.02 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 123.885 0.755 . . . . 0.0 112.232 178.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.3 170.56 12.86 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.108 0.563 . . . . 0.0 110.589 179.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -161.16 172.93 15.88 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.689 0.795 . . . . 0.0 109.913 -176.484 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 82.8 p -84.15 163.88 19.51 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -57.83 -40.78 80.87 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 175.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -59.51 -57.62 18.63 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 177.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -56.44 -40.45 74.8 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 117.589 0.695 . . . . 0.0 110.71 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 28.7 tp -61.05 -54.94 38.61 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 177.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -53.67 -46.36 70.61 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.314 0.506 . . . . 0.0 111.108 178.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -57.49 -53.71 55.04 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.581 0.753 . . . . 0.0 110.044 178.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -52.97 -54.02 41.33 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.327 1.051 . . . . 0.0 110.448 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.3 mt -59.27 -51.81 68.36 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.654 -179.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -54.77 -51.09 66.81 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.057 0.543 . . . . 0.0 110.661 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.2 -37.37 67.01 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.586 0.755 . . . . 0.0 111.46 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -78.13 -45.97 21.91 Favored 'General case' 0 C--O 1.227 -0.081 0 O-C-N 122.336 -0.227 . . . . 0.0 110.587 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 51.9 mt -58.23 -47.3 83.94 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.31 0 C-N-CA 123.286 0.634 . . . . 0.0 109.566 177.355 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.4 m . . . . . 0 N--CA 1.453 -0.325 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -73.85 63.4 0.9 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.906 0.882 . . . . 0.0 110.927 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -80.47 53.27 1.79 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.1 mt -113.42 144.86 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 124.206 1.003 . . . . 0.0 109.846 -174.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.7 mm -87.31 107.78 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 -79.74 92.03 5.37 Favored 'General case' 0 N--CA 1.461 0.082 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 177.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.2 mt -75.79 162.53 28.1 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.794 0.838 . . . . 0.0 111.685 -178.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.3 p -137.28 162.1 34.44 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 171.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -53.25 -44.93 68.55 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.368 0.667 . . . . 0.0 109.965 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -56.01 -39.86 72.53 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.853 1.261 . . . . 0.0 111.564 178.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.35 -43.48 27.63 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 122.089 -0.382 . . . . 0.0 109.98 -177.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -31.05 -55.71 0.23 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 127.702 2.401 . . . . 0.0 114.773 -177.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -55.35 -36.37 66.22 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -177.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.0 m -90.26 -53.4 4.47 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.527 0.679 . . . . 0.0 109.305 179.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.21 -50.55 72.65 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 113.08 0.771 . . . . 0.0 113.08 -174.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.0 t -94.14 -60.29 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 123.467 0.707 . . . . 0.0 111.077 -174.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 65.3 mt -62.72 -24.17 67.54 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -174.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -114.82 32.39 6.03 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 174.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.88 143.72 41.57 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -99.52 36.25 1.81 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.776 1.23 . . . . 0.0 110.369 177.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 159.52 -157.17 28.34 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.42 118.46 26.89 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.706 1.602 . . . . 0.0 110.369 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.2 mt -119.72 120.79 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 C-N-CA 124.782 1.233 . . . . 0.0 109.017 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.41 HD13 ' C ' ' A' ' 24' ' ' LEU . 3.1 tm? -91.78 106.41 18.45 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 105.788 -1.931 . . . . 0.0 105.788 175.396 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 53.9 t -98.02 108.74 22.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 123.36 0.664 . . . . 0.0 109.407 -178.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -93.9 110.09 21.77 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 177.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -81.52 119.44 23.76 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 175.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 27.7 p-90 -136.1 173.32 11.84 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.665 1.186 . . . . 0.0 112.049 -175.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.29 150.84 37.38 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.546 1.138 . . . . 0.0 108.721 175.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -56.92 -51.25 69.85 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.682 1.193 . . . . 0.0 111.834 -178.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 63.9 p-90 -68.68 -24.31 64.49 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.006 0.922 . . . . 0.0 112.835 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 51.4 t -79.35 79.26 5.8 Favored 'General case' 0 N--CA 1.456 -0.167 0 O-C-N 121.506 -0.746 . . . . 0.0 110.807 -177.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -26.78 -61.52 0.08 OUTLIER Glycine 0 CA--C 1.536 1.383 0 C-N-CA 127.018 2.246 . . . . 0.0 114.852 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -45.05 -29.54 3.98 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 124.493 3.462 . . . . 0.0 115.227 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 78.4 m -56.35 -40.98 75.37 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 121.219 -0.926 . . . . 0.0 109.615 176.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -71.21 -20.38 62.27 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.972 0.909 . . . . 0.0 111.23 178.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -74.98 -46.63 33.95 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 175.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 35.7 pt -72.49 -31.36 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.785 178.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -37.73 -60.28 0.96 Allowed Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -57.15 -40.27 84.37 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.297 1.998 . . . . 0.0 111.547 178.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.5 mt -58.7 -51.59 70.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.7 mt -56.54 -41.01 76.08 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.059 0.544 . . . . 0.0 110.347 177.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -60.28 -48.98 79.41 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.554 0.616 . . . . 0.0 110.013 177.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -57.06 -51.03 70.89 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 29.8 mm -54.9 -46.31 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 123.089 0.555 . . . . 0.0 109.738 177.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.93 -41.04 70.55 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.327 0.512 . . . . 0.0 110.754 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -69.8 -56.32 7.45 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 176.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -50.31 -49.94 52.19 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.955 0.902 . . . . 0.0 112.544 -178.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -97.08 27.15 4.23 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.444 1.098 . . . . 0.0 111.564 -177.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -55.94 124.38 17.48 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 119.202 0.91 . . . . 0.0 110.626 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.57 -10.47 37.39 Favored Glycine 0 CA--C 1.534 1.241 0 CA-C-O 119.423 -0.654 . . . . 0.0 113.238 -178.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.5 mttm -99.67 -42.15 7.0 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.56 1.144 . . . . 0.0 109.241 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.1 tp -134.72 128.61 33.27 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.282 1.033 . . . . 0.0 108.315 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 55.6 m -87.18 103.76 15.73 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 176.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.7 t -79.48 131.28 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 178.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.99 151.39 49.86 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.604 0.762 . . . . 0.0 110.076 -177.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.8 mttm -128.86 141.83 51.16 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 177.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 tt -132.13 114.84 15.0 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.002 0.921 . . . . 0.0 108.784 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 -80.65 108.32 14.19 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.1 pt -71.63 -23.17 22.29 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -179.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -61.58 -47.75 84.05 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 63.6 mm-40 -75.65 -33.81 60.47 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.347 178.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -119.76 70.79 13.99 Favored Pre-proline 0 N--CA 1.465 0.306 0 C-N-CA 123.954 0.902 . . . . 0.0 112.003 -177.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -61.45 -48.74 8.82 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 121.761 1.641 . . . . 0.0 111.231 -179.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -41.36 -42.68 3.43 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.416 1.484 . . . . 0.0 115.16 -178.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.55 -25.32 67.93 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.193 0.997 . . . . 0.0 112.609 -177.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.66 -64.26 3.09 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-O 118.306 -0.854 . . . . 0.0 112.61 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -59.72 -37.16 89.05 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.075 1.85 . . . . 0.0 111.184 178.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -51.98 -31.12 27.97 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 118.633 0.651 . . . . 0.0 111.865 178.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -119.29 22.2 11.89 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.115 0.566 . . . . 0.0 111.646 176.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 46.0 42.73 12.17 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.46 1.028 . . . . 0.0 113.126 177.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mp -50.17 117.31 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 117.865 0.833 . . . . 0.0 109.447 176.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.3 -36.87 39.0 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.208 1.003 . . . . 0.0 111.279 -175.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -170.74 -174.18 38.48 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 105.339 -3.104 . . . . 0.0 105.339 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.2 pt -140.13 151.61 65.26 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-N 119.503 1.651 . . . . 0.0 109.855 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -67.77 149.65 83.41 Favored 'Cis proline' 0 N--CA 1.457 -0.665 0 CA-C-N 119.593 0.89 . . . . 0.0 111.357 -0.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.5 m -134.07 145.38 49.33 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 175.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.2 mt -121.73 131.79 54.27 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -118.41 117.53 29.29 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 104.47 -2.419 . . . . 0.0 104.47 174.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -93.77 97.32 10.35 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -89.74 107.17 18.94 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.223 1.409 . . . . 0.0 110.935 -177.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -96.12 109.08 21.57 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 173.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 34.6 m120 48.08 47.89 18.73 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.314 1.046 . . . . 0.0 112.079 -179.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 86.0 -17.35 37.41 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 118.636 -1.091 . . . . 0.0 114.275 178.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -95.04 129.72 42.01 Favored 'General case' 0 N--CA 1.457 -0.093 0 CA-C-N 119.576 1.688 . . . . 0.0 110.146 178.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 90.4 t -69.03 109.5 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 176.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.05 -39.14 34.7 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.86 170.87 19.8 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.7 t -145.98 159.04 43.8 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -138.52 146.61 42.15 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 126.374 1.87 . . . . 0.0 106.946 -177.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.0 t -129.23 134.43 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 107.375 -1.342 . . . . 0.0 107.375 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.94 174.64 50.49 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 123.54 0.591 . . . . 0.0 111.687 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.3 167.95 19.35 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 122.783 0.433 . . . . 0.0 109.949 178.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -159.61 165.79 32.04 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.2 1.0 . . . . 0.0 108.487 -179.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 84.6 p -81.14 163.91 22.76 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -58.58 -41.32 85.47 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 174.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -56.88 -55.72 28.68 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 177.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -57.19 -44.73 83.87 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 122.059 -0.671 . . . . 0.0 110.28 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 48.0 tp -60.1 -51.13 70.95 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 117.792 0.269 . . . . 0.0 110.49 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -52.11 -50.26 62.0 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.661 0.784 . . . . 0.0 110.09 178.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -59.99 -51.36 69.98 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.096 0.158 . . . . 0.0 110.637 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -52.15 -53.63 40.57 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.026 0.93 . . . . 0.0 110.564 179.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.2 -53.21 60.37 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 122.872 0.469 . . . . 0.0 110.479 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -52.55 -51.28 60.43 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.05 0.54 . . . . 0.0 111.145 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.28 -37.7 67.65 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.57 0.748 . . . . 0.0 111.733 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -78.43 -43.88 26.2 Favored 'General case' 0 CA--C 1.524 -0.054 0 O-C-N 122.315 -0.24 . . . . 0.0 110.782 -178.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 46.3 mt -59.79 -47.31 86.2 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.261 0 C-N-CA 123.214 0.606 . . . . 0.0 109.642 177.351 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 18.9 m . . . . . 0 N--CA 1.451 -0.423 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -76.6 55.86 1.08 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.26 0.624 . . . . 0.0 110.063 177.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -82.13 58.42 3.97 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.8 mt -115.22 142.74 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 124.011 0.925 . . . . 0.0 111.155 -174.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.8 mm -91.21 104.29 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 175.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -79.52 81.85 5.73 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 77.3 mt -65.46 163.89 14.96 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -173.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 50.6 p -140.26 161.28 38.05 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 126.453 1.901 . . . . 0.0 106.733 175.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -52.62 -48.16 66.52 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.557 1.143 . . . . 0.0 111.29 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -62.35 -38.07 88.07 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.741 0.416 . . . . 0.0 112.029 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.3 m -78.07 -29.54 49.22 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 122.213 -0.304 . . . . 0.0 110.696 -178.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -42.16 -48.68 4.85 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.069 1.747 . . . . 0.0 113.517 -178.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -51.64 -63.8 1.02 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 121.617 0.722 . . . . 0.0 110.916 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.2 m -68.44 -43.84 76.24 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.171 -175.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -74.76 -48.14 27.19 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -174.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.8 t -95.64 -58.96 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.116 0 C-N-CA 123.269 0.628 . . . . 0.0 111.879 -175.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 80.3 mt -64.07 -39.49 94.18 Favored 'General case' 0 C--N 1.334 -0.085 0 C-N-CA 119.681 -0.808 . . . . 0.0 111.435 -174.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -96.83 30.13 2.78 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 176.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.84 156.11 34.31 Favored 'General case' 0 C--N 1.342 0.255 0 O-C-N 121.887 -0.508 . . . . 0.0 111.082 178.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -131.09 56.37 1.8 Allowed 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 124.808 1.243 . . . . 0.0 108.161 176.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 163.91 -173.66 39.98 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -178.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.64 115.17 25.98 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.47 1.508 . . . . 0.0 110.077 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 mt -114.85 116.67 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 124.561 1.144 . . . . 0.0 109.755 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 19.9 tp -88.26 93.67 9.59 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 176.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.8 t -86.21 103.81 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 123.024 0.53 . . . . 0.0 109.705 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -88.32 107.68 18.95 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 175.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -79.68 126.17 30.58 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 174.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 35.7 p-90 -139.45 169.84 17.01 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.347 1.059 . . . . 0.0 113.286 -174.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.41 136.52 21.07 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.27 1.428 . . . . 0.0 108.517 178.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 50.6 mp0 -49.68 -50.92 41.7 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.874 0.869 . . . . 0.0 112.126 -178.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 62.6 p-90 -64.41 -25.61 68.1 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.294 0.638 . . . . 0.0 112.38 -177.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 51.3 t -79.88 78.84 6.46 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 121.575 -0.703 . . . . 0.0 110.243 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -25.02 -61.07 0.06 OUTLIER Glycine 0 CA--C 1.536 1.389 0 C-N-CA 127.2 2.333 . . . . 0.0 114.936 178.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_exo -42.17 -34.92 3.06 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 124.315 3.343 . . . . 0.0 114.581 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 82.9 m -57.34 -48.67 78.4 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 121.44 0.638 . . . . 0.0 109.919 177.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -65.33 -33.93 77.13 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.32 0.648 . . . . 0.0 109.651 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 24.0 mmt -64.74 -44.52 89.87 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 110.083 -0.339 . . . . 0.0 110.083 177.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 30.7 pt -76.47 -26.13 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-O 118.367 -0.825 . . . . 0.0 112.642 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -38.05 -58.08 1.53 Allowed Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 120.092 1.315 . . . . 0.0 114.328 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -57.7 -37.18 97.6 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.207 1.938 . . . . 0.0 111.771 177.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.9 mt -62.6 -49.42 83.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.8 mt -56.61 -41.11 76.49 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 177.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -61.13 -47.85 84.35 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.586 0.63 . . . . 0.0 109.986 176.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -56.18 -51.87 66.47 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.9 mm -54.66 -49.31 68.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 122.946 0.498 . . . . 0.0 110.071 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.09 -42.48 69.41 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.295 0.638 . . . . 0.0 110.431 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -67.9 -58.81 3.95 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.819 0.342 . . . . 0.0 110.2 177.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -50.75 -46.96 59.56 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.006 1.323 . . . . 0.0 112.602 -178.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -100.29 25.54 7.47 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.541 1.137 . . . . 0.0 111.215 -178.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -54.49 126.97 25.65 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.171 0.896 . . . . 0.0 110.749 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.28 -12.79 24.24 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-O 119.189 -0.784 . . . . 0.0 113.333 -178.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -99.59 -41.83 7.16 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 118.657 1.228 . . . . 0.0 109.363 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.3 tp -130.8 130.56 43.84 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.419 1.087 . . . . 0.0 108.134 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 65.0 m -91.23 102.76 15.48 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 176.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 99.2 t -79.24 140.57 16.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -139.17 147.04 41.32 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 121.859 -0.526 . . . . 0.0 109.834 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.4 mtmt -128.68 99.47 5.36 Favored 'General case' 0 N--CA 1.46 0.065 0 C-N-CA 124.512 1.125 . . . . 0.0 109.087 -178.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.4 tt -97.54 115.08 27.15 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 121.795 -0.565 . . . . 0.0 110.771 -175.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -79.9 109.55 14.44 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.257 -178.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.8 pt -72.4 -25.77 23.52 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -61.43 -47.66 84.75 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 119.448 1.022 . . . . 0.0 108.447 178.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -70.96 -38.71 72.8 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 124.787 1.235 . . . . 0.0 110.003 177.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -118.39 71.83 9.57 Favored Pre-proline 0 N--CA 1.464 0.269 0 C-N-CA 124.16 0.984 . . . . 0.0 111.478 -176.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -60.6 -53.8 2.52 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.167 1.912 . . . . 0.0 112.419 -177.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -36.86 -49.03 1.4 Allowed Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.385 1.469 . . . . 0.0 114.45 -177.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -51.73 -34.61 39.81 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.281 1.032 . . . . 0.0 113.095 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.52 -68.34 0.72 Allowed Pre-proline 0 CA--C 1.538 0.497 0 CA-C-O 118.174 -0.917 . . . . 0.0 112.654 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -60.34 -37.66 80.49 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 121.757 1.638 . . . . 0.0 110.988 177.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -51.44 -38.27 52.84 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 119.065 0.848 . . . . 0.0 111.51 178.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -108.97 19.91 19.03 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 122.857 0.463 . . . . 0.0 112.004 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 51.0 39.7 41.46 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.108 0.861 . . . . 0.0 113.323 177.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.44 129.9 19.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 118.02 0.91 . . . . 0.0 108.563 177.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -87.33 -47.7 8.59 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.342 1.057 . . . . 0.0 108.985 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -169.09 142.26 7.24 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 107.73 -2.148 . . . . 0.0 107.73 178.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.453 ' H ' HD13 ' A' ' 75' ' ' ILE . 0.2 OUTLIER -88.25 151.96 49.56 Favored Pre-proline 0 N--CA 1.454 -0.265 0 CA-C-O 118.514 -0.755 . . . . 0.0 109.907 179.373 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.23 134.85 27.89 Favored 'Cis proline' 0 N--CA 1.456 -0.727 0 CA-C-N 120.102 1.072 . . . . 0.0 111.452 -0.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.48 109.92 14.44 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.354 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.1 mt -89.56 94.06 9.72 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.212 1.005 . . . . 0.0 109.858 -178.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.1 mp -92.02 112.88 24.98 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 176.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.4 tp -90.02 94.75 9.92 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -86.33 105.96 17.04 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 125.077 1.351 . . . . 0.0 110.617 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -94.74 108.4 20.4 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 173.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 49.98 52.24 15.05 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.87 0.868 . . . . 0.0 110.756 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 79.44 -16.4 10.32 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 118.918 -0.935 . . . . 0.0 114.33 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -94.21 118.89 32.22 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 119.579 1.69 . . . . 0.0 110.31 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 86.5 t -62.99 106.87 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 175.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.4 -42.44 25.51 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.921 0.888 . . . . 0.0 110.222 -179.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -153.4 154.76 35.1 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 58.1 p -132.83 111.46 11.11 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.139 0.976 . . . . 0.0 108.832 -177.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -103.58 113.19 26.5 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-N 118.718 0.69 . . . . 0.0 109.936 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.0 t -88.58 124.51 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 176.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.91 171.66 32.79 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 121.637 0.576 . . . . 0.0 113.017 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.61 173.16 8.43 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.152 0.981 . . . . 0.0 112.291 -178.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 mt -151.28 160.28 43.89 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 125.856 1.662 . . . . 0.0 108.729 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.1 p -91.43 152.9 20.19 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 171.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -52.58 -47.44 66.87 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.892 -0.505 . . . . 0.0 112.341 -176.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.53 -53.37 41.77 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-N 118.42 0.554 . . . . 0.0 112.16 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -60.15 -43.4 95.78 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 122.285 -0.538 . . . . 0.0 110.34 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 33.0 tp -59.99 -50.44 73.73 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -54.56 -46.1 73.6 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 118.609 0.64 . . . . 0.0 110.747 177.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -57.77 -52.85 63.76 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 178.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -52.24 -50.65 61.6 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.147 0.979 . . . . 0.0 110.324 178.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 87.4 mt -59.33 -50.98 71.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 122.927 0.491 . . . . 0.0 110.383 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -54.94 -50.6 68.46 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 118.054 0.388 . . . . 0.0 110.258 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.68 -38.31 69.49 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.452 0.701 . . . . 0.0 111.603 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -77.99 -44.09 27.69 Favored 'General case' 0 C--O 1.227 -0.099 0 O-C-N 122.243 -0.286 . . . . 0.0 110.72 -178.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 46.3 mt -59.73 -48.14 82.85 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.27 0 C-N-CA 123.116 0.566 . . . . 0.0 109.685 177.323 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.454 -0.231 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.16 -104.66 0.12 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.233 1.013 . . . . 0.0 111.155 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -124.55 24.99 7.72 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.218 1.407 . . . . 0.0 110.726 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.1 mt -79.95 139.06 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 123.311 0.644 . . . . 0.0 109.561 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.9 mm -89.27 111.56 23.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 123.616 0.766 . . . . 0.0 109.5 178.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -81.05 110.96 17.08 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 50.1 mt -92.05 170.02 10.18 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.53 1.132 . . . . 0.0 110.78 -178.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 67.7 p -136.67 159.54 41.53 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 171.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -56.75 -42.3 79.09 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.044 0.449 . . . . 0.0 109.793 177.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -60.34 -46.97 88.04 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.825 1.25 . . . . 0.0 111.338 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 90.0 p -79.27 -26.18 42.41 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -176.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -36.84 -47.37 0.68 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 127.329 2.252 . . . . 0.0 114.233 -179.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -55.89 -47.42 77.44 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.662 0.744 . . . . 0.0 111.321 -178.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.0 m -77.42 -45.56 25.46 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 123.57 0.748 . . . . 0.0 109.925 -177.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -69.05 -53.97 17.58 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -175.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 41.2 t -94.84 -56.68 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 124.147 0.979 . . . . 0.0 111.857 -173.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 77.3 mt -63.78 -39.42 94.22 Favored 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 119.216 -0.994 . . . . 0.0 111.398 -175.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -96.22 32.06 2.05 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.305 0.502 . . . . 0.0 110.137 174.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.43 146.02 49.76 Favored 'General case' 0 C--N 1.343 0.289 0 O-C-N 121.627 -0.671 . . . . 0.0 112.262 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -99.7 23.39 9.65 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.796 1.638 . . . . 0.0 111.961 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 171.27 -157.61 28.38 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.758 -0.537 . . . . 0.0 111.758 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.58 112.12 20.67 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 126.033 1.733 . . . . 0.0 110.601 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 mt -112.36 117.94 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 124.41 1.084 . . . . 0.0 110.048 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.8 tp -90.01 97.37 11.15 Favored 'General case' 0 C--N 1.338 0.089 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 175.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 56.6 t -87.41 107.43 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 123.416 0.687 . . . . 0.0 110.303 -178.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -92.41 108.18 19.77 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.009 0.924 . . . . 0.0 109.269 176.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -80.34 125.72 30.25 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 105.831 -1.915 . . . . 0.0 105.831 174.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 31.0 p-90 -145.43 175.16 10.53 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.073 0.949 . . . . 0.0 112.253 -176.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.95 147.61 16.72 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 125.487 1.515 . . . . 0.0 108.728 175.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -49.84 -51.65 38.44 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.681 1.193 . . . . 0.0 112.3 -178.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -60.39 -29.95 69.27 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -177.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 46.9 t -79.84 77.59 6.48 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 121.659 -0.651 . . . . 0.0 110.589 -178.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -24.45 -62.04 0.05 OUTLIER Glycine 0 CA--C 1.536 1.368 0 C-N-CA 127.089 2.281 . . . . 0.0 115.141 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -42.81 -33.21 2.92 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 124.725 3.617 . . . . 0.0 114.933 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 99.4 m -53.74 -43.32 69.0 Favored 'General case' 0 CA--C 1.529 0.172 0 O-C-N 121.808 -0.557 . . . . 0.0 110.061 176.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -66.96 -26.84 67.02 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.632 0.773 . . . . 0.0 111.173 178.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 22.7 mmt -76.1 -43.93 41.03 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 28.8 pt -74.74 -29.73 23.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.854 177.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -38.48 -59.6 1.26 Allowed Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 113.877 1.065 . . . . 0.0 113.877 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -57.38 -39.89 85.86 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.364 2.042 . . . . 0.0 111.733 178.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 20.1 mt -58.77 -52.35 61.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 177.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 72.3 mt -56.27 -42.75 77.94 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.085 0.554 . . . . 0.0 110.684 178.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -60.36 -48.34 82.19 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.402 0.546 . . . . 0.0 110.203 178.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -57.9 -51.35 69.96 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 23.1 mm -54.73 -45.8 73.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.749 0.82 . . . . 0.0 109.666 178.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.75 -44.74 70.23 Favored 'General case' 0 C--O 1.227 -0.089 0 C-N-CA 123.008 0.523 . . . . 0.0 110.391 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -68.84 -55.78 10.05 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 121.162 -0.215 . . . . 0.0 110.767 177.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -49.09 -48.85 44.01 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.784 0.834 . . . . 0.0 111.968 -178.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -98.26 24.68 6.93 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.067 0.947 . . . . 0.0 111.519 -178.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -55.07 125.86 22.26 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.571 1.078 . . . . 0.0 110.758 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.56 -11.36 32.82 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 119.522 -0.599 . . . . 0.0 113.353 -178.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.6 mttp -99.73 -42.86 6.67 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.933 1.293 . . . . 0.0 108.734 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.3 tp -133.97 131.55 39.11 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.164 1.386 . . . . 0.0 107.687 178.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 89.9 m -91.92 101.99 14.56 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 176.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 72.5 t -79.22 132.83 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 177.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.19 152.42 51.81 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 123.073 0.549 . . . . 0.0 110.17 -177.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.9 mttm -126.52 139.43 53.23 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 tt -130.94 119.96 22.87 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -87.79 99.07 11.83 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.048 0.539 . . . . 0.0 110.504 -175.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 20.7 pt -58.52 -29.3 38.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 O-C-N 121.266 -0.896 . . . . 0.0 113.224 -177.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -61.19 -25.94 67.37 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.048 0.84 . . . . 0.0 111.697 177.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -114.02 -10.95 12.81 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.312 1.045 . . . . 0.0 111.038 178.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -133.94 57.57 25.76 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 124.892 1.277 . . . . 0.0 108.524 -177.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.71 -49.22 4.44 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.166 1.91 . . . . 0.0 112.976 -174.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -40.26 -40.55 1.9 Allowed Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.421 1.486 . . . . 0.0 114.564 -177.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.64 -30.37 67.24 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.971 -0.723 . . . . 0.0 112.636 -178.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.28 -65.1 2.32 Favored Pre-proline 0 CA--C 1.539 0.542 0 O-C-N 121.257 -0.902 . . . . 0.0 112.501 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -59.27 -35.09 97.89 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.09 1.86 . . . . 0.0 111.276 178.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -51.75 -32.41 30.66 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.203 0.91 . . . . 0.0 112.131 177.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -115.08 17.84 16.58 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.097 0.559 . . . . 0.0 111.387 176.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 48.29 41.09 23.31 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.658 1.123 . . . . 0.0 111.887 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 53.2 mt -66.05 138.42 23.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-O 121.344 0.592 . . . . 0.0 110.623 -177.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -79.18 -42.37 26.24 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.211 1.404 . . . . 0.0 111.322 -176.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -171.36 -154.83 10.12 Favored Glycine 0 C--N 1.334 0.417 0 N-CA-C 108.17 -1.972 . . . . 0.0 108.17 -178.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.6 pt -146.13 156.6 50.61 Favored Pre-proline 0 CA--C 1.536 0.422 0 CA-C-N 118.19 0.995 . . . . 0.0 108.495 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -70.45 141.85 69.36 Favored 'Cis proline' 0 N--CA 1.456 -0.681 0 CA-C-N 120.156 1.091 . . . . 0.0 109.95 -1.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.4 m -139.06 122.33 17.04 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 mt -103.83 120.15 40.39 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.932 1.293 . . . . 0.0 109.318 -176.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.9 mp -110.5 121.89 46.39 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 175.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 tp -94.64 95.52 8.82 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -88.68 103.99 16.46 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.429 1.492 . . . . 0.0 110.713 -178.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -91.74 106.55 18.56 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 173.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 35.0 m120 49.29 51.19 16.77 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.664 0.786 . . . . 0.0 111.029 -178.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 79.81 -15.45 14.9 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-O 118.839 -0.978 . . . . 0.0 114.369 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -92.62 120.17 32.79 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.503 1.651 . . . . 0.0 109.668 179.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 88.5 t -64.45 106.75 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 175.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.97 -39.28 34.8 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.479 0.712 . . . . 0.0 109.356 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -159.83 171.37 19.59 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.6 m -150.32 149.41 30.07 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -178.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.5 mmtm -135.09 131.25 36.71 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 126.047 1.739 . . . . 0.0 107.648 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.2 t -113.33 125.12 70.54 Favored 'Isoleucine or valine' 0 C--O 1.231 0.1 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 178.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.13 179.06 33.0 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -177.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.6 170.99 15.09 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.065 0.546 . . . . 0.0 111.202 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.2 mt -143.55 154.61 43.78 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 125.138 1.375 . . . . 0.0 108.698 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.9 p -84.47 148.86 26.32 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 170.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -49.47 -47.84 48.15 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 122.143 -0.348 . . . . 0.0 111.728 -177.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.21 -53.09 42.87 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 111.889 -0.484 . . . . 0.0 111.889 179.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -61.37 -42.16 98.26 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.132 -0.628 . . . . 0.0 110.844 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 33.8 tp -60.15 -51.64 68.73 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 177.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -56.49 -44.34 80.55 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.638 -0.664 . . . . 0.0 111.169 177.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -55.87 -54.29 46.37 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.604 0.762 . . . . 0.0 109.685 177.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -53.28 -52.05 60.3 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.947 1.299 . . . . 0.0 110.444 178.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.0 mt -58.7 -50.61 73.26 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 122.647 0.379 . . . . 0.0 110.574 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -55.09 -50.53 68.94 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 178.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.84 -37.95 69.4 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.322 0.649 . . . . 0.0 111.784 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -77.97 -43.22 30.34 Favored 'General case' 0 C--N 1.339 0.125 0 O-C-N 122.129 -0.357 . . . . 0.0 110.708 -178.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 49.1 mt -61.42 -47.21 86.81 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.293 0 C-N-CA 123.094 0.557 . . . . 0.0 109.686 177.441 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.5 mt . . . . . 0 N--CA 1.463 0.178 0 CA-C-O 120.863 0.363 . . . . 0.0 110.45 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.5 mm -88.0 112.67 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 123.324 0.65 . . . . 0.0 109.488 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -83.52 106.43 15.25 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.75 -0.594 . . . . 0.0 109.662 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 43.0 mt -89.15 164.04 15.18 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.799 1.24 . . . . 0.0 111.14 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 35.0 p -136.78 167.16 21.97 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 175.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -58.33 -46.51 86.08 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 177.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -57.26 -46.79 82.71 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.976 0.911 . . . . 0.0 111.322 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.1 p -78.64 -25.63 45.03 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.932 -176.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -43.41 -46.81 6.81 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.59 1.556 . . . . 0.0 113.123 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -49.07 -65.69 0.53 Allowed 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 121.791 0.805 . . . . 0.0 110.48 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -71.37 -44.62 64.65 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.058 -174.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -73.14 -37.36 66.64 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -173.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.8 t -108.99 -60.42 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.058 0 C-N-CA 123.151 0.58 . . . . 0.0 110.706 -176.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 84.0 mt -63.73 -36.38 83.66 Favored 'General case' 0 C--N 1.334 -0.088 0 C-N-CA 120.029 -0.668 . . . . 0.0 112.597 -174.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -99.95 28.03 5.1 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.673 0.669 . . . . 0.0 110.148 176.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -74.84 172.53 12.04 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.959 0.885 . . . . 0.0 112.263 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -141.96 129.63 21.55 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 171.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.4 -172.0 27.21 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -175.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -98.15 120.43 38.54 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.064 1.346 . . . . 0.0 111.206 -177.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.7 mt -118.13 120.22 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 124.863 1.265 . . . . 0.0 109.01 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -93.42 107.77 19.55 Favored 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 176.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.1 t -98.38 109.4 23.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 123.503 0.721 . . . . 0.0 109.415 -178.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -93.59 108.8 20.46 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 123.669 0.788 . . . . 0.0 108.881 176.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -78.78 128.52 33.51 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 25.7 p-90 -145.43 173.7 11.77 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.623 0.769 . . . . 0.0 112.819 -176.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.51 144.37 22.74 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 125.593 1.557 . . . . 0.0 107.81 176.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -47.63 -51.09 22.59 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.533 1.133 . . . . 0.0 112.307 -177.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 62.2 p-90 -65.31 -23.76 67.1 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.819 0.847 . . . . 0.0 112.621 -178.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 35.3 t -79.91 72.83 6.68 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 121.482 -0.761 . . . . 0.0 111.481 -176.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -21.2 -64.17 0.02 OUTLIER Glycine 0 CA--C 1.537 1.462 0 C-N-CA 127.57 2.509 . . . . 0.0 116.043 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -48.55 -29.09 13.24 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 123.419 2.746 . . . . 0.0 114.443 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.8 m -59.26 -44.71 92.39 Favored 'General case' 0 N--CA 1.462 0.154 0 O-C-N 121.508 -0.745 . . . . 0.0 109.558 176.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -66.65 -36.24 82.08 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.562 0.745 . . . . 0.0 109.017 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 26.0 ttt -62.97 -46.34 88.16 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 119.614 -0.232 . . . . 0.0 110.48 177.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 38.3 pt -75.34 -28.02 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-O 118.417 -0.802 . . . . 0.0 112.363 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -37.11 -58.68 1.09 Allowed Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -58.05 -41.42 68.17 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.025 1.817 . . . . 0.0 111.4 177.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.0 mt -57.8 -51.16 73.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.6 mt -55.71 -41.36 73.7 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.108 0.563 . . . . 0.0 110.359 177.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -63.37 -45.95 88.77 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.226 0.921 . . . . 0.0 111.07 176.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -57.18 -50.56 72.46 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 25.8 mm -54.32 -50.18 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 C-N-CA 123.533 0.733 . . . . 0.0 109.303 176.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.16 -48.71 64.79 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 122.096 -0.377 . . . . 0.0 110.268 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -60.37 -55.23 36.13 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 122.448 0.299 . . . . 0.0 110.677 178.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -54.0 -44.96 71.34 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.093 0.957 . . . . 0.0 112.221 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -98.59 29.83 3.52 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.395 1.078 . . . . 0.0 111.943 -177.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -54.24 127.27 26.31 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.363 -0.836 . . . . 0.0 109.901 177.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.52 -13.62 16.02 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 119.234 -0.759 . . . . 0.0 113.188 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -99.61 -39.37 8.33 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 118.567 1.184 . . . . 0.0 109.994 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.9 tp -137.67 129.7 28.92 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 123.134 0.574 . . . . 0.0 110.272 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.8 m -89.83 101.57 14.27 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 175.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 91.8 t -79.83 130.19 36.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.81 154.43 51.2 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 123.673 0.789 . . . . 0.0 111.134 -177.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -127.49 143.78 51.15 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.306 1.442 . . . . 0.0 107.418 177.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.5 tt -132.32 115.01 15.08 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -80.23 104.35 10.73 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 122.38 0.272 . . . . 0.0 110.656 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.0 pt -70.23 -28.72 36.67 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.28 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -57.21 -45.95 83.33 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 119.103 0.865 . . . . 0.0 108.844 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.49 -38.41 59.53 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.221 0.608 . . . . 0.0 109.943 177.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -117.15 67.36 4.48 Favored Pre-proline 0 CA--C 1.534 0.335 0 C-N-CA 124.252 1.021 . . . . 0.0 112.173 -175.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -58.47 -47.8 17.88 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.476 2.117 . . . . 0.0 112.465 -176.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -40.49 -34.95 0.74 Allowed Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.863 1.696 . . . . 0.0 115.237 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 75.2 p -61.4 -38.72 88.09 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 117.795 0.798 . . . . 0.0 111.643 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.486 ' HB3' ' HD3' ' A' ' 68' ' ' PRO 0.284 . . -56.95 -62.76 4.52 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-O 118.071 -0.966 . . . . 0.0 111.571 -179.351 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.486 ' HD3' ' HB3' ' A' ' 67' ' ' ALA . 51.5 Cg_exo -49.07 -50.75 12.03 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.822 2.348 . . . . 0.0 111.525 173.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -51.88 -41.26 61.75 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -104.15 20.69 17.84 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 118.286 0.494 . . . . 0.0 111.75 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 44.79 42.03 7.51 Favored Glycine 0 C--N 1.341 0.844 0 C-N-CA 124.245 0.926 . . . . 0.0 111.624 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.7 mm -57.97 122.66 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-O 121.156 0.503 . . . . 0.0 110.091 -177.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 50.8 mmt-85 -79.7 -40.02 29.93 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.663 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -179.76 146.32 6.95 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 108.335 -1.906 . . . . 0.0 108.335 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.2 pt -93.67 153.43 41.16 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 123.876 0.87 . . . . 0.0 110.769 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.25 139.64 51.1 Favored 'Cis proline' 0 N--CA 1.458 -0.61 0 CA-C-N 119.614 0.898 . . . . 0.0 110.96 -1.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.8 112.98 16.01 Favored 'General case' 0 CA--C 1.523 -0.077 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.2 mt -94.81 122.05 37.03 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -114.61 117.97 32.37 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 177.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.5 tp -94.93 97.85 10.29 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -89.98 110.56 21.53 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.187 1.395 . . . . 0.0 111.288 -177.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -96.68 114.23 25.85 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 171.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.9 m120 47.24 48.66 15.97 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.011 0.524 . . . . 0.0 111.518 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 76.72 -6.8 37.42 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 118.737 -1.035 . . . . 0.0 115.083 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -102.03 126.32 48.94 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 119.575 1.687 . . . . 0.0 109.541 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 92.4 t -66.18 108.55 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.35 -41.07 28.69 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.947 0.899 . . . . 0.0 109.372 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -157.65 171.86 19.57 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.2 t -152.76 164.0 38.63 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -145.04 126.89 15.37 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.467 1.507 . . . . 0.0 107.398 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.2 t -101.58 122.89 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 174.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.49 175.54 32.67 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 -178.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.5 174.25 9.23 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.619 0.767 . . . . 0.0 111.733 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.1 mt -147.04 156.01 42.68 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.708 1.603 . . . . 0.0 107.962 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.9 p -87.09 154.8 20.46 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.357 -1.719 . . . . 0.0 106.357 171.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -49.58 -51.83 34.39 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 122.089 -0.382 . . . . 0.0 111.654 -177.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.05 -58.12 13.96 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -56.1 -41.29 75.0 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 122.411 -0.464 . . . . 0.0 110.927 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 37.2 tp -62.42 -49.37 75.76 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -55.24 -47.1 75.88 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.474 0.579 . . . . 0.0 110.356 177.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -57.11 -53.93 52.56 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.124 0.57 . . . . 0.0 110.397 178.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -52.65 -52.34 56.08 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.899 1.28 . . . . 0.0 110.857 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 76.0 mt -62.51 -50.87 69.66 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 122.176 -0.327 . . . . 0.0 110.305 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -53.57 -48.98 68.67 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.358 0.663 . . . . 0.0 110.771 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.56 -34.51 67.19 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.792 0.837 . . . . 0.0 111.607 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -78.94 -48.06 15.25 Favored 'General case' 0 C--O 1.228 -0.07 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 45.0 mt -58.39 -45.34 88.52 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.415 0.686 . . . . 0.0 110.827 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.172 0 C-N-CA 124.847 1.259 . . . . 0.0 111.711 179.135 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 15.7 mt . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.1 mm -87.4 104.76 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 177.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -79.44 80.6 5.8 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 177.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 77.6 mt -63.88 163.41 11.98 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.049 0.94 . . . . 0.0 113.208 -175.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 47.4 p -138.31 165.8 25.83 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 126.08 1.752 . . . . 0.0 106.506 174.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -55.23 -47.34 75.51 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.476 0.71 . . . . 0.0 110.932 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -63.72 -38.73 92.21 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.0 p -77.98 -32.5 51.35 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.03 0.377 . . . . 0.0 110.482 -177.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -36.61 -48.78 0.72 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.273 1.829 . . . . 0.0 113.364 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -49.36 -65.37 0.58 Allowed 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 121.961 0.886 . . . . 0.0 111.163 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.3 m -72.29 -45.21 61.0 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.569 -174.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -76.2 -21.83 55.99 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -174.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 45.9 t -120.77 -62.86 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.094 0 CA-C-N 119.548 1.067 . . . . 0.0 109.947 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 72.1 mt -58.81 -37.32 76.11 Favored 'General case' 0 CA--C 1.528 0.098 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -174.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -95.72 14.42 23.21 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 118.587 0.63 . . . . 0.0 111.924 177.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.38 103.36 16.01 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 119.073 0.852 . . . . 0.0 112.367 -178.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -76.31 72.67 3.08 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 174.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -174.63 179.39 45.97 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.95 118.76 32.34 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.489 1.516 . . . . 0.0 109.987 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.6 mt -127.57 115.97 41.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 124.796 1.239 . . . . 0.0 110.73 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 35.0 tp -83.53 96.41 8.6 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 174.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.4 t -86.51 105.85 15.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 122.999 0.519 . . . . 0.0 109.872 -179.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -91.35 112.42 24.33 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 176.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -85.05 120.82 26.99 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 173.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 21.9 p-90 -138.88 177.66 7.73 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.983 0.913 . . . . 0.0 112.351 -174.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -150.94 150.16 30.5 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.472 1.509 . . . . 0.0 107.716 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -62.84 -50.3 71.51 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.852 0.358 . . . . 0.0 111.308 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 63.9 p-90 -62.25 -26.25 68.28 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.489 0.716 . . . . 0.0 112.743 -178.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.6 t -79.16 77.68 5.65 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 121.554 -0.716 . . . . 0.0 109.829 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -22.15 -63.12 0.03 OUTLIER Glycine 0 CA--C 1.534 1.276 0 C-N-CA 127.661 2.553 . . . . 0.0 115.198 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -42.58 -36.0 4.4 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 124.503 3.469 . . . . 0.0 114.525 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 80.5 m -53.92 -46.06 71.36 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 121.508 0.67 . . . . 0.0 109.956 176.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.91 -24.47 63.38 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.348 0.659 . . . . 0.0 110.967 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 23.1 mmt -74.2 -43.92 55.33 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 30.4 pt -75.2 -27.23 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 118.905 -0.569 . . . . 0.0 111.694 177.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -36.6 -60.06 0.8 Allowed Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -56.89 -40.6 83.0 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.224 1.949 . . . . 0.0 111.918 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.0 mt -58.79 -50.72 78.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.7 mt -56.12 -43.77 78.5 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.592 0.357 . . . . 0.0 110.201 177.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -58.5 -49.59 76.82 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.255 0.55 . . . . 0.0 109.794 178.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -56.13 -52.07 65.68 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 31.7 mm -54.04 -50.01 56.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 123.066 0.547 . . . . 0.0 109.869 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.24 -46.47 65.73 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.219 0.608 . . . . 0.0 110.603 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -66.13 -56.91 9.1 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 178.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -47.25 -49.89 22.47 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.711 1.204 . . . . 0.0 112.329 -178.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -99.69 26.19 6.45 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.149 0.58 . . . . 0.0 111.705 -178.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.54 111.85 0.99 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.253 0.933 . . . . 0.0 111.022 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.35 -15.84 61.61 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.01 0.814 . . . . 0.0 112.243 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -99.52 -39.17 8.46 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.943 1.297 . . . . 0.0 109.158 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 46.9 tp -140.2 130.64 25.39 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 178.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 91.0 m -91.09 145.92 24.28 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 105.836 -1.912 . . . . 0.0 105.836 174.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 94.9 t -120.54 141.28 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 177.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.86 148.82 50.22 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.127 0.571 . . . . 0.0 109.889 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -127.33 96.57 4.61 Favored 'General case' 0 C--O 1.23 0.066 0 C-N-CA 124.906 1.283 . . . . 0.0 108.91 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 tt -96.7 109.4 22.05 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -176.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -80.45 108.61 14.22 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.934 -178.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.7 pt -64.46 -25.31 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-O 119.1 -0.476 . . . . 0.0 111.644 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -53.65 -25.72 19.19 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.825 0.739 . . . . 0.0 111.966 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -119.01 3.03 11.52 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.015 0.926 . . . . 0.0 110.89 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -147.23 62.75 7.5 Favored Pre-proline 0 CA--C 1.529 0.137 0 C-N-CA 124.614 1.166 . . . . 0.0 109.523 -177.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -61.82 -52.07 3.31 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 121.776 1.651 . . . . 0.0 111.285 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -40.83 -43.11 3.05 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.529 1.538 . . . . 0.0 114.918 -177.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.31 -31.12 67.22 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 117.808 0.804 . . . . 0.0 111.788 -178.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.36 -67.24 0.92 Allowed Pre-proline 0 CA--C 1.539 0.529 0 CA-C-O 118.276 -0.869 . . . . 0.0 112.619 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -60.0 -38.47 78.05 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 121.72 1.613 . . . . 0.0 110.882 178.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -52.25 -38.56 58.5 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 118.874 0.761 . . . . 0.0 111.484 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -106.67 19.77 20.0 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.657 0.383 . . . . 0.0 111.999 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.23 38.05 55.97 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.111 0.862 . . . . 0.0 113.528 176.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.38 129.23 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -89.79 -48.84 6.99 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.45 1.1 . . . . 0.0 110.095 -178.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -162.14 146.5 12.09 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 107.285 -2.326 . . . . 0.0 107.285 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.3 pt -98.55 149.14 35.44 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 123.461 0.704 . . . . 0.0 110.048 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.17 139.47 53.05 Favored 'Cis proline' 0 N--CA 1.455 -0.772 0 CA-C-N 119.873 0.99 . . . . 0.0 111.094 -0.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.77 139.49 52.23 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 176.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.6 mt -118.46 106.07 12.32 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.0 mp -100.16 113.23 25.73 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 176.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.9 tp -90.23 101.8 14.52 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -86.53 143.2 27.83 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.556 1.143 . . . . 0.0 109.166 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -140.96 110.42 6.33 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 175.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.1 t30 55.73 67.93 0.94 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 121.438 0.637 . . . . 0.0 110.337 -177.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.31 -31.76 0.26 Allowed Glycine 0 CA--C 1.533 1.187 0 N-CA-C 117.04 1.576 . . . . 0.0 117.04 176.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -97.71 155.03 17.2 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 119.5 1.65 . . . . 0.0 111.224 -177.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 93.3 t -76.19 118.31 22.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.93 -47.13 15.53 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 123.662 0.785 . . . . 0.0 109.177 177.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -156.77 171.9 19.57 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 123.944 0.898 . . . . 0.0 108.689 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 90.8 m -149.96 148.86 29.59 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 122.01 -0.431 . . . . 0.0 110.111 -178.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -130.59 151.14 51.38 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 126.314 1.846 . . . . 0.0 107.62 177.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.2 t -129.96 131.64 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -178.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.95 -178.58 45.2 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 111.439 -0.665 . . . . 0.0 111.439 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.75 165.72 24.28 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.836 0.454 . . . . 0.0 110.894 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.5 mt -145.05 151.41 38.5 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.662 1.185 . . . . 0.0 108.533 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.4 p -84.52 149.42 25.93 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 172.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -51.71 -45.04 63.42 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-O 119.481 -0.295 . . . . 0.0 111.648 -177.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.92 -55.34 29.58 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 118.343 0.52 . . . . 0.0 111.844 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -56.81 -47.67 79.73 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 122.048 -0.678 . . . . 0.0 110.077 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 48.4 tp -56.77 -51.59 68.3 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 119.539 -0.267 . . . . 0.0 110.489 178.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.1 mmmp? -51.93 -49.45 63.08 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.279 0.631 . . . . 0.0 110.336 177.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -58.87 -50.37 74.27 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 110.558 -0.164 . . . . 0.0 110.558 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -53.9 -53.01 58.58 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.546 0.739 . . . . 0.0 110.865 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.8 mt -59.97 -49.95 75.68 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 122.726 0.41 . . . . 0.0 110.377 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -54.74 -50.73 67.66 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 117.844 0.293 . . . . 0.0 110.353 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.75 -36.92 70.32 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.577 0.751 . . . . 0.0 111.696 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -77.7 -42.98 32.55 Favored 'General case' 0 C--O 1.227 -0.082 0 O-C-N 122.205 -0.309 . . . . 0.0 110.367 -178.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 47.3 mt -61.75 -47.37 85.52 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.29 0 C-N-CA 123.208 0.603 . . . . 0.0 109.644 177.518 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.2 mt . . . . . 0 N--CA 1.45 -0.475 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.5 mm -90.97 111.41 23.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 124.419 1.088 . . . . 0.0 109.387 178.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -82.37 101.44 10.6 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 67.1 mt -85.09 162.9 19.11 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.697 0.799 . . . . 0.0 111.849 -177.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 48.0 p -137.64 165.67 25.79 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 126.042 1.737 . . . . 0.0 106.406 175.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -56.58 -44.02 80.63 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.853 -0.529 . . . . 0.0 110.216 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -59.28 -44.16 92.49 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.025 0.93 . . . . 0.0 112.192 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.1 p -78.79 -30.94 45.79 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 122.107 -0.371 . . . . 0.0 111.003 -177.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -36.36 -56.48 0.78 Allowed 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 126.37 1.868 . . . . 0.0 114.092 -178.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -54.29 -57.59 10.64 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 121.822 -0.549 . . . . 0.0 110.953 -177.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.3 m -62.02 -47.62 83.97 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.708 0.803 . . . . 0.0 112.446 -177.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.16 -50.68 13.92 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -175.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.4 t -90.97 -57.05 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 124.048 0.939 . . . . 0.0 112.533 -173.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 72.2 mt -66.76 -41.06 88.38 Favored 'General case' 0 CA--C 1.523 -0.074 0 C-N-CA 119.564 -0.854 . . . . 0.0 110.918 -174.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -93.0 30.67 1.56 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 122.64 0.376 . . . . 0.0 110.041 176.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.0 156.66 36.82 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.766 -0.584 . . . . 0.0 110.826 177.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -131.69 55.18 1.88 Allowed 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 124.699 1.2 . . . . 0.0 108.109 176.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 164.5 -173.01 40.41 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.506 -1.037 . . . . 0.0 110.506 -178.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.95 113.65 23.81 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.543 1.537 . . . . 0.0 109.947 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.5 mt -113.52 117.46 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 124.258 1.023 . . . . 0.0 109.479 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.7 tp -89.72 96.32 10.64 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 177.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.7 t -89.32 109.35 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 123.427 0.691 . . . . 0.0 109.629 -179.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -93.58 105.36 17.41 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -79.18 123.95 27.88 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 175.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 24.5 p-90 -138.93 172.69 12.49 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 124.292 1.037 . . . . 0.0 111.943 -175.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.99 147.79 32.05 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.297 1.039 . . . . 0.0 108.651 175.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -54.61 -52.23 62.84 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.904 0.882 . . . . 0.0 111.78 -178.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 61.4 p-90 -67.25 -21.58 65.71 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.958 0.903 . . . . 0.0 112.747 -178.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 46.0 t -79.58 70.0 5.98 Favored 'General case' 0 N--CA 1.456 -0.144 0 O-C-N 121.38 -0.825 . . . . 0.0 110.935 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -16.14 -65.59 0.01 OUTLIER Glycine 0 CA--C 1.534 1.266 0 C-N-CA 128.253 2.835 . . . . 0.0 115.903 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -42.95 -32.38 2.65 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 124.532 3.488 . . . . 0.0 115.036 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 99.6 m -53.9 -44.73 70.76 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.221 0.608 . . . . 0.0 110.121 176.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -67.33 -26.6 66.58 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.323 0.649 . . . . 0.0 111.13 178.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 23.3 mmt -74.54 -43.68 54.64 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 19.6 pt -74.95 -28.95 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 119.006 -0.521 . . . . 0.0 111.922 178.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -38.67 -59.45 1.34 Allowed Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -56.6 -40.08 86.91 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.158 1.905 . . . . 0.0 111.441 177.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 16.3 mt -58.85 -48.82 85.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 74.7 mt -57.25 -43.67 83.16 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 119.415 -0.326 . . . . 0.0 110.352 177.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -60.02 -48.09 83.13 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.839 0.745 . . . . 0.0 110.446 177.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -57.01 -52.16 66.38 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.2 mm -55.44 -45.06 78.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 124.102 0.961 . . . . 0.0 110.017 178.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.51 -41.71 73.47 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 123.048 0.539 . . . . 0.0 110.05 178.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -67.67 -55.13 14.44 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 176.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -48.06 -48.99 33.02 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.903 0.881 . . . . 0.0 112.068 -178.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -103.2 28.87 5.95 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.654 0.782 . . . . 0.0 111.594 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -55.37 126.53 25.43 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.152 0.887 . . . . 0.0 111.212 -178.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.36 -13.13 29.16 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 119.237 -0.757 . . . . 0.0 113.21 -178.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -99.8 -43.93 6.26 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.455 1.127 . . . . 0.0 109.357 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.9 tp -125.4 125.5 43.5 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.755 1.222 . . . . 0.0 108.025 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 60.4 m -87.59 101.84 14.02 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 176.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.6 t -79.39 131.74 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.66 151.65 48.49 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 122.635 0.374 . . . . 0.0 110.096 -178.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -128.69 135.43 49.24 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 tt -124.54 113.62 18.33 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.645 0.778 . . . . 0.0 109.223 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -79.39 108.89 13.25 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.1 pt -70.74 -22.59 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -58.16 -48.47 80.17 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.221 0.919 . . . . 0.0 109.092 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -79.88 -31.76 40.34 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.914 0.885 . . . . 0.0 110.367 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -119.26 67.11 8.97 Favored Pre-proline 0 N--CA 1.463 0.219 0 C-N-CA 123.482 0.713 . . . . 0.0 112.082 -176.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.1 -47.04 8.94 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 121.877 1.718 . . . . 0.0 110.966 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -41.2 -41.0 2.7 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.756 1.646 . . . . 0.0 115.038 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.77 -27.08 68.65 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.158 0.979 . . . . 0.0 112.639 -178.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.8 -63.0 4.63 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 118.347 -0.835 . . . . 0.0 113.053 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -60.56 -37.03 83.27 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.151 1.901 . . . . 0.0 111.464 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -51.99 -31.43 29.35 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.813 0.733 . . . . 0.0 112.003 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -118.56 19.34 13.31 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.25 0.62 . . . . 0.0 111.658 177.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 47.35 43.59 19.9 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.46 1.029 . . . . 0.0 113.308 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.6 mp -53.49 117.66 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 117.908 0.854 . . . . 0.0 109.181 177.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 29.3 mmm180 -79.8 -45.48 18.7 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.238 1.015 . . . . 0.0 110.807 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -164.17 147.25 12.5 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 107.819 -2.112 . . . . 0.0 107.819 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.6 pt -100.27 152.82 37.94 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 123.913 0.885 . . . . 0.0 110.101 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -68.66 142.18 66.06 Favored 'Cis proline' 0 N--CA 1.456 -0.697 0 CA-C-N 119.519 0.864 . . . . 0.0 110.454 -1.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.37 109.82 15.35 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.3 mt -89.53 93.08 9.36 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.925 0.89 . . . . 0.0 109.781 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.2 mp -91.28 115.84 28.35 Favored 'General case' 0 CA--C 1.522 -0.105 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.3 tp -92.6 96.0 9.94 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -87.51 104.5 16.53 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.026 1.33 . . . . 0.0 110.226 -178.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -93.42 108.48 20.14 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 174.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 49.95 50.48 18.4 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.707 0.803 . . . . 0.0 110.626 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 79.75 -14.19 20.12 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 118.879 -0.956 . . . . 0.0 114.565 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -94.82 121.34 36.31 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 119.591 1.695 . . . . 0.0 110.141 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 98.3 t -64.15 104.86 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 175.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.31 -38.03 36.26 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.862 0.865 . . . . 0.0 109.813 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -155.44 166.17 34.37 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.71 0.804 . . . . 0.0 108.899 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 69.7 m -147.79 117.96 7.31 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.629 0.772 . . . . 0.0 108.986 -178.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -104.74 112.5 25.63 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.2 t -90.32 124.15 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 177.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.65 168.44 36.79 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 123.804 0.716 . . . . 0.0 112.249 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.62 166.23 19.49 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.082 0.553 . . . . 0.0 110.244 179.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -155.63 170.69 21.43 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.695 0.798 . . . . 0.0 109.863 -177.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 80.9 p -86.18 162.81 18.16 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 177.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.01 -39.01 80.57 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 175.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -57.06 -56.36 25.44 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 177.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -54.22 -46.56 72.54 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.942 0.371 . . . . 0.0 110.225 178.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 22.8 tp -59.06 -50.25 74.79 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 121.283 -0.167 . . . . 0.0 110.765 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.9 mmmm -54.53 -48.84 71.5 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.723 -0.611 . . . . 0.0 111.338 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -65.95 -43.5 87.78 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 119.584 -0.846 . . . . 0.0 111.022 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -53.24 -52.24 59.59 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.158 0.583 . . . . 0.0 109.497 177.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.8 mt -58.73 -55.19 38.27 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 122.743 0.417 . . . . 0.0 110.3 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -51.24 -50.53 59.02 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.04 0.382 . . . . 0.0 111.13 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.14 -38.45 70.84 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.397 0.679 . . . . 0.0 111.807 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -78.5 -43.48 26.83 Favored 'General case' 0 C--O 1.228 -0.048 0 O-C-N 122.199 -0.313 . . . . 0.0 111.049 -178.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 69.5 mt -63.58 -45.63 89.53 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.2 0 C-N-CA 122.909 0.483 . . . . 0.0 109.832 177.745 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 16.6 mt . . . . . 0 N--CA 1.455 -0.2 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.2 mm -90.31 114.43 27.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.433 1.093 . . . . 0.0 109.297 177.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -84.54 104.82 14.86 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.3 mt -87.84 163.79 16.23 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.598 1.159 . . . . 0.0 111.679 -178.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 61.3 p -138.48 165.19 27.46 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 126.257 1.823 . . . . 0.0 106.385 174.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -55.13 -44.69 75.28 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.128 0.571 . . . . 0.0 110.104 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -59.82 -43.83 94.32 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.867 0.867 . . . . 0.0 112.383 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.8 p -78.75 -30.47 45.75 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 122.152 -0.342 . . . . 0.0 111.22 -177.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -36.76 -54.77 0.9 Allowed 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 126.407 1.883 . . . . 0.0 114.017 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -54.07 -57.66 10.23 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.265 0.555 . . . . 0.0 111.132 -178.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.4 m -63.79 -48.07 78.37 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.385 0.674 . . . . 0.0 112.059 -177.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.59 -52.26 12.27 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -175.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.7 t -89.63 -56.22 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 123.891 0.876 . . . . 0.0 112.203 -174.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 66.6 mt -66.15 -42.7 88.7 Favored 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 119.489 -0.884 . . . . 0.0 111.168 -175.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -91.98 31.72 1.22 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 118.045 0.384 . . . . 0.0 110.18 175.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.68 143.67 57.14 Favored 'General case' 0 C--N 1.341 0.208 0 O-C-N 121.538 -0.726 . . . . 0.0 112.172 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -108.7 54.33 0.66 Allowed 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.495 1.118 . . . . 0.0 108.769 176.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 150.46 -160.47 28.58 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 123.759 0.695 . . . . 0.0 111.566 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.51 122.45 34.1 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 126.103 1.761 . . . . 0.0 110.356 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.5 mt -122.62 122.39 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 124.732 1.213 . . . . 0.0 109.18 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.418 ' C ' HD13 ' A' ' 24' ' ' LEU . 2.9 tm? -93.47 106.87 18.8 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 175.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 42.6 t -97.46 110.33 25.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -92.15 103.58 16.05 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 176.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -78.92 118.05 20.57 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 104.046 -2.576 . . . . 0.0 104.046 175.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 34.5 p-90 -130.66 168.71 16.69 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 124.545 1.138 . . . . 0.0 111.933 -175.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -141.49 143.05 33.61 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.087 1.355 . . . . 0.0 108.304 176.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -58.3 -49.13 78.24 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.261 1.024 . . . . 0.0 112.171 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.469 ' CH2' HD11 ' A' ' 75' ' ' ILE . 50.9 p-90 -63.96 -28.11 69.6 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.519 0.728 . . . . 0.0 112.358 -178.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.6 t -79.59 79.18 6.09 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 121.556 -0.715 . . . . 0.0 110.643 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -24.17 -62.88 0.05 OUTLIER Glycine 0 CA--C 1.535 1.324 0 C-N-CA 127.074 2.273 . . . . 0.0 114.44 178.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -40.46 -33.71 1.0 Allowed 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 125.035 3.823 . . . . 0.0 115.503 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 99.8 m -53.67 -43.04 68.54 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.589 0.709 . . . . 0.0 109.995 177.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -69.05 -26.89 65.19 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.411 1.084 . . . . 0.0 110.973 178.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -75.58 -43.15 49.78 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 33.7 pt -72.79 -29.85 31.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.607 177.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -37.81 -60.46 0.94 Allowed Pre-proline 0 CA--C 1.545 0.769 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -56.32 -39.35 91.88 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.363 2.042 . . . . 0.0 111.938 177.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 21.0 mt -59.61 -52.69 57.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 177.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 60.8 mt -55.12 -40.58 70.66 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.961 0.504 . . . . 0.0 110.363 177.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -61.26 -47.8 84.38 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.243 0.928 . . . . 0.0 110.023 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -56.8 -52.35 65.4 Favored 'General case' 0 C--N 1.34 0.18 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.0 mm -53.28 -49.08 54.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 123.37 0.668 . . . . 0.0 109.538 177.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.47 -43.4 68.13 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.506 0.722 . . . . 0.0 110.76 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -69.31 -55.66 9.79 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.71 0.29 . . . . 0.0 110.638 177.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -50.53 -47.66 57.43 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.57 1.148 . . . . 0.0 112.322 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -99.81 24.36 8.5 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.264 1.026 . . . . 0.0 110.795 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -55.39 124.18 16.3 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.516 -0.74 . . . . 0.0 110.122 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.34 -14.24 46.57 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 119.454 -0.637 . . . . 0.0 112.907 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -99.74 -42.27 6.92 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.371 1.069 . . . . 0.0 109.3 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.1 tp -133.01 125.35 29.5 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.726 1.211 . . . . 0.0 108.168 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 56.2 m -85.41 101.84 12.94 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 176.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 85.1 t -79.31 133.62 29.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -138.16 154.04 49.18 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.126 0.57 . . . . 0.0 110.417 -177.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -126.44 137.38 53.4 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.6 tt -127.28 115.15 18.59 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -78.66 104.54 9.34 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 pp -68.54 -29.11 42.82 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.19 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -56.86 -45.18 82.62 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 118.437 0.562 . . . . 0.0 109.752 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -81.48 -31.43 32.94 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.929 0.892 . . . . 0.0 110.395 177.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -119.83 68.91 12.51 Favored Pre-proline 0 C--O 1.235 0.326 0 C-N-CA 123.663 0.785 . . . . 0.0 111.557 -177.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -61.39 -52.64 3.03 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.463 2.109 . . . . 0.0 112.586 -177.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -38.28 -45.43 1.79 Allowed Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.538 1.542 . . . . 0.0 114.556 -177.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.45 -33.91 46.45 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.89 0.876 . . . . 0.0 112.964 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.55 -67.67 0.89 Allowed Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 118.136 -0.935 . . . . 0.0 112.184 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -59.42 -37.18 91.38 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.77 1.646 . . . . 0.0 111.218 177.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -51.35 -38.38 52.89 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.291 0.951 . . . . 0.0 111.778 178.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -110.83 22.53 15.25 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.895 0.478 . . . . 0.0 111.574 178.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 42.9 43.06 5.23 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 126.085 1.802 . . . . 0.0 112.976 178.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.3 mp -43.95 131.98 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 123.69 0.796 . . . . 0.0 112.137 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.15 -51.7 9.84 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.472 1.109 . . . . 0.0 109.218 -177.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -179.53 135.16 2.44 Favored Glycine 0 C--N 1.333 0.409 0 N-CA-C 107.228 -2.349 . . . . 0.0 107.228 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.469 HD11 ' CH2' ' A' ' 31' ' ' TRP . 2.0 pp -79.98 145.37 61.18 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 117.251 0.525 . . . . 0.0 111.511 -176.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.81 135.1 32.25 Favored 'Cis proline' 0 N--CA 1.456 -0.69 0 CA-C-N 119.744 0.944 . . . . 0.0 111.512 -0.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.5 m -123.23 117.51 25.48 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.6 mt -95.64 122.25 38.21 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -114.17 119.58 37.57 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 177.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.15 98.24 10.49 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -90.26 107.67 19.29 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.374 1.47 . . . . 0.0 110.786 -178.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -96.66 108.63 21.28 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 173.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 35.8 m120 48.43 51.59 14.99 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.75 0.82 . . . . 0.0 111.339 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.51 -13.97 14.51 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 118.851 -0.972 . . . . 0.0 114.64 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -94.71 122.59 37.48 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 119.563 1.682 . . . . 0.0 109.557 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 98.9 t -65.53 108.95 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 175.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.93 -39.52 34.5 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -163.16 173.9 12.85 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.5 t -149.73 159.39 44.39 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.7 mmtp -138.79 151.9 47.45 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.534 1.934 . . . . 0.0 107.271 177.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.9 t -129.08 135.22 62.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 124.722 1.209 . . . . 0.0 107.906 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.47 -171.12 51.23 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 112.077 -0.409 . . . . 0.0 112.077 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.63 163.31 27.86 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.051 0.541 . . . . 0.0 111.357 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.7 mt -146.25 154.62 41.92 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.303 1.441 . . . . 0.0 107.823 178.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.1 p -84.98 150.83 24.64 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 172.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -48.95 -49.32 40.93 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.063 0.545 . . . . 0.0 110.768 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.35 -59.13 10.55 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 112.108 -0.397 . . . . 0.0 112.108 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -55.32 -45.15 76.34 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 117.527 0.664 . . . . 0.0 111.077 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.2 tp -59.51 -50.21 74.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 177.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -55.33 -46.35 76.36 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.613 0.642 . . . . 0.0 111.222 177.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -57.11 -52.55 64.83 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.111 0.565 . . . . 0.0 109.769 178.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -53.81 -53.79 47.45 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.053 0.941 . . . . 0.0 110.781 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 88.3 mt -59.2 -49.76 76.63 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.256 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -54.71 -50.52 68.11 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 122.807 0.443 . . . . 0.0 110.489 178.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.3 -36.18 68.37 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.518 0.727 . . . . 0.0 111.651 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -78.04 -44.15 27.27 Favored 'General case' 0 N--CA 1.46 0.068 0 O-C-N 122.157 -0.339 . . . . 0.0 110.162 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 40.4 mt -59.51 -45.73 90.89 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.2 0 C-N-CA 123.183 0.593 . . . . 0.0 109.812 177.727 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 13.4 mt . . . . . 0 N--CA 1.452 -0.331 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 25.7 mm -91.36 116.72 33.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 177.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -82.92 113.29 20.42 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.3 mt -96.18 164.0 12.86 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.896 0.878 . . . . 0.0 112.148 -177.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 32.4 p -135.81 166.34 23.52 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 171.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -59.13 -47.8 83.96 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.446 0.566 . . . . 0.0 109.556 178.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -60.9 -44.56 96.97 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.663 0.785 . . . . 0.0 111.535 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 82.5 p -79.21 -24.41 43.15 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -176.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -34.21 -59.68 0.43 Allowed 'General case' 0 C--N 1.339 0.124 0 C-N-CA 126.598 1.959 . . . . 0.0 113.836 -178.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -51.69 -59.23 4.52 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.288 0.635 . . . . 0.0 110.82 -177.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 m -60.09 -43.69 95.36 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 123.248 0.619 . . . . 0.0 111.732 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -72.69 -36.7 67.92 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -174.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.4 t -112.88 -60.3 2.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 123.807 0.843 . . . . 0.0 111.205 -173.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.5 mt -61.37 -35.9 78.74 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-O 119.257 -0.402 . . . . 0.0 111.736 -175.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -92.22 10.47 29.4 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.368 0.531 . . . . 0.0 112.071 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.67 103.39 15.07 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 119.081 0.855 . . . . 0.0 109.965 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -74.31 65.38 1.2 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.524 0.73 . . . . 0.0 110.592 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -166.01 177.84 40.92 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.03 107.19 18.32 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.994 1.318 . . . . 0.0 111.059 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 mt -113.42 114.14 46.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 124.523 1.129 . . . . 0.0 110.78 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.4 tp -84.05 98.94 10.13 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 107.005 -1.479 . . . . 0.0 107.005 174.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.0 t -87.58 118.74 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 123.125 0.57 . . . . 0.0 109.54 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -102.63 108.19 19.37 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.52 1.128 . . . . 0.0 108.951 177.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -81.29 119.18 23.32 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 175.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 37.4 p-90 -135.28 171.97 13.68 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 124.154 0.981 . . . . 0.0 113.196 -174.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.11 132.05 17.15 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 125.736 1.614 . . . . 0.0 108.036 175.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.3 pm0 -49.42 -39.29 32.22 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -178.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 61.4 p-90 -77.26 -19.95 55.83 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 43.8 t -79.53 76.21 6.15 Favored 'General case' 0 N--CA 1.456 -0.162 0 O-C-N 121.409 -0.807 . . . . 0.0 110.411 -176.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -12.58 -69.75 0.01 OUTLIER Glycine 0 CA--C 1.536 1.39 0 C-N-CA 127.752 2.596 . . . . 0.0 115.565 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -41.63 -38.78 4.43 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 124.683 3.588 . . . . 0.0 114.766 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 87.7 m -50.86 -47.37 60.36 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.331 1.052 . . . . 0.0 110.584 177.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt -70.57 -28.67 65.06 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.582 0.753 . . . . 0.0 110.621 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 84.7 mmm -71.45 -43.29 66.96 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 177.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.3 pt -76.82 -27.91 16.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 CA-C-O 118.536 -0.745 . . . . 0.0 112.102 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -38.07 -59.21 1.25 Allowed Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -56.92 -41.15 78.4 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.208 1.939 . . . . 0.0 111.911 177.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 27.6 mt -58.27 -52.04 63.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 68.6 mt -56.68 -44.04 81.07 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.432 0.693 . . . . 0.0 110.494 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -58.43 -48.46 80.63 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.737 0.415 . . . . 0.0 110.281 178.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -60.7 -52.25 65.9 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.9 mm -50.79 -47.14 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.267 1.027 . . . . 0.0 110.402 177.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.48 -37.35 65.15 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.323 0.649 . . . . 0.0 110.848 178.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -75.04 -55.44 5.74 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 176.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -45.56 -51.4 11.99 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 125.37 1.468 . . . . 0.0 112.28 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -101.26 23.11 11.4 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.96 0.504 . . . . 0.0 111.637 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -55.35 130.26 41.76 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 119.455 1.025 . . . . 0.0 110.643 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.75 -19.68 23.56 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 119.466 -0.63 . . . . 0.0 112.625 -178.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -99.4 -41.24 7.5 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.261 1.024 . . . . 0.0 108.829 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.0 tp -133.29 143.88 49.34 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.243 1.817 . . . . 0.0 107.217 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 94.5 m -107.16 140.27 40.28 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 105.314 -2.106 . . . . 0.0 105.314 173.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.1 t -112.82 140.51 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 178.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.38 149.41 46.95 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -178.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -126.26 131.43 51.91 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.261 1.024 . . . . 0.0 108.255 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 tt -122.79 116.24 23.37 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.739 0.816 . . . . 0.0 109.653 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -80.06 107.62 12.99 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 pp -66.83 -30.89 51.13 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -177.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -60.08 -49.46 77.56 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 119.03 0.832 . . . . 0.0 109.295 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -69.89 -36.09 75.16 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.006 177.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -121.25 70.78 22.44 Favored Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 123.907 0.883 . . . . 0.0 112.049 -175.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.94 -52.36 2.25 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.543 2.162 . . . . 0.0 112.616 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -39.03 -44.31 1.98 Allowed Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.438 1.494 . . . . 0.0 114.276 -177.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -53.13 -32.92 50.01 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.813 0.845 . . . . 0.0 112.874 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.78 -68.27 0.76 Allowed Pre-proline 0 CA--C 1.538 0.513 0 CA-C-O 118.072 -0.966 . . . . 0.0 111.662 178.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -59.38 -36.86 93.11 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 121.55 1.5 . . . . 0.0 111.45 177.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -51.58 -40.56 60.01 Favored 'General case' 0 C--N 1.345 0.398 0 CA-C-N 119.558 1.072 . . . . 0.0 111.601 178.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -107.7 21.7 17.06 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 122.704 0.402 . . . . 0.0 111.275 178.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 43.88 43.5 6.82 Favored Glycine 0 C--N 1.338 0.684 0 C-N-CA 125.798 1.666 . . . . 0.0 113.034 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.3 mp -49.02 129.5 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 117.975 0.887 . . . . 0.0 110.839 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.73 -53.86 6.7 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.045 0.938 . . . . 0.0 108.924 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -168.87 150.12 15.15 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 107.062 -2.415 . . . . 0.0 107.062 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 23.8 pt -91.47 149.18 39.02 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-N 117.701 0.75 . . . . 0.0 110.373 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -70.88 137.69 47.89 Favored 'Cis proline' 0 N--CA 1.456 -0.684 0 CA-C-N 119.644 0.908 . . . . 0.0 110.416 -1.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.95 116.69 27.43 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 20.8 mt -98.29 120.83 39.37 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.5 mp -121.08 118.91 30.95 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 177.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.3 tp -93.35 96.11 9.74 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -84.97 101.86 12.71 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.665 1.186 . . . . 0.0 110.002 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -93.45 114.53 26.95 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 173.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 55.89 39.31 30.64 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.8 0.84 . . . . 0.0 110.979 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.51 -0.6 75.26 Favored Glycine 0 CA--C 1.532 1.121 0 CA-C-O 118.758 -1.024 . . . . 0.0 113.738 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -108.24 126.68 53.08 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.346 1.573 . . . . 0.0 109.354 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.7 t -63.57 106.36 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.08 -40.82 30.21 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.026 0.931 . . . . 0.0 109.535 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -156.78 169.46 24.69 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.9 t -151.84 159.63 43.81 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -146.75 131.41 17.87 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.6 t -102.36 125.58 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.26 170.92 38.04 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.21 166.1 16.98 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.685 0.794 . . . . 0.0 112.875 -177.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.0 mt -138.93 153.52 48.24 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 126.228 1.811 . . . . 0.0 107.513 177.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.1 p -84.09 155.54 22.61 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.514 -1.662 . . . . 0.0 106.514 171.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -50.31 -51.36 45.93 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 122.126 -0.359 . . . . 0.0 111.084 -178.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -53.64 -58.45 12.28 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 111.913 -0.475 . . . . 0.0 111.913 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -56.2 -42.34 77.01 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 122.232 -0.569 . . . . 0.0 110.856 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 30.9 tp -62.55 -48.49 79.28 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -54.78 -47.84 73.43 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.558 0.617 . . . . 0.0 110.125 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -57.51 -53.84 53.56 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.541 0.737 . . . . 0.0 110.397 178.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -52.19 -50.16 62.43 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.63 1.172 . . . . 0.0 110.174 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 87.2 mt -60.52 -52.29 65.81 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 119.184 -0.436 . . . . 0.0 110.329 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -52.8 -49.4 65.71 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 118.197 0.453 . . . . 0.0 110.459 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.66 -37.5 70.88 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.546 0.738 . . . . 0.0 111.658 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -78.07 -44.24 26.86 Favored 'General case' 0 N--CA 1.462 0.135 0 O-C-N 122.083 -0.385 . . . . 0.0 110.439 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 53.8 mt -59.05 -48.18 82.53 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.276 0 C-N-CA 123.259 0.623 . . . . 0.0 109.607 177.465 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.4 mt . . . . . 0 N--CA 1.449 -0.511 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.8 mm -87.1 106.9 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -82.2 105.67 13.48 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.9 mt -88.24 166.35 14.4 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.854 1.662 . . . . 0.0 112.161 -177.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 44.0 p -137.33 165.72 25.51 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 172.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -59.05 -46.57 87.89 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 118.271 0.487 . . . . 0.0 110.102 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -60.23 -45.36 93.49 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.498 0.719 . . . . 0.0 111.127 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 81.9 p -79.18 -24.24 43.35 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -176.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -37.71 -53.91 1.23 Allowed 'General case' 0 CA--C 1.527 0.073 0 C-N-CA 126.758 2.023 . . . . 0.0 114.359 -178.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -53.19 -60.35 3.4 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.307 0.575 . . . . 0.0 110.637 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.1 m -60.46 -45.54 93.33 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 123.062 0.545 . . . . 0.0 111.601 -178.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -71.63 -36.18 70.65 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -173.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 41.4 t -112.87 -60.92 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 123.619 0.768 . . . . 0.0 110.762 -174.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.4 mt -62.91 -35.51 80.29 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 119.183 -0.437 . . . . 0.0 111.991 -174.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -96.67 15.78 20.83 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.336 0.516 . . . . 0.0 111.765 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -102.87 104.13 14.35 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 118.877 0.762 . . . . 0.0 110.192 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -74.09 65.17 1.1 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.582 0.753 . . . . 0.0 110.995 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -165.84 177.27 41.05 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.56 103.8 14.73 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 125.204 1.402 . . . . 0.0 110.798 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mt -109.98 118.63 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 C-N-CA 123.937 0.895 . . . . 0.0 110.236 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 19.3 tp -89.38 98.06 11.55 Favored 'General case' 0 C--N 1.338 0.068 0 N-CA-C 106.444 -1.688 . . . . 0.0 106.444 175.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.4 t -85.94 110.31 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 123.387 0.675 . . . . 0.0 109.341 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -97.49 108.92 21.74 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.172 0.589 . . . . 0.0 109.679 177.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -81.63 123.25 28.54 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 175.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 37.9 p-90 -136.62 167.43 21.42 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 124.601 1.161 . . . . 0.0 112.122 -177.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -141.39 137.76 32.51 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.976 1.31 . . . . 0.0 107.834 177.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -52.33 -48.23 65.57 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.871 0.868 . . . . 0.0 112.495 -177.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 57.7 p-90 -68.74 -22.42 64.32 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.063 0.545 . . . . 0.0 112.407 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 42.1 t -79.75 77.37 6.39 Favored 'General case' 0 N--CA 1.456 -0.142 0 O-C-N 121.402 -0.811 . . . . 0.0 111.073 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -23.03 -62.69 0.03 OUTLIER Glycine 0 CA--C 1.536 1.401 0 C-N-CA 127.34 2.4 . . . . 0.0 115.499 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -44.16 -31.52 4.19 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 124.511 3.474 . . . . 0.0 114.955 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 88.1 m -55.97 -43.29 77.43 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.613 -0.68 . . . . 0.0 109.724 176.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -66.18 -33.09 74.97 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.703 0.801 . . . . 0.0 110.147 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 46.7 ttm -67.22 -44.36 79.74 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 19.6 pt -77.5 -27.31 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 118.954 -0.546 . . . . 0.0 112.451 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -39.7 -57.45 2.53 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -58.9 -39.44 81.2 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.074 1.849 . . . . 0.0 111.474 177.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 27.9 mt -58.15 -50.78 77.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 177.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 53.2 mt -57.13 -42.85 81.67 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.032 0.533 . . . . 0.0 110.411 177.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -59.0 -48.24 82.29 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.716 0.689 . . . . 0.0 110.492 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -59.63 -49.3 78.3 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.0 mm -55.66 -44.34 76.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 123.597 0.759 . . . . 0.0 109.657 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.18 -41.78 72.35 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.465 0.575 . . . . 0.0 110.355 178.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -66.6 -59.05 3.96 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.122 0.486 . . . . 0.0 110.075 177.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -51.29 -45.45 62.14 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.176 0.99 . . . . 0.0 112.375 -177.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -97.83 22.9 8.56 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.822 0.849 . . . . 0.0 111.78 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.4 130.14 26.64 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.293 0.951 . . . . 0.0 110.525 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.84 -16.54 4.2 Favored Glycine 0 CA--C 1.534 1.23 0 CA-C-O 119.22 -0.767 . . . . 0.0 113.948 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -99.66 -35.32 9.86 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.703 1.251 . . . . 0.0 110.129 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.8 tp -136.42 136.04 39.21 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.269 1.027 . . . . 0.0 108.783 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 85.6 m -97.03 104.73 16.77 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 175.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 63.2 t -79.86 128.15 38.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -129.88 151.85 50.0 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.59 0.756 . . . . 0.0 109.79 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.4 mttm -128.16 142.32 51.22 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.637 1.175 . . . . 0.0 108.135 177.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.4 tt -132.88 115.42 15.23 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -80.72 108.84 14.71 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.9 pt -72.04 -19.08 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -60.88 -47.83 84.61 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 119.342 0.974 . . . . 0.0 108.663 178.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -80.06 -32.85 39.35 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.169 0.988 . . . . 0.0 109.997 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -121.5 64.48 15.49 Favored Pre-proline 0 CA--C 1.533 0.319 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -175.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -65.69 -42.35 12.37 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 121.687 1.591 . . . . 0.0 110.674 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -45.23 -30.15 2.67 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 125.791 1.662 . . . . 0.0 114.922 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.22 -26.75 62.15 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.415 1.108 . . . . 0.0 112.297 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.494 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . . . -63.03 -58.59 15.58 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 119.307 0.958 . . . . 0.0 111.137 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.494 ' HD3' ' HB3' ' A' ' 67' ' ' ALA . 80.6 Cg_exo -45.68 -45.04 17.05 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 124.031 3.154 . . . . 0.0 113.201 175.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -50.78 -31.15 16.04 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -120.15 19.71 12.18 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.146 0.578 . . . . 0.0 110.781 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 45.92 37.66 7.55 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.527 1.537 . . . . 0.0 112.54 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.4 mt -60.76 140.22 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 117.351 0.575 . . . . 0.0 110.959 -177.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -79.38 -38.39 35.06 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.113 0.965 . . . . 0.0 112.169 -174.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -179.94 -152.27 10.69 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 107.074 -2.41 . . . . 0.0 107.074 -177.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -146.13 157.44 49.82 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-O 117.764 -1.112 . . . . 0.0 108.872 178.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -66.84 135.92 29.14 Favored 'Cis proline' 0 N--CA 1.457 -0.662 0 CA-C-N 120.494 1.212 . . . . 0.0 110.151 -1.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.9 m -132.58 146.76 52.15 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 106.09 -1.818 . . . . 0.0 106.09 175.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.8 mt -127.49 124.86 39.33 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.567 1.547 . . . . 0.0 107.363 -175.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.3 mp -121.3 119.46 32.28 Favored 'General case' 0 CA--C 1.522 -0.106 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 176.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.45 95.62 9.75 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -85.44 101.86 12.97 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.657 1.183 . . . . 0.0 109.207 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -93.78 114.04 26.22 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 174.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 56.16 40.06 30.19 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.676 0.79 . . . . 0.0 111.177 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.68 -1.61 66.56 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 118.734 -1.037 . . . . 0.0 113.521 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -107.01 128.69 54.59 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 119.419 1.609 . . . . 0.0 109.368 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.9 t -66.28 107.87 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.15 -40.94 29.67 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.596 0.758 . . . . 0.0 109.416 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.11 170.75 20.58 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 177.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.9 t -151.32 160.76 43.62 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.7 tptt -148.13 131.1 16.22 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.557 1.543 . . . . 0.0 107.221 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 94.7 t -108.32 133.21 54.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 106.538 -1.652 . . . . 0.0 106.538 177.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.72 173.28 41.17 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.934 -0.867 . . . . 0.0 110.934 -178.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.12 170.37 16.17 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.976 0.511 . . . . 0.0 110.858 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -161.68 164.52 29.12 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.723 1.609 . . . . 0.0 107.614 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 83.8 p -81.26 165.02 21.82 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.067 0.46 . . . . 0.0 110.077 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -57.21 -41.73 79.95 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 174.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.81 -55.24 30.94 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -57.03 -43.73 82.17 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 117.687 0.743 . . . . 0.0 109.94 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 27.6 tp -59.9 -49.69 76.7 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 177.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -53.53 -48.38 69.11 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.011 0.823 . . . . 0.0 111.463 177.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -59.27 -50.57 73.51 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -53.15 -51.82 60.74 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.892 0.877 . . . . 0.0 110.05 178.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.5 mt -57.95 -53.04 62.76 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 122.952 0.501 . . . . 0.0 110.538 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -53.74 -50.45 65.95 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 117.866 0.303 . . . . 0.0 110.637 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.7 -37.56 68.53 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.362 0.665 . . . . 0.0 111.631 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -78.22 -46.16 21.11 Favored 'General case' 0 C--O 1.227 -0.121 0 O-C-N 122.182 -0.324 . . . . 0.0 110.862 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 54.8 mt -60.85 -46.7 89.52 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.265 0.626 . . . . 0.0 109.397 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.282 0 C-N-CA 123.025 0.53 . . . . 0.0 109.75 177.568 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.2 mt . . . . . 0 N--CA 1.446 -0.652 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.9 mm -89.82 116.2 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 123.763 0.825 . . . . 0.0 109.356 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 -82.27 105.49 13.39 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.1 mt -90.76 155.14 19.02 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.369 0.668 . . . . 0.0 112.143 -177.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.0 p -126.06 158.5 35.25 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 172.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -55.13 -45.14 75.56 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.749 0.82 . . . . 0.0 109.815 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -57.7 -44.55 85.97 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.266 1.026 . . . . 0.0 111.309 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.9 p -78.22 -31.96 49.58 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -176.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -36.79 -48.43 0.73 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.605 1.962 . . . . 0.0 114.321 -176.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -55.3 -39.09 69.5 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -178.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.5 m -90.68 -50.66 5.79 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.348 0.659 . . . . 0.0 110.036 -178.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.87 -29.41 67.71 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -174.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.5 t -114.41 -60.69 2.77 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.076 0 CA-C-N 118.856 0.753 . . . . 0.0 110.723 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 72.1 mt -61.52 -30.94 70.96 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -174.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 42.6 mttp -97.95 16.61 20.43 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.045 0.838 . . . . 0.0 110.596 175.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.64 94.49 4.4 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 121.245 -0.909 . . . . 0.0 111.485 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -75.8 68.98 2.42 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 177.43 -170.56 43.11 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 108.386 -1.885 . . . . 0.0 108.386 -177.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -105.27 118.15 35.82 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.707 1.603 . . . . 0.0 110.783 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.1 mt -122.32 116.75 50.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 125.248 1.419 . . . . 0.0 110.036 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 24.5 tp -84.16 97.07 9.16 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 173.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 51.4 t -86.4 115.57 27.72 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.097 0 C-N-CA 123.361 0.664 . . . . 0.0 109.519 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -100.03 104.45 16.04 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.203 1.001 . . . . 0.0 109.212 177.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -79.57 120.79 24.41 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 105.026 -2.213 . . . . 0.0 105.026 174.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 13.7 p-90 -141.18 164.51 30.07 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -173.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -128.76 139.81 52.03 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.209 1.003 . . . . 0.0 109.215 175.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -54.2 -48.63 70.79 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.977 1.311 . . . . 0.0 111.419 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 54.9 p-90 -69.81 -21.59 63.38 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.794 0.838 . . . . 0.0 112.374 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 42.7 t -79.87 76.93 6.55 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 121.323 -0.861 . . . . 0.0 110.351 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -22.97 -60.99 0.03 OUTLIER Glycine 0 CA--C 1.535 1.315 0 C-N-CA 127.691 2.567 . . . . 0.0 115.632 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -44.21 -35.46 7.99 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 123.921 3.081 . . . . 0.0 114.129 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.8 m -59.12 -48.74 80.5 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 121.721 0.772 . . . . 0.0 109.844 177.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -65.5 -36.91 85.25 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 25.0 ttt -60.77 -45.33 94.78 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 119.622 -0.227 . . . . 0.0 110.715 177.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 34.8 pt -76.35 -25.72 16.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-O 118.635 -0.697 . . . . 0.0 112.49 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -37.26 -58.63 1.15 Allowed Pre-proline 0 CA--C 1.545 0.75 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -56.71 -40.32 85.16 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.241 1.96 . . . . 0.0 112.172 177.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 26.4 mt -59.24 -51.08 76.85 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 177.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 76.8 mt -56.59 -43.44 80.08 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.997 0.519 . . . . 0.0 110.804 178.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -60.22 -48.8 80.19 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.657 0.662 . . . . 0.0 110.215 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -59.25 -50.83 72.49 Favored 'General case' 0 C--O 1.226 -0.183 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.3 mm -54.3 -48.78 67.17 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.38 -49.34 64.61 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 122.975 0.51 . . . . 0.0 109.918 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -61.03 -57.85 10.86 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.785 0.326 . . . . 0.0 110.805 178.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -50.38 -45.96 55.68 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.44 1.096 . . . . 0.0 112.438 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -94.69 22.61 6.14 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -177.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -50.52 127.8 18.61 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.641 1.11 . . . . 0.0 110.384 177.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.48 -20.67 13.12 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-O 119.281 -0.733 . . . . 0.0 113.264 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -99.6 -40.49 7.78 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.566 1.183 . . . . 0.0 110.258 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.3 tp -143.18 136.9 28.61 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.853 0.861 . . . . 0.0 108.703 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 92.8 m -98.13 143.94 28.13 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 173.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 68.7 t -118.43 138.53 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 178.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.34 152.93 50.25 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -177.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.1 mttm -125.83 132.3 52.26 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.875 1.27 . . . . 0.0 107.623 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.8 tt -123.1 106.59 10.92 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -78.14 102.43 7.52 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.202 -177.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 pp -55.59 -30.99 27.6 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.231 0 C-N-CA 124.214 1.006 . . . . 0.0 112.072 -179.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -57.0 -45.36 83.05 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.26 0.482 . . . . 0.0 109.825 178.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -81.94 -35.92 28.57 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.077 0.951 . . . . 0.0 110.581 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -123.49 69.9 43.99 Favored Pre-proline 0 CA--C 1.529 0.15 0 C-N-CA 123.861 0.864 . . . . 0.0 111.182 -176.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -64.97 -41.98 15.72 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.033 1.822 . . . . 0.0 110.898 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -41.78 -41.02 3.27 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.456 1.503 . . . . 0.0 114.765 -178.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.92 -23.81 65.13 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.23 1.015 . . . . 0.0 112.975 -177.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.23 -62.14 6.15 Favored Pre-proline 0 CA--C 1.539 0.557 0 O-C-N 121.388 -0.82 . . . . 0.0 113.035 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -60.74 -37.48 78.4 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.087 1.858 . . . . 0.0 111.651 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -50.96 -36.54 39.38 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 118.836 0.744 . . . . 0.0 112.095 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -112.58 16.41 19.75 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.918 0.487 . . . . 0.0 111.44 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 49.01 43.6 31.73 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 125.043 1.306 . . . . 0.0 112.743 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mp -44.38 118.41 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 117.903 0.852 . . . . 0.0 110.585 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -79.56 -48.28 14.09 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.297 1.039 . . . . 0.0 111.153 -174.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -166.69 141.95 7.28 Favored Glycine 0 C--N 1.334 0.468 0 N-CA-C 107.609 -2.196 . . . . 0.0 107.609 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 22.9 pt -92.96 146.19 31.56 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 123.489 0.716 . . . . 0.0 110.665 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.41 133.19 24.14 Favored 'Cis proline' 0 N--CA 1.459 -0.511 0 CA-C-N 119.963 1.023 . . . . 0.0 110.424 -1.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.94 111.91 23.61 Favored 'General case' 0 C--N 1.338 0.078 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 24.3 mt -93.88 117.72 30.48 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.7 mp -118.17 115.67 25.27 Favored 'General case' 0 C--N 1.334 -0.106 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 177.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 tp -89.99 95.55 10.27 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -84.78 108.61 17.55 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.53 1.132 . . . . 0.0 110.231 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -107.36 122.91 47.53 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 174.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 52.39 47.59 24.41 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.379 0.609 . . . . 0.0 109.99 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.37 -3.0 6.4 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-O 118.181 -1.344 . . . . 0.0 115.687 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -111.99 143.43 43.0 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 120.051 1.925 . . . . 0.0 110.66 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.6 t -70.94 110.49 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.94 -41.41 29.44 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -158.53 169.98 23.22 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 177.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.5 t -150.47 161.25 42.88 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -147.66 131.11 16.68 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.0 t -102.2 121.61 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.38 171.7 38.08 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 121.444 0.469 . . . . 0.0 112.094 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.67 164.22 14.85 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.004 0.922 . . . . 0.0 112.761 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.9 mt -135.52 152.35 51.23 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.972 1.709 . . . . 0.0 108.194 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.9 p -81.77 150.04 28.11 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 170.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -49.84 -48.53 50.95 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -176.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.03 -57.63 17.44 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -55.6 -41.71 73.82 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 122.896 0.478 . . . . 0.0 110.686 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.3 tp -61.12 -51.53 68.71 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -55.41 -45.69 76.67 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.627 0.649 . . . . 0.0 110.906 177.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -57.84 -53.47 57.79 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.18 0.592 . . . . 0.0 110.274 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -52.71 -50.82 62.6 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.92 1.288 . . . . 0.0 110.149 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 98.2 mt -60.32 -51.28 70.18 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 122.592 0.357 . . . . 0.0 110.424 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -53.55 -49.36 67.82 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 117.964 0.347 . . . . 0.0 110.398 178.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.5 -35.67 70.51 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.759 0.823 . . . . 0.0 111.74 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -78.45 -43.65 26.69 Favored 'General case' 0 C--O 1.227 -0.12 0 CA-C-N 118.057 0.39 . . . . 0.0 110.582 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 53.7 mt -62.79 -46.6 87.26 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.241 0.616 . . . . 0.0 109.905 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.164 0 C-N-CA 124.743 1.217 . . . . 0.0 111.739 179.133 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 32.1 mt . . . . . 0 N--CA 1.45 -0.459 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.5 mm -87.81 104.61 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 177.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 29.6 m-70 -80.55 95.26 6.45 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 42.9 mt -79.01 162.51 25.89 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.835 1.254 . . . . 0.0 111.922 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 30.0 p -134.16 162.4 32.23 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.38 1.872 . . . . 0.0 106.574 172.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -54.2 -47.63 71.9 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.723 0.809 . . . . 0.0 110.337 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -56.25 -44.83 80.03 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.933 0.893 . . . . 0.0 111.759 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.5 p -78.31 -28.46 47.45 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -176.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -38.99 -49.82 1.73 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.738 1.615 . . . . 0.0 113.879 -176.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -50.81 -63.92 0.98 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.659 0.742 . . . . 0.0 111.0 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.3 m -68.31 -46.89 69.05 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.834 -175.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -75.53 -23.17 56.61 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 -174.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.0 t -118.34 -63.31 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-N 119.432 1.014 . . . . 0.0 110.057 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 72.4 mt -60.21 -37.53 80.58 Favored 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -174.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -93.45 12.28 25.54 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.598 0.636 . . . . 0.0 111.834 177.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.39 102.56 14.66 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 119.098 0.863 . . . . 0.0 110.885 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -76.09 65.7 2.14 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.377 0.671 . . . . 0.0 109.9 177.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -173.84 -175.03 41.2 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.87 124.42 35.97 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.269 1.427 . . . . 0.0 111.052 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.3 mt -133.32 124.07 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 124.811 1.244 . . . . 0.0 109.917 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -93.73 108.57 20.3 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 105.534 -2.025 . . . . 0.0 105.534 174.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.6 t -99.6 107.34 20.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -178.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -91.62 102.86 15.5 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -78.49 121.37 24.48 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 103.758 -2.682 . . . . 0.0 103.758 174.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 25.8 p-90 -137.0 168.54 19.4 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 123.61 0.764 . . . . 0.0 112.631 -174.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -141.48 140.45 33.54 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.813 1.245 . . . . 0.0 108.099 176.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -55.81 -50.76 69.63 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.483 0.713 . . . . 0.0 112.688 -176.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 43.3 p-90 -59.92 -29.68 68.54 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.77 0.828 . . . . 0.0 112.828 -178.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 48.8 t -79.6 80.45 5.98 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 121.432 -0.793 . . . . 0.0 110.507 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -23.06 -61.2 0.03 OUTLIER Glycine 0 CA--C 1.537 1.459 0 C-N-CA 127.422 2.439 . . . . 0.0 115.243 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -41.98 -37.77 4.57 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 124.309 3.34 . . . . 0.0 114.335 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 86.4 m -54.9 -44.23 73.97 Favored 'General case' 0 CA--C 1.527 0.058 0 C-N-CA 123.661 0.785 . . . . 0.0 110.597 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -69.92 -45.21 68.03 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 87.5 mmm -53.69 -42.76 68.31 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 30.7 pt -76.65 -12.06 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.22 -58.35 10.86 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 120.162 1.346 . . . . 0.0 112.79 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -55.43 -41.37 78.72 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.141 1.894 . . . . 0.0 111.377 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 19.2 mt -57.56 -53.65 41.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.3 mt -56.29 -39.19 72.29 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.312 0.645 . . . . 0.0 110.682 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -62.0 -48.84 78.5 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.013 0.824 . . . . 0.0 110.396 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -57.17 -51.73 68.13 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.2 mm -53.05 -48.06 53.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.675 1.19 . . . . 0.0 109.399 177.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.34 -45.76 76.42 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 122.927 0.491 . . . . 0.0 110.645 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -63.2 -53.17 57.4 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 177.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -50.29 -50.15 51.29 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.977 0.911 . . . . 0.0 111.687 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -98.86 30.5 3.33 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.464 0.706 . . . . 0.0 111.347 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -60.35 120.77 10.5 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.491 -0.755 . . . . 0.0 110.005 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.69 3.54 89.06 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 119.615 -0.547 . . . . 0.0 112.487 -177.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.1 mttm -114.03 -41.84 3.47 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.134 1.373 . . . . 0.0 109.281 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.0 tp -133.4 131.54 40.11 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.245 1.018 . . . . 0.0 108.498 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.5 m -86.87 100.35 12.49 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.1 t -79.3 125.07 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -131.74 151.72 51.45 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.58 0.752 . . . . 0.0 110.663 -176.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.7 mttm -127.22 143.76 51.18 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 176.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 tt -133.44 111.34 10.66 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -79.28 110.12 14.26 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.2 pt -71.28 -22.81 22.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 118.94 -0.552 . . . . 0.0 112.276 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -58.79 -46.58 87.22 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 119.352 0.978 . . . . 0.0 108.824 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -80.39 -25.18 39.23 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.282 1.033 . . . . 0.0 110.949 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -127.37 66.95 70.51 Favored Pre-proline 0 CA--C 1.534 0.341 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.48 -55.85 2.99 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.531 2.154 . . . . 0.0 113.265 -178.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -37.8 -46.61 1.69 Allowed Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.872 1.701 . . . . 0.0 114.544 -176.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -53.12 -34.56 57.26 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.489 0.715 . . . . 0.0 112.288 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.72 -68.6 0.57 Allowed Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 118.255 -0.878 . . . . 0.0 112.374 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -58.96 -38.24 89.14 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 CA-C-N 121.085 1.423 . . . . 0.0 110.94 177.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -52.26 -39.92 61.03 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 118.926 0.784 . . . . 0.0 111.732 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -104.59 19.46 20.33 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.106 0.412 . . . . 0.0 111.907 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.7 39.04 54.05 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 124.021 0.82 . . . . 0.0 113.216 177.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.5 mp -56.94 122.33 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -79.81 -47.24 15.51 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.721 0.808 . . . . 0.0 109.364 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -168.92 146.09 10.01 Favored Glycine 0 CA--C 1.521 0.424 0 N-CA-C 106.896 -2.481 . . . . 0.0 106.896 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.411 ' O ' HD12 ' A' ' 75' ' ' ILE . 1.6 pp -92.02 150.32 40.32 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 117.382 0.591 . . . . 0.0 110.378 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -70.93 136.5 41.61 Favored 'Cis proline' 0 N--CA 1.457 -0.649 0 CA-C-N 120.107 1.074 . . . . 0.0 111.31 0.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -120.68 113.47 20.26 Favored 'General case' 0 C--O 1.23 0.042 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 178.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.4 mt -95.9 101.17 12.82 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 -178.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -92.79 111.98 23.78 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 176.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 tp -92.77 105.59 17.7 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -93.81 143.66 26.13 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.24 1.416 . . . . 0.0 109.835 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -138.01 121.96 17.78 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 172.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 46.1 m-20 50.18 48.55 21.95 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.858 0.863 . . . . 0.0 110.803 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.57 -5.51 10.83 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 118.527 -1.152 . . . . 0.0 115.389 178.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -106.26 138.47 42.38 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 119.932 1.866 . . . . 0.0 110.163 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 94.2 t -66.55 109.17 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 176.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.75 -43.63 22.22 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 124.526 1.131 . . . . 0.0 109.604 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -150.55 169.32 21.81 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 97.2 m -150.98 139.34 20.36 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -177.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -131.47 137.02 48.4 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.0 t -110.94 122.2 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 177.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.01 171.76 37.09 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 123.38 0.514 . . . . 0.0 112.068 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.83 170.71 10.53 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.105 0.962 . . . . 0.0 112.441 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.1 mt -140.57 162.39 35.48 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 126.227 1.811 . . . . 0.0 108.321 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 99.9 p -83.67 162.11 20.86 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 169.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -57.06 -44.11 82.72 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 177.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -58.05 -57.59 19.01 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 123.37 0.51 . . . . 0.0 111.964 178.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -60.3 -38.64 84.26 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 121.842 -0.799 . . . . 0.0 110.739 -178.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.0 tp -64.17 -49.39 72.26 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 119.153 -0.451 . . . . 0.0 110.013 178.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 10.2 mmmm -52.65 -49.84 64.4 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.667 0.667 . . . . 0.0 109.47 176.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -56.13 -54.82 40.49 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.249 0.62 . . . . 0.0 110.73 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -52.59 -53.37 47.59 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.957 1.303 . . . . 0.0 111.05 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.3 mt -61.96 -52.14 65.25 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -51.92 -50.88 60.23 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.336 0.654 . . . . 0.0 110.842 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.43 -36.75 66.84 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.522 0.729 . . . . 0.0 111.664 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -78.52 -45.21 22.47 Favored 'General case' 0 N--CA 1.458 -0.057 0 O-C-N 122.263 -0.273 . . . . 0.0 110.516 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 53.2 mt -58.3 -47.45 83.63 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.306 0 C-N-CA 123.232 0.613 . . . . 0.0 109.665 177.423 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 16.0 mt . . . . . 0 C--O 1.232 0.135 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.5 mm -87.89 108.1 18.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -79.78 114.77 18.95 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 64.9 mt -96.35 167.03 11.42 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 124.38 1.072 . . . . 0.0 112.397 -176.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 33.9 p -136.86 164.58 27.97 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 171.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -59.27 -45.97 89.78 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.463 0.574 . . . . 0.0 109.923 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -59.85 -45.64 91.79 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.708 0.803 . . . . 0.0 111.263 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.8 p -78.86 -24.44 44.31 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -176.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -38.25 -49.93 1.41 Allowed 'General case' 0 CA--C 1.527 0.075 0 C-N-CA 126.576 1.95 . . . . 0.0 113.613 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -54.41 -61.18 2.47 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 121.483 0.659 . . . . 0.0 110.888 -178.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.7 m -63.27 -42.06 99.1 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.444 -177.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -71.16 -43.58 67.22 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -174.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.4 t -107.54 -59.12 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 123.861 0.864 . . . . 0.0 110.893 -174.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 64.4 mt -62.41 -35.62 79.78 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -173.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -90.43 7.05 40.71 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.555 0.616 . . . . 0.0 112.253 178.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.86 102.1 14.21 Favored 'General case' 0 C--N 1.341 0.239 0 CA-C-N 119.185 0.902 . . . . 0.0 111.946 -178.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -75.58 73.48 2.59 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 175.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -172.72 178.57 44.71 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.76 115.19 26.11 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.0 1.32 . . . . 0.0 109.943 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.4 mt -122.6 120.18 60.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 124.528 1.131 . . . . 0.0 109.833 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.4 tp -91.08 100.27 13.15 Favored 'General case' 0 CA--C 1.521 -0.159 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 175.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 63.4 t -90.88 114.25 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -101.14 110.19 22.18 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.953 0.901 . . . . 0.0 109.186 177.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -79.79 124.8 28.94 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 175.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 28.6 p-90 -140.17 172.48 12.69 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.731 0.812 . . . . 0.0 112.864 -175.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.4 132.28 17.08 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.549 1.539 . . . . 0.0 108.024 175.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -49.23 -39.52 30.39 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 61.3 p-90 -76.86 -19.98 56.85 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 40.4 t -79.58 77.0 6.2 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 121.372 -0.83 . . . . 0.0 111.511 -175.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -9.72 -71.87 0.01 OUTLIER Glycine 0 CA--C 1.538 1.509 0 C-N-CA 127.729 2.585 . . . . 0.0 116.349 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -47.29 -33.59 16.68 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 124.089 3.193 . . . . 0.0 114.61 -178.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 88.2 m -52.94 -47.98 67.65 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.635 0.774 . . . . 0.0 109.955 176.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -68.89 -29.19 67.42 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.385 0.674 . . . . 0.0 110.611 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 24.2 mmt -70.28 -44.91 67.42 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 34.3 pt -74.17 -30.53 27.26 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 CA-C-O 118.371 -0.823 . . . . 0.0 112.231 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -36.84 -60.1 0.82 Allowed Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -57.79 -40.39 79.37 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.0 1.8 . . . . 0.0 111.414 178.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 15.7 mt -58.68 -49.67 81.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 177.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 76.9 mt -55.63 -44.17 76.85 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.213 0.605 . . . . 0.0 110.071 177.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -60.7 -46.89 88.67 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.76 -0.587 . . . . 0.0 110.746 177.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -57.25 -51.51 69.08 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 23.4 mm -53.03 -49.28 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 124.057 0.943 . . . . 0.0 109.478 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.56 -47.6 73.05 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 117.967 0.349 . . . . 0.0 110.547 178.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -61.17 -44.47 97.26 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 122.284 0.234 . . . . 0.0 111.283 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -65.54 -46.27 80.21 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.364 1.065 . . . . 0.0 112.723 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -100.22 38.68 1.45 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.516 1.127 . . . . 0.0 110.807 -178.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.402 ' NE2' ' H ' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -53.1 122.13 8.82 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.644 -0.66 . . . . 0.0 111.905 -179.265 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.62 -5.95 6.76 Favored Glycine 0 CA--C 1.535 1.29 0 CA-C-O 119.487 -0.618 . . . . 0.0 113.7 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 51.7 mttt -99.68 -36.27 9.54 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.964 1.306 . . . . 0.0 108.491 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.3 tp -136.28 122.48 20.4 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 35.3 m -86.58 103.52 15.15 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 177.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 91.8 t -79.67 128.02 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 107.057 -1.461 . . . . 0.0 107.057 178.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -132.53 149.53 52.31 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.373 0.669 . . . . 0.0 110.05 -177.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -129.36 132.49 47.08 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 123.794 0.838 . . . . 0.0 108.89 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.5 tt -120.63 116.13 24.73 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.766 0.826 . . . . 0.0 110.059 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -78.22 108.03 11.24 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 pp -67.33 -29.8 46.99 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 C-N-CA 123.335 0.654 . . . . 0.0 112.701 -177.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -60.49 -47.71 84.93 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 118.934 0.788 . . . . 0.0 109.491 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -74.88 -32.92 61.99 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.147 176.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -121.23 69.95 21.03 Favored Pre-proline 0 CA--C 1.531 0.228 0 C-N-CA 123.651 0.78 . . . . 0.0 112.01 -176.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -64.8 -47.45 5.13 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.977 1.785 . . . . 0.0 111.431 -178.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -42.02 -40.72 3.39 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.358 1.456 . . . . 0.0 114.659 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.43 -29.31 69.86 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.62 -0.929 . . . . 0.0 112.479 -178.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.84 -65.23 1.79 Allowed Pre-proline 0 CA--C 1.537 0.456 0 CA-C-O 118.395 -0.812 . . . . 0.0 112.912 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -59.78 -38.44 80.29 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 121.718 1.612 . . . . 0.0 111.036 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -51.79 -36.38 47.41 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-N 118.683 0.674 . . . . 0.0 112.029 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -111.65 20.59 16.97 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.683 0.393 . . . . 0.0 111.883 178.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 51.09 40.33 43.6 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.043 0.83 . . . . 0.0 113.481 177.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mp -53.94 127.87 12.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 117.883 0.841 . . . . 0.0 109.069 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -92.91 -50.64 5.45 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.75 1.22 . . . . 0.0 110.133 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.02 146.56 13.2 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 107.406 -2.278 . . . . 0.0 107.406 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.7 pt -95.61 148.64 34.92 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 123.715 0.806 . . . . 0.0 110.131 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.96 140.89 60.75 Favored 'Cis proline' 0 N--CA 1.456 -0.71 0 CA-C-N 119.788 0.96 . . . . 0.0 110.72 -1.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.61 118.69 30.8 Favored 'General case' 0 CA--C 1.523 -0.083 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.8 mt -96.82 126.6 42.09 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -120.89 111.57 17.7 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 104.066 -2.568 . . . . 0.0 104.066 175.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.5 tp -93.29 99.54 12.06 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -84.7 142.02 30.16 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.569 1.148 . . . . 0.0 109.676 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -138.13 97.86 3.49 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 175.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.2 t30 55.42 71.52 0.54 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.3 0.64 . . . . 0.0 110.3 -176.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 70.62 -37.68 0.47 Allowed Glycine 0 CA--C 1.531 1.093 0 N-CA-C 116.146 1.218 . . . . 0.0 116.146 176.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -86.6 146.03 26.5 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 119.147 1.474 . . . . 0.0 110.529 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 96.6 t -79.04 115.19 20.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 175.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.3 -42.11 26.5 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.346 0.659 . . . . 0.0 109.448 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -155.34 169.86 23.24 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 177.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.8 t -147.88 168.35 22.46 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.68 146.22 23.15 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.827 1.251 . . . . 0.0 108.327 -177.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.9 t -124.01 124.8 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.26 177.11 37.54 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 123.324 0.487 . . . . 0.0 112.052 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.71 173.58 8.85 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.416 0.686 . . . . 0.0 111.885 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 mt -147.65 160.71 42.37 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 125.679 1.592 . . . . 0.0 108.708 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 44.6 p -90.4 154.15 19.89 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 170.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -51.76 -45.52 63.74 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 122.213 -0.305 . . . . 0.0 110.921 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -57.6 -57.24 20.86 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 111.74 -0.544 . . . . 0.0 111.74 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -58.01 -41.09 82.35 Favored 'General case' 0 N--CA 1.456 -0.168 0 O-C-N 121.996 -0.708 . . . . 0.0 110.739 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 29.3 tp -62.19 -49.21 76.71 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -52.93 -48.66 67.12 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.898 0.479 . . . . 0.0 109.895 176.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -56.98 -53.98 51.84 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.946 0.498 . . . . 0.0 110.617 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -52.25 -51.25 59.49 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.002 0.921 . . . . 0.0 110.437 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 89.7 mt -61.28 -51.49 68.69 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.631 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -52.78 -48.98 66.47 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.941 0.496 . . . . 0.0 110.406 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.05 -36.12 70.13 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.292 0.637 . . . . 0.0 111.832 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -78.89 -44.64 22.34 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 117.783 0.265 . . . . 0.0 111.013 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 56.9 mt -64.7 -43.08 94.66 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.434 0.694 . . . . 0.0 110.211 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.213 0 C-N-CA 124.84 1.256 . . . . 0.0 111.807 179.066 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.8 mt . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 120.678 0.275 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.9 mm -87.54 106.7 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 175.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 37.9 m-70 -81.26 95.54 6.99 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 177.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 44.8 mt -79.9 163.44 24.33 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.598 1.159 . . . . 0.0 113.067 -175.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.6 p -139.06 164.73 29.01 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 126.261 1.824 . . . . 0.0 106.459 174.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -57.46 -46.25 83.85 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.673 -0.642 . . . . 0.0 110.14 -178.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -61.87 -38.9 90.02 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.8 p -78.13 -35.52 48.99 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 121.992 -0.443 . . . . 0.0 110.223 -177.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -33.74 -51.17 0.38 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 126.912 2.085 . . . . 0.0 114.019 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -54.92 -48.09 73.54 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.07 0.462 . . . . 0.0 111.636 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.1 m -76.33 -52.09 10.64 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 121.996 -0.44 . . . . 0.0 110.769 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.52 -47.31 64.18 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -173.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.3 t -94.53 -50.09 12.12 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.11 0 C-N-CA 123.33 0.652 . . . . 0.0 111.915 -175.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 70.4 mt -73.67 -48.69 30.38 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.988 -177.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -91.36 42.33 1.1 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.134 0.879 . . . . 0.0 109.252 175.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.03 177.08 2.33 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 125.395 1.478 . . . . 0.0 113.686 -178.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -134.88 101.93 5.07 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.993 2.117 . . . . 0.0 106.594 175.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.09 -162.03 45.98 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-O 121.588 0.549 . . . . 0.0 113.87 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.48 117.9 20.11 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.47 1.508 . . . . 0.0 112.536 -177.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.1 mt -116.53 120.77 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 124.552 1.141 . . . . 0.0 109.049 176.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.409 ' C ' HD13 ' A' ' 24' ' ' LEU . 2.9 tm? -91.97 108.08 19.67 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 176.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.9 t -98.53 106.59 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 123.86 0.864 . . . . 0.0 109.954 -177.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -91.35 105.11 17.54 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 176.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -79.59 125.24 29.35 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 174.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 44.7 p-90 -142.39 169.52 17.42 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.828 0.851 . . . . 0.0 112.729 -176.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -146.93 137.97 23.96 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.954 1.302 . . . . 0.0 107.586 174.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -50.55 -48.54 57.33 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.586 0.754 . . . . 0.0 112.759 -176.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 58.5 p-90 -62.7 -26.05 68.47 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 50.8 t -79.8 79.44 6.31 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 121.316 -0.865 . . . . 0.0 109.233 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -25.96 -60.39 0.07 OUTLIER Glycine 0 CA--C 1.536 1.359 0 C-N-CA 127.139 2.304 . . . . 0.0 114.801 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -43.08 -35.06 4.46 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 124.315 3.343 . . . . 0.0 114.586 178.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 78.3 m -57.09 -47.24 81.52 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 121.588 -0.695 . . . . 0.0 109.846 176.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -65.87 -31.18 71.98 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.696 0.799 . . . . 0.0 109.776 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 85.1 mtp -68.5 -45.04 73.36 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 177.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.0 pt -75.39 -27.52 19.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 118.521 0.6 . . . . 0.0 112.33 178.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -37.94 -58.66 1.34 Allowed Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -58.27 -39.01 88.34 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.41 2.073 . . . . 0.0 111.514 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.5 mt -59.51 -51.08 76.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 177.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 44.3 mt -56.44 -42.55 78.3 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.621 0.368 . . . . 0.0 110.505 177.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -59.51 -48.7 80.64 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.674 0.67 . . . . 0.0 110.259 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -58.42 -52.62 64.86 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.677 -0.639 . . . . 0.0 109.606 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 11.2 mm -54.39 -46.29 69.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 124.735 1.214 . . . . 0.0 110.179 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.23 -44.73 68.31 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.361 0.664 . . . . 0.0 110.179 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -66.34 -56.78 9.48 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 176.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -45.71 -50.76 13.39 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.937 0.895 . . . . 0.0 112.423 -178.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -95.44 26.2 4.01 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.663 0.785 . . . . 0.0 112.463 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.58 130.15 23.62 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.264 0.938 . . . . 0.0 109.933 176.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.6 -16.48 5.04 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-O 119.147 -0.807 . . . . 0.0 114.181 -178.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -99.6 -39.08 8.48 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 118.87 1.335 . . . . 0.0 110.214 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 26.0 tp -137.78 126.55 23.87 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.8 m -86.94 102.39 14.32 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 176.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 96.3 t -79.02 137.51 21.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.42 147.41 45.39 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.023 0.929 . . . . 0.0 109.445 -177.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -125.26 135.3 52.39 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.6 tt -127.78 112.57 14.92 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.606 0.763 . . . . 0.0 109.692 -178.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -78.98 104.52 9.67 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 122.902 0.481 . . . . 0.0 109.824 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.2 pt -69.03 -24.25 28.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 118.866 -0.588 . . . . 0.0 112.559 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -53.31 -53.82 45.4 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.061 0.846 . . . . 0.0 109.502 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -78.2 -28.71 48.12 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.961 0.904 . . . . 0.0 110.763 179.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -118.11 67.0 6.26 Favored Pre-proline 0 C--O 1.235 0.315 0 C-N-CA 124.1 0.96 . . . . 0.0 111.495 -176.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -61.14 -53.65 2.36 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.465 2.11 . . . . 0.0 112.383 -176.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -37.97 -47.12 1.85 Allowed Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.631 1.586 . . . . 0.0 114.267 -177.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -51.71 -33.79 35.9 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.23 1.012 . . . . 0.0 112.962 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.27 -68.25 0.79 Allowed Pre-proline 0 CA--C 1.537 0.478 0 CA-C-O 117.987 -1.006 . . . . 0.0 112.017 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -59.32 -35.95 95.65 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.005 1.803 . . . . 0.0 111.358 177.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -51.44 -37.64 49.65 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.526 1.057 . . . . 0.0 111.661 177.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -111.9 22.31 15.04 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.098 0.559 . . . . 0.0 111.187 177.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 42.69 43.24 5.06 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 125.465 1.507 . . . . 0.0 113.04 178.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.5 mp -51.07 118.17 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 118.094 0.947 . . . . 0.0 109.315 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -79.14 -44.38 22.12 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.371 0.669 . . . . 0.0 110.415 -177.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -164.91 141.91 7.39 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 108.451 -1.86 . . . . 0.0 108.451 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.7 pt -95.79 148.88 35.26 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 124.017 0.927 . . . . 0.0 109.997 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.35 141.05 62.81 Favored 'Cis proline' 0 N--CA 1.456 -0.697 0 CA-C-N 119.846 0.981 . . . . 0.0 111.177 -0.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.02 114.81 21.46 Favored 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.7 mt -98.0 102.08 13.73 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.7 mp -96.58 118.59 33.39 Favored 'General case' 0 CA--C 1.523 -0.072 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 177.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 tp -92.19 98.67 11.67 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -89.27 103.33 15.96 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 125.225 1.41 . . . . 0.0 110.413 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -83.61 102.19 12.02 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 172.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 45.76 41.43 7.49 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.069 1.748 . . . . 0.0 113.934 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 106.2 -21.28 33.7 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-O 118.784 -1.009 . . . . 0.0 113.358 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -100.32 128.55 46.36 Favored 'General case' 0 C--O 1.227 -0.085 0 CA-C-N 119.254 1.527 . . . . 0.0 110.948 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 89.7 t -68.04 107.29 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.57 -41.61 26.81 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.884 0.874 . . . . 0.0 109.987 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -155.13 167.49 30.2 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 93.7 m -149.72 140.7 22.89 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -116.5 138.37 51.44 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 177.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 26.3 t -120.96 123.32 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 178.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.92 175.09 45.47 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 111.579 -0.609 . . . . 0.0 111.579 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.38 172.77 8.83 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.22 0.608 . . . . 0.0 110.954 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -162.8 167.99 22.07 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.625 1.17 . . . . 0.0 108.75 -177.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 88.2 p -81.67 160.1 23.8 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -57.48 -40.35 78.41 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 175.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.95 -53.06 42.38 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 176.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -60.46 -39.65 88.34 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 117.616 0.708 . . . . 0.0 111.148 178.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 23.3 tp -62.19 -50.93 69.85 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.586 0.63 . . . . 0.0 109.874 178.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -53.41 -49.52 67.12 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.32 0.648 . . . . 0.0 109.567 176.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -55.56 -55.86 27.03 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.063 0.945 . . . . 0.0 110.424 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -52.93 -54.38 35.64 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.489 1.516 . . . . 0.0 110.828 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.7 mt -61.32 -51.93 66.8 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.44 0.296 . . . . 0.0 110.658 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -53.95 -50.38 66.63 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.028 0.531 . . . . 0.0 110.631 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.02 -36.53 65.58 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.429 0.692 . . . . 0.0 111.623 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -78.64 -48.32 15.31 Favored 'General case' 0 C--O 1.227 -0.115 0 O-C-N 122.238 -0.289 . . . . 0.0 110.406 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 58.0 mt -59.18 -42.78 91.66 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.936 0.494 . . . . 0.0 110.294 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.282 0 C-N-CA 123.097 0.559 . . . . 0.0 109.777 177.889 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 36.9 mt . . . . . 0 N--CA 1.446 -0.648 0 CA-C-O 120.969 0.414 . . . . 0.0 110.674 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.2 mm -89.26 120.28 37.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 123.978 0.911 . . . . 0.0 109.492 178.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -85.71 111.39 20.07 Favored 'General case' 0 CA--C 1.528 0.099 0 O-C-N 121.515 -0.741 . . . . 0.0 109.349 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 65.8 mt -95.5 160.87 14.31 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 124.458 1.103 . . . . 0.0 111.203 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 48.9 p -134.68 163.48 29.67 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 174.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -58.48 -47.18 84.91 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.809 0.732 . . . . 0.0 109.601 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -63.69 -41.2 98.17 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.664 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.1 p -78.42 -24.82 45.98 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.38 0.536 . . . . 0.0 111.368 -177.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -41.6 -43.69 2.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 126.602 1.961 . . . . 0.0 113.068 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -52.39 -65.14 0.61 Allowed 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 121.697 0.761 . . . . 0.0 110.251 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.9 m -67.17 -42.53 84.13 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.583 -176.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -70.81 -39.3 73.14 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -174.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.0 t -112.84 -58.48 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 123.446 0.698 . . . . 0.0 110.345 -175.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 67.0 mt -61.43 -35.59 78.0 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -174.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -97.4 16.18 20.88 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.451 0.569 . . . . 0.0 111.73 178.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -102.15 102.43 12.88 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 119.042 0.837 . . . . 0.0 111.724 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -77.25 59.21 1.75 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.949 1.3 . . . . 0.0 110.305 176.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -159.05 168.08 35.01 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.5 114.09 20.68 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.257 0.623 . . . . 0.0 110.817 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.5 mt -120.25 122.44 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 124.537 1.135 . . . . 0.0 109.986 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.4 ' C ' HD13 ' A' ' 24' ' ' LEU . 3.0 tm? -91.99 107.55 19.29 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 175.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 67.2 t -96.19 108.09 20.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 123.992 0.917 . . . . 0.0 109.241 -178.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -97.18 105.32 17.44 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.592 1.157 . . . . 0.0 109.514 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -79.16 126.39 30.68 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 177.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 26.4 p-90 -141.47 173.86 11.1 Favored 'General case' 0 C--N 1.343 0.289 0 C-N-CA 124.304 1.042 . . . . 0.0 112.83 -176.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -149.97 156.89 42.52 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.985 1.714 . . . . 0.0 108.221 175.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.1 mp0 -63.3 -48.79 76.59 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.226 0.536 . . . . 0.0 110.688 -178.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 54.2 p-90 -65.73 -20.8 66.41 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.064 0.946 . . . . 0.0 112.562 -178.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 47.6 t -79.36 75.68 5.95 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 121.481 -0.762 . . . . 0.0 110.08 -178.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -25.74 -63.12 0.06 OUTLIER Glycine 0 CA--C 1.536 1.357 0 C-N-CA 126.509 2.004 . . . . 0.0 114.692 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -43.44 -35.83 6.17 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 124.559 3.506 . . . . 0.0 114.881 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 87.5 m -52.59 -40.71 62.94 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.172 0.589 . . . . 0.0 110.188 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -67.28 -30.83 70.8 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.633 0.773 . . . . 0.0 111.311 179.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -74.36 -46.12 42.6 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 28.0 pt -73.7 -29.26 26.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 118.66 -0.686 . . . . 0.0 112.255 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -39.16 -60.88 1.08 Allowed Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -56.59 -40.84 81.69 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.372 2.048 . . . . 0.0 111.673 178.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.8 mt -57.44 -52.35 58.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 177.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 47.6 mt -57.44 -40.52 78.59 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.281 0.632 . . . . 0.0 110.973 178.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -61.86 -47.86 83.12 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.1 0.864 . . . . 0.0 110.262 177.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -57.87 -52.59 64.87 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.6 mm -53.15 -47.5 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 124.035 0.934 . . . . 0.0 109.591 177.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.94 -49.95 62.14 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 122.842 0.457 . . . . 0.0 110.103 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -62.23 -54.29 42.91 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.723 0.296 . . . . 0.0 110.932 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -53.24 -46.74 69.29 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.767 0.827 . . . . 0.0 112.308 -178.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -94.48 26.99 3.15 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.967 0.907 . . . . 0.0 112.37 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -54.45 128.65 32.76 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.169 0.895 . . . . 0.0 109.724 176.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.1 -14.75 25.8 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-O 119.25 -0.75 . . . . 0.0 112.993 -178.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -99.82 -44.06 6.21 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 118.507 1.153 . . . . 0.0 109.881 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 24.6 tp -139.42 132.38 29.41 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.415 0.686 . . . . 0.0 110.431 -176.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 62.5 m -91.69 103.28 15.87 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 175.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 63.1 t -79.86 130.81 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.66 151.81 50.58 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.28 0.632 . . . . 0.0 110.844 -176.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -126.8 139.94 52.74 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.908 1.283 . . . . 0.0 108.948 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.5 tt -127.8 115.86 19.3 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.608 0.763 . . . . 0.0 109.734 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -79.25 107.15 11.8 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.9 pt -69.0 -26.96 33.59 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.29 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -177.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -59.75 -47.04 87.28 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 119.067 0.849 . . . . 0.0 109.744 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -77.18 -30.58 54.94 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.148 0.579 . . . . 0.0 110.241 176.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -121.79 67.42 22.21 Favored Pre-proline 0 C--O 1.234 0.25 0 C-N-CA 123.933 0.893 . . . . 0.0 111.735 -176.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -62.22 -53.43 1.97 Allowed 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 122.534 2.156 . . . . 0.0 112.777 -176.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -38.86 -47.2 2.38 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.189 1.376 . . . . 0.0 113.989 -177.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -50.52 -34.46 25.38 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.427 1.091 . . . . 0.0 112.897 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.71 -68.99 0.57 Allowed Pre-proline 0 CA--C 1.538 0.518 0 CA-C-O 118.241 -0.885 . . . . 0.0 112.168 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -59.19 -37.2 93.14 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.64 1.56 . . . . 0.0 111.149 177.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -50.83 -40.61 56.18 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-N 119.281 0.946 . . . . 0.0 111.67 178.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -106.76 19.83 19.9 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.586 0.354 . . . . 0.0 111.893 178.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 51.0 40.31 42.9 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.097 0.856 . . . . 0.0 113.043 177.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mp -53.24 120.7 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 177.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 55.5 mmt-85 -79.14 -46.89 17.07 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.769 0.828 . . . . 0.0 109.417 -178.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -170.72 145.53 9.07 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 106.601 -2.6 . . . . 0.0 106.601 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.5 pt -90.83 150.95 43.03 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-O 118.907 -0.568 . . . . 0.0 109.842 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -70.08 138.11 48.21 Favored 'Cis proline' 0 N--CA 1.458 -0.609 0 CA-C-N 119.485 0.852 . . . . 0.0 111.285 -0.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -123.62 120.27 32.29 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 178.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.3 mt -103.25 117.39 34.4 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -110.2 116.83 32.22 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 177.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 tp -92.28 101.22 13.71 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -90.83 145.42 24.78 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.096 1.358 . . . . 0.0 111.595 -178.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -141.59 116.86 10.09 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.317 1.847 . . . . 0.0 106.102 174.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 49.66 48.64 21.25 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.678 0.752 . . . . 0.0 110.61 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.51 -9.74 4.33 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-O 118.283 -1.287 . . . . 0.0 115.86 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -98.52 142.38 30.19 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 119.983 1.892 . . . . 0.0 109.851 178.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 89.5 t -76.72 116.84 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 177.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.19 -44.21 22.35 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 177.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -161.88 175.34 11.99 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.3 t -150.82 163.48 38.53 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 54.2 mmtt -141.74 148.5 39.09 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 126.96 2.104 . . . . 0.0 106.672 177.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.9 t -130.52 132.33 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.81 -177.33 46.49 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.82 165.3 24.38 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.978 0.511 . . . . 0.0 111.316 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.3 mt -144.35 157.17 44.4 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.44 1.496 . . . . 0.0 108.28 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 88.2 p -81.52 157.16 24.92 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 170.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -55.68 -44.03 76.94 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -56.29 -56.35 24.79 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 123.671 0.653 . . . . 0.0 111.852 177.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -60.89 -41.25 95.65 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 118.211 1.005 . . . . 0.0 111.298 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 37.6 tp -60.95 -50.99 71.15 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.877 -0.514 . . . . 0.0 109.625 178.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -54.24 -47.75 71.87 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.739 0.7 . . . . 0.0 110.407 176.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -55.05 -53.25 58.29 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.082 0.953 . . . . 0.0 109.919 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -55.21 -54.71 39.91 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.598 1.159 . . . . 0.0 110.894 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 89.8 mt -58.62 -50.17 74.82 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.311 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -55.77 -50.37 70.62 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.17 0.588 . . . . 0.0 110.467 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.8 -35.05 65.89 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.48 0.712 . . . . 0.0 111.479 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -78.03 -50.11 12.72 Favored 'General case' 0 CA--C 1.524 -0.057 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 53.0 mt -56.07 -45.23 79.39 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.049 0.539 . . . . 0.0 110.09 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.251 0 C-N-CA 123.085 0.554 . . . . 0.0 109.693 177.599 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 13.6 mt . . . . . 0 CA--C 1.527 0.076 0 CA-C-O 120.776 0.322 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.0 mm -88.02 107.12 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 123.476 0.71 . . . . 0.0 109.344 177.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -79.58 99.52 7.36 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 76.0 mt -81.85 160.76 23.4 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 122.071 0.939 . . . . 0.0 113.348 -175.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 35.4 p -134.66 163.32 30.02 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 126.951 2.1 . . . . 0.0 106.961 173.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -57.03 -44.09 82.57 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.467 0.707 . . . . 0.0 110.059 179.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -55.84 -46.01 78.27 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.939 0.896 . . . . 0.0 111.458 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.5 p -78.02 -27.26 48.85 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 122.242 -0.286 . . . . 0.0 111.207 -177.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -42.15 -46.79 4.47 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.252 1.421 . . . . 0.0 113.499 -177.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -51.88 -64.83 0.69 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.902 0.858 . . . . 0.0 111.261 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.9 m -68.67 -40.6 80.08 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.106 -174.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -76.53 -55.38 5.58 Favored 'General case' 0 N--CA 1.451 -0.375 0 O-C-N 122.251 -0.281 . . . . 0.0 111.659 -177.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.4 t -91.72 -53.31 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -172.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 68.8 mt -66.26 -37.03 84.51 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 118.924 -1.11 . . . . 0.0 111.163 -176.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -93.68 33.54 1.28 Allowed 'General case' 0 CA--C 1.543 0.711 0 O-C-N 122.064 -0.398 . . . . 0.0 110.048 173.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.94 81.47 0.3 Allowed 'General case' 0 C--N 1.342 0.258 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -77.41 62.87 2.48 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 174.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 163.3 176.47 35.33 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 126.464 1.983 . . . . 0.0 108.432 -177.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.12 123.57 32.92 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 117.605 0.703 . . . . 0.0 109.93 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.2 mt -126.07 120.63 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 124.429 1.092 . . . . 0.0 109.88 -179.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.6 tp -92.18 97.0 10.64 Favored 'General case' 0 N--CA 1.458 -0.064 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 176.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.6 t -86.6 103.88 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 123.757 0.823 . . . . 0.0 108.946 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -95.2 108.18 20.3 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.214 1.005 . . . . 0.0 108.495 177.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -79.72 129.07 34.16 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 176.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 25.8 p-90 -143.53 174.29 10.89 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.293 1.037 . . . . 0.0 112.8 -176.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.49 144.44 20.68 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 125.736 1.615 . . . . 0.0 108.359 176.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -50.09 -49.19 52.38 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.804 0.842 . . . . 0.0 111.981 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 59.8 p-90 -66.55 -22.65 66.15 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -177.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 49.3 t -79.79 69.87 6.21 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 121.439 -0.788 . . . . 0.0 111.233 -176.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -16.64 -65.74 0.01 OUTLIER Glycine 0 CA--C 1.535 1.307 0 C-N-CA 128.128 2.775 . . . . 0.0 115.889 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -44.08 -31.29 3.88 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 124.533 3.489 . . . . 0.0 115.253 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 96.1 m -53.44 -41.62 66.27 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.804 -0.56 . . . . 0.0 109.831 176.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -67.4 -28.24 67.75 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.651 0.781 . . . . 0.0 111.161 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 84.1 mtp -74.76 -45.23 45.19 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 29.9 pt -74.56 -28.02 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.88 177.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -38.09 -59.55 1.18 Allowed Pre-proline 0 CA--C 1.544 0.749 0 CA-C-N 119.899 1.227 . . . . 0.0 114.286 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -56.15 -40.21 86.29 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.179 1.919 . . . . 0.0 111.498 177.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 19.7 mt -59.4 -51.01 77.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 55.5 mt -55.63 -41.62 73.78 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.691 0.396 . . . . 0.0 110.054 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -61.44 -48.55 80.64 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.569 0.622 . . . . 0.0 110.61 177.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -55.94 -51.6 67.09 Favored 'General case' 0 N--CA 1.457 -0.083 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 33.4 mm -55.8 -46.87 80.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 123.377 0.671 . . . . 0.0 110.031 177.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.18 -40.48 67.57 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.212 0.605 . . . . 0.0 110.575 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -71.95 -58.58 3.32 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 176.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -47.54 -48.13 27.72 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.004 1.322 . . . . 0.0 112.921 -178.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -102.39 22.36 13.54 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.726 0.81 . . . . 0.0 111.45 -178.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -54.31 131.66 42.28 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.988 0.813 . . . . 0.0 110.731 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.36 -19.87 9.9 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-O 119.25 -0.75 . . . . 0.0 112.953 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -99.56 -41.17 7.47 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.594 1.197 . . . . 0.0 109.478 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.4 tp -128.38 126.45 40.69 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.78 1.232 . . . . 0.0 108.74 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 45.8 m -88.7 103.55 16.05 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 175.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.2 t -79.53 130.18 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -132.34 145.03 50.96 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 122.802 0.441 . . . . 0.0 110.3 -178.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.7 mtmt -124.05 104.87 9.13 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 124.231 1.012 . . . . 0.0 109.127 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.3 tt -97.54 115.47 27.9 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 121.695 -0.628 . . . . 0.0 110.556 -175.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -79.23 107.96 12.37 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.933 -178.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.2 pt -71.41 -32.14 45.57 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-O 118.997 -0.525 . . . . 0.0 111.969 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -54.97 -27.62 45.23 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.147 0.885 . . . . 0.0 111.749 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -109.84 -0.64 18.26 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.131 0.972 . . . . 0.0 111.406 177.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -146.93 62.5 7.5 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 124.068 0.947 . . . . 0.0 110.853 178.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -56.46 -48.23 20.07 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 121.75 1.633 . . . . 0.0 111.863 -178.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -40.68 -39.99 2.0 Allowed Glycine 0 CA--C 1.529 0.943 0 C-N-CA 126.106 1.812 . . . . 0.0 115.077 -177.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.59 -23.97 67.44 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 118.519 1.16 . . . . 0.0 112.808 -178.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.19 -62.69 5.13 Favored Pre-proline 0 CA--C 1.54 0.569 0 O-C-N 121.112 -0.992 . . . . 0.0 113.348 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -58.05 -34.13 98.09 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 C-N-CA 122.31 2.007 . . . . 0.0 111.906 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -52.58 -29.24 24.71 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.0 0.818 . . . . 0.0 112.024 177.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -119.29 17.72 13.05 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.223 0.609 . . . . 0.0 111.174 177.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 49.17 39.52 27.44 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 124.706 1.146 . . . . 0.0 112.006 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 58.6 mt -64.02 130.72 29.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 121.28 0.562 . . . . 0.0 110.335 -178.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -79.26 -34.72 42.37 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 125.332 1.453 . . . . 0.0 112.602 -175.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -175.92 -157.07 16.27 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 107.41 -2.276 . . . . 0.0 107.41 -178.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.9 pt -147.37 158.44 43.88 Favored Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -70.15 140.29 60.85 Favored 'Cis proline' 0 N--CA 1.458 -0.587 0 N-CA-C 109.289 -1.081 . . . . 0.0 109.289 -1.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 26.6 m -136.85 123.96 21.66 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -179.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.6 mt -100.84 119.24 38.38 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.143 1.777 . . . . 0.0 109.718 -176.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.8 mp -114.55 117.4 30.81 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 173.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 tp -93.38 100.8 13.06 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -90.38 136.67 32.91 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.476 1.11 . . . . 0.0 110.023 -178.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -139.44 119.35 13.38 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.746 1.619 . . . . 0.0 106.663 177.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 54.26 41.55 31.94 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.786 0.721 . . . . 0.0 110.211 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 73.56 -11.84 5.18 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 119.051 -0.861 . . . . 0.0 114.41 -178.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -93.73 136.39 34.07 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 119.139 1.47 . . . . 0.0 109.567 -178.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 95.8 t -73.12 112.85 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 175.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.87 -40.85 31.37 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -158.73 158.71 34.18 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 176.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 89.1 m -134.27 145.21 48.89 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.752 1.221 . . . . 0.0 108.285 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -137.38 122.59 19.26 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 63.5 t -104.11 126.61 58.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.53 166.43 28.55 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.09 0.852 . . . . 0.0 112.219 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.45 170.87 12.35 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.755 0.822 . . . . 0.0 111.542 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -162.96 172.7 14.67 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 124.885 1.274 . . . . 0.0 109.964 -178.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 90.9 p -88.02 162.7 16.68 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.513 0.725 . . . . 0.0 110.101 178.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -54.95 -45.04 74.85 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 175.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.52 -60.61 8.55 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 177.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -54.04 -42.08 68.78 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 117.858 0.829 . . . . 0.0 111.641 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 15.9 tp -59.37 -50.97 71.91 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 176.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -57.87 -42.13 83.89 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.397 -0.814 . . . . 0.0 111.988 178.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -57.92 -52.67 64.52 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.138 0.881 . . . . 0.0 109.493 175.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -52.82 -52.3 57.56 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.887 0.875 . . . . 0.0 110.332 179.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.9 mt -56.99 -53.97 52.03 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.853 0.461 . . . . 0.0 110.399 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -52.57 -51.11 61.32 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 122.754 0.422 . . . . 0.0 110.65 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.15 -39.12 69.11 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.1 0.56 . . . . 0.0 111.733 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -78.71 -42.11 29.21 Favored 'General case' 0 N--CA 1.462 0.128 0 O-C-N 122.223 -0.298 . . . . 0.0 111.567 -178.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 59.4 mt -64.64 -45.09 88.27 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.225 0 C-N-CA 123.016 0.526 . . . . 0.0 109.816 177.921 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.9 mt . . . . . 0 N--CA 1.453 -0.321 0 CA-C-O 120.84 0.352 . . . . 0.0 110.514 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.1 mm -87.81 114.39 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-O 121.237 0.542 . . . . 0.0 109.802 177.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 63.0 m80 -83.98 96.97 9.01 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 62.4 mt -86.95 163.57 17.04 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.247 1.019 . . . . 0.0 112.342 -175.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 31.4 p -138.71 165.15 27.7 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.15 1.78 . . . . 0.0 106.517 174.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -55.25 -46.68 76.08 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.034 0.534 . . . . 0.0 109.876 178.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -59.72 -43.54 94.12 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.099 0.959 . . . . 0.0 112.158 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.3 p -78.47 -29.8 47.01 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 122.084 -0.385 . . . . 0.0 111.419 -176.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -37.19 -49.12 0.89 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.244 1.818 . . . . 0.0 113.515 -179.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -50.36 -64.6 0.76 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 121.74 0.781 . . . . 0.0 110.955 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 m -69.83 -46.36 65.8 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.855 -175.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -77.21 -21.55 53.71 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 114.935 1.458 . . . . 0.0 114.935 -173.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.3 t -120.48 -61.37 2.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 119.475 1.034 . . . . 0.0 109.753 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 67.0 mt -60.33 -39.92 88.83 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -174.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -94.89 12.52 27.91 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.281 0.491 . . . . 0.0 111.511 178.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.91 98.61 11.17 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.01 0.823 . . . . 0.0 111.654 -178.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -76.44 67.1 2.58 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.492 0.663 . . . . 0.0 109.742 177.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -164.88 162.84 35.96 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.71 112.1 18.57 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.067 0.547 . . . . 0.0 110.47 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.7 mt -118.65 114.21 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 125.288 1.435 . . . . 0.0 110.666 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.9 tp -83.39 96.63 8.6 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 174.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.2 t -86.33 114.93 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 C-N-CA 123.243 0.617 . . . . 0.0 109.611 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -98.31 105.45 17.59 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.495 1.118 . . . . 0.0 108.501 177.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -79.79 121.64 25.62 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 104.672 -2.344 . . . . 0.0 104.672 174.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 38.5 p-90 -135.11 170.35 16.04 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 124.141 0.976 . . . . 0.0 113.347 -175.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.59 125.55 13.6 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.744 1.618 . . . . 0.0 107.558 177.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -46.65 -45.44 19.22 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.416 1.086 . . . . 0.0 113.915 -177.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 55.5 p-90 -68.93 -23.64 64.19 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.956 0.502 . . . . 0.0 112.316 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 42.4 t -79.86 74.24 6.59 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 121.284 -0.885 . . . . 0.0 111.083 -177.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -13.07 -66.15 0.01 OUTLIER Glycine 0 CA--C 1.535 1.319 0 C-N-CA 128.48 2.943 . . . . 0.0 115.891 178.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -41.27 -36.78 2.72 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 124.264 3.309 . . . . 0.0 114.881 178.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 98.8 m -56.11 -48.01 76.98 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.386 0.674 . . . . 0.0 110.003 177.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -64.77 -38.04 89.65 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.549 0.74 . . . . 0.0 109.345 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 52.6 mtm -64.28 -43.96 93.16 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 119.505 -0.283 . . . . 0.0 111.032 178.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 29.8 pt -76.33 -26.69 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 118.74 0.7 . . . . 0.0 112.494 179.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -38.17 -58.85 1.36 Allowed Pre-proline 0 CA--C 1.545 0.756 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -57.27 -39.71 87.85 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 121.959 1.773 . . . . 0.0 111.654 178.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 19.1 mt -59.35 -50.75 78.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 177.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.6 mt -56.05 -43.38 77.84 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.744 0.418 . . . . 0.0 110.434 178.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -59.58 -49.32 78.23 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.603 0.638 . . . . 0.0 109.683 177.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -56.34 -49.78 73.39 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 28.8 mm -56.02 -49.97 72.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 123.206 0.602 . . . . 0.0 109.709 177.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.77 -45.96 63.94 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.288 0.635 . . . . 0.0 110.296 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -66.3 -58.04 6.2 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.938 -0.119 . . . . 0.0 110.738 177.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -48.19 -49.25 33.49 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.52 1.128 . . . . 0.0 112.748 -177.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -98.05 21.79 10.27 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.231 0.612 . . . . 0.0 111.851 -177.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -52.81 128.35 26.47 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.597 1.089 . . . . 0.0 110.824 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.12 -17.35 23.42 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-O 119.33 -0.705 . . . . 0.0 113.419 -178.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -99.29 -42.95 6.78 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 118.477 1.138 . . . . 0.0 109.065 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.3 tp -136.29 137.7 40.99 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.444 1.497 . . . . 0.0 107.274 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.5 m -98.37 140.77 32.14 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 173.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 96.3 t -113.01 141.31 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 177.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -138.03 152.33 48.74 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -128.37 133.4 48.63 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.5 tt -127.8 115.75 19.13 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.72 0.808 . . . . 0.0 109.104 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -80.25 110.01 15.26 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 pp -67.76 -32.54 57.09 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.149 0 C-N-CA 123.412 0.685 . . . . 0.0 112.808 -177.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -60.36 -47.74 84.74 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 118.963 0.801 . . . . 0.0 109.155 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -69.42 -37.26 77.36 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.92 0.888 . . . . 0.0 110.131 177.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -119.87 72.31 16.55 Favored Pre-proline 0 C--O 1.233 0.231 0 C-N-CA 124.007 0.923 . . . . 0.0 111.779 -175.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -61.49 -53.6 2.22 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 122.361 2.04 . . . . 0.0 112.418 -177.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -38.32 -47.93 2.13 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 125.351 1.453 . . . . 0.0 114.377 -177.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.56 -33.34 45.26 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.299 1.039 . . . . 0.0 113.092 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.88 -68.43 0.72 Allowed Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 118.149 -0.929 . . . . 0.0 112.511 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -59.41 -38.23 85.2 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 121.68 1.587 . . . . 0.0 111.048 178.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -50.92 -39.44 54.61 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-N 118.903 0.774 . . . . 0.0 111.53 178.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -108.8 20.93 17.9 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 122.884 0.474 . . . . 0.0 112.132 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 51.49 38.82 43.5 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 124.128 0.87 . . . . 0.0 113.465 176.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mp -57.43 125.66 13.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 118.092 0.946 . . . . 0.0 108.47 177.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -88.92 -47.59 8.05 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.465 1.106 . . . . 0.0 109.118 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -166.64 145.41 9.92 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 107.363 -2.295 . . . . 0.0 107.363 178.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.497 HD13 ' H ' ' A' ' 75' ' ' ILE . 0.2 OUTLIER -91.19 154.71 44.87 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-O 118.834 -0.603 . . . . 0.0 110.306 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.31 129.26 12.46 Favored 'Cis proline' 0 N--CA 1.457 -0.624 0 CA-C-N 119.973 1.026 . . . . 0.0 110.628 -1.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -113.72 109.28 18.31 Favored 'General case' 0 N--CA 1.461 0.076 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 178.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.1 mt -89.75 122.55 32.95 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.0 mp -122.96 114.68 20.75 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 177.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 tp -90.11 95.93 10.44 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -87.02 142.29 28.04 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.688 1.195 . . . . 0.0 111.571 -177.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -137.81 109.61 7.12 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 174.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 52.31 48.67 22.16 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 118.983 0.81 . . . . 0.0 110.073 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.71 -13.21 2.42 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 118.731 -1.038 . . . . 0.0 114.957 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -88.59 125.25 34.71 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 119.637 1.719 . . . . 0.0 108.873 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 73.2 t -71.82 114.07 9.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 175.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.94 -41.25 29.82 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.304 0.641 . . . . 0.0 109.398 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -159.18 170.06 22.78 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 177.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.1 t -149.3 162.77 39.39 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -146.88 119.78 8.71 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.171 1.388 . . . . 0.0 108.08 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.2 t -94.24 120.71 44.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.39 174.92 29.97 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 121.537 0.52 . . . . 0.0 112.211 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.21 172.25 9.59 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.777 0.831 . . . . 0.0 112.156 -178.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.9 mt -144.4 158.47 43.73 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 125.81 1.644 . . . . 0.0 108.506 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.3 p -87.03 152.02 22.74 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 169.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -50.53 -47.93 57.33 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 122.065 -0.397 . . . . 0.0 111.006 -178.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.64 -53.53 38.44 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -62.38 -39.7 94.06 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.98 -0.718 . . . . 0.0 111.291 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 30.6 tp -62.53 -49.43 75.37 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -56.22 -44.92 80.03 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.429 0.559 . . . . 0.0 110.492 176.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -56.27 -54.68 42.46 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.569 0.748 . . . . 0.0 109.887 177.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -53.4 -51.66 61.83 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.669 1.188 . . . . 0.0 110.357 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.9 mt -58.83 -50.77 72.74 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.519 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -55.33 -49.86 71.12 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.8 -36.89 67.92 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.468 0.707 . . . . 0.0 111.601 178.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -78.06 -47.43 18.36 Favored 'General case' 0 C--N 1.337 0.042 0 O-C-N 122.113 -0.367 . . . . 0.0 110.475 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 54.2 mt -59.37 -44.67 92.7 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.227 0.611 . . . . 0.0 109.531 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.244 0 C-N-CA 122.933 0.493 . . . . 0.0 109.707 177.743 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.7 mt . . . . . 0 N--CA 1.447 -0.614 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.2 mm -87.71 108.78 18.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 176.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 27.1 m-70 -79.77 94.69 5.81 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 177.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 66.9 mt -82.09 159.18 23.47 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.832 0.853 . . . . 0.0 112.433 -177.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 26.6 p -134.25 163.15 30.27 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.991 1.716 . . . . 0.0 106.947 173.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -55.62 -46.58 77.37 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.492 0.717 . . . . 0.0 110.656 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -55.98 -45.13 79.07 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.997 0.919 . . . . 0.0 111.468 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.9 p -78.34 -29.78 47.76 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 111.6 0.222 . . . . 0.0 111.6 -177.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -37.62 -53.59 1.2 Allowed 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 125.782 1.633 . . . . 0.0 114.473 -176.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -50.87 -62.2 1.75 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.611 0.719 . . . . 0.0 111.045 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -66.39 -49.53 66.51 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.944 -176.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -74.39 -21.0 59.86 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -173.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.5 t -119.51 -64.99 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.23 0.066 0 CA-C-N 119.326 0.966 . . . . 0.0 110.161 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 67.9 mt -59.66 -37.46 78.79 Favored 'General case' 0 C--N 1.334 -0.082 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 -174.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -98.61 15.75 24.1 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.428 0.558 . . . . 0.0 111.949 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.58 108.39 20.98 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 118.979 0.809 . . . . 0.0 111.047 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -75.38 63.97 1.49 Allowed 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.933 1.293 . . . . 0.0 111.336 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -163.81 178.38 39.29 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.61 105.66 17.9 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.134 1.374 . . . . 0.0 109.44 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.7 mt -112.38 117.35 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 124.144 0.978 . . . . 0.0 110.352 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.5 tp -90.5 97.89 11.45 Favored 'General case' 0 CA--C 1.523 -0.062 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 175.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.8 t -88.78 111.79 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -95.54 106.8 18.93 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.709 1.204 . . . . 0.0 108.601 176.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -80.5 125.17 29.63 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 175.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 31.1 p-90 -143.84 176.2 9.43 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.858 0.863 . . . . 0.0 112.574 -174.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.17 144.71 16.15 Favored 'General case' 0 C--N 1.338 0.092 0 C-N-CA 125.065 1.346 . . . . 0.0 108.476 175.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 -48.93 -50.69 34.15 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.789 1.236 . . . . 0.0 112.099 -178.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 63.9 p-90 -60.41 -29.84 69.22 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -177.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 49.5 t -79.82 77.88 6.45 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 121.514 -0.741 . . . . 0.0 110.52 -178.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -24.66 -62.1 0.05 OUTLIER Glycine 0 CA--C 1.536 1.399 0 C-N-CA 127.094 2.283 . . . . 0.0 115.084 179.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -43.88 -31.16 3.49 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 124.683 3.589 . . . . 0.0 115.192 179.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 98.8 m -55.09 -42.73 73.21 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.688 -0.633 . . . . 0.0 109.705 176.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -67.77 -27.2 66.56 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.712 0.805 . . . . 0.0 111.007 178.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 12.7 tmm? -72.3 -48.99 38.03 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 43.5 pt -70.39 -31.49 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 118.696 -0.668 . . . . 0.0 112.209 178.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -37.53 -60.94 0.8 Allowed Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -57.48 -39.35 89.6 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.374 2.049 . . . . 0.0 111.734 178.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 16.1 mt -59.22 -52.27 62.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.5 mt -55.84 -43.64 77.22 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.652 0.781 . . . . 0.0 110.575 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -58.09 -50.52 73.19 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.121 0.486 . . . . 0.0 109.804 178.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -59.88 -49.98 75.57 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.6 mm -53.37 -46.59 58.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 123.688 0.795 . . . . 0.0 109.585 177.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.56 -45.96 70.08 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.753 0.421 . . . . 0.0 110.608 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -66.43 -55.65 14.73 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 177.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -50.36 -47.82 55.9 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.931 0.892 . . . . 0.0 112.291 -177.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -98.31 23.74 8.04 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.813 0.845 . . . . 0.0 111.614 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -53.82 130.86 38.49 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 119.396 0.998 . . . . 0.0 110.526 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.24 -18.64 12.92 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 119.151 -0.805 . . . . 0.0 113.087 -178.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -99.3 -42.38 7.03 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.788 1.294 . . . . 0.0 109.288 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.0 tp -132.42 131.87 42.22 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.511 1.125 . . . . 0.0 108.667 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 90.4 m -96.27 104.37 16.32 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 176.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 90.7 t -79.74 134.66 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.08 150.02 51.16 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.296 0.639 . . . . 0.0 109.284 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -126.39 136.27 52.48 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 178.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.5 tt -129.45 115.13 17.04 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.412 0.685 . . . . 0.0 109.16 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -80.63 111.11 16.75 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.1 pt -73.19 -25.1 21.19 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.139 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -177.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -61.54 -46.96 87.71 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 177.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -70.6 -40.13 73.41 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.222 1.009 . . . . 0.0 109.894 177.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -120.53 69.77 16.36 Favored Pre-proline 0 CA--C 1.532 0.269 0 C-N-CA 124.06 0.944 . . . . 0.0 112.691 -175.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -65.54 -41.42 15.23 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 121.802 1.668 . . . . 0.0 110.653 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -43.99 -35.99 3.65 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 125.569 1.557 . . . . 0.0 114.913 -178.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.98 -20.41 61.73 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.604 1.202 . . . . 0.0 112.92 -177.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.25 -59.22 13.6 Favored Pre-proline 0 CA--C 1.539 0.538 0 O-C-N 121.111 -0.993 . . . . 0.0 113.226 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -58.17 -33.25 97.29 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.281 1.987 . . . . 0.0 111.805 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -52.98 -29.0 26.48 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.87 0.759 . . . . 0.0 111.929 177.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -122.94 20.47 10.0 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.464 0.705 . . . . 0.0 110.57 177.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 40.3 43.39 2.74 Favored Glycine 0 C--N 1.342 0.875 0 C-N-CA 126.03 1.776 . . . . 0.0 111.535 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.5 mt -54.06 138.39 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -174.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.51 -41.4 32.47 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.55 1.14 . . . . 0.0 111.219 -174.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -178.25 -150.94 9.01 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 106.674 -2.57 . . . . 0.0 106.674 -177.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.3 pt -148.36 154.31 41.75 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 118.856 1.328 . . . . 0.0 108.979 178.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -70.72 141.41 68.38 Favored 'Cis proline' 0 N--CA 1.455 -0.767 0 CA-C-N 119.786 0.959 . . . . 0.0 110.333 -1.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 43.5 m -133.79 125.92 29.5 Favored 'General case' 0 C--O 1.231 0.111 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 178.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.2 mt -103.58 124.96 49.77 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.89 1.276 . . . . 0.0 109.15 -177.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -114.52 117.35 30.69 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 105.064 -2.199 . . . . 0.0 105.064 174.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.5 tp -94.98 95.41 8.6 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -86.88 102.9 14.77 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.162 1.385 . . . . 0.0 110.052 -178.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -97.93 114.68 26.85 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 174.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 54.23 46.99 24.11 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.536 0.734 . . . . 0.0 109.981 -178.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 69.55 -1.8 13.15 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-O 118.62 -1.1 . . . . 0.0 114.414 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -103.46 128.97 50.51 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 119.657 1.728 . . . . 0.0 109.253 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 98.8 t -66.35 102.7 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.17 -38.54 35.64 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.696 0.799 . . . . 0.0 109.652 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -150.76 167.29 27.88 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 97.4 m -147.49 149.92 33.57 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.13 141.31 31.16 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -177.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 36.7 t -125.36 128.44 72.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.38 175.87 37.37 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 123.829 0.728 . . . . 0.0 111.649 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.73 173.16 9.47 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.455 0.702 . . . . 0.0 111.44 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.0 mt -146.4 161.69 39.83 Favored 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 125.28 1.432 . . . . 0.0 109.333 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.6 p -92.47 152.42 19.69 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 169.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -51.1 -47.46 61.93 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 122.138 -0.351 . . . . 0.0 111.522 -177.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.8 -60.31 8.9 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -54.46 -41.36 69.38 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.989 -0.712 . . . . 0.0 111.422 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 30.3 tp -60.79 -48.67 80.74 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -55.65 -48.0 75.73 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 118.903 -0.57 . . . . 0.0 110.298 176.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -56.0 -52.13 65.31 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.975 0.807 . . . . 0.0 110.515 178.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -52.05 -51.34 58.14 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.789 0.835 . . . . 0.0 110.429 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 90.1 mt -61.97 -52.33 64.45 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.503 0.321 . . . . 0.0 110.723 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -50.55 -49.79 55.1 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.67 1.188 . . . . 0.0 110.126 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.47 -36.17 68.78 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.402 0.681 . . . . 0.0 111.906 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -78.88 -45.81 19.86 Favored 'General case' 0 N--CA 1.46 0.043 0 O-C-N 122.23 -0.294 . . . . 0.0 110.538 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 56.2 mt -60.26 -43.66 95.98 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.445 0.698 . . . . 0.0 109.655 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.278 0 C-N-CA 122.948 0.499 . . . . 0.0 109.795 177.827 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.3 mt . . . . . 0 N--CA 1.449 -0.505 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.9 mm -87.79 111.29 21.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 123.599 0.76 . . . . 0.0 109.073 178.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -83.04 101.21 10.97 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 70.7 mt -83.23 163.49 20.71 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.543 1.137 . . . . 0.0 112.139 -177.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 62.2 p -131.51 162.42 30.29 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 173.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -59.25 -46.09 89.43 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.866 0.757 . . . . 0.0 109.543 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -62.72 -41.62 99.25 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.896 0.478 . . . . 0.0 111.713 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 54.4 p -78.33 -26.16 46.75 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.409 0.55 . . . . 0.0 111.175 -177.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -41.85 -44.9 3.5 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 126.419 1.888 . . . . 0.0 112.415 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -53.25 -63.17 1.23 Allowed 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.535 0.684 . . . . 0.0 110.637 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.0 m -66.79 -42.63 85.65 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.742 -177.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -70.52 -50.14 40.89 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -175.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.0 t -100.07 -57.87 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 123.882 0.873 . . . . 0.0 111.141 -174.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 67.0 mt -63.21 -37.01 85.56 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 120.22 -0.592 . . . . 0.0 112.311 -174.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -94.5 21.94 6.68 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.344 0.52 . . . . 0.0 111.08 175.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.78 159.45 34.52 Favored 'General case' 0 C--N 1.34 0.16 0 O-C-N 121.471 -0.768 . . . . 0.0 110.568 177.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -138.6 58.41 1.66 Allowed 'General case' 0 C--O 1.226 -0.155 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 175.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 175.25 -174.2 46.66 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -178.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -86.55 128.28 34.96 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.595 1.158 . . . . 0.0 110.281 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.7 mt -132.99 121.08 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 124.417 1.087 . . . . 0.0 109.603 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -95.35 109.51 21.66 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 175.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.1 t -100.46 108.59 23.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 123.16 0.584 . . . . 0.0 110.043 -178.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -93.7 105.19 17.24 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.125 0.97 . . . . 0.0 109.745 178.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -79.57 114.25 18.35 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 105.048 -2.204 . . . . 0.0 105.048 174.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 39.4 p-90 -128.25 170.55 12.9 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.836 1.255 . . . . 0.0 112.185 -176.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -146.24 131.56 18.54 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.283 1.433 . . . . 0.0 107.763 176.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 -51.14 -37.05 43.98 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.923 0.889 . . . . 0.0 113.24 -178.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 57.7 p-90 -77.9 -20.49 52.83 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 52.8 t -79.83 74.16 6.56 Favored 'General case' 0 N--CA 1.456 -0.138 0 O-C-N 121.228 -0.92 . . . . 0.0 110.745 -177.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -9.68 -71.39 0.01 OUTLIER Glycine 0 CA--C 1.535 1.329 0 C-N-CA 128.294 2.854 . . . . 0.0 115.699 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -40.91 -32.81 0.97 Allowed 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 125.207 3.938 . . . . 0.0 115.61 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 89.3 m -52.66 -41.82 64.16 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.368 0.667 . . . . 0.0 110.207 177.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -66.23 -30.23 70.63 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.717 0.807 . . . . 0.0 111.234 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -75.61 -45.02 39.83 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.9 pt -73.28 -31.15 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-O 118.712 -0.661 . . . . 0.0 112.333 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -39.32 -60.95 1.09 Allowed Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -58.11 -36.86 97.57 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.376 2.051 . . . . 0.0 111.893 178.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 19.7 mt -60.92 -51.79 69.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 177.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.6 mt -56.31 -41.34 75.84 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.189 0.596 . . . . 0.0 110.117 177.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -60.76 -47.87 84.35 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.841 0.746 . . . . 0.0 110.093 176.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -56.91 -51.88 67.38 Favored 'General case' 0 C--N 1.339 0.117 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 31.4 mm -53.72 -46.12 61.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 123.302 0.641 . . . . 0.0 109.498 177.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.65 -36.75 67.39 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.939 0.496 . . . . 0.0 111.223 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -74.5 -58.14 3.48 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.938 0.399 . . . . 0.0 109.986 176.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -50.36 -41.91 52.36 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.734 1.214 . . . . 0.0 112.532 -177.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -107.07 25.45 11.36 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.642 1.177 . . . . 0.0 111.021 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -56.94 121.84 10.87 Favored 'General case' 0 CA--C 1.529 0.173 0 O-C-N 121.545 -0.722 . . . . 0.0 110.39 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.06 -9.83 55.54 Favored Glycine 0 CA--C 1.531 1.094 0 CA-C-O 119.556 -0.58 . . . . 0.0 112.85 -178.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 47.4 mttt -99.71 -41.3 7.35 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.691 1.196 . . . . 0.0 108.664 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 47.7 tp -131.82 133.6 44.86 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.572 1.149 . . . . 0.0 108.708 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.2 m -88.08 98.49 11.56 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 176.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 80.5 t -79.09 128.95 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 178.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.65 150.64 50.68 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.276 0.56 . . . . 0.0 110.662 -177.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -127.54 143.45 51.18 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.972 1.309 . . . . 0.0 107.597 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 tt -134.2 115.19 13.89 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -80.83 105.05 11.76 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pp -58.97 -33.87 51.25 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.242 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -177.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -63.05 -44.31 96.23 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.704 0.684 . . . . 0.0 110.226 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -72.06 -31.49 66.18 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 177.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -128.53 69.79 79.41 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -176.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.02 -50.89 10.89 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.488 2.792 . . . . 0.0 113.408 -178.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -41.37 -40.1 2.56 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 125.431 1.491 . . . . 0.0 114.34 -176.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.88 -30.64 69.13 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.767 -0.843 . . . . 0.0 113.113 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.11 -64.57 2.19 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-O 118.259 -0.877 . . . . 0.0 112.292 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -60.02 -37.21 86.3 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 121.833 1.689 . . . . 0.0 111.511 177.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -52.34 -37.18 55.35 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 119.386 0.994 . . . . 0.0 111.791 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -111.49 20.9 16.76 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.922 0.489 . . . . 0.0 110.92 177.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 41.9 45.08 4.73 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 125.537 1.541 . . . . 0.0 112.901 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mp -47.89 116.45 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 117.702 0.751 . . . . 0.0 110.411 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.41 -49.62 12.07 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.179 0.992 . . . . 0.0 110.295 -177.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -161.9 144.1 9.43 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 107.419 -2.272 . . . . 0.0 107.419 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.7 pt -96.85 150.8 37.31 Favored Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 123.837 0.855 . . . . 0.0 110.246 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -70.23 137.28 44.1 Favored 'Cis proline' 0 N--CA 1.457 -0.672 0 CA-C-N 119.591 0.89 . . . . 0.0 110.597 -1.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -115.43 118.91 34.51 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.3 mt -102.37 105.51 16.12 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -179.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -94.21 114.36 26.45 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 104.781 -2.304 . . . . 0.0 104.781 175.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.6 tp -97.24 105.53 17.7 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -179.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -94.18 150.01 20.71 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.584 1.554 . . . . 0.0 110.712 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -139.63 107.04 5.54 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 173.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 51.01 70.81 0.49 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.548 0.689 . . . . 0.0 111.457 -179.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 73.4 -37.09 0.82 Allowed Glycine 0 CA--C 1.531 1.04 0 N-CA-C 115.923 1.129 . . . . 0.0 115.923 176.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -90.14 147.88 23.32 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.146 1.473 . . . . 0.0 111.373 -177.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 75.3 t -74.38 114.66 14.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 175.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.04 -46.66 13.63 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.62 1.168 . . . . 0.0 109.852 178.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -148.64 170.85 17.22 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 58.9 m -152.57 144.92 24.0 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -177.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -135.29 143.88 46.46 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.4 t -121.94 120.77 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 178.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.03 169.7 35.05 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -177.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.27 170.53 8.57 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.983 0.913 . . . . 0.0 112.882 -178.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.1 mt -142.63 155.76 44.98 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 125.977 1.711 . . . . 0.0 108.572 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.6 p -87.78 152.51 22.06 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 171.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -48.21 -52.35 21.33 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -176.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -53.71 -57.26 16.63 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 26.8 mm100 -57.74 -40.93 80.79 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 122.194 -0.592 . . . . 0.0 111.122 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 42.2 tp -62.13 -49.4 76.01 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 177.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -54.1 -45.99 71.97 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.387 0.54 . . . . 0.0 110.403 176.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -57.96 -54.87 42.04 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 122.92 0.488 . . . . 0.0 110.453 178.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -51.44 -52.21 48.24 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.757 1.223 . . . . 0.0 110.584 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 85.4 mt -61.24 -53.39 57.45 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.805 0.442 . . . . 0.0 110.418 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -51.54 -50.29 60.3 Favored 'General case' 0 C--N 1.334 -0.083 0 C-N-CA 123.765 0.826 . . . . 0.0 111.067 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.82 -37.65 66.38 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.354 0.662 . . . . 0.0 111.654 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -78.78 -43.52 25.31 Favored 'General case' 0 N--CA 1.46 0.073 0 C-N-CA 122.456 0.302 . . . . 0.0 110.587 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 40.4 mt -58.82 -47.06 86.13 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.289 0 C-N-CA 123.364 0.666 . . . . 0.0 109.69 177.656 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 22.0 mt . . . . . 0 N--CA 1.447 -0.583 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.5 mm -88.03 112.09 23.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 -80.28 102.4 9.49 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 72.7 mt -90.93 161.96 14.97 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 121.814 0.816 . . . . 0.0 112.258 -177.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 82.6 p -139.96 167.15 22.78 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.733 2.013 . . . . 0.0 106.444 175.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -55.22 -47.77 74.87 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.459 0.704 . . . . 0.0 110.656 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -61.8 -40.15 94.22 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.2 p -78.74 -29.99 45.53 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 122.109 -0.369 . . . . 0.0 110.727 -178.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -39.27 -52.83 1.97 Allowed 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 125.841 1.656 . . . . 0.0 113.436 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -55.6 -59.18 5.2 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 121.868 -0.52 . . . . 0.0 110.908 -179.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.1 m -59.11 -48.85 80.08 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.222 1.009 . . . . 0.0 112.569 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.96 -47.1 16.97 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -174.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.8 t -94.56 -52.39 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 C-N-CA 123.347 0.659 . . . . 0.0 112.504 -174.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 73.6 mt -71.4 -42.72 68.0 Favored 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 119.545 -0.862 . . . . 0.0 111.218 -175.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -91.64 35.32 0.96 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 176.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -78.1 162.1 26.92 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.415 0.686 . . . . 0.0 111.987 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -141.8 94.28 2.66 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 172.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 135.52 -175.51 20.7 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -176.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.05 111.59 23.32 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.374 1.47 . . . . 0.0 109.687 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.0 mt -109.07 115.98 50.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 124.153 0.981 . . . . 0.0 109.686 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.6 tp -90.14 96.97 10.92 Favored 'General case' 0 C--N 1.338 0.076 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 176.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 45.4 t -88.51 114.58 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 123.328 0.651 . . . . 0.0 109.899 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -98.87 106.09 18.31 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 176.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -79.73 120.05 23.49 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 175.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 37.6 p-90 -133.84 170.52 15.47 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.332 1.053 . . . . 0.0 113.152 -175.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -142.76 138.68 30.64 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.192 1.397 . . . . 0.0 107.444 174.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -53.89 -47.64 70.92 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.015 0.526 . . . . 0.0 112.236 -177.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 62.6 p-90 -65.68 -23.75 66.85 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.108 0.563 . . . . 0.0 112.413 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 52.1 t -79.68 80.38 6.07 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 121.34 -0.85 . . . . 0.0 109.75 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -27.06 -59.89 0.09 OUTLIER Glycine 0 CA--C 1.535 1.304 0 C-N-CA 127.078 2.275 . . . . 0.0 114.391 178.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -41.75 -37.16 3.77 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 124.248 3.299 . . . . 0.0 114.699 177.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 75.1 m -58.24 -47.67 82.82 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.689 0.757 . . . . 0.0 109.837 177.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -65.37 -37.28 86.54 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.71 0.804 . . . . 0.0 109.094 178.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 54.3 mtm -63.44 -43.14 98.27 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 119.243 -0.408 . . . . 0.0 111.061 177.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 31.5 pt -75.46 -26.52 18.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 119.139 0.881 . . . . 0.0 112.164 178.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -38.26 -57.8 1.69 Allowed Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -57.42 -40.13 83.71 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.072 1.848 . . . . 0.0 111.499 177.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 16.4 mt -59.32 -49.19 84.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.9 mt -57.22 -43.53 82.89 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.75 0.42 . . . . 0.0 110.763 177.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.46 -50.76 72.58 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.725 0.693 . . . . 0.0 110.16 176.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -56.24 -52.1 65.68 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.4 mm -54.55 -46.88 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 124.891 1.276 . . . . 0.0 110.221 178.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.05 -44.69 79.07 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.723 0.409 . . . . 0.0 110.041 178.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -64.26 -53.34 50.48 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 177.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -49.46 -48.91 47.28 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.177 0.991 . . . . 0.0 111.684 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -100.82 29.63 4.45 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.347 0.659 . . . . 0.0 111.344 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -55.54 123.45 14.04 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.43 -0.794 . . . . 0.0 110.5 -179.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.71 -15.13 43.72 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 119.466 -0.63 . . . . 0.0 112.913 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -99.62 -40.23 7.9 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.371 1.086 . . . . 0.0 109.458 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.7 tp -126.41 132.88 51.41 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.656 1.183 . . . . 0.0 108.83 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.0 m -97.44 101.8 13.42 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 176.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 66.6 t -79.62 135.0 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 178.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.92 150.19 49.22 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.413 0.685 . . . . 0.0 109.732 -178.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 45.2 mttm -127.96 126.62 41.76 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.0 tt -116.66 115.82 26.39 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.442 0.697 . . . . 0.0 109.608 179.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -79.15 108.97 13.04 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 pp -68.37 -32.42 55.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 119.228 -0.415 . . . . 0.0 111.395 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -51.13 -33.19 25.51 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.654 0.661 . . . . 0.0 112.17 -179.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -110.43 1.32 18.26 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.41 1.084 . . . . 0.0 111.563 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -144.19 64.1 12.09 Favored Pre-proline 0 C--O 1.234 0.26 0 C-N-CA 124.42 1.088 . . . . 0.0 109.163 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -60.01 -53.33 3.22 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.646 2.231 . . . . 0.0 112.394 -177.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -38.42 -47.47 2.15 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.392 1.472 . . . . 0.0 114.478 -177.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.86 -33.29 49.14 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.367 1.067 . . . . 0.0 112.753 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.93 -68.32 0.75 Allowed Pre-proline 0 CA--C 1.54 0.564 0 CA-C-O 118.295 -0.859 . . . . 0.0 112.98 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.84 -39.36 82.31 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 121.484 1.456 . . . . 0.0 110.806 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -51.29 -38.48 53.03 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 118.415 0.552 . . . . 0.0 111.826 178.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -107.32 18.87 21.07 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 55.46 40.62 78.14 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 123.106 0.384 . . . . 0.0 113.043 176.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mp -63.52 104.31 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 176.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 47.6 mtt85 -79.62 -43.4 22.96 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.902 1.281 . . . . 0.0 110.186 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -157.49 141.91 8.18 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 107.874 -2.09 . . . . 0.0 107.874 179.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.1 pt -99.45 147.48 33.4 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 124.354 1.062 . . . . 0.0 109.762 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.57 142.41 66.88 Favored 'Cis proline' 0 N--CA 1.457 -0.649 0 CA-C-N 120.112 1.076 . . . . 0.0 111.156 0.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -121.38 110.69 16.4 Favored 'General case' 0 C--N 1.335 -0.062 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.2 mt -88.73 123.05 32.78 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.7 mp -122.32 118.97 29.74 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 176.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.8 tp -95.31 95.08 8.24 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -177.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -86.55 105.23 16.69 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.682 1.193 . . . . 0.0 110.768 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -93.62 111.07 22.67 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 173.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.5 m120 47.87 50.88 15.07 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.718 0.807 . . . . 0.0 111.169 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.38 -11.53 24.06 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 118.851 -0.972 . . . . 0.0 114.676 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -97.36 121.16 38.94 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 119.632 1.716 . . . . 0.0 109.745 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 89.4 t -64.07 106.08 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 175.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.98 -37.51 39.22 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.587 0.755 . . . . 0.0 109.553 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.81 170.04 21.51 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.3 t -149.59 156.89 42.67 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 178.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.2 tmtm? -138.55 116.38 11.54 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.853 1.661 . . . . 0.0 106.764 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 36.5 t -96.35 126.93 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -178.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.01 178.67 47.44 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.27 168.2 12.87 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.104 0.478 . . . . 0.0 110.342 178.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -158.09 165.33 35.28 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.842 0.857 . . . . 0.0 109.154 -178.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 83.1 p -80.2 160.29 25.67 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 177.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -58.62 -38.43 78.01 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 175.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -56.01 -54.73 33.31 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 110.656 -0.977 . . . . 0.0 110.656 176.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -52.91 -50.03 64.75 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 117.241 0.52 . . . . 0.0 110.424 177.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 14.6 tp -59.79 -50.11 75.1 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 121.141 -0.224 . . . . 0.0 110.704 -178.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -55.05 -49.14 72.34 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.185 0.594 . . . . 0.0 111.581 178.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -67.68 -43.81 79.29 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.509 -177.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -52.15 -53.0 48.32 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.655 0.782 . . . . 0.0 109.208 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 84.8 mt -59.42 -54.42 46.87 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 119.116 -0.469 . . . . 0.0 110.78 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -51.43 -50.01 60.55 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.106 0.412 . . . . 0.0 111.022 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.95 -38.8 73.44 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.492 0.717 . . . . 0.0 111.847 179.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -78.3 -40.93 35.31 Favored 'General case' 0 N--CA 1.461 0.117 0 O-C-N 122.092 -0.38 . . . . 0.0 110.995 -178.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 63.0 mt -64.14 -46.59 83.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.266 0 C-N-CA 122.922 0.489 . . . . 0.0 109.82 177.7 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.4 mt . . . . . 0 C--O 1.23 0.059 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.4 mm -87.03 108.2 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -81.68 110.55 17.12 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 177.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.0 mt -88.94 171.9 9.54 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.628 1.171 . . . . 0.0 110.502 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 51.0 p -136.21 164.26 28.48 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 171.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -57.1 -47.77 80.25 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 177.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -59.52 -45.35 91.99 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.674 1.19 . . . . 0.0 111.889 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 86.1 p -79.64 -24.43 41.89 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -176.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -31.7 -60.33 0.25 Allowed 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 127.121 2.169 . . . . 0.0 114.337 -178.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -52.36 -59.19 4.71 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.46 0.648 . . . . 0.0 111.048 -177.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.9 m -60.01 -41.66 92.65 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 123.6 0.76 . . . . 0.0 111.733 -178.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -74.79 -43.14 56.31 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -175.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 45.8 t -105.85 -57.31 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 C-N-CA 124.568 1.147 . . . . 0.0 112.08 -172.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 75.5 mt -61.38 -33.54 73.83 Favored 'General case' 0 N--CA 1.458 -0.037 0 O-C-N 121.702 -0.624 . . . . 0.0 111.876 -174.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -88.91 8.66 28.19 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 118.286 0.493 . . . . 0.0 111.809 177.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.79 100.58 11.02 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 121.253 -0.905 . . . . 0.0 112.489 -178.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -77.06 68.77 3.26 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 174.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -179.84 -172.11 43.5 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -178.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -99.6 115.76 30.14 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.562 1.545 . . . . 0.0 110.857 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 mt -121.53 123.44 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 125.43 1.492 . . . . 0.0 109.116 178.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.423 ' C ' HD13 ' A' ' 24' ' ' LEU . 2.9 tm? -92.86 108.32 19.9 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 175.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 32.2 t -97.3 109.91 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -93.57 106.36 18.34 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 177.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -79.66 125.52 29.74 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 175.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 38.0 p-90 -143.79 166.12 25.78 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -174.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -144.59 137.24 26.6 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.168 1.387 . . . . 0.0 108.909 174.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -51.75 -47.82 63.94 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.865 0.866 . . . . 0.0 112.372 -177.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 50.4 p-90 -60.75 -27.04 67.66 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 46.8 t -79.86 81.48 6.12 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 121.42 -0.8 . . . . 0.0 109.098 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -28.14 -59.17 0.13 Allowed Glycine 0 CA--C 1.538 1.525 0 C-N-CA 125.962 1.744 . . . . 0.0 114.27 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -41.89 -39.27 5.27 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 124.311 3.341 . . . . 0.0 114.464 177.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 94.1 m -56.02 -50.52 70.66 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 121.668 0.747 . . . . 0.0 109.985 176.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -64.18 -38.07 89.74 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.319 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 83.9 mtp -61.7 -44.16 97.47 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 119.472 -0.299 . . . . 0.0 110.827 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.5 pt -76.17 -26.96 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 118.741 0.7 . . . . 0.0 112.635 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -37.8 -57.93 1.48 Allowed Pre-proline 0 CA--C 1.546 0.79 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -58.14 -39.7 83.1 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.07 1.847 . . . . 0.0 111.672 178.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 14.0 mt -59.52 -49.65 82.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 177.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 44.2 mt -56.1 -42.33 76.62 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 122.564 0.346 . . . . 0.0 110.161 177.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -61.71 -46.86 87.83 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.994 0.815 . . . . 0.0 111.147 176.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -56.14 -51.12 69.1 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 24.0 mm -55.92 -44.78 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 123.428 0.691 . . . . 0.0 109.831 177.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.86 70.68 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 118.321 0.509 . . . . 0.0 110.787 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -72.55 -57.61 4.01 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 177.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -51.18 -46.09 62.0 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.231 1.012 . . . . 0.0 112.605 -178.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -98.26 19.82 13.6 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.438 1.095 . . . . 0.0 111.426 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -54.93 131.85 45.44 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.25 -0.906 . . . . 0.0 110.085 -178.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.25 -18.76 7.64 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 119.334 -0.703 . . . . 0.0 113.235 -178.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -99.61 -37.42 9.15 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.486 1.143 . . . . 0.0 109.923 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 26.6 tp -136.68 128.01 28.26 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.496 1.118 . . . . 0.0 108.181 178.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 57.6 m -88.55 105.08 17.4 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 91.2 t -79.53 130.36 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.96 153.19 51.94 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.938 0.895 . . . . 0.0 110.45 -177.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -128.74 144.02 51.06 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.658 1.183 . . . . 0.0 108.221 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.0 tt -134.04 117.4 16.61 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -87.19 99.76 12.18 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 122.125 -0.359 . . . . 0.0 110.984 -175.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.9 pt -55.26 -28.11 21.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -56.99 -43.55 81.84 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.828 0.74 . . . . 0.0 110.294 177.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -95.28 -17.5 21.61 Favored 'General case' 0 CA--C 1.53 0.212 0 C-N-CA 124.818 1.247 . . . . 0.0 111.577 -178.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -129.82 59.35 44.3 Favored Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 124.532 1.133 . . . . 0.0 108.822 -175.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -62.42 -52.18 2.77 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.609 2.206 . . . . 0.0 113.768 -174.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -44.75 -42.99 7.93 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.016 0.817 . . . . 0.0 113.466 -175.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.43 -33.35 43.62 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.055 0.942 . . . . 0.0 112.663 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.54 -68.51 0.63 Allowed Pre-proline 0 CA--C 1.538 0.503 0 CA-C-O 118.139 -0.934 . . . . 0.0 112.294 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -59.86 -38.24 80.84 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 121.595 1.53 . . . . 0.0 111.016 177.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -51.44 -41.31 60.74 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.266 0.939 . . . . 0.0 111.458 178.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -104.59 19.43 20.4 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.505 0.322 . . . . 0.0 111.753 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.16 39.07 49.62 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.224 0.916 . . . . 0.0 113.401 176.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.5 mp -57.01 127.6 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 118.102 0.951 . . . . 0.0 108.903 177.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -92.24 -47.02 7.43 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.658 1.183 . . . . 0.0 110.238 -178.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -160.55 144.94 10.45 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 107.999 -2.04 . . . . 0.0 107.999 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 9.1 pt -99.08 149.34 35.68 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 124.111 0.964 . . . . 0.0 110.275 -179.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.15 140.02 52.91 Favored 'Cis proline' 0 N--CA 1.457 -0.65 0 CA-C-N 119.961 1.022 . . . . 0.0 111.268 -0.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.85 109.56 15.72 Favored 'General case' 0 CA--C 1.527 0.096 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 178.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.5 mt -91.31 93.17 8.94 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.913 0.885 . . . . 0.0 108.758 -178.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.7 mp -90.56 114.47 26.7 Favored 'General case' 0 CA--C 1.522 -0.117 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 177.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -91.6 103.43 16.02 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -91.49 115.24 27.88 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.144 1.378 . . . . 0.0 110.15 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -111.64 125.27 53.77 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 173.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 53.08 46.11 27.36 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.57 0.7 . . . . 0.0 109.621 -178.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.2 7.16 23.5 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 118.167 -1.352 . . . . 0.0 115.449 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -118.03 142.0 47.86 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 120.002 1.901 . . . . 0.0 110.175 178.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 87.4 t -65.92 110.3 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.39 -42.62 25.1 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.895 0.878 . . . . 0.0 108.647 176.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -158.88 170.95 20.96 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.076 0.95 . . . . 0.0 108.662 177.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 91.2 m -147.33 129.86 15.89 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -179.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -112.2 112.95 24.92 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.0 t -92.02 123.46 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.69 167.43 35.02 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 123.885 0.755 . . . . 0.0 112.232 178.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.3 170.56 12.86 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.108 0.563 . . . . 0.0 110.589 179.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -161.16 172.93 15.88 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.689 0.795 . . . . 0.0 109.913 -176.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 82.8 p -84.15 163.88 19.51 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -57.83 -40.78 80.87 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 175.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -59.51 -57.62 18.63 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 177.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -56.44 -40.45 74.8 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 117.589 0.695 . . . . 0.0 110.71 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 28.7 tp -61.05 -54.94 38.61 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 177.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -53.67 -46.36 70.61 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.314 0.506 . . . . 0.0 111.108 178.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -57.49 -53.71 55.04 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.581 0.753 . . . . 0.0 110.044 178.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -52.97 -54.02 41.33 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.327 1.051 . . . . 0.0 110.448 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.3 mt -59.27 -51.81 68.36 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.654 -179.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -54.77 -51.09 66.81 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.057 0.543 . . . . 0.0 110.661 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.2 -37.37 67.01 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.586 0.755 . . . . 0.0 111.46 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -78.13 -45.97 21.91 Favored 'General case' 0 C--O 1.227 -0.081 0 O-C-N 122.336 -0.227 . . . . 0.0 110.587 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 51.9 mt -58.23 -47.3 83.94 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.31 0 C-N-CA 123.286 0.634 . . . . 0.0 109.566 177.355 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.1 mt . . . . . 0 N--CA 1.45 -0.466 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.7 mm -87.31 107.78 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 -79.74 92.03 5.37 Favored 'General case' 0 N--CA 1.461 0.082 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 177.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.2 mt -75.79 162.53 28.1 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.794 0.838 . . . . 0.0 111.685 -178.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.3 p -137.28 162.1 34.44 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 171.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -53.25 -44.93 68.55 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.368 0.667 . . . . 0.0 109.965 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -56.01 -39.86 72.53 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.853 1.261 . . . . 0.0 111.564 178.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.35 -43.48 27.63 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 122.089 -0.382 . . . . 0.0 109.98 -177.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -31.05 -55.71 0.23 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 127.702 2.401 . . . . 0.0 114.773 -177.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -55.35 -36.37 66.22 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -177.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.0 m -90.26 -53.4 4.47 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.527 0.679 . . . . 0.0 109.305 179.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.21 -50.55 72.65 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 113.08 0.771 . . . . 0.0 113.08 -174.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.0 t -94.14 -60.29 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 123.467 0.707 . . . . 0.0 111.077 -174.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 65.3 mt -62.72 -24.17 67.54 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -174.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -114.82 32.39 6.03 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 174.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.88 143.72 41.57 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -99.52 36.25 1.81 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.776 1.23 . . . . 0.0 110.369 177.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 159.52 -157.17 28.34 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.42 118.46 26.89 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.706 1.602 . . . . 0.0 110.369 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.2 mt -119.72 120.79 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 C-N-CA 124.782 1.233 . . . . 0.0 109.017 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.41 ' C ' HD13 ' A' ' 24' ' ' LEU . 3.1 tm? -91.78 106.41 18.45 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 105.788 -1.931 . . . . 0.0 105.788 175.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 53.9 t -98.02 108.74 22.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 123.36 0.664 . . . . 0.0 109.407 -178.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -93.9 110.09 21.77 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 177.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -81.52 119.44 23.76 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 175.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 27.7 p-90 -136.1 173.32 11.84 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.665 1.186 . . . . 0.0 112.049 -175.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.29 150.84 37.38 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.546 1.138 . . . . 0.0 108.721 175.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -56.92 -51.25 69.85 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.682 1.193 . . . . 0.0 111.834 -178.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 63.9 p-90 -68.68 -24.31 64.49 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.006 0.922 . . . . 0.0 112.835 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 51.4 t -79.35 79.26 5.8 Favored 'General case' 0 N--CA 1.456 -0.167 0 O-C-N 121.506 -0.746 . . . . 0.0 110.807 -177.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -26.78 -61.52 0.08 OUTLIER Glycine 0 CA--C 1.536 1.383 0 C-N-CA 127.018 2.246 . . . . 0.0 114.852 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -45.05 -29.54 3.98 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 124.493 3.462 . . . . 0.0 115.227 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 78.4 m -56.35 -40.98 75.37 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 121.219 -0.926 . . . . 0.0 109.615 176.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -71.21 -20.38 62.27 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.972 0.909 . . . . 0.0 111.23 178.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -74.98 -46.63 33.95 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 175.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 35.7 pt -72.49 -31.36 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.785 178.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -37.73 -60.28 0.96 Allowed Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -57.15 -40.27 84.37 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.297 1.998 . . . . 0.0 111.547 178.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.5 mt -58.7 -51.59 70.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.7 mt -56.54 -41.01 76.08 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.059 0.544 . . . . 0.0 110.347 177.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -60.28 -48.98 79.41 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.554 0.616 . . . . 0.0 110.013 177.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -57.06 -51.03 70.89 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 29.8 mm -54.9 -46.31 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 123.089 0.555 . . . . 0.0 109.738 177.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.93 -41.04 70.55 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.327 0.512 . . . . 0.0 110.754 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -69.8 -56.32 7.45 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 176.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -50.31 -49.94 52.19 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.955 0.902 . . . . 0.0 112.544 -178.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -97.08 27.15 4.23 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.444 1.098 . . . . 0.0 111.564 -177.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -55.94 124.38 17.48 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 119.202 0.91 . . . . 0.0 110.626 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.57 -10.47 37.39 Favored Glycine 0 CA--C 1.534 1.241 0 CA-C-O 119.423 -0.654 . . . . 0.0 113.238 -178.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.5 mttm -99.67 -42.15 7.0 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.56 1.144 . . . . 0.0 109.241 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.1 tp -134.72 128.61 33.27 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.282 1.033 . . . . 0.0 108.315 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 55.6 m -87.18 103.76 15.73 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 176.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.7 t -79.48 131.28 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 178.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.99 151.39 49.86 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.604 0.762 . . . . 0.0 110.076 -177.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.8 mttm -128.86 141.83 51.16 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 177.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 tt -132.13 114.84 15.0 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.002 0.921 . . . . 0.0 108.784 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 -80.65 108.32 14.19 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.1 pt -71.63 -23.17 22.29 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -179.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -61.58 -47.75 84.05 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 63.6 mm-40 -75.65 -33.81 60.47 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.347 178.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -119.76 70.79 13.99 Favored Pre-proline 0 N--CA 1.465 0.306 0 C-N-CA 123.954 0.902 . . . . 0.0 112.003 -177.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -61.45 -48.74 8.82 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 121.761 1.641 . . . . 0.0 111.231 -179.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -41.36 -42.68 3.43 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.416 1.484 . . . . 0.0 115.16 -178.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.55 -25.32 67.93 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.193 0.997 . . . . 0.0 112.609 -177.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.66 -64.26 3.09 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-O 118.306 -0.854 . . . . 0.0 112.61 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -59.72 -37.16 89.05 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.075 1.85 . . . . 0.0 111.184 178.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -51.98 -31.12 27.97 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 118.633 0.651 . . . . 0.0 111.865 178.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -119.29 22.2 11.89 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.115 0.566 . . . . 0.0 111.646 176.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 46.0 42.73 12.17 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.46 1.028 . . . . 0.0 113.126 177.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mp -50.17 117.31 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 117.865 0.833 . . . . 0.0 109.447 176.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.3 -36.87 39.0 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.208 1.003 . . . . 0.0 111.279 -175.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -170.74 -174.18 38.48 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 105.339 -3.104 . . . . 0.0 105.339 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.2 pt -140.13 151.61 65.26 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-N 119.503 1.651 . . . . 0.0 109.855 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -67.77 149.65 83.41 Favored 'Cis proline' 0 N--CA 1.457 -0.665 0 CA-C-N 119.593 0.89 . . . . 0.0 111.357 -0.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.5 m -134.07 145.38 49.33 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 175.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.2 mt -121.73 131.79 54.27 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -118.41 117.53 29.29 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 104.47 -2.419 . . . . 0.0 104.47 174.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -93.77 97.32 10.35 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -89.74 107.17 18.94 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.223 1.409 . . . . 0.0 110.935 -177.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -96.12 109.08 21.57 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 173.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 34.6 m120 48.08 47.89 18.73 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.314 1.046 . . . . 0.0 112.079 -179.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 86.0 -17.35 37.41 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 118.636 -1.091 . . . . 0.0 114.275 178.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -95.04 129.72 42.01 Favored 'General case' 0 N--CA 1.457 -0.093 0 CA-C-N 119.576 1.688 . . . . 0.0 110.146 178.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 90.4 t -69.03 109.5 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 176.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.05 -39.14 34.7 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.86 170.87 19.8 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.7 t -145.98 159.04 43.8 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -138.52 146.61 42.15 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 126.374 1.87 . . . . 0.0 106.946 -177.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.0 t -129.23 134.43 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 107.375 -1.342 . . . . 0.0 107.375 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.94 174.64 50.49 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 123.54 0.591 . . . . 0.0 111.687 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.3 167.95 19.35 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 122.783 0.433 . . . . 0.0 109.949 178.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -159.61 165.79 32.04 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.2 1.0 . . . . 0.0 108.487 -179.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 84.6 p -81.14 163.91 22.76 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -58.58 -41.32 85.47 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 174.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -56.88 -55.72 28.68 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 177.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -57.19 -44.73 83.87 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 122.059 -0.671 . . . . 0.0 110.28 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 48.0 tp -60.1 -51.13 70.95 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 117.792 0.269 . . . . 0.0 110.49 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -52.11 -50.26 62.0 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.661 0.784 . . . . 0.0 110.09 178.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -59.99 -51.36 69.98 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.096 0.158 . . . . 0.0 110.637 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -52.15 -53.63 40.57 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.026 0.93 . . . . 0.0 110.564 179.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.2 -53.21 60.37 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 122.872 0.469 . . . . 0.0 110.479 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -52.55 -51.28 60.43 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.05 0.54 . . . . 0.0 111.145 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.28 -37.7 67.65 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.57 0.748 . . . . 0.0 111.733 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -78.43 -43.88 26.2 Favored 'General case' 0 CA--C 1.524 -0.054 0 O-C-N 122.315 -0.24 . . . . 0.0 110.782 -178.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 46.3 mt -59.79 -47.31 86.2 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.261 0 C-N-CA 123.214 0.606 . . . . 0.0 109.642 177.351 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.8 mt . . . . . 0 N--CA 1.452 -0.338 0 CA-C-O 120.714 0.292 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.8 mm -91.21 104.29 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 175.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -79.52 81.85 5.73 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 77.3 mt -65.46 163.89 14.96 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -173.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 50.6 p -140.26 161.28 38.05 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 126.453 1.901 . . . . 0.0 106.733 175.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -52.62 -48.16 66.52 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.557 1.143 . . . . 0.0 111.29 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -62.35 -38.07 88.07 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.741 0.416 . . . . 0.0 112.029 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.3 m -78.07 -29.54 49.22 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 122.213 -0.304 . . . . 0.0 110.696 -178.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -42.16 -48.68 4.85 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.069 1.747 . . . . 0.0 113.517 -178.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -51.64 -63.8 1.02 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 121.617 0.722 . . . . 0.0 110.916 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.2 m -68.44 -43.84 76.24 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.171 -175.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -74.76 -48.14 27.19 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -174.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.8 t -95.64 -58.96 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.116 0 C-N-CA 123.269 0.628 . . . . 0.0 111.879 -175.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 80.3 mt -64.07 -39.49 94.18 Favored 'General case' 0 C--N 1.334 -0.085 0 C-N-CA 119.681 -0.808 . . . . 0.0 111.435 -174.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -96.83 30.13 2.78 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 176.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.84 156.11 34.31 Favored 'General case' 0 C--N 1.342 0.255 0 O-C-N 121.887 -0.508 . . . . 0.0 111.082 178.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -131.09 56.37 1.8 Allowed 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 124.808 1.243 . . . . 0.0 108.161 176.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 163.91 -173.66 39.98 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -178.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.64 115.17 25.98 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.47 1.508 . . . . 0.0 110.077 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 mt -114.85 116.67 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 124.561 1.144 . . . . 0.0 109.755 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 19.9 tp -88.26 93.67 9.59 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 176.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.8 t -86.21 103.81 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 123.024 0.53 . . . . 0.0 109.705 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -88.32 107.68 18.95 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 175.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -79.68 126.17 30.58 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 174.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 35.7 p-90 -139.45 169.84 17.01 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.347 1.059 . . . . 0.0 113.286 -174.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.41 136.52 21.07 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.27 1.428 . . . . 0.0 108.517 178.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 50.6 mp0 -49.68 -50.92 41.7 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.874 0.869 . . . . 0.0 112.126 -178.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 62.6 p-90 -64.41 -25.61 68.1 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.294 0.638 . . . . 0.0 112.38 -177.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 51.3 t -79.88 78.84 6.46 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 121.575 -0.703 . . . . 0.0 110.243 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -25.02 -61.07 0.06 OUTLIER Glycine 0 CA--C 1.536 1.389 0 C-N-CA 127.2 2.333 . . . . 0.0 114.936 178.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_exo -42.17 -34.92 3.06 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 124.315 3.343 . . . . 0.0 114.581 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 82.9 m -57.34 -48.67 78.4 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 121.44 0.638 . . . . 0.0 109.919 177.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -65.33 -33.93 77.13 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.32 0.648 . . . . 0.0 109.651 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 24.0 mmt -64.74 -44.52 89.87 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 110.083 -0.339 . . . . 0.0 110.083 177.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 30.7 pt -76.47 -26.13 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-O 118.367 -0.825 . . . . 0.0 112.642 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -38.05 -58.08 1.53 Allowed Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 120.092 1.315 . . . . 0.0 114.328 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -57.7 -37.18 97.6 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.207 1.938 . . . . 0.0 111.771 177.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.9 mt -62.6 -49.42 83.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.8 mt -56.61 -41.11 76.49 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 177.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -61.13 -47.85 84.35 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.586 0.63 . . . . 0.0 109.986 176.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -56.18 -51.87 66.47 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.9 mm -54.66 -49.31 68.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 122.946 0.498 . . . . 0.0 110.071 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.09 -42.48 69.41 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.295 0.638 . . . . 0.0 110.431 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -67.9 -58.81 3.95 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.819 0.342 . . . . 0.0 110.2 177.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -50.75 -46.96 59.56 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.006 1.323 . . . . 0.0 112.602 -178.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -100.29 25.54 7.47 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.541 1.137 . . . . 0.0 111.215 -178.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -54.49 126.97 25.65 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.171 0.896 . . . . 0.0 110.749 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.28 -12.79 24.24 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-O 119.189 -0.784 . . . . 0.0 113.333 -178.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -99.59 -41.83 7.16 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 118.657 1.228 . . . . 0.0 109.363 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.3 tp -130.8 130.56 43.84 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.419 1.087 . . . . 0.0 108.134 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 65.0 m -91.23 102.76 15.48 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 176.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 99.2 t -79.24 140.57 16.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -139.17 147.04 41.32 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 121.859 -0.526 . . . . 0.0 109.834 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.4 mtmt -128.68 99.47 5.36 Favored 'General case' 0 N--CA 1.46 0.065 0 C-N-CA 124.512 1.125 . . . . 0.0 109.087 -178.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.4 tt -97.54 115.08 27.15 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 121.795 -0.565 . . . . 0.0 110.771 -175.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -79.9 109.55 14.44 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.257 -178.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.8 pt -72.4 -25.77 23.52 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -61.43 -47.66 84.75 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 119.448 1.022 . . . . 0.0 108.447 178.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -70.96 -38.71 72.8 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 124.787 1.235 . . . . 0.0 110.003 177.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -118.39 71.83 9.57 Favored Pre-proline 0 N--CA 1.464 0.269 0 C-N-CA 124.16 0.984 . . . . 0.0 111.478 -176.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -60.6 -53.8 2.52 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.167 1.912 . . . . 0.0 112.419 -177.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -36.86 -49.03 1.4 Allowed Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.385 1.469 . . . . 0.0 114.45 -177.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -51.73 -34.61 39.81 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.281 1.032 . . . . 0.0 113.095 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.52 -68.34 0.72 Allowed Pre-proline 0 CA--C 1.538 0.497 0 CA-C-O 118.174 -0.917 . . . . 0.0 112.654 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -60.34 -37.66 80.49 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 121.757 1.638 . . . . 0.0 110.988 177.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -51.44 -38.27 52.84 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 119.065 0.848 . . . . 0.0 111.51 178.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -108.97 19.91 19.03 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 122.857 0.463 . . . . 0.0 112.004 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 51.0 39.7 41.46 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.108 0.861 . . . . 0.0 113.323 177.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.44 129.9 19.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 118.02 0.91 . . . . 0.0 108.563 177.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -87.33 -47.7 8.59 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.342 1.057 . . . . 0.0 108.985 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -169.09 142.26 7.24 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 107.73 -2.148 . . . . 0.0 107.73 178.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.453 HD13 ' H ' ' A' ' 75' ' ' ILE . 0.2 OUTLIER -88.25 151.96 49.56 Favored Pre-proline 0 N--CA 1.454 -0.265 0 CA-C-O 118.514 -0.755 . . . . 0.0 109.907 179.373 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.23 134.85 27.89 Favored 'Cis proline' 0 N--CA 1.456 -0.727 0 CA-C-N 120.102 1.072 . . . . 0.0 111.452 -0.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.48 109.92 14.44 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.1 mt -89.56 94.06 9.72 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.212 1.005 . . . . 0.0 109.858 -178.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.1 mp -92.02 112.88 24.98 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 176.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.4 tp -90.02 94.75 9.92 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -86.33 105.96 17.04 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 125.077 1.351 . . . . 0.0 110.617 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -94.74 108.4 20.4 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 173.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 49.98 52.24 15.05 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.87 0.868 . . . . 0.0 110.756 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 79.44 -16.4 10.32 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 118.918 -0.935 . . . . 0.0 114.33 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -94.21 118.89 32.22 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 119.579 1.69 . . . . 0.0 110.31 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 86.5 t -62.99 106.87 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 175.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.4 -42.44 25.51 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.921 0.888 . . . . 0.0 110.222 -179.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -153.4 154.76 35.1 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 58.1 p -132.83 111.46 11.11 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.139 0.976 . . . . 0.0 108.832 -177.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -103.58 113.19 26.5 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-N 118.718 0.69 . . . . 0.0 109.936 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.0 t -88.58 124.51 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 176.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.91 171.66 32.79 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 121.637 0.576 . . . . 0.0 113.017 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.61 173.16 8.43 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.152 0.981 . . . . 0.0 112.291 -178.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 mt -151.28 160.28 43.89 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 125.856 1.662 . . . . 0.0 108.729 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.1 p -91.43 152.9 20.19 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 171.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -52.58 -47.44 66.87 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.892 -0.505 . . . . 0.0 112.341 -176.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.53 -53.37 41.77 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-N 118.42 0.554 . . . . 0.0 112.16 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -60.15 -43.4 95.78 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 122.285 -0.538 . . . . 0.0 110.34 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 33.0 tp -59.99 -50.44 73.73 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -54.56 -46.1 73.6 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 118.609 0.64 . . . . 0.0 110.747 177.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -57.77 -52.85 63.76 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 178.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -52.24 -50.65 61.6 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.147 0.979 . . . . 0.0 110.324 178.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 87.4 mt -59.33 -50.98 71.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 122.927 0.491 . . . . 0.0 110.383 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -54.94 -50.6 68.46 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 118.054 0.388 . . . . 0.0 110.258 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.68 -38.31 69.49 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.452 0.701 . . . . 0.0 111.603 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -77.99 -44.09 27.69 Favored 'General case' 0 C--O 1.227 -0.099 0 O-C-N 122.243 -0.286 . . . . 0.0 110.72 -178.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 46.3 mt -59.73 -48.14 82.85 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.27 0 C-N-CA 123.116 0.566 . . . . 0.0 109.685 177.323 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.1 mt . . . . . 0 N--CA 1.454 -0.27 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.9 mm -89.27 111.56 23.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 123.616 0.766 . . . . 0.0 109.5 178.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -81.05 110.96 17.08 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 50.1 mt -92.05 170.02 10.18 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.53 1.132 . . . . 0.0 110.78 -178.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 67.7 p -136.67 159.54 41.53 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 171.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -56.75 -42.3 79.09 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.044 0.449 . . . . 0.0 109.793 177.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -60.34 -46.97 88.04 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.825 1.25 . . . . 0.0 111.338 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 90.0 p -79.27 -26.18 42.41 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -176.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -36.84 -47.37 0.68 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 127.329 2.252 . . . . 0.0 114.233 -179.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -55.89 -47.42 77.44 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.662 0.744 . . . . 0.0 111.321 -178.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.0 m -77.42 -45.56 25.46 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 123.57 0.748 . . . . 0.0 109.925 -177.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -69.05 -53.97 17.58 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -175.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 41.2 t -94.84 -56.68 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 124.147 0.979 . . . . 0.0 111.857 -173.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 77.3 mt -63.78 -39.42 94.22 Favored 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 119.216 -0.994 . . . . 0.0 111.398 -175.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -96.22 32.06 2.05 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.305 0.502 . . . . 0.0 110.137 174.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.43 146.02 49.76 Favored 'General case' 0 C--N 1.343 0.289 0 O-C-N 121.627 -0.671 . . . . 0.0 112.262 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -99.7 23.39 9.65 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.796 1.638 . . . . 0.0 111.961 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 171.27 -157.61 28.38 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.758 -0.537 . . . . 0.0 111.758 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.58 112.12 20.67 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 126.033 1.733 . . . . 0.0 110.601 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 mt -112.36 117.94 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 124.41 1.084 . . . . 0.0 110.048 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.8 tp -90.01 97.37 11.15 Favored 'General case' 0 C--N 1.338 0.089 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 175.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 56.6 t -87.41 107.43 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 123.416 0.687 . . . . 0.0 110.303 -178.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -92.41 108.18 19.77 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.009 0.924 . . . . 0.0 109.269 176.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -80.34 125.72 30.25 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 105.831 -1.915 . . . . 0.0 105.831 174.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 31.0 p-90 -145.43 175.16 10.53 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.073 0.949 . . . . 0.0 112.253 -176.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.95 147.61 16.72 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 125.487 1.515 . . . . 0.0 108.728 175.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -49.84 -51.65 38.44 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.681 1.193 . . . . 0.0 112.3 -178.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -60.39 -29.95 69.27 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -177.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 46.9 t -79.84 77.59 6.48 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 121.659 -0.651 . . . . 0.0 110.589 -178.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -24.45 -62.04 0.05 OUTLIER Glycine 0 CA--C 1.536 1.368 0 C-N-CA 127.089 2.281 . . . . 0.0 115.141 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -42.81 -33.21 2.92 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 124.725 3.617 . . . . 0.0 114.933 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 99.4 m -53.74 -43.32 69.0 Favored 'General case' 0 CA--C 1.529 0.172 0 O-C-N 121.808 -0.557 . . . . 0.0 110.061 176.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -66.96 -26.84 67.02 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.632 0.773 . . . . 0.0 111.173 178.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 22.7 mmt -76.1 -43.93 41.03 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 28.8 pt -74.74 -29.73 23.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.854 177.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -38.48 -59.6 1.26 Allowed Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 113.877 1.065 . . . . 0.0 113.877 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -57.38 -39.89 85.86 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.364 2.042 . . . . 0.0 111.733 178.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 20.1 mt -58.77 -52.35 61.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 177.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 72.3 mt -56.27 -42.75 77.94 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.085 0.554 . . . . 0.0 110.684 178.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -60.36 -48.34 82.19 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.402 0.546 . . . . 0.0 110.203 178.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -57.9 -51.35 69.96 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 23.1 mm -54.73 -45.8 73.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.749 0.82 . . . . 0.0 109.666 178.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.75 -44.74 70.23 Favored 'General case' 0 C--O 1.227 -0.089 0 C-N-CA 123.008 0.523 . . . . 0.0 110.391 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -68.84 -55.78 10.05 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 121.162 -0.215 . . . . 0.0 110.767 177.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -49.09 -48.85 44.01 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.784 0.834 . . . . 0.0 111.968 -178.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -98.26 24.68 6.93 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.067 0.947 . . . . 0.0 111.519 -178.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -55.07 125.86 22.26 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.571 1.078 . . . . 0.0 110.758 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.56 -11.36 32.82 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 119.522 -0.599 . . . . 0.0 113.353 -178.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.6 mttp -99.73 -42.86 6.67 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.933 1.293 . . . . 0.0 108.734 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.3 tp -133.97 131.55 39.11 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.164 1.386 . . . . 0.0 107.687 178.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 89.9 m -91.92 101.99 14.56 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 176.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 72.5 t -79.22 132.83 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 177.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.19 152.42 51.81 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 123.073 0.549 . . . . 0.0 110.17 -177.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.9 mttm -126.52 139.43 53.23 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 tt -130.94 119.96 22.87 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -87.79 99.07 11.83 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.048 0.539 . . . . 0.0 110.504 -175.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 20.7 pt -58.52 -29.3 38.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 O-C-N 121.266 -0.896 . . . . 0.0 113.224 -177.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -61.19 -25.94 67.37 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.048 0.84 . . . . 0.0 111.697 177.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -114.02 -10.95 12.81 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.312 1.045 . . . . 0.0 111.038 178.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -133.94 57.57 25.76 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 124.892 1.277 . . . . 0.0 108.524 -177.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.71 -49.22 4.44 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.166 1.91 . . . . 0.0 112.976 -174.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -40.26 -40.55 1.9 Allowed Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.421 1.486 . . . . 0.0 114.564 -177.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.64 -30.37 67.24 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.971 -0.723 . . . . 0.0 112.636 -178.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.28 -65.1 2.32 Favored Pre-proline 0 CA--C 1.539 0.542 0 O-C-N 121.257 -0.902 . . . . 0.0 112.501 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -59.27 -35.09 97.89 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.09 1.86 . . . . 0.0 111.276 178.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -51.75 -32.41 30.66 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.203 0.91 . . . . 0.0 112.131 177.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -115.08 17.84 16.58 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.097 0.559 . . . . 0.0 111.387 176.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 48.29 41.09 23.31 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.658 1.123 . . . . 0.0 111.887 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 53.2 mt -66.05 138.42 23.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-O 121.344 0.592 . . . . 0.0 110.623 -177.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -79.18 -42.37 26.24 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.211 1.404 . . . . 0.0 111.322 -176.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -171.36 -154.83 10.12 Favored Glycine 0 C--N 1.334 0.417 0 N-CA-C 108.17 -1.972 . . . . 0.0 108.17 -178.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.6 pt -146.13 156.6 50.61 Favored Pre-proline 0 CA--C 1.536 0.422 0 CA-C-N 118.19 0.995 . . . . 0.0 108.495 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -70.45 141.85 69.36 Favored 'Cis proline' 0 N--CA 1.456 -0.681 0 CA-C-N 120.156 1.091 . . . . 0.0 109.95 -1.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.4 m -139.06 122.33 17.04 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 mt -103.83 120.15 40.39 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.932 1.293 . . . . 0.0 109.318 -176.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.9 mp -110.5 121.89 46.39 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 175.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 tp -94.64 95.52 8.82 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -88.68 103.99 16.46 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.429 1.492 . . . . 0.0 110.713 -178.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -91.74 106.55 18.56 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 173.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 35.0 m120 49.29 51.19 16.77 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.664 0.786 . . . . 0.0 111.029 -178.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 79.81 -15.45 14.9 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-O 118.839 -0.978 . . . . 0.0 114.369 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -92.62 120.17 32.79 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.503 1.651 . . . . 0.0 109.668 179.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 88.5 t -64.45 106.75 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 175.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.97 -39.28 34.8 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.479 0.712 . . . . 0.0 109.356 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -159.83 171.37 19.59 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.6 m -150.32 149.41 30.07 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -178.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.5 mmtm -135.09 131.25 36.71 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 126.047 1.739 . . . . 0.0 107.648 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.2 t -113.33 125.12 70.54 Favored 'Isoleucine or valine' 0 C--O 1.231 0.1 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 178.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.13 179.06 33.0 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -177.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.6 170.99 15.09 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.065 0.546 . . . . 0.0 111.202 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.2 mt -143.55 154.61 43.78 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 125.138 1.375 . . . . 0.0 108.698 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.9 p -84.47 148.86 26.32 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 170.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -49.47 -47.84 48.15 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 122.143 -0.348 . . . . 0.0 111.728 -177.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.21 -53.09 42.87 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 111.889 -0.484 . . . . 0.0 111.889 179.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -61.37 -42.16 98.26 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.132 -0.628 . . . . 0.0 110.844 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 33.8 tp -60.15 -51.64 68.73 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 177.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -56.49 -44.34 80.55 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.638 -0.664 . . . . 0.0 111.169 177.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -55.87 -54.29 46.37 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.604 0.762 . . . . 0.0 109.685 177.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -53.28 -52.05 60.3 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.947 1.299 . . . . 0.0 110.444 178.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.0 mt -58.7 -50.61 73.26 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 122.647 0.379 . . . . 0.0 110.574 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -55.09 -50.53 68.94 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 178.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.84 -37.95 69.4 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.322 0.649 . . . . 0.0 111.784 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -77.97 -43.22 30.34 Favored 'General case' 0 C--N 1.339 0.125 0 O-C-N 122.129 -0.357 . . . . 0.0 110.708 -178.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 49.1 mt -61.42 -47.21 86.81 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.293 0 C-N-CA 123.094 0.557 . . . . 0.0 109.686 177.441 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.4 m . . . . . 0 CA--C 1.532 0.254 0 N-CA-C 113.024 0.749 . . . . 0.0 113.024 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -34.91 -47.31 0.35 Allowed 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 127.003 2.121 . . . . 0.0 112.798 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -129.37 44.51 2.96 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.336 0.654 . . . . 0.0 110.51 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.5 mt -121.15 139.13 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 O-C-N 121.947 -0.471 . . . . 0.0 110.45 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.5 mm -88.0 112.67 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 123.324 0.65 . . . . 0.0 109.488 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -83.52 106.43 15.25 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.75 -0.594 . . . . 0.0 109.662 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 43.0 mt -89.15 164.04 15.18 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.799 1.24 . . . . 0.0 111.14 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 35.0 p -136.78 167.16 21.97 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 175.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -58.33 -46.51 86.08 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 177.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -57.26 -46.79 82.71 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.976 0.911 . . . . 0.0 111.322 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.1 p -78.64 -25.63 45.03 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.932 -176.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -43.41 -46.81 6.81 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.59 1.556 . . . . 0.0 113.123 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -49.07 -65.69 0.53 Allowed 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 121.791 0.805 . . . . 0.0 110.48 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -71.37 -44.62 64.65 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.058 -174.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -73.14 -37.36 66.64 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -173.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.8 t -108.99 -60.42 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.058 0 C-N-CA 123.151 0.58 . . . . 0.0 110.706 -176.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 84.0 mt -63.73 -36.38 83.66 Favored 'General case' 0 C--N 1.334 -0.088 0 C-N-CA 120.029 -0.668 . . . . 0.0 112.597 -174.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -99.95 28.03 5.1 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.673 0.669 . . . . 0.0 110.148 176.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -74.84 172.53 12.04 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.959 0.885 . . . . 0.0 112.263 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -141.96 129.63 21.55 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 171.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.4 -172.0 27.21 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -175.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -98.15 120.43 38.54 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.064 1.346 . . . . 0.0 111.206 -177.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.7 mt -118.13 120.22 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 124.863 1.265 . . . . 0.0 109.01 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -93.42 107.77 19.55 Favored 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 176.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.1 t -98.38 109.4 23.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 123.503 0.721 . . . . 0.0 109.415 -178.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -93.59 108.8 20.46 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 123.669 0.788 . . . . 0.0 108.881 176.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -78.78 128.52 33.51 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 25.7 p-90 -145.43 173.7 11.77 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.623 0.769 . . . . 0.0 112.819 -176.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.51 144.37 22.74 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 125.593 1.557 . . . . 0.0 107.81 176.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -47.63 -51.09 22.59 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.533 1.133 . . . . 0.0 112.307 -177.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 62.2 p-90 -65.31 -23.76 67.1 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.819 0.847 . . . . 0.0 112.621 -178.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 35.3 t -79.91 72.83 6.68 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 121.482 -0.761 . . . . 0.0 111.481 -176.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -21.2 -64.17 0.02 OUTLIER Glycine 0 CA--C 1.537 1.462 0 C-N-CA 127.57 2.509 . . . . 0.0 116.043 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -48.55 -29.09 13.24 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 123.419 2.746 . . . . 0.0 114.443 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.8 m -59.26 -44.71 92.39 Favored 'General case' 0 N--CA 1.462 0.154 0 O-C-N 121.508 -0.745 . . . . 0.0 109.558 176.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -66.65 -36.24 82.08 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.562 0.745 . . . . 0.0 109.017 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 26.0 ttt -62.97 -46.34 88.16 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 119.614 -0.232 . . . . 0.0 110.48 177.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 38.3 pt -75.34 -28.02 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-O 118.417 -0.802 . . . . 0.0 112.363 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -37.11 -58.68 1.09 Allowed Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -58.05 -41.42 68.17 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.025 1.817 . . . . 0.0 111.4 177.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.0 mt -57.8 -51.16 73.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.6 mt -55.71 -41.36 73.7 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.108 0.563 . . . . 0.0 110.359 177.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -63.37 -45.95 88.77 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.226 0.921 . . . . 0.0 111.07 176.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -57.18 -50.56 72.46 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 25.8 mm -54.32 -50.18 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 C-N-CA 123.533 0.733 . . . . 0.0 109.303 176.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.16 -48.71 64.79 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 122.096 -0.377 . . . . 0.0 110.268 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -60.37 -55.23 36.13 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 122.448 0.299 . . . . 0.0 110.677 178.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -54.0 -44.96 71.34 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.093 0.957 . . . . 0.0 112.221 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -98.59 29.83 3.52 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.395 1.078 . . . . 0.0 111.943 -177.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -54.24 127.27 26.31 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.363 -0.836 . . . . 0.0 109.901 177.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.52 -13.62 16.02 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 119.234 -0.759 . . . . 0.0 113.188 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -99.61 -39.37 8.33 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 118.567 1.184 . . . . 0.0 109.994 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.9 tp -137.67 129.7 28.92 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 123.134 0.574 . . . . 0.0 110.272 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.8 m -89.83 101.57 14.27 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 175.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 91.8 t -79.83 130.19 36.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.81 154.43 51.2 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 123.673 0.789 . . . . 0.0 111.134 -177.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -127.49 143.78 51.15 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.306 1.442 . . . . 0.0 107.418 177.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.5 tt -132.32 115.01 15.08 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -80.23 104.35 10.73 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 122.38 0.272 . . . . 0.0 110.656 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.0 pt -70.23 -28.72 36.67 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.28 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -57.21 -45.95 83.33 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 119.103 0.865 . . . . 0.0 108.844 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.49 -38.41 59.53 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.221 0.608 . . . . 0.0 109.943 177.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -117.15 67.36 4.48 Favored Pre-proline 0 CA--C 1.534 0.335 0 C-N-CA 124.252 1.021 . . . . 0.0 112.173 -175.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -58.47 -47.8 17.88 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.476 2.117 . . . . 0.0 112.465 -176.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -40.49 -34.95 0.74 Allowed Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.863 1.696 . . . . 0.0 115.237 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 75.2 p -61.4 -38.72 88.09 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 117.795 0.798 . . . . 0.0 111.643 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.486 ' HB3' ' HD3' ' A' ' 68' ' ' PRO 0.284 . . -56.95 -62.76 4.52 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-O 118.071 -0.966 . . . . 0.0 111.571 -179.351 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.486 ' HD3' ' HB3' ' A' ' 67' ' ' ALA . 51.5 Cg_exo -49.07 -50.75 12.03 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.822 2.348 . . . . 0.0 111.525 173.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -51.88 -41.26 61.75 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -104.15 20.69 17.84 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 118.286 0.494 . . . . 0.0 111.75 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 44.79 42.03 7.51 Favored Glycine 0 C--N 1.341 0.844 0 C-N-CA 124.245 0.926 . . . . 0.0 111.624 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.7 mm -57.97 122.66 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-O 121.156 0.503 . . . . 0.0 110.091 -177.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 50.8 mmt-85 -79.7 -40.02 29.93 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.663 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -179.76 146.32 6.95 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 108.335 -1.906 . . . . 0.0 108.335 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.2 pt -93.67 153.43 41.16 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 123.876 0.87 . . . . 0.0 110.769 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.25 139.64 51.1 Favored 'Cis proline' 0 N--CA 1.458 -0.61 0 CA-C-N 119.614 0.898 . . . . 0.0 110.96 -1.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.8 112.98 16.01 Favored 'General case' 0 CA--C 1.523 -0.077 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.2 mt -94.81 122.05 37.03 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -114.61 117.97 32.37 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 177.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.5 tp -94.93 97.85 10.29 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -89.98 110.56 21.53 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.187 1.395 . . . . 0.0 111.288 -177.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -96.68 114.23 25.85 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 171.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.9 m120 47.24 48.66 15.97 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.011 0.524 . . . . 0.0 111.518 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 76.72 -6.8 37.42 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 118.737 -1.035 . . . . 0.0 115.083 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -102.03 126.32 48.94 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 119.575 1.687 . . . . 0.0 109.541 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 92.4 t -66.18 108.55 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.35 -41.07 28.69 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.947 0.899 . . . . 0.0 109.372 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -157.65 171.86 19.57 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.2 t -152.76 164.0 38.63 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -145.04 126.89 15.37 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.467 1.507 . . . . 0.0 107.398 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.2 t -101.58 122.89 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 174.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.49 175.54 32.67 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 -178.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.5 174.25 9.23 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.619 0.767 . . . . 0.0 111.733 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.1 mt -147.04 156.01 42.68 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.708 1.603 . . . . 0.0 107.962 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.9 p -87.09 154.8 20.46 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.357 -1.719 . . . . 0.0 106.357 171.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -49.58 -51.83 34.39 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 122.089 -0.382 . . . . 0.0 111.654 -177.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.05 -58.12 13.96 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -56.1 -41.29 75.0 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 122.411 -0.464 . . . . 0.0 110.927 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 37.2 tp -62.42 -49.37 75.76 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -55.24 -47.1 75.88 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.474 0.579 . . . . 0.0 110.356 177.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -57.11 -53.93 52.56 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.124 0.57 . . . . 0.0 110.397 178.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -52.65 -52.34 56.08 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.899 1.28 . . . . 0.0 110.857 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 76.0 mt -62.51 -50.87 69.66 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 122.176 -0.327 . . . . 0.0 110.305 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -53.57 -48.98 68.67 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.358 0.663 . . . . 0.0 110.771 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.56 -34.51 67.19 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.792 0.837 . . . . 0.0 111.607 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -78.94 -48.06 15.25 Favored 'General case' 0 C--O 1.228 -0.07 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 45.0 mt -58.39 -45.34 88.52 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.415 0.686 . . . . 0.0 110.827 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.172 0 C-N-CA 124.847 1.259 . . . . 0.0 111.711 179.135 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 37.3 p . . . . . 0 N--CA 1.454 -0.231 0 CA-C-O 120.765 0.317 . . . . 0.0 110.822 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -166.87 -136.88 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.76 1.624 . . . . 0.0 107.392 -177.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -81.67 54.47 2.4 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 119.3 0.955 . . . . 0.0 108.665 178.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 15.7 mt -125.02 140.62 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 C-N-CA 124.138 0.975 . . . . 0.0 108.701 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.1 mm -87.4 104.76 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 177.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -79.44 80.6 5.8 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 177.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 77.6 mt -63.88 163.41 11.98 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.049 0.94 . . . . 0.0 113.208 -175.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 47.4 p -138.31 165.8 25.83 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 126.08 1.752 . . . . 0.0 106.506 174.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -55.23 -47.34 75.51 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.476 0.71 . . . . 0.0 110.932 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -63.72 -38.73 92.21 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.0 p -77.98 -32.5 51.35 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.03 0.377 . . . . 0.0 110.482 -177.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -36.61 -48.78 0.72 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.273 1.829 . . . . 0.0 113.364 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -49.36 -65.37 0.58 Allowed 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 121.961 0.886 . . . . 0.0 111.163 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.3 m -72.29 -45.21 61.0 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.569 -174.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -76.2 -21.83 55.99 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -174.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 45.9 t -120.77 -62.86 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.094 0 CA-C-N 119.548 1.067 . . . . 0.0 109.947 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 72.1 mt -58.81 -37.32 76.11 Favored 'General case' 0 CA--C 1.528 0.098 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -174.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -95.72 14.42 23.21 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 118.587 0.63 . . . . 0.0 111.924 177.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.38 103.36 16.01 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 119.073 0.852 . . . . 0.0 112.367 -178.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -76.31 72.67 3.08 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 174.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -174.63 179.39 45.97 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.95 118.76 32.34 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.489 1.516 . . . . 0.0 109.987 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.6 mt -127.57 115.97 41.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 124.796 1.239 . . . . 0.0 110.73 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 35.0 tp -83.53 96.41 8.6 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 174.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.4 t -86.51 105.85 15.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 122.999 0.519 . . . . 0.0 109.872 -179.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -91.35 112.42 24.33 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 176.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -85.05 120.82 26.99 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 173.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 21.9 p-90 -138.88 177.66 7.73 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.983 0.913 . . . . 0.0 112.351 -174.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -150.94 150.16 30.5 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.472 1.509 . . . . 0.0 107.716 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -62.84 -50.3 71.51 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.852 0.358 . . . . 0.0 111.308 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 63.9 p-90 -62.25 -26.25 68.28 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.489 0.716 . . . . 0.0 112.743 -178.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.6 t -79.16 77.68 5.65 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 121.554 -0.716 . . . . 0.0 109.829 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -22.15 -63.12 0.03 OUTLIER Glycine 0 CA--C 1.534 1.276 0 C-N-CA 127.661 2.553 . . . . 0.0 115.198 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -42.58 -36.0 4.4 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 124.503 3.469 . . . . 0.0 114.525 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 80.5 m -53.92 -46.06 71.36 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 121.508 0.67 . . . . 0.0 109.956 176.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.91 -24.47 63.38 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.348 0.659 . . . . 0.0 110.967 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 23.1 mmt -74.2 -43.92 55.33 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 30.4 pt -75.2 -27.23 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 118.905 -0.569 . . . . 0.0 111.694 177.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -36.6 -60.06 0.8 Allowed Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -56.89 -40.6 83.0 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.224 1.949 . . . . 0.0 111.918 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.0 mt -58.79 -50.72 78.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.7 mt -56.12 -43.77 78.5 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.592 0.357 . . . . 0.0 110.201 177.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -58.5 -49.59 76.82 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.255 0.55 . . . . 0.0 109.794 178.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -56.13 -52.07 65.68 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 31.7 mm -54.04 -50.01 56.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 123.066 0.547 . . . . 0.0 109.869 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.24 -46.47 65.73 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.219 0.608 . . . . 0.0 110.603 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -66.13 -56.91 9.1 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 178.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -47.25 -49.89 22.47 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.711 1.204 . . . . 0.0 112.329 -178.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -99.69 26.19 6.45 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.149 0.58 . . . . 0.0 111.705 -178.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.54 111.85 0.99 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.253 0.933 . . . . 0.0 111.022 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.35 -15.84 61.61 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.01 0.814 . . . . 0.0 112.243 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -99.52 -39.17 8.46 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.943 1.297 . . . . 0.0 109.158 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 46.9 tp -140.2 130.64 25.39 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 178.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 91.0 m -91.09 145.92 24.28 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 105.836 -1.912 . . . . 0.0 105.836 174.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 94.9 t -120.54 141.28 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 177.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.86 148.82 50.22 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.127 0.571 . . . . 0.0 109.889 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -127.33 96.57 4.61 Favored 'General case' 0 C--O 1.23 0.066 0 C-N-CA 124.906 1.283 . . . . 0.0 108.91 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 tt -96.7 109.4 22.05 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -176.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -80.45 108.61 14.22 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.934 -178.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.7 pt -64.46 -25.31 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-O 119.1 -0.476 . . . . 0.0 111.644 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -53.65 -25.72 19.19 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.825 0.739 . . . . 0.0 111.966 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -119.01 3.03 11.52 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.015 0.926 . . . . 0.0 110.89 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -147.23 62.75 7.5 Favored Pre-proline 0 CA--C 1.529 0.137 0 C-N-CA 124.614 1.166 . . . . 0.0 109.523 -177.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -61.82 -52.07 3.31 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 121.776 1.651 . . . . 0.0 111.285 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -40.83 -43.11 3.05 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.529 1.538 . . . . 0.0 114.918 -177.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.31 -31.12 67.22 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 117.808 0.804 . . . . 0.0 111.788 -178.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.36 -67.24 0.92 Allowed Pre-proline 0 CA--C 1.539 0.529 0 CA-C-O 118.276 -0.869 . . . . 0.0 112.619 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -60.0 -38.47 78.05 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 121.72 1.613 . . . . 0.0 110.882 178.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -52.25 -38.56 58.5 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 118.874 0.761 . . . . 0.0 111.484 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -106.67 19.77 20.0 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.657 0.383 . . . . 0.0 111.999 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.23 38.05 55.97 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.111 0.862 . . . . 0.0 113.528 176.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.38 129.23 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -89.79 -48.84 6.99 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.45 1.1 . . . . 0.0 110.095 -178.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -162.14 146.5 12.09 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 107.285 -2.326 . . . . 0.0 107.285 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.3 pt -98.55 149.14 35.44 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 123.461 0.704 . . . . 0.0 110.048 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.17 139.47 53.05 Favored 'Cis proline' 0 N--CA 1.455 -0.772 0 CA-C-N 119.873 0.99 . . . . 0.0 111.094 -0.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.77 139.49 52.23 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 176.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.6 mt -118.46 106.07 12.32 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.0 mp -100.16 113.23 25.73 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 176.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.9 tp -90.23 101.8 14.52 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -86.53 143.2 27.83 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.556 1.143 . . . . 0.0 109.166 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -140.96 110.42 6.33 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 175.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.1 t30 55.73 67.93 0.94 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 121.438 0.637 . . . . 0.0 110.337 -177.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.31 -31.76 0.26 Allowed Glycine 0 CA--C 1.533 1.187 0 N-CA-C 117.04 1.576 . . . . 0.0 117.04 176.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -97.71 155.03 17.2 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 119.5 1.65 . . . . 0.0 111.224 -177.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 93.3 t -76.19 118.31 22.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.93 -47.13 15.53 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 123.662 0.785 . . . . 0.0 109.177 177.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -156.77 171.9 19.57 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 123.944 0.898 . . . . 0.0 108.689 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 90.8 m -149.96 148.86 29.59 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 122.01 -0.431 . . . . 0.0 110.111 -178.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -130.59 151.14 51.38 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 126.314 1.846 . . . . 0.0 107.62 177.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.2 t -129.96 131.64 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -178.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.95 -178.58 45.2 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 111.439 -0.665 . . . . 0.0 111.439 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.75 165.72 24.28 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.836 0.454 . . . . 0.0 110.894 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.5 mt -145.05 151.41 38.5 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.662 1.185 . . . . 0.0 108.533 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.4 p -84.52 149.42 25.93 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 172.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -51.71 -45.04 63.42 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-O 119.481 -0.295 . . . . 0.0 111.648 -177.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.92 -55.34 29.58 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 118.343 0.52 . . . . 0.0 111.844 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -56.81 -47.67 79.73 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 122.048 -0.678 . . . . 0.0 110.077 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 48.4 tp -56.77 -51.59 68.3 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 119.539 -0.267 . . . . 0.0 110.489 178.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.1 mmmp? -51.93 -49.45 63.08 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.279 0.631 . . . . 0.0 110.336 177.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -58.87 -50.37 74.27 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 110.558 -0.164 . . . . 0.0 110.558 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -53.9 -53.01 58.58 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.546 0.739 . . . . 0.0 110.865 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.8 mt -59.97 -49.95 75.68 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 122.726 0.41 . . . . 0.0 110.377 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -54.74 -50.73 67.66 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 117.844 0.293 . . . . 0.0 110.353 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.75 -36.92 70.32 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.577 0.751 . . . . 0.0 111.696 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -77.7 -42.98 32.55 Favored 'General case' 0 C--O 1.227 -0.082 0 O-C-N 122.205 -0.309 . . . . 0.0 110.367 -178.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 47.3 mt -61.75 -47.37 85.52 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.29 0 C-N-CA 123.208 0.603 . . . . 0.0 109.644 177.518 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.454 -0.263 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 21.6 t0 60.79 -73.53 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 126.38 1.872 . . . . 0.0 112.002 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -102.42 -19.99 14.73 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.677 1.191 . . . . 0.0 110.955 177.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.2 mt -79.45 133.7 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-N 118.118 0.417 . . . . 0.0 110.129 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.5 mm -90.97 111.41 23.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 124.419 1.088 . . . . 0.0 109.387 178.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -82.37 101.44 10.6 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 67.1 mt -85.09 162.9 19.11 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.697 0.799 . . . . 0.0 111.849 -177.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 48.0 p -137.64 165.67 25.79 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 126.042 1.737 . . . . 0.0 106.406 175.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -56.58 -44.02 80.63 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.853 -0.529 . . . . 0.0 110.216 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -59.28 -44.16 92.49 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.025 0.93 . . . . 0.0 112.192 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.1 p -78.79 -30.94 45.79 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 122.107 -0.371 . . . . 0.0 111.003 -177.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -36.36 -56.48 0.78 Allowed 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 126.37 1.868 . . . . 0.0 114.092 -178.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -54.29 -57.59 10.64 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 121.822 -0.549 . . . . 0.0 110.953 -177.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.3 m -62.02 -47.62 83.97 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.708 0.803 . . . . 0.0 112.446 -177.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.16 -50.68 13.92 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -175.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.4 t -90.97 -57.05 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 124.048 0.939 . . . . 0.0 112.533 -173.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 72.2 mt -66.76 -41.06 88.38 Favored 'General case' 0 CA--C 1.523 -0.074 0 C-N-CA 119.564 -0.854 . . . . 0.0 110.918 -174.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -93.0 30.67 1.56 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 122.64 0.376 . . . . 0.0 110.041 176.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.0 156.66 36.82 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.766 -0.584 . . . . 0.0 110.826 177.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -131.69 55.18 1.88 Allowed 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 124.699 1.2 . . . . 0.0 108.109 176.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 164.5 -173.01 40.41 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.506 -1.037 . . . . 0.0 110.506 -178.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.95 113.65 23.81 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.543 1.537 . . . . 0.0 109.947 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.5 mt -113.52 117.46 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 124.258 1.023 . . . . 0.0 109.479 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.7 tp -89.72 96.32 10.64 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 177.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.7 t -89.32 109.35 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 123.427 0.691 . . . . 0.0 109.629 -179.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -93.58 105.36 17.41 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -79.18 123.95 27.88 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 175.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 24.5 p-90 -138.93 172.69 12.49 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 124.292 1.037 . . . . 0.0 111.943 -175.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.99 147.79 32.05 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.297 1.039 . . . . 0.0 108.651 175.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -54.61 -52.23 62.84 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.904 0.882 . . . . 0.0 111.78 -178.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 61.4 p-90 -67.25 -21.58 65.71 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.958 0.903 . . . . 0.0 112.747 -178.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 46.0 t -79.58 70.0 5.98 Favored 'General case' 0 N--CA 1.456 -0.144 0 O-C-N 121.38 -0.825 . . . . 0.0 110.935 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -16.14 -65.59 0.01 OUTLIER Glycine 0 CA--C 1.534 1.266 0 C-N-CA 128.253 2.835 . . . . 0.0 115.903 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -42.95 -32.38 2.65 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 124.532 3.488 . . . . 0.0 115.036 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 99.6 m -53.9 -44.73 70.76 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.221 0.608 . . . . 0.0 110.121 176.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -67.33 -26.6 66.58 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.323 0.649 . . . . 0.0 111.13 178.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 23.3 mmt -74.54 -43.68 54.64 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 19.6 pt -74.95 -28.95 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 119.006 -0.521 . . . . 0.0 111.922 178.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -38.67 -59.45 1.34 Allowed Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -56.6 -40.08 86.91 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.158 1.905 . . . . 0.0 111.441 177.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 16.3 mt -58.85 -48.82 85.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 74.7 mt -57.25 -43.67 83.16 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 119.415 -0.326 . . . . 0.0 110.352 177.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -60.02 -48.09 83.13 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.839 0.745 . . . . 0.0 110.446 177.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -57.01 -52.16 66.38 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.2 mm -55.44 -45.06 78.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 124.102 0.961 . . . . 0.0 110.017 178.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.51 -41.71 73.47 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 123.048 0.539 . . . . 0.0 110.05 178.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -67.67 -55.13 14.44 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 176.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -48.06 -48.99 33.02 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.903 0.881 . . . . 0.0 112.068 -178.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -103.2 28.87 5.95 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.654 0.782 . . . . 0.0 111.594 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -55.37 126.53 25.43 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.152 0.887 . . . . 0.0 111.212 -178.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.36 -13.13 29.16 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 119.237 -0.757 . . . . 0.0 113.21 -178.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -99.8 -43.93 6.26 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.455 1.127 . . . . 0.0 109.357 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.9 tp -125.4 125.5 43.5 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.755 1.222 . . . . 0.0 108.025 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 60.4 m -87.59 101.84 14.02 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 176.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.6 t -79.39 131.74 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.66 151.65 48.49 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 122.635 0.374 . . . . 0.0 110.096 -178.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -128.69 135.43 49.24 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 tt -124.54 113.62 18.33 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.645 0.778 . . . . 0.0 109.223 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -79.39 108.89 13.25 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.1 pt -70.74 -22.59 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -58.16 -48.47 80.17 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.221 0.919 . . . . 0.0 109.092 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -79.88 -31.76 40.34 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.914 0.885 . . . . 0.0 110.367 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -119.26 67.11 8.97 Favored Pre-proline 0 N--CA 1.463 0.219 0 C-N-CA 123.482 0.713 . . . . 0.0 112.082 -176.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.1 -47.04 8.94 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 121.877 1.718 . . . . 0.0 110.966 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -41.2 -41.0 2.7 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.756 1.646 . . . . 0.0 115.038 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.77 -27.08 68.65 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.158 0.979 . . . . 0.0 112.639 -178.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.8 -63.0 4.63 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 118.347 -0.835 . . . . 0.0 113.053 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -60.56 -37.03 83.27 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.151 1.901 . . . . 0.0 111.464 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -51.99 -31.43 29.35 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.813 0.733 . . . . 0.0 112.003 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -118.56 19.34 13.31 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.25 0.62 . . . . 0.0 111.658 177.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 47.35 43.59 19.9 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.46 1.029 . . . . 0.0 113.308 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.6 mp -53.49 117.66 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 117.908 0.854 . . . . 0.0 109.181 177.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 29.3 mmm180 -79.8 -45.48 18.7 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.238 1.015 . . . . 0.0 110.807 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -164.17 147.25 12.5 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 107.819 -2.112 . . . . 0.0 107.819 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.6 pt -100.27 152.82 37.94 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 123.913 0.885 . . . . 0.0 110.101 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -68.66 142.18 66.06 Favored 'Cis proline' 0 N--CA 1.456 -0.697 0 CA-C-N 119.519 0.864 . . . . 0.0 110.454 -1.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.37 109.82 15.35 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.3 mt -89.53 93.08 9.36 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.925 0.89 . . . . 0.0 109.781 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.2 mp -91.28 115.84 28.35 Favored 'General case' 0 CA--C 1.522 -0.105 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.3 tp -92.6 96.0 9.94 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -87.51 104.5 16.53 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.026 1.33 . . . . 0.0 110.226 -178.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -93.42 108.48 20.14 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 174.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 49.95 50.48 18.4 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.707 0.803 . . . . 0.0 110.626 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 79.75 -14.19 20.12 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 118.879 -0.956 . . . . 0.0 114.565 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -94.82 121.34 36.31 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 119.591 1.695 . . . . 0.0 110.141 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 98.3 t -64.15 104.86 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 175.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.31 -38.03 36.26 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.862 0.865 . . . . 0.0 109.813 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -155.44 166.17 34.37 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.71 0.804 . . . . 0.0 108.899 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 69.7 m -147.79 117.96 7.31 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.629 0.772 . . . . 0.0 108.986 -178.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -104.74 112.5 25.63 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.2 t -90.32 124.15 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 177.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.65 168.44 36.79 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 123.804 0.716 . . . . 0.0 112.249 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.62 166.23 19.49 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.082 0.553 . . . . 0.0 110.244 179.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -155.63 170.69 21.43 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.695 0.798 . . . . 0.0 109.863 -177.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 80.9 p -86.18 162.81 18.16 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 177.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.01 -39.01 80.57 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 175.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -57.06 -56.36 25.44 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 177.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -54.22 -46.56 72.54 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.942 0.371 . . . . 0.0 110.225 178.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 22.8 tp -59.06 -50.25 74.79 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 121.283 -0.167 . . . . 0.0 110.765 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.9 mmmm -54.53 -48.84 71.5 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.723 -0.611 . . . . 0.0 111.338 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -65.95 -43.5 87.78 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 119.584 -0.846 . . . . 0.0 111.022 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -53.24 -52.24 59.59 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.158 0.583 . . . . 0.0 109.497 177.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.8 mt -58.73 -55.19 38.27 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 122.743 0.417 . . . . 0.0 110.3 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -51.24 -50.53 59.02 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.04 0.382 . . . . 0.0 111.13 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.14 -38.45 70.84 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.397 0.679 . . . . 0.0 111.807 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -78.5 -43.48 26.83 Favored 'General case' 0 C--O 1.228 -0.048 0 O-C-N 122.199 -0.313 . . . . 0.0 111.049 -178.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 69.5 mt -63.58 -45.63 89.53 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.2 0 C-N-CA 122.909 0.483 . . . . 0.0 109.832 177.745 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.415 ' H1 ' ' CD2' ' A' ' 6' ' ' HIS . 13.2 m . . . . . 0 N--CA 1.452 -0.356 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 36.0 t70 58.6 -71.79 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 127.244 2.218 . . . . 0.0 112.267 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -84.91 -33.04 22.81 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.991 0.917 . . . . 0.0 109.791 176.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 16.6 mt -79.82 135.8 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.2 mm -90.31 114.43 27.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.433 1.093 . . . . 0.0 109.297 177.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.415 ' CD2' ' H1 ' ' A' ' 1' ' ' SER . 11.1 m-70 -84.54 104.82 14.86 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.3 mt -87.84 163.79 16.23 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.598 1.159 . . . . 0.0 111.679 -178.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 61.3 p -138.48 165.19 27.46 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 126.257 1.823 . . . . 0.0 106.385 174.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -55.13 -44.69 75.28 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.128 0.571 . . . . 0.0 110.104 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -59.82 -43.83 94.32 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.867 0.867 . . . . 0.0 112.383 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.8 p -78.75 -30.47 45.75 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 122.152 -0.342 . . . . 0.0 111.22 -177.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -36.76 -54.77 0.9 Allowed 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 126.407 1.883 . . . . 0.0 114.017 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -54.07 -57.66 10.23 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.265 0.555 . . . . 0.0 111.132 -178.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.4 m -63.79 -48.07 78.37 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.385 0.674 . . . . 0.0 112.059 -177.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.59 -52.26 12.27 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -175.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.7 t -89.63 -56.22 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 123.891 0.876 . . . . 0.0 112.203 -174.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 66.6 mt -66.15 -42.7 88.7 Favored 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 119.489 -0.884 . . . . 0.0 111.168 -175.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -91.98 31.72 1.22 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 118.045 0.384 . . . . 0.0 110.18 175.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.68 143.67 57.14 Favored 'General case' 0 C--N 1.341 0.208 0 O-C-N 121.538 -0.726 . . . . 0.0 112.172 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -108.7 54.33 0.66 Allowed 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.495 1.118 . . . . 0.0 108.769 176.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 150.46 -160.47 28.58 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 123.759 0.695 . . . . 0.0 111.566 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.51 122.45 34.1 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 126.103 1.761 . . . . 0.0 110.356 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.5 mt -122.62 122.39 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 124.732 1.213 . . . . 0.0 109.18 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.418 ' C ' HD13 ' A' ' 24' ' ' LEU . 2.9 tm? -93.47 106.87 18.8 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 175.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 42.6 t -97.46 110.33 25.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -92.15 103.58 16.05 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 176.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -78.92 118.05 20.57 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 104.046 -2.576 . . . . 0.0 104.046 175.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 34.5 p-90 -130.66 168.71 16.69 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 124.545 1.138 . . . . 0.0 111.933 -175.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -141.49 143.05 33.61 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.087 1.355 . . . . 0.0 108.304 176.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -58.3 -49.13 78.24 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.261 1.024 . . . . 0.0 112.171 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.469 ' CH2' HD11 ' A' ' 75' ' ' ILE . 50.9 p-90 -63.96 -28.11 69.6 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.519 0.728 . . . . 0.0 112.358 -178.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.6 t -79.59 79.18 6.09 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 121.556 -0.715 . . . . 0.0 110.643 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -24.17 -62.88 0.05 OUTLIER Glycine 0 CA--C 1.535 1.324 0 C-N-CA 127.074 2.273 . . . . 0.0 114.44 178.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -40.46 -33.71 1.0 Allowed 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 125.035 3.823 . . . . 0.0 115.503 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 99.8 m -53.67 -43.04 68.54 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.589 0.709 . . . . 0.0 109.995 177.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -69.05 -26.89 65.19 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.411 1.084 . . . . 0.0 110.973 178.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -75.58 -43.15 49.78 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 33.7 pt -72.79 -29.85 31.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.607 177.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -37.81 -60.46 0.94 Allowed Pre-proline 0 CA--C 1.545 0.769 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -56.32 -39.35 91.88 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.363 2.042 . . . . 0.0 111.938 177.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 21.0 mt -59.61 -52.69 57.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 177.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 60.8 mt -55.12 -40.58 70.66 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.961 0.504 . . . . 0.0 110.363 177.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -61.26 -47.8 84.38 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.243 0.928 . . . . 0.0 110.023 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -56.8 -52.35 65.4 Favored 'General case' 0 C--N 1.34 0.18 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.0 mm -53.28 -49.08 54.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 123.37 0.668 . . . . 0.0 109.538 177.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.47 -43.4 68.13 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.506 0.722 . . . . 0.0 110.76 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -69.31 -55.66 9.79 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.71 0.29 . . . . 0.0 110.638 177.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -50.53 -47.66 57.43 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.57 1.148 . . . . 0.0 112.322 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -99.81 24.36 8.5 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.264 1.026 . . . . 0.0 110.795 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -55.39 124.18 16.3 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.516 -0.74 . . . . 0.0 110.122 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.34 -14.24 46.57 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 119.454 -0.637 . . . . 0.0 112.907 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -99.74 -42.27 6.92 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.371 1.069 . . . . 0.0 109.3 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.1 tp -133.01 125.35 29.5 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.726 1.211 . . . . 0.0 108.168 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 56.2 m -85.41 101.84 12.94 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 176.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 85.1 t -79.31 133.62 29.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -138.16 154.04 49.18 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.126 0.57 . . . . 0.0 110.417 -177.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -126.44 137.38 53.4 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.6 tt -127.28 115.15 18.59 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -78.66 104.54 9.34 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 pp -68.54 -29.11 42.82 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.19 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -56.86 -45.18 82.62 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 118.437 0.562 . . . . 0.0 109.752 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -81.48 -31.43 32.94 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.929 0.892 . . . . 0.0 110.395 177.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -119.83 68.91 12.51 Favored Pre-proline 0 C--O 1.235 0.326 0 C-N-CA 123.663 0.785 . . . . 0.0 111.557 -177.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -61.39 -52.64 3.03 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.463 2.109 . . . . 0.0 112.586 -177.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -38.28 -45.43 1.79 Allowed Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.538 1.542 . . . . 0.0 114.556 -177.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.45 -33.91 46.45 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.89 0.876 . . . . 0.0 112.964 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.55 -67.67 0.89 Allowed Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 118.136 -0.935 . . . . 0.0 112.184 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -59.42 -37.18 91.38 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.77 1.646 . . . . 0.0 111.218 177.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -51.35 -38.38 52.89 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.291 0.951 . . . . 0.0 111.778 178.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -110.83 22.53 15.25 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.895 0.478 . . . . 0.0 111.574 178.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 42.9 43.06 5.23 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 126.085 1.802 . . . . 0.0 112.976 178.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.3 mp -43.95 131.98 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 123.69 0.796 . . . . 0.0 112.137 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.15 -51.7 9.84 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.472 1.109 . . . . 0.0 109.218 -177.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -179.53 135.16 2.44 Favored Glycine 0 C--N 1.333 0.409 0 N-CA-C 107.228 -2.349 . . . . 0.0 107.228 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.469 HD11 ' CH2' ' A' ' 31' ' ' TRP . 2.0 pp -79.98 145.37 61.18 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 117.251 0.525 . . . . 0.0 111.511 -176.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.81 135.1 32.25 Favored 'Cis proline' 0 N--CA 1.456 -0.69 0 CA-C-N 119.744 0.944 . . . . 0.0 111.512 -0.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.5 m -123.23 117.51 25.48 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.6 mt -95.64 122.25 38.21 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -114.17 119.58 37.57 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 177.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.15 98.24 10.49 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -90.26 107.67 19.29 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.374 1.47 . . . . 0.0 110.786 -178.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -96.66 108.63 21.28 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 173.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 35.8 m120 48.43 51.59 14.99 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.75 0.82 . . . . 0.0 111.339 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.51 -13.97 14.51 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 118.851 -0.972 . . . . 0.0 114.64 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -94.71 122.59 37.48 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 119.563 1.682 . . . . 0.0 109.557 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 98.9 t -65.53 108.95 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 175.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.93 -39.52 34.5 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -163.16 173.9 12.85 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.5 t -149.73 159.39 44.39 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.7 mmtp -138.79 151.9 47.45 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.534 1.934 . . . . 0.0 107.271 177.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.9 t -129.08 135.22 62.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 124.722 1.209 . . . . 0.0 107.906 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.47 -171.12 51.23 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 112.077 -0.409 . . . . 0.0 112.077 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.63 163.31 27.86 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.051 0.541 . . . . 0.0 111.357 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.7 mt -146.25 154.62 41.92 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.303 1.441 . . . . 0.0 107.823 178.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.1 p -84.98 150.83 24.64 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 172.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -48.95 -49.32 40.93 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.063 0.545 . . . . 0.0 110.768 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.35 -59.13 10.55 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 112.108 -0.397 . . . . 0.0 112.108 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -55.32 -45.15 76.34 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 117.527 0.664 . . . . 0.0 111.077 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.2 tp -59.51 -50.21 74.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 177.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -55.33 -46.35 76.36 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.613 0.642 . . . . 0.0 111.222 177.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -57.11 -52.55 64.83 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.111 0.565 . . . . 0.0 109.769 178.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -53.81 -53.79 47.45 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.053 0.941 . . . . 0.0 110.781 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 88.3 mt -59.2 -49.76 76.63 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.256 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -54.71 -50.52 68.11 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 122.807 0.443 . . . . 0.0 110.489 178.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.3 -36.18 68.37 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.518 0.727 . . . . 0.0 111.651 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -78.04 -44.15 27.27 Favored 'General case' 0 N--CA 1.46 0.068 0 O-C-N 122.157 -0.339 . . . . 0.0 110.162 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 40.4 mt -59.51 -45.73 90.89 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.2 0 C-N-CA 123.183 0.593 . . . . 0.0 109.812 177.727 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.449 -0.507 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 43.56 42.31 3.95 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.145 1.778 . . . . 0.0 112.962 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -80.77 57.79 3.11 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.386 1.075 . . . . 0.0 108.872 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 13.4 mt -103.99 139.7 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 124.794 1.238 . . . . 0.0 110.355 -177.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 25.7 mm -91.36 116.72 33.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 177.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -82.92 113.29 20.42 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.3 mt -96.18 164.0 12.86 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.896 0.878 . . . . 0.0 112.148 -177.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 32.4 p -135.81 166.34 23.52 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 171.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -59.13 -47.8 83.96 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.446 0.566 . . . . 0.0 109.556 178.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -60.9 -44.56 96.97 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.663 0.785 . . . . 0.0 111.535 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 82.5 p -79.21 -24.41 43.15 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -176.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -34.21 -59.68 0.43 Allowed 'General case' 0 C--N 1.339 0.124 0 C-N-CA 126.598 1.959 . . . . 0.0 113.836 -178.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -51.69 -59.23 4.52 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.288 0.635 . . . . 0.0 110.82 -177.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 m -60.09 -43.69 95.36 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 123.248 0.619 . . . . 0.0 111.732 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -72.69 -36.7 67.92 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -174.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.4 t -112.88 -60.3 2.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 123.807 0.843 . . . . 0.0 111.205 -173.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.5 mt -61.37 -35.9 78.74 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-O 119.257 -0.402 . . . . 0.0 111.736 -175.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -92.22 10.47 29.4 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.368 0.531 . . . . 0.0 112.071 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.67 103.39 15.07 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 119.081 0.855 . . . . 0.0 109.965 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -74.31 65.38 1.2 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.524 0.73 . . . . 0.0 110.592 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -166.01 177.84 40.92 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.03 107.19 18.32 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.994 1.318 . . . . 0.0 111.059 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 mt -113.42 114.14 46.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 124.523 1.129 . . . . 0.0 110.78 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.4 tp -84.05 98.94 10.13 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 107.005 -1.479 . . . . 0.0 107.005 174.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.0 t -87.58 118.74 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 123.125 0.57 . . . . 0.0 109.54 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -102.63 108.19 19.37 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.52 1.128 . . . . 0.0 108.951 177.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -81.29 119.18 23.32 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 175.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 37.4 p-90 -135.28 171.97 13.68 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 124.154 0.981 . . . . 0.0 113.196 -174.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.11 132.05 17.15 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 125.736 1.614 . . . . 0.0 108.036 175.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.3 pm0 -49.42 -39.29 32.22 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -178.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 61.4 p-90 -77.26 -19.95 55.83 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 43.8 t -79.53 76.21 6.15 Favored 'General case' 0 N--CA 1.456 -0.162 0 O-C-N 121.409 -0.807 . . . . 0.0 110.411 -176.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -12.58 -69.75 0.01 OUTLIER Glycine 0 CA--C 1.536 1.39 0 C-N-CA 127.752 2.596 . . . . 0.0 115.565 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -41.63 -38.78 4.43 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 124.683 3.588 . . . . 0.0 114.766 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 87.7 m -50.86 -47.37 60.36 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.331 1.052 . . . . 0.0 110.584 177.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt -70.57 -28.67 65.06 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.582 0.753 . . . . 0.0 110.621 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 84.7 mmm -71.45 -43.29 66.96 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 177.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.3 pt -76.82 -27.91 16.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 CA-C-O 118.536 -0.745 . . . . 0.0 112.102 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -38.07 -59.21 1.25 Allowed Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -56.92 -41.15 78.4 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.208 1.939 . . . . 0.0 111.911 177.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 27.6 mt -58.27 -52.04 63.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 68.6 mt -56.68 -44.04 81.07 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.432 0.693 . . . . 0.0 110.494 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -58.43 -48.46 80.63 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.737 0.415 . . . . 0.0 110.281 178.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -60.7 -52.25 65.9 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.9 mm -50.79 -47.14 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.267 1.027 . . . . 0.0 110.402 177.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.48 -37.35 65.15 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.323 0.649 . . . . 0.0 110.848 178.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -75.04 -55.44 5.74 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 176.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -45.56 -51.4 11.99 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 125.37 1.468 . . . . 0.0 112.28 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -101.26 23.11 11.4 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.96 0.504 . . . . 0.0 111.637 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -55.35 130.26 41.76 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 119.455 1.025 . . . . 0.0 110.643 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.75 -19.68 23.56 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 119.466 -0.63 . . . . 0.0 112.625 -178.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -99.4 -41.24 7.5 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.261 1.024 . . . . 0.0 108.829 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.0 tp -133.29 143.88 49.34 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.243 1.817 . . . . 0.0 107.217 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 94.5 m -107.16 140.27 40.28 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 105.314 -2.106 . . . . 0.0 105.314 173.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.1 t -112.82 140.51 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 178.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.38 149.41 46.95 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -178.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -126.26 131.43 51.91 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.261 1.024 . . . . 0.0 108.255 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 tt -122.79 116.24 23.37 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.739 0.816 . . . . 0.0 109.653 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -80.06 107.62 12.99 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 pp -66.83 -30.89 51.13 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -177.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -60.08 -49.46 77.56 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 119.03 0.832 . . . . 0.0 109.295 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -69.89 -36.09 75.16 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.006 177.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -121.25 70.78 22.44 Favored Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 123.907 0.883 . . . . 0.0 112.049 -175.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.94 -52.36 2.25 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.543 2.162 . . . . 0.0 112.616 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -39.03 -44.31 1.98 Allowed Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.438 1.494 . . . . 0.0 114.276 -177.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -53.13 -32.92 50.01 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.813 0.845 . . . . 0.0 112.874 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.78 -68.27 0.76 Allowed Pre-proline 0 CA--C 1.538 0.513 0 CA-C-O 118.072 -0.966 . . . . 0.0 111.662 178.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -59.38 -36.86 93.11 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 121.55 1.5 . . . . 0.0 111.45 177.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -51.58 -40.56 60.01 Favored 'General case' 0 C--N 1.345 0.398 0 CA-C-N 119.558 1.072 . . . . 0.0 111.601 178.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -107.7 21.7 17.06 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 122.704 0.402 . . . . 0.0 111.275 178.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 43.88 43.5 6.82 Favored Glycine 0 C--N 1.338 0.684 0 C-N-CA 125.798 1.666 . . . . 0.0 113.034 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.3 mp -49.02 129.5 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 117.975 0.887 . . . . 0.0 110.839 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.73 -53.86 6.7 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.045 0.938 . . . . 0.0 108.924 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -168.87 150.12 15.15 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 107.062 -2.415 . . . . 0.0 107.062 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 23.8 pt -91.47 149.18 39.02 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-N 117.701 0.75 . . . . 0.0 110.373 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -70.88 137.69 47.89 Favored 'Cis proline' 0 N--CA 1.456 -0.684 0 CA-C-N 119.644 0.908 . . . . 0.0 110.416 -1.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.95 116.69 27.43 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 20.8 mt -98.29 120.83 39.37 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.5 mp -121.08 118.91 30.95 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 177.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.3 tp -93.35 96.11 9.74 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -84.97 101.86 12.71 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.665 1.186 . . . . 0.0 110.002 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -93.45 114.53 26.95 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 173.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 55.89 39.31 30.64 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.8 0.84 . . . . 0.0 110.979 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.51 -0.6 75.26 Favored Glycine 0 CA--C 1.532 1.121 0 CA-C-O 118.758 -1.024 . . . . 0.0 113.738 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -108.24 126.68 53.08 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.346 1.573 . . . . 0.0 109.354 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.7 t -63.57 106.36 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.08 -40.82 30.21 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.026 0.931 . . . . 0.0 109.535 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -156.78 169.46 24.69 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.9 t -151.84 159.63 43.81 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -146.75 131.41 17.87 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.6 t -102.36 125.58 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.26 170.92 38.04 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.21 166.1 16.98 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.685 0.794 . . . . 0.0 112.875 -177.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.0 mt -138.93 153.52 48.24 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 126.228 1.811 . . . . 0.0 107.513 177.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.1 p -84.09 155.54 22.61 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.514 -1.662 . . . . 0.0 106.514 171.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -50.31 -51.36 45.93 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 122.126 -0.359 . . . . 0.0 111.084 -178.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -53.64 -58.45 12.28 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 111.913 -0.475 . . . . 0.0 111.913 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -56.2 -42.34 77.01 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 122.232 -0.569 . . . . 0.0 110.856 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 30.9 tp -62.55 -48.49 79.28 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -54.78 -47.84 73.43 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.558 0.617 . . . . 0.0 110.125 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -57.51 -53.84 53.56 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.541 0.737 . . . . 0.0 110.397 178.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -52.19 -50.16 62.43 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.63 1.172 . . . . 0.0 110.174 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 87.2 mt -60.52 -52.29 65.81 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 119.184 -0.436 . . . . 0.0 110.329 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -52.8 -49.4 65.71 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 118.197 0.453 . . . . 0.0 110.459 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.66 -37.5 70.88 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.546 0.738 . . . . 0.0 111.658 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -78.07 -44.24 26.86 Favored 'General case' 0 N--CA 1.462 0.135 0 O-C-N 122.083 -0.385 . . . . 0.0 110.439 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 53.8 mt -59.05 -48.18 82.53 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.276 0 C-N-CA 123.259 0.623 . . . . 0.0 109.607 177.465 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 7.8 p . . . . . 0 CA--C 1.533 0.323 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -70.78 61.28 0.25 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.703 1.601 . . . . 0.0 111.826 -178.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.4 mtmm -82.23 58.63 4.11 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 177.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.4 mt -131.0 148.21 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 123.875 0.87 . . . . 0.0 109.379 -173.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.8 mm -87.1 106.9 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -82.2 105.67 13.48 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.9 mt -88.24 166.35 14.4 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.854 1.662 . . . . 0.0 112.161 -177.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 44.0 p -137.33 165.72 25.51 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 172.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -59.05 -46.57 87.89 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 118.271 0.487 . . . . 0.0 110.102 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -60.23 -45.36 93.49 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.498 0.719 . . . . 0.0 111.127 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 81.9 p -79.18 -24.24 43.35 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -176.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -37.71 -53.91 1.23 Allowed 'General case' 0 CA--C 1.527 0.073 0 C-N-CA 126.758 2.023 . . . . 0.0 114.359 -178.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -53.19 -60.35 3.4 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.307 0.575 . . . . 0.0 110.637 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.1 m -60.46 -45.54 93.33 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 123.062 0.545 . . . . 0.0 111.601 -178.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -71.63 -36.18 70.65 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -173.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 41.4 t -112.87 -60.92 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 123.619 0.768 . . . . 0.0 110.762 -174.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.4 mt -62.91 -35.51 80.29 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 119.183 -0.437 . . . . 0.0 111.991 -174.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -96.67 15.78 20.83 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.336 0.516 . . . . 0.0 111.765 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -102.87 104.13 14.35 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 118.877 0.762 . . . . 0.0 110.192 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -74.09 65.17 1.1 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.582 0.753 . . . . 0.0 110.995 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -165.84 177.27 41.05 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.56 103.8 14.73 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 125.204 1.402 . . . . 0.0 110.798 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mt -109.98 118.63 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 C-N-CA 123.937 0.895 . . . . 0.0 110.236 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 19.3 tp -89.38 98.06 11.55 Favored 'General case' 0 C--N 1.338 0.068 0 N-CA-C 106.444 -1.688 . . . . 0.0 106.444 175.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.4 t -85.94 110.31 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 123.387 0.675 . . . . 0.0 109.341 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -97.49 108.92 21.74 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.172 0.589 . . . . 0.0 109.679 177.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -81.63 123.25 28.54 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 175.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 37.9 p-90 -136.62 167.43 21.42 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 124.601 1.161 . . . . 0.0 112.122 -177.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -141.39 137.76 32.51 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.976 1.31 . . . . 0.0 107.834 177.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -52.33 -48.23 65.57 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.871 0.868 . . . . 0.0 112.495 -177.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 57.7 p-90 -68.74 -22.42 64.32 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.063 0.545 . . . . 0.0 112.407 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 42.1 t -79.75 77.37 6.39 Favored 'General case' 0 N--CA 1.456 -0.142 0 O-C-N 121.402 -0.811 . . . . 0.0 111.073 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -23.03 -62.69 0.03 OUTLIER Glycine 0 CA--C 1.536 1.401 0 C-N-CA 127.34 2.4 . . . . 0.0 115.499 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -44.16 -31.52 4.19 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 124.511 3.474 . . . . 0.0 114.955 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 88.1 m -55.97 -43.29 77.43 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.613 -0.68 . . . . 0.0 109.724 176.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -66.18 -33.09 74.97 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.703 0.801 . . . . 0.0 110.147 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 46.7 ttm -67.22 -44.36 79.74 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 19.6 pt -77.5 -27.31 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 118.954 -0.546 . . . . 0.0 112.451 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -39.7 -57.45 2.53 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -58.9 -39.44 81.2 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.074 1.849 . . . . 0.0 111.474 177.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 27.9 mt -58.15 -50.78 77.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 177.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 53.2 mt -57.13 -42.85 81.67 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.032 0.533 . . . . 0.0 110.411 177.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -59.0 -48.24 82.29 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.716 0.689 . . . . 0.0 110.492 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -59.63 -49.3 78.3 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.0 mm -55.66 -44.34 76.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 123.597 0.759 . . . . 0.0 109.657 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.18 -41.78 72.35 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.465 0.575 . . . . 0.0 110.355 178.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -66.6 -59.05 3.96 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.122 0.486 . . . . 0.0 110.075 177.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -51.29 -45.45 62.14 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.176 0.99 . . . . 0.0 112.375 -177.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -97.83 22.9 8.56 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.822 0.849 . . . . 0.0 111.78 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.4 130.14 26.64 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.293 0.951 . . . . 0.0 110.525 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.84 -16.54 4.2 Favored Glycine 0 CA--C 1.534 1.23 0 CA-C-O 119.22 -0.767 . . . . 0.0 113.948 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -99.66 -35.32 9.86 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.703 1.251 . . . . 0.0 110.129 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.8 tp -136.42 136.04 39.21 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.269 1.027 . . . . 0.0 108.783 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 85.6 m -97.03 104.73 16.77 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 175.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 63.2 t -79.86 128.15 38.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -129.88 151.85 50.0 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.59 0.756 . . . . 0.0 109.79 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.4 mttm -128.16 142.32 51.22 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.637 1.175 . . . . 0.0 108.135 177.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.4 tt -132.88 115.42 15.23 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -80.72 108.84 14.71 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.9 pt -72.04 -19.08 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -60.88 -47.83 84.61 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 119.342 0.974 . . . . 0.0 108.663 178.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -80.06 -32.85 39.35 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.169 0.988 . . . . 0.0 109.997 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -121.5 64.48 15.49 Favored Pre-proline 0 CA--C 1.533 0.319 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -175.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -65.69 -42.35 12.37 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 121.687 1.591 . . . . 0.0 110.674 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -45.23 -30.15 2.67 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 125.791 1.662 . . . . 0.0 114.922 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.22 -26.75 62.15 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.415 1.108 . . . . 0.0 112.297 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.494 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . . . -63.03 -58.59 15.58 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 119.307 0.958 . . . . 0.0 111.137 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.494 ' HD3' ' HB3' ' A' ' 67' ' ' ALA . 80.6 Cg_exo -45.68 -45.04 17.05 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 124.031 3.154 . . . . 0.0 113.201 175.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -50.78 -31.15 16.04 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -120.15 19.71 12.18 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.146 0.578 . . . . 0.0 110.781 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 45.92 37.66 7.55 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.527 1.537 . . . . 0.0 112.54 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.4 mt -60.76 140.22 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 117.351 0.575 . . . . 0.0 110.959 -177.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -79.38 -38.39 35.06 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.113 0.965 . . . . 0.0 112.169 -174.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -179.94 -152.27 10.69 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 107.074 -2.41 . . . . 0.0 107.074 -177.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -146.13 157.44 49.82 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-O 117.764 -1.112 . . . . 0.0 108.872 178.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -66.84 135.92 29.14 Favored 'Cis proline' 0 N--CA 1.457 -0.662 0 CA-C-N 120.494 1.212 . . . . 0.0 110.151 -1.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.9 m -132.58 146.76 52.15 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 106.09 -1.818 . . . . 0.0 106.09 175.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.8 mt -127.49 124.86 39.33 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.567 1.547 . . . . 0.0 107.363 -175.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.3 mp -121.3 119.46 32.28 Favored 'General case' 0 CA--C 1.522 -0.106 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 176.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.45 95.62 9.75 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -85.44 101.86 12.97 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.657 1.183 . . . . 0.0 109.207 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -93.78 114.04 26.22 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 174.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 56.16 40.06 30.19 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.676 0.79 . . . . 0.0 111.177 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.68 -1.61 66.56 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 118.734 -1.037 . . . . 0.0 113.521 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -107.01 128.69 54.59 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 119.419 1.609 . . . . 0.0 109.368 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.9 t -66.28 107.87 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.15 -40.94 29.67 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.596 0.758 . . . . 0.0 109.416 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.11 170.75 20.58 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 177.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.9 t -151.32 160.76 43.62 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.7 tptt -148.13 131.1 16.22 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.557 1.543 . . . . 0.0 107.221 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 94.7 t -108.32 133.21 54.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 106.538 -1.652 . . . . 0.0 106.538 177.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.72 173.28 41.17 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.934 -0.867 . . . . 0.0 110.934 -178.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.12 170.37 16.17 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.976 0.511 . . . . 0.0 110.858 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -161.68 164.52 29.12 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.723 1.609 . . . . 0.0 107.614 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 83.8 p -81.26 165.02 21.82 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.067 0.46 . . . . 0.0 110.077 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -57.21 -41.73 79.95 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 174.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.81 -55.24 30.94 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -57.03 -43.73 82.17 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 117.687 0.743 . . . . 0.0 109.94 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 27.6 tp -59.9 -49.69 76.7 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 177.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -53.53 -48.38 69.11 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.011 0.823 . . . . 0.0 111.463 177.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -59.27 -50.57 73.51 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -53.15 -51.82 60.74 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.892 0.877 . . . . 0.0 110.05 178.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.5 mt -57.95 -53.04 62.76 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 122.952 0.501 . . . . 0.0 110.538 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -53.74 -50.45 65.95 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 117.866 0.303 . . . . 0.0 110.637 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.7 -37.56 68.53 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.362 0.665 . . . . 0.0 111.631 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -78.22 -46.16 21.11 Favored 'General case' 0 C--O 1.227 -0.121 0 O-C-N 122.182 -0.324 . . . . 0.0 110.862 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 54.8 mt -60.85 -46.7 89.52 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.265 0.626 . . . . 0.0 109.397 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.282 0 C-N-CA 123.025 0.53 . . . . 0.0 109.75 177.568 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 43.3 m . . . . . 0 N--CA 1.451 -0.385 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -65.37 141.9 58.4 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -69.0 -33.06 73.06 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 175.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.2 mt -80.07 139.25 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 C-N-CA 123.276 0.631 . . . . 0.0 109.357 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.9 mm -89.82 116.2 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 123.763 0.825 . . . . 0.0 109.356 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 -82.27 105.49 13.39 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.1 mt -90.76 155.14 19.02 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.369 0.668 . . . . 0.0 112.143 -177.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.0 p -126.06 158.5 35.25 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 172.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -55.13 -45.14 75.56 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.749 0.82 . . . . 0.0 109.815 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -57.7 -44.55 85.97 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.266 1.026 . . . . 0.0 111.309 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.9 p -78.22 -31.96 49.58 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -176.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -36.79 -48.43 0.73 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.605 1.962 . . . . 0.0 114.321 -176.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -55.3 -39.09 69.5 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -178.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.5 m -90.68 -50.66 5.79 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.348 0.659 . . . . 0.0 110.036 -178.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.87 -29.41 67.71 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -174.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.5 t -114.41 -60.69 2.77 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.076 0 CA-C-N 118.856 0.753 . . . . 0.0 110.723 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 72.1 mt -61.52 -30.94 70.96 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -174.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 42.6 mttp -97.95 16.61 20.43 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.045 0.838 . . . . 0.0 110.596 175.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.64 94.49 4.4 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 121.245 -0.909 . . . . 0.0 111.485 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -75.8 68.98 2.42 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 177.43 -170.56 43.11 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 108.386 -1.885 . . . . 0.0 108.386 -177.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -105.27 118.15 35.82 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.707 1.603 . . . . 0.0 110.783 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.1 mt -122.32 116.75 50.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 125.248 1.419 . . . . 0.0 110.036 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 24.5 tp -84.16 97.07 9.16 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 173.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 51.4 t -86.4 115.57 27.72 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.097 0 C-N-CA 123.361 0.664 . . . . 0.0 109.519 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -100.03 104.45 16.04 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.203 1.001 . . . . 0.0 109.212 177.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -79.57 120.79 24.41 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 105.026 -2.213 . . . . 0.0 105.026 174.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 13.7 p-90 -141.18 164.51 30.07 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -173.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -128.76 139.81 52.03 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.209 1.003 . . . . 0.0 109.215 175.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -54.2 -48.63 70.79 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.977 1.311 . . . . 0.0 111.419 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 54.9 p-90 -69.81 -21.59 63.38 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.794 0.838 . . . . 0.0 112.374 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 42.7 t -79.87 76.93 6.55 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 121.323 -0.861 . . . . 0.0 110.351 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -22.97 -60.99 0.03 OUTLIER Glycine 0 CA--C 1.535 1.315 0 C-N-CA 127.691 2.567 . . . . 0.0 115.632 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -44.21 -35.46 7.99 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 123.921 3.081 . . . . 0.0 114.129 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.8 m -59.12 -48.74 80.5 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 121.721 0.772 . . . . 0.0 109.844 177.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -65.5 -36.91 85.25 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 25.0 ttt -60.77 -45.33 94.78 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 119.622 -0.227 . . . . 0.0 110.715 177.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 34.8 pt -76.35 -25.72 16.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-O 118.635 -0.697 . . . . 0.0 112.49 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -37.26 -58.63 1.15 Allowed Pre-proline 0 CA--C 1.545 0.75 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -56.71 -40.32 85.16 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.241 1.96 . . . . 0.0 112.172 177.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 26.4 mt -59.24 -51.08 76.85 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 177.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 76.8 mt -56.59 -43.44 80.08 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.997 0.519 . . . . 0.0 110.804 178.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -60.22 -48.8 80.19 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.657 0.662 . . . . 0.0 110.215 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -59.25 -50.83 72.49 Favored 'General case' 0 C--O 1.226 -0.183 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.3 mm -54.3 -48.78 67.17 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.38 -49.34 64.61 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 122.975 0.51 . . . . 0.0 109.918 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -61.03 -57.85 10.86 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.785 0.326 . . . . 0.0 110.805 178.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -50.38 -45.96 55.68 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.44 1.096 . . . . 0.0 112.438 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -94.69 22.61 6.14 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -177.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -50.52 127.8 18.61 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.641 1.11 . . . . 0.0 110.384 177.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.48 -20.67 13.12 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-O 119.281 -0.733 . . . . 0.0 113.264 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -99.6 -40.49 7.78 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.566 1.183 . . . . 0.0 110.258 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.3 tp -143.18 136.9 28.61 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.853 0.861 . . . . 0.0 108.703 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 92.8 m -98.13 143.94 28.13 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 173.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 68.7 t -118.43 138.53 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 178.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.34 152.93 50.25 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -177.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.1 mttm -125.83 132.3 52.26 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.875 1.27 . . . . 0.0 107.623 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.8 tt -123.1 106.59 10.92 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -78.14 102.43 7.52 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.202 -177.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 pp -55.59 -30.99 27.6 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.231 0 C-N-CA 124.214 1.006 . . . . 0.0 112.072 -179.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -57.0 -45.36 83.05 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.26 0.482 . . . . 0.0 109.825 178.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -81.94 -35.92 28.57 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.077 0.951 . . . . 0.0 110.581 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -123.49 69.9 43.99 Favored Pre-proline 0 CA--C 1.529 0.15 0 C-N-CA 123.861 0.864 . . . . 0.0 111.182 -176.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -64.97 -41.98 15.72 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.033 1.822 . . . . 0.0 110.898 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -41.78 -41.02 3.27 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.456 1.503 . . . . 0.0 114.765 -178.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.92 -23.81 65.13 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.23 1.015 . . . . 0.0 112.975 -177.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.23 -62.14 6.15 Favored Pre-proline 0 CA--C 1.539 0.557 0 O-C-N 121.388 -0.82 . . . . 0.0 113.035 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -60.74 -37.48 78.4 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.087 1.858 . . . . 0.0 111.651 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -50.96 -36.54 39.38 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 118.836 0.744 . . . . 0.0 112.095 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -112.58 16.41 19.75 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.918 0.487 . . . . 0.0 111.44 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 49.01 43.6 31.73 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 125.043 1.306 . . . . 0.0 112.743 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mp -44.38 118.41 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 117.903 0.852 . . . . 0.0 110.585 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -79.56 -48.28 14.09 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.297 1.039 . . . . 0.0 111.153 -174.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -166.69 141.95 7.28 Favored Glycine 0 C--N 1.334 0.468 0 N-CA-C 107.609 -2.196 . . . . 0.0 107.609 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 22.9 pt -92.96 146.19 31.56 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 123.489 0.716 . . . . 0.0 110.665 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.41 133.19 24.14 Favored 'Cis proline' 0 N--CA 1.459 -0.511 0 CA-C-N 119.963 1.023 . . . . 0.0 110.424 -1.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.94 111.91 23.61 Favored 'General case' 0 C--N 1.338 0.078 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 24.3 mt -93.88 117.72 30.48 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.7 mp -118.17 115.67 25.27 Favored 'General case' 0 C--N 1.334 -0.106 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 177.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 tp -89.99 95.55 10.27 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -84.78 108.61 17.55 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.53 1.132 . . . . 0.0 110.231 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -107.36 122.91 47.53 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 174.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 52.39 47.59 24.41 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.379 0.609 . . . . 0.0 109.99 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.37 -3.0 6.4 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-O 118.181 -1.344 . . . . 0.0 115.687 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -111.99 143.43 43.0 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 120.051 1.925 . . . . 0.0 110.66 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.6 t -70.94 110.49 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.94 -41.41 29.44 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -158.53 169.98 23.22 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 177.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.5 t -150.47 161.25 42.88 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -147.66 131.11 16.68 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.0 t -102.2 121.61 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.38 171.7 38.08 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 121.444 0.469 . . . . 0.0 112.094 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.67 164.22 14.85 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.004 0.922 . . . . 0.0 112.761 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.9 mt -135.52 152.35 51.23 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.972 1.709 . . . . 0.0 108.194 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.9 p -81.77 150.04 28.11 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 170.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -49.84 -48.53 50.95 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -176.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.03 -57.63 17.44 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -55.6 -41.71 73.82 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 122.896 0.478 . . . . 0.0 110.686 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.3 tp -61.12 -51.53 68.71 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -55.41 -45.69 76.67 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.627 0.649 . . . . 0.0 110.906 177.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -57.84 -53.47 57.79 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.18 0.592 . . . . 0.0 110.274 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -52.71 -50.82 62.6 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.92 1.288 . . . . 0.0 110.149 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 98.2 mt -60.32 -51.28 70.18 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 122.592 0.357 . . . . 0.0 110.424 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -53.55 -49.36 67.82 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 117.964 0.347 . . . . 0.0 110.398 178.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.5 -35.67 70.51 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.759 0.823 . . . . 0.0 111.74 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -78.45 -43.65 26.69 Favored 'General case' 0 C--O 1.227 -0.12 0 CA-C-N 118.057 0.39 . . . . 0.0 110.582 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 53.7 mt -62.79 -46.6 87.26 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.241 0.616 . . . . 0.0 109.905 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.164 0 C-N-CA 124.743 1.217 . . . . 0.0 111.739 179.133 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 20.1 p . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -70.3 63.33 0.24 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.488 1.515 . . . . 0.0 111.524 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -82.41 57.74 3.8 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 178.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 32.1 mt -133.64 147.62 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 123.447 0.699 . . . . 0.0 109.64 -174.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.5 mm -87.81 104.61 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 177.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 29.6 m-70 -80.55 95.26 6.45 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 42.9 mt -79.01 162.51 25.89 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.835 1.254 . . . . 0.0 111.922 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 30.0 p -134.16 162.4 32.23 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.38 1.872 . . . . 0.0 106.574 172.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -54.2 -47.63 71.9 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.723 0.809 . . . . 0.0 110.337 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -56.25 -44.83 80.03 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.933 0.893 . . . . 0.0 111.759 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.5 p -78.31 -28.46 47.45 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -176.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -38.99 -49.82 1.73 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.738 1.615 . . . . 0.0 113.879 -176.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -50.81 -63.92 0.98 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.659 0.742 . . . . 0.0 111.0 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.3 m -68.31 -46.89 69.05 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.834 -175.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -75.53 -23.17 56.61 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 -174.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.0 t -118.34 -63.31 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-N 119.432 1.014 . . . . 0.0 110.057 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 72.4 mt -60.21 -37.53 80.58 Favored 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -174.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -93.45 12.28 25.54 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.598 0.636 . . . . 0.0 111.834 177.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.39 102.56 14.66 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 119.098 0.863 . . . . 0.0 110.885 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -76.09 65.7 2.14 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.377 0.671 . . . . 0.0 109.9 177.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -173.84 -175.03 41.2 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.87 124.42 35.97 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.269 1.427 . . . . 0.0 111.052 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.3 mt -133.32 124.07 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 124.811 1.244 . . . . 0.0 109.917 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -93.73 108.57 20.3 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 105.534 -2.025 . . . . 0.0 105.534 174.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.6 t -99.6 107.34 20.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -178.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -91.62 102.86 15.5 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -78.49 121.37 24.48 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 103.758 -2.682 . . . . 0.0 103.758 174.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 25.8 p-90 -137.0 168.54 19.4 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 123.61 0.764 . . . . 0.0 112.631 -174.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -141.48 140.45 33.54 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.813 1.245 . . . . 0.0 108.099 176.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -55.81 -50.76 69.63 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.483 0.713 . . . . 0.0 112.688 -176.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 43.3 p-90 -59.92 -29.68 68.54 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.77 0.828 . . . . 0.0 112.828 -178.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 48.8 t -79.6 80.45 5.98 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 121.432 -0.793 . . . . 0.0 110.507 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -23.06 -61.2 0.03 OUTLIER Glycine 0 CA--C 1.537 1.459 0 C-N-CA 127.422 2.439 . . . . 0.0 115.243 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -41.98 -37.77 4.57 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 124.309 3.34 . . . . 0.0 114.335 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 86.4 m -54.9 -44.23 73.97 Favored 'General case' 0 CA--C 1.527 0.058 0 C-N-CA 123.661 0.785 . . . . 0.0 110.597 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -69.92 -45.21 68.03 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 87.5 mmm -53.69 -42.76 68.31 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 30.7 pt -76.65 -12.06 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.22 -58.35 10.86 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 120.162 1.346 . . . . 0.0 112.79 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -55.43 -41.37 78.72 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.141 1.894 . . . . 0.0 111.377 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 19.2 mt -57.56 -53.65 41.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.3 mt -56.29 -39.19 72.29 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.312 0.645 . . . . 0.0 110.682 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -62.0 -48.84 78.5 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.013 0.824 . . . . 0.0 110.396 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -57.17 -51.73 68.13 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.2 mm -53.05 -48.06 53.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.675 1.19 . . . . 0.0 109.399 177.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.34 -45.76 76.42 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 122.927 0.491 . . . . 0.0 110.645 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -63.2 -53.17 57.4 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 177.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -50.29 -50.15 51.29 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.977 0.911 . . . . 0.0 111.687 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -98.86 30.5 3.33 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.464 0.706 . . . . 0.0 111.347 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -60.35 120.77 10.5 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.491 -0.755 . . . . 0.0 110.005 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.69 3.54 89.06 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 119.615 -0.547 . . . . 0.0 112.487 -177.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.1 mttm -114.03 -41.84 3.47 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.134 1.373 . . . . 0.0 109.281 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.0 tp -133.4 131.54 40.11 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.245 1.018 . . . . 0.0 108.498 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.5 m -86.87 100.35 12.49 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.1 t -79.3 125.07 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -131.74 151.72 51.45 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.58 0.752 . . . . 0.0 110.663 -176.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.7 mttm -127.22 143.76 51.18 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 176.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 tt -133.44 111.34 10.66 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -79.28 110.12 14.26 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.2 pt -71.28 -22.81 22.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 118.94 -0.552 . . . . 0.0 112.276 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -58.79 -46.58 87.22 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 119.352 0.978 . . . . 0.0 108.824 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -80.39 -25.18 39.23 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.282 1.033 . . . . 0.0 110.949 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -127.37 66.95 70.51 Favored Pre-proline 0 CA--C 1.534 0.341 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.48 -55.85 2.99 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.531 2.154 . . . . 0.0 113.265 -178.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -37.8 -46.61 1.69 Allowed Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.872 1.701 . . . . 0.0 114.544 -176.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -53.12 -34.56 57.26 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.489 0.715 . . . . 0.0 112.288 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.72 -68.6 0.57 Allowed Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 118.255 -0.878 . . . . 0.0 112.374 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -58.96 -38.24 89.14 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 CA-C-N 121.085 1.423 . . . . 0.0 110.94 177.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -52.26 -39.92 61.03 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 118.926 0.784 . . . . 0.0 111.732 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -104.59 19.46 20.33 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.106 0.412 . . . . 0.0 111.907 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.7 39.04 54.05 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 124.021 0.82 . . . . 0.0 113.216 177.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.5 mp -56.94 122.33 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -79.81 -47.24 15.51 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.721 0.808 . . . . 0.0 109.364 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -168.92 146.09 10.01 Favored Glycine 0 CA--C 1.521 0.424 0 N-CA-C 106.896 -2.481 . . . . 0.0 106.896 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.411 ' O ' HD12 ' A' ' 75' ' ' ILE . 1.6 pp -92.02 150.32 40.32 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 117.382 0.591 . . . . 0.0 110.378 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -70.93 136.5 41.61 Favored 'Cis proline' 0 N--CA 1.457 -0.649 0 CA-C-N 120.107 1.074 . . . . 0.0 111.31 0.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -120.68 113.47 20.26 Favored 'General case' 0 C--O 1.23 0.042 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 178.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.4 mt -95.9 101.17 12.82 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 -178.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -92.79 111.98 23.78 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 176.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 tp -92.77 105.59 17.7 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -93.81 143.66 26.13 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.24 1.416 . . . . 0.0 109.835 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -138.01 121.96 17.78 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 172.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 46.1 m-20 50.18 48.55 21.95 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.858 0.863 . . . . 0.0 110.803 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.57 -5.51 10.83 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 118.527 -1.152 . . . . 0.0 115.389 178.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -106.26 138.47 42.38 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 119.932 1.866 . . . . 0.0 110.163 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 94.2 t -66.55 109.17 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 176.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.75 -43.63 22.22 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 124.526 1.131 . . . . 0.0 109.604 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -150.55 169.32 21.81 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 97.2 m -150.98 139.34 20.36 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -177.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -131.47 137.02 48.4 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.0 t -110.94 122.2 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 177.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.01 171.76 37.09 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 123.38 0.514 . . . . 0.0 112.068 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.83 170.71 10.53 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.105 0.962 . . . . 0.0 112.441 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.1 mt -140.57 162.39 35.48 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 126.227 1.811 . . . . 0.0 108.321 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 99.9 p -83.67 162.11 20.86 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 169.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -57.06 -44.11 82.72 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 177.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -58.05 -57.59 19.01 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 123.37 0.51 . . . . 0.0 111.964 178.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -60.3 -38.64 84.26 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 121.842 -0.799 . . . . 0.0 110.739 -178.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.0 tp -64.17 -49.39 72.26 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 119.153 -0.451 . . . . 0.0 110.013 178.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 10.2 mmmm -52.65 -49.84 64.4 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.667 0.667 . . . . 0.0 109.47 176.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -56.13 -54.82 40.49 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.249 0.62 . . . . 0.0 110.73 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -52.59 -53.37 47.59 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.957 1.303 . . . . 0.0 111.05 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.3 mt -61.96 -52.14 65.25 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -51.92 -50.88 60.23 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.336 0.654 . . . . 0.0 110.842 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.43 -36.75 66.84 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.522 0.729 . . . . 0.0 111.664 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -78.52 -45.21 22.47 Favored 'General case' 0 N--CA 1.458 -0.057 0 O-C-N 122.263 -0.273 . . . . 0.0 110.516 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 53.2 mt -58.3 -47.45 83.63 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.306 0 C-N-CA 123.232 0.613 . . . . 0.0 109.665 177.423 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.1 m . . . . . 0 N--CA 1.451 -0.412 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -74.74 -47.56 30.54 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -140.28 46.1 1.83 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.678 1.191 . . . . 0.0 108.171 177.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 16.0 mt -122.75 139.18 50.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 C-N-CA 123.633 0.773 . . . . 0.0 109.939 -177.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.5 mm -87.89 108.1 18.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -79.78 114.77 18.95 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 64.9 mt -96.35 167.03 11.42 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 124.38 1.072 . . . . 0.0 112.397 -176.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 33.9 p -136.86 164.58 27.97 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 171.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -59.27 -45.97 89.78 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.463 0.574 . . . . 0.0 109.923 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -59.85 -45.64 91.79 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.708 0.803 . . . . 0.0 111.263 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.8 p -78.86 -24.44 44.31 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -176.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -38.25 -49.93 1.41 Allowed 'General case' 0 CA--C 1.527 0.075 0 C-N-CA 126.576 1.95 . . . . 0.0 113.613 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -54.41 -61.18 2.47 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 121.483 0.659 . . . . 0.0 110.888 -178.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.7 m -63.27 -42.06 99.1 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.444 -177.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -71.16 -43.58 67.22 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -174.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.4 t -107.54 -59.12 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 123.861 0.864 . . . . 0.0 110.893 -174.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 64.4 mt -62.41 -35.62 79.78 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -173.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -90.43 7.05 40.71 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.555 0.616 . . . . 0.0 112.253 178.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.86 102.1 14.21 Favored 'General case' 0 C--N 1.341 0.239 0 CA-C-N 119.185 0.902 . . . . 0.0 111.946 -178.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -75.58 73.48 2.59 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 175.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -172.72 178.57 44.71 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.76 115.19 26.11 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.0 1.32 . . . . 0.0 109.943 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.4 mt -122.6 120.18 60.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 124.528 1.131 . . . . 0.0 109.833 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.4 tp -91.08 100.27 13.15 Favored 'General case' 0 CA--C 1.521 -0.159 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 175.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 63.4 t -90.88 114.25 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -101.14 110.19 22.18 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.953 0.901 . . . . 0.0 109.186 177.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -79.79 124.8 28.94 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 175.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 28.6 p-90 -140.17 172.48 12.69 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.731 0.812 . . . . 0.0 112.864 -175.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.4 132.28 17.08 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.549 1.539 . . . . 0.0 108.024 175.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -49.23 -39.52 30.39 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 61.3 p-90 -76.86 -19.98 56.85 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 40.4 t -79.58 77.0 6.2 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 121.372 -0.83 . . . . 0.0 111.511 -175.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -9.72 -71.87 0.01 OUTLIER Glycine 0 CA--C 1.538 1.509 0 C-N-CA 127.729 2.585 . . . . 0.0 116.349 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -47.29 -33.59 16.68 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 124.089 3.193 . . . . 0.0 114.61 -178.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 88.2 m -52.94 -47.98 67.65 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.635 0.774 . . . . 0.0 109.955 176.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -68.89 -29.19 67.42 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.385 0.674 . . . . 0.0 110.611 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 24.2 mmt -70.28 -44.91 67.42 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 34.3 pt -74.17 -30.53 27.26 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 CA-C-O 118.371 -0.823 . . . . 0.0 112.231 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -36.84 -60.1 0.82 Allowed Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -57.79 -40.39 79.37 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.0 1.8 . . . . 0.0 111.414 178.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 15.7 mt -58.68 -49.67 81.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 177.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 76.9 mt -55.63 -44.17 76.85 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.213 0.605 . . . . 0.0 110.071 177.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -60.7 -46.89 88.67 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.76 -0.587 . . . . 0.0 110.746 177.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -57.25 -51.51 69.08 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 23.4 mm -53.03 -49.28 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 124.057 0.943 . . . . 0.0 109.478 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.56 -47.6 73.05 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 117.967 0.349 . . . . 0.0 110.547 178.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -61.17 -44.47 97.26 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 122.284 0.234 . . . . 0.0 111.283 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -65.54 -46.27 80.21 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.364 1.065 . . . . 0.0 112.723 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -100.22 38.68 1.45 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.516 1.127 . . . . 0.0 110.807 -178.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.402 ' NE2' ' H ' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -53.1 122.13 8.82 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.644 -0.66 . . . . 0.0 111.905 -179.265 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.62 -5.95 6.76 Favored Glycine 0 CA--C 1.535 1.29 0 CA-C-O 119.487 -0.618 . . . . 0.0 113.7 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 51.7 mttt -99.68 -36.27 9.54 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.964 1.306 . . . . 0.0 108.491 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.3 tp -136.28 122.48 20.4 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 35.3 m -86.58 103.52 15.15 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 177.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 91.8 t -79.67 128.02 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 107.057 -1.461 . . . . 0.0 107.057 178.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -132.53 149.53 52.31 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.373 0.669 . . . . 0.0 110.05 -177.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -129.36 132.49 47.08 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 123.794 0.838 . . . . 0.0 108.89 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.5 tt -120.63 116.13 24.73 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.766 0.826 . . . . 0.0 110.059 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -78.22 108.03 11.24 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 pp -67.33 -29.8 46.99 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 C-N-CA 123.335 0.654 . . . . 0.0 112.701 -177.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -60.49 -47.71 84.93 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 118.934 0.788 . . . . 0.0 109.491 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -74.88 -32.92 61.99 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.147 176.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -121.23 69.95 21.03 Favored Pre-proline 0 CA--C 1.531 0.228 0 C-N-CA 123.651 0.78 . . . . 0.0 112.01 -176.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -64.8 -47.45 5.13 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.977 1.785 . . . . 0.0 111.431 -178.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -42.02 -40.72 3.39 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.358 1.456 . . . . 0.0 114.659 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.43 -29.31 69.86 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.62 -0.929 . . . . 0.0 112.479 -178.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.84 -65.23 1.79 Allowed Pre-proline 0 CA--C 1.537 0.456 0 CA-C-O 118.395 -0.812 . . . . 0.0 112.912 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -59.78 -38.44 80.29 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 121.718 1.612 . . . . 0.0 111.036 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -51.79 -36.38 47.41 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-N 118.683 0.674 . . . . 0.0 112.029 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -111.65 20.59 16.97 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.683 0.393 . . . . 0.0 111.883 178.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 51.09 40.33 43.6 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.043 0.83 . . . . 0.0 113.481 177.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mp -53.94 127.87 12.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 117.883 0.841 . . . . 0.0 109.069 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -92.91 -50.64 5.45 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.75 1.22 . . . . 0.0 110.133 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.02 146.56 13.2 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 107.406 -2.278 . . . . 0.0 107.406 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.7 pt -95.61 148.64 34.92 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 123.715 0.806 . . . . 0.0 110.131 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.96 140.89 60.75 Favored 'Cis proline' 0 N--CA 1.456 -0.71 0 CA-C-N 119.788 0.96 . . . . 0.0 110.72 -1.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.61 118.69 30.8 Favored 'General case' 0 CA--C 1.523 -0.083 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.8 mt -96.82 126.6 42.09 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -120.89 111.57 17.7 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 104.066 -2.568 . . . . 0.0 104.066 175.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.5 tp -93.29 99.54 12.06 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -84.7 142.02 30.16 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.569 1.148 . . . . 0.0 109.676 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -138.13 97.86 3.49 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 175.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.2 t30 55.42 71.52 0.54 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.3 0.64 . . . . 0.0 110.3 -176.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 70.62 -37.68 0.47 Allowed Glycine 0 CA--C 1.531 1.093 0 N-CA-C 116.146 1.218 . . . . 0.0 116.146 176.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -86.6 146.03 26.5 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 119.147 1.474 . . . . 0.0 110.529 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 96.6 t -79.04 115.19 20.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 175.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.3 -42.11 26.5 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.346 0.659 . . . . 0.0 109.448 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -155.34 169.86 23.24 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 177.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.8 t -147.88 168.35 22.46 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.68 146.22 23.15 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.827 1.251 . . . . 0.0 108.327 -177.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.9 t -124.01 124.8 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.26 177.11 37.54 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 123.324 0.487 . . . . 0.0 112.052 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.71 173.58 8.85 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.416 0.686 . . . . 0.0 111.885 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 mt -147.65 160.71 42.37 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 125.679 1.592 . . . . 0.0 108.708 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 44.6 p -90.4 154.15 19.89 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 170.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -51.76 -45.52 63.74 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 122.213 -0.305 . . . . 0.0 110.921 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -57.6 -57.24 20.86 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 111.74 -0.544 . . . . 0.0 111.74 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -58.01 -41.09 82.35 Favored 'General case' 0 N--CA 1.456 -0.168 0 O-C-N 121.996 -0.708 . . . . 0.0 110.739 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 29.3 tp -62.19 -49.21 76.71 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -52.93 -48.66 67.12 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.898 0.479 . . . . 0.0 109.895 176.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -56.98 -53.98 51.84 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.946 0.498 . . . . 0.0 110.617 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -52.25 -51.25 59.49 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.002 0.921 . . . . 0.0 110.437 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 89.7 mt -61.28 -51.49 68.69 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.631 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -52.78 -48.98 66.47 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.941 0.496 . . . . 0.0 110.406 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.05 -36.12 70.13 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.292 0.637 . . . . 0.0 111.832 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -78.89 -44.64 22.34 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 117.783 0.265 . . . . 0.0 111.013 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 56.9 mt -64.7 -43.08 94.66 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.434 0.694 . . . . 0.0 110.211 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.213 0 C-N-CA 124.84 1.256 . . . . 0.0 111.807 179.066 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.6 m . . . . . 0 N--CA 1.451 -0.412 0 CA-C-O 120.531 0.205 . . . . 0.0 111.473 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -74.0 54.74 0.53 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.384 1.074 . . . . 0.0 111.661 -178.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -81.79 56.89 3.2 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 176.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.8 mt -122.83 149.0 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 124.559 1.144 . . . . 0.0 110.854 -172.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.9 mm -87.54 106.7 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 175.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 37.9 m-70 -81.26 95.54 6.99 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 177.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 44.8 mt -79.9 163.44 24.33 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.598 1.159 . . . . 0.0 113.067 -175.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.6 p -139.06 164.73 29.01 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 126.261 1.824 . . . . 0.0 106.459 174.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -57.46 -46.25 83.85 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.673 -0.642 . . . . 0.0 110.14 -178.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -61.87 -38.9 90.02 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.8 p -78.13 -35.52 48.99 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 121.992 -0.443 . . . . 0.0 110.223 -177.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -33.74 -51.17 0.38 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 126.912 2.085 . . . . 0.0 114.019 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -54.92 -48.09 73.54 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.07 0.462 . . . . 0.0 111.636 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.1 m -76.33 -52.09 10.64 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 121.996 -0.44 . . . . 0.0 110.769 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.52 -47.31 64.18 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -173.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.3 t -94.53 -50.09 12.12 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.11 0 C-N-CA 123.33 0.652 . . . . 0.0 111.915 -175.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 70.4 mt -73.67 -48.69 30.38 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.988 -177.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -91.36 42.33 1.1 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.134 0.879 . . . . 0.0 109.252 175.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.03 177.08 2.33 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 125.395 1.478 . . . . 0.0 113.686 -178.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -134.88 101.93 5.07 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.993 2.117 . . . . 0.0 106.594 175.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.09 -162.03 45.98 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-O 121.588 0.549 . . . . 0.0 113.87 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.48 117.9 20.11 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.47 1.508 . . . . 0.0 112.536 -177.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.1 mt -116.53 120.77 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 124.552 1.141 . . . . 0.0 109.049 176.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.409 ' C ' HD13 ' A' ' 24' ' ' LEU . 2.9 tm? -91.97 108.08 19.67 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 176.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.9 t -98.53 106.59 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 123.86 0.864 . . . . 0.0 109.954 -177.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -91.35 105.11 17.54 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 176.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -79.59 125.24 29.35 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 174.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 44.7 p-90 -142.39 169.52 17.42 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.828 0.851 . . . . 0.0 112.729 -176.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -146.93 137.97 23.96 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.954 1.302 . . . . 0.0 107.586 174.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -50.55 -48.54 57.33 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.586 0.754 . . . . 0.0 112.759 -176.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 58.5 p-90 -62.7 -26.05 68.47 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 50.8 t -79.8 79.44 6.31 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 121.316 -0.865 . . . . 0.0 109.233 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -25.96 -60.39 0.07 OUTLIER Glycine 0 CA--C 1.536 1.359 0 C-N-CA 127.139 2.304 . . . . 0.0 114.801 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -43.08 -35.06 4.46 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 124.315 3.343 . . . . 0.0 114.586 178.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 78.3 m -57.09 -47.24 81.52 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 121.588 -0.695 . . . . 0.0 109.846 176.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -65.87 -31.18 71.98 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.696 0.799 . . . . 0.0 109.776 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 85.1 mtp -68.5 -45.04 73.36 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 177.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.0 pt -75.39 -27.52 19.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 118.521 0.6 . . . . 0.0 112.33 178.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -37.94 -58.66 1.34 Allowed Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -58.27 -39.01 88.34 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.41 2.073 . . . . 0.0 111.514 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.5 mt -59.51 -51.08 76.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 177.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 44.3 mt -56.44 -42.55 78.3 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.621 0.368 . . . . 0.0 110.505 177.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -59.51 -48.7 80.64 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.674 0.67 . . . . 0.0 110.259 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -58.42 -52.62 64.86 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.677 -0.639 . . . . 0.0 109.606 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 11.2 mm -54.39 -46.29 69.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 124.735 1.214 . . . . 0.0 110.179 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.23 -44.73 68.31 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.361 0.664 . . . . 0.0 110.179 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -66.34 -56.78 9.48 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 176.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -45.71 -50.76 13.39 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.937 0.895 . . . . 0.0 112.423 -178.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -95.44 26.2 4.01 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.663 0.785 . . . . 0.0 112.463 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.58 130.15 23.62 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.264 0.938 . . . . 0.0 109.933 176.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.6 -16.48 5.04 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-O 119.147 -0.807 . . . . 0.0 114.181 -178.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -99.6 -39.08 8.48 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 118.87 1.335 . . . . 0.0 110.214 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 26.0 tp -137.78 126.55 23.87 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.8 m -86.94 102.39 14.32 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 176.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 96.3 t -79.02 137.51 21.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.42 147.41 45.39 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.023 0.929 . . . . 0.0 109.445 -177.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -125.26 135.3 52.39 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.6 tt -127.78 112.57 14.92 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.606 0.763 . . . . 0.0 109.692 -178.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -78.98 104.52 9.67 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 122.902 0.481 . . . . 0.0 109.824 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.2 pt -69.03 -24.25 28.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 118.866 -0.588 . . . . 0.0 112.559 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -53.31 -53.82 45.4 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.061 0.846 . . . . 0.0 109.502 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -78.2 -28.71 48.12 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.961 0.904 . . . . 0.0 110.763 179.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -118.11 67.0 6.26 Favored Pre-proline 0 C--O 1.235 0.315 0 C-N-CA 124.1 0.96 . . . . 0.0 111.495 -176.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -61.14 -53.65 2.36 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.465 2.11 . . . . 0.0 112.383 -176.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -37.97 -47.12 1.85 Allowed Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.631 1.586 . . . . 0.0 114.267 -177.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -51.71 -33.79 35.9 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.23 1.012 . . . . 0.0 112.962 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.27 -68.25 0.79 Allowed Pre-proline 0 CA--C 1.537 0.478 0 CA-C-O 117.987 -1.006 . . . . 0.0 112.017 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -59.32 -35.95 95.65 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.005 1.803 . . . . 0.0 111.358 177.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -51.44 -37.64 49.65 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.526 1.057 . . . . 0.0 111.661 177.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -111.9 22.31 15.04 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.098 0.559 . . . . 0.0 111.187 177.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 42.69 43.24 5.06 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 125.465 1.507 . . . . 0.0 113.04 178.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.5 mp -51.07 118.17 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 118.094 0.947 . . . . 0.0 109.315 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -79.14 -44.38 22.12 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.371 0.669 . . . . 0.0 110.415 -177.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -164.91 141.91 7.39 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 108.451 -1.86 . . . . 0.0 108.451 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.7 pt -95.79 148.88 35.26 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 124.017 0.927 . . . . 0.0 109.997 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.35 141.05 62.81 Favored 'Cis proline' 0 N--CA 1.456 -0.697 0 CA-C-N 119.846 0.981 . . . . 0.0 111.177 -0.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.02 114.81 21.46 Favored 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.7 mt -98.0 102.08 13.73 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.7 mp -96.58 118.59 33.39 Favored 'General case' 0 CA--C 1.523 -0.072 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 177.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 tp -92.19 98.67 11.67 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -89.27 103.33 15.96 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 125.225 1.41 . . . . 0.0 110.413 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -83.61 102.19 12.02 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 172.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 45.76 41.43 7.49 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.069 1.748 . . . . 0.0 113.934 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 106.2 -21.28 33.7 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-O 118.784 -1.009 . . . . 0.0 113.358 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -100.32 128.55 46.36 Favored 'General case' 0 C--O 1.227 -0.085 0 CA-C-N 119.254 1.527 . . . . 0.0 110.948 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 89.7 t -68.04 107.29 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.57 -41.61 26.81 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.884 0.874 . . . . 0.0 109.987 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -155.13 167.49 30.2 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 93.7 m -149.72 140.7 22.89 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -116.5 138.37 51.44 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 177.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 26.3 t -120.96 123.32 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 178.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.92 175.09 45.47 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 111.579 -0.609 . . . . 0.0 111.579 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.38 172.77 8.83 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.22 0.608 . . . . 0.0 110.954 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -162.8 167.99 22.07 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.625 1.17 . . . . 0.0 108.75 -177.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 88.2 p -81.67 160.1 23.8 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -57.48 -40.35 78.41 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 175.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.95 -53.06 42.38 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 176.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -60.46 -39.65 88.34 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 117.616 0.708 . . . . 0.0 111.148 178.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 23.3 tp -62.19 -50.93 69.85 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.586 0.63 . . . . 0.0 109.874 178.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -53.41 -49.52 67.12 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.32 0.648 . . . . 0.0 109.567 176.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -55.56 -55.86 27.03 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.063 0.945 . . . . 0.0 110.424 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -52.93 -54.38 35.64 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.489 1.516 . . . . 0.0 110.828 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.7 mt -61.32 -51.93 66.8 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.44 0.296 . . . . 0.0 110.658 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -53.95 -50.38 66.63 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.028 0.531 . . . . 0.0 110.631 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.02 -36.53 65.58 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.429 0.692 . . . . 0.0 111.623 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -78.64 -48.32 15.31 Favored 'General case' 0 C--O 1.227 -0.115 0 O-C-N 122.238 -0.289 . . . . 0.0 110.406 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 58.0 mt -59.18 -42.78 91.66 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.936 0.494 . . . . 0.0 110.294 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.282 0 C-N-CA 123.097 0.559 . . . . 0.0 109.777 177.889 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.8 p . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -61.84 134.92 57.3 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -72.67 -30.76 64.54 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.574 0.75 . . . . 0.0 109.843 177.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 36.9 mt -79.86 141.15 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 124.28 1.032 . . . . 0.0 110.674 -176.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.2 mm -89.26 120.28 37.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 123.978 0.911 . . . . 0.0 109.492 178.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -85.71 111.39 20.07 Favored 'General case' 0 CA--C 1.528 0.099 0 O-C-N 121.515 -0.741 . . . . 0.0 109.349 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 65.8 mt -95.5 160.87 14.31 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 124.458 1.103 . . . . 0.0 111.203 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 48.9 p -134.68 163.48 29.67 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 174.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -58.48 -47.18 84.91 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.809 0.732 . . . . 0.0 109.601 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -63.69 -41.2 98.17 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.664 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.1 p -78.42 -24.82 45.98 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.38 0.536 . . . . 0.0 111.368 -177.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -41.6 -43.69 2.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 126.602 1.961 . . . . 0.0 113.068 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -52.39 -65.14 0.61 Allowed 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 121.697 0.761 . . . . 0.0 110.251 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.9 m -67.17 -42.53 84.13 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.583 -176.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -70.81 -39.3 73.14 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -174.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.0 t -112.84 -58.48 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 123.446 0.698 . . . . 0.0 110.345 -175.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 67.0 mt -61.43 -35.59 78.0 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -174.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -97.4 16.18 20.88 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.451 0.569 . . . . 0.0 111.73 178.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -102.15 102.43 12.88 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 119.042 0.837 . . . . 0.0 111.724 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -77.25 59.21 1.75 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.949 1.3 . . . . 0.0 110.305 176.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -159.05 168.08 35.01 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.5 114.09 20.68 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.257 0.623 . . . . 0.0 110.817 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.5 mt -120.25 122.44 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 124.537 1.135 . . . . 0.0 109.986 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.4 ' C ' HD13 ' A' ' 24' ' ' LEU . 3.0 tm? -91.99 107.55 19.29 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 175.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 67.2 t -96.19 108.09 20.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 123.992 0.917 . . . . 0.0 109.241 -178.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -97.18 105.32 17.44 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.592 1.157 . . . . 0.0 109.514 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -79.16 126.39 30.68 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 177.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 26.4 p-90 -141.47 173.86 11.1 Favored 'General case' 0 C--N 1.343 0.289 0 C-N-CA 124.304 1.042 . . . . 0.0 112.83 -176.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -149.97 156.89 42.52 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.985 1.714 . . . . 0.0 108.221 175.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.1 mp0 -63.3 -48.79 76.59 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.226 0.536 . . . . 0.0 110.688 -178.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 54.2 p-90 -65.73 -20.8 66.41 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.064 0.946 . . . . 0.0 112.562 -178.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 47.6 t -79.36 75.68 5.95 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 121.481 -0.762 . . . . 0.0 110.08 -178.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -25.74 -63.12 0.06 OUTLIER Glycine 0 CA--C 1.536 1.357 0 C-N-CA 126.509 2.004 . . . . 0.0 114.692 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -43.44 -35.83 6.17 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 124.559 3.506 . . . . 0.0 114.881 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 87.5 m -52.59 -40.71 62.94 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.172 0.589 . . . . 0.0 110.188 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -67.28 -30.83 70.8 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.633 0.773 . . . . 0.0 111.311 179.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -74.36 -46.12 42.6 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 28.0 pt -73.7 -29.26 26.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 118.66 -0.686 . . . . 0.0 112.255 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -39.16 -60.88 1.08 Allowed Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -56.59 -40.84 81.69 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.372 2.048 . . . . 0.0 111.673 178.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.8 mt -57.44 -52.35 58.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 177.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 47.6 mt -57.44 -40.52 78.59 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.281 0.632 . . . . 0.0 110.973 178.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -61.86 -47.86 83.12 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.1 0.864 . . . . 0.0 110.262 177.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -57.87 -52.59 64.87 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.6 mm -53.15 -47.5 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 124.035 0.934 . . . . 0.0 109.591 177.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.94 -49.95 62.14 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 122.842 0.457 . . . . 0.0 110.103 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -62.23 -54.29 42.91 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.723 0.296 . . . . 0.0 110.932 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -53.24 -46.74 69.29 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.767 0.827 . . . . 0.0 112.308 -178.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -94.48 26.99 3.15 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.967 0.907 . . . . 0.0 112.37 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -54.45 128.65 32.76 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.169 0.895 . . . . 0.0 109.724 176.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.1 -14.75 25.8 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-O 119.25 -0.75 . . . . 0.0 112.993 -178.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -99.82 -44.06 6.21 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 118.507 1.153 . . . . 0.0 109.881 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 24.6 tp -139.42 132.38 29.41 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.415 0.686 . . . . 0.0 110.431 -176.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 62.5 m -91.69 103.28 15.87 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 175.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 63.1 t -79.86 130.81 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.66 151.81 50.58 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.28 0.632 . . . . 0.0 110.844 -176.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -126.8 139.94 52.74 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.908 1.283 . . . . 0.0 108.948 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.5 tt -127.8 115.86 19.3 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.608 0.763 . . . . 0.0 109.734 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -79.25 107.15 11.8 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.9 pt -69.0 -26.96 33.59 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.29 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -177.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -59.75 -47.04 87.28 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 119.067 0.849 . . . . 0.0 109.744 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -77.18 -30.58 54.94 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.148 0.579 . . . . 0.0 110.241 176.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -121.79 67.42 22.21 Favored Pre-proline 0 C--O 1.234 0.25 0 C-N-CA 123.933 0.893 . . . . 0.0 111.735 -176.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -62.22 -53.43 1.97 Allowed 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 122.534 2.156 . . . . 0.0 112.777 -176.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -38.86 -47.2 2.38 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.189 1.376 . . . . 0.0 113.989 -177.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -50.52 -34.46 25.38 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.427 1.091 . . . . 0.0 112.897 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.71 -68.99 0.57 Allowed Pre-proline 0 CA--C 1.538 0.518 0 CA-C-O 118.241 -0.885 . . . . 0.0 112.168 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -59.19 -37.2 93.14 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.64 1.56 . . . . 0.0 111.149 177.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -50.83 -40.61 56.18 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-N 119.281 0.946 . . . . 0.0 111.67 178.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -106.76 19.83 19.9 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.586 0.354 . . . . 0.0 111.893 178.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 51.0 40.31 42.9 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.097 0.856 . . . . 0.0 113.043 177.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mp -53.24 120.7 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 177.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 55.5 mmt-85 -79.14 -46.89 17.07 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.769 0.828 . . . . 0.0 109.417 -178.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -170.72 145.53 9.07 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 106.601 -2.6 . . . . 0.0 106.601 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.5 pt -90.83 150.95 43.03 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-O 118.907 -0.568 . . . . 0.0 109.842 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -70.08 138.11 48.21 Favored 'Cis proline' 0 N--CA 1.458 -0.609 0 CA-C-N 119.485 0.852 . . . . 0.0 111.285 -0.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -123.62 120.27 32.29 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 178.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.3 mt -103.25 117.39 34.4 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -110.2 116.83 32.22 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 177.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 tp -92.28 101.22 13.71 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -90.83 145.42 24.78 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.096 1.358 . . . . 0.0 111.595 -178.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -141.59 116.86 10.09 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.317 1.847 . . . . 0.0 106.102 174.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 49.66 48.64 21.25 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.678 0.752 . . . . 0.0 110.61 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.51 -9.74 4.33 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-O 118.283 -1.287 . . . . 0.0 115.86 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -98.52 142.38 30.19 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 119.983 1.892 . . . . 0.0 109.851 178.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 89.5 t -76.72 116.84 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 177.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.19 -44.21 22.35 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 177.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -161.88 175.34 11.99 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.3 t -150.82 163.48 38.53 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 54.2 mmtt -141.74 148.5 39.09 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 126.96 2.104 . . . . 0.0 106.672 177.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.9 t -130.52 132.33 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.81 -177.33 46.49 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.82 165.3 24.38 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.978 0.511 . . . . 0.0 111.316 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.3 mt -144.35 157.17 44.4 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.44 1.496 . . . . 0.0 108.28 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 88.2 p -81.52 157.16 24.92 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 170.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -55.68 -44.03 76.94 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -56.29 -56.35 24.79 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 123.671 0.653 . . . . 0.0 111.852 177.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -60.89 -41.25 95.65 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 118.211 1.005 . . . . 0.0 111.298 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 37.6 tp -60.95 -50.99 71.15 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.877 -0.514 . . . . 0.0 109.625 178.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -54.24 -47.75 71.87 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.739 0.7 . . . . 0.0 110.407 176.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -55.05 -53.25 58.29 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.082 0.953 . . . . 0.0 109.919 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -55.21 -54.71 39.91 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.598 1.159 . . . . 0.0 110.894 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 89.8 mt -58.62 -50.17 74.82 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.311 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -55.77 -50.37 70.62 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.17 0.588 . . . . 0.0 110.467 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.8 -35.05 65.89 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.48 0.712 . . . . 0.0 111.479 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -78.03 -50.11 12.72 Favored 'General case' 0 CA--C 1.524 -0.057 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 53.0 mt -56.07 -45.23 79.39 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.049 0.539 . . . . 0.0 110.09 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.251 0 C-N-CA 123.085 0.554 . . . . 0.0 109.693 177.599 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 18.5 m . . . . . 0 CA--C 1.533 0.324 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -23.95 -56.33 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 127.857 2.463 . . . . 0.0 114.877 -177.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -138.45 43.31 2.15 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.205 1.002 . . . . 0.0 108.676 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 13.6 mt -107.52 138.71 32.33 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 C-N-CA 123.573 0.749 . . . . 0.0 111.042 -177.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.0 mm -88.02 107.12 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 123.476 0.71 . . . . 0.0 109.344 177.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -79.58 99.52 7.36 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 76.0 mt -81.85 160.76 23.4 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 122.071 0.939 . . . . 0.0 113.348 -175.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 35.4 p -134.66 163.32 30.02 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 126.951 2.1 . . . . 0.0 106.961 173.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -57.03 -44.09 82.57 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.467 0.707 . . . . 0.0 110.059 179.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -55.84 -46.01 78.27 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.939 0.896 . . . . 0.0 111.458 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.5 p -78.02 -27.26 48.85 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 122.242 -0.286 . . . . 0.0 111.207 -177.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -42.15 -46.79 4.47 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.252 1.421 . . . . 0.0 113.499 -177.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -51.88 -64.83 0.69 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.902 0.858 . . . . 0.0 111.261 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.9 m -68.67 -40.6 80.08 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.106 -174.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -76.53 -55.38 5.58 Favored 'General case' 0 N--CA 1.451 -0.375 0 O-C-N 122.251 -0.281 . . . . 0.0 111.659 -177.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.4 t -91.72 -53.31 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -172.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 68.8 mt -66.26 -37.03 84.51 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 118.924 -1.11 . . . . 0.0 111.163 -176.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -93.68 33.54 1.28 Allowed 'General case' 0 CA--C 1.543 0.711 0 O-C-N 122.064 -0.398 . . . . 0.0 110.048 173.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.94 81.47 0.3 Allowed 'General case' 0 C--N 1.342 0.258 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -77.41 62.87 2.48 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 174.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 163.3 176.47 35.33 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 126.464 1.983 . . . . 0.0 108.432 -177.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.12 123.57 32.92 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 117.605 0.703 . . . . 0.0 109.93 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.2 mt -126.07 120.63 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 124.429 1.092 . . . . 0.0 109.88 -179.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.6 tp -92.18 97.0 10.64 Favored 'General case' 0 N--CA 1.458 -0.064 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 176.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.6 t -86.6 103.88 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 123.757 0.823 . . . . 0.0 108.946 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -95.2 108.18 20.3 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.214 1.005 . . . . 0.0 108.495 177.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -79.72 129.07 34.16 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 176.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 25.8 p-90 -143.53 174.29 10.89 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.293 1.037 . . . . 0.0 112.8 -176.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.49 144.44 20.68 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 125.736 1.615 . . . . 0.0 108.359 176.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -50.09 -49.19 52.38 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.804 0.842 . . . . 0.0 111.981 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 59.8 p-90 -66.55 -22.65 66.15 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -177.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 49.3 t -79.79 69.87 6.21 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 121.439 -0.788 . . . . 0.0 111.233 -176.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -16.64 -65.74 0.01 OUTLIER Glycine 0 CA--C 1.535 1.307 0 C-N-CA 128.128 2.775 . . . . 0.0 115.889 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -44.08 -31.29 3.88 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 124.533 3.489 . . . . 0.0 115.253 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 96.1 m -53.44 -41.62 66.27 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.804 -0.56 . . . . 0.0 109.831 176.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -67.4 -28.24 67.75 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.651 0.781 . . . . 0.0 111.161 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 84.1 mtp -74.76 -45.23 45.19 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 29.9 pt -74.56 -28.02 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.88 177.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -38.09 -59.55 1.18 Allowed Pre-proline 0 CA--C 1.544 0.749 0 CA-C-N 119.899 1.227 . . . . 0.0 114.286 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -56.15 -40.21 86.29 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.179 1.919 . . . . 0.0 111.498 177.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 19.7 mt -59.4 -51.01 77.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 55.5 mt -55.63 -41.62 73.78 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.691 0.396 . . . . 0.0 110.054 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -61.44 -48.55 80.64 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.569 0.622 . . . . 0.0 110.61 177.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -55.94 -51.6 67.09 Favored 'General case' 0 N--CA 1.457 -0.083 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 33.4 mm -55.8 -46.87 80.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 123.377 0.671 . . . . 0.0 110.031 177.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.18 -40.48 67.57 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.212 0.605 . . . . 0.0 110.575 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -71.95 -58.58 3.32 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 176.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -47.54 -48.13 27.72 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.004 1.322 . . . . 0.0 112.921 -178.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -102.39 22.36 13.54 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.726 0.81 . . . . 0.0 111.45 -178.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -54.31 131.66 42.28 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.988 0.813 . . . . 0.0 110.731 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.36 -19.87 9.9 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-O 119.25 -0.75 . . . . 0.0 112.953 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -99.56 -41.17 7.47 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.594 1.197 . . . . 0.0 109.478 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.4 tp -128.38 126.45 40.69 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.78 1.232 . . . . 0.0 108.74 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 45.8 m -88.7 103.55 16.05 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 175.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.2 t -79.53 130.18 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -132.34 145.03 50.96 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 122.802 0.441 . . . . 0.0 110.3 -178.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.7 mtmt -124.05 104.87 9.13 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 124.231 1.012 . . . . 0.0 109.127 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.3 tt -97.54 115.47 27.9 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 121.695 -0.628 . . . . 0.0 110.556 -175.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -79.23 107.96 12.37 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.933 -178.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.2 pt -71.41 -32.14 45.57 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-O 118.997 -0.525 . . . . 0.0 111.969 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -54.97 -27.62 45.23 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.147 0.885 . . . . 0.0 111.749 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -109.84 -0.64 18.26 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.131 0.972 . . . . 0.0 111.406 177.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -146.93 62.5 7.5 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 124.068 0.947 . . . . 0.0 110.853 178.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -56.46 -48.23 20.07 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 121.75 1.633 . . . . 0.0 111.863 -178.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -40.68 -39.99 2.0 Allowed Glycine 0 CA--C 1.529 0.943 0 C-N-CA 126.106 1.812 . . . . 0.0 115.077 -177.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.59 -23.97 67.44 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 118.519 1.16 . . . . 0.0 112.808 -178.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.19 -62.69 5.13 Favored Pre-proline 0 CA--C 1.54 0.569 0 O-C-N 121.112 -0.992 . . . . 0.0 113.348 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -58.05 -34.13 98.09 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 C-N-CA 122.31 2.007 . . . . 0.0 111.906 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -52.58 -29.24 24.71 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.0 0.818 . . . . 0.0 112.024 177.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -119.29 17.72 13.05 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.223 0.609 . . . . 0.0 111.174 177.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 49.17 39.52 27.44 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 124.706 1.146 . . . . 0.0 112.006 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 58.6 mt -64.02 130.72 29.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 121.28 0.562 . . . . 0.0 110.335 -178.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -79.26 -34.72 42.37 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 125.332 1.453 . . . . 0.0 112.602 -175.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -175.92 -157.07 16.27 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 107.41 -2.276 . . . . 0.0 107.41 -178.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.9 pt -147.37 158.44 43.88 Favored Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -70.15 140.29 60.85 Favored 'Cis proline' 0 N--CA 1.458 -0.587 0 N-CA-C 109.289 -1.081 . . . . 0.0 109.289 -1.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 26.6 m -136.85 123.96 21.66 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -179.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.6 mt -100.84 119.24 38.38 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.143 1.777 . . . . 0.0 109.718 -176.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.8 mp -114.55 117.4 30.81 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 173.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 tp -93.38 100.8 13.06 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -90.38 136.67 32.91 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.476 1.11 . . . . 0.0 110.023 -178.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -139.44 119.35 13.38 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.746 1.619 . . . . 0.0 106.663 177.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 54.26 41.55 31.94 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.786 0.721 . . . . 0.0 110.211 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 73.56 -11.84 5.18 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 119.051 -0.861 . . . . 0.0 114.41 -178.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -93.73 136.39 34.07 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 119.139 1.47 . . . . 0.0 109.567 -178.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 95.8 t -73.12 112.85 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 175.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.87 -40.85 31.37 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -158.73 158.71 34.18 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 176.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 89.1 m -134.27 145.21 48.89 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.752 1.221 . . . . 0.0 108.285 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -137.38 122.59 19.26 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 63.5 t -104.11 126.61 58.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.53 166.43 28.55 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.09 0.852 . . . . 0.0 112.219 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.45 170.87 12.35 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.755 0.822 . . . . 0.0 111.542 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -162.96 172.7 14.67 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 124.885 1.274 . . . . 0.0 109.964 -178.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 90.9 p -88.02 162.7 16.68 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.513 0.725 . . . . 0.0 110.101 178.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -54.95 -45.04 74.85 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 175.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.52 -60.61 8.55 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 177.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -54.04 -42.08 68.78 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 117.858 0.829 . . . . 0.0 111.641 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 15.9 tp -59.37 -50.97 71.91 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 176.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -57.87 -42.13 83.89 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.397 -0.814 . . . . 0.0 111.988 178.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -57.92 -52.67 64.52 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.138 0.881 . . . . 0.0 109.493 175.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -52.82 -52.3 57.56 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.887 0.875 . . . . 0.0 110.332 179.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.9 mt -56.99 -53.97 52.03 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.853 0.461 . . . . 0.0 110.399 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -52.57 -51.11 61.32 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 122.754 0.422 . . . . 0.0 110.65 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.15 -39.12 69.11 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.1 0.56 . . . . 0.0 111.733 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -78.71 -42.11 29.21 Favored 'General case' 0 N--CA 1.462 0.128 0 O-C-N 122.223 -0.298 . . . . 0.0 111.567 -178.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 59.4 mt -64.64 -45.09 88.27 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.225 0 C-N-CA 123.016 0.526 . . . . 0.0 109.816 177.921 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.9 p . . . . . 0 N--CA 1.451 -0.422 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -72.83 62.06 0.57 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.037 1.335 . . . . 0.0 110.265 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -80.61 54.74 2.16 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.031 0.932 . . . . 0.0 108.688 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.9 mt -107.19 136.83 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 123.67 0.788 . . . . 0.0 110.514 -177.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.1 mm -87.81 114.39 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-O 121.237 0.542 . . . . 0.0 109.802 177.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 63.0 m80 -83.98 96.97 9.01 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 62.4 mt -86.95 163.57 17.04 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.247 1.019 . . . . 0.0 112.342 -175.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 31.4 p -138.71 165.15 27.7 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.15 1.78 . . . . 0.0 106.517 174.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -55.25 -46.68 76.08 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.034 0.534 . . . . 0.0 109.876 178.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -59.72 -43.54 94.12 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.099 0.959 . . . . 0.0 112.158 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.3 p -78.47 -29.8 47.01 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 122.084 -0.385 . . . . 0.0 111.419 -176.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -37.19 -49.12 0.89 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.244 1.818 . . . . 0.0 113.515 -179.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -50.36 -64.6 0.76 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 121.74 0.781 . . . . 0.0 110.955 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 m -69.83 -46.36 65.8 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.855 -175.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -77.21 -21.55 53.71 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 114.935 1.458 . . . . 0.0 114.935 -173.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.3 t -120.48 -61.37 2.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 119.475 1.034 . . . . 0.0 109.753 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 67.0 mt -60.33 -39.92 88.83 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -174.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -94.89 12.52 27.91 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.281 0.491 . . . . 0.0 111.511 178.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.91 98.61 11.17 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.01 0.823 . . . . 0.0 111.654 -178.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -76.44 67.1 2.58 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.492 0.663 . . . . 0.0 109.742 177.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -164.88 162.84 35.96 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.71 112.1 18.57 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.067 0.547 . . . . 0.0 110.47 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.7 mt -118.65 114.21 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 125.288 1.435 . . . . 0.0 110.666 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.9 tp -83.39 96.63 8.6 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 174.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.2 t -86.33 114.93 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 C-N-CA 123.243 0.617 . . . . 0.0 109.611 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -98.31 105.45 17.59 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.495 1.118 . . . . 0.0 108.501 177.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -79.79 121.64 25.62 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 104.672 -2.344 . . . . 0.0 104.672 174.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 38.5 p-90 -135.11 170.35 16.04 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 124.141 0.976 . . . . 0.0 113.347 -175.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.59 125.55 13.6 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.744 1.618 . . . . 0.0 107.558 177.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -46.65 -45.44 19.22 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.416 1.086 . . . . 0.0 113.915 -177.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 55.5 p-90 -68.93 -23.64 64.19 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.956 0.502 . . . . 0.0 112.316 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 42.4 t -79.86 74.24 6.59 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 121.284 -0.885 . . . . 0.0 111.083 -177.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -13.07 -66.15 0.01 OUTLIER Glycine 0 CA--C 1.535 1.319 0 C-N-CA 128.48 2.943 . . . . 0.0 115.891 178.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -41.27 -36.78 2.72 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 124.264 3.309 . . . . 0.0 114.881 178.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 98.8 m -56.11 -48.01 76.98 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.386 0.674 . . . . 0.0 110.003 177.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -64.77 -38.04 89.65 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.549 0.74 . . . . 0.0 109.345 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 52.6 mtm -64.28 -43.96 93.16 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 119.505 -0.283 . . . . 0.0 111.032 178.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 29.8 pt -76.33 -26.69 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 118.74 0.7 . . . . 0.0 112.494 179.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -38.17 -58.85 1.36 Allowed Pre-proline 0 CA--C 1.545 0.756 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -57.27 -39.71 87.85 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 121.959 1.773 . . . . 0.0 111.654 178.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 19.1 mt -59.35 -50.75 78.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 177.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.6 mt -56.05 -43.38 77.84 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.744 0.418 . . . . 0.0 110.434 178.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -59.58 -49.32 78.23 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.603 0.638 . . . . 0.0 109.683 177.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -56.34 -49.78 73.39 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 28.8 mm -56.02 -49.97 72.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 123.206 0.602 . . . . 0.0 109.709 177.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.77 -45.96 63.94 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.288 0.635 . . . . 0.0 110.296 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -66.3 -58.04 6.2 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.938 -0.119 . . . . 0.0 110.738 177.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -48.19 -49.25 33.49 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.52 1.128 . . . . 0.0 112.748 -177.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -98.05 21.79 10.27 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.231 0.612 . . . . 0.0 111.851 -177.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -52.81 128.35 26.47 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.597 1.089 . . . . 0.0 110.824 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.12 -17.35 23.42 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-O 119.33 -0.705 . . . . 0.0 113.419 -178.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -99.29 -42.95 6.78 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 118.477 1.138 . . . . 0.0 109.065 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.3 tp -136.29 137.7 40.99 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.444 1.497 . . . . 0.0 107.274 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.5 m -98.37 140.77 32.14 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 173.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 96.3 t -113.01 141.31 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 177.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -138.03 152.33 48.74 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -128.37 133.4 48.63 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.5 tt -127.8 115.75 19.13 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.72 0.808 . . . . 0.0 109.104 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -80.25 110.01 15.26 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 pp -67.76 -32.54 57.09 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.149 0 C-N-CA 123.412 0.685 . . . . 0.0 112.808 -177.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -60.36 -47.74 84.74 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 118.963 0.801 . . . . 0.0 109.155 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -69.42 -37.26 77.36 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.92 0.888 . . . . 0.0 110.131 177.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -119.87 72.31 16.55 Favored Pre-proline 0 C--O 1.233 0.231 0 C-N-CA 124.007 0.923 . . . . 0.0 111.779 -175.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -61.49 -53.6 2.22 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 122.361 2.04 . . . . 0.0 112.418 -177.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -38.32 -47.93 2.13 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 125.351 1.453 . . . . 0.0 114.377 -177.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.56 -33.34 45.26 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.299 1.039 . . . . 0.0 113.092 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.88 -68.43 0.72 Allowed Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 118.149 -0.929 . . . . 0.0 112.511 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -59.41 -38.23 85.2 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 121.68 1.587 . . . . 0.0 111.048 178.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -50.92 -39.44 54.61 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-N 118.903 0.774 . . . . 0.0 111.53 178.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -108.8 20.93 17.9 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 122.884 0.474 . . . . 0.0 112.132 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 51.49 38.82 43.5 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 124.128 0.87 . . . . 0.0 113.465 176.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mp -57.43 125.66 13.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 118.092 0.946 . . . . 0.0 108.47 177.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -88.92 -47.59 8.05 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.465 1.106 . . . . 0.0 109.118 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -166.64 145.41 9.92 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 107.363 -2.295 . . . . 0.0 107.363 178.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.497 HD13 ' H ' ' A' ' 75' ' ' ILE . 0.2 OUTLIER -91.19 154.71 44.87 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-O 118.834 -0.603 . . . . 0.0 110.306 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.31 129.26 12.46 Favored 'Cis proline' 0 N--CA 1.457 -0.624 0 CA-C-N 119.973 1.026 . . . . 0.0 110.628 -1.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -113.72 109.28 18.31 Favored 'General case' 0 N--CA 1.461 0.076 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 178.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.1 mt -89.75 122.55 32.95 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.0 mp -122.96 114.68 20.75 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 177.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 tp -90.11 95.93 10.44 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -87.02 142.29 28.04 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.688 1.195 . . . . 0.0 111.571 -177.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -137.81 109.61 7.12 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 174.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 52.31 48.67 22.16 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 118.983 0.81 . . . . 0.0 110.073 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.71 -13.21 2.42 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 118.731 -1.038 . . . . 0.0 114.957 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -88.59 125.25 34.71 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 119.637 1.719 . . . . 0.0 108.873 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 73.2 t -71.82 114.07 9.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 175.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.94 -41.25 29.82 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.304 0.641 . . . . 0.0 109.398 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -159.18 170.06 22.78 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 177.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.1 t -149.3 162.77 39.39 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -146.88 119.78 8.71 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.171 1.388 . . . . 0.0 108.08 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.2 t -94.24 120.71 44.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.39 174.92 29.97 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 121.537 0.52 . . . . 0.0 112.211 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.21 172.25 9.59 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.777 0.831 . . . . 0.0 112.156 -178.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.9 mt -144.4 158.47 43.73 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 125.81 1.644 . . . . 0.0 108.506 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.3 p -87.03 152.02 22.74 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 169.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -50.53 -47.93 57.33 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 122.065 -0.397 . . . . 0.0 111.006 -178.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.64 -53.53 38.44 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -62.38 -39.7 94.06 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.98 -0.718 . . . . 0.0 111.291 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 30.6 tp -62.53 -49.43 75.37 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -56.22 -44.92 80.03 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.429 0.559 . . . . 0.0 110.492 176.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -56.27 -54.68 42.46 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.569 0.748 . . . . 0.0 109.887 177.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -53.4 -51.66 61.83 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.669 1.188 . . . . 0.0 110.357 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 94.9 mt -58.83 -50.77 72.74 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.519 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -55.33 -49.86 71.12 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.8 -36.89 67.92 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.468 0.707 . . . . 0.0 111.601 178.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -78.06 -47.43 18.36 Favored 'General case' 0 C--N 1.337 0.042 0 O-C-N 122.113 -0.367 . . . . 0.0 110.475 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 54.2 mt -59.37 -44.67 92.7 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.227 0.611 . . . . 0.0 109.531 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.244 0 C-N-CA 122.933 0.493 . . . . 0.0 109.707 177.743 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 20.0 m . . . . . 0 CA--C 1.528 0.12 0 CA-C-O 120.691 0.281 . . . . 0.0 111.299 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -74.31 78.65 1.84 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 120.994 0.426 . . . . 0.0 110.614 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -77.4 57.5 1.53 Allowed 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 175.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.7 mt -117.55 147.72 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 C-N-CA 125.631 1.572 . . . . 0.0 109.706 -173.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.2 mm -87.71 108.78 18.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 176.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 27.1 m-70 -79.77 94.69 5.81 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 177.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 66.9 mt -82.09 159.18 23.47 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.832 0.853 . . . . 0.0 112.433 -177.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 26.6 p -134.25 163.15 30.27 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.991 1.716 . . . . 0.0 106.947 173.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -55.62 -46.58 77.37 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.492 0.717 . . . . 0.0 110.656 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -55.98 -45.13 79.07 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.997 0.919 . . . . 0.0 111.468 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.9 p -78.34 -29.78 47.76 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 111.6 0.222 . . . . 0.0 111.6 -177.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -37.62 -53.59 1.2 Allowed 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 125.782 1.633 . . . . 0.0 114.473 -176.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -50.87 -62.2 1.75 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.611 0.719 . . . . 0.0 111.045 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -66.39 -49.53 66.51 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.944 -176.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -74.39 -21.0 59.86 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -173.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.5 t -119.51 -64.99 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.23 0.066 0 CA-C-N 119.326 0.966 . . . . 0.0 110.161 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 67.9 mt -59.66 -37.46 78.79 Favored 'General case' 0 C--N 1.334 -0.082 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 -174.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -98.61 15.75 24.1 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.428 0.558 . . . . 0.0 111.949 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.58 108.39 20.98 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 118.979 0.809 . . . . 0.0 111.047 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -75.38 63.97 1.49 Allowed 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.933 1.293 . . . . 0.0 111.336 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -163.81 178.38 39.29 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.61 105.66 17.9 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.134 1.374 . . . . 0.0 109.44 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.7 mt -112.38 117.35 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 124.144 0.978 . . . . 0.0 110.352 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.5 tp -90.5 97.89 11.45 Favored 'General case' 0 CA--C 1.523 -0.062 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 175.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.8 t -88.78 111.79 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -95.54 106.8 18.93 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.709 1.204 . . . . 0.0 108.601 176.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -80.5 125.17 29.63 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 175.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 31.1 p-90 -143.84 176.2 9.43 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.858 0.863 . . . . 0.0 112.574 -174.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.17 144.71 16.15 Favored 'General case' 0 C--N 1.338 0.092 0 C-N-CA 125.065 1.346 . . . . 0.0 108.476 175.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 -48.93 -50.69 34.15 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.789 1.236 . . . . 0.0 112.099 -178.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 63.9 p-90 -60.41 -29.84 69.22 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -177.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 49.5 t -79.82 77.88 6.45 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 121.514 -0.741 . . . . 0.0 110.52 -178.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -24.66 -62.1 0.05 OUTLIER Glycine 0 CA--C 1.536 1.399 0 C-N-CA 127.094 2.283 . . . . 0.0 115.084 179.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -43.88 -31.16 3.49 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 124.683 3.589 . . . . 0.0 115.192 179.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 98.8 m -55.09 -42.73 73.21 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.688 -0.633 . . . . 0.0 109.705 176.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -67.77 -27.2 66.56 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.712 0.805 . . . . 0.0 111.007 178.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 12.7 tmm? -72.3 -48.99 38.03 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 43.5 pt -70.39 -31.49 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 118.696 -0.668 . . . . 0.0 112.209 178.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -37.53 -60.94 0.8 Allowed Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -57.48 -39.35 89.6 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.374 2.049 . . . . 0.0 111.734 178.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 16.1 mt -59.22 -52.27 62.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.5 mt -55.84 -43.64 77.22 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.652 0.781 . . . . 0.0 110.575 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -58.09 -50.52 73.19 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.121 0.486 . . . . 0.0 109.804 178.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -59.88 -49.98 75.57 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.6 mm -53.37 -46.59 58.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 123.688 0.795 . . . . 0.0 109.585 177.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.56 -45.96 70.08 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.753 0.421 . . . . 0.0 110.608 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -66.43 -55.65 14.73 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 177.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -50.36 -47.82 55.9 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.931 0.892 . . . . 0.0 112.291 -177.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -98.31 23.74 8.04 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.813 0.845 . . . . 0.0 111.614 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -53.82 130.86 38.49 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 119.396 0.998 . . . . 0.0 110.526 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.24 -18.64 12.92 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 119.151 -0.805 . . . . 0.0 113.087 -178.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -99.3 -42.38 7.03 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.788 1.294 . . . . 0.0 109.288 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.0 tp -132.42 131.87 42.22 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.511 1.125 . . . . 0.0 108.667 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 90.4 m -96.27 104.37 16.32 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 176.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 90.7 t -79.74 134.66 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.08 150.02 51.16 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.296 0.639 . . . . 0.0 109.284 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -126.39 136.27 52.48 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 178.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.5 tt -129.45 115.13 17.04 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.412 0.685 . . . . 0.0 109.16 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -80.63 111.11 16.75 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.1 pt -73.19 -25.1 21.19 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.139 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -177.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -61.54 -46.96 87.71 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 177.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -70.6 -40.13 73.41 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.222 1.009 . . . . 0.0 109.894 177.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -120.53 69.77 16.36 Favored Pre-proline 0 CA--C 1.532 0.269 0 C-N-CA 124.06 0.944 . . . . 0.0 112.691 -175.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -65.54 -41.42 15.23 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 121.802 1.668 . . . . 0.0 110.653 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -43.99 -35.99 3.65 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 125.569 1.557 . . . . 0.0 114.913 -178.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.98 -20.41 61.73 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.604 1.202 . . . . 0.0 112.92 -177.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.25 -59.22 13.6 Favored Pre-proline 0 CA--C 1.539 0.538 0 O-C-N 121.111 -0.993 . . . . 0.0 113.226 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -58.17 -33.25 97.29 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.281 1.987 . . . . 0.0 111.805 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -52.98 -29.0 26.48 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.87 0.759 . . . . 0.0 111.929 177.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -122.94 20.47 10.0 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.464 0.705 . . . . 0.0 110.57 177.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 40.3 43.39 2.74 Favored Glycine 0 C--N 1.342 0.875 0 C-N-CA 126.03 1.776 . . . . 0.0 111.535 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.5 mt -54.06 138.39 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -174.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.51 -41.4 32.47 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.55 1.14 . . . . 0.0 111.219 -174.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -178.25 -150.94 9.01 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 106.674 -2.57 . . . . 0.0 106.674 -177.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.3 pt -148.36 154.31 41.75 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 118.856 1.328 . . . . 0.0 108.979 178.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -70.72 141.41 68.38 Favored 'Cis proline' 0 N--CA 1.455 -0.767 0 CA-C-N 119.786 0.959 . . . . 0.0 110.333 -1.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 43.5 m -133.79 125.92 29.5 Favored 'General case' 0 C--O 1.231 0.111 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 178.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.2 mt -103.58 124.96 49.77 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.89 1.276 . . . . 0.0 109.15 -177.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -114.52 117.35 30.69 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 105.064 -2.199 . . . . 0.0 105.064 174.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.5 tp -94.98 95.41 8.6 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -86.88 102.9 14.77 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.162 1.385 . . . . 0.0 110.052 -178.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -97.93 114.68 26.85 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 174.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 54.23 46.99 24.11 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.536 0.734 . . . . 0.0 109.981 -178.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 69.55 -1.8 13.15 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-O 118.62 -1.1 . . . . 0.0 114.414 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -103.46 128.97 50.51 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 119.657 1.728 . . . . 0.0 109.253 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 98.8 t -66.35 102.7 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.17 -38.54 35.64 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.696 0.799 . . . . 0.0 109.652 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -150.76 167.29 27.88 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 97.4 m -147.49 149.92 33.57 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.13 141.31 31.16 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -177.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 36.7 t -125.36 128.44 72.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.38 175.87 37.37 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 123.829 0.728 . . . . 0.0 111.649 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.73 173.16 9.47 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.455 0.702 . . . . 0.0 111.44 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.0 mt -146.4 161.69 39.83 Favored 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 125.28 1.432 . . . . 0.0 109.333 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.6 p -92.47 152.42 19.69 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 169.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -51.1 -47.46 61.93 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 122.138 -0.351 . . . . 0.0 111.522 -177.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.8 -60.31 8.9 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -54.46 -41.36 69.38 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.989 -0.712 . . . . 0.0 111.422 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 30.3 tp -60.79 -48.67 80.74 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -55.65 -48.0 75.73 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 118.903 -0.57 . . . . 0.0 110.298 176.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -56.0 -52.13 65.31 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.975 0.807 . . . . 0.0 110.515 178.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -52.05 -51.34 58.14 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.789 0.835 . . . . 0.0 110.429 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 90.1 mt -61.97 -52.33 64.45 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.503 0.321 . . . . 0.0 110.723 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -50.55 -49.79 55.1 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.67 1.188 . . . . 0.0 110.126 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.47 -36.17 68.78 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.402 0.681 . . . . 0.0 111.906 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -78.88 -45.81 19.86 Favored 'General case' 0 N--CA 1.46 0.043 0 O-C-N 122.23 -0.294 . . . . 0.0 110.538 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 56.2 mt -60.26 -43.66 95.98 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.445 0.698 . . . . 0.0 109.655 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.278 0 C-N-CA 122.948 0.499 . . . . 0.0 109.795 177.827 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 35.8 p . . . . . 0 N--CA 1.452 -0.34 0 N-CA-C 110.512 -0.181 . . . . 0.0 110.512 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 28.1 t70 63.89 -70.81 0.07 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 126.979 2.112 . . . . 0.0 110.408 -177.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -116.38 -21.09 9.43 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.396 1.478 . . . . 0.0 110.796 176.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.3 mt -79.5 136.98 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.9 mm -87.79 111.29 21.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 123.599 0.76 . . . . 0.0 109.073 178.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -83.04 101.21 10.97 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 70.7 mt -83.23 163.49 20.71 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.543 1.137 . . . . 0.0 112.139 -177.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 62.2 p -131.51 162.42 30.29 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 173.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -59.25 -46.09 89.43 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.866 0.757 . . . . 0.0 109.543 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -62.72 -41.62 99.25 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.896 0.478 . . . . 0.0 111.713 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 54.4 p -78.33 -26.16 46.75 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.409 0.55 . . . . 0.0 111.175 -177.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -41.85 -44.9 3.5 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 126.419 1.888 . . . . 0.0 112.415 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -53.25 -63.17 1.23 Allowed 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.535 0.684 . . . . 0.0 110.637 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.0 m -66.79 -42.63 85.65 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.742 -177.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -70.52 -50.14 40.89 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -175.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.0 t -100.07 -57.87 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 123.882 0.873 . . . . 0.0 111.141 -174.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 67.0 mt -63.21 -37.01 85.56 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 120.22 -0.592 . . . . 0.0 112.311 -174.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -94.5 21.94 6.68 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.344 0.52 . . . . 0.0 111.08 175.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.78 159.45 34.52 Favored 'General case' 0 C--N 1.34 0.16 0 O-C-N 121.471 -0.768 . . . . 0.0 110.568 177.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -138.6 58.41 1.66 Allowed 'General case' 0 C--O 1.226 -0.155 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 175.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 175.25 -174.2 46.66 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -178.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -86.55 128.28 34.96 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.595 1.158 . . . . 0.0 110.281 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.7 mt -132.99 121.08 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 124.417 1.087 . . . . 0.0 109.603 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -95.35 109.51 21.66 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 175.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.1 t -100.46 108.59 23.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 123.16 0.584 . . . . 0.0 110.043 -178.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -93.7 105.19 17.24 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.125 0.97 . . . . 0.0 109.745 178.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -79.57 114.25 18.35 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 105.048 -2.204 . . . . 0.0 105.048 174.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 39.4 p-90 -128.25 170.55 12.9 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.836 1.255 . . . . 0.0 112.185 -176.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -146.24 131.56 18.54 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.283 1.433 . . . . 0.0 107.763 176.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 -51.14 -37.05 43.98 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.923 0.889 . . . . 0.0 113.24 -178.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 57.7 p-90 -77.9 -20.49 52.83 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 52.8 t -79.83 74.16 6.56 Favored 'General case' 0 N--CA 1.456 -0.138 0 O-C-N 121.228 -0.92 . . . . 0.0 110.745 -177.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -9.68 -71.39 0.01 OUTLIER Glycine 0 CA--C 1.535 1.329 0 C-N-CA 128.294 2.854 . . . . 0.0 115.699 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -40.91 -32.81 0.97 Allowed 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 125.207 3.938 . . . . 0.0 115.61 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 89.3 m -52.66 -41.82 64.16 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.368 0.667 . . . . 0.0 110.207 177.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -66.23 -30.23 70.63 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.717 0.807 . . . . 0.0 111.234 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -75.61 -45.02 39.83 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.9 pt -73.28 -31.15 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-O 118.712 -0.661 . . . . 0.0 112.333 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -39.32 -60.95 1.09 Allowed Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -58.11 -36.86 97.57 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.376 2.051 . . . . 0.0 111.893 178.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 19.7 mt -60.92 -51.79 69.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 177.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.6 mt -56.31 -41.34 75.84 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.189 0.596 . . . . 0.0 110.117 177.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -60.76 -47.87 84.35 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.841 0.746 . . . . 0.0 110.093 176.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -56.91 -51.88 67.38 Favored 'General case' 0 C--N 1.339 0.117 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 31.4 mm -53.72 -46.12 61.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 123.302 0.641 . . . . 0.0 109.498 177.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.65 -36.75 67.39 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.939 0.496 . . . . 0.0 111.223 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -74.5 -58.14 3.48 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.938 0.399 . . . . 0.0 109.986 176.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -50.36 -41.91 52.36 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.734 1.214 . . . . 0.0 112.532 -177.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -107.07 25.45 11.36 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.642 1.177 . . . . 0.0 111.021 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -56.94 121.84 10.87 Favored 'General case' 0 CA--C 1.529 0.173 0 O-C-N 121.545 -0.722 . . . . 0.0 110.39 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.06 -9.83 55.54 Favored Glycine 0 CA--C 1.531 1.094 0 CA-C-O 119.556 -0.58 . . . . 0.0 112.85 -178.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 47.4 mttt -99.71 -41.3 7.35 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.691 1.196 . . . . 0.0 108.664 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 47.7 tp -131.82 133.6 44.86 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.572 1.149 . . . . 0.0 108.708 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.2 m -88.08 98.49 11.56 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 176.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 80.5 t -79.09 128.95 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 178.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.65 150.64 50.68 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.276 0.56 . . . . 0.0 110.662 -177.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -127.54 143.45 51.18 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.972 1.309 . . . . 0.0 107.597 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 tt -134.2 115.19 13.89 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -80.83 105.05 11.76 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pp -58.97 -33.87 51.25 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.242 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -177.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -63.05 -44.31 96.23 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.704 0.684 . . . . 0.0 110.226 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -72.06 -31.49 66.18 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 177.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -128.53 69.79 79.41 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -176.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.02 -50.89 10.89 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.488 2.792 . . . . 0.0 113.408 -178.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -41.37 -40.1 2.56 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 125.431 1.491 . . . . 0.0 114.34 -176.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.88 -30.64 69.13 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.767 -0.843 . . . . 0.0 113.113 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.11 -64.57 2.19 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-O 118.259 -0.877 . . . . 0.0 112.292 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -60.02 -37.21 86.3 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 121.833 1.689 . . . . 0.0 111.511 177.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -52.34 -37.18 55.35 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 119.386 0.994 . . . . 0.0 111.791 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -111.49 20.9 16.76 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.922 0.489 . . . . 0.0 110.92 177.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 41.9 45.08 4.73 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 125.537 1.541 . . . . 0.0 112.901 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mp -47.89 116.45 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 117.702 0.751 . . . . 0.0 110.411 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.41 -49.62 12.07 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.179 0.992 . . . . 0.0 110.295 -177.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -161.9 144.1 9.43 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 107.419 -2.272 . . . . 0.0 107.419 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.7 pt -96.85 150.8 37.31 Favored Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 123.837 0.855 . . . . 0.0 110.246 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -70.23 137.28 44.1 Favored 'Cis proline' 0 N--CA 1.457 -0.672 0 CA-C-N 119.591 0.89 . . . . 0.0 110.597 -1.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -115.43 118.91 34.51 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.3 mt -102.37 105.51 16.12 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -179.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -94.21 114.36 26.45 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 104.781 -2.304 . . . . 0.0 104.781 175.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.6 tp -97.24 105.53 17.7 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -179.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -94.18 150.01 20.71 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.584 1.554 . . . . 0.0 110.712 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -139.63 107.04 5.54 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 173.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 51.01 70.81 0.49 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.548 0.689 . . . . 0.0 111.457 -179.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 73.4 -37.09 0.82 Allowed Glycine 0 CA--C 1.531 1.04 0 N-CA-C 115.923 1.129 . . . . 0.0 115.923 176.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -90.14 147.88 23.32 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.146 1.473 . . . . 0.0 111.373 -177.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 75.3 t -74.38 114.66 14.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 175.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.04 -46.66 13.63 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.62 1.168 . . . . 0.0 109.852 178.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -148.64 170.85 17.22 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 58.9 m -152.57 144.92 24.0 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -177.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -135.29 143.88 46.46 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.4 t -121.94 120.77 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 178.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.03 169.7 35.05 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -177.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.27 170.53 8.57 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.983 0.913 . . . . 0.0 112.882 -178.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.1 mt -142.63 155.76 44.98 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 125.977 1.711 . . . . 0.0 108.572 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.6 p -87.78 152.51 22.06 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 171.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -48.21 -52.35 21.33 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -176.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -53.71 -57.26 16.63 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 26.8 mm100 -57.74 -40.93 80.79 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 122.194 -0.592 . . . . 0.0 111.122 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 42.2 tp -62.13 -49.4 76.01 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 177.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -54.1 -45.99 71.97 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.387 0.54 . . . . 0.0 110.403 176.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -57.96 -54.87 42.04 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 122.92 0.488 . . . . 0.0 110.453 178.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -51.44 -52.21 48.24 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.757 1.223 . . . . 0.0 110.584 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 85.4 mt -61.24 -53.39 57.45 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.805 0.442 . . . . 0.0 110.418 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -51.54 -50.29 60.3 Favored 'General case' 0 C--N 1.334 -0.083 0 C-N-CA 123.765 0.826 . . . . 0.0 111.067 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.82 -37.65 66.38 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.354 0.662 . . . . 0.0 111.654 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -78.78 -43.52 25.31 Favored 'General case' 0 N--CA 1.46 0.073 0 C-N-CA 122.456 0.302 . . . . 0.0 110.587 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 40.4 mt -58.82 -47.06 86.13 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.289 0 C-N-CA 123.364 0.666 . . . . 0.0 109.69 177.656 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 CA--C 1.531 0.239 0 CA-C-O 120.745 0.307 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 26.1 t0 47.81 42.91 16.59 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.993 1.717 . . . . 0.0 112.183 -178.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -82.02 58.07 3.77 Favored 'General case' 0 N--CA 1.457 -0.125 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 175.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 22.0 mt -135.79 143.87 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 123.858 0.863 . . . . 0.0 109.104 -173.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.5 mm -88.03 112.09 23.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 -80.28 102.4 9.49 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 72.7 mt -90.93 161.96 14.97 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 121.814 0.816 . . . . 0.0 112.258 -177.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 82.6 p -139.96 167.15 22.78 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.733 2.013 . . . . 0.0 106.444 175.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -55.22 -47.77 74.87 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.459 0.704 . . . . 0.0 110.656 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -61.8 -40.15 94.22 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.2 p -78.74 -29.99 45.53 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 122.109 -0.369 . . . . 0.0 110.727 -178.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -39.27 -52.83 1.97 Allowed 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 125.841 1.656 . . . . 0.0 113.436 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -55.6 -59.18 5.2 Favored 'General case' 0 N--CA 1.455 -0.202 0 O-C-N 121.868 -0.52 . . . . 0.0 110.908 -179.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.1 m -59.11 -48.85 80.08 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.222 1.009 . . . . 0.0 112.569 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.96 -47.1 16.97 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -174.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.8 t -94.56 -52.39 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 C-N-CA 123.347 0.659 . . . . 0.0 112.504 -174.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 73.6 mt -71.4 -42.72 68.0 Favored 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 119.545 -0.862 . . . . 0.0 111.218 -175.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -91.64 35.32 0.96 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 176.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -78.1 162.1 26.92 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.415 0.686 . . . . 0.0 111.987 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -141.8 94.28 2.66 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 172.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 135.52 -175.51 20.7 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -176.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.05 111.59 23.32 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.374 1.47 . . . . 0.0 109.687 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.0 mt -109.07 115.98 50.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 124.153 0.981 . . . . 0.0 109.686 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.6 tp -90.14 96.97 10.92 Favored 'General case' 0 C--N 1.338 0.076 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 176.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 45.4 t -88.51 114.58 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 123.328 0.651 . . . . 0.0 109.899 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -98.87 106.09 18.31 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 176.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -79.73 120.05 23.49 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 175.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 37.6 p-90 -133.84 170.52 15.47 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.332 1.053 . . . . 0.0 113.152 -175.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -142.76 138.68 30.64 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.192 1.397 . . . . 0.0 107.444 174.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -53.89 -47.64 70.92 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.015 0.526 . . . . 0.0 112.236 -177.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 62.6 p-90 -65.68 -23.75 66.85 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.108 0.563 . . . . 0.0 112.413 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 52.1 t -79.68 80.38 6.07 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 121.34 -0.85 . . . . 0.0 109.75 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -27.06 -59.89 0.09 OUTLIER Glycine 0 CA--C 1.535 1.304 0 C-N-CA 127.078 2.275 . . . . 0.0 114.391 178.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -41.75 -37.16 3.77 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 124.248 3.299 . . . . 0.0 114.699 177.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 75.1 m -58.24 -47.67 82.82 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.689 0.757 . . . . 0.0 109.837 177.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -65.37 -37.28 86.54 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.71 0.804 . . . . 0.0 109.094 178.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 54.3 mtm -63.44 -43.14 98.27 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 119.243 -0.408 . . . . 0.0 111.061 177.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 31.5 pt -75.46 -26.52 18.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 119.139 0.881 . . . . 0.0 112.164 178.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -38.26 -57.8 1.69 Allowed Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -57.42 -40.13 83.71 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.072 1.848 . . . . 0.0 111.499 177.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 16.4 mt -59.32 -49.19 84.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.9 mt -57.22 -43.53 82.89 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.75 0.42 . . . . 0.0 110.763 177.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.46 -50.76 72.58 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.725 0.693 . . . . 0.0 110.16 176.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -56.24 -52.1 65.68 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.4 mm -54.55 -46.88 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 124.891 1.276 . . . . 0.0 110.221 178.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.05 -44.69 79.07 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.723 0.409 . . . . 0.0 110.041 178.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -64.26 -53.34 50.48 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 177.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -49.46 -48.91 47.28 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.177 0.991 . . . . 0.0 111.684 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -100.82 29.63 4.45 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.347 0.659 . . . . 0.0 111.344 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -55.54 123.45 14.04 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.43 -0.794 . . . . 0.0 110.5 -179.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.71 -15.13 43.72 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 119.466 -0.63 . . . . 0.0 112.913 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -99.62 -40.23 7.9 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.371 1.086 . . . . 0.0 109.458 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.7 tp -126.41 132.88 51.41 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.656 1.183 . . . . 0.0 108.83 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.0 m -97.44 101.8 13.42 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 176.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 66.6 t -79.62 135.0 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 178.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.92 150.19 49.22 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.413 0.685 . . . . 0.0 109.732 -178.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 45.2 mttm -127.96 126.62 41.76 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.0 tt -116.66 115.82 26.39 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.442 0.697 . . . . 0.0 109.608 179.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -79.15 108.97 13.04 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 pp -68.37 -32.42 55.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 119.228 -0.415 . . . . 0.0 111.395 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -51.13 -33.19 25.51 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.654 0.661 . . . . 0.0 112.17 -179.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -110.43 1.32 18.26 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.41 1.084 . . . . 0.0 111.563 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -144.19 64.1 12.09 Favored Pre-proline 0 C--O 1.234 0.26 0 C-N-CA 124.42 1.088 . . . . 0.0 109.163 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -60.01 -53.33 3.22 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.646 2.231 . . . . 0.0 112.394 -177.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -38.42 -47.47 2.15 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.392 1.472 . . . . 0.0 114.478 -177.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.86 -33.29 49.14 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.367 1.067 . . . . 0.0 112.753 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.93 -68.32 0.75 Allowed Pre-proline 0 CA--C 1.54 0.564 0 CA-C-O 118.295 -0.859 . . . . 0.0 112.98 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.84 -39.36 82.31 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 121.484 1.456 . . . . 0.0 110.806 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -51.29 -38.48 53.03 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 118.415 0.552 . . . . 0.0 111.826 178.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -107.32 18.87 21.07 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 55.46 40.62 78.14 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 123.106 0.384 . . . . 0.0 113.043 176.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mp -63.52 104.31 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 176.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 47.6 mtt85 -79.62 -43.4 22.96 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.902 1.281 . . . . 0.0 110.186 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -157.49 141.91 8.18 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 107.874 -2.09 . . . . 0.0 107.874 179.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.1 pt -99.45 147.48 33.4 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 124.354 1.062 . . . . 0.0 109.762 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.57 142.41 66.88 Favored 'Cis proline' 0 N--CA 1.457 -0.649 0 CA-C-N 120.112 1.076 . . . . 0.0 111.156 0.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -121.38 110.69 16.4 Favored 'General case' 0 C--N 1.335 -0.062 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.2 mt -88.73 123.05 32.78 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.7 mp -122.32 118.97 29.74 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 176.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.8 tp -95.31 95.08 8.24 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -177.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -86.55 105.23 16.69 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.682 1.193 . . . . 0.0 110.768 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -93.62 111.07 22.67 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 173.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.5 m120 47.87 50.88 15.07 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.718 0.807 . . . . 0.0 111.169 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.38 -11.53 24.06 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 118.851 -0.972 . . . . 0.0 114.676 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -97.36 121.16 38.94 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 119.632 1.716 . . . . 0.0 109.745 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 89.4 t -64.07 106.08 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 175.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.98 -37.51 39.22 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.587 0.755 . . . . 0.0 109.553 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.81 170.04 21.51 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.3 t -149.59 156.89 42.67 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 178.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.2 tmtm? -138.55 116.38 11.54 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.853 1.661 . . . . 0.0 106.764 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 36.5 t -96.35 126.93 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -178.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.01 178.67 47.44 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.27 168.2 12.87 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.104 0.478 . . . . 0.0 110.342 178.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -158.09 165.33 35.28 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.842 0.857 . . . . 0.0 109.154 -178.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 83.1 p -80.2 160.29 25.67 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 177.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -58.62 -38.43 78.01 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 175.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -56.01 -54.73 33.31 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 110.656 -0.977 . . . . 0.0 110.656 176.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -52.91 -50.03 64.75 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 117.241 0.52 . . . . 0.0 110.424 177.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 14.6 tp -59.79 -50.11 75.1 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 121.141 -0.224 . . . . 0.0 110.704 -178.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -55.05 -49.14 72.34 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.185 0.594 . . . . 0.0 111.581 178.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -67.68 -43.81 79.29 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.509 -177.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -52.15 -53.0 48.32 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.655 0.782 . . . . 0.0 109.208 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 84.8 mt -59.42 -54.42 46.87 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 119.116 -0.469 . . . . 0.0 110.78 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -51.43 -50.01 60.55 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.106 0.412 . . . . 0.0 111.022 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.95 -38.8 73.44 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.492 0.717 . . . . 0.0 111.847 179.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -78.3 -40.93 35.31 Favored 'General case' 0 N--CA 1.461 0.117 0 O-C-N 122.092 -0.38 . . . . 0.0 110.995 -178.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 63.0 mt -64.14 -46.59 83.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.266 0 C-N-CA 122.922 0.489 . . . . 0.0 109.82 177.7 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 CA--C 1.532 0.277 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -36.7 -45.2 0.51 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.619 1.968 . . . . 0.0 113.57 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -129.33 35.63 4.23 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.094 0.558 . . . . 0.0 110.881 178.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.4 mt -110.57 137.12 44.32 Favored 'Isoleucine or valine' 0 C--O 1.23 0.059 0 C-N-CA 122.77 0.428 . . . . 0.0 110.077 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.4 mm -87.03 108.2 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -81.68 110.55 17.12 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 177.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.0 mt -88.94 171.9 9.54 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.628 1.171 . . . . 0.0 110.502 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 51.0 p -136.21 164.26 28.48 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 171.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -57.1 -47.77 80.25 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 177.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -59.52 -45.35 91.99 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.674 1.19 . . . . 0.0 111.889 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 86.1 p -79.64 -24.43 41.89 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -176.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -31.7 -60.33 0.25 Allowed 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 127.121 2.169 . . . . 0.0 114.337 -178.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -52.36 -59.19 4.71 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.46 0.648 . . . . 0.0 111.048 -177.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.9 m -60.01 -41.66 92.65 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 123.6 0.76 . . . . 0.0 111.733 -178.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -74.79 -43.14 56.31 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -175.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 45.8 t -105.85 -57.31 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 C-N-CA 124.568 1.147 . . . . 0.0 112.08 -172.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 75.5 mt -61.38 -33.54 73.83 Favored 'General case' 0 N--CA 1.458 -0.037 0 O-C-N 121.702 -0.624 . . . . 0.0 111.876 -174.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -88.91 8.66 28.19 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 118.286 0.493 . . . . 0.0 111.809 177.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.79 100.58 11.02 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 121.253 -0.905 . . . . 0.0 112.489 -178.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -77.06 68.77 3.26 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 174.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -179.84 -172.11 43.5 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -178.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -99.6 115.76 30.14 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.562 1.545 . . . . 0.0 110.857 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 mt -121.53 123.44 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 125.43 1.492 . . . . 0.0 109.116 178.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.423 ' C ' HD13 ' A' ' 24' ' ' LEU . 2.9 tm? -92.86 108.32 19.9 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 175.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 32.2 t -97.3 109.91 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -93.57 106.36 18.34 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 177.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -79.66 125.52 29.74 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 175.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 38.0 p-90 -143.79 166.12 25.78 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -174.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -144.59 137.24 26.6 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.168 1.387 . . . . 0.0 108.909 174.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -51.75 -47.82 63.94 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.865 0.866 . . . . 0.0 112.372 -177.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 50.4 p-90 -60.75 -27.04 67.66 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 46.8 t -79.86 81.48 6.12 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 121.42 -0.8 . . . . 0.0 109.098 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -28.14 -59.17 0.13 Allowed Glycine 0 CA--C 1.538 1.525 0 C-N-CA 125.962 1.744 . . . . 0.0 114.27 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -41.89 -39.27 5.27 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 124.311 3.341 . . . . 0.0 114.464 177.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 94.1 m -56.02 -50.52 70.66 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 121.668 0.747 . . . . 0.0 109.985 176.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -64.18 -38.07 89.74 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.319 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 83.9 mtp -61.7 -44.16 97.47 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 119.472 -0.299 . . . . 0.0 110.827 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.5 pt -76.17 -26.96 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 118.741 0.7 . . . . 0.0 112.635 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -37.8 -57.93 1.48 Allowed Pre-proline 0 CA--C 1.546 0.79 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -58.14 -39.7 83.1 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.07 1.847 . . . . 0.0 111.672 178.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 14.0 mt -59.52 -49.65 82.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 177.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 44.2 mt -56.1 -42.33 76.62 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 122.564 0.346 . . . . 0.0 110.161 177.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -61.71 -46.86 87.83 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.994 0.815 . . . . 0.0 111.147 176.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -56.14 -51.12 69.1 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 24.0 mm -55.92 -44.78 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 123.428 0.691 . . . . 0.0 109.831 177.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.86 70.68 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 118.321 0.509 . . . . 0.0 110.787 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -72.55 -57.61 4.01 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 177.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -51.18 -46.09 62.0 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.231 1.012 . . . . 0.0 112.605 -178.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -98.26 19.82 13.6 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.438 1.095 . . . . 0.0 111.426 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -54.93 131.85 45.44 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.25 -0.906 . . . . 0.0 110.085 -178.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.25 -18.76 7.64 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 119.334 -0.703 . . . . 0.0 113.235 -178.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -99.61 -37.42 9.15 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.486 1.143 . . . . 0.0 109.923 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 26.6 tp -136.68 128.01 28.26 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.496 1.118 . . . . 0.0 108.181 178.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 57.6 m -88.55 105.08 17.4 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 91.2 t -79.53 130.36 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.96 153.19 51.94 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.938 0.895 . . . . 0.0 110.45 -177.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -128.74 144.02 51.06 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.658 1.183 . . . . 0.0 108.221 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.0 tt -134.04 117.4 16.61 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -87.19 99.76 12.18 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 122.125 -0.359 . . . . 0.0 110.984 -175.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.9 pt -55.26 -28.11 21.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -56.99 -43.55 81.84 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.828 0.74 . . . . 0.0 110.294 177.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -95.28 -17.5 21.61 Favored 'General case' 0 CA--C 1.53 0.212 0 C-N-CA 124.818 1.247 . . . . 0.0 111.577 -178.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -129.82 59.35 44.3 Favored Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 124.532 1.133 . . . . 0.0 108.822 -175.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -62.42 -52.18 2.77 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.609 2.206 . . . . 0.0 113.768 -174.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -44.75 -42.99 7.93 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.016 0.817 . . . . 0.0 113.466 -175.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.43 -33.35 43.62 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.055 0.942 . . . . 0.0 112.663 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.54 -68.51 0.63 Allowed Pre-proline 0 CA--C 1.538 0.503 0 CA-C-O 118.139 -0.934 . . . . 0.0 112.294 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -59.86 -38.24 80.84 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 121.595 1.53 . . . . 0.0 111.016 177.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -51.44 -41.31 60.74 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.266 0.939 . . . . 0.0 111.458 178.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -104.59 19.43 20.4 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.505 0.322 . . . . 0.0 111.753 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.16 39.07 49.62 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.224 0.916 . . . . 0.0 113.401 176.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.5 mp -57.01 127.6 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 118.102 0.951 . . . . 0.0 108.903 177.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -92.24 -47.02 7.43 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.658 1.183 . . . . 0.0 110.238 -178.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -160.55 144.94 10.45 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 107.999 -2.04 . . . . 0.0 107.999 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 9.1 pt -99.08 149.34 35.68 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 124.111 0.964 . . . . 0.0 110.275 -179.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.15 140.02 52.91 Favored 'Cis proline' 0 N--CA 1.457 -0.65 0 CA-C-N 119.961 1.022 . . . . 0.0 111.268 -0.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.85 109.56 15.72 Favored 'General case' 0 CA--C 1.527 0.096 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 178.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.5 mt -91.31 93.17 8.94 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.913 0.885 . . . . 0.0 108.758 -178.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.7 mp -90.56 114.47 26.7 Favored 'General case' 0 CA--C 1.522 -0.117 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 177.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -91.6 103.43 16.02 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -91.49 115.24 27.88 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.144 1.378 . . . . 0.0 110.15 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -111.64 125.27 53.77 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 173.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 53.08 46.11 27.36 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.57 0.7 . . . . 0.0 109.621 -178.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.2 7.16 23.5 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 118.167 -1.352 . . . . 0.0 115.449 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -118.03 142.0 47.86 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 120.002 1.901 . . . . 0.0 110.175 178.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 87.4 t -65.92 110.3 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.39 -42.62 25.1 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.895 0.878 . . . . 0.0 108.647 176.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -158.88 170.95 20.96 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.076 0.95 . . . . 0.0 108.662 177.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 91.2 m -147.33 129.86 15.89 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -179.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -112.2 112.95 24.92 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.0 t -92.02 123.46 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.69 167.43 35.02 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 123.885 0.755 . . . . 0.0 112.232 178.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.3 170.56 12.86 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.108 0.563 . . . . 0.0 110.589 179.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -161.16 172.93 15.88 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.689 0.795 . . . . 0.0 109.913 -176.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 82.8 p -84.15 163.88 19.51 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -57.83 -40.78 80.87 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 175.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -59.51 -57.62 18.63 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 177.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -56.44 -40.45 74.8 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 117.589 0.695 . . . . 0.0 110.71 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 28.7 tp -61.05 -54.94 38.61 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 177.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -53.67 -46.36 70.61 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.314 0.506 . . . . 0.0 111.108 178.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -57.49 -53.71 55.04 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.581 0.753 . . . . 0.0 110.044 178.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -52.97 -54.02 41.33 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.327 1.051 . . . . 0.0 110.448 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.3 mt -59.27 -51.81 68.36 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.654 -179.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -54.77 -51.09 66.81 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.057 0.543 . . . . 0.0 110.661 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.2 -37.37 67.01 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.586 0.755 . . . . 0.0 111.46 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -78.13 -45.97 21.91 Favored 'General case' 0 C--O 1.227 -0.081 0 O-C-N 122.336 -0.227 . . . . 0.0 110.587 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 51.9 mt -58.23 -47.3 83.94 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.31 0 C-N-CA 123.286 0.634 . . . . 0.0 109.566 177.355 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.4 m . . . . . 0 N--CA 1.453 -0.325 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -73.85 63.4 0.9 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.906 0.882 . . . . 0.0 110.927 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -80.47 53.27 1.79 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.1 mt -113.42 144.86 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 124.206 1.003 . . . . 0.0 109.846 -174.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.7 mm -87.31 107.78 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 -79.74 92.03 5.37 Favored 'General case' 0 N--CA 1.461 0.082 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 177.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.2 mt -75.79 162.53 28.1 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.794 0.838 . . . . 0.0 111.685 -178.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.3 p -137.28 162.1 34.44 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 171.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -53.25 -44.93 68.55 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.368 0.667 . . . . 0.0 109.965 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -56.01 -39.86 72.53 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.853 1.261 . . . . 0.0 111.564 178.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.35 -43.48 27.63 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 122.089 -0.382 . . . . 0.0 109.98 -177.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -31.05 -55.71 0.23 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 127.702 2.401 . . . . 0.0 114.773 -177.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -55.35 -36.37 66.22 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -177.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.0 m -90.26 -53.4 4.47 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.527 0.679 . . . . 0.0 109.305 179.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.21 -50.55 72.65 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 113.08 0.771 . . . . 0.0 113.08 -174.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.0 t -94.14 -60.29 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 123.467 0.707 . . . . 0.0 111.077 -174.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 65.3 mt -62.72 -24.17 67.54 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -174.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -114.82 32.39 6.03 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 174.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.88 143.72 41.57 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -99.52 36.25 1.81 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.776 1.23 . . . . 0.0 110.369 177.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 159.52 -157.17 28.34 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.42 118.46 26.89 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.706 1.602 . . . . 0.0 110.369 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.2 mt -119.72 120.79 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 C-N-CA 124.782 1.233 . . . . 0.0 109.017 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.41 ' C ' HD13 ' A' ' 24' ' ' LEU . 3.1 tm? -91.78 106.41 18.45 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 105.788 -1.931 . . . . 0.0 105.788 175.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 53.9 t -98.02 108.74 22.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 123.36 0.664 . . . . 0.0 109.407 -178.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -93.9 110.09 21.77 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 177.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -81.52 119.44 23.76 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 175.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 27.7 p-90 -136.1 173.32 11.84 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.665 1.186 . . . . 0.0 112.049 -175.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.29 150.84 37.38 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.546 1.138 . . . . 0.0 108.721 175.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -56.92 -51.25 69.85 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.682 1.193 . . . . 0.0 111.834 -178.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 63.9 p-90 -68.68 -24.31 64.49 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.006 0.922 . . . . 0.0 112.835 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 51.4 t -79.35 79.26 5.8 Favored 'General case' 0 N--CA 1.456 -0.167 0 O-C-N 121.506 -0.746 . . . . 0.0 110.807 -177.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -26.78 -61.52 0.08 OUTLIER Glycine 0 CA--C 1.536 1.383 0 C-N-CA 127.018 2.246 . . . . 0.0 114.852 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -45.05 -29.54 3.98 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 124.493 3.462 . . . . 0.0 115.227 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 78.4 m -56.35 -40.98 75.37 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 121.219 -0.926 . . . . 0.0 109.615 176.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -71.21 -20.38 62.27 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.972 0.909 . . . . 0.0 111.23 178.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -74.98 -46.63 33.95 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 175.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 35.7 pt -72.49 -31.36 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.785 178.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -37.73 -60.28 0.96 Allowed Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -57.15 -40.27 84.37 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.297 1.998 . . . . 0.0 111.547 178.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.5 mt -58.7 -51.59 70.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.7 mt -56.54 -41.01 76.08 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.059 0.544 . . . . 0.0 110.347 177.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -60.28 -48.98 79.41 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.554 0.616 . . . . 0.0 110.013 177.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -57.06 -51.03 70.89 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 29.8 mm -54.9 -46.31 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 123.089 0.555 . . . . 0.0 109.738 177.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.93 -41.04 70.55 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.327 0.512 . . . . 0.0 110.754 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -69.8 -56.32 7.45 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 176.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -50.31 -49.94 52.19 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.955 0.902 . . . . 0.0 112.544 -178.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -97.08 27.15 4.23 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.444 1.098 . . . . 0.0 111.564 -177.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -55.94 124.38 17.48 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 119.202 0.91 . . . . 0.0 110.626 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.57 -10.47 37.39 Favored Glycine 0 CA--C 1.534 1.241 0 CA-C-O 119.423 -0.654 . . . . 0.0 113.238 -178.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.5 mttm -99.67 -42.15 7.0 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.56 1.144 . . . . 0.0 109.241 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.1 tp -134.72 128.61 33.27 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.282 1.033 . . . . 0.0 108.315 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 55.6 m -87.18 103.76 15.73 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 176.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.7 t -79.48 131.28 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 178.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.99 151.39 49.86 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.604 0.762 . . . . 0.0 110.076 -177.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.8 mttm -128.86 141.83 51.16 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 177.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 tt -132.13 114.84 15.0 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.002 0.921 . . . . 0.0 108.784 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 -80.65 108.32 14.19 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.1 pt -71.63 -23.17 22.29 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -179.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -61.58 -47.75 84.05 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 63.6 mm-40 -75.65 -33.81 60.47 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.347 178.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -119.76 70.79 13.99 Favored Pre-proline 0 N--CA 1.465 0.306 0 C-N-CA 123.954 0.902 . . . . 0.0 112.003 -177.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -61.45 -48.74 8.82 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 121.761 1.641 . . . . 0.0 111.231 -179.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -41.36 -42.68 3.43 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.416 1.484 . . . . 0.0 115.16 -178.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.55 -25.32 67.93 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.193 0.997 . . . . 0.0 112.609 -177.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.66 -64.26 3.09 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-O 118.306 -0.854 . . . . 0.0 112.61 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -59.72 -37.16 89.05 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.075 1.85 . . . . 0.0 111.184 178.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -51.98 -31.12 27.97 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 118.633 0.651 . . . . 0.0 111.865 178.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -119.29 22.2 11.89 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.115 0.566 . . . . 0.0 111.646 176.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 46.0 42.73 12.17 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.46 1.028 . . . . 0.0 113.126 177.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mp -50.17 117.31 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 117.865 0.833 . . . . 0.0 109.447 176.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.3 -36.87 39.0 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.208 1.003 . . . . 0.0 111.279 -175.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -170.74 -174.18 38.48 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 105.339 -3.104 . . . . 0.0 105.339 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.2 pt -140.13 151.61 65.26 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-N 119.503 1.651 . . . . 0.0 109.855 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -67.77 149.65 83.41 Favored 'Cis proline' 0 N--CA 1.457 -0.665 0 CA-C-N 119.593 0.89 . . . . 0.0 111.357 -0.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.5 m -134.07 145.38 49.33 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 175.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.2 mt -121.73 131.79 54.27 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -118.41 117.53 29.29 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 104.47 -2.419 . . . . 0.0 104.47 174.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -93.77 97.32 10.35 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -89.74 107.17 18.94 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.223 1.409 . . . . 0.0 110.935 -177.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -96.12 109.08 21.57 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 173.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 34.6 m120 48.08 47.89 18.73 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.314 1.046 . . . . 0.0 112.079 -179.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 86.0 -17.35 37.41 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 118.636 -1.091 . . . . 0.0 114.275 178.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -95.04 129.72 42.01 Favored 'General case' 0 N--CA 1.457 -0.093 0 CA-C-N 119.576 1.688 . . . . 0.0 110.146 178.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 90.4 t -69.03 109.5 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 176.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.05 -39.14 34.7 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.86 170.87 19.8 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.7 t -145.98 159.04 43.8 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -138.52 146.61 42.15 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 126.374 1.87 . . . . 0.0 106.946 -177.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.0 t -129.23 134.43 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 107.375 -1.342 . . . . 0.0 107.375 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.94 174.64 50.49 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 123.54 0.591 . . . . 0.0 111.687 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.3 167.95 19.35 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 122.783 0.433 . . . . 0.0 109.949 178.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -159.61 165.79 32.04 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.2 1.0 . . . . 0.0 108.487 -179.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 84.6 p -81.14 163.91 22.76 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -58.58 -41.32 85.47 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 174.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -56.88 -55.72 28.68 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 177.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -57.19 -44.73 83.87 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 122.059 -0.671 . . . . 0.0 110.28 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 48.0 tp -60.1 -51.13 70.95 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 117.792 0.269 . . . . 0.0 110.49 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -52.11 -50.26 62.0 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.661 0.784 . . . . 0.0 110.09 178.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -59.99 -51.36 69.98 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.096 0.158 . . . . 0.0 110.637 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -52.15 -53.63 40.57 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.026 0.93 . . . . 0.0 110.564 179.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.2 -53.21 60.37 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 122.872 0.469 . . . . 0.0 110.479 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -52.55 -51.28 60.43 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.05 0.54 . . . . 0.0 111.145 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.28 -37.7 67.65 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.57 0.748 . . . . 0.0 111.733 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -78.43 -43.88 26.2 Favored 'General case' 0 CA--C 1.524 -0.054 0 O-C-N 122.315 -0.24 . . . . 0.0 110.782 -178.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 46.3 mt -59.79 -47.31 86.2 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.261 0 C-N-CA 123.214 0.606 . . . . 0.0 109.642 177.351 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 18.9 m . . . . . 0 N--CA 1.451 -0.423 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -76.6 55.86 1.08 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.26 0.624 . . . . 0.0 110.063 177.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -82.13 58.42 3.97 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.8 mt -115.22 142.74 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 124.011 0.925 . . . . 0.0 111.155 -174.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.8 mm -91.21 104.29 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 175.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -79.52 81.85 5.73 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 77.3 mt -65.46 163.89 14.96 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -173.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 50.6 p -140.26 161.28 38.05 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 126.453 1.901 . . . . 0.0 106.733 175.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -52.62 -48.16 66.52 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.557 1.143 . . . . 0.0 111.29 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -62.35 -38.07 88.07 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.741 0.416 . . . . 0.0 112.029 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.3 m -78.07 -29.54 49.22 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 122.213 -0.304 . . . . 0.0 110.696 -178.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -42.16 -48.68 4.85 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.069 1.747 . . . . 0.0 113.517 -178.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -51.64 -63.8 1.02 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 121.617 0.722 . . . . 0.0 110.916 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.2 m -68.44 -43.84 76.24 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.171 -175.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -74.76 -48.14 27.19 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -174.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.8 t -95.64 -58.96 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.116 0 C-N-CA 123.269 0.628 . . . . 0.0 111.879 -175.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 80.3 mt -64.07 -39.49 94.18 Favored 'General case' 0 C--N 1.334 -0.085 0 C-N-CA 119.681 -0.808 . . . . 0.0 111.435 -174.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -96.83 30.13 2.78 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 176.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.84 156.11 34.31 Favored 'General case' 0 C--N 1.342 0.255 0 O-C-N 121.887 -0.508 . . . . 0.0 111.082 178.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -131.09 56.37 1.8 Allowed 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 124.808 1.243 . . . . 0.0 108.161 176.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 163.91 -173.66 39.98 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -178.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.64 115.17 25.98 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.47 1.508 . . . . 0.0 110.077 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 mt -114.85 116.67 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 124.561 1.144 . . . . 0.0 109.755 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 19.9 tp -88.26 93.67 9.59 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 176.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.8 t -86.21 103.81 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 123.024 0.53 . . . . 0.0 109.705 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -88.32 107.68 18.95 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 175.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -79.68 126.17 30.58 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 174.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 35.7 p-90 -139.45 169.84 17.01 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.347 1.059 . . . . 0.0 113.286 -174.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.41 136.52 21.07 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.27 1.428 . . . . 0.0 108.517 178.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 50.6 mp0 -49.68 -50.92 41.7 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.874 0.869 . . . . 0.0 112.126 -178.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 62.6 p-90 -64.41 -25.61 68.1 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.294 0.638 . . . . 0.0 112.38 -177.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 51.3 t -79.88 78.84 6.46 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 121.575 -0.703 . . . . 0.0 110.243 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -25.02 -61.07 0.06 OUTLIER Glycine 0 CA--C 1.536 1.389 0 C-N-CA 127.2 2.333 . . . . 0.0 114.936 178.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_exo -42.17 -34.92 3.06 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 124.315 3.343 . . . . 0.0 114.581 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 82.9 m -57.34 -48.67 78.4 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 121.44 0.638 . . . . 0.0 109.919 177.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -65.33 -33.93 77.13 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.32 0.648 . . . . 0.0 109.651 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 24.0 mmt -64.74 -44.52 89.87 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 110.083 -0.339 . . . . 0.0 110.083 177.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 30.7 pt -76.47 -26.13 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-O 118.367 -0.825 . . . . 0.0 112.642 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -38.05 -58.08 1.53 Allowed Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 120.092 1.315 . . . . 0.0 114.328 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -57.7 -37.18 97.6 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.207 1.938 . . . . 0.0 111.771 177.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.9 mt -62.6 -49.42 83.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.8 mt -56.61 -41.11 76.49 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 177.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -61.13 -47.85 84.35 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.586 0.63 . . . . 0.0 109.986 176.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -56.18 -51.87 66.47 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.9 mm -54.66 -49.31 68.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 122.946 0.498 . . . . 0.0 110.071 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.09 -42.48 69.41 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.295 0.638 . . . . 0.0 110.431 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -67.9 -58.81 3.95 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.819 0.342 . . . . 0.0 110.2 177.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -50.75 -46.96 59.56 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.006 1.323 . . . . 0.0 112.602 -178.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -100.29 25.54 7.47 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.541 1.137 . . . . 0.0 111.215 -178.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -54.49 126.97 25.65 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.171 0.896 . . . . 0.0 110.749 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.28 -12.79 24.24 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-O 119.189 -0.784 . . . . 0.0 113.333 -178.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -99.59 -41.83 7.16 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 118.657 1.228 . . . . 0.0 109.363 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.3 tp -130.8 130.56 43.84 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.419 1.087 . . . . 0.0 108.134 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 65.0 m -91.23 102.76 15.48 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 176.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 99.2 t -79.24 140.57 16.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -139.17 147.04 41.32 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 121.859 -0.526 . . . . 0.0 109.834 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.4 mtmt -128.68 99.47 5.36 Favored 'General case' 0 N--CA 1.46 0.065 0 C-N-CA 124.512 1.125 . . . . 0.0 109.087 -178.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.4 tt -97.54 115.08 27.15 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 121.795 -0.565 . . . . 0.0 110.771 -175.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -79.9 109.55 14.44 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.257 -178.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.8 pt -72.4 -25.77 23.52 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -61.43 -47.66 84.75 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 119.448 1.022 . . . . 0.0 108.447 178.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -70.96 -38.71 72.8 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 124.787 1.235 . . . . 0.0 110.003 177.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -118.39 71.83 9.57 Favored Pre-proline 0 N--CA 1.464 0.269 0 C-N-CA 124.16 0.984 . . . . 0.0 111.478 -176.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -60.6 -53.8 2.52 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.167 1.912 . . . . 0.0 112.419 -177.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -36.86 -49.03 1.4 Allowed Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.385 1.469 . . . . 0.0 114.45 -177.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -51.73 -34.61 39.81 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.281 1.032 . . . . 0.0 113.095 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.52 -68.34 0.72 Allowed Pre-proline 0 CA--C 1.538 0.497 0 CA-C-O 118.174 -0.917 . . . . 0.0 112.654 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -60.34 -37.66 80.49 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 121.757 1.638 . . . . 0.0 110.988 177.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -51.44 -38.27 52.84 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 119.065 0.848 . . . . 0.0 111.51 178.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -108.97 19.91 19.03 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 122.857 0.463 . . . . 0.0 112.004 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 51.0 39.7 41.46 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.108 0.861 . . . . 0.0 113.323 177.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.44 129.9 19.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 118.02 0.91 . . . . 0.0 108.563 177.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -87.33 -47.7 8.59 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.342 1.057 . . . . 0.0 108.985 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -169.09 142.26 7.24 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 107.73 -2.148 . . . . 0.0 107.73 178.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.453 HD13 ' H ' ' A' ' 75' ' ' ILE . 0.2 OUTLIER -88.25 151.96 49.56 Favored Pre-proline 0 N--CA 1.454 -0.265 0 CA-C-O 118.514 -0.755 . . . . 0.0 109.907 179.373 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.23 134.85 27.89 Favored 'Cis proline' 0 N--CA 1.456 -0.727 0 CA-C-N 120.102 1.072 . . . . 0.0 111.452 -0.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.48 109.92 14.44 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.1 mt -89.56 94.06 9.72 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.212 1.005 . . . . 0.0 109.858 -178.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.1 mp -92.02 112.88 24.98 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 176.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.4 tp -90.02 94.75 9.92 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -86.33 105.96 17.04 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 125.077 1.351 . . . . 0.0 110.617 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -94.74 108.4 20.4 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 173.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 49.98 52.24 15.05 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.87 0.868 . . . . 0.0 110.756 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 79.44 -16.4 10.32 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 118.918 -0.935 . . . . 0.0 114.33 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -94.21 118.89 32.22 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 119.579 1.69 . . . . 0.0 110.31 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 86.5 t -62.99 106.87 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 175.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.4 -42.44 25.51 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.921 0.888 . . . . 0.0 110.222 -179.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -153.4 154.76 35.1 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 58.1 p -132.83 111.46 11.11 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.139 0.976 . . . . 0.0 108.832 -177.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -103.58 113.19 26.5 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-N 118.718 0.69 . . . . 0.0 109.936 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.0 t -88.58 124.51 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 176.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.91 171.66 32.79 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 121.637 0.576 . . . . 0.0 113.017 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.61 173.16 8.43 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.152 0.981 . . . . 0.0 112.291 -178.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 mt -151.28 160.28 43.89 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 125.856 1.662 . . . . 0.0 108.729 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.1 p -91.43 152.9 20.19 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 171.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -52.58 -47.44 66.87 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.892 -0.505 . . . . 0.0 112.341 -176.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.53 -53.37 41.77 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-N 118.42 0.554 . . . . 0.0 112.16 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -60.15 -43.4 95.78 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 122.285 -0.538 . . . . 0.0 110.34 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 33.0 tp -59.99 -50.44 73.73 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -54.56 -46.1 73.6 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 118.609 0.64 . . . . 0.0 110.747 177.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -57.77 -52.85 63.76 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 178.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -52.24 -50.65 61.6 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.147 0.979 . . . . 0.0 110.324 178.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 87.4 mt -59.33 -50.98 71.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 122.927 0.491 . . . . 0.0 110.383 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -54.94 -50.6 68.46 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 118.054 0.388 . . . . 0.0 110.258 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.68 -38.31 69.49 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.452 0.701 . . . . 0.0 111.603 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -77.99 -44.09 27.69 Favored 'General case' 0 C--O 1.227 -0.099 0 O-C-N 122.243 -0.286 . . . . 0.0 110.72 -178.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 46.3 mt -59.73 -48.14 82.85 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.27 0 C-N-CA 123.116 0.566 . . . . 0.0 109.685 177.323 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.454 -0.231 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.16 -104.66 0.12 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.233 1.013 . . . . 0.0 111.155 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -124.55 24.99 7.72 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.218 1.407 . . . . 0.0 110.726 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.1 mt -79.95 139.06 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 123.311 0.644 . . . . 0.0 109.561 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.9 mm -89.27 111.56 23.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 123.616 0.766 . . . . 0.0 109.5 178.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -81.05 110.96 17.08 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 50.1 mt -92.05 170.02 10.18 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.53 1.132 . . . . 0.0 110.78 -178.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 67.7 p -136.67 159.54 41.53 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 171.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -56.75 -42.3 79.09 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.044 0.449 . . . . 0.0 109.793 177.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -60.34 -46.97 88.04 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.825 1.25 . . . . 0.0 111.338 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 90.0 p -79.27 -26.18 42.41 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -176.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -36.84 -47.37 0.68 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 127.329 2.252 . . . . 0.0 114.233 -179.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -55.89 -47.42 77.44 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.662 0.744 . . . . 0.0 111.321 -178.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.0 m -77.42 -45.56 25.46 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 123.57 0.748 . . . . 0.0 109.925 -177.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -69.05 -53.97 17.58 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -175.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 41.2 t -94.84 -56.68 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 124.147 0.979 . . . . 0.0 111.857 -173.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 77.3 mt -63.78 -39.42 94.22 Favored 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 119.216 -0.994 . . . . 0.0 111.398 -175.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -96.22 32.06 2.05 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.305 0.502 . . . . 0.0 110.137 174.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.43 146.02 49.76 Favored 'General case' 0 C--N 1.343 0.289 0 O-C-N 121.627 -0.671 . . . . 0.0 112.262 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -99.7 23.39 9.65 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.796 1.638 . . . . 0.0 111.961 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 171.27 -157.61 28.38 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.758 -0.537 . . . . 0.0 111.758 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.58 112.12 20.67 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 126.033 1.733 . . . . 0.0 110.601 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 mt -112.36 117.94 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 124.41 1.084 . . . . 0.0 110.048 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.8 tp -90.01 97.37 11.15 Favored 'General case' 0 C--N 1.338 0.089 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 175.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 56.6 t -87.41 107.43 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 123.416 0.687 . . . . 0.0 110.303 -178.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -92.41 108.18 19.77 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.009 0.924 . . . . 0.0 109.269 176.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -80.34 125.72 30.25 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 105.831 -1.915 . . . . 0.0 105.831 174.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 31.0 p-90 -145.43 175.16 10.53 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.073 0.949 . . . . 0.0 112.253 -176.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.95 147.61 16.72 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 125.487 1.515 . . . . 0.0 108.728 175.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -49.84 -51.65 38.44 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.681 1.193 . . . . 0.0 112.3 -178.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -60.39 -29.95 69.27 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -177.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 46.9 t -79.84 77.59 6.48 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 121.659 -0.651 . . . . 0.0 110.589 -178.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -24.45 -62.04 0.05 OUTLIER Glycine 0 CA--C 1.536 1.368 0 C-N-CA 127.089 2.281 . . . . 0.0 115.141 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -42.81 -33.21 2.92 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 124.725 3.617 . . . . 0.0 114.933 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 99.4 m -53.74 -43.32 69.0 Favored 'General case' 0 CA--C 1.529 0.172 0 O-C-N 121.808 -0.557 . . . . 0.0 110.061 176.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -66.96 -26.84 67.02 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.632 0.773 . . . . 0.0 111.173 178.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 22.7 mmt -76.1 -43.93 41.03 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 28.8 pt -74.74 -29.73 23.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.854 177.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -38.48 -59.6 1.26 Allowed Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 113.877 1.065 . . . . 0.0 113.877 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -57.38 -39.89 85.86 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.364 2.042 . . . . 0.0 111.733 178.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 20.1 mt -58.77 -52.35 61.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 177.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 72.3 mt -56.27 -42.75 77.94 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.085 0.554 . . . . 0.0 110.684 178.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -60.36 -48.34 82.19 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.402 0.546 . . . . 0.0 110.203 178.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -57.9 -51.35 69.96 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 23.1 mm -54.73 -45.8 73.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.749 0.82 . . . . 0.0 109.666 178.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.75 -44.74 70.23 Favored 'General case' 0 C--O 1.227 -0.089 0 C-N-CA 123.008 0.523 . . . . 0.0 110.391 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -68.84 -55.78 10.05 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 121.162 -0.215 . . . . 0.0 110.767 177.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -49.09 -48.85 44.01 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.784 0.834 . . . . 0.0 111.968 -178.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -98.26 24.68 6.93 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.067 0.947 . . . . 0.0 111.519 -178.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -55.07 125.86 22.26 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.571 1.078 . . . . 0.0 110.758 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.56 -11.36 32.82 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 119.522 -0.599 . . . . 0.0 113.353 -178.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.6 mttp -99.73 -42.86 6.67 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.933 1.293 . . . . 0.0 108.734 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.3 tp -133.97 131.55 39.11 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.164 1.386 . . . . 0.0 107.687 178.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 89.9 m -91.92 101.99 14.56 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 176.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 72.5 t -79.22 132.83 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 177.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.19 152.42 51.81 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 123.073 0.549 . . . . 0.0 110.17 -177.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.9 mttm -126.52 139.43 53.23 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 tt -130.94 119.96 22.87 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -87.79 99.07 11.83 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.048 0.539 . . . . 0.0 110.504 -175.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 20.7 pt -58.52 -29.3 38.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 O-C-N 121.266 -0.896 . . . . 0.0 113.224 -177.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -61.19 -25.94 67.37 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.048 0.84 . . . . 0.0 111.697 177.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -114.02 -10.95 12.81 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.312 1.045 . . . . 0.0 111.038 178.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -133.94 57.57 25.76 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 124.892 1.277 . . . . 0.0 108.524 -177.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.71 -49.22 4.44 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.166 1.91 . . . . 0.0 112.976 -174.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -40.26 -40.55 1.9 Allowed Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.421 1.486 . . . . 0.0 114.564 -177.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.64 -30.37 67.24 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.971 -0.723 . . . . 0.0 112.636 -178.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.28 -65.1 2.32 Favored Pre-proline 0 CA--C 1.539 0.542 0 O-C-N 121.257 -0.902 . . . . 0.0 112.501 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -59.27 -35.09 97.89 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.09 1.86 . . . . 0.0 111.276 178.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -51.75 -32.41 30.66 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.203 0.91 . . . . 0.0 112.131 177.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -115.08 17.84 16.58 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.097 0.559 . . . . 0.0 111.387 176.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 48.29 41.09 23.31 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.658 1.123 . . . . 0.0 111.887 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 53.2 mt -66.05 138.42 23.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-O 121.344 0.592 . . . . 0.0 110.623 -177.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -79.18 -42.37 26.24 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.211 1.404 . . . . 0.0 111.322 -176.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -171.36 -154.83 10.12 Favored Glycine 0 C--N 1.334 0.417 0 N-CA-C 108.17 -1.972 . . . . 0.0 108.17 -178.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.6 pt -146.13 156.6 50.61 Favored Pre-proline 0 CA--C 1.536 0.422 0 CA-C-N 118.19 0.995 . . . . 0.0 108.495 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -70.45 141.85 69.36 Favored 'Cis proline' 0 N--CA 1.456 -0.681 0 CA-C-N 120.156 1.091 . . . . 0.0 109.95 -1.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.4 m -139.06 122.33 17.04 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 mt -103.83 120.15 40.39 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.932 1.293 . . . . 0.0 109.318 -176.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.9 mp -110.5 121.89 46.39 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 175.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 tp -94.64 95.52 8.82 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -88.68 103.99 16.46 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.429 1.492 . . . . 0.0 110.713 -178.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -91.74 106.55 18.56 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 173.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 35.0 m120 49.29 51.19 16.77 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.664 0.786 . . . . 0.0 111.029 -178.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 79.81 -15.45 14.9 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-O 118.839 -0.978 . . . . 0.0 114.369 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -92.62 120.17 32.79 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.503 1.651 . . . . 0.0 109.668 179.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 88.5 t -64.45 106.75 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 175.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.97 -39.28 34.8 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.479 0.712 . . . . 0.0 109.356 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -159.83 171.37 19.59 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.6 m -150.32 149.41 30.07 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -178.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.5 mmtm -135.09 131.25 36.71 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 126.047 1.739 . . . . 0.0 107.648 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.2 t -113.33 125.12 70.54 Favored 'Isoleucine or valine' 0 C--O 1.231 0.1 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 178.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.13 179.06 33.0 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -177.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.6 170.99 15.09 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.065 0.546 . . . . 0.0 111.202 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.2 mt -143.55 154.61 43.78 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 125.138 1.375 . . . . 0.0 108.698 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.9 p -84.47 148.86 26.32 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 170.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -49.47 -47.84 48.15 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 122.143 -0.348 . . . . 0.0 111.728 -177.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.21 -53.09 42.87 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 111.889 -0.484 . . . . 0.0 111.889 179.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -61.37 -42.16 98.26 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.132 -0.628 . . . . 0.0 110.844 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 33.8 tp -60.15 -51.64 68.73 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 177.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -56.49 -44.34 80.55 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.638 -0.664 . . . . 0.0 111.169 177.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -55.87 -54.29 46.37 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.604 0.762 . . . . 0.0 109.685 177.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -53.28 -52.05 60.3 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.947 1.299 . . . . 0.0 110.444 178.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.0 mt -58.7 -50.61 73.26 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 122.647 0.379 . . . . 0.0 110.574 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -55.09 -50.53 68.94 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 178.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.84 -37.95 69.4 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.322 0.649 . . . . 0.0 111.784 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -77.97 -43.22 30.34 Favored 'General case' 0 C--N 1.339 0.125 0 O-C-N 122.129 -0.357 . . . . 0.0 110.708 -178.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 49.1 mt -61.42 -47.21 86.81 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.293 0 C-N-CA 123.094 0.557 . . . . 0.0 109.686 177.441 . . . . . . . . 0 0 . 1 stop_ save_